Citrus Sinensis ID: 017558
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 369 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LV48 | 652 | Proline-rich receptor-lik | yes | no | 0.514 | 0.291 | 0.794 | 7e-88 | |
| Q8GX23 | 670 | Proline-rich receptor-lik | no | no | 0.943 | 0.519 | 0.522 | 5e-87 | |
| Q9LK03 | 717 | Proline-rich receptor-lik | no | no | 0.791 | 0.407 | 0.572 | 8e-87 | |
| Q9C821 | 509 | Proline-rich receptor-lik | no | no | 0.490 | 0.355 | 0.784 | 3e-86 | |
| Q9ZNQ8 | 633 | Proline-rich receptor-lik | no | no | 0.772 | 0.450 | 0.537 | 3e-83 | |
| Q9XI96 | 699 | Proline-rich receptor-lik | no | no | 0.512 | 0.270 | 0.773 | 9e-83 | |
| Q9LS95 | 700 | Putative proline-rich rec | no | no | 0.501 | 0.264 | 0.762 | 3e-82 | |
| Q9CAL8 | 710 | Proline-rich receptor-lik | no | no | 0.859 | 0.446 | 0.479 | 2e-81 | |
| Q1PEM5 | 513 | Proline-rich receptor-lik | no | no | 0.528 | 0.380 | 0.717 | 3e-81 | |
| Q9ZUE0 | 720 | Proline-rich receptor-lik | no | no | 0.758 | 0.388 | 0.498 | 6e-77 |
| >sp|Q9LV48|PERK1_ARATH Proline-rich receptor-like protein kinase PERK1 OS=Arabidopsis thaliana GN=PERK1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 324 bits (830), Expect = 7e-88, Method: Compositional matrix adjust.
Identities = 151/190 (79%), Positives = 168/190 (88%)
Query: 180 SPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSG 239
SPG+ +G KSTFTYEEL AT+ FSEANLLGQGGFGYVHKG+L +GK VA+KQLKAGSG
Sbjct: 256 SPGLVLGFSKSTFTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGSG 315
Query: 240 QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNW 299
QGEREFQAE+EIIS+VHHRHLVSL+GYC G QRLLVYEFVPN LEFHLHGK RP M W
Sbjct: 316 QGEREFQAEVEIISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHGKGRPTMEW 375
Query: 300 PTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 359
TR+KIALGSA+GL+YLHEDC PKIIHRDIK++NIL+D FEAKVADFGLAK + DT+TH
Sbjct: 376 STRLKIALGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTH 435
Query: 360 VSTRVMGTFG 369
VSTRVMGTFG
Sbjct: 436 VSTRVMGTFG 445
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q8GX23|PERK5_ARATH Proline-rich receptor-like protein kinase PERK5 OS=Arabidopsis thaliana GN=PERK5 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 321 bits (823), Expect = 5e-87, Method: Compositional matrix adjust.
Identities = 201/385 (52%), Positives = 243/385 (63%), Gaps = 37/385 (9%)
Query: 11 PAPPETNSTFSPPAP-PPSVSA---------VSAPAPGNLTSPPSSGTPTSGS------- 53
PAPP+T S SP P PPS A + G+ SPPSSG TSG
Sbjct: 104 PAPPQTPSNQSPERPTPPSPGANDDRNRTNGGNNNRDGSTPSPPSSGNRTSGDGGSPSPP 163
Query: 54 ---TVGTRRPSPTRNGYLPPGALAGMVVGVVIGAGIVLAAVGIFLIFYKRRKRKLAAQNL 110
+ + P A G+++GV++GAG++L I R+K+K + Q
Sbjct: 164 RSISPPQNSGDSDSSSGNHPQANIGLIIGVLVGAGLLLLLAVCICICCNRKKKKKSPQVN 223
Query: 111 PL---KNDPFAGKPHHWQQNVSAPSDYQELPKPSLP--PSNGPTAPLPTVPVSAFNEPLS 165
+ N+P+ G P Y+ P+ + G P PVS P S
Sbjct: 224 HMHYYNNNPYGGAP------SGNGGYYKGTPQDHVVNMAGQGGGNWGPQQPVSG---PHS 274
Query: 166 TSGSLDSDKPFPRQSP-GMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLT 224
+ +L P SP +G+ +STFTY+EL IAT+ F+++NLLGQGGFGYVHKGVL
Sbjct: 275 DASNLTGRTAIP--SPQAATLGHNQSTFTYDELSIATEGFAQSNLLGQGGFGYVHKGVLP 332
Query: 225 NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKT 284
+GK VA+K LK GSGQGEREFQAE++IIS+VHHRHLVSLVGYC G QRLLVYEF+PN T
Sbjct: 333 SGKEVAVKSLKLGSGQGEREFQAEVDIISRVHHRHLVSLVGYCISGGQRLLVYEFIPNNT 392
Query: 285 LEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKV 344
LEFHLHGK RPV++WPTR+KIALGSARGLAYLHEDC P+IIHRDIK+ANILLD SFE KV
Sbjct: 393 LEFHLHGKGRPVLDWPTRVKIALGSARGLAYLHEDCHPRIIHRDIKAANILLDFSFETKV 452
Query: 345 ADFGLAKHSLDTDTHVSTRVMGTFG 369
ADFGLAK S D THVSTRVMGTFG
Sbjct: 453 ADFGLAKLSQDNYTHVSTRVMGTFG 477
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LK03|PERK2_ARATH Proline-rich receptor-like protein kinase PERK2 OS=Arabidopsis thaliana GN=PERK2 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 320 bits (821), Expect = 8e-87, Method: Compositional matrix adjust.
Identities = 170/297 (57%), Positives = 206/297 (69%), Gaps = 5/297 (1%)
Query: 75 GMVVGVVIGAGIVL--AAVGIFLIFYKRRKRKLAAQNLPLKNDPFAGKPHHWQQNVSAPS 132
G +VG+ IG G VL A IF + K+R+R A P+ P+ G+ QQN S S
Sbjct: 226 GAMVGIAIGGGFVLLVALALIFFLCKKKRRRDNEAPPAPIDGVPYGGQQ---QQNASRRS 282
Query: 133 DYQELPKPSLPPSNGPTAPLPTVPVSAFNEPLSTSGSLDSDKPFPRQSPGMPVGNFKSTF 192
D+ + P + P S + ++ S S P P + +G ++ TF
Sbjct: 283 DHVVMSVPPPKSPSSAPPRPPHFMSSGSSGDYDSNYSDQSVLPPPSPGLALGLGIYQGTF 342
Query: 193 TYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEII 252
YEEL AT+ FSEANLLGQGGFGYV KG+L NGK VA+KQLK GS QGEREFQAE+ II
Sbjct: 343 NYEELSRATNGFSEANLLGQGGFGYVFKGMLRNGKEVAVKQLKEGSSQGEREFQAEVGII 402
Query: 253 SQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARG 312
S+VHHRHLV+LVGYC +QRLLVYEFVPN TLEFHLHGK RP M W +R+KIA+GSA+G
Sbjct: 403 SRVHHRHLVALVGYCIADAQRLLVYEFVPNNTLEFHLHGKGRPTMEWSSRLKIAVGSAKG 462
Query: 313 LAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFG 369
L+YLHE+C PKIIHRDIK++NIL+D FEAKVADFGLAK + DT+THVSTRVMGTFG
Sbjct: 463 LSYLHENCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVSTRVMGTFG 519
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9C821|PEK15_ARATH Proline-rich receptor-like protein kinase PERK15 OS=Arabidopsis thaliana GN=PERK15 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 318 bits (816), Expect = 3e-86, Method: Compositional matrix adjust.
Identities = 142/181 (78%), Positives = 163/181 (90%)
Query: 189 KSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAE 248
++ FTYE+L AT NFS NLLGQGGFGYVH+GVL +G +VAIKQLK+GSGQGEREFQAE
Sbjct: 128 QNLFTYEDLSKATSNFSNTNLLGQGGFGYVHRGVLVDGTLVAIKQLKSGSGQGEREFQAE 187
Query: 249 IEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALG 308
I+ IS+VHHRHLVSL+GYC G+QRLLVYEFVPNKTLEFHLH K+RPVM W RMKIALG
Sbjct: 188 IQTISRVHHRHLVSLLGYCITGAQRLLVYEFVPNKTLEFHLHEKERPVMEWSKRMKIALG 247
Query: 309 SARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF 368
+A+GLAYLHEDC PK IHRD+K+ANIL+DDS+EAK+ADFGLA+ SLDTDTHVSTR+MGTF
Sbjct: 248 AAKGLAYLHEDCNPKTIHRDVKAANILIDDSYEAKLADFGLARSSLDTDTHVSTRIMGTF 307
Query: 369 G 369
G
Sbjct: 308 G 308
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZNQ8|PERK4_ARATH Proline-rich receptor-like protein kinase PERK4 OS=Arabidopsis thaliana GN=PERK4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 308 bits (790), Expect = 3e-83, Method: Compositional matrix adjust.
Identities = 165/307 (53%), Positives = 211/307 (68%), Gaps = 22/307 (7%)
Query: 76 MVVGVVIGAGIVLAAVGIFLIFYKRRKRKLAAQNLPLKNDPFAGKPH-----------HW 124
++VGV++GAG+++ + I + +++KRK + P+K + + + +W
Sbjct: 152 IIVGVLVGAGLLMIVL-IIVCLRRKKKRKDSFYPEPMKGNQYQYYGNNNNNNASQNYPNW 210
Query: 125 QQNVSAPSDYQELPKPSLPPSNGPTAPLPTV--PVSAFNEPLSTSGSLDSDKPFPRQSPG 182
N + PS P +PT S ++ P S P SP
Sbjct: 211 HLNSQGQNQQSTGGWGGGGPSPPPPPRMPTSGEDSSMYSGP--------SRPVLPPPSPA 262
Query: 183 MPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGE 242
+ +G KSTFTY+EL AT F++ANLLGQGGFGYVHKGVL +GK VA+K LKAGSGQGE
Sbjct: 263 LALGFNKSTFTYQELAAATGGFTDANLLGQGGFGYVHKGVLPSGKEVAVKSLKAGSGQGE 322
Query: 243 REFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTR 302
REFQAE++IIS+VHHR+LVSLVGYC QR+LVYEFVPNKTLE+HLHGK+ PVM + TR
Sbjct: 323 REFQAEVDIISRVHHRYLVSLVGYCIADGQRMLVYEFVPNKTLEYHLHGKNLPVMEFSTR 382
Query: 303 MKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 362
++IALG+A+GLAYLHEDC P+IIHRDIKSANILLD +F+A VADFGLAK + D +THVST
Sbjct: 383 LRIALGAAKGLAYLHEDCHPRIIHRDIKSANILLDFNFDAMVADFGLAKLTSDNNTHVST 442
Query: 363 RVMGTFG 369
RVMGTFG
Sbjct: 443 RVMGTFG 449
|
Required during abscisic acid (ABA)-mediated activation of Ca(2+) channels. Regulates ABA signaling pathways. Modulates the expression of genes related to cell elongation and ABA signaling during root growth. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9XI96|PERK7_ARATH Proline-rich receptor-like protein kinase PERK7 OS=Arabidopsis thaliana GN=PERK7 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 307 bits (786), Expect = 9e-83, Method: Compositional matrix adjust.
Identities = 147/190 (77%), Positives = 164/190 (86%), Gaps = 1/190 (0%)
Query: 181 PGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQ 240
P + +G STFTYEEL AT FS+ LLGQGGFGYVHKG+L NGK +A+K LKAGSGQ
Sbjct: 313 PSVALGFNNSTFTYEELASATQGFSKDRLLGQGGFGYVHKGILPNGKEIAVKSLKAGSGQ 372
Query: 241 GEREFQAEIEIISQVHHRHLVSLVGYCT-FGSQRLLVYEFVPNKTLEFHLHGKDRPVMNW 299
GEREFQAE+EIIS+VHHRHLVSLVGYC+ G QRLLVYEF+PN TLEFHLHGK VM+W
Sbjct: 373 GEREFQAEVEIISRVHHRHLVSLVGYCSNAGGQRLLVYEFLPNDTLEFHLHGKSGTVMDW 432
Query: 300 PTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 359
PTR+KIALGSA+GLAYLHEDC PKIIHRDIK++NILLD +FEAKVADFGLAK S D +TH
Sbjct: 433 PTRLKIALGSAKGLAYLHEDCHPKIIHRDIKASNILLDHNFEAKVADFGLAKLSQDNNTH 492
Query: 360 VSTRVMGTFG 369
VSTRVMGTFG
Sbjct: 493 VSTRVMGTFG 502
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LS95|PERK6_ARATH Putative proline-rich receptor-like protein kinase PERK6 OS=Arabidopsis thaliana GN=PERK6 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 305 bits (782), Expect = 3e-82, Method: Compositional matrix adjust.
Identities = 141/185 (76%), Positives = 162/185 (87%)
Query: 185 VGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGERE 244
+G KSTFTY+EL AT FS++ LLGQGGFGYVHKG+L NGK +A+K LKAGSGQGERE
Sbjct: 318 LGFNKSTFTYDELAAATQGFSQSRLLGQGGFGYVHKGILPNGKEIAVKSLKAGSGQGERE 377
Query: 245 FQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMK 304
FQAE++IIS+VHHR LVSLVGYC G QR+LVYEF+PN TLEFHLHGK V++WPTR+K
Sbjct: 378 FQAEVDIISRVHHRFLVSLVGYCIAGGQRMLVYEFLPNDTLEFHLHGKSGKVLDWPTRLK 437
Query: 305 IALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRV 364
IALGSA+GLAYLHEDC P+IIHRDIK++NILLD+SFEAKVADFGLAK S D THVSTR+
Sbjct: 438 IALGSAKGLAYLHEDCHPRIIHRDIKASNILLDESFEAKVADFGLAKLSQDNVTHVSTRI 497
Query: 365 MGTFG 369
MGTFG
Sbjct: 498 MGTFG 502
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9CAL8|PEK13_ARATH Proline-rich receptor-like protein kinase PERK13 OS=Arabidopsis thaliana GN=PERK13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 303 bits (775), Expect = 2e-81, Method: Compositional matrix adjust.
Identities = 172/359 (47%), Positives = 220/359 (61%), Gaps = 42/359 (11%)
Query: 21 SPPAPPPSVSAVSAPAPGNLTSPPSSGTPTSGSTVGTRRPSPTRNGYLPPGALAGMVVGV 80
S A PP +A P LTSP S G P+SG++V P P +G G + G
Sbjct: 192 SSHALPPKSTAAGGP----LTSP-SRGVPSSGNSV----PPPANSG---GGYQGKTMAGF 239
Query: 81 VIGAGIVLAAVGIFLIFYKRRKRKLAA---------QNLPLKNDPFAGKPHHWQQNVSAP 131
I V+A + + + +++KR + A N +K+D F
Sbjct: 240 AIAGFAVIALMAVVFLVRRKKKRNIDAYSDSQYLPPSNFSIKSDGFL------------- 286
Query: 132 SDYQELPKPSLPPSNGPTAPLPTVPVSAFNEPLSTSGSLDSDKPFPRQSPGMPV-GNFKS 190
Y + P G + + ++F G S +P V G+ ++
Sbjct: 287 --YGQNPTKGYSGPGGYNSQQQSNSGNSFGSQRGGGGYTRSG-----SAPDSAVMGSGQT 339
Query: 191 TFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIE 250
FTYEEL T+ FS+ N+LG+GGFG V+KG L +GK+VA+KQLK GSGQG+REF+AE+E
Sbjct: 340 HFTYEELTDITEGFSKHNILGEGGFGCVYKGKLNDGKLVAVKQLKVGSGQGDREFKAEVE 399
Query: 251 IISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSA 310
IIS+VHHRHLVSLVGYC S+RLL+YE+VPN+TLE HLHGK RPV+ W R++IA+GSA
Sbjct: 400 IISRVHHRHLVSLVGYCIADSERLLIYEYVPNQTLEHHLHGKGRPVLEWARRVRIAIGSA 459
Query: 311 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFG 369
+GLAYLHEDC PKIIHRDIKSANILLDD FEA+VADFGLAK + T THVSTRVMGTFG
Sbjct: 460 KGLAYLHEDCHPKIIHRDIKSANILLDDEFEAQVADFGLAKLNDSTQTHVSTRVMGTFG 518
|
Regulates negatively root hairs elongation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q1PEM5|PERK3_ARATH Proline-rich receptor-like protein kinase PERK3 OS=Arabidopsis thaliana GN=PERK3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 302 bits (773), Expect = 3e-81, Method: Compositional matrix adjust.
Identities = 142/198 (71%), Positives = 167/198 (84%), Gaps = 3/198 (1%)
Query: 173 DKPFPRQSP-GMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAI 231
DK P +P G+ +G +STFTY EL AT+ FSEANLLG+GGFG+V+KG+L NG VA+
Sbjct: 153 DKALP--APIGLVLGIHQSTFTYGELARATNKFSEANLLGEGGFGFVYKGILNNGNEVAV 210
Query: 232 KQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHG 291
KQLK GS QGE+EFQAE+ IISQ+HHR+LVSLVGYC G+QRLLVYEFVPN TLEFHLHG
Sbjct: 211 KQLKVGSAQGEKEFQAEVNIISQIHHRNLVSLVGYCIAGAQRLLVYEFVPNNTLEFHLHG 270
Query: 292 KDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351
K RP M W R+KIA+ S++GL+YLHE+C PKIIHRDIK+ANIL+D FEAKVADFGLAK
Sbjct: 271 KGRPTMEWSLRLKIAVSSSKGLSYLHENCNPKIIHRDIKAANILIDFKFEAKVADFGLAK 330
Query: 352 HSLDTDTHVSTRVMGTFG 369
+LDT+THVSTRVMGTFG
Sbjct: 331 IALDTNTHVSTRVMGTFG 348
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUE0|PEK12_ARATH Proline-rich receptor-like protein kinase PERK12 OS=Arabidopsis thaliana GN=PERK12 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 288 bits (736), Expect = 6e-77, Method: Compositional matrix adjust.
Identities = 151/303 (49%), Positives = 199/303 (65%), Gaps = 23/303 (7%)
Query: 77 VVGVVIGAGIVLAAVGIFLIFYKRRKRKLAAQNLPLKNDPFAGKPHHWQQ----NVSAPS 132
+VG+ + ++A +G+ + +++KR + + N H Q N S S
Sbjct: 247 MVGMAVAGFAIMALIGVVFLVRRKKKRNIDSYN-------------HSQYLPHPNFSVKS 293
Query: 133 D-YQELPKPSLPPSNGPTAPLPTVPVSAFNEPLSTSGSLDSDKPFPR-QSPGMP----VG 186
D + P S+GP + + ++ G+ P + QS G P +G
Sbjct: 294 DGFLYGQDPGKGYSSGPNGSMYNNSQQQQSSMGNSYGTAGGGYPHHQMQSSGTPDSAILG 353
Query: 187 NFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQ 246
+ ++ F+YEEL T F+ N+LG+GGFG V+KG L +GKVVA+KQLKAGSGQG+REF+
Sbjct: 354 SGQTHFSYEELAEITQGFARKNILGEGGFGCVYKGTLQDGKVVAVKQLKAGSGQGDREFK 413
Query: 247 AEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIA 306
AE+EIIS+VHHRHLVSLVGYC RLL+YE+V N+TLE HLHGK PV+ W R++IA
Sbjct: 414 AEVEIISRVHHRHLVSLVGYCISDQHRLLIYEYVSNQTLEHHLHGKGLPVLEWSKRVRIA 473
Query: 307 LGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMG 366
+GSA+GLAYLHEDC PKIIHRDIKSANILLDD +EA+VADFGLA+ + T THVSTRVMG
Sbjct: 474 IGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEYEAQVADFGLARLNDTTQTHVSTRVMG 533
Query: 367 TFG 369
TFG
Sbjct: 534 TFG 536
|
Regulates the auxin-related MAX (More Axillary Growth) pathway during the shoot branching. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 369 | ||||||
| 225442587 | 551 | PREDICTED: proline-rich receptor-like pr | 0.810 | 0.542 | 0.620 | 3e-99 | |
| 147828268 | 603 | hypothetical protein VITISV_010509 [Viti | 0.810 | 0.495 | 0.620 | 7e-99 | |
| 121308607 | 665 | PERK1-like protein kinase [Nicotiana tab | 0.810 | 0.449 | 0.6 | 8e-97 | |
| 359484580 | 650 | PREDICTED: proline-rich receptor-like pr | 0.799 | 0.453 | 0.613 | 1e-96 | |
| 356521887 | 570 | PREDICTED: proline-rich receptor-like pr | 0.956 | 0.619 | 0.535 | 2e-94 | |
| 224059084 | 410 | predicted protein [Populus trichocarpa] | 0.542 | 0.487 | 0.8 | 1e-92 | |
| 224073929 | 400 | predicted protein [Populus trichocarpa] | 0.542 | 0.5 | 0.775 | 7e-91 | |
| 356520519 | 671 | PREDICTED: proline-rich receptor-like pr | 0.764 | 0.420 | 0.632 | 5e-90 | |
| 351725713 | 443 | putative receptor protein kinase PERK1 [ | 0.514 | 0.428 | 0.826 | 7e-90 | |
| 357134253 | 652 | PREDICTED: proline-rich receptor-like pr | 0.810 | 0.458 | 0.576 | 1e-89 |
| >gi|225442587|ref|XP_002279197.1| PREDICTED: proline-rich receptor-like protein kinase PERK1 [Vitis vinifera] gi|297743250|emb|CBI36117.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 367 bits (943), Expect = 3e-99, Method: Compositional matrix adjust.
Identities = 190/306 (62%), Positives = 223/306 (72%), Gaps = 7/306 (2%)
Query: 68 LPPGALAGMVVGVVIGAGIVLAAVGIFLIFYKRRKRK--LAAQNLPLKNDPFAGKPHHWQ 125
L L ++VG+VIG VL VG+ +IF +++KR+ N+ D + HWQ
Sbjct: 47 LTTATLITLIVGIVIGGLFVLIGVGVLVIFCRQKKRREQYGLTNVSGSKDDPSAPLQHWQ 106
Query: 126 QNVSAPSDYQE--LPKPSLPPSNGPTAPLPTVPVSAFNEPLSTSGSLDSDKPFPRQSPGM 183
QN P++ + LPK + S G L V + A P+ G L ++KP SPG+
Sbjct: 107 QNAHQPTNNTDPMLPKHAPLLSIGSKPQLSPVHIPASPPPM---GILGTEKPLAPPSPGI 163
Query: 184 PVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGER 243
+G KS FTYEEL IATD FS NLLGQGGFGYVHKGVL NG+ VAIK LKAGSGQGER
Sbjct: 164 SLGFSKSAFTYEELAIATDGFSNINLLGQGGFGYVHKGVLPNGREVAIKHLKAGSGQGER 223
Query: 244 EFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRM 303
EFQAE+EIIS+VHH+HLVSLVGYCT G+QR+LVYEFVPN TL+ HLHG RP MNW TR+
Sbjct: 224 EFQAEVEIISRVHHKHLVSLVGYCTTGAQRMLVYEFVPNGTLQHHLHGTGRPTMNWATRI 283
Query: 304 KIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTR 363
KIALGSA+GLAYLHEDC PKIIHRDIK+ANILLD +FEAKVADFGLAK + DTDTHVSTR
Sbjct: 284 KIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDHNFEAKVADFGLAKFASDTDTHVSTR 343
Query: 364 VMGTFG 369
VMGTFG
Sbjct: 344 VMGTFG 349
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147828268|emb|CAN75405.1| hypothetical protein VITISV_010509 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 367 bits (941), Expect = 7e-99, Method: Compositional matrix adjust.
Identities = 190/306 (62%), Positives = 223/306 (72%), Gaps = 7/306 (2%)
Query: 68 LPPGALAGMVVGVVIGAGIVLAAVGIFLIFYKRRKRK--LAAQNLPLKNDPFAGKPHHWQ 125
L L ++VG+VIG VL VG+ +IF +++KR+ N+ D + HWQ
Sbjct: 99 LTTATLITLIVGIVIGGLFVLIGVGVLVIFCRQKKRREQYGLTNVSGSKDDPSAPLQHWQ 158
Query: 126 QNVSAPSDYQE--LPKPSLPPSNGPTAPLPTVPVSAFNEPLSTSGSLDSDKPFPRQSPGM 183
QN P++ + LPK + S G L V + A P+ G L ++KP SPG+
Sbjct: 159 QNAHQPTNNTDPMLPKHAPLLSIGSKPQLSPVHIPASPPPM---GILGTEKPLAPPSPGI 215
Query: 184 PVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGER 243
+G KS FTYEEL IATD FS NLLGQGGFGYVHKGVL NG+ VAIK LKAGSGQGER
Sbjct: 216 SLGFSKSAFTYEELAIATDGFSNINLLGQGGFGYVHKGVLPNGREVAIKHLKAGSGQGER 275
Query: 244 EFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRM 303
EFQAE+EIIS+VHH+HLVSLVGYCT G+QR+LVYEFVPN TL+ HLHG RP MNW TR+
Sbjct: 276 EFQAEVEIISRVHHKHLVSLVGYCTTGAQRMLVYEFVPNGTLQHHLHGTGRPTMNWATRI 335
Query: 304 KIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTR 363
KIALGSA+GLAYLHEDC PKIIHRDIK+ANILLD +FEAKVADFGLAK + DTDTHVSTR
Sbjct: 336 KIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDHNFEAKVADFGLAKFASDTDTHVSTR 395
Query: 364 VMGTFG 369
VMGTFG
Sbjct: 396 VMGTFG 401
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|121308607|dbj|BAF43699.1| PERK1-like protein kinase [Nicotiana tabacum] | Back alignment and taxonomy information |
|---|
Score = 360 bits (923), Expect = 8e-97, Method: Compositional matrix adjust.
Identities = 192/320 (60%), Positives = 223/320 (69%), Gaps = 21/320 (6%)
Query: 71 GALAGMVVGVVIGAGIVLAAVGIFLIFYKRRKRKLA---------AQNLPL--KNDPFAG 119
G G+VVG+ IG ++LA + + I RRK++ AQ P+ K DP+
Sbjct: 135 GVSTGLVVGIAIGGVLILAVLSLLFICCSRRKKRRNHGPVEYYPPAQPPPMGYKADPYGD 194
Query: 120 KPHHWQQNVSAPSDY---------QELPKPSLPPSNGPTAP-LPTVPVSAFNEPLSTSGS 169
HHWQ N +P+D+ S PP + TA L P + S +
Sbjct: 195 PVHHWQHNAPSPADHVVSIPPKPSPPPAGASRPPHSPVTASSLQPPPPPPYMSSSGASSN 254
Query: 170 LDSDKPFPRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVV 229
P P SPGM +G KSTFTYEEL ATD FS ANLLGQGGFGYVH+GVL NGK V
Sbjct: 255 YSGFDPLPPPSPGMVLGFSKSTFTYEELVRATDGFSNANLLGQGGFGYVHRGVLPNGKEV 314
Query: 230 AIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHL 289
A+KQLKAGSGQGEREFQAE+EIIS+VHH+HLVSLVGYC GSQRLLVYEFVPN TLEFHL
Sbjct: 315 AVKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYCITGSQRLLVYEFVPNNTLEFHL 374
Query: 290 HGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGL 349
HGK RP ++WP R+KIALGSA+GLAYLHEDCQPKIIHRDIK+ANIL+D +FEAKVADFGL
Sbjct: 375 HGKGRPPLDWPIRLKIALGSAKGLAYLHEDCQPKIIHRDIKAANILVDFNFEAKVADFGL 434
Query: 350 AKHSLDTDTHVSTRVMGTFG 369
AK + D +THVSTRVMGTFG
Sbjct: 435 AKLTSDVNTHVSTRVMGTFG 454
|
Source: Nicotiana tabacum Species: Nicotiana tabacum Genus: Nicotiana Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359484580|ref|XP_002284430.2| PREDICTED: proline-rich receptor-like protein kinase PERK1-like isoform 2 [Vitis vinifera] gi|297738823|emb|CBI28068.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 359 bits (921), Expect = 1e-96, Method: Compositional matrix adjust.
Identities = 192/313 (61%), Positives = 221/313 (70%), Gaps = 18/313 (5%)
Query: 75 GMVVGVVIGAGIVLAAVGIFLIFYKRRKRKLAAQNLPL------KNDPFAGKPHHWQQNV 128
G+VVG+ IG ++L + + I K++KR+ Q+ + KNDP+ G P WQ NV
Sbjct: 131 GLVVGIAIGGVVILVVLSLLFICCKKKKRRDHRQDYYVPPPPGPKNDPYGGPPQQWQHNV 190
Query: 129 SAPSDY--QELPKPSLPPSNGPTAPLPTVPVS----------AFNEPLSTSGSLDSDKPF 176
P+D+ PKPS PP P V V + S S SD P
Sbjct: 191 PPPADHAVTVFPKPSPPPGTASRPPHSPVQVPTPPPPPQPPFVSSSGGSGSNYSGSDNPL 250
Query: 177 PRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKA 236
P SP + +G KSTFTYEEL +ATD FS ANLLGQGGFGYVH+GVL NGK VA+KQLKA
Sbjct: 251 PPPSPSIALGFSKSTFTYEELVMATDGFSNANLLGQGGFGYVHRGVLPNGKEVAVKQLKA 310
Query: 237 GSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPV 296
GSGQGEREFQAE+EIIS+VHH+HLV+L GYC GS RLLVYEFVPN TLEFHLHGK RP
Sbjct: 311 GSGQGEREFQAEVEIISRVHHKHLVTLAGYCITGSHRLLVYEFVPNNTLEFHLHGKGRPT 370
Query: 297 MNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356
M+W TR+KIALGSA+GLAYLHEDC PKIIHRDIK+ANILLD FEAKVADFGLAK S D
Sbjct: 371 MDWSTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKFSSDA 430
Query: 357 DTHVSTRVMGTFG 369
+THVSTRVMGTFG
Sbjct: 431 NTHVSTRVMGTFG 443
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356521887|ref|XP_003529582.1| PREDICTED: proline-rich receptor-like protein kinase PERK1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 352 bits (902), Expect = 2e-94, Method: Compositional matrix adjust.
Identities = 198/370 (53%), Positives = 247/370 (66%), Gaps = 17/370 (4%)
Query: 10 LPAPPETNS-TFSPPA---PPPSVSAVSAPAPGNLTSPPSSGTPTSGSTVGTRRPSPTRN 65
+ AP E S T SPP+ P P+ +A+S P P + + T + P+ T N
Sbjct: 1 MSAPAEAPSFTASPPSETTPSPNSTALSPPPPSTINA-----TVSPPPPEAASPPTSTVN 55
Query: 66 GYLPPGALAGMVVGVVIGAGIVLAAVGIFLIFYKRRKRKLAAQNLPL-KNDPFAGKPHHW 124
L G ++G+V+G V+G+ +L GIF FY+ KRK P K D G +W
Sbjct: 56 SGLSTGTVSGIVIGAVLGSVGMLIIGGIFFCFYRNWKRKKNHSQPPQPKADIAGGTLQNW 115
Query: 125 QQNVSAPSDYQELPKPSLPP-----SNGPTAPLPTVPVSAFNEPLSTSGSLDSDKPFPRQ 179
Q +V +D + P PP +A L T+ V++ S+S + K +
Sbjct: 116 QDSVPPTTDGKVGFSPKPPPGGLVNQQQSSAALLTLVVNS--SNTSSSLGSEKAKSYISP 173
Query: 180 SPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSG 239
SPG + +STFTY+EL +ATD FS +NLLGQGGFGYVHKGVL NGK+VA+KQLK+ S
Sbjct: 174 SPGTSLALSQSTFTYDELSMATDGFSRSNLLGQGGFGYVHKGVLPNGKIVAVKQLKSESR 233
Query: 240 QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNW 299
QGEREF AE+++IS+VHHRHLVSLVGYC SQ++LVYE+V N TLEFHLHGKDR M+W
Sbjct: 234 QGEREFHAEVDVISRVHHRHLVSLVGYCVSDSQKMLVYEYVENDTLEFHLHGKDRLPMDW 293
Query: 300 PTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 359
TRMKIA+GSA+GLAYLHEDC PKIIHRDIK++NILLD+SFEAKVADFGLAK S DTDTH
Sbjct: 294 STRMKIAIGSAKGLAYLHEDCNPKIIHRDIKASNILLDESFEAKVADFGLAKFSSDTDTH 353
Query: 360 VSTRVMGTFG 369
VSTRVMGTFG
Sbjct: 354 VSTRVMGTFG 363
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224059084|ref|XP_002299708.1| predicted protein [Populus trichocarpa] gi|222846966|gb|EEE84513.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 346 bits (887), Expect = 1e-92, Method: Compositional matrix adjust.
Identities = 160/200 (80%), Positives = 179/200 (89%)
Query: 170 LDSDKPFPRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVV 229
+ SDK FP +PG+ +G +STFTYEEL +ATDNFSEANLLGQGGFGYVHKG+L NG VV
Sbjct: 1 MGSDKQFPPPTPGIALGYSQSTFTYEELAMATDNFSEANLLGQGGFGYVHKGILANGTVV 60
Query: 230 AIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHL 289
AIKQLK+GSGQGEREF+AEIEIIS+VHHRHLVSL GYC G+QR+LVYEFVPN TLEFHL
Sbjct: 61 AIKQLKSGSGQGEREFRAEIEIISRVHHRHLVSLFGYCIAGAQRMLVYEFVPNYTLEFHL 120
Query: 290 HGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGL 349
H RP MNW T MKIA+G+A+GLAYLHEDCQPKIIHRDIK++NIL+D SFEAKVADFGL
Sbjct: 121 HENGRPTMNWSTTMKIAVGAAKGLAYLHEDCQPKIIHRDIKASNILIDHSFEAKVADFGL 180
Query: 350 AKHSLDTDTHVSTRVMGTFG 369
AKHSLDT+THVSTRVMGTFG
Sbjct: 181 AKHSLDTETHVSTRVMGTFG 200
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224073929|ref|XP_002304200.1| predicted protein [Populus trichocarpa] gi|222841632|gb|EEE79179.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 340 bits (872), Expect = 7e-91, Method: Compositional matrix adjust.
Identities = 155/200 (77%), Positives = 175/200 (87%)
Query: 170 LDSDKPFPRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVV 229
+ SDK + G+ +G ++TFT EEL +ATDNFS ANLLGQGGFGYVHKG+L NG VV
Sbjct: 1 MGSDKQVISHTSGISLGYSQTTFTSEELAMATDNFSNANLLGQGGFGYVHKGILANGTVV 60
Query: 230 AIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHL 289
AIKQLK+GSGQGEREFQAEIEIIS+VHHRHLVSLVGYC GSQR+LVYEFVPN TLEFHL
Sbjct: 61 AIKQLKSGSGQGEREFQAEIEIISRVHHRHLVSLVGYCITGSQRMLVYEFVPNDTLEFHL 120
Query: 290 HGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGL 349
HG P M+W TRM+IA+GSA+GL YLHEDCQPKIIHRDIK+ANIL+D SFEAKVADFGL
Sbjct: 121 HGNGNPTMSWSTRMRIAVGSAKGLTYLHEDCQPKIIHRDIKAANILIDQSFEAKVADFGL 180
Query: 350 AKHSLDTDTHVSTRVMGTFG 369
A++SLDT+THVSTRVMGTFG
Sbjct: 181 ARYSLDTETHVSTRVMGTFG 200
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356520519|ref|XP_003528909.1| PREDICTED: proline-rich receptor-like protein kinase PERK15-like isoform 2 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 337 bits (864), Expect = 5e-90, Method: Compositional matrix adjust.
Identities = 186/294 (63%), Positives = 212/294 (72%), Gaps = 12/294 (4%)
Query: 88 LAAVGIFLIFYKRRKRKLAAQNLPL--------KNDPFAGKPHHWQQNVSAPSDY---QE 136
L + I I +++KR+ + K+D + G P WQ NV P D+
Sbjct: 171 LLVLSILCICCRKKKRRRDEEYYAPPPQPPRGPKDDAYGGPPRQWQHNVPPPQDHVVSMM 230
Query: 137 LPKPSLPPSNGPTAPLPTVPVSAFNEPLSTSGSLDSDKPF-PRQSPGMPVGNFKSTFTYE 195
PKPS PP+ A P P F SGS S F P SPG+ +G KSTFTYE
Sbjct: 231 PPKPSPPPAPPAYAAQPPPPPPPFIISSGGSGSNYSGGEFLPPPSPGIALGFSKSTFTYE 290
Query: 196 ELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQV 255
EL ATD FS+ANLLGQGGFGYVH+G+L NGK VA+KQLKAGSGQGEREFQAE+EIIS+V
Sbjct: 291 ELARATDGFSDANLLGQGGFGYVHRGILPNGKEVAVKQLKAGSGQGEREFQAEVEIISRV 350
Query: 256 HHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAY 315
HH+HLVSLVGYC GSQRLLVYEFVPN TLEFHLHG+ RP M+WPTR++IALGSA+GLAY
Sbjct: 351 HHKHLVSLVGYCITGSQRLLVYEFVPNNTLEFHLHGRGRPTMDWPTRLRIALGSAKGLAY 410
Query: 316 LHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFG 369
LHEDC PKIIHRDIK+ANILLD FEAKVADFGLAK S D +THVSTRVMGTFG
Sbjct: 411 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKFSSDVNTHVSTRVMGTFG 464
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351725713|ref|NP_001237102.1| putative receptor protein kinase PERK1 [Glycine max] gi|77403742|dbj|BAE46451.1| putative receptor protein kinase PERK1 [Glycine max] gi|223452349|gb|ACM89502.1| PERK1-like protein kinase [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 337 bits (863), Expect = 7e-90, Method: Compositional matrix adjust.
Identities = 157/190 (82%), Positives = 171/190 (90%)
Query: 180 SPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSG 239
SPG+ +G KSTFTYEEL ATD FS+ANLLGQGGFGYVH+G+L NGK VA+KQLKAGSG
Sbjct: 47 SPGISLGFSKSTFTYEELARATDGFSDANLLGQGGFGYVHRGILPNGKEVAVKQLKAGSG 106
Query: 240 QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNW 299
QGEREFQAE+EIIS+VHH+HLVSLVGYC GSQRLLVYEFVPN TLEFHLHGK RP M+W
Sbjct: 107 QGEREFQAEVEIISRVHHKHLVSLVGYCITGSQRLLVYEFVPNNTLEFHLHGKGRPTMDW 166
Query: 300 PTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 359
PTR++IALGSA+GLAYLHEDC PKIIHRDIKSANILLD FEAKVADFGLAK S D +TH
Sbjct: 167 PTRLRIALGSAKGLAYLHEDCHPKIIHRDIKSANILLDFKFEAKVADFGLAKFSSDVNTH 226
Query: 360 VSTRVMGTFG 369
VSTRVMGTFG
Sbjct: 227 VSTRVMGTFG 236
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357134253|ref|XP_003568732.1| PREDICTED: proline-rich receptor-like protein kinase PERK1-like [Brachypodium distachyon] | Back alignment and taxonomy information |
|---|
Score = 336 bits (861), Expect = 1e-89, Method: Compositional matrix adjust.
Identities = 180/312 (57%), Positives = 210/312 (67%), Gaps = 13/312 (4%)
Query: 71 GALAGMVVGVVIGAGIVLAAVGIFLIFYKRRKRK----------LAAQNLPLKNDPFAGK 120
G +V+GV +G ++L + R+KR+ K DP+ G
Sbjct: 132 GLSTSVVIGVAVGGFVLLLLATFVCLCCLRKKRRRQPPPPHYGYPPPPPPQYKEDPYGGT 191
Query: 121 PHHWQQNVSAPS-DYQELPKPSLPPS--NGPTAPLPTVPVSAFNEPLSTSGSLDSDKPFP 177
WQQN P D+ PS PP+ N P P P N + + + P
Sbjct: 192 YQSWQQNAPPPPPDHVVKMHPSPPPAYANRPPQAPPPPPPPMINSSGGSGSNYSGGEILP 251
Query: 178 RQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAG 237
SPG +G KSTFTYEEL ATD FS+ANLLGQGGFGYVHKGVL NGK +A+KQLK G
Sbjct: 252 PPSPGTALGFSKSTFTYEELVRATDGFSDANLLGQGGFGYVHKGVLPNGKEIAVKQLKLG 311
Query: 238 SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVM 297
SGQGEREFQAE+EIIS+VHH+HLVSLVGYC G +RLLVYEFV N TLEFHLHGK RPVM
Sbjct: 312 SGQGEREFQAEVEIISRVHHKHLVSLVGYCISGGKRLLVYEFVTNNTLEFHLHGKGRPVM 371
Query: 298 NWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357
WPTR++IALG+A+GLAY+HEDC PKIIHRDIKS+NILLD FEAKVADFGLAK + D +
Sbjct: 372 EWPTRLRIALGAAKGLAYIHEDCHPKIIHRDIKSSNILLDFKFEAKVADFGLAKFTSDNN 431
Query: 358 THVSTRVMGTFG 369
THVSTRVMGTFG
Sbjct: 432 THVSTRVMGTFG 443
|
Source: Brachypodium distachyon Species: Brachypodium distachyon Genus: Brachypodium Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 369 | ||||||
| TAIR|locus:2091722 | 652 | PERK1 "proline-rich extensin-l | 0.688 | 0.389 | 0.686 | 2.1e-92 | |
| UNIPROTKB|Q9ARH1 | 647 | Q9ARH1 "Receptor protein kinas | 0.688 | 0.392 | 0.670 | 1.9e-89 | |
| TAIR|locus:2010282 | 699 | PERK7 "proline-rich extensin-l | 0.647 | 0.341 | 0.654 | 7.4e-82 | |
| TAIR|locus:2139474 | 670 | PERK5 "proline-rich extensin-l | 0.682 | 0.376 | 0.627 | 1.5e-81 | |
| TAIR|locus:2018209 | 509 | PERK15 "proline-rich extensin- | 0.490 | 0.355 | 0.784 | 5.8e-80 | |
| TAIR|locus:2093999 | 700 | PERK6 "proline-rich extensin-l | 0.644 | 0.34 | 0.644 | 6.8e-79 | |
| TAIR|locus:2046268 | 633 | PERK4 "proline-rich extensin-l | 0.593 | 0.345 | 0.671 | 3.6e-78 | |
| TAIR|locus:2026846 | 710 | PERK13 "proline-rich extensin- | 0.663 | 0.345 | 0.596 | 1.2e-73 | |
| TAIR|locus:2028911 | 720 | PERK12 "proline-rich extensin- | 0.726 | 0.372 | 0.537 | 2.9e-72 | |
| TAIR|locus:2028756 | 762 | PERK10 "proline-rich extensin- | 0.544 | 0.263 | 0.605 | 8.6e-72 |
| TAIR|locus:2091722 PERK1 "proline-rich extensin-like receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 896 (320.5 bits), Expect = 2.1e-92, Sum P(2) = 2.1e-92
Identities = 182/265 (68%), Positives = 204/265 (76%)
Query: 111 PLKNDPFAGKPHHWQQ-NVSAPSDYQ---ELPKPSLPPSNGPTAPLPTVPVSAFNEPLST 166
P P+ G+ +WQQ N S PSD LP P PPS P P P P AF +S+
Sbjct: 186 PKAGGPYGGQQQYWQQQNASRPSDNHVVTSLPPPK-PPSP-PRKPPPPPPPPAF---MSS 240
Query: 167 SGSLD-SDKP-FPRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLT 224
SG D SD P P SPG+ +G KSTFTYEEL AT+ FSEANLLGQGGFGYVHKG+L
Sbjct: 241 SGGSDYSDLPVLPPPSPGLVLGFSKSTFTYEELSRATNGFSEANLLGQGGFGYVHKGILP 300
Query: 225 NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKT 284
+GK VA+KQLKAGSGQGEREFQAE+EIIS+VHHRHLVSL+GYC G QRLLVYEFVPN
Sbjct: 301 SGKEVAVKQLKAGSGQGEREFQAEVEIISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNN 360
Query: 285 LEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKV 344
LEFHLHGK RP M W TR+KIALGSA+GL+YLHEDC PKIIHRDIK++NIL+D FEAKV
Sbjct: 361 LEFHLHGKGRPTMEWSTRLKIALGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKV 420
Query: 345 ADFGLAKHSLDTDTHVSTRVMGTFG 369
ADFGLAK + DT+THVSTRVMGTFG
Sbjct: 421 ADFGLAKIASDTNTHVSTRVMGTFG 445
|
|
| UNIPROTKB|Q9ARH1 Q9ARH1 "Receptor protein kinase PERK1" [Brassica napus (taxid:3708)] | Back alignment and assigned GO terms |
|---|
Score = 873 (312.4 bits), Expect = 1.9e-89, Sum P(2) = 1.9e-89
Identities = 177/264 (67%), Positives = 202/264 (76%)
Query: 111 PLKNDPFAGKPHHW-QQNVSAPSDY--QELPKPSLPPSNGPTAPLPTVPVSAFNEPLSTS 167
P P+ G+ W QQN + PSD+ LP P PS P P P P F +S+S
Sbjct: 182 PKAGGPYGGQQQQWRQQNATPPSDHVVTSLPPPPKAPSP-PRQP-PPPPPPPF---MSSS 236
Query: 168 GSLD-SDKP-FPRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTN 225
G D SD+P P SPG+ +G KSTFTYEEL AT+ FSEANLLGQGGFGYVHKGVL +
Sbjct: 237 GGSDYSDRPVLPPPSPGLVLGFSKSTFTYEELARATNGFSEANLLGQGGFGYVHKGVLPS 296
Query: 226 GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTL 285
GK VA+KQLK GSGQGEREFQAE+EIIS+VHHRHLVSLVGYC G++RLLVYEFVPN L
Sbjct: 297 GKEVAVKQLKVGSGQGEREFQAEVEIISRVHHRHLVSLVGYCIAGAKRLLVYEFVPNNNL 356
Query: 286 EFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVA 345
E HLHG+ RP M W TR+KIALGSA+GL+YLHEDC PKIIHRDIK++NIL+D FEAKVA
Sbjct: 357 ELHLHGEGRPTMEWSTRLKIALGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVA 416
Query: 346 DFGLAKHSLDTDTHVSTRVMGTFG 369
DFGLAK + DT+THVSTRVMGTFG
Sbjct: 417 DFGLAKIASDTNTHVSTRVMGTFG 440
|
|
| TAIR|locus:2010282 PERK7 "proline-rich extensin-like receptor kinase 7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 800 (286.7 bits), Expect = 7.4e-82, Sum P(2) = 7.4e-82
Identities = 163/249 (65%), Positives = 187/249 (75%)
Query: 129 SAPSDYQELPKPSLPPSNGPTAPLPTVPVSAFNEPLSTSGSLDSD---KPF----PRQSP 181
S +++ P P PP N P P PVS + SG + S+ P+ P P
Sbjct: 256 SMGTNWVSSPPPP-PPGNWQPMPSPPAPVSGGANVIQ-SGEMSSNFSSGPYAPSLPPPHP 313
Query: 182 GMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQG 241
+ +G STFTYEEL AT FS+ LLGQGGFGYVHKG+L NGK +A+K LKAGSGQG
Sbjct: 314 SVALGFNNSTFTYEELASATQGFSKDRLLGQGGFGYVHKGILPNGKEIAVKSLKAGSGQG 373
Query: 242 EREFQAEIEIISQVHHRHLVSLVGYCT-FGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWP 300
EREFQAE+EIIS+VHHRHLVSLVGYC+ G QRLLVYEF+PN TLEFHLHGK VM+WP
Sbjct: 374 EREFQAEVEIISRVHHRHLVSLVGYCSNAGGQRLLVYEFLPNDTLEFHLHGKSGTVMDWP 433
Query: 301 TRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 360
TR+KIALGSA+GLAYLHEDC PKIIHRDIK++NILLD +FEAKVADFGLAK S D +THV
Sbjct: 434 TRLKIALGSAKGLAYLHEDCHPKIIHRDIKASNILLDHNFEAKVADFGLAKLSQDNNTHV 493
Query: 361 STRVMGTFG 369
STRVMGTFG
Sbjct: 494 STRVMGTFG 502
|
|
| TAIR|locus:2139474 PERK5 "proline-rich extensin-like receptor kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 797 (285.6 bits), Expect = 1.5e-81, Sum P(2) = 1.5e-81
Identities = 167/266 (62%), Positives = 193/266 (72%)
Query: 113 KNDPFAGKPHHWQQNV--SAPSD----YQELPKPSLPPSNGPTAPL--PTVPVSAFNEPL 164
K P H++ N APS Y+ P+ + G P PVS P
Sbjct: 217 KKSPQVNHMHYYNNNPYGGAPSGNGGYYKGTPQDHVVNMAGQGGGNWGPQQPVSG---PH 273
Query: 165 STSGSLDSDKPFPRQSP-GMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVL 223
S + +L P SP +G+ +STFTY+EL IAT+ F+++NLLGQGGFGYVHKGVL
Sbjct: 274 SDASNLTGRTAIP--SPQAATLGHNQSTFTYDELSIATEGFAQSNLLGQGGFGYVHKGVL 331
Query: 224 TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNK 283
+GK VA+K LK GSGQGEREFQAE++IIS+VHHRHLVSLVGYC G QRLLVYEF+PN
Sbjct: 332 PSGKEVAVKSLKLGSGQGEREFQAEVDIISRVHHRHLVSLVGYCISGGQRLLVYEFIPNN 391
Query: 284 TLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAK 343
TLEFHLHGK RPV++WPTR+KIALGSARGLAYLHEDC P+IIHRDIK+ANILLD SFE K
Sbjct: 392 TLEFHLHGKGRPVLDWPTRVKIALGSARGLAYLHEDCHPRIIHRDIKAANILLDFSFETK 451
Query: 344 VADFGLAKHSLDTDTHVSTRVMGTFG 369
VADFGLAK S D THVSTRVMGTFG
Sbjct: 452 VADFGLAKLSQDNYTHVSTRVMGTFG 477
|
|
| TAIR|locus:2018209 PERK15 "proline-rich extensin-like receptor kinase 15" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 772 (276.8 bits), Expect = 5.8e-80, Sum P(2) = 5.8e-80
Identities = 142/181 (78%), Positives = 163/181 (90%)
Query: 189 KSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAE 248
++ FTYE+L AT NFS NLLGQGGFGYVH+GVL +G +VAIKQLK+GSGQGEREFQAE
Sbjct: 128 QNLFTYEDLSKATSNFSNTNLLGQGGFGYVHRGVLVDGTLVAIKQLKSGSGQGEREFQAE 187
Query: 249 IEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALG 308
I+ IS+VHHRHLVSL+GYC G+QRLLVYEFVPNKTLEFHLH K+RPVM W RMKIALG
Sbjct: 188 IQTISRVHHRHLVSLLGYCITGAQRLLVYEFVPNKTLEFHLHEKERPVMEWSKRMKIALG 247
Query: 309 SARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF 368
+A+GLAYLHEDC PK IHRD+K+ANIL+DDS+EAK+ADFGLA+ SLDTDTHVSTR+MGTF
Sbjct: 248 AAKGLAYLHEDCNPKTIHRDVKAANILIDDSYEAKLADFGLARSSLDTDTHVSTRIMGTF 307
Query: 369 G 369
G
Sbjct: 308 G 308
|
|
| TAIR|locus:2093999 PERK6 "proline-rich extensin-like receptor kinase 6" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 793 (284.2 bits), Expect = 6.8e-79, P = 6.8e-79
Identities = 156/242 (64%), Positives = 184/242 (76%)
Query: 132 SDYQELPKPSLPPSNGPTAPLPTVPVSAFNEPLSTSGSLDSDKPF----PRQSPGMPVGN 187
+++ P P P S P+ P P PVS S+ S + P P P + +G
Sbjct: 261 NNWMNSPPPPPPGSWQPSPPPPPPPVSGGMNGNSSDFSSNYSGPHGPSVPPPHPSVALGF 320
Query: 188 FKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQA 247
KSTFTY+EL AT FS++ LLGQGGFGYVHKG+L NGK +A+K LKAGSGQGEREFQA
Sbjct: 321 NKSTFTYDELAAATQGFSQSRLLGQGGFGYVHKGILPNGKEIAVKSLKAGSGQGEREFQA 380
Query: 248 EIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIAL 307
E++IIS+VHHR LVSLVGYC G QR+LVYEF+PN TLEFHLHGK V++WPTR+KIAL
Sbjct: 381 EVDIISRVHHRFLVSLVGYCIAGGQRMLVYEFLPNDTLEFHLHGKSGKVLDWPTRLKIAL 440
Query: 308 GSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGT 367
GSA+GLAYLHEDC P+IIHRDIK++NILLD+SFEAKVADFGLAK S D THVSTR+MGT
Sbjct: 441 GSAKGLAYLHEDCHPRIIHRDIKASNILLDESFEAKVADFGLAKLSQDNVTHVSTRIMGT 500
Query: 368 FG 369
FG
Sbjct: 501 FG 502
|
|
| TAIR|locus:2046268 PERK4 "proline-rich extensin-like receptor kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 766 (274.7 bits), Expect = 3.6e-78, Sum P(2) = 3.6e-78
Identities = 151/225 (67%), Positives = 181/225 (80%)
Query: 147 GPTAPLPT-VPVSAFNEPLSTSGSLDSDKP-FPRQSPGMPVGNFKSTFTYEELKIATDNF 204
GP+ P P +P S + + + S +P P SP + +G KSTFTY+EL AT F
Sbjct: 229 GPSPPPPPRMPTSGEDSSMYSGPS----RPVLPPPSPALALGFNKSTFTYQELAAATGGF 284
Query: 205 SEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLV 264
++ANLLGQGGFGYVHKGVL +GK VA+K LKAGSGQGEREFQAE++IIS+VHHR+LVSLV
Sbjct: 285 TDANLLGQGGFGYVHKGVLPSGKEVAVKSLKAGSGQGEREFQAEVDIISRVHHRYLVSLV 344
Query: 265 GYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKI 324
GYC QR+LVYEFVPNKTLE+HLHGK+ PVM + TR++IALG+A+GLAYLHEDC P+I
Sbjct: 345 GYCIADGQRMLVYEFVPNKTLEYHLHGKNLPVMEFSTRLRIALGAAKGLAYLHEDCHPRI 404
Query: 325 IHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFG 369
IHRDIKSANILLD +F+A VADFGLAK + D +THVSTRVMGTFG
Sbjct: 405 IHRDIKSANILLDFNFDAMVADFGLAKLTSDNNTHVSTRVMGTFG 449
|
|
| TAIR|locus:2026846 PERK13 "proline-rich extensin-like receptor kinase 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 720 (258.5 bits), Expect = 1.2e-73, Sum P(2) = 1.2e-73
Identities = 154/258 (59%), Positives = 190/258 (73%)
Query: 125 QQNVSAPSDYQELPKPSLP-PSNGPT-APLPTVPVSA---FN-EPLSTSG-SLDSDKP-- 175
++N+ A SD Q LP + S+G PT S +N + S SG S S +
Sbjct: 261 KRNIDAYSDSQYLPPSNFSIKSDGFLYGQNPTKGYSGPGGYNSQQQSNSGNSFGSQRGGG 320
Query: 176 -FPRQ--SPGMPV-GNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAI 231
+ R +P V G+ ++ FTYEEL T+ FS+ N+LG+GGFG V+KG L +GK+VA+
Sbjct: 321 GYTRSGSAPDSAVMGSGQTHFTYEELTDITEGFSKHNILGEGGFGCVYKGKLNDGKLVAV 380
Query: 232 KQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHG 291
KQLK GSGQG+REF+AE+EIIS+VHHRHLVSLVGYC S+RLL+YE+VPN+TLE HLHG
Sbjct: 381 KQLKVGSGQGDREFKAEVEIISRVHHRHLVSLVGYCIADSERLLIYEYVPNQTLEHHLHG 440
Query: 292 KDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351
K RPV+ W R++IA+GSA+GLAYLHEDC PKIIHRDIKSANILLDD FEA+VADFGLAK
Sbjct: 441 KGRPVLEWARRVRIAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEFEAQVADFGLAK 500
Query: 352 HSLDTDTHVSTRVMGTFG 369
+ T THVSTRVMGTFG
Sbjct: 501 LNDSTQTHVSTRVMGTFG 518
|
|
| TAIR|locus:2028911 PERK12 "proline-rich extensin-like receptor kinase 12" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 701 (251.8 bits), Expect = 2.9e-72, Sum P(2) = 2.9e-72
Identities = 151/281 (53%), Positives = 191/281 (67%)
Query: 95 LIFYKRRKRKLAAQNLPLKNDPFAGKPHHWQQNVSAPSD-YQELPKPSLPPSNGPTAPLP 153
++F RRK+K +N+ N PH N S SD + P S+GP +
Sbjct: 263 VVFLVRRKKK---RNIDSYNHS-QYLPH---PNFSVKSDGFLYGQDPGKGYSSGPNGSMY 315
Query: 154 TVPVSAFNEPLSTSGSLDSDKPFPR-QSPGMP----VGNFKSTFTYEELKIATDNFSEAN 208
+ ++ G+ P + QS G P +G+ ++ F+YEEL T F+ N
Sbjct: 316 NNSQQQQSSMGNSYGTAGGGYPHHQMQSSGTPDSAILGSGQTHFSYEELAEITQGFARKN 375
Query: 209 LLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCT 268
+LG+GGFG V+KG L +GKVVA+KQLKAGSGQG+REF+AE+EIIS+VHHRHLVSLVGYC
Sbjct: 376 ILGEGGFGCVYKGTLQDGKVVAVKQLKAGSGQGDREFKAEVEIISRVHHRHLVSLVGYCI 435
Query: 269 FGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRD 328
RLL+YE+V N+TLE HLHGK PV+ W R++IA+GSA+GLAYLHEDC PKIIHRD
Sbjct: 436 SDQHRLLIYEYVSNQTLEHHLHGKGLPVLEWSKRVRIAIGSAKGLAYLHEDCHPKIIHRD 495
Query: 329 IKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFG 369
IKSANILLDD +EA+VADFGLA+ + T THVSTRVMGTFG
Sbjct: 496 IKSANILLDDEYEAQVADFGLARLNDTTQTHVSTRVMGTFG 536
|
|
| TAIR|locus:2028756 PERK10 "proline-rich extensin-like receptor kinase 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 655 (235.6 bits), Expect = 8.6e-72, Sum P(3) = 8.6e-72
Identities = 123/203 (60%), Positives = 163/203 (80%)
Query: 168 GSLDSDKPFPRQS-PGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNG 226
G+ S++ + QS PG G + F+YEEL IAT+ FS+ NLLG+GGFG V+KGVL +
Sbjct: 394 GNRSSNRTYLSQSEPG-GFGQSRELFSYEELVIATNGFSDENLLGEGGFGRVYKGVLPDE 452
Query: 227 KVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLE 286
+VVA+KQLK G GQG+REF+AE++ IS+VHHR+L+S+VGYC ++RLL+Y++VPN L
Sbjct: 453 RVVAVKQLKIGGGQGDREFKAEVDTISRVHHRNLLSMVGYCISENRRLLIYDYVPNNNLY 512
Query: 287 FHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVAD 346
FHLH P ++W TR+KIA G+ARGLAYLHEDC P+IIHRDIKS+NILL+++F A V+D
Sbjct: 513 FHLHAAGTPGLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLENNFHALVSD 572
Query: 347 FGLAKHSLDTDTHVSTRVMGTFG 369
FGLAK +LD +TH++TRVMGTFG
Sbjct: 573 FGLAKLALDCNTHITTRVMGTFG 595
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9LV48 | PERK1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7947 | 0.5149 | 0.2914 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 369 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-40 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-38 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-38 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-38 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 9e-38 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-36 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-32 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-28 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-25 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-25 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 7e-25 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-24 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-23 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-23 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-23 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-22 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-21 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-21 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-21 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-21 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-21 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 9e-21 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-20 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-20 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-20 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-20 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 7e-20 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 8e-20 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 6e-19 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-18 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-18 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-18 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-18 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 7e-18 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 7e-18 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-17 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-17 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-17 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 8e-17 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 9e-17 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-16 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-16 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-16 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 6e-16 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 9e-16 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-15 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-15 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-15 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-15 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-15 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-15 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-15 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-15 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-15 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-15 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 5e-15 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-15 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 6e-15 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-14 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-14 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-14 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-14 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-14 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-14 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-14 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-14 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-14 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-14 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-14 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-14 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-14 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-14 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-14 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 5e-14 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 5e-14 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-14 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 6e-14 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 8e-14 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 9e-14 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 9e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-13 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-13 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-13 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-13 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-13 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-13 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-13 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-13 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-13 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-13 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-13 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 6e-13 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 6e-13 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 7e-13 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 9e-13 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-12 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-12 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-12 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-12 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-12 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-12 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-12 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-12 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-12 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-12 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 6e-12 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 7e-12 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 7e-12 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 7e-12 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 9e-12 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-11 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-11 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-11 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-11 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-11 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-11 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-11 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-11 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-11 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-11 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 5e-11 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-11 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 6e-11 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 6e-11 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 7e-11 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 8e-11 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-10 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-10 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-10 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-10 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-10 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-10 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-10 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-10 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-10 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-10 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-10 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-10 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 5e-10 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 6e-10 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 6e-10 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-09 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-09 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-09 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-09 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-09 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-09 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-09 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-09 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-09 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-09 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-09 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-09 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-09 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-09 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 5e-09 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-09 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-09 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 7e-09 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 7e-09 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 7e-09 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 9e-09 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-08 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-08 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-08 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-08 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-08 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-08 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-08 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-08 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-08 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-08 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-08 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-08 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-08 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 5e-08 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 6e-08 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 7e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 7e-08 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 9e-08 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-08 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 9e-08 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-07 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-07 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-07 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-07 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-07 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-07 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-07 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-07 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-07 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-07 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-07 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-07 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 5e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-07 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 5e-07 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-07 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 6e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 7e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 7e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 7e-07 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-06 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-06 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-06 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-06 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-06 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-06 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-06 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-06 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-06 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-06 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-06 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-06 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-06 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 6e-06 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 6e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 7e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 9e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-05 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-05 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-05 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-05 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-05 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-05 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-05 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-05 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-05 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-05 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 4e-05 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-05 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-05 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-05 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-05 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 5e-05 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 6e-05 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 7e-05 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 7e-05 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 7e-05 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 8e-05 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 9e-05 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 9e-05 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 1e-04 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-04 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-04 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 2e-04 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-04 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-04 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-04 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-04 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-04 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-04 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-04 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-04 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-04 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-04 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-04 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-04 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-04 | |
| PRK06975 | 656 | PRK06975, PRK06975, bifunctional uroporphyrinogen- | 6e-04 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 6e-04 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 8e-04 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 0.001 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 0.001 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 0.001 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 0.001 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 0.001 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 0.001 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 0.001 | |
| pfam03600 | 377 | pfam03600, CitMHS, Citrate transporter | 0.002 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 0.002 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 0.002 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 0.002 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 0.003 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 0.003 | |
| pfam08693 | 40 | pfam08693, SKG6, Transmembrane alpha-helix domain | 0.003 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 0.003 | |
| cd12087 | 38 | cd12087, TM_EGFR-like, Transmembrane domain of the | 0.004 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 0.004 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 1e-40
Identities = 58/163 (35%), Positives = 86/163 (52%), Gaps = 8/163 (4%)
Query: 210 LGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGERE-FQAEIEIISQVHHRHLVSLVGYC 267
LG+GGFG V+ GK VAIK +K E EIEI+ +++H ++V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 268 TFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHR 327
+ LV E+ +L+ L + ++ ++I L GL YLH + IIHR
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGK-LSEDEILRILLQILEGLEYLHSN---GIIHR 116
Query: 328 DIKSANILLD-DSFEAKVADFGLAKHSLDTDTHVSTRVMGTFG 369
D+K NILLD D+ + K+ADFGL+K L +D + ++GT
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKL-LTSDKSLLKTIVGTPA 158
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 1e-38
Identities = 51/159 (32%), Positives = 82/159 (51%), Gaps = 10/159 (6%)
Query: 210 LGQGGFGYVHKGVLTNGKV-----VAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVSL 263
LG+G FG V+KG L VA+K LK + + + EF E I+ ++ H ++V L
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 264 VGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPK 323
+G CT +V E++ L +L K+RP ++ + AL ARG+ YL
Sbjct: 67 LGVCTEEEPLYIVMEYMEGGDLLSYLR-KNRPKLSLSDLLSFALQIARGMEYLESK---N 122
Query: 324 IIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 362
IHRD+ + N L+ ++ K++DFGL++ D D +
Sbjct: 123 FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKR 161
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 1e-38
Identities = 51/158 (32%), Positives = 79/158 (50%), Gaps = 9/158 (5%)
Query: 210 LGQGGFGYVHKGVLTNGKV-----VAIKQLKAG-SGQGEREFQAEIEIISQVHHRHLVSL 263
LG+G FG V+KG L VA+K LK S Q EF E I+ ++ H ++V L
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 264 VGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPK 323
+G CT ++V E++P L +L ++ + AL ARG+ YL
Sbjct: 67 LGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---N 123
Query: 324 IIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVS 361
IHRD+ + N L+ ++ K++DFGL++ D D +
Sbjct: 124 FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKV 161
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 1e-38
Identities = 50/159 (31%), Positives = 82/159 (51%), Gaps = 10/159 (6%)
Query: 210 LGQGGFGYVHKGVLT-----NGKVVAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVSL 263
LG+G FG V+KG L VA+K LK G+ + ER EF E I+ ++ H ++V L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 264 VGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPK 323
+G CT G +V E++P L L + +++AL A+G+ YL
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKL-TLKDLLQMALQIAKGMEYLESK---N 122
Query: 324 IIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 362
+HRD+ + N L+ ++ K++DFGL++ + D +
Sbjct: 123 FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKR 161
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 9e-38
Identities = 47/168 (27%), Positives = 81/168 (48%), Gaps = 15/168 (8%)
Query: 208 NLLGQGGFGYVHKGVLTNGK----VVAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVS 262
LG+G FG V+KG L VA+K LK + + ER +F E ++ ++ H ++V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 263 LVGYCTFGSQRLLVYEFVPNKTLEFHLHGK-------DRPVMNWPTRMKIALGSARGLAY 315
L+G CT LV E++ L +L ++ ++ + A+ A+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 316 LHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTR 363
L K +HRD+ + N L+ + K++DFGL++ D D +
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKT 165
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 2e-36
Identities = 55/162 (33%), Positives = 78/162 (48%), Gaps = 9/162 (5%)
Query: 208 NLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGERE-FQAEIEIISQVHHRHLVSLVG 265
LG+G FG V+ GK+VAIK +K + +RE EI+I+ ++ H ++V L
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 266 YCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKII 325
+ LV E+ L L K R ++ L YLH I+
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLL--KKRGRLSEDEARFYLRQILSALEYLHSK---GIV 119
Query: 326 HRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGT 367
HRD+K NILLD+ K+ADFGLA+ LD ++T V GT
Sbjct: 120 HRDLKPENILLDEDGHVKLADFGLARQ-LDPGEKLTTFV-GT 159
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 121 bits (307), Expect = 2e-32
Identities = 61/162 (37%), Positives = 87/162 (53%), Gaps = 11/162 (6%)
Query: 210 LGQGGFGYVHKGV-LTNGKVVAIKQLK---AGSGQGEREFQAEIEIISQVHHRHLVSLVG 265
LG G FG V+K GK+VA+K LK S + ++ + EI I+ ++ H ++V L+
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKK-DQTARREIRILRRLSHPNIVRLID 65
Query: 266 YCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKII 325
LV E+ L F + P ++ KIAL RGL YLH + II
Sbjct: 66 AFEDKDHLYLVMEYCEGGDL-FDYLSRGGP-LSEDEAKKIALQILRGLEYLHSN---GII 120
Query: 326 HRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGT 367
HRD+K NILLD++ K+ADFGLAK L + + ++T V GT
Sbjct: 121 HRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GT 161
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 1e-28
Identities = 55/169 (32%), Positives = 82/169 (48%), Gaps = 17/169 (10%)
Query: 208 NLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGE--REFQAEIEIISQVHHRHLVSLV 264
LLG+G FG V+ + G+++A+K ++ E + EI I+S + H ++V
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 265 GYCT--FGSQRLLVYEFVPNKTLEFHLHGKDR---PVMNWPTRMKIALGSARGLAYLHED 319
G + + E+V +L L + PV+ TR + GLAYLH +
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQIL-----EGLAYLHSN 120
Query: 320 CQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVM-GT 367
I+HRDIK ANIL+D K+ADFG AK D +T T + GT
Sbjct: 121 ---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGT 166
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-25
Identities = 54/165 (32%), Positives = 82/165 (49%), Gaps = 7/165 (4%)
Query: 204 FSEANLLGQGGFGYVHKG-VLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVS 262
F +G+GGFG V+K GK VAIK +K S + + + EI+I+ + H ++V
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 263 LVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQP 322
G + +V EF +L+ L ++ + + +GL YLH +
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQT-LTESQIAYVCKELLKGLEYLHSN--- 117
Query: 323 KIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGT 367
IIHRDIK+ANILL E K+ DFGL+ +DT ++GT
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSAQL--SDTKARNTMVGT 160
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-25
Identities = 48/145 (33%), Positives = 77/145 (53%), Gaps = 5/145 (3%)
Query: 209 LLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCT 268
+G+G FG V G KV A+K LK S + F AE +++ + H +LV L+G
Sbjct: 13 TIGKGEFGDVMLGDYRGQKV-AVKCLKDDSTAAQ-AFLAEASVMTTLRHPNLVQLLGVVL 70
Query: 269 FGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRD 328
G+ +V E++ +L +L + R V+ ++ AL G+ YL E +HRD
Sbjct: 71 QGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRD 127
Query: 329 IKSANILLDDSFEAKVADFGLAKHS 353
+ + N+L+ + AKV+DFGLAK +
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAKEA 152
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 7e-25
Identities = 51/148 (34%), Positives = 81/148 (54%), Gaps = 3/148 (2%)
Query: 204 FSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSL 263
F+ LG G FG V +G+ N VAIK LK+ +++FQ E++ + ++ H+HL+SL
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 264 VGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPK 323
C+ G ++ E + +L L + V+ + + +A A G+AYL E
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---N 124
Query: 324 IIHRDIKSANILLDDSFEAKVADFGLAK 351
IHRD+ + NIL+ + KVADFGLA+
Sbjct: 125 SIHRDLAARNILVGEDLVCKVADFGLAR 152
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 3e-24
Identities = 52/147 (35%), Positives = 80/147 (54%), Gaps = 11/147 (7%)
Query: 210 LGQGGFGYVHKGV--LTNGKV--VAIKQLKAG-SGQGEREFQAEIEIISQVHHRHLVSLV 264
LG G FG V KGV + +GK VA+K LK G++EF E +++Q+ H +V L+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 265 GYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKI 324
G C G +LV E P L +L K R + ++A A G+AYL
Sbjct: 63 GVCK-GEPLMLVMELAPLGPLLKYL--KKRREIPVSDLKELAHQVAMGMAYLESK---HF 116
Query: 325 IHRDIKSANILLDDSFEAKVADFGLAK 351
+HRD+ + N+LL + +AK++DFG+++
Sbjct: 117 VHRDLAARNVLLVNRHQAKISDFGMSR 143
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 3e-23
Identities = 47/152 (30%), Positives = 75/152 (49%), Gaps = 12/152 (7%)
Query: 208 NLLGQGGFGYVHKGVLTN-----GKVVAIKQLKA-GSGQGEREFQAEIEIISQVHHRHLV 261
LG+G FG V G+ VA+K L G Q +F+ EIEI+ + H ++V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 262 SLVGYCTFGSQR--LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHED 319
G C R L+ E++P+ +L +L + R +N + + +G+ YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQ-RHRDQINLKRLLLFSSQICKGMDYLGSQ 128
Query: 320 CQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351
+ IHRD+ + NIL++ K++DFGLAK
Sbjct: 129 ---RYIHRDLAARNILVESEDLVKISDFGLAK 157
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 3e-23
Identities = 49/142 (34%), Positives = 75/142 (52%), Gaps = 4/142 (2%)
Query: 210 LGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTF 269
LG G FG V +G+ N VA+K LK G+ + +F AE +I+ ++ H L+ L CT
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK-DFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 270 GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDI 329
+V E + +L +L G + P + +A A G+AYL IHRD+
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDL 129
Query: 330 KSANILLDDSFEAKVADFGLAK 351
+ N+L+ ++ KVADFGLA+
Sbjct: 130 AARNVLVGENNICKVADFGLAR 151
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.2 bits (240), Expect = 5e-23
Identities = 53/172 (30%), Positives = 85/172 (49%), Gaps = 17/172 (9%)
Query: 203 NFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLK-AGSGQGE-REFQAEIEIISQVHHRH 259
N+ +L+G+G FG V+KG+ L G VAIKQ+ + + EI+++ + H +
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 260 LVSLVGYCTFGSQRLLVYEFVPNKTLE--FHLHGK--DRPVMNWPTRMKIALGSARGLAY 315
+V +G ++ E+ N +L G + V + ++ +GLAY
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQV------LQGLAY 114
Query: 316 LHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGT 367
LHE +IHRDIK+ANIL K+ADFG+A L+ + V+GT
Sbjct: 115 LHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATK-LNDVSKDDASVVGT 162
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 94.9 bits (237), Expect = 2e-22
Identities = 44/172 (25%), Positives = 83/172 (48%), Gaps = 23/172 (13%)
Query: 208 NLLGQGGFGYVHKGV-LTNGKVVAIKQLK-AGSGQGEREF-QAEIEIISQVHHRHLVSLV 264
+G+G FG V+ ++GK+ +K++ + + ERE E++I+ +++H +++
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 265 GYCTFGSQRLL-VYEFVPNKTLEFHLH---GKDRP-----VMNWPTRMKIALGSARGLAY 315
+L V E+ L + + +P +++W ++ L L Y
Sbjct: 66 E-SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFV--QLCLA----LKY 118
Query: 316 LHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGT 367
LH KI+HRDIK NI L + K+ DFG++K L + ++ V+GT
Sbjct: 119 LHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISK-VLSSTVDLAKTVVGT 166
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 1e-21
Identities = 47/142 (33%), Positives = 70/142 (49%), Gaps = 4/142 (2%)
Query: 210 LGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTF 269
LG G FG V G VA+K LK G+ E F E +I+ ++ H LV L C+
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPE-AFLQEAQIMKKLRHDKLVQLYAVCSE 72
Query: 270 GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDI 329
+V E++ +L L + + P + +A A G+AYL IHRD+
Sbjct: 73 EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDL 129
Query: 330 KSANILLDDSFEAKVADFGLAK 351
+ NIL+ ++ K+ADFGLA+
Sbjct: 130 AARNILVGENLVCKIADFGLAR 151
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 2e-21
Identities = 50/156 (32%), Positives = 78/156 (50%), Gaps = 19/156 (12%)
Query: 209 LLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGE-----REFQAEIEIISQVHHRHLVS 262
LLG G FG V++G+ L +G A+K++ ++ + EI ++S++ H ++V
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 263 LVGYCTFGSQRLLVYEFVPNKTLEFHLHGK----DRPVMNWPTRMKIALGSARGLAYLHE 318
+G + E VP +L L K PV+ TR + GL YLH+
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLA-KLLKKYGSFPEPVIRLYTRQILL-----GLEYLHD 120
Query: 319 DCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354
+HRDIK ANIL+D + K+ADFG+AK +
Sbjct: 121 R---NTVHRDIKGANILVDTNGVVKLADFGMAKQVV 153
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 3e-21
Identities = 50/153 (32%), Positives = 81/153 (52%), Gaps = 6/153 (3%)
Query: 210 LGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTF 269
+G G FG V G + VAIK ++ G+ E +F E +++ ++ H LV L G CT
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 270 GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDI 329
S LV+EF+ + L +L + R + T + + L G+AYL +IHRD+
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRAQ-RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDL 126
Query: 330 KSANILLDDSFEAKVADFGLAKHSLDTDTHVST 362
+ N L+ ++ KV+DFG+ + LD D + S+
Sbjct: 127 AARNCLVGENQVVKVSDFGMTRFVLD-DQYTSS 158
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 3e-21
Identities = 51/177 (28%), Positives = 84/177 (47%), Gaps = 25/177 (14%)
Query: 210 LGQGGFGYVHKGVLTNGK------VVAIKQLKAGSGQGERE-FQAEIEIISQVHHRHLVS 262
LG+G FG V G + + +VA+K LK + R+ F+ E E+++ H ++V
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 263 LVGYCTFGSQRLLVYEFVPNKTLEFHL--HGKDRPVMNWP-------TR---MKIALGSA 310
G CT G ++V+E++ + L L HG D + P T ++IA+ A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 311 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGT 367
G+ YL +HRD+ + N L+ K+ DFG+++ TD + RV G
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYY---RVGGH 183
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 4e-21
Identities = 52/161 (32%), Positives = 84/161 (52%), Gaps = 9/161 (5%)
Query: 208 NLLGQGGFGYVHKGVLT-NGK---VVAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVS 262
++G G FG V +G L GK VAIK LKAGS +R +F E I+ Q H +++
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 263 LVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQP 322
L G T +++ E++ N +L+ L D + + G A G+ YL E
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLRENDGKF-TVGQLVGMLRGIASGMKYLSEMN-- 126
Query: 323 KIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTR 363
+HRD+ + NIL++ + KV+DFGL++ D++ +T+
Sbjct: 127 -YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK 166
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 92.1 bits (227), Expect = 9e-21
Identities = 52/163 (31%), Positives = 73/163 (44%), Gaps = 11/163 (6%)
Query: 209 LLGQGGFGYVHKGVLTNGKVVAIKQLK---AGSGQGEREFQAEIEIISQV-HHRHLVSLV 264
LG+G FG V+ K+VA+K L + F EI+I++ + H ++V L
Sbjct: 7 KLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 265 GYCTFGSQRLLVYEFVPNKTLEFHL-HGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPK 323
+ LV E+V +LE L + ++ + I L YLH
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--- 121
Query: 324 IIHRDIKSANILLD-DSFEAKVADFGLAKHSLDTDTHVSTRVM 365
IIHRDIK NILLD D K+ DFGLAK D + S +
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPAL 164
|
Length = 384 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 1e-20
Identities = 49/161 (30%), Positives = 78/161 (48%), Gaps = 9/161 (5%)
Query: 210 LGQGGFGYVHKGVL-TNGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVG-Y 266
LGQG G V+K GK+ A+K++ + ++ E++ + ++V G +
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68
Query: 267 CTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIH 326
G + V E++ +L L K + P IA +GL YLH IIH
Sbjct: 69 YKEGEISI-VLEYMDGGSLA-DLLKKVGKI-PEPVLAYIARQILKGLDYLHTK--RHIIH 123
Query: 327 RDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGT 367
RDIK +N+L++ E K+ADFG++K +T +T V GT
Sbjct: 124 RDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GT 163
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.9 bits (224), Expect = 1e-20
Identities = 42/159 (26%), Positives = 76/159 (47%), Gaps = 32/159 (20%)
Query: 210 LGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGERE---FQA--EIEIISQVHHRHLVSL 263
+G+G +G V+K G++VA+K+++ + E+E A EI+++ ++ H ++V L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIR---MENEKEGFPITAIREIKLLQKLRHPNIVRL 63
Query: 264 VGYCT--FGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSAR--------GL 313
T +V+E++ + + +K + GL
Sbjct: 64 KEIVTSKGKGSIYMVFEYMDHDLTGLLDSPE----------VKFTESQIKCYMKQLLEGL 113
Query: 314 AYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352
YLH I+HRDIK +NIL+++ K+ADFGLA+
Sbjct: 114 QYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARP 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 3e-20
Identities = 58/176 (32%), Positives = 83/176 (47%), Gaps = 40/176 (22%)
Query: 209 LLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVG-- 265
LG+G +G V+K + G+VVAIK + +E EI I+ Q ++V G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDL--QEIIKEISILKQCDSPYIVKYYGSY 67
Query: 266 -----------YCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIAL---GSAR 311
YC GS ++ + NKTL T +IA + +
Sbjct: 68 FKNTDLWIVMEYCGAGSVSDIMK--ITNKTL---------------TEEEIAAILYQTLK 110
Query: 312 GLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGT 367
GL YLH K IHRDIK+ NILL++ +AK+ADFG++ DT +T V+GT
Sbjct: 111 GLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT-VIGT 162
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 5e-20
Identities = 53/159 (33%), Positives = 84/159 (52%), Gaps = 22/159 (13%)
Query: 210 LGQGGFGYVHKGVLT----NGKV-VAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSL 263
LG G FG V+KGV K+ VAIK L+ + + +E E +++ V H H+V L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 264 VGYCTFGSQRLLVYEFVPNKTLEFHLHG-KDR----PVMNWPTRMKIALGSARGLAYLHE 318
+G C SQ L+ + +P L ++ KD ++NW ++ A+G++YL E
Sbjct: 75 LGIC-LSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKGMSYLEE 127
Query: 319 DCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357
+++HRD+ + N+L+ K+ DFGLAK LD D
Sbjct: 128 K---RLVHRDLAARNVLVKTPQHVKITDFGLAK-LLDVD 162
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.9 bits (219), Expect = 7e-20
Identities = 47/162 (29%), Positives = 77/162 (47%), Gaps = 21/162 (12%)
Query: 210 LGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQA----EIEIISQVHHRHLVSLV 264
LG+G +G V+K G++VA+K+++ E + EI ++ ++ H ++V L+
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIR--LDNEEEGIPSTALREISLLKELKHPNIVKLL 64
Query: 265 GYCTFGSQRLLVYEFVPNKTLEFHLHG---KDRPVMNWPTRMKIALGSARGLAYLHEDCQ 321
+ LV+E+ + L K ++ I RGLAY H
Sbjct: 65 DVIHTERKLYLVFEY-----CDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH---S 116
Query: 322 PKIIHRDIKSANILLDDSFEAKVADFGLAK---HSLDTDTHV 360
+I+HRD+K NIL++ K+ADFGLA+ L T TH
Sbjct: 117 HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHE 158
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 8e-20
Identities = 52/165 (31%), Positives = 87/165 (52%), Gaps = 19/165 (11%)
Query: 210 LGQGGFGYVHK-GVLTNGKVVAIKQLKAGSGQGEREFQA--EIEIISQVHHRHLVSLVGY 266
+G+G G V K G+ VA+K++ +G QA EI+ + H ++V L+
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 267 CTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTR--MKIALGSARGLAYLHEDCQPKI 324
GS +LV E++P+ L L ++RP+ + M++ L +G+AY+H + I
Sbjct: 68 FPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRMLL---KGVAYMHAN---GI 120
Query: 325 IHRDIKSANILLDDSFEAKVADFGLAKHSLDTD-----TH-VSTR 363
+HRD+K AN+L+ K+ADFGLA+ + +H V+TR
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLAR-LFSEEEPRLYSHQVATR 164
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 6e-19
Identities = 47/153 (30%), Positives = 77/153 (50%), Gaps = 6/153 (3%)
Query: 210 LGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTF 269
LG G FG VH G VAIK ++ G+ E +F E +++ ++ H +LV L G CT
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 270 GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDI 329
+V E++ N L +L + + + + + + YL + IHRD+
Sbjct: 71 QRPIFIVTEYMANGCLLNYLR-ERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDL 126
Query: 330 KSANILLDDSFEAKVADFGLAKHSLDTDTHVST 362
+ N L+ + KV+DFGLA++ LD D + S+
Sbjct: 127 AARNCLVGEDNVVKVSDFGLARYVLD-DQYTSS 158
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 84.9 bits (211), Expect = 1e-18
Identities = 52/166 (31%), Positives = 91/166 (54%), Gaps = 17/166 (10%)
Query: 208 NLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGSGQGERE---FQA--EIEIISQVHHRHLV 261
LG+G + V+K G++VAIK++K G + ++ F A EI+++ ++ H +++
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65
Query: 262 SLVGYCTFGSQRL--LVYEFVPNKTLEFHLHGKDRPVMNWPTRMK-IALGSARGLAYLHE 318
L+ FG + LV+EF+ LE + KD+ ++ P +K L + RGL YLH
Sbjct: 66 GLLD--VFGHKSNINLVFEFMETD-LEKVI--KDKSIVLTPADIKSYMLMTLRGLEYLHS 120
Query: 319 DCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRV 364
+ I+HRD+K N+L+ K+ADFGLA+ + ++ +V
Sbjct: 121 N---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQV 163
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 2e-18
Identities = 50/151 (33%), Positives = 77/151 (50%), Gaps = 14/151 (9%)
Query: 210 LGQGGFGYV--HKGVLTN---GKVVAIKQLKAGSGQGERE-FQAEIEIISQVHHRHLVSL 263
LG+G FG V + N G++VA+K LK GQ ++ EI I+ ++H ++V
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 264 VGYCTFGSQR--LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQ 321
G C+ + L+ E+VP +L +L + +N + A G+AYLH
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYL---PKHKLNLAQLLLFAQQICEGMAYLHSQ-- 126
Query: 322 PKIIHRDIKSANILLDDSFEAKVADFGLAKH 352
IHRD+ + N+LLD+ K+ DFGLAK
Sbjct: 127 -HYIHRDLAARNVLLDNDRLVKIGDFGLAKA 156
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.0 bits (206), Expect = 3e-18
Identities = 57/180 (31%), Positives = 81/180 (45%), Gaps = 37/180 (20%)
Query: 204 FSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREF-QAEIEIISQVHHRHLV 261
F+ +G+G FG V+K + +VVAIK + + E E Q EI+ +SQ ++
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 262 SLVG-------------YCTFGSQR-LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIAL 307
G YC GS LL + + F L R V+
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFIL----REVL---------- 108
Query: 308 GSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGT 367
GL YLHE+ IHRDIK+ANILL + + K+ADFG++ T + +T V GT
Sbjct: 109 ---LGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GT 161
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 5e-18
Identities = 48/165 (29%), Positives = 75/165 (45%), Gaps = 8/165 (4%)
Query: 208 NLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGE--REFQAEIEIISQVHHRHLVSLV 264
N +G G FG V+ V L G+++A+K+++ + +E E++++ + H +LV
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 265 GYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKI 324
G + + E+ TLE L + + L GLAYLH I
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQL--LEGLAYLHSH---GI 120
Query: 325 IHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFG 369
+HRDIK ANI LD + K+ DFG A + T + V G
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAG 165
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 7e-18
Identities = 47/151 (31%), Positives = 78/151 (51%), Gaps = 13/151 (8%)
Query: 209 LLGQGGFGYVHKGVL-----TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSL 263
LG+G FG V G+VVA+K+L+ + + R+F+ EIEI+ + H ++V
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70
Query: 264 VGYCTFGSQRL---LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDC 320
G C + + R LV E++P +L +L K R ++ + A +G+ YL
Sbjct: 71 KGVC-YSAGRRNLRLVMEYLPYGSLRDYLQ-KHRERLDHRKLLLYASQICKGMEYLGSK- 127
Query: 321 QPKIIHRDIKSANILLDDSFEAKVADFGLAK 351
+ +HRD+ + NIL++ K+ DFGL K
Sbjct: 128 --RYVHRDLATRNILVESENRVKIGDFGLTK 156
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (203), Expect = 7e-18
Identities = 55/172 (31%), Positives = 76/172 (44%), Gaps = 30/172 (17%)
Query: 210 LGQGGFGYV----HKGVLTNGKVVAIKQLKAGSGQGEREFQ---AEIEIISQVHHRHLVS 262
LG+G FG V K GK+ A+K LK +E + E I+S+++H +V
Sbjct: 1 LGKGSFGKVLLVRKKD---TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK 57
Query: 263 LVGYCTFGSQR--LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMK-----IALGSARGLAY 315
L + F ++ LV E+ P L HL + R + I L L Y
Sbjct: 58 L--HYAFQTEEKLYLVLEYAPGGELFSHL--SKEGRFS-EERARFYAAEIVLA----LEY 108
Query: 316 LHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGT 367
LH II+RD+K NILLD K+ DFGLAK + +T GT
Sbjct: 109 LHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GT 156
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 1e-17
Identities = 45/145 (31%), Positives = 76/145 (52%), Gaps = 5/145 (3%)
Query: 208 NLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGY 266
+ LG G +G V++GV VA+K LK + + E EF E ++ ++ H +LV L+G
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 70
Query: 267 CTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIH 326
CT ++ EF+ L +L +R +N + +A + + YL + IH
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIH 127
Query: 327 RDIKSANILLDDSFEAKVADFGLAK 351
RD+ + N L+ ++ KVADFGL++
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSR 152
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 1e-17
Identities = 49/155 (31%), Positives = 81/155 (52%), Gaps = 15/155 (9%)
Query: 202 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHL 260
+++ +G G +G V+K + G++VAIK +K G Q EI ++ + H ++
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNI 62
Query: 261 VSLVG-YCTFGSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIAL---GSARGLAY 315
V+ G Y +L +V E+ +L+ P+ + ++IA + +GLAY
Sbjct: 63 VAYFGSY--LRRDKLWIVMEYCGGGSLQDIYQVTRGPL----SELQIAYVCRETLKGLAY 116
Query: 316 LHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLA 350
LHE IHRDIK ANILL + + K+ADFG++
Sbjct: 117 LHET---GKIHRDIKGANILLTEDGDVKLADFGVS 148
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 3e-17
Identities = 48/142 (33%), Positives = 72/142 (50%), Gaps = 5/142 (3%)
Query: 210 LGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTF 269
LG G FG V G VAIK LK GS E F AE ++ Q+ H LV L T
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPE-AFLAEANLMKQLQHPRLVRLYAVVT- 71
Query: 270 GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDI 329
++ E++ N +L L + + + +A A G+A++ + IHRD+
Sbjct: 72 QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDL 128
Query: 330 KSANILLDDSFEAKVADFGLAK 351
++ANIL+ ++ K+ADFGLA+
Sbjct: 129 RAANILVSETLCCKIADFGLAR 150
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 8e-17
Identities = 54/174 (31%), Positives = 87/174 (50%), Gaps = 19/174 (10%)
Query: 203 NFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQ--LKAGSGQGEREFQAEIEIISQVHHRH 259
+F N +G+G FG V K V + +V A+KQ L + + E E +++++ +
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 260 LVSLVGYCTFGSQRLL--VYEFVPNKTLEFHLHG-KDRPVMN---WPTRMKIALGSARGL 313
++ Y +F + L V E+ N L L + RP+ W ++I LG L
Sbjct: 61 IIRY--YESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG----L 114
Query: 314 AYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGT 367
A+LH KI+HRDIKS N+ LD K+ D G+AK L +T+ + ++GT
Sbjct: 115 AHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAK-LLSDNTNFANTIVGT 164
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 9e-17
Identities = 48/163 (29%), Positives = 78/163 (47%), Gaps = 18/163 (11%)
Query: 210 LGQGGFGYVHKGVLTN------GKVVAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVS 262
LGQG FG V++G+ VAIK + + ER EF E ++ + + H+V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 263 LVGYCTFGSQRLLVYEFVPNKTLEFHLHGK-----DRPVMNWPTRMKI---ALGSARGLA 314
L+G + G L+V E + L+ +L + + P + PT K A A G+A
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 315 YLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357
YL K +HRD+ + N ++ + K+ DFG+ + +TD
Sbjct: 134 YLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETD 173
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 1e-16
Identities = 54/159 (33%), Positives = 81/159 (50%), Gaps = 10/159 (6%)
Query: 210 LGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTF 269
LG G FG V G VAIK +K GS E EF E +++ ++ H LV L G CT
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 270 GSQRLLVYEFVPNKTLEFHLH-GKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRD 328
+V E++ N L +L R + +++ G+AYL + IHRD
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLREHGKRFQPS--QLLEMCKDVCEGMAYLESK---QFIHRD 125
Query: 329 IKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGT 367
+ + N L+DD KV+DFGL+++ LD D + S+ +G+
Sbjct: 126 LAARNCLVDDQGCVKVSDFGLSRYVLD-DEYTSS--VGS 161
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 1e-16
Identities = 45/146 (30%), Positives = 74/146 (50%), Gaps = 9/146 (6%)
Query: 209 LLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGERE-FQAEIEIISQVHHRHLVSLVGYC 267
+G+G FG V+KGVL VA+K ++ + F E EI+ Q H ++V L+G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 268 TFGSQRLLVYEFVPNKTLEFHLHGKDR--PVMNWPTRMKIALGSARGLAYLHEDCQPKII 325
+V E VP +L L K V ++++L +A G+ YL I
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKK---LLQMSLDAAAGMEYLESKN---CI 115
Query: 326 HRDIKSANILLDDSFEAKVADFGLAK 351
HRD+ + N L+ ++ K++DFG+++
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR 141
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 3e-16
Identities = 48/175 (27%), Positives = 83/175 (47%), Gaps = 30/175 (17%)
Query: 210 LGQGGFGYVHK----GVLTNGK--VVAIKQLKAG-SGQGEREFQAEIEIISQVHHRHLVS 262
+GQG FG V + G+L +VA+K LK S + +FQ E ++++ H ++V
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 263 LVGYCTFGSQRLLVYEFV--------------------PNKTLEFHLHGKDRPVMNWPTR 302
L+G C G L++E++ + T G + ++ +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 303 MKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357
+ IA A G+AYL E K +HRD+ + N L+ ++ K+ADFGL+++ D
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 184
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 6e-16
Identities = 52/176 (29%), Positives = 81/176 (46%), Gaps = 23/176 (13%)
Query: 210 LGQGGFGYVHKGVLTN------GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSL 263
LG+G FG V N +VA+K LK S ++FQ E E+++ + H+H+V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 264 VGYCTFGSQRLLVYEFVPNKTLEFHL--HGKDRPVMN-----------WPTRMKIALGSA 310
G CT G L+V+E++ + L L HG D ++ + IA A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 311 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH-VSTRVM 365
G+ YL +HRD+ + N L+ K+ DFG+++ TD + V R M
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 185
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 9e-16
Identities = 53/150 (35%), Positives = 80/150 (53%), Gaps = 9/150 (6%)
Query: 209 LLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVSLVGYC 267
LLG+G FG V KG L + VA+K K Q + +F +E I+ Q H ++V L+G C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 268 TFGSQRLLVYEFVPNKT-LEFHLHGKDRPVMNWPTRMKIALGSARGLAYLH-EDCQPKII 325
T +V E VP L F KD + +K AL +A G+AYL ++C I
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKKKDE--LKTKQLVKFALDAAAGMAYLESKNC----I 115
Query: 326 HRDIKSANILLDDSFEAKVADFGLAKHSLD 355
HRD+ + N L+ ++ K++DFG+++ D
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQEDD 145
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 1e-15
Identities = 49/167 (29%), Positives = 79/167 (47%), Gaps = 20/167 (11%)
Query: 210 LGQGGFGYVHKGVLTN------GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSL 263
LG+G FG V N +VA+K LK S ++F E E+++ + H H+V
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 264 VGYCTFGSQRLLVYEFVPNKTLEFHL--HGKDRPVM---NWPTRMK------IALGSARG 312
G C G ++V+E++ + L L HG D +M N P + IA A G
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 313 LAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 359
+ YL +HRD+ + N L+ ++ K+ DFG+++ TD +
Sbjct: 133 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYY 176
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 2e-15
Identities = 48/159 (30%), Positives = 87/159 (54%), Gaps = 9/159 (5%)
Query: 198 KIATDNFSEANLLGQGGFGYVHKGVL-TNGK---VVAIKQLKAGSGQGER-EFQAEIEII 252
+I + ++ ++G G FG V +G+L G+ VAIK LK G + +R +F +E I+
Sbjct: 1 EIHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIM 60
Query: 253 SQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARG 312
Q H +++ L G T +++ E++ N L+ +L D ++ + + G A G
Sbjct: 61 GQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQL-VGMLRGIAAG 119
Query: 313 LAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351
+ YL + +HRD+ + NIL++ + E KV+DFGL++
Sbjct: 120 MKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSR 155
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 2e-15
Identities = 54/194 (27%), Positives = 85/194 (43%), Gaps = 47/194 (24%)
Query: 194 YEELKIATDNFSEANLLGQGGFGYVHKGV--LTNGKVVAIKQLKAGSGQGEREFQ---AE 248
YE L+ +G+G FG V K V ++GK++ K++ G+ E+E Q +E
Sbjct: 2 YEVLET----------IGKGSFGTVRK-VRRKSDGKILVWKEIDYGN-MTEKEKQQLVSE 49
Query: 249 IEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTL----EFHLHG----------KDR 294
+ I+ ++ H ++V Y R++ N+TL E+ G K+R
Sbjct: 50 VNILRELKHPNIV---RYY----DRIIDRS---NQTLYIVMEYCEGGDLAQLIQKCKKER 99
Query: 295 PVMNWPTRMKIALGSARGLAYLH--EDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK- 351
+ +I L H D ++HRD+K ANI LD + K+ DFGLAK
Sbjct: 100 KYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159
Query: 352 ---HSLDTDTHVST 362
S T+V T
Sbjct: 160 LGHDSSFAKTYVGT 173
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 3e-15
Identities = 52/162 (32%), Positives = 91/162 (56%), Gaps = 15/162 (9%)
Query: 210 LGQGGFGYVH------KGVLTNGKVVAIKQLKAGSGQGE-REFQAEIEIISQVHHRHLVS 262
LG+G FG V +G T G+ VA+K LK SG + + EIEI+ ++H ++V
Sbjct: 12 LGEGHFGKVELCRYDPEGDNT-GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70
Query: 263 LVGYCT--FGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDC 320
G CT G+ L+ EF+P+ +L+ +L +++ +N ++K A+ +G+ YL
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYL-PRNKNKINLKQQLKYAVQICKGMDYLGSR- 128
Query: 321 QPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 362
+ +HRD+ + N+L++ + K+ DFGL K +++TD T
Sbjct: 129 --QYVHRDLAARNVLVESEHQVKIGDFGLTK-AIETDKEYYT 167
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 3e-15
Identities = 49/143 (34%), Positives = 76/143 (53%), Gaps = 7/143 (4%)
Query: 210 LGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTF 269
LGQG FG V G VAIK LK G+ E F E +++ ++ H LV L Y
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQL--YAVV 70
Query: 270 GSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRD 328
+ + +V E++ +L L G+ + P + +A A G+AY+ + +HRD
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 127
Query: 329 IKSANILLDDSFEAKVADFGLAK 351
+++ANIL+ ++ KVADFGLA+
Sbjct: 128 LRAANILVGENLVCKVADFGLAR 150
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 4e-15
Identities = 48/181 (26%), Positives = 83/181 (45%), Gaps = 34/181 (18%)
Query: 210 LGQGGFGYVHKGVLTNGK------VVAIKQLKAGSGQGE-REFQAEIEIISQVHHRHLVS 262
LG+G FG V K K VA+K LK + E R+ +E ++ QV+H H++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 263 LVGYCTFGSQRLLVYEFVPNKTLEFHL-----------------------HGKDRPVMNW 299
L G C+ LL+ E+ +L L + +R +
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL-TM 126
Query: 300 PTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 359
+ A +RG+ YL E K++HRD+ + N+L+ + + K++DFGL++ + D++
Sbjct: 127 GDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183
Query: 360 V 360
V
Sbjct: 184 V 184
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.2 bits (183), Expect = 4e-15
Identities = 53/183 (28%), Positives = 78/183 (42%), Gaps = 48/183 (26%)
Query: 197 LKIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQV 255
L T F ++G+G +G V+K G++VAIK + E E + E I+ +
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDI-IEDEEEEIKEEYNILRKY 59
Query: 256 -HHRHLVSLVG-------------------YCTFGSQRLLVYEFVPNKTLEFHLHGKDRP 295
+H ++ + G C GS V + V L K +
Sbjct: 60 SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGS----VTDLVKG------LRKKGK- 108
Query: 296 VMNWPTRMK------IALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGL 349
R+K I + RGLAYLHE+ K+IHRDIK NILL + E K+ DFG+
Sbjct: 109 ------RLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGV 159
Query: 350 AKH 352
+
Sbjct: 160 SAQ 162
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 4e-15
Identities = 52/183 (28%), Positives = 86/183 (46%), Gaps = 38/183 (20%)
Query: 196 ELKIATDNFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLK-AGSGQGEREFQAE 248
E+ ++ F E LG+G FG V+KG LT + VAIK LK + ++EF+ E
Sbjct: 1 EIPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQE 58
Query: 249 IEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTR------ 302
E++S + H ++V L+G CT +++E++ + L L V N P
Sbjct: 59 AELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFL------VRNSPHSDVGAES 112
Query: 303 --------------MKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFG 348
+ IA+ A G+ YL +HRD+ + N L+ + K++DFG
Sbjct: 113 GDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFG 169
Query: 349 LAK 351
L++
Sbjct: 170 LSR 172
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 5e-15
Identities = 46/143 (32%), Positives = 80/143 (55%), Gaps = 9/143 (6%)
Query: 210 LGQGGFGYVHKGVLTNGKVVAIKQLKAG-SGQGEREFQAEIEIISQVHHRHLVSLVGYCT 268
+G+G FG V +G T G+ VA+K +K + Q F E +++++HH++LV L+G
Sbjct: 14 IGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLG-VI 68
Query: 269 FGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRD 328
+ +V E + L L + R +++ ++ +L A G+ YL K++HRD
Sbjct: 69 LHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRD 125
Query: 329 IKSANILLDDSFEAKVADFGLAK 351
+ + NIL+ + AKV+DFGLA+
Sbjct: 126 LAARNILVSEDGVAKVSDFGLAR 148
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 5e-15
Identities = 50/155 (32%), Positives = 77/155 (49%), Gaps = 7/155 (4%)
Query: 198 KIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHH 257
+I ++ LG G FG V G VA+K LK G+ E F E +I+ ++ H
Sbjct: 2 EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPE-SFLEEAQIMKKLRH 60
Query: 258 RHLVSLVGYCTFGSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYL 316
LV L Y + + +V E++ +L L + + P + +A A G+AY+
Sbjct: 61 DKLVQL--YAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYI 118
Query: 317 HEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351
+ IHRD++SANIL+ D K+ADFGLA+
Sbjct: 119 E---RMNYIHRDLRSANILVGDGLVCKIADFGLAR 150
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 5e-15
Identities = 45/163 (27%), Positives = 84/163 (51%), Gaps = 22/163 (13%)
Query: 208 NLLGQGGFGYVHKGVLTNGKV---VAIKQLKAGSGQGE-REFQAEIEIISQV-HHRHLVS 262
+++G+G FG V K + + AIK++K + + + R+F E+E++ ++ HH ++++
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72
Query: 263 LVGYCTFGSQRLLVYEFVPNKTL--------------EFHLHGKDRPVMNWPTRMKIALG 308
L+G C L E+ P+ L F + ++ + A
Sbjct: 73 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132
Query: 309 SARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351
ARG+ YL Q + IHRD+ + NIL+ +++ AK+ADFGL++
Sbjct: 133 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 5e-15
Identities = 45/163 (27%), Positives = 75/163 (46%), Gaps = 13/163 (7%)
Query: 209 LLGQGGFGYVHKG-VLTNGKVVAIKQLKAGSGQGE--REFQAEIEIISQVHHRHLVSLVG 265
++G+G +G V K G++VAIK+ K + + E++++ Q+ H ++V+L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 266 YCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKII 325
+ LV+E+V LE L + + +AY H II
Sbjct: 68 AFRRKGRLYLVFEYVERTLLE--LLEASPGGLPPDAVRSYIWQLLQAIAYCH---SHNII 122
Query: 326 HRDIKSANILLDDSFEAKVADFGLAKH-----SLDTDTHVSTR 363
HRDIK NIL+ +S K+ DFG A+ + +V+TR
Sbjct: 123 HRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATR 165
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 74.2 bits (183), Expect = 6e-15
Identities = 46/151 (30%), Positives = 67/151 (44%), Gaps = 6/151 (3%)
Query: 201 TDNFSEANLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRH 259
+ + +G+G G V+K GK VAIK+++ E EI I+ H +
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIIN-EILIMKDCKHPN 76
Query: 260 LVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHED 319
+V G + +V E++ +L + MN P + +GL YLH
Sbjct: 77 IVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVR-MNEPQIAYVCREVLQGLEYLH-- 133
Query: 320 CQPKIIHRDIKSANILLDDSFEAKVADFGLA 350
+IHRDIKS NILL K+ADFG A
Sbjct: 134 -SQNVIHRDIKSDNILLSKDGSVKLADFGFA 163
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 73.0 bits (180), Expect = 1e-14
Identities = 51/168 (30%), Positives = 71/168 (42%), Gaps = 34/168 (20%)
Query: 202 DNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQL---------KAGSGQGEREFQAEIEI 251
D+F ++G+G F V K AIK L K + E+E +
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKE------V 54
Query: 252 ISQV-HHRHLVSLVGYCTFGSQRLL--VYEFVPNKTLEFHLH---GKDRPVMNWPTRMKI 305
++++ H ++ L Y TF + L V E+ PN L ++ D TR
Sbjct: 55 LTRLNGHPGIIKL--YYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKC----TRFYA 108
Query: 306 A-LGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352
A + A L YLH IIHRD+K NILLD K+ DFG AK
Sbjct: 109 AEILLA--LEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKV 151
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 1e-14
Identities = 52/169 (30%), Positives = 81/169 (47%), Gaps = 18/169 (10%)
Query: 198 KIATDNFSEANLLGQGGFGYVHKGVLTNGKV------VAIKQL-KAGSGQGEREFQAEIE 250
++ D+ + LG G FG V++G+ VA+K L ++ S Q E +F E
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61
Query: 251 IISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLE-FHLHGKDRPVMNWPTRMK----I 305
I+S+ +H+++V L+G R ++ E + L+ F + RP MK
Sbjct: 62 IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFC 121
Query: 306 ALGSARGLAYLHEDCQPKIIHRDIKSANILLDD---SFEAKVADFGLAK 351
A A+G YL E+ IHRDI + N LL AK+ADFG+A+
Sbjct: 122 ARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMAR 167
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 1e-14
Identities = 47/158 (29%), Positives = 85/158 (53%), Gaps = 25/158 (15%)
Query: 209 LLGQGGFGYVHKGV-LTNGKVVAIKQ--LKAGSGQGERE-------FQAEIEIISQVHHR 258
L+G G FG V+ G+ ++G+++A+KQ L + S + EI ++ ++ H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 259 HLVSLVGYCTFGSQRLLVY-EFVPNKTLEFHLHG----KDRPVMNWPTRMKIALGSARGL 313
++V +G + + L ++ E+VP ++ L+ ++ V N+ ++ +GL
Sbjct: 67 NIVQYLG-SSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQI------LKGL 119
Query: 314 AYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351
YLH IIHRDIK ANIL+D+ K++DFG++K
Sbjct: 120 NYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISK 154
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 1e-14
Identities = 45/171 (26%), Positives = 86/171 (50%), Gaps = 22/171 (12%)
Query: 209 LLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQ----------AEIEIISQVHH 257
L+G+G +G V+ + +T G+++A+KQ++ + R +EIE + + H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 258 RHLVSLVGYCTFGSQRLLVYEFVPNKTLE--FHLHGK-DRPVMNWPTRMKIALGSARGLA 314
++V +G+ T + E+VP ++ +G+ + ++ + T + GLA
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVL-----EGLA 122
Query: 315 YLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVM 365
YLH I+HRD+K+ N+L+D K++DFG++K S D + M
Sbjct: 123 YLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSM 170
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 1e-14
Identities = 44/157 (28%), Positives = 85/157 (54%), Gaps = 17/157 (10%)
Query: 204 FSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQ---GEREF---QAEIEIISQVHH 257
+++ +LG+G +G V+ G+ G+++A+KQ++ + E+E+ Q E++++ + H
Sbjct: 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61
Query: 258 RHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLH---GKDRPVMNWPTRMKIALGSARGLA 314
++V +G C + + EFVP ++ L+ PV T+ + G+A
Sbjct: 62 VNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQIL-----DGVA 116
Query: 315 YLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351
YLH +C ++HRDIK N++L + K+ DFG A+
Sbjct: 117 YLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCAR 150
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 2e-14
Identities = 47/153 (30%), Positives = 76/153 (49%), Gaps = 6/153 (3%)
Query: 210 LGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTF 269
LG G FG VH G VAIK + G+ E +F E +++ ++ H LV L G CT
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70
Query: 270 GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDI 329
+V EF+ N L +L + + ++ + + G+ YL + IHRD+
Sbjct: 71 QKPLYIVTEFMENGCLLNYLRQR-QGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDL 126
Query: 330 KSANILLDDSFEAKVADFGLAKHSLDTDTHVST 362
+ N L+ + KV+DFG+ ++ LD D + S+
Sbjct: 127 AARNCLVSSTGVVKVSDFGMTRYVLD-DEYTSS 158
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 2e-14
Identities = 46/162 (28%), Positives = 80/162 (49%), Gaps = 14/162 (8%)
Query: 210 LGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQA--EIEIISQVHHRHLVSLVGY 266
+G+G +G V+K G++VAIK++K A EI+++ +++H +++ L+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 267 CTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIH 326
LV+EF+ + L + + R + +GLA+ H I+H
Sbjct: 67 FRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPE-SLIKSYLYQLLQGLAFCH---SHGILH 121
Query: 327 RDIKSANILLDDSFEAKVADFGLAKHSLDTD----TH-VSTR 363
RD+K N+L++ K+ADFGLA+ S + TH V TR
Sbjct: 122 RDLKPENLLINTEGVLKLADFGLAR-SFGSPVRPYTHYVVTR 162
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 2e-14
Identities = 45/162 (27%), Positives = 75/162 (46%), Gaps = 29/162 (17%)
Query: 211 GQGGFGYVHKGVLTN---GKVVAIKQLKAGSGQGEREFQA---EIEIISQVHHRHLVSLV 264
G+G +G V+K N GK AIK+ K Q Q+ EI ++ ++ H ++VSLV
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLV 68
Query: 265 GYC-TFGSQRL-LVYEFVPNKTLE---FHLHGKDRPVMNWPTRMKIALGSA-----RGLA 314
+ + L++++ + + FH K + P M + S G+
Sbjct: 69 EVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSI---PPSM---VKSLLWQILNGVH 122
Query: 315 YLHEDCQPKIIHRDIKSANILL----DDSFEAKVADFGLAKH 352
YLH + ++HRD+K ANIL+ + K+ D GLA+
Sbjct: 123 YLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARL 161
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 2e-14
Identities = 51/176 (28%), Positives = 90/176 (51%), Gaps = 20/176 (11%)
Query: 198 KIATDNFSEANLLGQGGFGYVHKGVLTNGKV-------VAIKQLKAGSGQGER-EFQAEI 249
++A + + + LGQG FG V++G+ G V VAIK + + ER EF E
Sbjct: 2 EVAREKITMSRELGQGSFGMVYEGI-AKGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 60
Query: 250 EIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHG-----KDRPVMNWPTRMK 304
++ + + H+V L+G + G L++ E + L+ +L ++ PV P+ K
Sbjct: 61 SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKK 120
Query: 305 I---ALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357
+ A A G+AYL+ + K +HRD+ + N ++ + F K+ DFG+ + +TD
Sbjct: 121 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 173
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (180), Expect = 2e-14
Identities = 47/196 (23%), Positives = 75/196 (38%), Gaps = 71/196 (36%)
Query: 208 NLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQA---------EIEIISQVHH 257
+G G +G V V G+ VAIK++ F EI+++ + H
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKI-------SNVFDDLIDAKRILREIKLLRHLRH 58
Query: 258 RHLVSLVGYCTFGSQRLLVYEFVPNKTLEFH------------LHGKDRPVMNWPTRMKI 305
+++ L L + P +F+ LH V+ +
Sbjct: 59 ENIIGL----------LDI--LRPPSPEDFNDVYIVTELMETDLH----KVI----KSPQ 98
Query: 306 ALGSA----------RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355
L RGL YLH +IHRD+K +NIL++ + + K+ DFGLA+ +D
Sbjct: 99 PLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLAR-GVD 154
Query: 356 TDT--------HVSTR 363
D +V TR
Sbjct: 155 PDEDEKGFLTEYVVTR 170
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 3e-14
Identities = 52/169 (30%), Positives = 87/169 (51%), Gaps = 13/169 (7%)
Query: 202 DNFSEANLLGQGGFGYVHK----GVLTNGKV--VAIKQLKAGSGQGERE-FQAEIEIISQ 254
+N S LG G FG V + G+ + V VA+K LK + ERE +E++I+S
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 255 V-HHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGL 313
+ +H ++V+L+G CT G L++ E+ L L K + + + A+G+
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGM 154
Query: 314 AYL-HEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVS 361
A+L ++C IHRD+ + N+LL K+ DFGLA+ ++ +V
Sbjct: 155 AFLASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVV 199
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 3e-14
Identities = 45/154 (29%), Positives = 74/154 (48%), Gaps = 4/154 (2%)
Query: 198 KIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHH 257
+I ++ LG G FG V G N VA+K LK G+ + F E ++ + H
Sbjct: 2 EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQH 60
Query: 258 RHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLH 317
LV L T ++ E++ +L L + + P + + A G+AY+
Sbjct: 61 DKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE 120
Query: 318 EDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351
+ IHRD+++AN+L+ +S K+ADFGLA+
Sbjct: 121 ---RKNYIHRDLRAANVLVSESLMCKIADFGLAR 151
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 3e-14
Identities = 47/156 (30%), Positives = 68/156 (43%), Gaps = 9/156 (5%)
Query: 209 LLGQGGFGYVHKGVLTN--GKV--VAIKQLKAGSGQG-EREFQAEIEIISQVHHRHLVSL 263
LG G FG V +G + GKV VA+K LK+ +F E I+ + H +L+ L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 264 VGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPK 323
G ++V E P +L L T A+ A G+ YL +
Sbjct: 62 YG-VVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKR 117
Query: 324 IIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 359
IHRD+ + NILL + K+ DFGL + + H
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH 153
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 3e-14
Identities = 51/154 (33%), Positives = 83/154 (53%), Gaps = 8/154 (5%)
Query: 203 NFSEANLLGQGGFGYVHK-GVLTNGKVVAIKQLKAGS-GQGEREFQA-EIEIISQVHHRH 259
+F LG+G +G V+K L++ + A+K++ GS Q ERE EI I++ V+H +
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 260 LVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRM--KIALGSARGLAYLH 317
++S G++ +V E+ P L + + + P + +I + RGL LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 318 EDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351
E KI+HRD+KSANILL + K+ D G++K
Sbjct: 121 EQ---KILHRDLKSANILLVANDLVKIGDLGISK 151
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 4e-14
Identities = 52/143 (36%), Positives = 75/143 (52%), Gaps = 7/143 (4%)
Query: 210 LGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTF 269
LGQG FG V G VAIK LK G+ E F E +I+ ++ H LV L Y
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPE-AFLQEAQIMKKLRHDKLVPL--YAVV 70
Query: 270 GSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRD 328
+ + +V EF+ +L L D + P + +A A G+AY+ + IHRD
Sbjct: 71 SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRD 127
Query: 329 IKSANILLDDSFEAKVADFGLAK 351
+++ANIL+ D+ K+ADFGLA+
Sbjct: 128 LRAANILVGDNLVCKIADFGLAR 150
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 5e-14
Identities = 53/157 (33%), Positives = 84/157 (53%), Gaps = 14/157 (8%)
Query: 209 LLGQGGFGYVHKGVLTN-GK---VVAIKQLKAG-SGQGEREFQAEIEIISQVHHRHLVSL 263
++G G FG V +G L GK VAIK LK+G + + R+F +E I+ Q H +++ L
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 264 VGYCTFGSQRLLVYEFVPNKTLEFHLHGKDR--PVMNWPTRMKIALGSARGLAYLHEDCQ 321
G T +++ EF+ N L+ L D V+ ++ G A G+ YL E
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLR---GIAAGMKYLSE--- 124
Query: 322 PKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 358
+HRD+ + NIL++ + KV+DFGL++ L+ DT
Sbjct: 125 MNYVHRDLAARNILVNSNLVCKVSDFGLSRF-LEDDT 160
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 5e-14
Identities = 54/163 (33%), Positives = 76/163 (46%), Gaps = 13/163 (7%)
Query: 210 LGQGGFGYVHKGVLTNGKV---VAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVSLVG 265
LG G FG V KGV K VAIK LK + + R E E EI+ Q+ + ++V ++G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 266 YCTFGSQRLLVYEFVPNKTLEFHLHGKDR--PVMNWPTRMKIALGSARGLAYLHEDCQPK 323
C +LV E L L GK V N M + G+ YL
Sbjct: 63 VCE-AEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQV---SMGMKYLEGK---N 115
Query: 324 IIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMG 366
+HRD+ + N+LL + AK++DFGL+K D++ R G
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG 158
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 5e-14
Identities = 52/160 (32%), Positives = 78/160 (48%), Gaps = 22/160 (13%)
Query: 208 NLLGQGGFGYVHKGVL--TNGKVV--AIKQLKAGSGQGERE-FQAEIEIISQVHHRHLVS 262
++G+G FG V+ G L ++G+ + A+K L + E E F E I+ H +++S
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 263 LVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTR-------MKIALGSARGLAY 315
L+G C L E P L + HG R + T + L A+G+ Y
Sbjct: 61 LLGIC-------LPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEY 113
Query: 316 LHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355
L K +HRD+ + N +LD+SF KVADFGLA+ D
Sbjct: 114 L---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYD 150
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 6e-14
Identities = 51/173 (29%), Positives = 80/173 (46%), Gaps = 34/173 (19%)
Query: 200 ATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREF-----QAEIEIIS 253
++ LG+G FG V+K + G+VVA+K++ + E++ EI+I+
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHN---EKDGFPITALREIKILK 62
Query: 254 QVHHRHLVSLVGYC-----TFGSQRLLVYEFVP------NKTLE---FHLHGKDRPVMNW 299
++ H ++V L+ +R VY P + LE L
Sbjct: 63 KLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCY-- 120
Query: 300 PTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352
M L G+ YLHE+ I+HRDIK+ANIL+D+ K+ADFGLA+
Sbjct: 121 ---MLQLL---EGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARP 164
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 8e-14
Identities = 45/171 (26%), Positives = 83/171 (48%), Gaps = 10/171 (5%)
Query: 199 IATDNFSEANLLGQGGFGYVHKGVLTNGK----VVAIKQLKAGSGQGERE-FQAEIEIIS 253
I ++ + +G+G FG V++GV + + VA+K K + RE F E I+
Sbjct: 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMR 62
Query: 254 QVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGL 313
Q H H+V L+G T + +V E P L +L ++ ++ + + + + L
Sbjct: 63 QFDHPHIVKLIGVIT-ENPVWIVMELAPLGELRSYLQ-VNKYSLDLASLILYSYQLSTAL 120
Query: 314 AYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRV 364
AYL + +HRDI + N+L+ K+ DFGL+++ D + +++
Sbjct: 121 AYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKG 168
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 9e-14
Identities = 47/172 (27%), Positives = 79/172 (45%), Gaps = 29/172 (16%)
Query: 209 LLGQGGFGYVHKGVL------TNGKVVAIKQLKAGSGQGE-REFQAEIEIISQV-HHRHL 260
LG+G FG V K VA+K LK + + + + +E+E++ + H+++
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 261 VSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVM-------NWPTRMKI-------- 305
++L+G CT +V E+ + L L + RP P +
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRAR-RPPGEYASPDDPRPPEETLTQKDLVSF 137
Query: 306 ALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK--HSLD 355
A ARG+ +L K IHRD+ + N+L+ + K+ADFGLA+ H +D
Sbjct: 138 AYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHID 186
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 9e-14
Identities = 50/158 (31%), Positives = 81/158 (51%), Gaps = 17/158 (10%)
Query: 203 NFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAG--SGQGEREFQA---EIEIISQVH 256
N+ LLGQG FG V+ + G+ +A+KQ+ S + ++E A EI+++ +
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62
Query: 257 HRHLVSLVGYCTFGSQRLLVY-EFVPNKTLEFHL--HGKDRPVMNWPTRMKIALGSARGL 313
H +V G C + L ++ E++P +++ L +G + TR K G+
Sbjct: 63 HERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYG---ALTETVTR-KYTRQILEGV 117
Query: 314 AYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351
YLH + I+HRDIK ANIL D + K+ DFG +K
Sbjct: 118 EYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 152
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 1e-13
Identities = 48/153 (31%), Positives = 76/153 (49%), Gaps = 15/153 (9%)
Query: 210 LGQGGFGYVHK------GVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSL 263
LG G FG V+K G L KV+ K S + ++ EIEI++ +H ++V L
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETK-----SEEELEDYMVEIEILATCNHPYIVKL 74
Query: 264 VGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPK 323
+G + + ++ EF P ++ + DR + P I L YLH K
Sbjct: 75 LGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTE-PQIQVICRQMLEALQYLH---SMK 130
Query: 324 IIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356
IIHRD+K+ N+LL + K+ADFG++ ++ T
Sbjct: 131 IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT 163
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 1e-13
Identities = 49/152 (32%), Positives = 73/152 (48%), Gaps = 20/152 (13%)
Query: 209 LLGQGGFGYV----HKGVLTNGKVVAIKQLKAGSGQGEREFQA--EIEIISQVHHRHLVS 262
L+G+G +G V HK G++VAIK+ + A EI ++ Q+ H +LV+
Sbjct: 8 LVGEGSYGMVMKCKHK---ETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVN 64
Query: 263 LVGYCTFGSQRLLVYEFVPNKTL---EFHLHGKDRPVMNWPTRMKIALGSARGLAYLHED 319
L+ + LV+EFV + L E + +G D + K RG+ + H
Sbjct: 65 LIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVR-----KYLFQILRGIEFCHSH 119
Query: 320 CQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351
IIHRDIK NIL+ S K+ DFG A+
Sbjct: 120 ---NIIHRDIKPENILVSQSGVVKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 1e-13
Identities = 54/167 (32%), Positives = 83/167 (49%), Gaps = 8/167 (4%)
Query: 204 FSEANLLGQGGFGYVHKGVLTNGK-VVAIKQLKAGSGQGERE-FQAEIEIISQVHHRHLV 261
F++ +G+G FG V KG+ + VVAIK + + E E Q EI ++SQ ++
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 262 SLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQ 321
G G++ ++ E++ + L T +K L +GL YLH +
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL---KGLDYLHSE-- 120
Query: 322 PKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF 368
K IHRDIK+AN+LL + + K+ADFG+A DT +T V F
Sbjct: 121 -KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPF 166
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 1e-13
Identities = 44/154 (28%), Positives = 73/154 (47%), Gaps = 5/154 (3%)
Query: 210 LGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCT 268
LG G FG V+K G A K ++ S + +F EI+I+S+ H ++V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 269 FGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRD 328
+ ++ ++ EF L+ + +R + P + L +LH K+IHRD
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERG-LTEPQIRYVCRQMLEALNFLHSH---KVIHRD 128
Query: 329 IKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 362
+K+ NILL + K+ADFG++ + T T
Sbjct: 129 LKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT 162
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.5 bits (171), Expect = 2e-13
Identities = 45/173 (26%), Positives = 77/173 (44%), Gaps = 36/173 (20%)
Query: 210 LGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQA--------EIEIISQV-HHRH 259
LG G FG V+ G++VAIK++K ++F + E++ + ++ H +
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMK-------KKFYSWEECMNLREVKSLRKLNEHPN 59
Query: 260 LVSL-----VGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLA 314
+V L + V+E++ + K +P + I +GLA
Sbjct: 60 IVKLKEVFRENDELY-----FVFEYMEGNLYQLMKDRKGKP-FSESVIRSIIYQILQGLA 113
Query: 315 YLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD----TDTHVSTR 363
++H+ HRD+K N+L+ K+ADFGLA+ TD +VSTR
Sbjct: 114 HIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTD-YVSTR 162
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 2e-13
Identities = 49/155 (31%), Positives = 79/155 (50%), Gaps = 25/155 (16%)
Query: 209 LLGQGGFGYVHKGV-LTNGKV----VAIKQLKAGSGQGEREFQA---EIEIISQVHHRHL 260
LLG G FG VHKG+ + G VAIK ++ SG+ + FQ + + + H ++
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGR--QTFQEITDHMLAMGSLDHAYI 71
Query: 261 VSLVGYCTFGSQRLLVYEFVPNKTLEFHLH---GKDRP--VMNWPTRMKIALGSARGLAY 315
V L+G C G+ LV + P +L H+ P ++NW ++ A+G+ Y
Sbjct: 72 VRLLGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQI------AKGMYY 124
Query: 316 LHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLA 350
L E ++HR++ + NILL ++ADFG+A
Sbjct: 125 LEEHR---MVHRNLAARNILLKSDSIVQIADFGVA 156
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 2e-13
Identities = 49/162 (30%), Positives = 77/162 (47%), Gaps = 21/162 (12%)
Query: 208 NLLGQGGFGYVHKGVLTN------GKV-VAIKQLKAGSGQGER-EFQAEIEIISQVHHRH 259
N LG G FG V++G T+ G + VA+K L+ G+ E+ EF E ++S +H +
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 260 LVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDR-----PVMNWPTRMKIALGSARGLA 314
+V L+G C + ++ E + L +L P++ + I L A+G
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 315 YLHEDCQPKIIHRDIKSANILL-----DDSFEAKVADFGLAK 351
YL Q IHRD+ + N L+ D K+ DFGLA+
Sbjct: 121 YLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 3e-13
Identities = 48/168 (28%), Positives = 85/168 (50%), Gaps = 36/168 (21%)
Query: 202 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGERE-FQA----EIEIISQV 255
D + + N + +G +G V++ G++VA+K+LK E+E F EI I+ ++
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEK---EKEGFPITSLREINILLKL 61
Query: 256 HHRHLVSLVGYCTFGS---QRLLVYEFVPN--KTLEFHLHG-------KDRPVMNWPTRM 303
H ++V+ V GS + +V E+V + K+L + K M
Sbjct: 62 QHPNIVT-VKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVK--------CLM 112
Query: 304 KIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351
L G+A+LH++ I+HRD+K++N+LL++ K+ DFGLA+
Sbjct: 113 LQLL---SGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAR 154
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 3e-13
Identities = 49/159 (30%), Positives = 83/159 (52%), Gaps = 21/159 (13%)
Query: 204 FSEANLLGQGGFGYVHKGVLT----NGKV-VAIKQLK-AGSGQGEREFQAEIEIISQVHH 257
F + +LG G FG V+KG+ K+ VAIK+L+ A S + +E E +++ V +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 258 RHLVSLVGYCTFGSQRLLVYEFVP-NKTLEFHLHGKDR----PVMNWPTRMKIALGSARG 312
H+ L+G C S L+ + +P L++ KD ++NW ++ A+G
Sbjct: 69 PHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 121
Query: 313 LAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351
+ YL E +++HRD+ + N+L+ K+ DFGLAK
Sbjct: 122 MNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAK 157
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 4e-13
Identities = 49/168 (29%), Positives = 80/168 (47%), Gaps = 23/168 (13%)
Query: 210 LGQGGFGYV-----HKGVLTNGK-VVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSL 263
LG+G FG V + T K +VA+K LK + ++FQ E E+++ + H H+V
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 264 VGYCTFGSQRLLVYEFVPNKTLEFHL--HGKDRPVM--NWPTRMKIALG----------S 309
G C G ++V+E++ + L L HG D ++ P + K LG
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 310 ARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357
A G+ YL +HRD+ + N L+ + K+ DFG+++ TD
Sbjct: 133 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD 177
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 5e-13
Identities = 50/155 (32%), Positives = 75/155 (48%), Gaps = 17/155 (10%)
Query: 204 FSEANLLGQGGFGYVH--KGVLTNGKVVAIKQLKAGSGQGEREFQ---AEIEIISQVHHR 258
F++ +G G FG V+ + V TN +VVAIK++ Q ++Q E+ + Q+ H
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTN-EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHP 75
Query: 259 HLVSLVGYCTFGSQRLLVYEFV---PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAY 315
+ + G LV E+ + LE H + + I G+ +GLAY
Sbjct: 76 NTIEYKGCYLREHTAWLVMEYCLGSASDILEVH-----KKPLQEVEIAAICHGALQGLAY 130
Query: 316 LHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLA 350
LH + IHRDIK+ NILL + K+ADFG A
Sbjct: 131 LHSHER---IHRDIKAGNILLTEPGTVKLADFGSA 162
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 6e-13
Identities = 51/154 (33%), Positives = 85/154 (55%), Gaps = 21/154 (13%)
Query: 209 LLGQGGFGYVHKGV-LTNGKVV----AIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVS 262
+LG G FG V+KG+ + G+ V AIK L +G + EF E I++ + H HLV
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 263 LVGYCTFGSQRLLVYEFVPNKTLEFHLH-GKD----RPVMNWPTRMKIALGSARGLAYLH 317
L+G C + +L V + +P+ L ++H KD + ++NW ++ A+G+ YL
Sbjct: 74 LLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AKGMMYLE 126
Query: 318 EDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351
E +++HRD+ + N+L+ K+ DFGLA+
Sbjct: 127 ER---RLVHRDLAARNVLVKSPNHVKITDFGLAR 157
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 6e-13
Identities = 51/166 (30%), Positives = 80/166 (48%), Gaps = 42/166 (25%)
Query: 210 LGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQA-------EIEIISQVHHRHLV 261
+GQG FG V K ++VA+K++ E E + EI+I+ + H ++V
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLM-----ENEKEGFPITALREIKILQLLKHENVV 74
Query: 262 SLVGYCT--------FGSQRLLVYEF--------VPNKTLEFHLHGKDRPVMNWPTRMKI 305
+L+ C + LV+EF + NK ++F L + MK+
Sbjct: 75 NLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTL-----SEIK--KVMKM 127
Query: 306 ALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351
L GL Y+H + KI+HRD+K+ANIL+ K+ADFGLA+
Sbjct: 128 LLN---GLYYIHRN---KILHRDMKAANILITKDGILKLADFGLAR 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 7e-13
Identities = 53/184 (28%), Positives = 87/184 (47%), Gaps = 44/184 (23%)
Query: 203 NFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQA-------EIEIISQ 254
F + N +G+G +G V++ T+G++VA+K+++ + E EI ++
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRM-----DNERDGIPISSLREITLLLN 62
Query: 255 VHHRHLVSL----VGYCTFGSQRL----LVYEFVPNKTLEFHLHGKDRPVMNWPT----- 301
+ H ++V L VG + L LV E+ + N PT
Sbjct: 63 LRHPNIVELKEVVVG------KHLDSIFLVMEYCE--------QDLASLLDNMPTPFSES 108
Query: 302 RMK-IALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 360
++K + L RGL YLHE+ IIHRD+K +N+LL D K+ADFGLA+ +
Sbjct: 109 QVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM 165
Query: 361 STRV 364
+ +V
Sbjct: 166 TPKV 169
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 9e-13
Identities = 47/151 (31%), Positives = 78/151 (51%), Gaps = 8/151 (5%)
Query: 210 LGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTF 269
+G+G FG V G G VA+K +K + + F AE +++Q+ H +LV L+G
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 270 GSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRD 328
L +V E++ +L +L + R V+ +K +L + YL + +HRD
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRD 127
Query: 329 IKSANILLDDSFEAKVADFGLAKHSLDT-DT 358
+ + N+L+ + AKV+DFGL K + T DT
Sbjct: 128 LAARNVLVSEDNVAKVSDFGLTKEASSTQDT 158
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-12
Identities = 45/164 (27%), Positives = 80/164 (48%), Gaps = 24/164 (14%)
Query: 208 NLLGQGGFGYVHKGVLT---NGKVVAIKQLKA-GSGQGEREFQAEIEIISQV-HHRHLVS 262
+++G+G FG V + ++ AIK LK S R+F E+E++ ++ HH ++++
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 263 LVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPT---------------RMKIAL 307
L+G C + E+ P L L K R + P ++ A
Sbjct: 68 LLGACENRGYLYIAIEYAPYGNLLDFLR-KSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 308 GSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351
A G+ YL E + IHRD+ + N+L+ ++ +K+ADFGL++
Sbjct: 127 DVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR 167
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-12
Identities = 53/177 (29%), Positives = 85/177 (48%), Gaps = 28/177 (15%)
Query: 204 FSEANLLGQGGFGYVHKGVLTNGK-VVAIKQLKAGSGQGERE-FQAEIEIISQVHHRHLV 261
F++ +G+G FG V+KG+ K VVAIK + + E E Q EI ++SQ ++
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 262 SLVGYCTFGSQRLLVYEFV----------PNKTLEFHLHGKDRPVMNWPTRMKIALGSAR 311
G G++ ++ E++ P E ++ R ++ +
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREIL-------------K 112
Query: 312 GLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF 368
GL YLH + + IHRDIK+AN+LL + + K+ADFG+A DT +T V F
Sbjct: 113 GLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPF 166
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 2e-12
Identities = 48/151 (31%), Positives = 73/151 (48%), Gaps = 9/151 (5%)
Query: 210 LGQGGFGYVHK-GVLTNGKVVAIKQL---KAGSGQGEREFQAEIEIISQVHHRHLVSLVG 265
LG+GGFG V V GK+ A K+L + +GE+ E +I+ +V R +VSL
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59
Query: 266 YCTFGSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKI 324
Y L LV + L++H++ P + A GL +LH Q +I
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRI 116
Query: 325 IHRDIKSANILLDDSFEAKVADFGLAKHSLD 355
++RD+K N+LLDD +++D GLA
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLAVELKG 147
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 66.1 bits (162), Expect = 2e-12
Identities = 48/155 (30%), Positives = 73/155 (47%), Gaps = 27/155 (17%)
Query: 210 LGQGGFG--YVHKGVLTNGKVVAIKQLKAGSGQGEREFQ---AEIEIISQVHHRHLVSLV 264
+ +G +G ++ K T G + AIK +K + + E +I+SQ ++V L
Sbjct: 1 ISKGAYGRVFLAKKKST-GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL- 58
Query: 265 GYCTF-GSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRM------KIALGSARGLAYL 316
Y +F G + L LV E++P L L V + + +I L L YL
Sbjct: 59 -YYSFQGKKNLYLVMEYLPGGDLASLLEN----VGSLDEDVARIYIAEIVLA----LEYL 109
Query: 317 HEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351
H IIHRD+K NIL+D + K+ DFGL+K
Sbjct: 110 H---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSK 141
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 43/166 (25%), Positives = 74/166 (44%), Gaps = 35/166 (21%)
Query: 208 NLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGSGQGEREFQA--------------EIEII 252
LG+G +G V K T GK+VAIK++K + E++I+
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 253 SQVHHRHLVSLVG-YCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMK------I 305
+++ H +++ LV Y +F+ N ++ + + V++ R+ I
Sbjct: 75 NEIKHENIMGLVDVYVE--------GDFI-NLVMDI-MASDLKKVVDRKIRLTESQVKCI 124
Query: 306 ALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351
L GL LH + +HRD+ ANI ++ K+ADFGLA+
Sbjct: 125 LLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLAR 167
|
Length = 335 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 2e-12
Identities = 45/164 (27%), Positives = 79/164 (48%), Gaps = 16/164 (9%)
Query: 196 ELKIATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQ 254
E + D E +LG+G +G V+ L+ +AIK++ + + EI + S
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSY 61
Query: 255 VHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGK------DRPVMNWPTRMKIALG 308
+ HR++V +G + + E VP +L L K + + + T+ +
Sbjct: 62 LKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL--- 118
Query: 309 SARGLAYLHEDCQPKIIHRDIKSANILLDD-SFEAKVADFGLAK 351
GL YLH++ +I+HRDIK N+L++ S K++DFG +K
Sbjct: 119 --EGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSK 157
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 2e-12
Identities = 49/165 (29%), Positives = 80/165 (48%), Gaps = 13/165 (7%)
Query: 210 LGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGE-REFQAEIEIISQVHHRHLVSLVGYC 267
+G G V+ + L N + VAIK++ Q E + E++ +SQ +H ++V Y
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKY--YT 66
Query: 268 TF--GSQRLLVYEFVPNKTLEFHL--HGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPK 323
+F G + LV ++ +L + R ++ + +GL YLH + Q
Sbjct: 67 SFVVGDELWLVMPYLSGGSL-LDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ-- 123
Query: 324 IIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF 368
IHRDIK+ NILL + K+ADFG++ SL + +V TF
Sbjct: 124 -IHRDIKAGNILLGEDGSVKIADFGVSA-SLADGGDRTRKVRKTF 166
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 2e-12
Identities = 46/183 (25%), Positives = 87/183 (47%), Gaps = 32/183 (17%)
Query: 210 LGQGGFGYVH----KGVLT-----------NGKVVAIKQLKAGSGQGER-EFQAEIEIIS 253
LG+G FG VH +G+ +VA+K L+A + R +F EI+I+S
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 254 QVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHL----------HGKDRPVMNWPTRM 303
++ + +++ L+G C ++ E++ N L L H + P ++ +
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132
Query: 304 KIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTR 363
+A+ A G+ YL +HRD+ + N L+ + + K+ADFG++++ D + R
Sbjct: 133 YMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYY---R 186
Query: 364 VMG 366
+ G
Sbjct: 187 IQG 189
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 2e-12
Identities = 50/150 (33%), Positives = 80/150 (53%), Gaps = 13/150 (8%)
Query: 209 LLGQGGFGYVHKGVL-TNGK---VVAIKQLKAG-SGQGEREFQAEIEIISQVHHRHLVSL 263
++G G FG V G L GK VAIK LKAG + + R+F +E I+ Q H +++ L
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 264 VGYCTFGSQRLLVYEFVPNKTLEFHLHGKDR--PVMNWPTRMKIALGSARGLAYLHEDCQ 321
G T ++V E++ N +L+ L D V+ ++ G A G+ YL +
Sbjct: 71 EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLR---GIASGMKYLSD--- 124
Query: 322 PKIIHRDIKSANILLDDSFEAKVADFGLAK 351
+HRD+ + NIL++ + KV+DFGL++
Sbjct: 125 MGYVHRDLAARNILVNSNLVCKVSDFGLSR 154
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 3e-12
Identities = 45/163 (27%), Positives = 86/163 (52%), Gaps = 22/163 (13%)
Query: 208 NLLGQGGFGYVHKGVLTNGKV---VAIKQLKAGSGQGE-REFQAEIEIISQV-HHRHLVS 262
+++G+G FG V K + + AIK++K + + + R+F E+E++ ++ HH ++++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 263 LVGYCTFGSQRLLVYEFVP----------NKTLE----FHLHGKDRPVMNWPTRMKIALG 308
L+G C L E+ P ++ LE F + ++ + A
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 309 SARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351
ARG+ YL + + IHRD+ + NIL+ +++ AK+ADFGL++
Sbjct: 121 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR 160
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 4e-12
Identities = 46/179 (25%), Positives = 74/179 (41%), Gaps = 23/179 (12%)
Query: 204 FSEANLLGQGGFGYVHKGVL-----TNGKVVAIKQLKA-GSGQGE-REFQAEIEIISQVH 256
+LG+G FG V +G L + KV A+K +K E EF +E +
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKV-AVKTMKLDIHTYSEIEEFLSEAACMKDFD 59
Query: 257 HRHLVSLVGYCTFGSQR------LLVYEFVPNKTLE---FHLHGKDRPVMNWPTRM--KI 305
H +++ L+G C S +++ F+ + L + P P + K
Sbjct: 60 HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPE-KLPLQTLLKF 118
Query: 306 ALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRV 364
+ A G+ YL IHRD+ + N +L + VADFGL+K D + R+
Sbjct: 119 MVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRI 174
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 6e-12
Identities = 55/170 (32%), Positives = 81/170 (47%), Gaps = 9/170 (5%)
Query: 204 FSEANLLGQGGFGYVHK-GVLTNGKVVAIKQL---KAGSGQGEREFQAEIEIISQVHHRH 259
F + +LG+GGFG V V GK+ A K+L + +GE E +I+ +V+ R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 260 LVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHED 319
+VSL LV + L+FH++ + A GL LH
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH-- 119
Query: 320 CQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFG 369
Q +I++RD+K NILLDD +++D GLA H + T + RV GT G
Sbjct: 120 -QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVG 166
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 7e-12
Identities = 47/175 (26%), Positives = 73/175 (41%), Gaps = 28/175 (16%)
Query: 203 NFSEANLLGQGGFGYV----HKGVLTNGKVVAIKQL---KAGSGQGEREFQAEIEIISQV 255
+F ++G+G FG V + K+ A+K + K R E I+ ++
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKR---DTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL 57
Query: 256 HHRHLVSLVGYCTF--GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIA-LGSARG 312
+H LV+L + +F LV + + L +HL + + I + A
Sbjct: 58 NHPFLVNL--WYSFQDEENMYLVVDLLLGGDLRYHL-SQKVKFSEEQVKFWICEIVLA-- 112
Query: 313 LAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGT 367
L YLH IIHRDIK NILLD+ + DF +A T V+ + T
Sbjct: 113 LEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIA-------TKVTPDTLTT 157
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 7e-12
Identities = 53/164 (32%), Positives = 73/164 (44%), Gaps = 21/164 (12%)
Query: 210 LGQGGFGYV----HKGVLTNGKVVAIKQLKAGSGQGEREFQAE------IEIISQVHHRH 259
LG+G FG V +K G++ AIK LK G E ++ E + H
Sbjct: 7 LGRGHFGKVLLAEYKK---TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63
Query: 260 LVSLVGYCTFGSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHE 318
LV+L C + V E+ L H+H V + P + A GL YLHE
Sbjct: 64 LVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIH---TDVFSEPRAVFYAACVVLGLQYLHE 119
Query: 319 DCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 362
+ KI++RD+K N+LLD K+ADFGL K + ST
Sbjct: 120 N---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTST 160
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 7e-12
Identities = 44/154 (28%), Positives = 69/154 (44%), Gaps = 11/154 (7%)
Query: 202 DNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQG-EREFQAEIEIISQVHHRH 259
+ E + LG+G G V K L G + A+K + +++ E+EI +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 260 LVSLVGYCTFGSQRLL--VYEFVPNKTLEFHLHGKDRP---VMNWPTRMKIALGSARGLA 314
+V G S + E+ +L+ ++ K + + KIA +GL+
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLD-SIYKKVKKRGGRIGEKVLGKIAESVLKGLS 119
Query: 315 YLHEDCQPKIIHRDIKSANILLDDSFEAKVADFG 348
YLH KIIHRDIK +NILL + K+ DFG
Sbjct: 120 YLHSR---KIIHRDIKPSNILLTRKGQVKLCDFG 150
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 64.9 bits (159), Expect = 9e-12
Identities = 55/170 (32%), Positives = 71/170 (41%), Gaps = 26/170 (15%)
Query: 202 DNFSEANLLGQGGFGYV----HKGVLTNGKVVAIKQLKAG----SGQGEREFQAEIEIIS 253
D+F LG G FG V HKG +GK A+K L Q E E I+
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKG---SGKYYALKILSKAKIVKLKQVEHVL-NEKRILQ 56
Query: 254 QVHHRHLVSLVGYCTFGSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRM---KIALGS 309
+ H LV+L G L LV E+VP L F K R ++ L
Sbjct: 57 SIRHPFLVNLYG-SFQDDSNLYLVMEYVPGGEL-FSHLRKSGRFPEPVARFYAAQVVLA- 113
Query: 310 ARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 359
L YLH I++RD+K N+LLD K+ DFG AK + T+
Sbjct: 114 ---LEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKR-VKGRTY 156
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 1e-11
Identities = 43/154 (27%), Positives = 82/154 (53%), Gaps = 11/154 (7%)
Query: 203 NFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQA-EIEIISQVHHRHL 260
NF + LG+G + V+KG T G++VA+K++ + +G EI ++ ++ H ++
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 261 VSLVGYCTFGSQRLLVYEFVPN---KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLH 317
V L ++ +LV+E++ K ++ H + L +G+A+ H
Sbjct: 61 VRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLL---KGIAFCH 117
Query: 318 EDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351
E+ +++HRD+K N+L++ E K+ADFGLA+
Sbjct: 118 EN---RVLHRDLKPQNLLINKRGELKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 55/190 (28%), Positives = 84/190 (44%), Gaps = 53/190 (27%)
Query: 202 DNFSEANLLGQGGFGYVHKGVLTNGKV-VAIKQLKAGSGQGEREFQA---------EIEI 251
D + + +G G +G V T VAIK+L R FQ+ E+ +
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLS-------RPFQSAIHAKRTYRELRL 67
Query: 252 ISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLE-F-------HLHGKDRPVMNWPTRM 303
+ + H +++ L L V F P +LE F HL G D +N +
Sbjct: 68 LKHMDHENVIGL----------LDV--FTPASSLEDFQDVYLVTHLMGAD---LNNIVKC 112
Query: 304 K---------IALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354
+ + RGL Y+H IIHRD+K +NI +++ E K+ DFGLA+H+
Sbjct: 113 QKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD 169
Query: 355 DTDT-HVSTR 363
D T +V+TR
Sbjct: 170 DEMTGYVATR 179
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 1e-11
Identities = 45/149 (30%), Positives = 74/149 (49%), Gaps = 13/149 (8%)
Query: 210 LGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQA---EIEIISQVHHRHLVSLVG 265
LG+GGFG V + GK+ A K+L + + ++ E I+++VH R +VSL
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLA- 59
Query: 266 YCTFGSQR--LLVYEFVPNKTLEFHLHG--KDRPVMNWPTRMKIALGSARGLAYLHEDCQ 321
F ++ LV + L +H++ ++ P P GL +LH Q
Sbjct: 60 -YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---Q 115
Query: 322 PKIIHRDIKSANILLDDSFEAKVADFGLA 350
+II+RD+K N+LLD+ +++D GLA
Sbjct: 116 RRIIYRDLKPENVLLDNDGNVRISDLGLA 144
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 1e-11
Identities = 50/154 (32%), Positives = 81/154 (52%), Gaps = 11/154 (7%)
Query: 202 DNFSEANLLGQGGFGYVHKG-VLTNGKVVAIKQLKAGSGQGEREFQA--EIEIISQVHHR 258
D++ + LG+G + V+KG NGK+VA+K ++ +G F A E ++ + H
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGT-PFTAIREASLLKGLKHA 63
Query: 259 HLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSA-RGLAYLH 317
++V L LV+E+V ++ P P +K+ L RGL+Y+H
Sbjct: 64 NIVLLHDIIHTKETLTLVFEYVHTDLCQYM---DKHPGGLHPENVKLFLFQLLRGLSYIH 120
Query: 318 EDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351
Q I+HRD+K N+L+ D+ E K+ADFGLA+
Sbjct: 121 ---QRYILHRDLKPQNLLISDTGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 51/165 (30%), Positives = 72/165 (43%), Gaps = 31/165 (18%)
Query: 202 DNFSEANLLGQGGFGYV----HKGVLTNGKVVAIKQLKAG----SGQGEREFQAEIEIIS 253
D+F ++G+G FG V K G+V A+K L+ Q +AE +I++
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDK---DTGQVYAMKVLRKSDMIKRNQ-IAHVRAERDILA 56
Query: 254 QVHHRHLVSLVGYCTFGSQRLL--VYEFVPNKTLEFHLHGKDRPVMNWPTR-----MKIA 306
+V L Y +F + L V E++P L L KD R + +A
Sbjct: 57 DADSPWIVKL--YYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEET-ARFYIAELVLA 113
Query: 307 LGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351
L S L + IHRDIK NIL+D K+ADFGL K
Sbjct: 114 LDSVHKLGF---------IHRDIKPDNILIDADGHIKLADFGLCK 149
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 2e-11
Identities = 48/163 (29%), Positives = 79/163 (48%), Gaps = 18/163 (11%)
Query: 210 LGQGGFGYVHKGV---LTNGKV---VAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVS 262
LGQG FG V++G + G+ VA+K + + ER EF E ++ H+V
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 263 LVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTR--------MKIALGSARGLA 314
L+G + G L+V E + + L+ +L N P R +++A A G+A
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 315 YLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357
YL+ K +HRD+ + N ++ F K+ DFG+ + +TD
Sbjct: 134 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETD 173
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 2e-11
Identities = 46/157 (29%), Positives = 80/157 (50%), Gaps = 15/157 (9%)
Query: 203 NFSEANLLGQGGFG--YVHKGVLTNGKVVAIKQLK---AGSGQGEREFQA---EIEIISQ 254
+ + LG G F Y + V T G ++A+KQ+ S + E +A EI ++++
Sbjct: 1 EWLKGQQLGTGAFSSCYQARDVKT-GTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMAR 59
Query: 255 VHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLA 314
++H H++ ++G S L E++ ++ L K + RGL+
Sbjct: 60 LNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLS-KYGAFKEAVI-INYTEQLLRGLS 117
Query: 315 YLHEDCQPKIIHRDIKSANILLDDSFE-AKVADFGLA 350
YLHE+ +IIHRD+K AN+L+D + + ++ADFG A
Sbjct: 118 YLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAA 151
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 43/148 (29%), Positives = 74/148 (50%), Gaps = 5/148 (3%)
Query: 210 LGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGERE-FQAEIEIISQVHHRHLVSLVGYCT 268
LG G FG V+K V+A ++ + E E + EI+I++ H ++V L+
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 269 FGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRD 328
+ + ++ EF ++ + +RP+ P + + L YLHE+ KIIHRD
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELERPLTE-PQIRVVCKQTLEALNYLHEN---KIIHRD 128
Query: 329 IKSANILLDDSFEAKVADFGLAKHSLDT 356
+K+ NIL + K+ADFG++ + T
Sbjct: 129 LKAGNILFTLDGDIKLADFGVSAKNTRT 156
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 2e-11
Identities = 56/175 (32%), Positives = 90/175 (51%), Gaps = 34/175 (19%)
Query: 198 KIATDNFSEANLLGQGGFGYVHKGV--LTNGKVVAIKQLKAGSGQGERE-FQA----EIE 250
K D F +G+G +G V+K T G++VA+K+++ E+E F EI+
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDT-GELVALKKVRL---DNEKEGFPITAIREIK 58
Query: 251 IISQVHHRHLVSLVGYCTFGSQRL----------LVYEFVPNK---TLEFHL-HGKDRPV 296
I+ Q++HR++V+L T L LV+E++ + LE L H + +
Sbjct: 59 ILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHI 118
Query: 297 MNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351
++ MK L GL Y H+ +HRDIK +NILL++ + K+ADFGLA+
Sbjct: 119 KSF---MKQLL---EGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLAR 164
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 3e-11
Identities = 51/155 (32%), Positives = 78/155 (50%), Gaps = 8/155 (5%)
Query: 204 FSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGERE-FQAEIEIISQVHHRHLV 261
F++ +G+G FG V KG+ KVVAIK + + E E Q EI ++SQ ++
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 262 SLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQ 321
G ++ ++ E++ + L T ++ L +GL YLH +
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREIL---KGLDYLHSE-- 120
Query: 322 PKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356
K IHRDIK+AN+LL + E K+ADFG+A DT
Sbjct: 121 -KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 154
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 4e-11
Identities = 44/151 (29%), Positives = 74/151 (49%), Gaps = 19/151 (12%)
Query: 210 LGQGGFGYVHKGVLT---NGKVVAIKQLKAGSGQG--EREFQAEIEIISQVHHRHLVSLV 264
LG G FG V KG+ + K VA+K LK + + E E ++ Q+ + ++V ++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 265 GYCTFGSQRLLVYEFVP----NKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDC 320
G C +LV E NK L+ + H ++ + ++ + G+ YL E
Sbjct: 63 GICE-AESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSM------GMKYLEET- 114
Query: 321 QPKIIHRDIKSANILLDDSFEAKVADFGLAK 351
+HRD+ + N+LL AK++DFGL+K
Sbjct: 115 --NFVHRDLAARNVLLVTQHYAKISDFGLSK 143
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 4e-11
Identities = 49/160 (30%), Positives = 76/160 (47%), Gaps = 15/160 (9%)
Query: 210 LGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQ---AEIEIISQVHHRHLVSLVG 265
+G G FG V+ +VVA+K++ Q ++Q E++ + Q+ H + + G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 266 YCTFGSQRLLVYEFV---PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQP 322
LV E+ + LE H +P+ I G+ +GLAYLH
Sbjct: 89 CYLKEHTAWLVMEYCLGSASDLLEVH----KKPLQEVEI-AAITHGALQGLAYLHSHN-- 141
Query: 323 KIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 362
+IHRDIK+ NILL + + K+ADFG A S ++ V T
Sbjct: 142 -MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFVGT 180
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 5e-11
Identities = 48/161 (29%), Positives = 81/161 (50%), Gaps = 19/161 (11%)
Query: 204 FSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLK-AGSGQGE-----REFQAEIEIISQVH 256
+ E +G+G +G V+K L G+ VA+K+++ S +G RE A ++ +
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREI-ALLKQLESFE 59
Query: 257 HRHLVSLVGYCTFGSQR------LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSA 310
H ++V L+ C G + LV+E V ++ L +L +P + T +
Sbjct: 60 HPNIVRLLDVCH-GPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIKDLMRQLL 117
Query: 311 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351
RG+ +LH I+HRD+K NIL+ + K+ADFGLA+
Sbjct: 118 RGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 5e-11
Identities = 42/161 (26%), Positives = 81/161 (50%), Gaps = 13/161 (8%)
Query: 210 LGQGGFGYV----HKGVLTNGKVVAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVSLV 264
LG G G V H+ GK++A+K ++ + + + E++I+ + + ++V
Sbjct: 9 LGAGNSGVVSKVLHRP---TGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFY 65
Query: 265 GYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKI 324
G + E++ +L+ + + + + KIA+ +GL YLHE + KI
Sbjct: 66 GAFYNNGDISICMEYMDGGSLD-KILKEVQGRIPERILGKIAVAVLKGLTYLHE--KHKI 122
Query: 325 IHRDIKSANILLDDSFEAKVADFGLAKHSLDT--DTHVSTR 363
IHRD+K +NIL++ + K+ DFG++ +++ T V T
Sbjct: 123 IHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTS 163
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 6e-11
Identities = 50/171 (29%), Positives = 82/171 (47%), Gaps = 20/171 (11%)
Query: 210 LGQGGFGYVHKGVLTNGKV---VAIKQLK-AGSGQGERE-FQAEIEIISQVHHRHLVSLV 264
LG+G FG V +G L VA+K +K A + E E F +E + + H +++ L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 265 GYCTFGSQR------LLVYEFVPNKTLE-FHLHGK--DRPVMNWPTRM--KIALGSARGL 313
G C + +++ F+ + L F L+ + D P PT+M K A G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQY-LPTQMLVKFMTDIASGM 125
Query: 314 AYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRV 364
YL IHRD+ + N +L+++ VADFGL+K + D + R+
Sbjct: 126 EYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRI 173
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 6e-11
Identities = 48/155 (30%), Positives = 76/155 (49%), Gaps = 12/155 (7%)
Query: 204 FSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHRHLV 261
F L+G G +G V+KG + G++ AIK + +G E E + EI ++ + HHR++
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TGDEEEEIKQEINMLKKYSHHRNIA 66
Query: 262 SLVGYCT------FGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAY 315
+ G Q LV EF ++ + + I RGL++
Sbjct: 67 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSH 126
Query: 316 LHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLA 350
LH Q K+IHRDIK N+LL ++ E K+ DFG++
Sbjct: 127 LH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVS 158
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 7e-11
Identities = 44/176 (25%), Positives = 85/176 (48%), Gaps = 23/176 (13%)
Query: 203 NFSEANLLGQGGFGYVHKGVL----TNGKVVAIKQ--LKAGSGQGEREFQAEIEIISQVH 256
++ +LG+G FG + L + +V K+ L S + R+ EI I+S +
Sbjct: 1 HYIPIRVLGKGAFG---EATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQ 57
Query: 257 HRHLVSLVGYCTFGSQRLLVYEFVPNKTL-EFHLHGK----DRPVMNWPTRMKIALGSAR 311
H ++++ + + L+ E+ TL + + K + ++ W + SA
Sbjct: 58 HPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLW---YLFQIVSA- 113
Query: 312 GLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGT 367
++Y+H+ I+HRDIK+ NI L + K+ DFG++K L ++ ++ V+GT
Sbjct: 114 -VSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISK-ILGSEYSMAETVVGT 164
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 8e-11
Identities = 49/183 (26%), Positives = 88/183 (48%), Gaps = 26/183 (14%)
Query: 196 ELKIATDNFSEANLLGQGGFGYVHKGVL-----TNGKVVAIKQLK-AGSGQGEREFQAEI 249
EL ++ F E LG+ FG ++KG L + ++VAIK LK + Q EFQ E
Sbjct: 1 ELPLSAVRFMEE--LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEA 58
Query: 250 EIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTL-EFHL--------------HGKDR 294
+++++HH ++V L+G T +++E++ L EF + G +
Sbjct: 59 SLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVK 118
Query: 295 PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354
++ + IA+ A G+ YL +H+D+ + NIL+ + K++D GL++
Sbjct: 119 SSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIY 175
Query: 355 DTD 357
D
Sbjct: 176 SAD 178
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 1e-10
Identities = 40/138 (28%), Positives = 65/138 (47%), Gaps = 17/138 (12%)
Query: 210 LGQGGFGYVHKGVL-------TNGKVVAIKQLKAGSGQGER---EFQAEIEIISQVHHRH 259
LGQG F ++KGVL G + + G R F ++SQ+ H+H
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 260 LVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPV-MNWPTRMKIALGSARGLAYLHE 318
LV L G C + ++V E+V L+ LH + V ++W ++ +A A L YL +
Sbjct: 63 LVKLYGVCV-RDENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLED 119
Query: 319 DCQPKIIHRDIKSANILL 336
K++H ++ NIL+
Sbjct: 120 K---KLVHGNVCGKNILV 134
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 1e-10
Identities = 54/170 (31%), Positives = 82/170 (48%), Gaps = 9/170 (5%)
Query: 204 FSEANLLGQGGFGYVHK-GVLTNGKVVAIKQL---KAGSGQGEREFQAEIEIISQVHHRH 259
F +LG+GGFG V V GK+ A K+L + +GE E +I+ +V+ R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 260 LVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHED 319
+VSL LV + L+FH++ P + + A GL LH +
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE 121
Query: 320 CQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFG 369
+I++RD+K NILLDD +++D GLA + +T + RV GT G
Sbjct: 122 ---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET-IRGRV-GTVG 166
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-10
Identities = 52/167 (31%), Positives = 82/167 (49%), Gaps = 17/167 (10%)
Query: 204 FSEANLLGQGGFG--YVHKGVLTNGKVVAIKQLKAGSGQGEREFQ---AEIEIISQVHHR 258
F++ +G G FG Y + V TN +VVAIK++ Q ++Q E++ + ++ H
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTN-EVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHP 85
Query: 259 HLVSLVGYCTFGSQRLLVYEFV---PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAY 315
+ + G LV E+ + LE H +P+ I G+ +GLAY
Sbjct: 86 NSIEYKGCYLREHTAWLVMEYCLGSASDLLEVH----KKPLQEVEI-AAITHGALQGLAY 140
Query: 316 LHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 362
LH +IHRDIK+ NILL + + K+ADFG A + ++ V T
Sbjct: 141 LHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFVGT 184
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 1e-10
Identities = 43/148 (29%), Positives = 67/148 (45%), Gaps = 10/148 (6%)
Query: 210 LGQGGFGYVHKGVLTNGKVVA---IKQLKAGSGQGER-EFQAEIEIISQVHHRHLVSLVG 265
+G G FG V G G A +K+L+A + E+ F E++ +++H +++ +G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 266 YCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRM---KIALGSARGLAYLHEDCQP 322
C LLV EF P L+ +L V + ++A A GL +LH Q
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QA 119
Query: 323 KIIHRDIKSANILLDDSFEAKVADFGLA 350
IH D+ N L K+ D+GLA
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLA 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 1e-10
Identities = 42/151 (27%), Positives = 82/151 (54%), Gaps = 19/151 (12%)
Query: 210 LGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQA-------EIEIISQVHHRHLV 261
+G+G +G V+K G++VA+K+++ E E + EI ++ +++H ++V
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRL-----ETEDEGVPSTAIREISLLKELNHPNIV 61
Query: 262 SLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGS-ARGLAYLHEDC 320
L+ ++ LV+EF+ + L+ ++ ++ P +K L +G+AY H
Sbjct: 62 RLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLD-PPLIKSYLYQLLQGIAYCH--- 116
Query: 321 QPKIIHRDIKSANILLDDSFEAKVADFGLAK 351
+++HRD+K N+L+D K+ADFGLA+
Sbjct: 117 SHRVLHRDLKPQNLLIDREGALKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 51/160 (31%), Positives = 84/160 (52%), Gaps = 22/160 (13%)
Query: 209 LLGQGGFGYVHKGVLT----NGKV-VAIKQLKAG-SGQGEREFQAEIEIISQVHHRHLVS 262
+LG G FG V+KG+ N K+ VAIK L+ S + +E E +++ V ++
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 263 LVGYCTFGSQRLLVYEFVPNKTLEFHL-HGKDR----PVMNWPTRMKIALGSARGLAYLH 317
L+G C S LV + +P L ++ KDR ++NW ++ A+G++YL
Sbjct: 74 LLGIC-LTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMSYLE 126
Query: 318 EDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357
E +++HRD+ + N+L+ K+ DFGLA+ LD D
Sbjct: 127 E---VRLVHRDLAARNVLVKSPNHVKITDFGLAR-LLDID 162
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-10
Identities = 47/147 (31%), Positives = 79/147 (53%), Gaps = 16/147 (10%)
Query: 210 LGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCT 268
+G G +G V+K L G++ A+K +K G Q EI ++ + H ++V+ G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 269 FGSQRLLVYEFVPNKTLE--FHLHGKDRPVMNWPTRMKIAL---GSARGLAYLHEDCQPK 323
+ + E+ +L+ +H+ G P+ + ++IA + +GLAYLH +
Sbjct: 77 SREKLWICMEYCGGGSLQDIYHVTG---PL----SELQIAYVCRETLQGLAYLHSKGK-- 127
Query: 324 IIHRDIKSANILLDDSFEAKVADFGLA 350
+HRDIK ANILL D+ + K+ADFG+A
Sbjct: 128 -MHRDIKGANILLTDNGDVKLADFGVA 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 2e-10
Identities = 45/151 (29%), Positives = 71/151 (47%), Gaps = 7/151 (4%)
Query: 204 FSEANLLGQGGFGYVHK-GVLTNGKVVAIKQL---KAGSGQGEREFQAEIEIISQVHHRH 259
F + +LG+GGFG V V GK+ A K+L + +GE E +I+ +V+ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 260 LVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHED 319
+V+L LV + L+FH++ P + A GL LH
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH-- 119
Query: 320 CQPKIIHRDIKSANILLDDSFEAKVADFGLA 350
+ ++RD+K NILLDD +++D GLA
Sbjct: 120 -RENTVYRDLKPENILLDDYGHIRISDLGLA 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 46/173 (26%), Positives = 76/173 (43%), Gaps = 32/173 (18%)
Query: 203 NFSEANLLGQGGFGYVH------------KGVLTNGKV-----VAIKQLKAGSGQGER-E 244
NF E LG+G FG VH K N VA+K L+ + R +
Sbjct: 8 NFVE--KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARED 65
Query: 245 FQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVP----NKTLEFHLHGKDRPVMNWP 300
F E++I+S++ ++ L+G CT ++ E++ N+ L+ H+ N
Sbjct: 66 FLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSK 125
Query: 301 -----TRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFG 348
T + +A A G+ YL +HRD+ + N L+ ++ K+ADFG
Sbjct: 126 SLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRNCLVGKNYTIKIADFG 175
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 2e-10
Identities = 48/169 (28%), Positives = 75/169 (44%), Gaps = 29/169 (17%)
Query: 204 FSEANLLGQGGFGYVHKGVLT----NGKVVAIKQLKAG--SGQGEREFQAEIEIISQVHH 257
F+ +LG+G FG V + L + + VA+K LKA S EF E + + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 258 RHLVSLVGYC--TFGSQRLLVYEFVPNKTLEFHLHGK-----------DRPVMNWP--TR 302
+++ L+G + RL + P L F HG + P P T
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPI----PMVILPFMKHGDLHTFLLMSRIGEEPF-TLPLQTL 115
Query: 303 MKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351
++ + A G+ YL IHRD+ + N +L+++ VADFGL+K
Sbjct: 116 VRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-10
Identities = 56/171 (32%), Positives = 82/171 (47%), Gaps = 11/171 (6%)
Query: 204 FSEANLLGQGGFGYVHK-GVLTNGKVVAIKQL---KAGSGQGEREFQAEIEIISQVHHRH 259
F +LG+GGFG V V GK+ A K+L + +GE E I+ +V+ R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 260 LVSLVGYCTFGSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHE 318
+VSL Y L LV + L+FH++ P + + A GL L
Sbjct: 62 VVSL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR 120
Query: 319 DCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFG 369
+ +I++RD+K NILLDD +++D GLA + +T V RV GT G
Sbjct: 121 E---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-VRGRV-GTVG 166
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 3e-10
Identities = 46/173 (26%), Positives = 83/173 (47%), Gaps = 20/173 (11%)
Query: 204 FSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGE-REFQAEIEIISQVHHRHLV 261
+ L+G+G +G V++G + G+VVA+K + + + + Q E+ ++SQ+
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62
Query: 262 SLVGY--CTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMN-WPTRMKIALGSAR----GLA 314
++ Y RL + +E+ G R +M P K R L
Sbjct: 63 NITKYYGSYLKGPRLWI-------IMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALK 115
Query: 315 YLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGT 367
Y+H+ +IHRDIK+ANIL+ ++ K+ DFG+A L+ ++ + +GT
Sbjct: 116 YIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAA-LLNQNSSKRSTFVGT 164
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 4e-10
Identities = 41/153 (26%), Positives = 83/153 (54%), Gaps = 8/153 (5%)
Query: 203 NFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQA--EIEIISQVHHRH 259
++++ +G+G +G V+KG G++VA+K+++ S + A EI ++ ++ H +
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60
Query: 260 LVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGS-ARGLAYLHE 318
+V L S+ L++EF+ + L+ +L + +K L +G+ + H
Sbjct: 61 IVCLQDVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH- 118
Query: 319 DCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351
+++HRD+K N+L+D+ K+ADFGLA+
Sbjct: 119 --SRRVLHRDLKPQNLLIDNKGVIKLADFGLAR 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 4e-10
Identities = 48/160 (30%), Positives = 77/160 (48%), Gaps = 21/160 (13%)
Query: 202 DNFSEANLLGQGGFGYV----HKGVLTNGKVVAIKQLKAGSGQGERE----FQAEIEIIS 253
D+F ++G+G FG V K G + A+K+L+ S E+E +AE +I++
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKK---DTGHIYAMKKLRK-SEMLEKEQVAHVRAERDILA 56
Query: 254 QVHHRHLVSLVGYCTFGSQR--LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSAR 311
+ + +V L Y +F + L+ E++P + L KD TR IA +
Sbjct: 57 EADNPWVVKL--YYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEE-ETRFYIA-ETIL 112
Query: 312 GLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351
+ +H + IHRDIK N+LLD K++DFGL
Sbjct: 113 AIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCT 149
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 4e-10
Identities = 47/157 (29%), Positives = 77/157 (49%), Gaps = 13/157 (8%)
Query: 203 NFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLK--AGSGQGEREFQA---EIEIISQVH 256
N+ LLGQG FG V+ + G+ +A KQ++ S + +E A EI+++ +
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 257 HRHLVSLVGYCTFGSQRLLV--YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLA 314
H +V G +++ L E++P +++ L K + K G++
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL--KAYGALTESVTRKYTRQILEGMS 120
Query: 315 YLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351
YLH + I+HRDIK ANIL D + K+ DFG +K
Sbjct: 121 YLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 5e-10
Identities = 38/176 (21%), Positives = 80/176 (45%), Gaps = 16/176 (9%)
Query: 197 LKIATDNFSEANLLGQGGFGYVHKGVLTNGKV-----VAIKQLKAGSGQGERE-FQAEIE 250
+ I+ D + ++LL +G FG + G+L + K V +K +K + + + E
Sbjct: 1 IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESC 60
Query: 251 IISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNK-TLEFHLH-GKDRPVMNW---PTRMKI 305
++ + H++++ ++ C + V N L+ L + N T+ +
Sbjct: 61 LLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLV 120
Query: 306 ALGS--ARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 359
+ A G++YLH + +IH+DI + N ++D+ + K+ D L++ D H
Sbjct: 121 HMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYH 173
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 6e-10
Identities = 45/183 (24%), Positives = 85/183 (46%), Gaps = 40/183 (21%)
Query: 192 FTYEELKIATDNFSEANLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGSGQGE-REFQAEI 249
FT E+LK + +G+G FG V+K + G ++A+K++++ + E + ++
Sbjct: 1 FTAEDLK-------DLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDL 53
Query: 250 EIISQVHHRHLVSLVGY--CTFGSQRLLV------------YEFVPNKTLEFHLHGKDRP 295
+++ + +V + F + Y++V + K
Sbjct: 54 DVV--MRSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYV-------YEVLKSV- 103
Query: 296 VMNWPTRM--KIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353
P + KIA+ + + L YL E+ KIIHRD+K +NILLD + K+ DFG++
Sbjct: 104 ---IPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQL 158
Query: 354 LDT 356
+D+
Sbjct: 159 VDS 161
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 6e-10
Identities = 46/142 (32%), Positives = 67/142 (47%), Gaps = 5/142 (3%)
Query: 210 LGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTF 269
LG G FG V VA+K +K GS E F AE ++ + H LV L T
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHAVVT- 71
Query: 270 GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDI 329
++ EF+ +L L + P + + A G+A++ Q IHRD+
Sbjct: 72 KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDL 128
Query: 330 KSANILLDDSFEAKVADFGLAK 351
++ANIL+ S K+ADFGLA+
Sbjct: 129 RAANILVSASLVCKIADFGLAR 150
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 1e-09
Identities = 44/170 (25%), Positives = 83/170 (48%), Gaps = 11/170 (6%)
Query: 203 NFSEANLLGQGGFGYVH--KGVLTNGKVVAIKQLKA-GSGQGERE-FQAEIEIISQVHHR 258
+ + ++G+G FG VH + + K+V IKQ+ + ER Q E +++ + H
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRR-KADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHP 59
Query: 259 HLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHE 318
+++ ++V E+ P TL ++ + +++ T + + L ++H
Sbjct: 60 NIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH- 118
Query: 319 DCQPKIIHRDIKSANILLDD-SFEAKVADFGLAKHSLDTDTHVSTRVMGT 367
I+HRD+K+ NILLD K+ DFG++K L + + T V+GT
Sbjct: 119 --TKLILHRDLKTQNILLDKHKMVVKIGDFGISK-ILSSKSKAYT-VVGT 164
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 1e-09
Identities = 50/169 (29%), Positives = 79/169 (46%), Gaps = 21/169 (12%)
Query: 204 FSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQ---AEIEIISQVHHRH 259
FS+ +G G FG V+ + N +VVAIK++ Q ++Q E+ + ++ H +
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 260 LVSLVGYCTFGSQRLLVYEFV---PNKTLEFHLHGKDRPVMNWPTRMKIAL---GSARGL 313
+ G LV E+ + LE H +P+ ++IA G+ +GL
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVH----KKPLQ----EVEIAAVTHGALQGL 128
Query: 314 AYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 362
AYLH +IHRD+K+ NILL + K+ DFG A + V T
Sbjct: 129 AYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGT 174
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 46/157 (29%), Positives = 76/157 (48%), Gaps = 13/157 (8%)
Query: 203 NFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQL--KAGSGQGEREFQA---EIEIISQVH 256
N+ LLG+G FG V+ G+ +A+KQ+ S + +E A EI+++ +
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 257 HRHLVSLVGYCTFGSQRLL--VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLA 314
H +V G ++ L E++P +++ L N R + +G++
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQI--LQGVS 120
Query: 315 YLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351
YLH + I+HRDIK ANIL D + K+ DFG +K
Sbjct: 121 YLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 1e-09
Identities = 47/185 (25%), Positives = 83/185 (44%), Gaps = 27/185 (14%)
Query: 202 DNFSEANLLGQGGFGYV--------HKGVLTNGKVVAIKQLKAGSGQGE-REFQAEIEII 252
D + LG+G FG V K VA+K LK + + + + +E+E++
Sbjct: 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 74
Query: 253 SQV-HHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNW----------PT 301
+ H+++++L+G CT ++ E+ L +L + P M +
Sbjct: 75 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQM 134
Query: 302 RMKIALGS----ARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357
K + ARG+ YL K IHRD+ + N+L+ ++ K+ADFGLA+ + D
Sbjct: 135 TFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNID 191
Query: 358 THVST 362
+ T
Sbjct: 192 YYKKT 196
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 1e-09
Identities = 49/184 (26%), Positives = 86/184 (46%), Gaps = 29/184 (15%)
Query: 198 KIATDNFSEANLLGQGGFGYV--------HKGVLTNGKVVAIKQLKAGSGQGE-REFQAE 248
++ D LG+G FG V K VA+K LK+ + + + + +E
Sbjct: 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISE 73
Query: 249 IEIISQV-HHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNW---PTRMK 304
+E++ + H+++++L+G CT ++ E+ L +L + P M + PT++
Sbjct: 74 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVP 133
Query: 305 IALGS-----------ARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK-- 351
S ARG+ YL K IHRD+ + N+L+ + K+ADFGLA+
Sbjct: 134 EEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 190
Query: 352 HSLD 355
H +D
Sbjct: 191 HHID 194
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 47/172 (27%), Positives = 81/172 (47%), Gaps = 29/172 (16%)
Query: 210 LGQGGFGYV--------HKGVLTNGKVVAIKQLKA-GSGQGEREFQAEIEIISQV-HHRH 259
LG+G FG V K VA+K LK + + + +E+E++ + H++
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 260 LVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNW-------PTR-------MKI 305
+++L+G CT ++ E+ L +L + P M++ P +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 306 ALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK--HSLD 355
A ARG+ YL K IHRD+ + N+L+ + K+ADFGLA+ H++D
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNID 188
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-09
Identities = 47/155 (30%), Positives = 75/155 (48%), Gaps = 12/155 (7%)
Query: 204 FSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHRHLV 261
F ++G G +G V+KG + G++ AIK + + E E + EI ++ + HHR++
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE-EEEIKLEINMLKKYSHHRNIA 76
Query: 262 SLVGYCTFGS------QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAY 315
+ G S Q LV EF ++ + + I RGLA+
Sbjct: 77 TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAH 136
Query: 316 LHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLA 350
LH K+IHRDIK N+LL ++ E K+ DFG++
Sbjct: 137 LHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVS 168
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 2e-09
Identities = 43/178 (24%), Positives = 84/178 (47%), Gaps = 38/178 (21%)
Query: 210 LGQGGFGYVHKGVLTNGK-----------------VVAIKQLKAGSGQGER-EFQAEIEI 251
LG+G FG VH + N + +VA+K L+ + + R +F E++I
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72
Query: 252 ISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHL---HGKDR-------------- 294
+S++ +++ L+G C ++ E++ N L L H D+
Sbjct: 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132
Query: 295 PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352
P +++ + + +AL A G+ YL +HRD+ + N L+ ++ K+ADFG++++
Sbjct: 133 PAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRN 187
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 37/131 (28%), Positives = 62/131 (47%), Gaps = 12/131 (9%)
Query: 226 GKVVAIKQLKAGSGQGERE---FQAEIEIISQVHHRHLVSLVGYCTFGSQRLL-VYEFVP 281
G VAIK L+ + + E + F+ E + ++++H ++V+L+ L V+E+VP
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 282 NKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILL---DD 338
+TL L + ++ L LA H I+HRD+K NI++
Sbjct: 63 GRTLREVLAADG--ALPAGETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQTGV 117
Query: 339 SFEAKVADFGL 349
AKV DFG+
Sbjct: 118 RPHAKVLDFGI 128
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 2e-09
Identities = 48/155 (30%), Positives = 79/155 (50%), Gaps = 16/155 (10%)
Query: 202 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHL 260
++F +G G +G V+K + G++ AIK +K G+ Q EI ++ H ++
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNI 68
Query: 261 VSLVGYCTFGSQRLLVYEFVPNKTLE--FHLHGKDRPVMNWPTRMKIALGSA---RGLAY 315
V+ G + + EF +L+ +H+ G P+ + +IA S +GL Y
Sbjct: 69 VAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG---PL----SESQIAYVSRETLQGLYY 121
Query: 316 LHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLA 350
LH + +HRDIK ANILL D+ K+ADFG++
Sbjct: 122 LHSKGK---MHRDIKGANILLTDNGHVKLADFGVS 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 3e-09
Identities = 46/159 (28%), Positives = 77/159 (48%), Gaps = 10/159 (6%)
Query: 210 LGQGGFGYVHKGVLTNG---KVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVG 265
+G G FG V G + +G V +K+L+ + Q + +F E + + H +L+ +G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 266 YCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWP---TRMKIALGSARGLAYLHEDCQP 322
CT + LLV EF P L+ +L + + P T ++A A GL +LH++
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN--- 119
Query: 323 KIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVS 361
IH D+ N LL K+ D+GL+ + D +V+
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 3e-09
Identities = 42/154 (27%), Positives = 73/154 (47%), Gaps = 26/154 (16%)
Query: 210 LGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQA------EIEIISQVHHRHLVS 262
+G+G +G V K G++VAIK+ + E + EI ++ Q+ H +LV+
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFV----ESEDDPVIKKIALREIRMLKQLKHPNLVN 64
Query: 263 LVGYCTFGSQRL--LVYEFVPN---KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLH 317
L+ F +R LV+E+ + LE + G ++ KI + + + + H
Sbjct: 65 LIE--VFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLI-----KKIIWQTLQAVNFCH 117
Query: 318 EDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351
+ IHRD+K NIL+ + K+ DFG A+
Sbjct: 118 ---KHNCIHRDVKPENILITKQGQIKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 3e-09
Identities = 36/148 (24%), Positives = 72/148 (48%), Gaps = 14/148 (9%)
Query: 210 LGQGGFGYVHKGVLTN-GKVVAIKQLK---AGSGQGEREFQAEIEIISQVHHRHLVSLVG 265
+G+G +G V K ++VA+K+++ G + EI ++ ++ H+++V L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHKNIVRLYD 66
Query: 266 YCTFGSQRLLVYEFVPNKTLEF--HLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPK 323
+ LV+E+ ++ +G ++ +GLA+ H
Sbjct: 67 VLHSDKKLTLVFEYCDQDLKKYFDSCNGD----IDPEIVKSFMFQLLKGLAFCHSH---N 119
Query: 324 IIHRDIKSANILLDDSFEAKVADFGLAK 351
++HRD+K N+L++ + E K+ADFGLA+
Sbjct: 120 VLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 5e-09
Identities = 43/151 (28%), Positives = 81/151 (53%), Gaps = 21/151 (13%)
Query: 210 LGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQA--EIEIISQVHHRHLVSLVGY 266
LG+G + V+KG G++VA+K+++ +G F A E ++ + H ++V+L +
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGA-PFTAIREASLLKDLKHANIVTL--H 69
Query: 267 CTFGSQRLL--VYEFVPN---KTLEFHLHGKDRPVMNWPTRMKIALGS-ARGLAYLHEDC 320
+++ L V+E++ + ++ G +++ L RGLAY H
Sbjct: 70 DIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLS------MHNVRLFLFQLLRGLAYCH--- 120
Query: 321 QPKIIHRDIKSANILLDDSFEAKVADFGLAK 351
Q +++HRD+K N+L+ + E K+ADFGLA+
Sbjct: 121 QRRVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 5e-09
Identities = 48/157 (30%), Positives = 74/157 (47%), Gaps = 13/157 (8%)
Query: 203 NFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLK--AGSGQGEREFQA---EIEIISQVH 256
N+ LLGQG FG V+ G+ +A+KQ++ S + +E A EI+++ +
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 257 HRHLVSLVGYCTFGSQRLL--VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLA 314
H +V G +R L E +P +++ L K + K G++
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL--KSYGALTENVTRKYTRQILEGVS 120
Query: 315 YLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351
YLH + I+HRDIK ANIL D K+ DFG +K
Sbjct: 121 YLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASK 154
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 5e-09
Identities = 43/155 (27%), Positives = 69/155 (44%), Gaps = 20/155 (12%)
Query: 210 LGQGGFGYVHKGVL-TNGKVVAIK--------QLKAGSGQGEREFQAEIEIISQVHHRHL 260
+G+G FG V G L + VA+K LKA +F E I+ Q H ++
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKA-------KFLQEARILKQYSHPNI 55
Query: 261 VSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDC 320
V L+G CT +V E V L + P + +++ +A G+ YL
Sbjct: 56 VRLIGVCTQKQPIYIVMELVQGGDFLTFLR-TEGPRLKVKELIQMVENAAAGMEYLESKH 114
Query: 321 QPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355
IHRD+ + N L+ + K++DFG+++ D
Sbjct: 115 ---CIHRDLAARNCLVTEKNVLKISDFGMSREEED 146
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 5e-09
Identities = 42/170 (24%), Positives = 76/170 (44%), Gaps = 20/170 (11%)
Query: 201 TDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQ---AEIEIISQVH 256
NF +G+G F V+K + L +G+VVA+K+++ + Q EI+++ Q+
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 257 HRHLVSLVGYCTFGSQRLLVYEFVPN---KTLEFHLHGKDRPVMNWPTRMKIALGSARGL 313
H +++ + ++ +V E + H + R + T K + L
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPE-RTIWKYFVQLCSAL 119
Query: 314 AYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGL---------AKHSL 354
++H +I+HRDIK AN+ + + K+ D GL A HSL
Sbjct: 120 EHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL 166
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 6e-09
Identities = 47/150 (31%), Positives = 69/150 (46%), Gaps = 14/150 (9%)
Query: 209 LLGQGGFGYVHKGVLTN-GKVVAIKQLKAGSGQGEREF---QAEIEIISQV-HHRHLVSL 263
+LG+G FG V L ++ A+K LK + + E +++ H L L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61
Query: 264 VGYCTFGSQ-RL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQ 321
+ F ++ RL V E+V L FH+ R + P A GL +LHE
Sbjct: 62 --HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGR--FDEPRARFYAAEIVLGLQFLHER-- 115
Query: 322 PKIIHRDIKSANILLDDSFEAKVADFGLAK 351
II+RD+K N+LLD K+ADFG+ K
Sbjct: 116 -GIIYRDLKLDNVLLDSEGHIKIADFGMCK 144
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 7e-09
Identities = 46/155 (29%), Positives = 84/155 (54%), Gaps = 12/155 (7%)
Query: 210 LGQGGFGYVHKG--VLTNGKVVAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVSLVGY 266
LG+G + V KG LT +VA+K+++ +G E+ ++ + H ++V+L
Sbjct: 13 LGEGTYATVFKGRSKLT-ENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71
Query: 267 CTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSA-RGLAYLHEDCQPKII 325
LV+E++ + ++ + + M+ +KI + RGL+Y H+ KI+
Sbjct: 72 IHTERCLTLVFEYLDSDLKQYLDNCGNLMSMH---NVKIFMFQLLRGLSYCHKR---KIL 125
Query: 326 HRDIKSANILLDDSFEAKVADFGLAK-HSLDTDTH 359
HRD+K N+L+++ E K+ADFGLA+ S+ T T+
Sbjct: 126 HRDLKPQNLLINEKGELKLADFGLARAKSVPTKTY 160
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 7e-09
Identities = 47/159 (29%), Positives = 71/159 (44%), Gaps = 10/159 (6%)
Query: 209 LLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQA---EIEIISQVHHRHLVSLV 264
+LG+G FG V L +G++ A+K LK + + + E I+S + ++ +
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 265 GYCTFGSQRLL-VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPK 323
C RL V EFV L FH+ R + A L +LH+
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRR--FDEARARFYAAEITSALMFLHDK---G 116
Query: 324 IIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 362
II+RD+K N+LLD K+ADFG+ K + ST
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST 155
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 7e-09
Identities = 41/152 (26%), Positives = 80/152 (52%), Gaps = 7/152 (4%)
Query: 203 NFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQA--EIEIISQVHHRH 259
NF + +G+G +G V+K G+VVA+K+++ + A EI ++ +++H +
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 260 LVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHED 319
+V L+ ++ LV+EF+ ++ L+ + + P +GLA+ H
Sbjct: 61 IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH 119
Query: 320 CQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351
+++HRD+K N+L++ K+ADFGLA+
Sbjct: 120 ---RVLHRDLKPQNLLINTEGAIKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 9e-09
Identities = 43/145 (29%), Positives = 69/145 (47%), Gaps = 9/145 (6%)
Query: 209 LLGQGGFGYVHKGVLT-NGK---VVAIKQLKAG-SGQGEREFQAEIEIISQVHHRHLVSL 263
+LG G FG + +G L K VAI L+AG S + R F AE + Q H ++V L
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 264 VGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPK 323
G T G+ ++V E++ N L+ L K + M + G A G+ YL E
Sbjct: 72 EGVITRGNTMMIVTEYMSNGALDSFLR-KHEGQLVAGQLMGMLPGLASGMKYLSE---MG 127
Query: 324 IIHRDIKSANILLDDSFEAKVADFG 348
+H+ + + +L++ K++ F
Sbjct: 128 YVHKGLAAHKVLVNSDLVCKISGFR 152
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 55.3 bits (134), Expect = 1e-08
Identities = 47/150 (31%), Positives = 69/150 (46%), Gaps = 17/150 (11%)
Query: 210 LGQGGFGYVHK-GVLTNGKVVAIKQLKAG---SGQGEREFQAEIEIISQVHHRHLVSLVG 265
LG GGFG V V + + A+K +K + +E EI+ + +H +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-- 58
Query: 266 YCTFGSQRLLVY---EFVPNKTLEFHLHGKDRPVMN-WPTRMKIALGSARGLAYLHEDCQ 321
Y TF ++ +Y E+ L L DR + + + R IA YLH
Sbjct: 59 YRTFKDKKY-IYMLMEYCLGGELWTILR--DRGLFDEYTARFYIA-CVVLAFEYLHNR-- 112
Query: 322 PKIIHRDIKSANILLDDSFEAKVADFGLAK 351
II+RD+K N+LLD + K+ DFG AK
Sbjct: 113 -GIIYRDLKPENLLLDSNGYVKLVDFGFAK 141
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 1e-08
Identities = 49/165 (29%), Positives = 86/165 (52%), Gaps = 30/165 (18%)
Query: 202 DNFSEANLLGQGGFGYVHKGV--LTNGKVVAIKQLKAGSGQGEREFQA-------EIEII 252
D + + +G+G +G V+K +TN + +A+K+++ E+E + EI ++
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTN-ETIALKKIRL-----EQEDEGVPSTAIREISLL 55
Query: 253 SQVHHRHLVSL--VGYCTFGSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRM-KIALG 308
++ H ++V L V + +RL LV+E++ L+ H P R+ K L
Sbjct: 56 KEMQHGNIVRLQDVVHS---EKRLYLVFEYL---DLDLKKHMDSSPDFAKNPRLIKTYLY 109
Query: 309 SA-RGLAYLHEDCQPKIIHRDIKSANILLDDSFEA-KVADFGLAK 351
RG+AY H +++HRD+K N+L+D A K+ADFGLA+
Sbjct: 110 QILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLAR 151
|
Length = 294 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 46/160 (28%), Positives = 69/160 (43%), Gaps = 13/160 (8%)
Query: 202 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAG---SGQGEREFQAEIEIISQVHH 257
D+ +G G FG VH + A+K + + E+ E ++ +V H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 258 RHLVSLVGYCTFGSQRLL--VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAY 315
++ L + T QR L + E+VP L +L R + T + A L Y
Sbjct: 61 PFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGR--FSNSTGLFYASEIVCALEY 116
Query: 316 LHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355
LH +I++RD+K NILLD K+ DFG AK D
Sbjct: 117 LHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 1e-08
Identities = 47/169 (27%), Positives = 84/169 (49%), Gaps = 14/169 (8%)
Query: 201 TDNFSEANLLGQGGFGYV--HKGVLTNGKVVAIKQLK---AGSGQGEREFQAEIEIISQV 255
T+ + + +G G FG V + LT G+ VAIK++ + +R ++ E++++ +
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLT-GQNVAIKKIMKPFSTPVLAKRTYR-ELKLLKHL 66
Query: 256 HHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAY 315
H +++SL F S +Y + H RP+ + RGL Y
Sbjct: 67 RHENIISLSD--IFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQY-FLYQILRGLKY 123
Query: 316 LHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT-HVSTR 363
+H ++HRD+K +NIL++++ + K+ DFGLA+ T +VSTR
Sbjct: 124 VH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTR 169
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 2e-08
Identities = 42/163 (25%), Positives = 75/163 (46%), Gaps = 17/163 (10%)
Query: 203 NFSEANLLGQGGFGYVHKGVLTNG------KVVAIKQLKAGSGQG-EREFQAEIEIISQV 255
N E LG+G FG V +V +K L+ + + EF+ E+++ ++
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65
Query: 256 HHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHL---HGKDRPVMNWP--TRMKIALGS- 309
H+++V L+G C ++ E+ L+ L KD + P T+ K+AL +
Sbjct: 66 SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125
Query: 310 -ARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351
A G+ +L + +HRD+ + N L+ E KV+ L+K
Sbjct: 126 IALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSK 165
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 50/161 (31%), Positives = 73/161 (45%), Gaps = 14/161 (8%)
Query: 209 LLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQ---AEIEIISQV-HHRHLVSL 263
+LG+G FG V L + AIK LK + + + E ++S H L L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 264 VGYCTFGSQRLL--VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQ 321
YCTF ++ L V E++ L FH+ + + P A GL +LH
Sbjct: 62 --YCTFQTKENLFFVMEYLNGGDLMFHIQSCHK--FDLPRATFYAAEIICGLQFLHSK-- 115
Query: 322 PKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 362
I++RD+K NILLD K+ADFG+ K ++ D T
Sbjct: 116 -GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT 155
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 2e-08
Identities = 42/149 (28%), Positives = 68/149 (45%), Gaps = 12/149 (8%)
Query: 202 DNFSEANLLGQGGFGYVHKG-VLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHL 260
DNF + +G+G G V + G+ VA+K++ Q E+ I+ H ++
Sbjct: 22 DNFVK---IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNI 78
Query: 261 VSLVGYCTFGSQRLLVYEFVPNKTL-EFHLHGKDRPVMNWPTRMKIALGSARGLAYLHED 319
V + G + +V EF+ L + H + MN + L + L++LH
Sbjct: 79 VEMYSSYLVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIATVCLAVLKALSFLHAQ 134
Query: 320 CQPKIIHRDIKSANILLDDSFEAKVADFG 348
+IHRDIKS +ILL K++DFG
Sbjct: 135 ---GVIHRDIKSDSILLTSDGRVKLSDFG 160
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 2e-08
Identities = 37/135 (27%), Positives = 67/135 (49%), Gaps = 12/135 (8%)
Query: 210 LGQGGFGYVHKG----VLTNGKV----VAIKQLKAGSGQGEREFQAEIEIISQVHHRHLV 261
LGQG F + KG V G++ V +K L F ++SQ+ H+HLV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 262 SLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQ 321
G C G + ++V E+V +L+ +L K++ ++N ++++A A L +L +
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLK-KNKNLINISWKLEVAKQLAWALHFLEDK-- 119
Query: 322 PKIIHRDIKSANILL 336
+ H ++ + N+LL
Sbjct: 120 -GLTHGNVCAKNVLL 133
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 3e-08
Identities = 46/154 (29%), Positives = 82/154 (53%), Gaps = 10/154 (6%)
Query: 210 LGQGGFGYVHKG--VLTNGKVVAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVSLVGY 266
LG+G + V+KG LT+ +VA+K+++ +G E+ ++ + H ++V+L
Sbjct: 14 LGEGTYATVYKGRSKLTD-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 267 CTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIH 326
LV+E++ +K L+ +L +N RGL Y H + K++H
Sbjct: 73 IHTEKSLTLVFEYL-DKDLKQYLDDCGN-SINMHNVKLFLFQLLRGLNYCH---RRKVLH 127
Query: 327 RDIKSANILLDDSFEAKVADFGLAK-HSLDTDTH 359
RD+K N+L+++ E K+ADFGLA+ S+ T T+
Sbjct: 128 RDLKPQNLLINERGELKLADFGLARAKSIPTKTY 161
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 3e-08
Identities = 41/145 (28%), Positives = 69/145 (47%), Gaps = 7/145 (4%)
Query: 210 LGQGGFGYVHK-GVLTNGKVVAIKQL---KAGSGQGEREFQAEIEIISQVHHRHLVSLVG 265
LG+GGFG V V GK+ A K+L + GE+ E EI+ +V+ +V+L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 266 YCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKII 325
+ LV + L++H++ + + + G+ +LH I+
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MDIV 117
Query: 326 HRDIKSANILLDDSFEAKVADFGLA 350
+RD+K N+LLDD +++D GLA
Sbjct: 118 YRDMKPENVLLDDQGNCRLSDLGLA 142
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 3e-08
Identities = 45/153 (29%), Positives = 74/153 (48%), Gaps = 15/153 (9%)
Query: 210 LGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEI-----ISQVHHRHLVSL 263
+G G +G V+K +G VA+K ++ + + E+ + H ++V L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 264 VGYC-TFGSQR----LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHE 318
+ C T + R LV+E V ++ L +L P + T + RGL +LH
Sbjct: 68 MDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA 126
Query: 319 DCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351
+C I+HRD+K NIL+ + K+ADFGLA+
Sbjct: 127 NC---IVHRDLKPENILVTSGGQVKLADFGLAR 156
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 3e-08
Identities = 51/162 (31%), Positives = 75/162 (46%), Gaps = 17/162 (10%)
Query: 209 LLGQGGFGYVHKGVLT----NGKVVAIKQLKAG----SGQGEREFQAEIEIISQVHHRHL 260
+LG+GG+G V + GK+ A+K LK + + +AE I+ V H +
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 261 VSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGS-ARGLAYLHED 319
V L+ G + L+ E++ L HL +R + L + L +LH
Sbjct: 63 VDLIYAFQTGGKLYLILEYLSGGELFMHL---EREGIFMEDTACFYLSEISLALEHLH-- 117
Query: 320 CQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL--DTDTH 359
Q II+RD+K NILLD K+ DFGL K S+ T TH
Sbjct: 118 -QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTH 158
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 4e-08
Identities = 54/223 (24%), Positives = 92/223 (41%), Gaps = 18/223 (8%)
Query: 138 PKPSLPPSNGPTAPLPTVPVSAFNEPLSTSGSLDSDK----PFPRQSPGMPVGNFKSTFT 193
P P P+ T P T D P P P + S+
Sbjct: 3 PIQPPPGVPLPSTARHTTKSRPRRRPDLTLPLPQRDPSLAVPLPLPPPSSSSSSSSSSSA 62
Query: 194 YEELKIATDNFSE---ANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQG-EREFQAE 248
A + SE N +G G G V+K + G++ A+K + R+ E
Sbjct: 63 SGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICRE 122
Query: 249 IEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALG 308
IEI+ V+H ++V + ++ EF+ +LE ++ + + +A
Sbjct: 123 IEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLAD------VARQ 176
Query: 309 SARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351
G+AYLH + I+HRDIK +N+L++ + K+ADFG+++
Sbjct: 177 ILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSR 216
|
Length = 353 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 5e-08
Identities = 46/185 (24%), Positives = 79/185 (42%), Gaps = 27/185 (14%)
Query: 202 DNFSEANLLGQGGFGYV--------HKGVLTNGKVVAIKQLK-AGSGQGEREFQAEIEII 252
D LG+G FG V K VA+K LK + + + +E+E++
Sbjct: 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELM 71
Query: 253 SQV-HHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMN------------- 298
+ H+++++L+G CT ++ E+ L L + P +
Sbjct: 72 KLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQL 131
Query: 299 -WPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357
+ + A ARG+ YL + IHRD+ + N+L+ + K+ADFGLA+ D D
Sbjct: 132 SFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDID 188
Query: 358 THVST 362
+ T
Sbjct: 189 YYKKT 193
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 5e-08
Identities = 41/170 (24%), Positives = 79/170 (46%), Gaps = 30/170 (17%)
Query: 210 LGQGGFGYVH----KGVLTNGK-------------VVAIKQLKAGSGQGER-EFQAEIEI 251
LG+G FG VH +G+ +VA+K L+ + + R +F EI+I
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 252 ISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHL---------HGKDRPVMNWPTR 302
+S++ +++ L+ C ++ E++ N L L D +++ T
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132
Query: 303 MKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352
+ +A A G+ YL +HRD+ + N L+ ++ K+ADFG++++
Sbjct: 133 IFMATQIASGMKYLS---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRN 179
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 6e-08
Identities = 40/160 (25%), Positives = 85/160 (53%), Gaps = 8/160 (5%)
Query: 202 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAG-SGQGEREFQAEIEI-ISQVHHR 258
D+ LG+G +G V K + G ++A+K+++A + Q ++ +++I + V
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCP 60
Query: 259 HLVSLVGYCTFGSQRLLVYEFVPNKTLE-FHLHGKDRPV-MNWPTRMKIALGSARGLAYL 316
+ V+ G F + + V + +L+ F+ D+ + + KIA+ + L YL
Sbjct: 61 YTVTFYG-ALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYL 119
Query: 317 HEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356
H + +IHRD+K +N+L++ + + K+ DFG++ + +D+
Sbjct: 120 HS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 7e-08
Identities = 44/154 (28%), Positives = 78/154 (50%), Gaps = 16/154 (10%)
Query: 210 LGQGGFGYVHKG--VLTNGKVVAIKQLKAGSGQGEREFQA--EIEIISQVH---HRHLVS 262
+G+G +G V K + G+ VA+K+++ +G+ E+ ++ + H ++V
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 263 LVGYCTFG-----SQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLH 317
L CT ++ LV+E V ++ L +L P + T + RGL +LH
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127
Query: 318 EDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351
+++HRD+K NIL+ S + K+ADFGLA+
Sbjct: 128 SH---RVVHRDLKPQNILVTSSGQIKLADFGLAR 158
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 7e-08
Identities = 50/157 (31%), Positives = 86/157 (54%), Gaps = 16/157 (10%)
Query: 210 LGQGGFGYVHKG--VLTNGKVVAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVSLVGY 266
LG+G + V KG LT +VA+K+++ +G E+ ++ + H ++V+L
Sbjct: 14 LGEGTYATVFKGRSKLTE-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 267 CTFGSQRLLVYEFVPNKTLEFHLH--GKDRPVMNWPTRMKIALGSA-RGLAYLHEDCQPK 323
LV+E++ +K L+ ++ G + N +KI L RGLAY H + K
Sbjct: 73 VHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHN----VKIFLYQILRGLAYCH---RRK 124
Query: 324 IIHRDIKSANILLDDSFEAKVADFGLAK-HSLDTDTH 359
++HRD+K N+L+++ E K+ADFGLA+ S+ T T+
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTY 161
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 9e-08
Identities = 21/61 (34%), Positives = 35/61 (57%), Gaps = 11/61 (18%)
Query: 311 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK--------HSLDTDTHVST 362
RGL Y+H +IHRD+K +N+L+++ E ++ DFG+A+ H +V+T
Sbjct: 118 RGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVAT 174
Query: 363 R 363
R
Sbjct: 175 R 175
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 9e-08
Identities = 36/137 (26%), Positives = 67/137 (48%), Gaps = 10/137 (7%)
Query: 206 EANLLGQGGFGYVHKG-VLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLV 264
E N++ +G G +KG + NG +K++ + +EI + ++ H ++V L+
Sbjct: 694 EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPS----SEIADMGKLQHPNIVKLI 749
Query: 265 GYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKI 324
G C L++E++ K L L ++W R KIA+G A+ L +LH C P +
Sbjct: 750 GLCRSEKGAYLIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAV 804
Query: 325 IHRDIKSANILLDDSFE 341
+ ++ I++D E
Sbjct: 805 VVGNLSPEKIIIDGKDE 821
|
Length = 968 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 9e-08
Identities = 39/126 (30%), Positives = 58/126 (46%), Gaps = 8/126 (6%)
Query: 225 NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKT 284
GK VA+K++ Q E+ I+ HH ++V + G + +V EF+
Sbjct: 46 TGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA 105
Query: 285 L-EFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAK 343
L + H + MN + L R L+YLH +IHRDIKS +ILL K
Sbjct: 106 LTDIVTHTR----MNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIK 158
Query: 344 VADFGL 349
++DFG
Sbjct: 159 LSDFGF 164
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 1e-07
Identities = 54/164 (32%), Positives = 77/164 (46%), Gaps = 22/164 (13%)
Query: 210 LGQGGFGYV----HKGVLTNGKVVAIKQLKAGSGQGERE---FQAEIEI-ISQVHHRHLV 261
+G+G FG V HK +GK A+K L+ + ++E AE + + V H LV
Sbjct: 3 IGKGSFGKVLLAKHK---ADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLV 59
Query: 262 SLVGYCTFGSQRLL--VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIA-LGSARGLAYLHE 318
L + +F + L V ++V L FHL ++R R A + SA L YLH
Sbjct: 60 GL--HYSFQTADKLYFVLDYVNGGELFFHLQ-RERSFPEPRARFYAAEIASA--LGYLHS 114
Query: 319 DCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 362
II+RD+K NILLD + DFGL K ++ ST
Sbjct: 115 ---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST 155
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 1e-07
Identities = 48/176 (27%), Positives = 78/176 (44%), Gaps = 39/176 (22%)
Query: 209 LLGQGGFGYVHKG-VLTNGKVVAIKQL-KAGSGQGEREFQAEIEIISQVHH-RHLVSLVG 265
+G G G V+K G V+A+KQ+ + G+ + + +++++ + H ++V G
Sbjct: 22 EIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYG 81
Query: 266 YCTFGS-------------QRLL--VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSA 310
Y S +LL + +P L GK M +A+ A
Sbjct: 82 YFITDSDVFICMELMSTCLDKLLKRIQGPIPEDIL-----GK----------MTVAIVKA 126
Query: 311 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMG 366
L YL E +IHRD+K +NILLD S K+ DFG++ +D+ TR G
Sbjct: 127 --LHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--TRSAG 176
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 1e-07
Identities = 44/178 (24%), Positives = 86/178 (48%), Gaps = 40/178 (22%)
Query: 210 LGQGGFGYV----HKGVLTNGKVVAIKQL--KAGSGQGEREFQAEIEIISQVHHRHLVS- 262
+G+G +G V H+ T+GK IK+L + S + + + E +++SQ+ H ++V+
Sbjct: 8 VGKGSYGEVSLVRHR---TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64
Query: 263 -------------LVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGS 309
++G+C G +Y + + + + V+ W ++ +AL
Sbjct: 65 RESWEGEDGLLYIVMGFCEGGD----LYHKLKEQKGKLLP---ENQVVEWFVQIAMAL-- 115
Query: 310 ARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGT 367
YLHE I+HRD+K+ N+ L + KV D G+A+ L+ +++ ++GT
Sbjct: 116 ----QYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIAR-VLENQCDMASTLIGT 165
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 1e-07
Identities = 52/160 (32%), Positives = 73/160 (45%), Gaps = 23/160 (14%)
Query: 203 NFSEANLLGQGGFGYV----HKGVLTNGKVVAIKQLKAGSGQGEREFQ---AEIEIISQV 255
+F LG G FG V HKG G+ AIK LK ++ Q E I+ ++
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKG---TGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL 75
Query: 256 HHRHLVSLVGYCTFGSQRLL--VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGL 313
H +V++ C+F + + + EFV L HL R +P + + L
Sbjct: 76 SHPFIVNM--MCSFQDENRVYFLLEFVVGGELFTHL----RKAGRFPNDVAKFYHAELVL 129
Query: 314 A--YLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351
A YLH II+RD+K N+LLD+ KV DFG AK
Sbjct: 130 AFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAK 166
|
Length = 329 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 2e-07
Identities = 40/158 (25%), Positives = 83/158 (52%), Gaps = 15/158 (9%)
Query: 210 LGQGGFGYVHKG-VLTNGKVVAIKQLKAG-SGQGEREFQAEIEIISQVHHRHLVSLVGYC 267
LG G G V+K L +++A+K + + + +++ +E+EI+ + +++ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYG-A 67
Query: 268 TFGSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIH 326
F R+ + EF+ +L+ ++ K + +IA+ +GL YL KI+H
Sbjct: 68 FFVENRISICTEFMDGGSLD--VYRK----IPEHVLGRIAVAVVKGLTYL---WSLKILH 118
Query: 327 RDIKSANILLDDSFEAKVADFGLAKHSLDT--DTHVST 362
RD+K +N+L++ + K+ DFG++ +++ T+V T
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGT 156
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 51.8 bits (125), Expect = 2e-07
Identities = 24/63 (38%), Positives = 34/63 (53%), Gaps = 14/63 (22%)
Query: 311 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT----------HV 360
+ L Y+H +IHRD+K +NILL+ K+ADFGLA+ SL +V
Sbjct: 118 KALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLAR-SLSELEENPENPVLTDYV 173
Query: 361 STR 363
+TR
Sbjct: 174 ATR 176
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 2e-07
Identities = 42/161 (26%), Positives = 74/161 (45%), Gaps = 38/161 (23%)
Query: 210 LGQGGFGYVHKGVL----TNGKVVAIKQLKAGSGQG-ER-EFQAEIEIISQVHHRHLVS- 262
+G+G FG K +L +GK IK++ ER E + E+ ++S + H ++V
Sbjct: 8 IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64
Query: 263 ------------LVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSA 310
++ YC G L + + + F + +++W ++ +AL
Sbjct: 65 QESFEENGNLYIVMDYCEGGD---LYKKINAQRGVLF----PEDQILDWFVQICLAL--- 114
Query: 311 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351
++H+ KI+HRDIKS NI L K+ DFG+A+
Sbjct: 115 ---KHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIAR 149
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 2e-07
Identities = 49/155 (31%), Positives = 68/155 (43%), Gaps = 19/155 (12%)
Query: 209 LLGQGGFGYVHKGVL----TNGKVVAIKQLKAGSGQGEREFQ---AEIEIISQVHHRHLV 261
LLG+G FG V +L GK A+K LK + E E ++ H L
Sbjct: 2 LLGKGTFGKV---ILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLT 58
Query: 262 SLVGYCTFGSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIA-LGSARGLAYLHED 319
+L Y RL V E+ L FHL ++R R A + SA L YLH
Sbjct: 59 AL-KYSFQTHDRLCFVMEYANGGELFFHL-SRERVFSEDRARFYGAEIVSA--LGYLHSC 114
Query: 320 CQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354
+++RD+K N++LD K+ DFGL K +
Sbjct: 115 ---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 146
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 2e-07
Identities = 53/163 (32%), Positives = 81/163 (49%), Gaps = 27/163 (16%)
Query: 209 LLGQGGFG---YVHKGVLTN-GKVVAIKQLKAGSGQGEREFQAEIE--IISQVHHRHLVS 262
+LGQG FG V K + G++ A+K LK + + + ++E I+++V+H +V
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 263 L-VGYCTFGSQRLLVYEFVPNKTLEFHLHGKD------RPVMNWPTRMKIALGS-ARGLA 314
L + T G L+ L+F L G D + VM +K L A L
Sbjct: 63 LHYAFQTEGKLYLI---------LDF-LRGGDLFTRLSKEVMFTEEDVKFYLAELALALD 112
Query: 315 YLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357
+LH II+RD+K NILLD+ K+ DFGL+K S+D +
Sbjct: 113 HLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 152
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 2e-07
Identities = 48/160 (30%), Positives = 76/160 (47%), Gaps = 12/160 (7%)
Query: 209 LLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQ---AEIEIISQVHHRHLVSLV 264
+LG+G FG V L G+ A+K LK + + + E +++ ++ +
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 265 GYCTFGSQRLL--VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQP 322
YCTF ++ L V EF+ L FH+ K R + T + GL +LH
Sbjct: 62 -YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVC--GLQFLHSK--- 115
Query: 323 KIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 362
II+RD+K N++LD K+ADFG+ K ++ D ST
Sbjct: 116 GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST 155
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 3e-07
Identities = 44/150 (29%), Positives = 70/150 (46%), Gaps = 12/150 (8%)
Query: 202 DNFSEANLLGQGGFGYVH-KGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHL 260
DNF + +G+G G V V ++GK+VA+K++ Q E+ I+ H ++
Sbjct: 23 DNFIK---IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 79
Query: 261 VSLVGYCTFGSQRLLVYEFVPNKTL-EFHLHGKDRPVMNWPTRMKIALGSARGLAYLHED 319
V + G + +V EF+ L + H + MN + L + L+ LH
Sbjct: 80 VEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLKALSVLHAQ 135
Query: 320 CQPKIIHRDIKSANILLDDSFEAKVADFGL 349
+IHRDIKS +ILL K++DFG
Sbjct: 136 ---GVIHRDIKSDSILLTHDGRVKLSDFGF 162
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 4e-07
Identities = 43/160 (26%), Positives = 72/160 (45%), Gaps = 21/160 (13%)
Query: 209 LLGQGGFGYVHKGVLTNG--KVVAIKQLKA-----GSGQGERE-----FQAEIEII-SQV 255
LG G FG V+K N ++A+K++ G + ER+ +E+ II Q+
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 256 HHRHLVSLVGYCTF--GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRM--KIALGSAR 311
H ++V Y TF + +V + + L H + + I +
Sbjct: 67 RHPNIVRY--YKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL 124
Query: 312 GLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351
L YLH+ + +I+HRD+ NI+L + + + DFGLAK
Sbjct: 125 ALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAK 162
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 5e-07
Identities = 33/107 (30%), Positives = 50/107 (46%), Gaps = 23/107 (21%)
Query: 266 YCTFGSQRLL--VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSAR--------GLAY 315
+CTF ++ L V E++ L FH+ R AR GL +
Sbjct: 62 FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGR----------FDEARARFYAAEIICGLQF 111
Query: 316 LHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 362
LH+ II+RD+K N+LLD K+ADFG+ K +++ + ST
Sbjct: 112 LHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST 155
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 5e-07
Identities = 25/54 (46%), Positives = 37/54 (68%), Gaps = 4/54 (7%)
Query: 311 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT-HVSTR 363
RGL Y+H IIHRD+K +N+ +++ E K+ DFGLA+H+ D T +V+TR
Sbjct: 131 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 181
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 5e-07
Identities = 49/192 (25%), Positives = 85/192 (44%), Gaps = 29/192 (15%)
Query: 196 ELKIATDNFSEANLLGQGGFGYVHKGVL------TNGKVVAIKQLK-AGSGQGEREFQAE 248
E+ ++T F E LG+ FG V+KG L + VAIK LK G EF+ E
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 249 IEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHL-----HGK------DRPV- 296
+ S++ H ++V L+G T +++ + + L L H D+ V
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 297 --MNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354
+ + I A G+ +L ++H+D+ + N+L+ D K++D GL +
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVY 175
Query: 355 DTDTHVSTRVMG 366
D + ++MG
Sbjct: 176 AADYY---KLMG 184
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 5e-07
Identities = 26/62 (41%), Positives = 41/62 (66%), Gaps = 4/62 (6%)
Query: 304 KIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT--DTHVS 361
KI++ RGL YL E + KI+HRD+K +NIL++ E K+ DFG++ +D+ ++ V
Sbjct: 103 KISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVG 160
Query: 362 TR 363
TR
Sbjct: 161 TR 162
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 6e-07
Identities = 40/163 (24%), Positives = 75/163 (46%), Gaps = 17/163 (10%)
Query: 202 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQA--EIEIISQVHHR 258
D + + +G+G +G V+K GK+VA+K+ + + A EI ++ +
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 259 -HLVSL-----VGYCTFGSQRLLVYEFVPN---KTLEFHLHGKDRPVMNWPTRMKIALGS 309
++V L V LV+E++ + K ++ + G RP + T
Sbjct: 61 IYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRP-LPAKTIKSFMYQL 119
Query: 310 ARGLAYLHEDCQPKIIHRDIKSANILLDDSFEA-KVADFGLAK 351
+G+A+ H+ ++HRD+K N+L+D K+AD GL +
Sbjct: 120 LKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 7e-07
Identities = 32/122 (26%), Positives = 56/122 (45%), Gaps = 9/122 (7%)
Query: 234 LKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKD 293
+KAG G E I+ ++H ++ L G T+ L+ +P + + +
Sbjct: 122 IKAGQRGGT---ATEAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAA 175
Query: 294 RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353
+ + + I R + YLHE+ +IIHRDIK+ NI ++ + + DFG A
Sbjct: 176 KRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFP 232
Query: 354 LD 355
+D
Sbjct: 233 VD 234
|
Length = 391 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 7e-07
Identities = 53/216 (24%), Positives = 81/216 (37%), Gaps = 77/216 (35%)
Query: 210 LGQGGFGYVHK----GV--LTNGKVVAIKQLKAGSGQGE-REFQAEIEIISQV-HHRHLV 261
LG+G FG V + G+ + VA+K LK G+ E R +E++I+ + HH ++V
Sbjct: 15 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 74
Query: 262 SLVGYCTFGSQRLLVY------------------EFVPNKTLEFHLHGKDRPVMNWPTRM 303
+L+G CT L+V EFVP KT + + +
Sbjct: 75 NLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDL 134
Query: 304 KIALGS------------------------------------------------ARGLAY 315
K L S A+G+ +
Sbjct: 135 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEF 194
Query: 316 LHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351
L K IHRD+ + NILL ++ K+ DFGLA+
Sbjct: 195 L---ASRKCIHRDLAARNILLSENNVVKICDFGLAR 227
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 7e-07
Identities = 40/145 (27%), Positives = 61/145 (42%), Gaps = 16/145 (11%)
Query: 210 LGQGGFGYVH----KGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVG 265
L G G V G KV+ +KA +G EI+I+ + HR +++L+
Sbjct: 100 LTPGSEGEVFVCTKHGDEQRKKVI----VKAVTGGKTPG--REIDILKTISHRAIINLIH 153
Query: 266 YCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKII 325
+ S +V +P + + + + I LAYLH II
Sbjct: 154 AYRWKSTVCMV---MPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGR---GII 207
Query: 326 HRDIKSANILLDDSFEAKVADFGLA 350
HRD+K+ NI LD+ A + DFG A
Sbjct: 208 HRDVKTENIFLDEPENAVLGDFGAA 232
|
Length = 392 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 1e-06
Identities = 55/191 (28%), Positives = 85/191 (44%), Gaps = 29/191 (15%)
Query: 195 EELKIATDNFSEANLLGQGGFGYVHKGVLTN---GKVVAIKQLKAGSGQGEREFQAEIEI 251
E L TD + +G+G +G V+K +TN G + A+K L S E E +AE I
Sbjct: 15 ESLGDPTDTWEIIETIGKGTYGKVYK--VTNKKDGSLAAVKILDPISDVDE-EIEAEYNI 71
Query: 252 ISQV-HHRHLVSLVG------YCTFGSQRLLVYEFVPNKTLEFHLHGK-------DRPVM 297
+ + +H ++V G G Q LV E ++ + G D ++
Sbjct: 72 LQSLPNHPNVVKFYGMFYKADKLV-GGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMI 130
Query: 298 NWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357
++ I G+ GL +LH + +IIHRD+K NILL K+ DFG++ T
Sbjct: 131 SY-----ILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR 182
Query: 358 THVSTRVMGTF 368
+T V F
Sbjct: 183 LRRNTSVGTPF 193
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 1e-06
Identities = 36/150 (24%), Positives = 72/150 (48%), Gaps = 17/150 (11%)
Query: 210 LGQGGFGYVHKGVL--TNGKVVAIKQLKAGSGQGE-REFQAEIEIISQVHHRHLVSLVGY 266
LG+G +G V+K VL G +A+K+++ + + + E++I+ + ++V G
Sbjct: 9 LGKGNYGSVYK-VLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGA 67
Query: 267 CTFGSQRLLVYEFVPNKTLE------FHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDC 320
+ E++ +L+ G V+ +I +GL +L E+
Sbjct: 68 FFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLR-----RITYAVVKGLKFLKEEH 122
Query: 321 QPKIIHRDIKSANILLDDSFEAKVADFGLA 350
IIHRD+K N+L++ + + K+ DFG++
Sbjct: 123 N--IIHRDVKPTNVLVNGNGQVKLCDFGVS 150
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 21/57 (36%), Positives = 35/57 (61%), Gaps = 7/57 (12%)
Query: 311 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD----THVSTR 363
RGL Y+H ++HRD+K +N+LL+ + + K+ DFGLA+ + + +V TR
Sbjct: 119 RGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTR 172
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 2e-06
Identities = 47/160 (29%), Positives = 82/160 (51%), Gaps = 12/160 (7%)
Query: 210 LGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQA--EIEIISQVHHRHLVSLVGY 266
LG+G + V+KG+ NG++VA+K + + +G F A E ++ + H ++V L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEG-VPFTAIREASLLKGLKHANIVLLHDI 71
Query: 267 CTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSA-RGLAYLHEDCQPKII 325
V+E++ ++ + P P +++ + RGLAY+H I+
Sbjct: 72 IHTKETLTFVFEYMHTDLAQYMIQ---HPGGLHPYNVRLFMFQLLRGLAYIHGQ---HIL 125
Query: 326 HRDIKSANILLDDSFEAKVADFGLAK-HSLDTDTHVSTRV 364
HRD+K N+L+ E K+ADFGLA+ S+ + T+ S V
Sbjct: 126 HRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV 165
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 20/55 (36%), Positives = 33/55 (60%), Gaps = 5/55 (9%)
Query: 311 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVM 365
RGL Y+H ++HRD+K +N+LL+ + + K+ DFGLA+ + H T +
Sbjct: 117 RGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLAR--IADPEHDHTGFL 166
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 2e-06
Identities = 29/86 (33%), Positives = 47/86 (54%), Gaps = 4/86 (4%)
Query: 251 IISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSA 310
++ QV H+H+V L G C + ++V EFV L+ +H K + P + K+A A
Sbjct: 57 MMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTT-PWKFKVAKQLA 115
Query: 311 RGLAYLHEDCQPKIIHRDIKSANILL 336
L+YL ED ++H ++ + NILL
Sbjct: 116 SALSYL-ED--KDLVHGNVCTKNILL 138
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 23/55 (41%), Positives = 31/55 (56%), Gaps = 4/55 (7%)
Query: 311 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLA-KHSLDTDTHVSTRV 364
RGL YLH I+HRDIK N+L++ + K+ DFGLA D H++ V
Sbjct: 114 RGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEV 165
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 56/167 (33%), Positives = 73/167 (43%), Gaps = 18/167 (10%)
Query: 209 LLGQGGFGYVHKGVL----TNGKVVAIKQLKAGSGQGEREFQ---AEIEIISQVHHRHLV 261
LLG+G FG V +L +GK A+K LK + E E ++ H L
Sbjct: 2 LLGKGTFGKV---ILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLT 58
Query: 262 SLVGYCTFGSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDC 320
SL Y RL V E+V L FHL ++R TR A L YLH
Sbjct: 59 SL-KYSFQTKDRLCFVMEYVNGGELFFHL-SRERVFSEDRTRFYGA-EIVSALDYLHSG- 114
Query: 321 QPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGT 367
KI++RD+K N++LD K+ DFGL K + TD GT
Sbjct: 115 --KIVYRDLKLENLMLDKDGHIKITDFGLCKEGI-TDAATMKTFCGT 158
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 2e-06
Identities = 46/176 (26%), Positives = 74/176 (42%), Gaps = 46/176 (26%)
Query: 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQA---------EIEI 251
D + + +G G +G V + G VAIK+L R FQ+ E+ +
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKL-------YRPFQSELFAKRAYRELRL 67
Query: 252 ISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLE-FHLHGKDRPVM--NWPTRMKIA-L 307
+ + H +++ L+ F P+ +L+ FH P M + MK L
Sbjct: 68 LKHMKHENVIGLLDV------------FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKL 115
Query: 308 GSAR----------GLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353
R GL Y+H IIHRD+K N+ +++ E K+ DFGLA+ +
Sbjct: 116 SEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQT 168
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 3e-06
Identities = 44/166 (26%), Positives = 75/166 (45%), Gaps = 28/166 (16%)
Query: 196 ELKIATDNFSEANLLGQGGFGYV----HKGVLTNGKVVAIKQLKAGSGQGERE---FQAE 248
+L++ ++F ++G+G FG V HK ++ +V A+K L + F E
Sbjct: 37 KLRMKAEDFDVIKVIGRGAFGEVQLVRHK---SSKQVYAMKLLSKFEMIKRSDSAFFWEE 93
Query: 249 IEIISQVHHRHLVSLVGYCTFGSQRLL--VYEFVPNKTLEFHLHGKDRPVMNWP----TR 302
+I++ + +V L + F + L V E++P L + D P W
Sbjct: 94 RDIMAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIP-EKWARFYTAE 150
Query: 303 MKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFG 348
+ +AL + + + IHRD+K N+LLD S K+ADFG
Sbjct: 151 VVLALDAIHSMGF---------IHRDVKPDNMLLDKSGHLKLADFG 187
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 3e-06
Identities = 43/176 (24%), Positives = 84/176 (47%), Gaps = 22/176 (12%)
Query: 203 NFSEANLLGQGGFG--YVHKGVLTNGKVVAIKQ--LKAGSGQGEREFQAEIEIISQVHHR 258
+ +G+G FG Y+ K + V IK+ L + + + E+ +++++ H
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCV-IKEIDLTKMPVKEKEASKKEVILLAKMKHP 59
Query: 259 HLVSLVGYCTFGSQRLLVYEFVPNKTLEFHL---HG---KDRPVMNWPTRMKIALGSARG 312
++V+ + +V E+ L + G + +++W ++I+LG
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW--FVQISLG---- 113
Query: 313 LAYLHEDCQPKIIHRDIKSANILLD-DSFEAKVADFGLAKHSLDTDTHVSTRVMGT 367
L ++H+ KI+HRDIKS NI L + AK+ DFG+A+ L+ ++ +GT
Sbjct: 114 LKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIAR-QLNDSMELAYTCVGT 165
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 3e-06
Identities = 43/151 (28%), Positives = 67/151 (44%), Gaps = 19/151 (12%)
Query: 210 LGQGGFGYVHKGVLTN-GKVVAIKQLKAGSGQGEREFQ---AEIEIISQVHHRHLVSLVG 265
+GQGG+G V + G++VA+K++K E + E +I++ LV L+
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL- 67
Query: 266 YCTFGSQRL-LVYEFVPNKTLEFHLHG----KDRPVMNWPTRMKIALGSARGLAYLHEDC 320
Y + L L E+VP L+ + + M A+ + L Y
Sbjct: 68 YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGY----- 122
Query: 321 QPKIIHRDIKSANILLDDSFEAKVADFGLAK 351
IHRD+K N L+D S K+ DFGL+K
Sbjct: 123 ----IHRDLKPENFLIDASGHIKLTDFGLSK 149
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 3e-06
Identities = 50/158 (31%), Positives = 68/158 (43%), Gaps = 13/158 (8%)
Query: 209 LLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGERE---FQAEIEII-SQVHHRHLVSL 263
++G+G FG V +GK A+K L+ +E AE ++ V H LV L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 264 VGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPK 323
+ V +FV L FHL ++R R A A L YLH
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQ-RERSFPEPRARFYAA-EIASALGYLH---SIN 116
Query: 324 IIHRDIKSANILLDDSFEAKVADFGLAKHSL---DTDT 358
I++RD+K NILLD + DFGL K + DT T
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTT 154
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 4e-06
Identities = 48/176 (27%), Positives = 85/176 (48%), Gaps = 20/176 (11%)
Query: 198 KIATDNFSEANLLGQGGFGYVHK------GVLTNGKVVAIKQLKAGSGQGEREFQAEIEI 251
++ D+F + LG G G V K G++ K++ ++ A Q RE Q +
Sbjct: 1 ELKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQ----V 56
Query: 252 ISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRM--KIALGS 309
+ + + ++V G + + E + +L+ L R P + K+++
Sbjct: 57 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR----IPEEILGKVSIAV 112
Query: 310 ARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT--DTHVSTR 363
RGLAYL E Q I+HRD+K +NIL++ E K+ DFG++ +D+ ++ V TR
Sbjct: 113 LRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR 166
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 6e-06
Identities = 31/86 (36%), Positives = 47/86 (54%), Gaps = 8/86 (9%)
Query: 202 DNFSEANLLGQGGFGYVHK------GVLTNGKVVAIKQLKAGSGQGERE-FQAEIEIISQ 254
DN LG G FG V + G N VA+K LKA + ERE +E++I+S
Sbjct: 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSH 97
Query: 255 V-HHRHLVSLVGYCTFGSQRLLVYEF 279
+ H+++V+L+G CT G L++ E+
Sbjct: 98 LGQHKNIVNLLGACTHGGPVLVITEY 123
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 6e-06
Identities = 17/41 (41%), Positives = 25/41 (60%), Gaps = 3/41 (7%)
Query: 311 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351
GL YLH +IIHRD+K+ NI ++D + + D G A+
Sbjct: 168 EGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQ 205
|
Length = 357 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 7e-06
Identities = 51/210 (24%), Positives = 80/210 (38%), Gaps = 71/210 (33%)
Query: 210 LGQGGFGYVHK------GVLTNGKVVAIKQLKAGSGQGE-REFQAEIEIISQV-HHRHLV 261
LG+G FG V + + + VA+K LK G+ E + E++I+ + HH ++V
Sbjct: 15 LGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVV 74
Query: 262 SLVG--------------YCTFGSQ----RLLVYEFVP--NKTLEFHLH----GKDRPVM 297
+L+G YC FG+ R F P NK+ GK + +
Sbjct: 75 NLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLD 134
Query: 298 NWPTRMKIALGS------------------------------------ARGLAYLHEDCQ 321
+ + A ARG+ +L
Sbjct: 135 SVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFL---AS 191
Query: 322 PKIIHRDIKSANILLDDSFEAKVADFGLAK 351
K IHRD+ + NILL ++ K+ DFGLA+
Sbjct: 192 RKCIHRDLAARNILLSENNVVKICDFGLAR 221
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 9e-06
Identities = 47/167 (28%), Positives = 79/167 (47%), Gaps = 22/167 (13%)
Query: 208 NLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGY 266
N++G G FG V++ + + + VAIK++ RE I+ ++H +++ L Y
Sbjct: 72 NIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELL----IMKNLNHINIIFLKDY 127
Query: 267 CTFGSQRL--------LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGS---ARGLAY 315
+ +V EF+P +T+ ++ R P + + L S R LAY
Sbjct: 128 YYTECFKKNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFL-VKLYSYQLCRALAY 185
Query: 316 LHEDCQPKIIHRDIKSANILLD-DSFEAKVADFGLAKHSLDTDTHVS 361
+H I HRD+K N+L+D ++ K+ DFG AK+ L VS
Sbjct: 186 IHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVS 229
|
Length = 440 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 1e-05
Identities = 42/175 (24%), Positives = 72/175 (41%), Gaps = 49/175 (28%)
Query: 204 FSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEI---------EIIS 253
++ +G G +G V + G+ VAIK+L R FQ+EI ++
Sbjct: 17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKL-------SRPFQSEIFAKRAYRELTLLK 69
Query: 254 QVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGL 313
+ H +++ L+ F S ++ +F+L VM + M+ L G
Sbjct: 70 HMQHENVIGLLD--VFTSAVSG------DEFQDFYL------VMPY---MQTDLQKIMGH 112
Query: 314 AYLHEDCQ---------------PKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353
+ Q IIHRD+K N+ +++ E K+ DFGLA+H+
Sbjct: 113 PLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHA 167
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 1e-05
Identities = 41/160 (25%), Positives = 77/160 (48%), Gaps = 32/160 (20%)
Query: 210 LGQGGFGYVHKGVLTNGKVVA------IKQLKAGSGQGEREFQAEIE--IISQVHHRHLV 261
LG+G FG V+ ++ + K VA +K++ G QA E ++S++ H +V
Sbjct: 8 LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65
Query: 262 SLVGYCTFGSQR--LLVYEFVPNKTLEFHLH-----GKDRP---VMNWPTRMKIALGSAR 311
+ +F + ++ E+ + L+ L GK V W ++ +
Sbjct: 66 KF--HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL------ 117
Query: 312 GLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351
G+ Y+H Q +I+HRD+K+ NI L ++ K+ DFG+++
Sbjct: 118 GVHYMH---QRRILHRDLKAKNIFLKNNL-LKIGDFGVSR 153
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 1e-05
Identities = 23/54 (42%), Positives = 36/54 (66%), Gaps = 4/54 (7%)
Query: 311 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT-HVSTR 363
RGL Y+H IIHRD+K +N+ +++ E ++ DFGLA+ + D T +V+TR
Sbjct: 129 RGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR 179
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 49/176 (27%), Positives = 87/176 (49%), Gaps = 19/176 (10%)
Query: 195 EELKIATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQG-EREFQAEIEII 252
E+L+ +D LG G G V K + G V+A K + G+ ++ E++I+
Sbjct: 5 EDLETISD-------LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIM 57
Query: 253 SQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRM--KIALGSA 310
+ ++VS G + + EF+ +L+ ++ K P+ P + KIA+
Sbjct: 58 HECRSPYIVSFYGAFLNENNICMCMEFMDCGSLD-RIYKKGGPI---PVEILGKIAVAVV 113
Query: 311 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT--DTHVSTRV 364
GL YL+ +I+HRDIK +NIL++ + K+ DFG++ +++ DT V T
Sbjct: 114 EGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFVGTST 167
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 2e-05
Identities = 36/146 (24%), Positives = 65/146 (44%), Gaps = 9/146 (6%)
Query: 210 LGQGGFGYVHKGVLTNGKVVA---IKQLKAGSGQGER-EFQAEIEIISQVHHRHLVSLVG 265
+G G FG V + VA +K+LKA + E+ EF + + + H +++ +G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 266 YCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRM--KIALGSARGLAYLHEDCQPK 323
C LLV+E+ L+ +L + N + ++A A G+ ++H+
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---N 119
Query: 324 IIHRDIKSANILLDDSFEAKVADFGL 349
+H D+ N L KV D+G+
Sbjct: 120 FLHSDLALRNCFLTSDLTVKVGDYGI 145
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 49/163 (30%), Positives = 77/163 (47%), Gaps = 18/163 (11%)
Query: 209 LLGQGGFGYV----HKGVLTNGKVVAIKQLKAGSGQGERE---FQAEIEII-SQVHHRHL 260
++G+G FG V K ++G A+K L+ + ++E AE ++ + H L
Sbjct: 2 VIGKGSFGKVLLAKRK---SDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFL 58
Query: 261 VSLVGYCTFGSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHED 319
V L Y +++L V ++V L FHL ++R + P A A + YLH
Sbjct: 59 VGL-HYSFQTAEKLYFVLDYVNGGELFFHLQ-RERCFLE-PRARFYAAEVASAIGYLH-- 113
Query: 320 CQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 362
II+RD+K NILLD + DFGL K ++ + ST
Sbjct: 114 -SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST 155
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 2e-05
Identities = 21/56 (37%), Positives = 33/56 (58%), Gaps = 8/56 (14%)
Query: 312 GLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGT 367
G+ LH+ IIHRDIK N+L+D + K+ DFGL+++ L + + +GT
Sbjct: 109 GVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGL-----ENKKFVGT 156
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 54/188 (28%), Positives = 78/188 (41%), Gaps = 15/188 (7%)
Query: 191 TFTYEELKIATDNFSEANLLGQGGFGYVHKGVLT--NGKVVAIKQLKAGSGQGEREFQAE 248
T ++ +D + +G+G +G V K VL NG A+K L E E +AE
Sbjct: 7 TIIFDSFPDPSDTWEIIETIGKGTYGKVFK-VLNKKNGSKAAVKILDPIHDIDE-EIEAE 64
Query: 249 IEIISQVH-HRHLVSLVGY-----CTFGSQRLLVYEFVPNKTLEFHLHG--KDRPVMNWP 300
I+ + H ++V G G Q LV E ++ + G K M P
Sbjct: 65 YNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEP 124
Query: 301 TRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 360
I + GL +LH + K IHRD+K NILL K+ DFG++ T
Sbjct: 125 IIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR 181
Query: 361 STRVMGTF 368
+T V F
Sbjct: 182 NTSVGTPF 189
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 3e-05
Identities = 40/142 (28%), Positives = 69/142 (48%), Gaps = 9/142 (6%)
Query: 210 LGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQA-EIEIISQVHHRHLVSLVGYC 267
+GQG G V+ + + G+ VAIKQ+ Q ++E EI ++ + H ++V+ +
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNL-QQQPKKELIINEILVMRENKHPNIVNYLDSY 85
Query: 268 TFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHR 327
G + +V E++ +L + M+ + + L +LH + ++IHR
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLHSN---QVIHR 139
Query: 328 DIKSANILLDDSFEAKVADFGL 349
DIKS NILL K+ DFG
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGF 161
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 3e-05
Identities = 48/173 (27%), Positives = 76/173 (43%), Gaps = 13/173 (7%)
Query: 193 TYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKV--VAIKQLKAGSGQGEREFQ---A 247
+ K+ ++F+ LG G FG V N VAIK+ + +++ +
Sbjct: 21 PKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFS 80
Query: 248 EIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIAL 307
E +I++ ++H V+L G S LV EFV L R +P +
Sbjct: 81 ERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKR----FPN--DVGC 134
Query: 308 GSARGLAYLHEDCQP-KIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 359
A + + E Q I++RD+K N+LLD K+ DFG AK +DT T+
Sbjct: 135 FYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAK-VVDTRTY 186
|
Length = 340 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 4e-05
Identities = 51/177 (28%), Positives = 76/177 (42%), Gaps = 34/177 (19%)
Query: 203 NFSEANLLGQGGFGYV----HKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHR 258
+F+ +LG+G FG V KG ++ AIK LK + Q + + V R
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKG---TDELYAIKILKK-----DVIIQDDDVECTMVEKR 52
Query: 259 ---------HLVSLVGYCTFGS-QRL-LVYEFVPNKTLEFHLH--GKDRPVMNWPTRMKI 305
L L + F + RL V E+V L +H+ GK + P +
Sbjct: 53 VLALPGKPPFLTQL--HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKE----PHAVFY 106
Query: 306 ALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 362
A A GL +LH II+RD+K N++LD K+ADFG+ K ++ T
Sbjct: 107 AAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT 160
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 4e-05
Identities = 50/164 (30%), Positives = 72/164 (43%), Gaps = 20/164 (12%)
Query: 209 LLGQGGFGYV----HKGVLTNGKVVAIKQLKAGSGQGEREFQ---AEIEIIS-QVHHRHL 260
+LG+G FG V KG +V AIK LK + + E I++ H L
Sbjct: 2 VLGKGSFGKVMLAELKG---TDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFL 58
Query: 261 VSLVGYCTF-GSQRLL-VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHE 318
+L +C F RL V E+V L F + + R +R A L +LH
Sbjct: 59 TAL--HCCFQTKDRLFFVMEYVNGGDLMFQIQ-RSRKFDEPRSRF-YAAEVTLALMFLH- 113
Query: 319 DCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 362
+ +I+RD+K NILLD K+ADFG+ K + +T
Sbjct: 114 --RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTT 155
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 4e-05
Identities = 46/163 (28%), Positives = 76/163 (46%), Gaps = 29/163 (17%)
Query: 202 DNFSEANLLGQGGFG---YVHKGVLTNGKVVAIKQLKAGSGQGEREF---QAEIEIISQV 255
++F ++G+G FG V K GK+ A+K L + + +AE +++++
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQK--KDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAES 58
Query: 256 HHRHLVSLVGYCTF-GSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWP------TRMKIAL 307
+VSL Y +F +Q L L+ EF+P L L + + TR +A
Sbjct: 59 DSPWVVSL--YYSFQDAQYLYLIMEFLPGGDLMTML-------IKYDTFSEDVTRFYMA- 108
Query: 308 GSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLA 350
+ +H + IHRDIK NIL+D K++DFGL+
Sbjct: 109 ECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 4e-05
Identities = 24/62 (38%), Positives = 41/62 (66%), Gaps = 4/62 (6%)
Query: 304 KIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT--DTHVS 361
K+++ +GL YL E + KI+HRD+K +NIL++ E K+ DFG++ +D+ ++ V
Sbjct: 107 KVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVG 164
Query: 362 TR 363
TR
Sbjct: 165 TR 166
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 4e-05
Identities = 25/56 (44%), Positives = 30/56 (53%), Gaps = 3/56 (5%)
Query: 313 LAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF 368
L +H +IHRDIKSANILL + K+ DFG +K T VS V TF
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAAT---VSDDVGRTF 205
|
Length = 496 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 4e-05
Identities = 40/156 (25%), Positives = 70/156 (44%), Gaps = 7/156 (4%)
Query: 210 LGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCT 268
+GQG G V+ + + G+ VAIKQ+ + EI ++ + + ++V+ +
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 269 FGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRD 328
G + +V E++ +L + M+ + + L +LH + ++IHRD
Sbjct: 87 VGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALDFLHSN---QVIHRD 140
Query: 329 IKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRV 364
IKS NILL K+ DFG + ST V
Sbjct: 141 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV 176
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 4e-05
Identities = 46/177 (25%), Positives = 74/177 (41%), Gaps = 22/177 (12%)
Query: 202 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGERE---FQAEIEIISQVHH 257
+F +L+G+G FG V G + A+K +K + F+ E +I+S +
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 258 RHLVSLVGYCTFGSQRL-LVYEFVPNKTLEFHLHGKDRP-----VMNWPTRMKIALGSAR 311
+ L Y L LV E+ P L L+ + + + +A+ S
Sbjct: 61 PWIPQLQ-YAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVH 119
Query: 312 GLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV-STRVMGT 367
+ Y +HRDIK N+L+D + K+ADFG A L + V S +GT
Sbjct: 120 QMGY---------VHRDIKPENVLIDRTGHIKLADFGSAA-RLTANKMVNSKLPVGT 166
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 5e-05
Identities = 46/162 (28%), Positives = 73/162 (45%), Gaps = 16/162 (9%)
Query: 209 LLGQGGFGYV----HKGVLTNGKVVAIKQLKAGS---GQGEREFQAEIEII-SQVHHRHL 260
++G+G FG V HK K A+K L+ + + E+ +E ++ V H L
Sbjct: 2 VIGKGSFGKVLLARHK---AEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFL 58
Query: 261 VSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDC 320
V L + V +++ L +HL ++R + P A A L YLH
Sbjct: 59 VGLHFSFQTADKLYFVLDYINGGELFYHLQ-RERCFLE-PRARFYAAEIASALGYLH--- 113
Query: 321 QPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 362
I++RD+K NILLD + DFGL K +++ + ST
Sbjct: 114 SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST 155
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 6e-05
Identities = 50/197 (25%), Positives = 84/197 (42%), Gaps = 31/197 (15%)
Query: 169 SLDSDKPFPRQSPGMPVGNFKSTFT-----YEELKIATDNFSEANLLGQGGFGYV----H 219
+L D FP + NF + + +L++ +++ ++G+G FG V H
Sbjct: 5 ALVYDLDFPALRKNKNIDNFLNRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRH 64
Query: 220 KGVLTNGKVVAIKQLKAGSGQGERE---FQAEIEIISQVHHRHLVSLVGYCTFGSQRLL- 275
K + KV A+K L + F E +I++ + +V L + F R L
Sbjct: 65 K---STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL--FYAFQDDRYLY 119
Query: 276 -VYEFVPNKTLEFHLHGKDRP---VMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKS 331
V E++P L + D P + + +AL + + + IHRD+K
Sbjct: 120 MVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGF---------IHRDVKP 170
Query: 332 ANILLDDSFEAKVADFG 348
N+LLD S K+ADFG
Sbjct: 171 DNMLLDKSGHLKLADFG 187
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 7e-05
Identities = 39/156 (25%), Positives = 70/156 (44%), Gaps = 7/156 (4%)
Query: 210 LGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCT 268
+GQG G V + + G+ VAIKQ+ + EI ++ ++ + ++V+ +
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 269 FGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRD 328
G + +V E++ +L + M+ + + L +LH + ++IHRD
Sbjct: 87 VGDELFVVMEYLAGGSLTDVV---TETCMDEAQIAAVCRECLQALEFLHAN---QVIHRD 140
Query: 329 IKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRV 364
IKS N+LL K+ DFG + ST V
Sbjct: 141 IKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV 176
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 7e-05
Identities = 44/161 (27%), Positives = 71/161 (44%), Gaps = 16/161 (9%)
Query: 201 TDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQ---AEIEIISQVH 256
NF +LG+G FG V ++ AIK LK + + + E +++
Sbjct: 1 DFNFL--MVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQD 58
Query: 257 HRHLVSLVGYCTFGSQRL-LVYEFVPNKTLEFHLH--GKDRPVMNWPTRMKIALGSARGL 313
++ + C RL V E+V L +H+ GK + P + A + GL
Sbjct: 59 KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKE----PQAVFYAAEISVGL 114
Query: 314 AYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354
+LH II+RD+K N++LD K+ADFG+ K +
Sbjct: 115 FFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHM 152
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 7e-05
Identities = 46/155 (29%), Positives = 76/155 (49%), Gaps = 15/155 (9%)
Query: 202 DNFSEANLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGSGQGERE----FQAEIEIISQVH 256
D+F ++G+G FG V + G + A+K L+ + E+E +AE +I+ +
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRK-ADMLEKEQVAHIRAERDILVEAD 59
Query: 257 HRHLVSLVGYCTFGSQR--LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLA 314
+V + + +F +R L+ EF+P + L KD + T+ IA + +
Sbjct: 60 GAWVVKM--FYSFQDKRNLYLIMEFLPGGDMMTLLMKKD-TLSEEATQFYIA-ETVLAID 115
Query: 315 YLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGL 349
+H Q IHRDIK N+LLD K++DFGL
Sbjct: 116 AIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 8e-05
Identities = 50/197 (25%), Positives = 85/197 (43%), Gaps = 31/197 (15%)
Query: 169 SLDSDKPFPRQSPGMPVGNFKSTF-----TYEELKIATDNFSEANLLGQGGFGYV----H 219
SL D FP + NF + + +L++ +++ ++G+G FG V H
Sbjct: 5 SLVLDLDFPALRKNKNIDNFLNRYEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRH 64
Query: 220 KGVLTNGKVVAIKQLKAGSGQGERE---FQAEIEIISQVHHRHLVSLVGYCTFGSQRLL- 275
K ++ KV A+K L + F E +I++ + +V L +C F + L
Sbjct: 65 K---SSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL--FCAFQDDKYLY 119
Query: 276 -VYEFVPNKTLEFHLHGKDRP---VMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKS 331
V E++P L + D P + + +AL + + +IHRD+K
Sbjct: 120 MVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMG---------LIHRDVKP 170
Query: 332 ANILLDDSFEAKVADFG 348
N+LLD K+ADFG
Sbjct: 171 DNMLLDKHGHLKLADFG 187
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 9e-05
Identities = 37/183 (20%), Positives = 48/183 (26%), Gaps = 9/183 (4%)
Query: 5 PPLTSLPAPPETNSTFSPPAPPPSVSAVSAPAPG-NLTSPPSSGTPTSGSTVGTRRPSPT 63
S SP P +AV APA + P+ P S T P P
Sbjct: 2784 TRPAVASLSESRESLPSPWDPADPPAAVLAPAAALPPAASPAGPLPPPTSAQPTA-PPPP 2842
Query: 64 RNGYLPPGALAGMVV--GVVIGAGIVLAAVGIFLIFYKRRKRKLAAQNLPLKNDPFAGKP 121
P L G V G V + + R+LA + + FA P
Sbjct: 2843 PGPPPPSLPLGGSVAPGGDVRRRPPSRSPAAKPAAPARPPVRRLARPAVSRSTESFALPP 2902
Query: 122 HHWQQNVSAPSDYQELPKPSLPPSNGPTAPLPTVPVSAFNEPLSTSGSLDSDKPFPRQSP 181
+ + P P P P P P P P S
Sbjct: 2903 -----DQPERPPQPQAPPPPQPQPQPPPPPQPQPPPPPPPRPQPPLAPTTDPAGAGEPSG 2957
Query: 182 GMP 184
+P
Sbjct: 2958 AVP 2960
|
Length = 3151 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 9e-05
Identities = 31/87 (35%), Positives = 49/87 (56%), Gaps = 6/87 (6%)
Query: 251 IISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLH-GKDRPVMNWPTRMKIALGS 309
++SQV H HL + G C GS+ ++V EFV + L+ L K R + W ++ +A
Sbjct: 69 LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KITVAQQL 126
Query: 310 ARGLAYLHEDCQPKIIHRDIKSANILL 336
A L+YL ED ++H ++ + NILL
Sbjct: 127 ASALSYL-ED--KNLVHGNVCAKNILL 150
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 36/180 (20%), Positives = 44/180 (24%), Gaps = 13/180 (7%)
Query: 5 PPLTSLPAPPETNSTFSPPAPPPSVSAVSAPAPGNLTSPPSSGTPTSGSTVGTRRPSPTR 64
PP T PAP S P P + S P P P + PT
Sbjct: 2704 PPPTPEPAPHALVSATPLPPGPAAARQASPALPAAPAPPAVPAGPATPGGPARPARPPTT 2763
Query: 65 NGYLPPGALAGMVVGVVIGAGIVLAAVGIFLIFYKRRKRKLAAQNLPLKNDPFAGKPHHW 124
G P A G A + ++LP DP
Sbjct: 2764 AGPPAPAPPAAPAAGPPRRLTRPAVA-----------SLSESRESLPSPWDPADPPAAVL 2812
Query: 125 QQNVSAPSDYQELPKPSLPPSNGPTAPLPTVPVSAFNEPLSTSGSLDSDKPFPRQSPGMP 184
+ P P LPP P P L GS+ R+ P
Sbjct: 2813 APAAALPP--AASPAGPLPPPTSAQPTAPPPPPGPPPPSLPLGGSVAPGGDVRRRPPSRS 2870
|
Length = 3151 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 37/110 (33%), Positives = 50/110 (45%), Gaps = 6/110 (5%)
Query: 246 QAEIEIISQV-HHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMK 304
Q E + Q +H LV L S+ V E+V L FH+ + R + R
Sbjct: 43 QTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ-RQRKLPEEHARFY 101
Query: 305 IALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354
A S L YLHE II+RD+K N+LLD K+ D+G+ K L
Sbjct: 102 SAEISL-ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 147
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 20/52 (38%), Positives = 32/52 (61%), Gaps = 3/52 (5%)
Query: 310 ARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVS 361
A L YLH + IIHRD+K N+L+ + K+ DFGL+K +L+ + ++
Sbjct: 114 ALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNMM 162
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 1e-04
Identities = 36/141 (25%), Positives = 66/141 (46%), Gaps = 7/141 (4%)
Query: 210 LGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCT 268
+GQG G V+ + + G+ VAI+Q+ + EI ++ + + ++V+ +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 269 FGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRD 328
G + +V E++ +L + M+ + + L +LH + ++IHRD
Sbjct: 88 VGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLHSN---QVIHRD 141
Query: 329 IKSANILLDDSFEAKVADFGL 349
IKS NILL K+ DFG
Sbjct: 142 IKSDNILLGMDGSVKLTDFGF 162
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 2e-04
Identities = 22/67 (32%), Positives = 38/67 (56%), Gaps = 9/67 (13%)
Query: 299 WPTRM----KIALGSARGLAYL-HEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353
WP + + + A+G+ +L ++C IHRD+ + N+LL D AK+ DFGLA+
Sbjct: 207 WPLDLDDLLRFSSQVAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLARDI 262
Query: 354 LDTDTHV 360
++ +V
Sbjct: 263 MNDSNYV 269
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 37/161 (22%), Positives = 51/161 (31%), Gaps = 7/161 (4%)
Query: 2 TSQPPLTSLPAPPETNSTFSPPAPP---PSVSAVSAPAPG-NLTSPPSSGTPTSGSTVGT 57
LT + S S P+P +AV APA + P+ P S T
Sbjct: 2778 GPPRRLTRPAVASLSESRESLPSPWDPADPPAAVLAPAAALPPAASPAGPLPPPTSAQPT 2837
Query: 58 RRPSPTRNGYLPPGALAGMVV--GVVIGAGIVLAAVGIFLIFYKRRKRKLAAQNLPLKND 115
P P P L G V G V + + R+LA + +
Sbjct: 2838 -APPPPPGPPPPSLPLGGSVAPGGDVRRRPPSRSPAAKPAAPARPPVRRLARPAVSRSTE 2896
Query: 116 PFAGKPHHWQQNVSAPSDYQELPKPSLPPSNGPTAPLPTVP 156
FA P ++ + P+P PP P P P P
Sbjct: 2897 SFALPPDQPERPPQPQAPPPPQPQPQPPPPPQPQPPPPPPP 2937
|
Length = 3151 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 38/158 (24%), Positives = 75/158 (47%), Gaps = 16/158 (10%)
Query: 202 DNFSEANLLGQGGFGYV----HKGVLTNGKVVAIKQLKAGSGQGEREFQA--EIEIISQV 255
+ F ++G+G +G V HK ++VAIK+ K E + E++++ +
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHK---ETKEIVAIKKFKDSEENEEVKETTLRELKMLRTL 57
Query: 256 HHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGS-ARGLA 314
++V L + LV+E+V LE ++ P P +++ + + +
Sbjct: 58 KQENIVELKEAFRRRGKLYLVFEYVEKNMLELL---EEMPNGVPPEKVRSYIYQLIKAIH 114
Query: 315 YLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352
+ H++ I+HRDIK N+L+ + K+ DFG A++
Sbjct: 115 WCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARN 149
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 45/179 (25%), Positives = 77/179 (43%), Gaps = 24/179 (13%)
Query: 203 NFSEANLLGQGGFGYV--------HKGVLTNGKVVAIKQLKAGS----GQGEREFQAEIE 250
NF +LG G +G V H +GK+ A+K LK + + + E +
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHD----SGKLYAMKVLKKATIVQKAKTTEHTRTERQ 56
Query: 251 IISQVHHRHLVSLVGYCTFGSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGS 309
++ + + + Y +L L+ +++ L HL ++R ++I G
Sbjct: 57 VLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQ---EVQIYSGE 113
Query: 310 -ARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGT 367
L +LH + II+RDIK NILLD + + DFGL+K + + + GT
Sbjct: 114 IVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGT 169
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 48/170 (28%), Positives = 73/170 (42%), Gaps = 33/170 (19%)
Query: 209 LLGQGGFGYVH----KGVLTNGKVVAIKQLKAGSGQGEREFQ---AEIEIISQVHHRHLV 261
LLG+G G V KG GK+ A+K L + + E EI++ + H L
Sbjct: 8 LLGKGDVGRVFLVRLKGT---GKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLP 64
Query: 262 SLVGYCTFGSQR--LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSAR-------- 311
+L Y +F ++ LV ++ P E + +P ++ AR
Sbjct: 65 TL--YASFQTETYLCLVMDYCPGG--ELFRLLQRQP------GKCLSEEVARFYAAEVLL 114
Query: 312 GLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVS 361
L YLH I++RD+K NILL +S ++DF L+K S VS
Sbjct: 115 ALEYLH--LL-GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVS 161
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 44/159 (27%), Positives = 70/159 (44%), Gaps = 17/159 (10%)
Query: 209 LLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREF---QAEIEIISQV-HHRHLVSL 263
++G+G + V L ++ A+K +K + + Q E + +H LV L
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61
Query: 264 VGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRM---KIALGSARGLAYLHEDC 320
S+ V EFV L FH+ + R + R +I+L L +LHE
Sbjct: 62 HSCFQTESRLFFVIEFVSGGDLMFHMQ-RQRKLPEEHARFYSAEISLA----LNFLHER- 115
Query: 321 QPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL-DTDT 358
II+RD+K N+LLD K+ D+G+ K + DT
Sbjct: 116 --GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT 152
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 36/171 (21%), Positives = 79/171 (46%), Gaps = 10/171 (5%)
Query: 203 NFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLK---AGSGQGEREFQAEIEIISQVHHR 258
NF +G+G F V++ L + K VA+K+++ + ++ EI+++ Q++H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 259 HLVSLVGYCTFGSQRLLVYEFVPNKTLE--FHLHGKDRPVMNWPTRMKIALGSARGLAYL 316
+++ + ++ +V E L K + ++ T K + + ++
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 317 HEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGT 367
H +++HRDIK AN+ + + K+ D GL + + T + ++GT
Sbjct: 123 HSR---RVMHRDIKPANVFITATGVVKLGDLGLGRF-FSSKTTAAHSLVGT 169
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 2e-04
Identities = 43/157 (27%), Positives = 81/157 (51%), Gaps = 20/157 (12%)
Query: 210 LGQGGFGYVHKGVLTNGK---VVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGY 266
+G+G +G+V+K +GK A+KQ++ G+G + EI ++ ++ H ++++L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIE-GTGISMSACR-EIALLRELKHPNVIALQKV 66
Query: 267 CTFGSQR--LLVYEFVPNK---TLEFHLHGK-DRPVMNWPTRMKIAL--GSARGLAYLHE 318
S R L++++ + ++FH K ++ M P M +L G+ YLH
Sbjct: 67 FLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA 126
Query: 319 DCQPKIIHRDIKSANILL----DDSFEAKVADFGLAK 351
+ ++HRD+K ANIL+ + K+AD G A+
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 2e-04
Identities = 42/163 (25%), Positives = 67/163 (41%), Gaps = 43/163 (26%)
Query: 210 LGQGGFGYVHKG-VLTNGKVVAIKQLKAGSGQGE-----REFQAEIEIISQVHHRHLVSL 263
+G+G F V K GK AIK +K E RE QA + H +++ L
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQA---LRRLSPHPNILRL 63
Query: 264 VGYCTFGSQRLLVYEFVPNK-TLEFHL---------HGKDRP-----VMNWPTRMKIALG 308
+ ++++ + L F L G+ RP V ++ ++
Sbjct: 64 IE---------VLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQL----- 109
Query: 309 SARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351
+ L ++H + I HRDIK NIL+ D K+ADFG +
Sbjct: 110 -LKSLDHMH---RNGIFHRDIKPENILIKDD-ILKLADFGSCR 147
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 2e-04
Identities = 23/60 (38%), Positives = 32/60 (53%), Gaps = 10/60 (16%)
Query: 311 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK-HSLDTDT------HVSTR 363
R L Y+H + HRD+K NIL + + K+ DFGLA+ DT T +V+TR
Sbjct: 114 RALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 41.8 bits (99), Expect = 3e-04
Identities = 29/113 (25%), Positives = 50/113 (44%), Gaps = 17/113 (15%)
Query: 248 EIEIISQVH-----HRHLVSLVGYCTFGSQR--LLVYEFVPNKTLEFHLHGKDRPVMNWP 300
IE + VH + + + L Y + + + +L+ +++ + L F L K+ +
Sbjct: 56 AIEPM--VHQLMKDNPNFIKL--YYSVTTLKGHVLIMDYIKDGDL-FDLLKKEGKLSEAE 110
Query: 301 TRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS-FEAKVADFGLAKH 352
+ KI L LH+ IIH DIK N+L D + + D+GL K
Sbjct: 111 VK-KIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKI 159
|
Length = 267 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 3e-04
Identities = 27/86 (31%), Positives = 47/86 (54%), Gaps = 8/86 (9%)
Query: 202 DNFSEANLLGQGGFGYVHK----GVLTNGKV--VAIKQLKAGSGQGERE-FQAEIEIISQ 254
+ S LG G FG V + G+ + VA+K LK + ERE +E++++S
Sbjct: 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 94
Query: 255 V-HHRHLVSLVGYCTFGSQRLLVYEF 279
+ +H ++V+L+G CT G L++ E+
Sbjct: 95 LGNHINIVNLLGACTVGGPTLVITEY 120
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 17/41 (41%), Positives = 26/41 (63%), Gaps = 3/41 (7%)
Query: 311 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351
GL Y+H ++HRD+K N+L++ E K+ DFGLA+
Sbjct: 116 CGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLAR 153
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 3e-04
Identities = 20/39 (51%), Positives = 24/39 (61%), Gaps = 3/39 (7%)
Query: 313 LAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351
L +LH Q II+RDIK NILLD + DFGL+K
Sbjct: 118 LDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSK 153
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 3e-04
Identities = 47/225 (20%), Positives = 85/225 (37%), Gaps = 76/225 (33%)
Query: 198 KIATDNFSEANLLGQGGFGYV--------HKGVLTNGKVVAIKQLKAGSGQGE-REFQAE 248
+ D +LG G FG V K ++ VA+K LK G+ E + +E
Sbjct: 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKK--SSCNTVAVKMLKEGATASEHKALMSE 60
Query: 249 IEIISQV-HHRHLVSLVG--------------YCTFGS---------------------Q 272
++I+ + +H ++V+L+G +C +G+ Q
Sbjct: 61 LKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQ 120
Query: 273 RLLVYEFVPNKTLEFHLH-GKDRPVMN-------------------WPTRMKI------A 306
R V ++ + G+ + + W + + + +
Sbjct: 121 RGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYS 180
Query: 307 LGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351
ARG+ +L K IHRD+ + NILL ++ K+ DFGLA+
Sbjct: 181 FQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLAR 222
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 3e-04
Identities = 45/152 (29%), Positives = 71/152 (46%), Gaps = 9/152 (5%)
Query: 202 DNFSEANLLGQGGFGYVHKGVLTN-GKVVAIKQL-KAGSGQGER--EFQAEIEIISQVHH 257
++F ++G+G FG V + G V A+K L KA + E+ +AE +I+ +
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 258 RHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLH 317
+V + L+ EF+P + L KD + T+ IA + + +H
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKD-TLTEEETQFYIA-ETVLAIDSIH 118
Query: 318 EDCQPKIIHRDIKSANILLDDSFEAKVADFGL 349
Q IHRDIK N+LLD K++DFGL
Sbjct: 119 ---QLGFIHRDIKPDNLLLDSKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 3e-04
Identities = 17/42 (40%), Positives = 27/42 (64%), Gaps = 4/42 (9%)
Query: 311 RGLAYLHEDCQPKIIHRDIKSANILLD-DSFEAKVADFGLAK 351
RGL Y+H ++HRD+K AN+ ++ + K+ DFGLA+
Sbjct: 125 RGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLAR 163
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 4e-04
Identities = 50/177 (28%), Positives = 77/177 (43%), Gaps = 33/177 (18%)
Query: 209 LLGQGGFGYVHKGVLTN-GKVVAIKQL---KAGSGQGEREFQAEIEIISQVHHRHLVSLV 264
++G+GGFG V+ + GK+ A+K L + QGE ++ R ++SLV
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGE---------TLALNERIMLSLV 51
Query: 265 --GYCTFGSQRLLVYEF-VPNKTL---------EFHLHGKDRPVMNWPTRMKIALGSARG 312
G C F + Y F P+K + H H V + A G
Sbjct: 52 STGDCPF--IVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILG 109
Query: 313 LAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFG 369
L ++H +++RD+K ANILLD+ +++D GLA H S +GT G
Sbjct: 110 LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHG 160
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|235899 PRK06975, PRK06975, bifunctional uroporphyrinogen-III synthetase/uroporphyrin-III C-methyltransferase; Reviewed | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 6e-04
Identities = 21/104 (20%), Positives = 29/104 (27%), Gaps = 20/104 (19%)
Query: 5 PPLTSLPAPPETNSTFSPPAPPPSVSAVSAPAPGNLTSPPSSGTPTSGSTVGTRRPSPTR 64
P T+ PAP S S S PA P P + RR
Sbjct: 271 QPATAAPAPS------RMTDTNDSKSVTSQPAAAAAAPAPPPNPPATPPEPPARRGR--- 321
Query: 65 NGYLPPGALAGMVVGVVIGAGIVLAAVGIFLIFYKRRKRKLAAQ 108
+ V+ AAVG + R+ +L +
Sbjct: 322 ---------GSAALWFVVVVLACAAAVGGY--ALNRKVDRLDQE 354
|
Length = 656 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 6e-04
Identities = 49/163 (30%), Positives = 70/163 (42%), Gaps = 19/163 (11%)
Query: 209 LLGQGGFGYVHKGVL----TNGKVVAIKQLKAGSGQGEREFQ---AEIEIISQVHHRHLV 261
LLG+G FG V +L G+ A+K L+ + E E ++ H L
Sbjct: 2 LLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 58
Query: 262 SLVGYCTFGSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIA-LGSARGLAYLHED 319
+L Y RL V E+ L FHL ++R R A + SA L YLH
Sbjct: 59 AL-KYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFYGAEIVSA--LEYLHSR 114
Query: 320 CQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 362
+++RDIK N++LD K+ DFGL K + + T
Sbjct: 115 ---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 154
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 8e-04
Identities = 37/171 (21%), Positives = 78/171 (45%), Gaps = 10/171 (5%)
Query: 203 NFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKA---GSGQGEREFQAEIEIISQVHHR 258
NF +G+G F V++ L +G VA+K+++ + + EI+++ Q++H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 259 HLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLH--GKDRPVMNWPTRMKIALGSARGLAYL 316
+++ ++ +V E L + K + ++ T K + L ++
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 317 HEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGT 367
H +++HRDIK AN+ + + K+ D GL + + T + ++GT
Sbjct: 123 HSR---RVMHRDIKPANVFITATGVVKLGDLGLGRF-FSSKTTAAHSLVGT 169
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 42/157 (26%), Positives = 81/157 (51%), Gaps = 20/157 (12%)
Query: 210 LGQGGFGYVHKGVLTNGKV---VAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGY 266
+G+G +G+V+K +GK A+KQ++ G+G + EI ++ ++ H +++SL
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIE-GTGISMSACR-EIALLRELKHPNVISLQKV 66
Query: 267 CTFGSQR--LLVYEFVPNK---TLEFHLHGK-DRPVMNWPTRMKIAL--GSARGLAYLHE 318
+ R L++++ + ++FH K ++ + P M +L G+ YLH
Sbjct: 67 FLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA 126
Query: 319 DCQPKIIHRDIKSANILL----DDSFEAKVADFGLAK 351
+ ++HRD+K ANIL+ + K+AD G A+
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.001
Identities = 17/40 (42%), Positives = 25/40 (62%), Gaps = 3/40 (7%)
Query: 312 GLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351
G+ +LH IIHRD+K +NI++ K+ DFGLA+
Sbjct: 130 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 166
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.001
Identities = 46/154 (29%), Positives = 66/154 (42%), Gaps = 16/154 (10%)
Query: 209 LLGQGGFGYVHKGVL----TNGKVVAIKQLKAGSGQGEREFQ---AEIEIISQVHHRHLV 261
LLG+G FG V +L G+ A+K LK + E E ++ H L
Sbjct: 2 LLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 58
Query: 262 SLVGYCTFGSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDC 320
+L Y RL V E+ L FHL ++R R A L YLH
Sbjct: 59 AL-KYSFQTHDRLCFVMEYANGGELFFHL-SRERVFSEDRARFYGA-EIVSALDYLHS-- 113
Query: 321 QPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354
+ +++RD+K N++LD K+ DFGL K +
Sbjct: 114 EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 147
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.001
Identities = 19/56 (33%), Positives = 33/56 (58%), Gaps = 9/56 (16%)
Query: 296 VMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351
++ W +M + G+ ++HE +++HRDIKS NI L + + K+ DFG A+
Sbjct: 102 ILQWFVQMCL------GVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSAR 148
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.001
Identities = 28/148 (18%), Positives = 57/148 (38%), Gaps = 22/148 (14%)
Query: 210 LGQGGFGYVHKGVLTNGKVVAIKQ--LKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYC 267
++ K +VA+K+ L + S + + Q EI Q+ H +++ V
Sbjct: 10 FEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF 68
Query: 268 TFGSQRLLVYEFVPNKTLEFHLHGKDRPVM--NWPTRMK---IAL---GSARGLAYLHED 319
S+ +V + +G ++ ++P + IA L Y+H
Sbjct: 69 IVDSELYVVSPLMA--------YGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIH-- 118
Query: 320 CQPKIIHRDIKSANILLDDSFEAKVADF 347
IHR +K+++ILL + ++
Sbjct: 119 -SKGFIHRSVKASHILLSGDGKVVLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.001
Identities = 36/118 (30%), Positives = 51/118 (43%), Gaps = 6/118 (5%)
Query: 246 QAEIEIISQVHHRHLVSLVGYCTFGSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMK 304
Q E + Q + + C + RL LV E+V L FH+ + R + R
Sbjct: 43 QTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQ-RQRKLPEEHARF- 100
Query: 305 IALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 362
A L +LHE II+RD+K N+LLD K+ D+G+ K L ST
Sbjct: 101 YAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTST 155
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.001
Identities = 26/80 (32%), Positives = 39/80 (48%), Gaps = 5/80 (6%)
Query: 275 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANI 334
V E+V L + + R P + A A GL +LH II+RD+K N+
Sbjct: 78 FVMEYVNGGDLMYQIQQVGR--FKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNV 132
Query: 335 LLDDSFEAKVADFGLAKHSL 354
+LD K+ADFG+ K ++
Sbjct: 133 MLDSEGHIKIADFGMCKENM 152
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|217633 pfam03600, CitMHS, Citrate transporter | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 0.002
Identities = 22/102 (21%), Positives = 37/102 (36%), Gaps = 13/102 (12%)
Query: 22 PPAPPPSVSAVSAPAPGNLTSPPSSGTPTSGSTVGTRRPSPTRNGYLPPGALAGMVVGVV 81
PP A+ A G + +P G P R + + P A M+ GV+
Sbjct: 131 PPRLLLGAIALGANI-GGMLTPW--GGPQ------NRAAAGL--NFFPTDFFAPMIPGVI 179
Query: 82 IGAGIVLAAVGIFLIFYKRRKRKLAAQNLPLKNDPFAGKPHH 123
G IV+ G + + K RKR + ++ + +
Sbjct: 180 AGLLIVIL--GAYYLGKKERKRLGEGELELERDTLEELEAEY 219
|
Length = 377 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.002
Identities = 33/125 (26%), Positives = 56/125 (44%), Gaps = 6/125 (4%)
Query: 225 NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKT 284
+G+ VA+K + Q E+ I+ H+++V + G + ++ EF+
Sbjct: 45 SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104
Query: 285 LEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKV 344
L + + R +N + + L YLH +IHRDIKS +ILL K+
Sbjct: 105 LT-DIVSQTR--LNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKL 158
Query: 345 ADFGL 349
+DFG
Sbjct: 159 SDFGF 163
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.002
Identities = 50/177 (28%), Positives = 75/177 (42%), Gaps = 33/177 (18%)
Query: 209 LLGQGGFGYVHKGVLTN-GKVVAIKQL---KAGSGQGEREFQAEIEIISQVHHRHLVSLV 264
++G+GGFG V+ + GK+ A+K L + QGE ++ R ++SLV
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGE---------TLALNERIMLSLV 51
Query: 265 --GYCTFGSQRLLVYEFVPNKTLEF----------HLHGKDRPVMNWPTRMKIALGSARG 312
G C F + Y F L F H H V + A G
Sbjct: 52 STGDCPF--IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILG 109
Query: 313 LAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFG 369
L ++H +++RD+K ANILLD+ +++D GLA H S +GT G
Sbjct: 110 LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHG 160
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.002
Identities = 19/50 (38%), Positives = 30/50 (60%), Gaps = 3/50 (6%)
Query: 313 LAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 362
L +LH+ I++RD+K NILLD + + DFGL+K +L + +T
Sbjct: 109 LEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT 155
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.003
Identities = 49/186 (26%), Positives = 78/186 (41%), Gaps = 40/186 (21%)
Query: 202 DNFSEANLLGQGGFGYVHKGVLTNG-KVVAIKQLKAGSGQGERE---FQAEIEI------ 251
++F ++G+G FG V L N KV A+K L E F+ E ++
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 252 --ISQVHH-----RHLVSLVGYCTFGSQRLLVYEF---VPNKTLEFHLHGKDRPVMNWPT 301
I+ +H+ +L ++ Y G L+ +F +P F+L
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYL-----------A 109
Query: 302 RMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVS 361
M IA+ S L Y +HRDIK NIL+D + ++ADFG ++ T S
Sbjct: 110 EMVIAIDSVHQLHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS 160
Query: 362 TRVMGT 367
+ +GT
Sbjct: 161 SVAVGT 166
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 38.4 bits (90), Expect = 0.003
Identities = 25/95 (26%), Positives = 47/95 (49%), Gaps = 15/95 (15%)
Query: 275 LVYEFVPNK---TLEFHLHGKD-RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIK 330
+VY+ P+ +E ++ GK + V+ ++ R + LH+ I+H D+
Sbjct: 63 VVYDVDPDNKTIVME-YIEGKPLKDVIE-EGNDELLREIGRLVGKLHKA---GIVHGDLT 117
Query: 331 SANILLDDSFEAKVADFGLAKHSLD-----TDTHV 360
++NI++ D + + DFGL K+S + D HV
Sbjct: 118 TSNIIVRDD-KLYLIDFGLGKYSDEIEDKAVDLHV 151
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|149674 pfam08693, SKG6, Transmembrane alpha-helix domain | Back alignment and domain information |
|---|
Score = 34.6 bits (80), Expect = 0.003
Identities = 12/30 (40%), Positives = 18/30 (60%)
Query: 74 AGMVVGVVIGAGIVLAAVGIFLIFYKRRKR 103
+ VGVVI G++ A + FL + RRK+
Sbjct: 11 VAIAVGVVIPVGVIAAVLLAFLFLWYRRKK 40
|
SKG6/Axl2 are membrane proteins that show polarised intracellular localisation. SKG6_Tmem is the highly conserved transmembrane alpha-helical domain of SKG6 and Axl2 proteins. The full-length fungal protein has a negative regulatory function in cytokinesis. Length = 40 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 38.6 bits (90), Expect = 0.003
Identities = 46/163 (28%), Positives = 74/163 (45%), Gaps = 21/163 (12%)
Query: 202 DNFSEANLLGQGGFGYV----HKGVLTNGKVVAI-KQLKAGSGQGEREFQAEIEIISQVH 256
++F L+ G +G V HK + I KQ Q ++ F E +I++
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVF-VERDILTFAE 59
Query: 257 HRHLVSLVGYCTFGSQRLL--VYEFVPN---KTLEFHLHGKDRPVMNWPTRMKIALGSAR 311
+ +VS+ +C+F ++R L V E+V TL ++ + RM A +
Sbjct: 60 NPFVVSM--FCSFETKRHLCMVMEYVEGGDCATLLKNIG----ALPVDMARMYFA-ETVL 112
Query: 312 GLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354
L YLH I+HRD+K N+L+ K+ DFGL+K L
Sbjct: 113 ALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGL 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|213052 cd12087, TM_EGFR-like, Transmembrane domain of the Epidermal Growth Factor Receptor family of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 34.4 bits (80), Expect = 0.004
Identities = 7/35 (20%), Positives = 17/35 (48%)
Query: 70 PGALAGMVVGVVIGAGIVLAAVGIFLIFYKRRKRK 104
+ + V+G +VL +G+ + ++RR+
Sbjct: 1 RTSKTTSIAAGVVGGLLVLVILGLIVFLFRRRRHI 35
|
PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. They are receptor PTKs (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane (TM) helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. They are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. The TM domain not only serves as a membrane anchor, but also plays an important role in receptor dimerization and optimal activation. Mutations in the TM domain of EGFR family RTKs have been associated with increased breast cancer risk. Length = 38 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 37.4 bits (87), Expect = 0.004
Identities = 24/131 (18%), Positives = 47/131 (35%), Gaps = 17/131 (12%)
Query: 224 TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVS--LVGYCTFGSQRLLVYEFVP 281
T + +K S + + + E+ I+ + + L ++ L+ E++
Sbjct: 19 TKDEDYVLKIN--PSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIE 76
Query: 282 NKTLEFHLHGKDRPVMNWPTRMKIALGSARG--LAYLHEDCQPKIIHRDIKSANILLDDS 339
+TL+ K + LA LH+ + H D+ NIL+DD
Sbjct: 77 GETLD-----------EVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDG 125
Query: 340 FEAKVADFGLA 350
+ D+ A
Sbjct: 126 KILGIIDWEYA 136
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 38.6 bits (90), Expect = 0.004
Identities = 49/186 (26%), Positives = 75/186 (40%), Gaps = 40/186 (21%)
Query: 202 DNFSEANLLGQGGFGYVHKGVLTN-GKVVAIK------QLKAGSGQGERE-----FQAEI 249
D+F ++G+G FG V + N G+V A+K LK RE +
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 250 EIISQVHH-----RHLVSLVGYCTFGSQRLLVYEF---VPNKTLEFHLHGKDRPVMNWPT 301
I+ +H+ +L ++ Y G L+ +F +P F+L
Sbjct: 61 RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYL-----------A 109
Query: 302 RMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVS 361
M +A+ S L Y +HRDIK N+LLD + ++ADFG L T S
Sbjct: 110 EMVLAIDSVHQLGY---------VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQS 160
Query: 362 TRVMGT 367
+GT
Sbjct: 161 NVAVGT 166
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 369 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 99.98 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.98 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 99.97 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 99.97 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 99.97 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 99.97 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.97 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.97 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 99.97 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 99.97 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 99.97 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 99.97 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 99.96 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 99.96 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.96 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.96 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.96 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.96 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.96 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.96 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.96 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.96 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.96 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.96 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.96 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.96 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.96 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.96 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.96 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.96 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.96 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.96 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.96 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.96 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.96 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.96 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.95 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 99.95 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.95 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.95 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.95 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.95 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.95 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.95 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.95 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.95 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.95 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.95 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.95 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.95 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.95 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.95 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.95 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.95 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.95 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.95 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.95 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.95 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.95 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.95 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.95 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.95 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.95 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.95 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.95 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.95 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.95 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.95 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.95 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.95 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.95 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.95 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.95 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.95 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.95 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.95 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.94 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.94 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.94 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.94 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.94 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.94 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.94 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.94 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.94 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.94 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.94 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.94 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.94 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.94 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.94 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.94 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.94 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.94 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.94 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.94 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.94 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.94 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.94 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.94 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.94 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.94 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.94 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.94 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.94 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.94 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.94 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.94 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.94 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.94 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.94 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.94 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.94 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.94 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.94 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.94 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.94 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.94 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.94 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.94 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.94 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.94 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.94 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.94 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.93 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.93 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.93 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.93 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.93 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.93 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.93 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.93 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.93 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.93 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.93 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.93 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.93 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.93 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.93 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.93 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.93 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.93 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.93 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.93 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.93 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.93 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.93 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.93 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.93 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.93 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.93 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.93 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.93 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.93 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.93 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.93 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.93 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.93 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.93 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.93 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.93 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.93 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.93 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.93 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.93 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.93 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.93 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.93 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.93 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.93 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.93 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.93 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.93 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.93 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.93 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.93 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.93 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.93 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.93 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.93 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.93 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.93 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.93 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.93 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.93 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.93 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.93 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.93 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.92 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.92 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.92 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.92 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.92 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.92 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.92 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.92 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.92 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.92 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.92 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.92 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.92 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.92 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.92 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.92 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.92 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.92 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.92 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.92 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.92 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.92 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.92 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.92 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.92 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.92 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.92 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.92 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.92 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.92 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.92 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.92 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.92 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.92 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.92 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.92 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.92 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.92 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.92 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.92 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.92 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.92 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.92 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.92 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.92 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.92 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.92 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.92 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.91 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.91 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.91 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.91 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.91 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.91 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.91 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.91 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.91 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.91 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.91 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.91 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.91 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.91 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.91 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.91 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.91 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.91 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.91 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.91 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.91 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.91 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.91 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.91 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.91 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.91 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.9 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.9 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.9 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.9 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.9 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.9 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.9 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.9 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.9 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.9 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.9 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.9 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.9 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.9 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.9 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.9 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.9 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.89 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.89 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.89 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.89 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.89 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.89 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.89 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.89 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.88 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.88 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.88 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.88 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.88 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.88 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.88 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.88 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.87 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.86 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.86 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.86 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.85 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.85 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.85 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.85 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.85 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.84 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.84 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.84 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.83 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.83 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.8 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.8 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.78 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.78 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.78 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.75 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.75 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.75 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.67 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.66 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.57 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.57 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.51 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.5 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.49 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.47 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.47 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.42 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.42 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.42 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.41 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.33 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.31 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.26 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.25 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.18 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.06 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.05 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 99.01 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.0 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 99.0 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.99 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.97 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.95 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.86 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.85 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.8 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.76 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 98.76 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.73 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.7 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 98.68 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.67 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.65 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.6 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.54 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.53 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.4 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.37 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.36 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.31 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.29 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.24 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.16 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 98.13 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 98.13 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 98.09 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 98.09 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.99 | |
| PF01102 | 122 | Glycophorin_A: Glycophorin A; InterPro: IPR001195 | 97.92 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.63 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.63 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.61 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 97.53 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.53 | |
| PTZ00382 | 96 | Variant-specific surface protein (VSP); Provisiona | 97.48 | |
| PF08693 | 40 | SKG6: Transmembrane alpha-helix domain; InterPro: | 97.48 | |
| PLN02236 | 344 | choline kinase | 97.45 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.39 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.35 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 97.35 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.31 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.3 | |
| PF02439 | 38 | Adeno_E3_CR2: Adenovirus E3 region protein CR2; In | 97.3 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.28 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 97.28 | |
| PF04478 | 154 | Mid2: Mid2 like cell wall stress sensor; InterPro: | 97.14 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 97.1 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.02 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.99 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.98 | |
| PF04478 | 154 | Mid2: Mid2 like cell wall stress sensor; InterPro: | 96.98 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.92 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.84 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.53 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.41 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 96.21 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=317.05 Aligned_cols=181 Identities=64% Similarity=1.067 Sum_probs=159.5
Q ss_pred CCccCHHHHHHhhcCCcccceecccCceEEEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEE
Q 017558 189 KSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCT 268 (369)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~ 268 (369)
...|.+.++..++++|...+.||+|+||.||+|.+.++..||||++........++|.+|++++.+++|+|+|+|+|||.
T Consensus 62 ~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~ 141 (361)
T KOG1187|consen 62 LRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCL 141 (361)
T ss_pred cceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEe
Confidence 35789999999999999999999999999999999988999999887655431456999999999999999999999999
Q ss_pred eCC-eeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeee
Q 017558 269 FGS-QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADF 347 (369)
Q Consensus 269 ~~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DF 347 (369)
+.+ +.+||||||++|+|.++|+......++|..|++||.++|+||+|||+.+.+.|||||||++|||||+++++||+||
T Consensus 142 e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDF 221 (361)
T KOG1187|consen 142 EGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDF 221 (361)
T ss_pred cCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCc
Confidence 988 5999999999999999999865436899999999999999999999998888999999999999999999999999
Q ss_pred ccceeeCCCCceeeeeecccCC
Q 017558 348 GLAKHSLDTDTHVSTRVMGTFG 369 (369)
Q Consensus 348 Gla~~~~~~~~~~~~~~~gt~g 369 (369)
|||+.....+.+..+...||+|
T Consensus 222 GLa~~~~~~~~~~~~~~~gt~g 243 (361)
T KOG1187|consen 222 GLAKLGPEGDTSVSTTVMGTFG 243 (361)
T ss_pred cCcccCCccccceeeecCCCCc
Confidence 9997765413232222278876
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=292.05 Aligned_cols=162 Identities=27% Similarity=0.477 Sum_probs=146.9
Q ss_pred HHHHhhcCCcccceecccCceEEEEEEEcCCeEEEEEeeccCCccc-HHHHHHHHHHHHhcCCCccccEeeEEEeCCeeE
Q 017558 196 ELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQG-EREFQAEIEIISQVHHRHLVSLVGYCTFGSQRL 274 (369)
Q Consensus 196 ~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 274 (369)
-.++..+...+.+.||+|.||+|.+|+..++..||||+++...... .++|.+||++|.+|+||||++|+|+|..++.++
T Consensus 532 l~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePic 611 (807)
T KOG1094|consen 532 LVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLC 611 (807)
T ss_pred hhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchH
Confidence 3455667788889999999999999999888999999999876554 479999999999999999999999999999999
Q ss_pred EEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 275 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 275 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
||+|||++|+|..||.....+.+.....++|+.||+.||+||.+. ++|||||.++|||+|.++++||+||||+|.++
T Consensus 612 mI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ly 688 (807)
T KOG1094|consen 612 MITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLY 688 (807)
T ss_pred HHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccc
Confidence 999999999999999877655556677889999999999999998 99999999999999999999999999999999
Q ss_pred CCCcee
Q 017558 355 DTDTHV 360 (369)
Q Consensus 355 ~~~~~~ 360 (369)
..+++.
T Consensus 689 sg~yy~ 694 (807)
T KOG1094|consen 689 SGDYYR 694 (807)
T ss_pred cCCcee
Confidence 888754
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=274.50 Aligned_cols=161 Identities=27% Similarity=0.388 Sum_probs=140.6
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccC--CcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEE
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 277 (369)
..+|...+.||+|.|+.||+|+++ ++..||||.+... .....+.+..|+.+|+.++|||||+|+++++.++.+||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 357788888999999999999964 5789999999766 3444566889999999999999999999999999999999
Q ss_pred EecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCC------CcEEEeeeccce
Q 017558 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS------FEAKVADFGLAK 351 (369)
Q Consensus 278 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~------~~~ki~DFGla~ 351 (369)
|||++|||.+||+.++ .+++.....++.|||.||++||++ +||||||||.||||+.. -.+||+|||+||
T Consensus 89 EyC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 9999999999998765 599999999999999999999999 99999999999999764 468999999999
Q ss_pred eeCCCCceeeeeecccC
Q 017558 352 HSLDTDTHVSTRVMGTF 368 (369)
Q Consensus 352 ~~~~~~~~~~~~~~gt~ 368 (369)
.+.... ...+++|++
T Consensus 164 ~L~~~~--~a~tlcGSp 178 (429)
T KOG0595|consen 164 FLQPGS--MAETLCGSP 178 (429)
T ss_pred hCCchh--HHHHhhCCc
Confidence 987543 334466664
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=266.33 Aligned_cols=163 Identities=30% Similarity=0.424 Sum_probs=140.1
Q ss_pred hhcCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCCcc-------cHHHHHHHHHHHHhcCCCccccEeeEEEeCC
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQ-------GEREFQAEIEIISQVHHRHLVSLVGYCTFGS 271 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~ 271 (369)
..+.|...+.||+|+||.|-+|.. ++|+.||||++.+.... ......+|+++|.+++|||||++.+++...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 345677889999999999999984 56899999999654211 1234679999999999999999999999999
Q ss_pred eeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCC---CcEEEeeec
Q 017558 272 QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS---FEAKVADFG 348 (369)
Q Consensus 272 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~---~~~ki~DFG 348 (369)
..|||||||+||+|++++..+. .+.+.....+++|++.|+.|||++ ||+||||||+|||+..+ ..+||+|||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk--~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANK--YLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred ceEEEEEEecCccHHHHHHhcc--ccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccc
Confidence 9999999999999999997654 478888889999999999999999 99999999999999765 889999999
Q ss_pred cceeeCCCCceeeeeecccCC
Q 017558 349 LAKHSLDTDTHVSTRVMGTFG 369 (369)
Q Consensus 349 la~~~~~~~~~~~~~~~gt~g 369 (369)
||+...+ .+. ..+.+||++
T Consensus 325 lAK~~g~-~sf-m~TlCGTps 343 (475)
T KOG0615|consen 325 LAKVSGE-GSF-MKTLCGTPS 343 (475)
T ss_pred hhhcccc-cee-hhhhcCCcc
Confidence 9998873 333 345899985
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=277.14 Aligned_cols=154 Identities=33% Similarity=0.544 Sum_probs=138.9
Q ss_pred hcCCcccceecccCceEEEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEec
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 280 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 280 (369)
.+.+...+.||+|.||.||.|.+.+...||+|.++... ...++|.+|+++|.+|+|+|||+|+|+|..++.+|||||||
T Consensus 205 r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m 283 (468)
T KOG0197|consen 205 REELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYM 283 (468)
T ss_pred HHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEec
Confidence 33445578899999999999999877799999998763 33468999999999999999999999999989999999999
Q ss_pred CCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCCCc
Q 017558 281 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 358 (369)
Q Consensus 281 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~~~ 358 (369)
+.|+|.+||+......+...+.+.++.|||+||+||+++ ++|||||.++||||+++..+||+||||||...++.+
T Consensus 284 ~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y 358 (468)
T KOG0197|consen 284 PKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEY 358 (468)
T ss_pred ccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCce
Confidence 999999999986667799999999999999999999999 999999999999999999999999999996555444
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=272.65 Aligned_cols=163 Identities=37% Similarity=0.601 Sum_probs=138.7
Q ss_pred cCCcccceecccCceEEEEEEEcCCeEEEEEeeccCCccc--HHHHHHHHHHHHhcCCCccccEeeEEEeCC-eeEEEEE
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQG--EREFQAEIEIISQVHHRHLVSLVGYCTFGS-QRLLVYE 278 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-~~~lv~e 278 (369)
+++...+.||+|+||+||+|.+.+...||||++....... .++|.+|+.+|.+++|||||+|+|+|.... ..+||||
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtE 120 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTE 120 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEE
Confidence 3444456699999999999999655559999997654332 458999999999999999999999999877 7899999
Q ss_pred ecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-eeecCCCCCcEEECCCC-cEEEeeeccceeeCCC
Q 017558 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPK-IIHRDIKSANILLDDSF-EAKVADFGLAKHSLDT 356 (369)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~-ivHrdlk~~Nill~~~~-~~ki~DFGla~~~~~~ 356 (369)
||++|+|..+|+......+++..+++|+.|||+||+|||++ + |||||||++||||+.++ ++||+|||+++.....
T Consensus 121 y~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 121 YMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred eCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 99999999999885445799999999999999999999998 6 99999999999999997 9999999999987653
Q ss_pred CceeeeeecccC
Q 017558 357 DTHVSTRVMGTF 368 (369)
Q Consensus 357 ~~~~~~~~~gt~ 368 (369)
.. ..+...||+
T Consensus 198 ~~-~~~~~~GT~ 208 (362)
T KOG0192|consen 198 KT-SMTSVAGTY 208 (362)
T ss_pred cc-cccCCCCCc
Confidence 21 222356765
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=260.30 Aligned_cols=163 Identities=30% Similarity=0.423 Sum_probs=144.4
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcc---cHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEE
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ---GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 275 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 275 (369)
..++|++.++||+|+||+||.++.+ +++.+|+|.+++.... +.+...+|..+|.+++||+||.|+-.|++.+.+||
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 3578999999999999999999954 5789999999876432 34578899999999999999999999999999999
Q ss_pred EEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 276 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 276 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
|+||+.||.|+.+|.++. .+.+..+..++.+|+.||.|||++ +||||||||+|||||.+|+++|+|||||+...+
T Consensus 103 Vld~~~GGeLf~hL~~eg--~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQREG--RFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EEeccCCccHHHHHHhcC--CcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 999999999999997664 489999999999999999999999 999999999999999999999999999998766
Q ss_pred CCceeeeeecccC
Q 017558 356 TDTHVSTRVMGTF 368 (369)
Q Consensus 356 ~~~~~~~~~~gt~ 368 (369)
.+. .+.+++||+
T Consensus 178 ~~~-~t~tfcGT~ 189 (357)
T KOG0598|consen 178 DGD-ATRTFCGTP 189 (357)
T ss_pred CCC-ccccccCCc
Confidence 543 334488885
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=284.32 Aligned_cols=161 Identities=27% Similarity=0.522 Sum_probs=143.1
Q ss_pred HHHhhcCCcccceecccCceEEEEEEEc------CCeEEEEEeeccCCcc-cHHHHHHHHHHHHhcCCCccccEeeEEEe
Q 017558 197 LKIATDNFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVSLVGYCTF 269 (369)
Q Consensus 197 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~ 269 (369)
.++...+.+..+.||+|.||+||+|+.. +...||||.+++.+.. ...+|++|+++|+.|+|||||+|+|+|.+
T Consensus 481 ~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~ 560 (774)
T KOG1026|consen 481 LEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE 560 (774)
T ss_pred eEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc
Confidence 3445566777889999999999999853 2457999999988766 56799999999999999999999999999
Q ss_pred CCeeEEEEEecCCCcHhhhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEC
Q 017558 270 GSQRLLVYEFVPNKTLEFHLHGKD------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLD 337 (369)
Q Consensus 270 ~~~~~lv~e~~~~g~L~~~l~~~~------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~ 337 (369)
++.+|||+|||..|||.+||.... ...|+..+.+.||.|||.||+||-++ .+|||||+.||+||.
T Consensus 561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVg 637 (774)
T KOG1026|consen 561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVG 637 (774)
T ss_pred CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceec
Confidence 999999999999999999997421 23388899999999999999999998 899999999999999
Q ss_pred CCCcEEEeeeccceeeCCCCcee
Q 017558 338 DSFEAKVADFGLAKHSLDTDTHV 360 (369)
Q Consensus 338 ~~~~~ki~DFGla~~~~~~~~~~ 360 (369)
++..|||+||||+|+.+..|++.
T Consensus 638 e~l~VKIsDfGLsRdiYssDYYk 660 (774)
T KOG1026|consen 638 ENLVVKISDFGLSRDIYSSDYYK 660 (774)
T ss_pred cceEEEecccccchhhhhhhhhc
Confidence 99999999999999999888753
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=270.11 Aligned_cols=161 Identities=27% Similarity=0.404 Sum_probs=145.0
Q ss_pred cCCcccceecccCceEEEEEEE-cCCeEEEEEeeccC---CcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEE
Q 017558 202 DNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAG---SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 277 (369)
.+|...++||+|+|..||+++. ..|+.||+|++.+. +....+.+.+||+|.++|+|||||+++++|++.+.+|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5688999999999999999996 78999999999653 3344568899999999999999999999999999999999
Q ss_pred EecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCCC
Q 017558 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (369)
Q Consensus 278 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~~ 357 (369)
|+|.+++|..++.. +..+++.++.++..||+.||.|||++ +|||||||..|+||++++++||+|||||-.+..++
T Consensus 98 ELC~~~sL~el~Kr--rk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 98 ELCHRGSLMELLKR--RKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG 172 (592)
T ss_pred EecCCccHHHHHHh--cCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCcc
Confidence 99999999999873 45699999999999999999999999 99999999999999999999999999999987553
Q ss_pred ceeeeeecccC
Q 017558 358 THVSTRVMGTF 368 (369)
Q Consensus 358 ~~~~~~~~gt~ 368 (369)
....+++||+
T Consensus 173 -Erk~TlCGTP 182 (592)
T KOG0575|consen 173 -ERKKTLCGTP 182 (592)
T ss_pred -cccceecCCC
Confidence 2345589997
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=263.48 Aligned_cols=155 Identities=29% Similarity=0.440 Sum_probs=133.7
Q ss_pred hhcCCcccceecccCceEEEEEE-EcCCeEEEEEeeccCCcc--cHHHHHHHHHHHHhcCCCccccEeeEEEeC--CeeE
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQ--GEREFQAEIEIISQVHHRHLVSLVGYCTFG--SQRL 274 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~ 274 (369)
..+.|+.+++||+|+||.||+++ ..+|+.||+|+++.+..+ ...-..+||.||++|+||||++|.+...+. ..+|
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 44668888999999999999999 567999999999876533 234567999999999999999999998876 7899
Q ss_pred EEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 275 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 275 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
||+|||+. ||.-++.... -.|++.++..|+.|++.||+|+|++ +|+|||||.+|||||++|.+||+|||||+.+.
T Consensus 195 lVFeYMdh-DL~GLl~~p~-vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLLSSPG-VKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred EEEecccc-hhhhhhcCCC-cccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeecc
Confidence 99999965 6666665433 3599999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCce
Q 017558 355 DTDTH 359 (369)
Q Consensus 355 ~~~~~ 359 (369)
.....
T Consensus 270 ~~~~~ 274 (560)
T KOG0600|consen 270 PSGSA 274 (560)
T ss_pred CCCCc
Confidence 65543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=254.92 Aligned_cols=159 Identities=29% Similarity=0.430 Sum_probs=137.7
Q ss_pred cCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCc-ccHHHHHHHHHHHHhcCCCccccEeeEEEeCC-eeEEEEE
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGS-QRLLVYE 278 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-~~~lv~e 278 (369)
++++..+.||+|..|.||+++++ +++.+|+|.+..+.. ...+++.+|++++.+++||+||.++|.|.... .++|+||
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 34455788999999999999975 578999999955433 34568999999999999999999999999988 5999999
Q ss_pred ecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCCCc
Q 017558 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 358 (369)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~~~ 358 (369)
||++|+|+.++... ..+++....+|+.+|++||.|||+.. +||||||||+||||+..|++||||||.++.+.+.
T Consensus 159 YMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-- 232 (364)
T KOG0581|consen 159 YMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-- 232 (364)
T ss_pred hcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence 99999999999755 34889999999999999999999732 8999999999999999999999999999998765
Q ss_pred eeeeeeccc
Q 017558 359 HVSTRVMGT 367 (369)
Q Consensus 359 ~~~~~~~gt 367 (369)
...+.+||
T Consensus 233 -~a~tfvGT 240 (364)
T KOG0581|consen 233 -IANTFVGT 240 (364)
T ss_pred -hccccccc
Confidence 33445666
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=271.92 Aligned_cols=154 Identities=31% Similarity=0.495 Sum_probs=138.5
Q ss_pred HhhcCCcccceecccCceEEEEEEEcC----CeEEEEEeeccCCc-ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCee
Q 017558 199 IATDNFSEANLLGQGGFGYVHKGVLTN----GKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQR 273 (369)
Q Consensus 199 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 273 (369)
+......+.++||.|.||+||+|+++- ...||||.++.... ..+.+|+.|+.||.+++||||++|.|+.......
T Consensus 626 Id~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~Pv 705 (996)
T KOG0196|consen 626 IDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPV 705 (996)
T ss_pred cChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCcee
Confidence 334556778999999999999999753 35799999998754 3456999999999999999999999999999999
Q ss_pred EEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceee
Q 017558 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (369)
Q Consensus 274 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~ 353 (369)
+||.|||+||+|+.||+.++. .|.+.+...+..+||.||+||-+. ++|||||.++||||+.+..|||+||||+|.+
T Consensus 706 MIiTEyMENGsLDsFLR~~DG-qftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvl 781 (996)
T KOG0196|consen 706 MIITEYMENGSLDSFLRQNDG-QFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL 781 (996)
T ss_pred EEEhhhhhCCcHHHHHhhcCC-ceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeec
Confidence 999999999999999998764 499999999999999999999998 9999999999999999999999999999977
Q ss_pred CCC
Q 017558 354 LDT 356 (369)
Q Consensus 354 ~~~ 356 (369)
.++
T Consensus 782 edd 784 (996)
T KOG0196|consen 782 EDD 784 (996)
T ss_pred ccC
Confidence 554
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=239.06 Aligned_cols=159 Identities=31% Similarity=0.374 Sum_probs=141.5
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcccH---HHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEE
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGE---REFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 276 (369)
.++|+..+.||.|+||+|.+++.+ +|..+|+|++.+...... +...+|..+|..+.||++++|++.|.+...+|||
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 357788899999999999999954 578999999987644333 4567899999999999999999999999999999
Q ss_pred EEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCC
Q 017558 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 277 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~ 356 (369)
|||++||.|+.+|++.+ .|++..+.++|.||+.||+|||++ .|++|||||+|||||.+|.+||+|||+|+...+.
T Consensus 123 meyv~GGElFS~Lrk~~--rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRKSG--RFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred EeccCCccHHHHHHhcC--CCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 99999999999998654 499999999999999999999998 9999999999999999999999999999998643
Q ss_pred CceeeeeecccC
Q 017558 357 DTHVSTRVMGTF 368 (369)
Q Consensus 357 ~~~~~~~~~gt~ 368 (369)
+-+.+||+
T Consensus 198 ----T~TlCGTP 205 (355)
T KOG0616|consen 198 ----TWTLCGTP 205 (355)
T ss_pred ----EEEecCCc
Confidence 44578886
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.9e-33 Score=241.33 Aligned_cols=149 Identities=25% Similarity=0.375 Sum_probs=130.5
Q ss_pred cCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcc-c-HHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEE
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ-G-EREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~-~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 278 (369)
++|+....+|+|+||.||+|+.+ +|+.||||++.+..++ . .+-.++||++|++++|+|+|.|+.+|.....++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 56778889999999999999965 5899999999765432 2 2346899999999999999999999999999999999
Q ss_pred ecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
||+..-|.++-+ .. ..++.+...++++|++.|+.|+|++ ++|||||||+||||+.++.+||||||+||.+..
T Consensus 82 ~~dhTvL~eLe~-~p-~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~ 153 (396)
T KOG0593|consen 82 YCDHTVLHELER-YP-NGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA 153 (396)
T ss_pred ecchHHHHHHHh-cc-CCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC
Confidence 998877765543 22 3488889999999999999999999 999999999999999999999999999999874
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.1e-33 Score=249.53 Aligned_cols=161 Identities=25% Similarity=0.411 Sum_probs=142.4
Q ss_pred hhcCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCCcccHH---HHHHHHHHHHhcCCCccccEeeEEEeCCeeEE
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGER---EFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 275 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~---~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 275 (369)
...+|++.+.||+|+||+|-++.. ..|+.||||.++++...++. .+++||+||+.|+||||++++.+|++.+.+.|
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 346788889999999999999984 67999999999987666554 47899999999999999999999999999999
Q ss_pred EEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 276 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 276 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
||||..+|.|.+|+... ..|++.+..+|+.||..|+.|+|.+ +++|||||.+|||||.++++||+||||+..+.+
T Consensus 131 vMEYaS~GeLYDYiSer--~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 131 VMEYASGGELYDYISER--GSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EEEecCCccHHHHHHHh--ccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 99999999999999765 4599999999999999999999999 999999999999999999999999999988765
Q ss_pred CCceeeeeeccc
Q 017558 356 TDTHVSTRVMGT 367 (369)
Q Consensus 356 ~~~~~~~~~~gt 367 (369)
... .++++|.
T Consensus 206 ~kf--LqTFCGS 215 (668)
T KOG0611|consen 206 KKF--LQTFCGS 215 (668)
T ss_pred ccH--HHHhcCC
Confidence 442 2334554
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-32 Score=257.50 Aligned_cols=156 Identities=29% Similarity=0.487 Sum_probs=137.1
Q ss_pred HHHHHhhcCCcccceecccCceEEEEEEEcCC----eE-EEEEeeccC---CcccHHHHHHHHHHHHhcCCCccccEeeE
Q 017558 195 EELKIATDNFSEANLLGQGGFGYVHKGVLTNG----KV-VAIKQLKAG---SGQGEREFQAEIEIISQVHHRHLVSLVGY 266 (369)
Q Consensus 195 ~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~----~~-vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~ 266 (369)
+.+++.-++....++||+|+||+||+|+++.. .. ||||..+.. ......+|.+|+++|++++|+|||+|+|+
T Consensus 150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGV 229 (474)
T KOG0194|consen 150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGV 229 (474)
T ss_pred cccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 33455566677779999999999999996532 23 899998852 24455789999999999999999999999
Q ss_pred EEeCCeeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEee
Q 017558 267 CTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVAD 346 (369)
Q Consensus 267 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~D 346 (369)
+..+.++|+|||+|.||+|.+||+.... .++..++++++.+.|+||+|||++ ++|||||.+||||++.++.+||+|
T Consensus 230 a~~~~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISD 305 (474)
T KOG0194|consen 230 AVLEEPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISD 305 (474)
T ss_pred EcCCCccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCc
Confidence 9999999999999999999999987654 589999999999999999999999 999999999999999999999999
Q ss_pred eccceeeC
Q 017558 347 FGLAKHSL 354 (369)
Q Consensus 347 FGla~~~~ 354 (369)
|||++...
T Consensus 306 FGLs~~~~ 313 (474)
T KOG0194|consen 306 FGLSRAGS 313 (474)
T ss_pred cccccCCc
Confidence 99998764
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-33 Score=241.68 Aligned_cols=165 Identities=26% Similarity=0.398 Sum_probs=138.2
Q ss_pred cCCcccceecccCceEEEEEE-EcCCeEEEEEeeccC--CcccHHHHHHHHHHHHhcCCCccccEeeE-EEeCCe-eEEE
Q 017558 202 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSLVGY-CTFGSQ-RLLV 276 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~-~~~~~~-~~lv 276 (369)
.+|++.++||+|.||+||++. ..+|..+|.|.+.-+ +....+++..|+.+|++|+|||||+++++ +..+.+ ++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 456778899999999999998 568899999998643 23344689999999999999999999994 444455 7999
Q ss_pred EEecCCCcHhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eeecCCCCCcEEECCCCcEEEeeecccee
Q 017558 277 YEFVPNKTLEFHLHG--KDRPVMNWPTRMKIALGSARGLAYLHEDCQPK--IIHRDIKSANILLDDSFEAKVADFGLAKH 352 (369)
Q Consensus 277 ~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~--ivHrdlk~~Nill~~~~~~ki~DFGla~~ 352 (369)
|||++.|||..+++. +....+++...++++.|+++||.++|++.. + |+||||||.||+|+.+|.+||+||||+|.
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~-r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIP-RGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhcccc-ccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 999999999999864 334568999999999999999999999532 5 99999999999999999999999999998
Q ss_pred eCCCCceeeeeecccC
Q 017558 353 SLDTDTHVSTRVMGTF 368 (369)
Q Consensus 353 ~~~~~~~~~~~~~gt~ 368 (369)
+.... ......+||+
T Consensus 178 l~s~~-tfA~S~VGTP 192 (375)
T KOG0591|consen 178 LSSKT-TFAHSLVGTP 192 (375)
T ss_pred hcchh-HHHHhhcCCC
Confidence 76543 3345578886
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=228.74 Aligned_cols=152 Identities=32% Similarity=0.545 Sum_probs=135.0
Q ss_pred cCCcccceecccCceEEEEEE-EcCCeEEEEEeeccCCccc--HHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEE
Q 017558 202 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQG--EREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 278 (369)
++|...+.||+|.||.||+|+ ..+|+.||||+++..+..+ .....+||+.|+.++|+||+.|+++|...+.+-||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 457778999999999999999 4578999999998764332 2467899999999999999999999999999999999
Q ss_pred ecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCCCc
Q 017558 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 358 (369)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~~~ 358 (369)
||+ .+|+..++... ..+...+...++.++++||+|||.+ .|+||||||.|+||+.+|.+||+||||||.+...+.
T Consensus 82 fm~-tdLe~vIkd~~-i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 82 FMP-TDLEVVIKDKN-IILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred ecc-ccHHHHhcccc-cccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 994 68988887654 4688999999999999999999999 899999999999999999999999999999886553
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-32 Score=251.12 Aligned_cols=154 Identities=27% Similarity=0.365 Sum_probs=135.0
Q ss_pred HhhcCCcccceecccCceEEEEEE-EcCCeEEEEEeeccCCcccH-HHHHHHHHHHHhcC-CCccccEeeEEEeCC-eeE
Q 017558 199 IATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGE-REFQAEIEIISQVH-HRHLVSLVGYCTFGS-QRL 274 (369)
Q Consensus 199 ~~~~~~~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~-~~~~~E~~~l~~l~-h~niv~l~g~~~~~~-~~~ 274 (369)
...++|...+.||.|+||.||+|+ ...+..||||+++..-...+ ..=++|++.|++++ |||||+|.+++.+.+ .+|
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 345778889999999999999999 45688999999986543322 23468999999999 999999999998877 999
Q ss_pred EEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 275 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 275 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
+|||||+ -+|.+++..+ +..|++..+..|+.||+.||+|+|.+ |+.||||||+|||+.....+||+||||||...
T Consensus 87 fVfE~Md-~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 87 FVFEFMD-CNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eeHHhhh-hhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccccc
Confidence 9999995 5799988877 56799999999999999999999999 99999999999999988899999999999987
Q ss_pred CCC
Q 017558 355 DTD 357 (369)
Q Consensus 355 ~~~ 357 (369)
...
T Consensus 162 Skp 164 (538)
T KOG0661|consen 162 SKP 164 (538)
T ss_pred cCC
Confidence 643
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=249.78 Aligned_cols=153 Identities=29% Similarity=0.339 Sum_probs=136.6
Q ss_pred HHhhcCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCC---cccHHHHHHHHHHHHhc-CCCccccEeeEEEeCCe
Q 017558 198 KIATDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGS---GQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQ 272 (369)
Q Consensus 198 ~~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~ 272 (369)
....++|.+++.||+|+|++|++|+. ..++.||||++.+.- ....+.+..|-++|.+| .||.|++|+-.|+++..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 34557899999999999999999994 568999999986542 22334678899999999 79999999999999999
Q ss_pred eEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeecccee
Q 017558 273 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (369)
Q Consensus 273 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~ 352 (369)
+|+|+||+++|+|.++|++.+ .|++....+++.+|+.||+|||++ |||||||||+|||||+|+++||+|||-|+.
T Consensus 149 LYFvLe~A~nGdll~~i~K~G--sfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~ 223 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYG--SFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKI 223 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhC--cchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeecccccc
Confidence 999999999999999998764 499999999999999999999999 999999999999999999999999999998
Q ss_pred eCC
Q 017558 353 SLD 355 (369)
Q Consensus 353 ~~~ 355 (369)
+..
T Consensus 224 l~~ 226 (604)
T KOG0592|consen 224 LSP 226 (604)
T ss_pred CCh
Confidence 654
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-32 Score=230.20 Aligned_cols=163 Identities=31% Similarity=0.420 Sum_probs=143.4
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC---cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEE
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 275 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 275 (369)
..++|++++.||+|.||.||+|+.+ ++-.||+|++.+.. .....++.+|++|-+.|+||||+++++||.++...||
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 3477888999999999999999964 56789999986542 2234688999999999999999999999999999999
Q ss_pred EEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 276 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 276 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
++||..+|.|...|.......+++.....+..|+|.||.|+|.+ +||||||||+|+|++.++.+||+|||.+.....
T Consensus 100 ilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~ 176 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 176 (281)
T ss_pred EEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecCC
Confidence 99999999999999876666799999999999999999999998 999999999999999999999999999987642
Q ss_pred CCceeeeeecccC
Q 017558 356 TDTHVSTRVMGTF 368 (369)
Q Consensus 356 ~~~~~~~~~~gt~ 368 (369)
....+++||+
T Consensus 177 ---~kR~tlcgt~ 186 (281)
T KOG0580|consen 177 ---NKRKTLCGTL 186 (281)
T ss_pred ---CCceeeeccc
Confidence 2345578885
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=242.84 Aligned_cols=151 Identities=30% Similarity=0.553 Sum_probs=134.9
Q ss_pred HHHHHhhcCCcccceecccCceEEEEEEEcCCeEEEEEeeccCCc--ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCe
Q 017558 195 EELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQ 272 (369)
Q Consensus 195 ~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 272 (369)
+++++..+.+.+.+.||+|.||+||+|+|.+ .||||.++.... ...+.|++|+.+|++-+|.||+-+.|||.....
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 5666777777888999999999999999953 599999987643 345689999999999999999999999997776
Q ss_pred eEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeecccee
Q 017558 273 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (369)
Q Consensus 273 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~ 352 (369)
.||..||+|-+|+.+||..+ ..|+..+.+.||.||+.||.|||.+ +|||||||..||||.+++.|||+||||+-.
T Consensus 463 -AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatv 537 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATV 537 (678)
T ss_pred -eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceee
Confidence 99999999999999999765 3588888999999999999999999 999999999999999999999999999853
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=242.96 Aligned_cols=152 Identities=26% Similarity=0.345 Sum_probs=136.8
Q ss_pred HHhhcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcc---cHHHHHHHHHHHHhcCCCccccEeeEEEeCCee
Q 017558 198 KIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ---GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQR 273 (369)
Q Consensus 198 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 273 (369)
++..++|+.+.+||+|+||.||+|+.+ +|.++|+|++++.... ..+.++.|-++|...++++||+|+-.|++.+.+
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 456789999999999999999999954 5899999999876433 345678999999999999999999999999999
Q ss_pred EEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceee
Q 017558 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (369)
Q Consensus 274 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~ 353 (369)
||||||++|||+..+|...+ .|+++...+++.+++.|++-||.. |+|||||||+|+|||..|++||+|||||.-+
T Consensus 217 YLiMEylPGGD~mTLL~~~~--~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl 291 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRKD--TLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGL 291 (550)
T ss_pred EEEEEecCCccHHHHHHhcC--cCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchh
Confidence 99999999999999997654 589999999999999999999998 9999999999999999999999999999654
Q ss_pred C
Q 017558 354 L 354 (369)
Q Consensus 354 ~ 354 (369)
.
T Consensus 292 ~ 292 (550)
T KOG0605|consen 292 D 292 (550)
T ss_pred h
Confidence 3
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=243.58 Aligned_cols=163 Identities=26% Similarity=0.355 Sum_probs=139.1
Q ss_pred hhcCCcccceecccCceEEEEEEE-cCCeEEEEEeeccC----Cc-ccHHHHHHHHHHHHhcC-CCccccEeeEEEeCCe
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAG----SG-QGEREFQAEIEIISQVH-HRHLVSLVGYCTFGSQ 272 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~ 272 (369)
...+|...+.||+|+||+|++|.. .++..||+|.+... .. ...+.+.+|+.++++++ ||||++++.++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 456889999999999999999984 46799999977553 11 22346778999999999 9999999999999999
Q ss_pred eEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCC-CcEEEeeeccce
Q 017558 273 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS-FEAKVADFGLAK 351 (369)
Q Consensus 273 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~-~~~ki~DFGla~ 351 (369)
.|+||||+.+|+|++++... ..+.+....+++.|++.|++|||++ +|+|||||++|||+|.+ +++||+|||+++
T Consensus 95 ~~ivmEy~~gGdL~~~i~~~--g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVNK--GRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLSA 169 (370)
T ss_pred EEEEEEecCCccHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence 99999999999999999873 4588899999999999999999999 99999999999999999 999999999999
Q ss_pred eeCCCCceeeeeecccC
Q 017558 352 HSLDTDTHVSTRVMGTF 368 (369)
Q Consensus 352 ~~~~~~~~~~~~~~gt~ 368 (369)
.....+. .....+||+
T Consensus 170 ~~~~~~~-~l~t~cGsp 185 (370)
T KOG0583|consen 170 ISPGEDG-LLKTFCGSP 185 (370)
T ss_pred ccCCCCC-cccCCCCCc
Confidence 8842222 233456664
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-31 Score=240.18 Aligned_cols=151 Identities=28% Similarity=0.426 Sum_probs=129.1
Q ss_pred HHhhcCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCCc--------------ccHHHHHHHHHHHHhcCCCcccc
Q 017558 198 KIATDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSG--------------QGEREFQAEIEIISQVHHRHLVS 262 (369)
Q Consensus 198 ~~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~h~niv~ 262 (369)
....++|++++.||+|.||.|-+|+. .+++.||||++.+... ...+.+++||.+|++|+|+|||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 34557899999999999999999995 4688999999854321 11257889999999999999999
Q ss_pred EeeEEEe--CCeeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCC
Q 017558 263 LVGYCTF--GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF 340 (369)
Q Consensus 263 l~g~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~ 340 (369)
|+.+..+ .+.+|||+|||..|.+...-- ....+.+.++.+|+.++..||+|||.+ +||||||||+|+||+++|
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~--d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPP--DKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDG 247 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCCC--CcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCC
Confidence 9999866 568999999999998754321 222389999999999999999999999 999999999999999999
Q ss_pred cEEEeeeccceee
Q 017558 341 EAKVADFGLAKHS 353 (369)
Q Consensus 341 ~~ki~DFGla~~~ 353 (369)
++||+|||.+...
T Consensus 248 ~VKIsDFGVs~~~ 260 (576)
T KOG0585|consen 248 TVKISDFGVSNEF 260 (576)
T ss_pred cEEeeccceeeec
Confidence 9999999999876
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=235.07 Aligned_cols=150 Identities=32% Similarity=0.491 Sum_probs=133.2
Q ss_pred cCCcccceecccCceEEEEEEEcC-CeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCC--eeEEEEE
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGS--QRLLVYE 278 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~--~~~lv~e 278 (369)
.++...+.||+|+||.||++...+ |..+|||.+...+....+.+.+|+.+|.+++|||||+++|...... .++++||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 456678999999999999999754 8899999987654333567899999999999999999999855444 6889999
Q ss_pred ecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECC-CCcEEEeeeccceeeCC
Q 017558 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD-SFEAKVADFGLAKHSLD 355 (369)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~-~~~~ki~DFGla~~~~~ 355 (369)
|+++|+|.+++.+.+. .+++....++..||++||+|||++ +|||+|||++||||+. ++.+||+|||+++....
T Consensus 97 y~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred ccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 9999999999987765 699999999999999999999999 9999999999999999 79999999999998763
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=248.85 Aligned_cols=164 Identities=32% Similarity=0.457 Sum_probs=142.9
Q ss_pred HHhhcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCc---ccHHHHHHHHHHHHhcC-CCccccEeeEEEeCCe
Q 017558 198 KIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG---QGEREFQAEIEIISQVH-HRHLVSLVGYCTFGSQ 272 (369)
Q Consensus 198 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~ 272 (369)
....++|.+.++||+|+||+|+++.++ +++.+|||.++++.. ++.+..+.|.+|+...+ ||.+++|+..|+..++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 445688999999999999999999975 478999999988753 34566788999988775 9999999999999999
Q ss_pred eEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeecccee
Q 017558 273 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (369)
Q Consensus 273 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~ 352 (369)
+|+||||+.||++..+.+ ...|++..+..++..|+.||+|||++ +|||||||.+|||||.+|++||+||||||.
T Consensus 444 l~fvmey~~Ggdm~~~~~---~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHIH---TDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred EEEEEEecCCCcEEEEEe---cccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccc
Confidence 999999999999554443 24599999999999999999999999 999999999999999999999999999999
Q ss_pred eCCCCceeeeeecccC
Q 017558 353 SLDTDTHVSTRVMGTF 368 (369)
Q Consensus 353 ~~~~~~~~~~~~~gt~ 368 (369)
....+. .+++.+||+
T Consensus 518 ~m~~g~-~TsTfCGTp 532 (694)
T KOG0694|consen 518 GMGQGD-RTSTFCGTP 532 (694)
T ss_pred cCCCCC-ccccccCCh
Confidence 775544 456689996
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-30 Score=233.76 Aligned_cols=145 Identities=37% Similarity=0.580 Sum_probs=127.4
Q ss_pred CcccceecccCceEEEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHh--cCCCccccEeeEEEeCC----eeEEEE
Q 017558 204 FSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQ--VHHRHLVSLVGYCTFGS----QRLLVY 277 (369)
Q Consensus 204 ~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~g~~~~~~----~~~lv~ 277 (369)
..+.++||+|.||.||+|++. ++.||||++.. ++...|+.|-+|++. ++|+||++++++-.... +.|||+
T Consensus 212 l~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt 287 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT 287 (534)
T ss_pred hhhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence 444678999999999999994 59999999964 335678899888875 57999999999876554 889999
Q ss_pred EecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCCeeecCCCCCcEEECCCCcEEEeeeccce
Q 017558 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHED------CQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351 (369)
Q Consensus 278 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~------~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~ 351 (369)
||.+.|+|.+||.. ..++|....+|+..+++||.|||+. +++.|+|||||++||||.+|+++.|+|||||.
T Consensus 288 ~fh~kGsL~dyL~~---ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl 364 (534)
T KOG3653|consen 288 EFHPKGSLCDYLKA---NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL 364 (534)
T ss_pred eeccCCcHHHHHHh---ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence 99999999999975 3589999999999999999999975 46789999999999999999999999999999
Q ss_pred eeCC
Q 017558 352 HSLD 355 (369)
Q Consensus 352 ~~~~ 355 (369)
.+.-
T Consensus 365 ~~~p 368 (534)
T KOG3653|consen 365 RLEP 368 (534)
T ss_pred EecC
Confidence 8763
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-31 Score=244.69 Aligned_cols=160 Identities=29% Similarity=0.429 Sum_probs=142.5
Q ss_pred cCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCc--ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEE
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 278 (369)
++|-+.+.||+|.||.||||+.+ +.+.||+|.+.+... .+.+.+++|++|+++++|||||.++++|+...+.|+|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 56778899999999999999954 568999999866433 345678999999999999999999999999999999999
Q ss_pred ecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCCCc
Q 017558 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 358 (369)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~~~ 358 (369)
|+.| +|+.+|... ..+.++....|+.++..||.|||++ +|+|||+||+|||++.++.+|+||||+||.... .+
T Consensus 82 ~a~g-~L~~il~~d--~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILEQD--GKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMST-NT 154 (808)
T ss_pred hhhh-hHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhccc-Cc
Confidence 9976 999999654 4599999999999999999999999 999999999999999999999999999998765 45
Q ss_pred eeeeeecccC
Q 017558 359 HVSTRVMGTF 368 (369)
Q Consensus 359 ~~~~~~~gt~ 368 (369)
.+.+.+.||+
T Consensus 155 ~vltsikGtP 164 (808)
T KOG0597|consen 155 SVLTSIKGTP 164 (808)
T ss_pred eeeeeccCcc
Confidence 6777888886
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=229.49 Aligned_cols=151 Identities=26% Similarity=0.355 Sum_probs=129.6
Q ss_pred cCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCCcccH--HHHHHHHHHHHhcCCCccccEeeEEEe--CCeeEEE
Q 017558 202 DNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGE--REFQAEIEIISQVHHRHLVSLVGYCTF--GSQRLLV 276 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lv 276 (369)
++|+..+.|++|+||.||+|+. +++++||+|+++......- ---++||.+|.+++|||||.+-.+... -+.+|||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 4577788999999999999995 5689999999987542211 135799999999999999999988754 4579999
Q ss_pred EEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCC
Q 017558 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 277 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~ 356 (369)
||||+ -||..+++... ..|...+...+..|+++|++|||.+ .|+|||||++|+|+++.|.+||+||||||.+.+.
T Consensus 156 Me~~E-hDLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 156 MEYVE-HDLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred HHHHH-hhHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 99995 57888887765 3588888889999999999999999 7999999999999999999999999999998876
Q ss_pred C
Q 017558 357 D 357 (369)
Q Consensus 357 ~ 357 (369)
-
T Consensus 231 ~ 231 (419)
T KOG0663|consen 231 L 231 (419)
T ss_pred c
Confidence 3
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=263.36 Aligned_cols=158 Identities=32% Similarity=0.513 Sum_probs=140.1
Q ss_pred hcCCcccceecccCceEEEEEEEcC--C----eEEEEEeeccCCc-ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCee
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLTN--G----KVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQR 273 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~~--~----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 273 (369)
.++..+.+.||+|.||.||+|.+.+ + ..||||.+++... ++..+|.+|..+|++++|||||+|+|+|......
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 4566778999999999999999754 3 2489999987654 4556999999999999999999999999999999
Q ss_pred EEEEEecCCCcHhhhhcCCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeec
Q 017558 274 LLVYEFVPNKTLEFHLHGKD-----RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFG 348 (369)
Q Consensus 274 ~lv~e~~~~g~L~~~l~~~~-----~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFG 348 (369)
+|++|||++|||..||+... ...+.-.+.+.|+.|||+|++||+++ ++|||||.+|||||+....+||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccc
Confidence 99999999999999998641 34588899999999999999999999 89999999999999999999999999
Q ss_pred cceeeCCCCceee
Q 017558 349 LAKHSLDTDTHVS 361 (369)
Q Consensus 349 la~~~~~~~~~~~ 361 (369)
|||+.++.++...
T Consensus 848 lArDiy~~~yyr~ 860 (1025)
T KOG1095|consen 848 LARDIYDKDYYRK 860 (1025)
T ss_pred hhHhhhhchheec
Confidence 9998888776543
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-30 Score=241.45 Aligned_cols=160 Identities=26% Similarity=0.390 Sum_probs=144.3
Q ss_pred cCCcccceecccCceEEEEEE-EcCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEec
Q 017558 202 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 280 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 280 (369)
..|.....||+|..|.||.+. ..+++.||||++.......++-+.+|+.+|+..+|+|||++++.|...+++|+|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 457778899999999999998 4567899999998877776778899999999999999999999999999999999999
Q ss_pred CCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCCCcee
Q 017558 281 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 360 (369)
Q Consensus 281 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~~~~~ 360 (369)
++|+|-+.+.. ..+++.++..|+.+++.||+|||.+ +|+|||||.+|||++.+|.+||+|||+|..+..... .
T Consensus 353 ~ggsLTDvVt~---~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-K 425 (550)
T KOG0578|consen 353 EGGSLTDVVTK---TRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-K 425 (550)
T ss_pred CCCchhhhhhc---ccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccC-c
Confidence 99999988854 3489999999999999999999999 999999999999999999999999999999877665 4
Q ss_pred eeeecccC
Q 017558 361 STRVMGTF 368 (369)
Q Consensus 361 ~~~~~gt~ 368 (369)
.++++||+
T Consensus 426 R~TmVGTP 433 (550)
T KOG0578|consen 426 RSTMVGTP 433 (550)
T ss_pred cccccCCC
Confidence 45688886
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=229.58 Aligned_cols=155 Identities=23% Similarity=0.334 Sum_probs=140.5
Q ss_pred hhcCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCCcc-cHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEE
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 277 (369)
..++|++.++||.|..+.||+|+. ..++.||||++..++.. +.+.+++|+..|+.++||||++++..|..+..+|+||
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 457899999999999999999994 46799999999765433 3578999999999999999999999999999999999
Q ss_pred EecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCCC
Q 017558 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (369)
Q Consensus 278 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~~ 357 (369)
.||.+|++.+.+...-...+++..+..|..++++||.|||.+ |.||||||+.||||+.+|.+||+|||.+-.+.+..
T Consensus 104 pfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 999999999999876556699999999999999999999999 99999999999999999999999999988877655
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=225.91 Aligned_cols=150 Identities=28% Similarity=0.418 Sum_probs=129.5
Q ss_pred hcCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCCcc--cHHHHHHHHHHHHhcCCCc-cccEeeEEEeCC-----
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQ--GEREFQAEIEIISQVHHRH-LVSLVGYCTFGS----- 271 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~n-iv~l~g~~~~~~----- 271 (369)
..+|...+.||+|+||.||+|+. .+|+.||+|+++....+ --....+|+.+|.+++|+| |+.|++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 34566678899999999999994 56889999999876442 2235689999999999999 999999998877
Q ss_pred -eeEEEEEecCCCcHhhhhcCCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeec
Q 017558 272 -QRLLVYEFVPNKTLEFHLHGKDR--PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFG 348 (369)
Q Consensus 272 -~~~lv~e~~~~g~L~~~l~~~~~--~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFG 348 (369)
.++||+||+ .-+|..++..... ..++......++.||+.||.|||++ +|+||||||.||||+++|.+||+|||
T Consensus 90 ~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccc
Confidence 789999999 5688888876542 3466678899999999999999999 99999999999999999999999999
Q ss_pred cceeeC
Q 017558 349 LAKHSL 354 (369)
Q Consensus 349 la~~~~ 354 (369)
+||.+.
T Consensus 166 lAra~~ 171 (323)
T KOG0594|consen 166 LARAFS 171 (323)
T ss_pred hHHHhc
Confidence 999765
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=238.57 Aligned_cols=165 Identities=23% Similarity=0.263 Sum_probs=139.5
Q ss_pred HHhhcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC---cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCee
Q 017558 198 KIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQR 273 (369)
Q Consensus 198 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 273 (369)
....++|+..+.||+|+||.||+++.. +++.+|+|.+.... ....+.+.+|+.++..++||||+++++++..+...
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 344578999999999999999999975 47889999986422 22334678999999999999999999999999999
Q ss_pred EEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceee
Q 017558 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (369)
Q Consensus 274 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~ 353 (369)
|+||||+++|+|.+++... .+++.....++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+..
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~ 192 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKM 192 (370)
T ss_pred EEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceec
Confidence 9999999999999999643 378888999999999999999998 9999999999999999999999999999987
Q ss_pred CCCCceeeeeecccC
Q 017558 354 LDTDTHVSTRVMGTF 368 (369)
Q Consensus 354 ~~~~~~~~~~~~gt~ 368 (369)
............||+
T Consensus 193 ~~~~~~~~~~~~gt~ 207 (370)
T cd05621 193 DETGMVRCDTAVGTP 207 (370)
T ss_pred ccCCceecccCCCCc
Confidence 544332223345654
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=229.69 Aligned_cols=152 Identities=30% Similarity=0.428 Sum_probs=131.3
Q ss_pred HHhhcCCcccceecccCceEEEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHh--cCCCccccEeeEEEeC----C
Q 017558 198 KIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQ--VHHRHLVSLVGYCTFG----S 271 (369)
Q Consensus 198 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~g~~~~~----~ 271 (369)
+....+..+.+.||+|.||+||+|.|+ |+.||||++.. .+++.+.+|.+|+.. |+|+||+.+++.-..+ .
T Consensus 207 RTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T 282 (513)
T KOG2052|consen 207 RTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT 282 (513)
T ss_pred HhhhheeEEEEEecCccccceeecccc-CCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence 334566778899999999999999995 78899999964 335678889998876 4999999999876443 3
Q ss_pred eeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-----CCCCCeeecCCCCCcEEECCCCcEEEee
Q 017558 272 QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHE-----DCQPKIIHRDIKSANILLDDSFEAKVAD 346 (369)
Q Consensus 272 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-----~~~~~ivHrdlk~~Nill~~~~~~ki~D 346 (369)
++|||.||-++|+|+|||.. ..++.+..++++..+|.||+|||. +++|.|.|||||+.||||.+++.+.|+|
T Consensus 283 QLwLvTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD 359 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 359 (513)
T ss_pred EEEEeeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence 78999999999999999976 458999999999999999999996 4678999999999999999999999999
Q ss_pred eccceeeCCC
Q 017558 347 FGLAKHSLDT 356 (369)
Q Consensus 347 FGla~~~~~~ 356 (369)
+|||....+.
T Consensus 360 LGLAv~h~~~ 369 (513)
T KOG2052|consen 360 LGLAVRHDSD 369 (513)
T ss_pred ceeeEEeccc
Confidence 9999876554
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=234.85 Aligned_cols=154 Identities=29% Similarity=0.517 Sum_probs=130.9
Q ss_pred HhhcCCcccceecccCceEEEEEEE------cCCeEEEEEeeccCCcc-cHHHHHHHHHHHHhc-CCCccccEeeEEEeC
Q 017558 199 IATDNFSEANLLGQGGFGYVHKGVL------TNGKVVAIKQLKAGSGQ-GEREFQAEIEIISQV-HHRHLVSLVGYCTFG 270 (369)
Q Consensus 199 ~~~~~~~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~ 270 (369)
+..++|++.+.||+|+||.||+|.. .++..||||+++..... ..+.+.+|+++|.++ +|+||++++++|...
T Consensus 4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 4567899999999999999999974 23467999999754332 345789999999999 899999999998764
Q ss_pred -CeeEEEEEecCCCcHhhhhcCCC--------------------------------------------------------
Q 017558 271 -SQRLLVYEFVPNKTLEFHLHGKD-------------------------------------------------------- 293 (369)
Q Consensus 271 -~~~~lv~e~~~~g~L~~~l~~~~-------------------------------------------------------- 293 (369)
...++||||+++|+|.+++....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 46789999999999999987431
Q ss_pred ----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 294 ----RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 294 ----~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
...+++..++.++.||+.||.|||++ +|+||||||+|||+++++.+||+|||+++....
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~ 226 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYK 226 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeeccccccccc
Confidence 12377888999999999999999998 999999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=231.04 Aligned_cols=152 Identities=23% Similarity=0.278 Sum_probs=133.5
Q ss_pred cCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC---cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEE
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 277 (369)
++|++.+.||+|+||.||+++.. +++.||+|.+.... ....+.+.+|+.++..++|+||+++++++...+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47889999999999999999964 47899999986421 223356889999999999999999999999999999999
Q ss_pred EecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCCC
Q 017558 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (369)
Q Consensus 278 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~~ 357 (369)
||+++|+|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 81 e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 81 DYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred ecCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence 9999999999996532 3588899999999999999999998 99999999999999999999999999998765443
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.4e-29 Score=235.44 Aligned_cols=148 Identities=26% Similarity=0.364 Sum_probs=132.5
Q ss_pred cCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC---cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEE
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 277 (369)
++|+..+.||+|+||.||+|+.. +++.||||+++... ......+.+|+++|..++|+||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47889999999999999999964 57899999997532 223346788999999999999999999999999999999
Q ss_pred EecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 278 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.+.
T Consensus 81 E~~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 152 (364)
T cd05599 81 EYLPGGDMMTLLMKKD--TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK 152 (364)
T ss_pred CCCCCcHHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceecc
Confidence 9999999999997543 489999999999999999999998 99999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=230.42 Aligned_cols=163 Identities=21% Similarity=0.232 Sum_probs=137.8
Q ss_pred cCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC---cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEE
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 277 (369)
++|.+.+.||+|+||.||+++.. +++.||+|.+.... ......+.+|+.++..++|+||+++++++...+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 57889999999999999999964 56789999986532 222345788999999999999999999999999999999
Q ss_pred EecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCCC
Q 017558 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (369)
Q Consensus 278 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~~ 357 (369)
||+++|+|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 81 Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 81 DYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred eCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence 9999999999997533 3588889999999999999999998 99999999999999999999999999998776544
Q ss_pred ceeeeeecccC
Q 017558 358 THVSTRVMGTF 368 (369)
Q Consensus 358 ~~~~~~~~gt~ 368 (369)
........||+
T Consensus 157 ~~~~~~~~gt~ 167 (331)
T cd05624 157 TVQSSVAVGTP 167 (331)
T ss_pred ceeeccccCCc
Confidence 33333345554
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.1e-29 Score=235.12 Aligned_cols=148 Identities=25% Similarity=0.348 Sum_probs=132.1
Q ss_pred cCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC---cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEE
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 277 (369)
++|+..+.||+|+||.||++... +++.||||+++... ......+.+|+.++.+++|+||+++++++.+....||||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47889999999999999999864 57899999997532 122346788999999999999999999999999999999
Q ss_pred EecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 278 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
||+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++...
T Consensus 81 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~ 152 (363)
T cd05628 81 EFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK 152 (363)
T ss_pred cCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence 999999999999754 3589999999999999999999998 99999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=224.81 Aligned_cols=149 Identities=31% Similarity=0.426 Sum_probs=131.7
Q ss_pred CcccceecccCceEEEEEEE-cCCeEEEEEeeccCCc---ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEe
Q 017558 204 FSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSG---QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (369)
Q Consensus 204 ~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 279 (369)
|+..+.||+|+||.||++.. .+++.||||.+..... .....+.+|++++.+++|+||+.+++++.+++..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 67789999999999999985 4688999999865432 2234678999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
+++|+|.+++.......+++..+..++.|++.||.|||++ +|+||||||+|||+++++.+||+|||+++...+
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPE 154 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC
Confidence 9999999888654444689999999999999999999998 999999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=230.99 Aligned_cols=151 Identities=28% Similarity=0.370 Sum_probs=134.0
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC---cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEE
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 276 (369)
.++|++.+.||+|+||.||+|+.. +++.||||.++... ....+.+.+|+.++.+++||||+++++++..++..|+|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 367888999999999999999975 57899999986532 22345688999999999999999999999999999999
Q ss_pred EEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCC
Q 017558 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 277 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~ 356 (369)
|||+++|+|.+++.... .+.+..+..++.||+.||+|||++ +|+||||||+||||++++.+||+|||+++...+.
T Consensus 97 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 97 LEFVVGGELFTHLRKAG--RFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred EcCCCCChHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 99999999999997543 478888999999999999999998 9999999999999999999999999999876543
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=235.24 Aligned_cols=147 Identities=26% Similarity=0.337 Sum_probs=130.9
Q ss_pred cCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCC---cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEE
Q 017558 202 DNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 277 (369)
++|.+.+.||+|+||.||++.. .+++.||||++.... ....+.+.+|++++.+++|+||+++++++.+....||||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 4788899999999999999985 467899999986532 223356888999999999999999999999999999999
Q ss_pred EecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceee
Q 017558 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (369)
Q Consensus 278 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~ 353 (369)
||+++|+|.+++... ..+++.....++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.+
T Consensus 81 E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~ 151 (377)
T cd05629 81 EFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151 (377)
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccc
Confidence 999999999999754 3488889999999999999999998 9999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=226.28 Aligned_cols=154 Identities=27% Similarity=0.521 Sum_probs=132.6
Q ss_pred hcCCcccceecccCceEEEEEEEcC-----------------CeEEEEEeeccCCcc-cHHHHHHHHHHHHhcCCCcccc
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLTN-----------------GKVVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVS 262 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~~-----------------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~ 262 (369)
.++|.+.+.||+|+||.||+|.+.+ +..||+|.++..... ...+|.+|+++|.+++|+||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 4678889999999999999998532 346999998765332 3457999999999999999999
Q ss_pred EeeEEEeCCeeEEEEEecCCCcHhhhhcCCC-----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCee
Q 017558 263 LVGYCTFGSQRLLVYEFVPNKTLEFHLHGKD-----------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKII 325 (369)
Q Consensus 263 l~g~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iv 325 (369)
+++++.+.+..++||||+++|+|.+++.... ...+++...++++.||+.||.|||++ +|+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Ccc
Confidence 9999999999999999999999999985421 12467888999999999999999998 999
Q ss_pred ecCCCCCcEEECCCCcEEEeeeccceeeCCCC
Q 017558 326 HRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (369)
Q Consensus 326 Hrdlk~~Nill~~~~~~ki~DFGla~~~~~~~ 357 (369)
||||||+|||+++++.+||+|||+++.....+
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~ 192 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGD 192 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCc
Confidence 99999999999999999999999998765443
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=228.94 Aligned_cols=142 Identities=28% Similarity=0.367 Sum_probs=126.3
Q ss_pred ceecccCceEEEEEEE-cCCeEEEEEeeccCC---cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEecCCC
Q 017558 208 NLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNK 283 (369)
Q Consensus 208 ~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 283 (369)
+.||+|+||.||+++. .+++.||||+++... ......+.+|++++.+++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999986 468899999987542 223346788999999999999999999999999999999999999
Q ss_pred cHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 284 TLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 284 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
+|.+++... ..+++.....++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~ 146 (323)
T cd05571 81 ELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 146 (323)
T ss_pred cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccc
Confidence 999998754 3588999999999999999999998 99999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=229.92 Aligned_cols=149 Identities=28% Similarity=0.367 Sum_probs=132.9
Q ss_pred cCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC---cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEE
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 277 (369)
++|++.+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|++++.+++|+||+++++++...+..||||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36888999999999999999975 47899999997542 223456889999999999999999999999999999999
Q ss_pred EecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 278 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
||+++|+|.+++... ..+.+.....++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 81 EYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 999999999999654 3488999999999999999999998 999999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=233.32 Aligned_cols=169 Identities=23% Similarity=0.259 Sum_probs=141.7
Q ss_pred HHHHHHhhcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC---cccHHHHHHHHHHHHhcCCCccccEeeEEEe
Q 017558 194 YEELKIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTF 269 (369)
Q Consensus 194 ~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~ 269 (369)
+.++....++|++.+.||+|+||.||+++.. +++.+|+|.+.... ....+.+.+|+.++..++||||+++++++..
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 3445566789999999999999999999965 57889999986422 2233467889999999999999999999999
Q ss_pred CCeeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeecc
Q 017558 270 GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGL 349 (369)
Q Consensus 270 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGl 349 (369)
+...|+||||+++|+|.+++... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~ 188 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGT 188 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCc
Confidence 99999999999999999998643 378888889999999999999998 999999999999999999999999999
Q ss_pred ceeeCCCCceeeeeecccC
Q 017558 350 AKHSLDTDTHVSTRVMGTF 368 (369)
Q Consensus 350 a~~~~~~~~~~~~~~~gt~ 368 (369)
++..............||+
T Consensus 189 a~~~~~~~~~~~~~~~gt~ 207 (371)
T cd05622 189 CMKMNKEGMVRCDTAVGTP 207 (371)
T ss_pred eeEcCcCCcccccCcccCc
Confidence 9887544332233345554
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=229.10 Aligned_cols=152 Identities=24% Similarity=0.282 Sum_probs=134.5
Q ss_pred cCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCc---ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEE
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG---QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 277 (369)
++|.+.+.||+|+||.||+++.. +++.||+|+++.... ...+.+.+|+.++..++|+||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46888999999999999999964 578999999975422 23456889999999999999999999999999999999
Q ss_pred EecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCCC
Q 017558 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (369)
Q Consensus 278 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~~ 357 (369)
||+++|+|.+++.... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 81 e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 81 EYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred CCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence 9999999999997653 3589999999999999999999998 99999999999999999999999999998875543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=234.17 Aligned_cols=153 Identities=24% Similarity=0.275 Sum_probs=133.6
Q ss_pred HHhhcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC---cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCee
Q 017558 198 KIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQR 273 (369)
Q Consensus 198 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 273 (369)
....++|++.+.||+|+||.||+++.. +++.||+|.+.... ......+.+|+.+++.++|+||+++++++.+....
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~ 118 (370)
T cd05596 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL 118 (370)
T ss_pred CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 344578999999999999999999964 57899999986432 22334578899999999999999999999999999
Q ss_pred EEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceee
Q 017558 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (369)
Q Consensus 274 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~ 353 (369)
|+||||+++|+|.+++... .+++.....++.||+.||.|||++ +|+||||||+|||+++++.+||+|||+++..
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 119 YMVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred EEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 9999999999999998653 377888889999999999999998 9999999999999999999999999999876
Q ss_pred CCC
Q 017558 354 LDT 356 (369)
Q Consensus 354 ~~~ 356 (369)
...
T Consensus 193 ~~~ 195 (370)
T cd05596 193 DAN 195 (370)
T ss_pred cCC
Confidence 543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-28 Score=229.50 Aligned_cols=151 Identities=28% Similarity=0.291 Sum_probs=132.7
Q ss_pred hhcCCcccceecccCceEEEEEEEcC--CeEEEEEeeccCC---cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeE
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVLTN--GKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRL 274 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 274 (369)
..++|.+.+.||+|+||.||+|...+ +..||+|++.... ....+.+.+|++++..++||||+++++++.+.+..|
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence 34578889999999999999998643 3689999986432 223456889999999999999999999999999999
Q ss_pred EEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 275 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 275 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
+||||+++|+|.+++.... .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 108 lv~Ey~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRRNK--RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 9999999999999997543 488999999999999999999998 99999999999999999999999999998764
Q ss_pred C
Q 017558 355 D 355 (369)
Q Consensus 355 ~ 355 (369)
.
T Consensus 183 ~ 183 (340)
T PTZ00426 183 T 183 (340)
T ss_pred C
Confidence 3
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-28 Score=228.31 Aligned_cols=161 Identities=26% Similarity=0.317 Sum_probs=134.8
Q ss_pred CCcccceecccCceEEEEEEEc----CCeEEEEEeeccCC----cccHHHHHHHHHHHHhc-CCCccccEeeEEEeCCee
Q 017558 203 NFSEANLLGQGGFGYVHKGVLT----NGKVVAIKQLKAGS----GQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQR 273 (369)
Q Consensus 203 ~~~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 273 (369)
+|++.+.||+|+||.||+++.. +++.||+|+++... ....+.+..|++++.++ +|+||+.+++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4788999999999999999853 57899999986432 22234678899999999 599999999999999999
Q ss_pred EEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceee
Q 017558 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (369)
Q Consensus 274 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~ 353 (369)
++||||+++|+|.+++... ..+++.....++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 9999999999999998654 3488999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCceeeeeecccC
Q 017558 354 LDTDTHVSTRVMGTF 368 (369)
Q Consensus 354 ~~~~~~~~~~~~gt~ 368 (369)
...+........||+
T Consensus 156 ~~~~~~~~~~~~gt~ 170 (332)
T cd05614 156 LSEEKERTYSFCGTI 170 (332)
T ss_pred cccCCCccccccCCc
Confidence 443322222344553
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-29 Score=245.28 Aligned_cols=155 Identities=25% Similarity=0.367 Sum_probs=137.2
Q ss_pred HHHhhcCCcccceecccCceEEEEEEEcCC-eEEEEEeeccCCcccHHHHHHHHHHHHhcC-CCccccEeeE-EEe----
Q 017558 197 LKIATDNFSEANLLGQGGFGYVHKGVLTNG-KVVAIKQLKAGSGQGEREFQAEIEIISQVH-HRHLVSLVGY-CTF---- 269 (369)
Q Consensus 197 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~-~~~---- 269 (369)
+.+...++++.++|.+|+|+.||+++...+ ..||+|++-..+....+.+.+||++|++|. |+|||.|++. ...
T Consensus 32 ~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~ 111 (738)
T KOG1989|consen 32 FTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSN 111 (738)
T ss_pred EEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCC
Confidence 345667788899999999999999998776 999999998877778889999999999997 9999999993 221
Q ss_pred --CCeeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeee
Q 017558 270 --GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADF 347 (369)
Q Consensus 270 --~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DF 347 (369)
..+.+|+||||.+|.|-+++..+....|++.++++|++|+++|+.+||.. .++|||||||.+||||+.++..|||||
T Consensus 112 ~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDF 190 (738)
T KOG1989|consen 112 NGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDF 190 (738)
T ss_pred CceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcc
Confidence 23678999999999999999866656699999999999999999999986 778999999999999999999999999
Q ss_pred cccee
Q 017558 348 GLAKH 352 (369)
Q Consensus 348 Gla~~ 352 (369)
|-|-.
T Consensus 191 GSatt 195 (738)
T KOG1989|consen 191 GSATT 195 (738)
T ss_pred ccccc
Confidence 98754
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=238.44 Aligned_cols=159 Identities=27% Similarity=0.422 Sum_probs=143.3
Q ss_pred HHHHHHhhcCCcccceecccCceEEEEEEEcCC-eEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCe
Q 017558 194 YEELKIATDNFSEANLLGQGGFGYVHKGVLTNG-KVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQ 272 (369)
Q Consensus 194 ~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 272 (369)
+.+++....+.....+||.|.||+||.|.|+.. ..||||.++++... .++|+.|+.+|+.++|||+|+|+|+|..+..
T Consensus 259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMe-veEFLkEAAvMKeikHpNLVqLLGVCT~EpP 337 (1157)
T KOG4278|consen 259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP 337 (1157)
T ss_pred cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchh-HHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence 355666666777788999999999999998763 57999999876543 6799999999999999999999999999999
Q ss_pred eEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeecccee
Q 017558 273 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (369)
Q Consensus 273 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~ 352 (369)
.|||.|||.+|+|.+||+..++..+..--.++++.||..||+||..+ ++|||||.++|||+.++..+||+||||+|.
T Consensus 338 FYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRl 414 (1157)
T KOG4278|consen 338 FYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRL 414 (1157)
T ss_pred eEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhh
Confidence 99999999999999999987777777778899999999999999988 999999999999999999999999999998
Q ss_pred eCCC
Q 017558 353 SLDT 356 (369)
Q Consensus 353 ~~~~ 356 (369)
+..+
T Consensus 415 MtgD 418 (1157)
T KOG4278|consen 415 MTGD 418 (1157)
T ss_pred hcCC
Confidence 7654
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=223.64 Aligned_cols=150 Identities=25% Similarity=0.256 Sum_probs=136.0
Q ss_pred hcCCcccceecccCceEEEEEEEcC-CeEEEEEeeccCCcc---cHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEE
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGSGQ---GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 276 (369)
.+.|+..+.||.|.-|.||++++++ +..+|+|++.+.... .......|-+||+.++||.++.|++.++.+...|+|
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence 3456678899999999999999865 488999999765432 334667899999999999999999999999999999
Q ss_pred EEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceee
Q 017558 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (369)
Q Consensus 277 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~ 353 (369)
||||+||+|..+++++....|++..+.+++.+|+.||+|||.. |||+|||||+||||-++|++.|+||.|+...
T Consensus 156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRC 229 (459)
T ss_pred EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccC
Confidence 9999999999999999888999999999999999999999988 9999999999999999999999999998765
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=233.79 Aligned_cols=164 Identities=25% Similarity=0.375 Sum_probs=144.5
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcc--cHHHHHHHHHHHHhcCCCccccEeeEEEeCCe-eEEE
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ--GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQ-RLLV 276 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~-~~lv 276 (369)
.++|...++||+|+||.+++++.+ ++..+++|+++..+.. ..+....|+.++++++|||||.+.+.|..++. .+||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 367888999999999999998854 4678999998765432 33467899999999999999999999998888 9999
Q ss_pred EEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCC
Q 017558 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 277 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~ 356 (369)
|+|++||+|.+.|..+....|.++....++.|++.|++|||++ .|+|||||+.|||++.+..+||+|||+||.+...
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 9999999999999887767799999999999999999999988 8999999999999999999999999999999877
Q ss_pred CceeeeeecccC
Q 017558 357 DTHVSTRVMGTF 368 (369)
Q Consensus 357 ~~~~~~~~~gt~ 368 (369)
+. ...+++||+
T Consensus 160 ~~-~a~tvvGTp 170 (426)
T KOG0589|consen 160 DS-LASTVVGTP 170 (426)
T ss_pred hh-hhheecCCC
Confidence 63 334578885
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-28 Score=227.37 Aligned_cols=142 Identities=31% Similarity=0.392 Sum_probs=126.5
Q ss_pred ceecccCceEEEEEEEc-CCeEEEEEeeccCC---cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEecCCC
Q 017558 208 NLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNK 283 (369)
Q Consensus 208 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 283 (369)
+.||+|+||.||+++.. +++.||||+++... ......+.+|++++.+++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999854 57899999997542 223456788999999999999999999999999999999999999
Q ss_pred cHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 284 TLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 284 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
+|..++... ..+++.....++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~ 146 (328)
T cd05593 81 ELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGI 146 (328)
T ss_pred CHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCC
Confidence 999988654 3588999999999999999999998 99999999999999999999999999998644
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-28 Score=233.10 Aligned_cols=146 Identities=24% Similarity=0.289 Sum_probs=130.0
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC---cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEE
Q 017558 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (369)
Q Consensus 203 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 278 (369)
.|+..+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|++++.+++|+||+++++++.+.+..|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5788999999999999999854 57899999996542 2234568899999999999999999999999999999999
Q ss_pred ecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceee
Q 017558 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (369)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~ 353 (369)
|+++|+|.+++.... .+++.....++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++.+
T Consensus 82 ~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~ 151 (381)
T cd05626 82 YIPGGDMMSLLIRME--VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGF 151 (381)
T ss_pred cCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCccc
Confidence 999999999997543 488888899999999999999998 9999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=225.73 Aligned_cols=149 Identities=28% Similarity=0.350 Sum_probs=132.6
Q ss_pred cCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC---cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEE
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 277 (369)
++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++.+++||||+++++++.+....|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46888999999999999999965 57899999986432 123456889999999999999999999999999999999
Q ss_pred EecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 278 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
||+++|+|.+++... ..+++.....++.||+.||.|||++ +++||||||+|||+++++.+||+|||+++...+
T Consensus 81 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 999999999999754 3488999999999999999999998 999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-28 Score=227.41 Aligned_cols=142 Identities=27% Similarity=0.371 Sum_probs=126.1
Q ss_pred ceecccCceEEEEEEEc-CCeEEEEEeeccCC---cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEecCCC
Q 017558 208 NLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNK 283 (369)
Q Consensus 208 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 283 (369)
+.||+|+||.||+++.. ++..||+|+++... ......+.+|++++.+++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999964 57899999997542 223346778999999999999999999999999999999999999
Q ss_pred cHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 284 TLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 284 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
+|..++... ..+++..+..++.||+.||.|||++ +|+||||||+|||+++++.+||+|||+++...
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~ 146 (323)
T cd05595 81 ELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 146 (323)
T ss_pred cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhcccc
Confidence 999988654 3588999999999999999999998 99999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-28 Score=227.15 Aligned_cols=163 Identities=23% Similarity=0.267 Sum_probs=137.2
Q ss_pred cCCcccceecccCceEEEEEEEcC-CeEEEEEeeccCC---cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEE
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 277 (369)
++|++.+.||+|+||.||+++... ++.+|+|.+.+.. ......+.+|+.++..++|+||+.+++++...+..|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 478889999999999999999754 6789999986422 122345888999999999999999999999999999999
Q ss_pred EecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCCC
Q 017558 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (369)
Q Consensus 278 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~~ 357 (369)
||+++|+|.+++.... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 81 ey~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 81 DYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred eccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence 9999999999997533 3588999999999999999999998 99999999999999999999999999998765443
Q ss_pred ceeeeeecccC
Q 017558 358 THVSTRVMGTF 368 (369)
Q Consensus 358 ~~~~~~~~gt~ 368 (369)
........||+
T Consensus 157 ~~~~~~~~gt~ 167 (332)
T cd05623 157 TVQSSVAVGTP 167 (332)
T ss_pred cceecccccCc
Confidence 33333345654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-28 Score=228.35 Aligned_cols=162 Identities=26% Similarity=0.308 Sum_probs=142.4
Q ss_pred hhcCCcccceecccCceEEEEEEEcC-CeEEEEEeeccCCcc---cHHHHHHHHHHHHhcC-CCccccEeeEEEeCCeeE
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGSGQ---GEREFQAEIEIISQVH-HRHLVSLVGYCTFGSQRL 274 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~ 274 (369)
..+.|++.+.||+|.||.||+|+.+. |+.+|+|.+.+.... +.+.+.+|+.+|.++. |||||.+.++|++....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 34678888999999999999999655 899999999765433 3468999999999998 999999999999999999
Q ss_pred EEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCC----CcEEEeeeccc
Q 017558 275 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS----FEAKVADFGLA 350 (369)
Q Consensus 275 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~----~~~ki~DFGla 350 (369)
+|||++.||.|++.+... .+++.....++.||+.++.|||+. +|+||||||+|+|+... +.+|++|||++
T Consensus 113 lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla 186 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGLA 186 (382)
T ss_pred EEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence 999999999999999766 289999999999999999999998 99999999999999643 57999999999
Q ss_pred eeeCCCCceeeeeecccCC
Q 017558 351 KHSLDTDTHVSTRVMGTFG 369 (369)
Q Consensus 351 ~~~~~~~~~~~~~~~gt~g 369 (369)
+.... ......++||++
T Consensus 187 ~~~~~--~~~~~~~~Gtp~ 203 (382)
T KOG0032|consen 187 KFIKP--GERLHTIVGTPE 203 (382)
T ss_pred eEccC--CceEeeecCCcc
Confidence 99876 234556888874
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-28 Score=232.74 Aligned_cols=146 Identities=23% Similarity=0.283 Sum_probs=129.8
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC---cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEE
Q 017558 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (369)
Q Consensus 203 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 278 (369)
.|+..+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++|+||+++++++.+.+..|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5888999999999999999964 57889999986532 2233568899999999999999999999999999999999
Q ss_pred ecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceee
Q 017558 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (369)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~ 353 (369)
|+++|+|.+++... ..+++.....++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.+
T Consensus 82 ~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~ 151 (382)
T cd05625 82 YIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151 (382)
T ss_pred CCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCccc
Confidence 99999999999754 3478888899999999999999998 9999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-28 Score=231.38 Aligned_cols=146 Identities=23% Similarity=0.296 Sum_probs=130.0
Q ss_pred cCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC---cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEE
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 277 (369)
.+|++.+.||+|+||.||+++.. +++.||||++.... ......+.+|+++|.+++|+||+++++.+.+++..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36889999999999999999954 57899999986432 123356889999999999999999999999999999999
Q ss_pred EecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeecccee
Q 017558 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (369)
Q Consensus 278 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~ 352 (369)
||+++|+|.+++... ..+++.....++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|..
T Consensus 81 E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~ 150 (376)
T cd05598 81 DYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTG 150 (376)
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcc
Confidence 999999999999754 3478888889999999999999998 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.8e-28 Score=224.57 Aligned_cols=143 Identities=27% Similarity=0.367 Sum_probs=125.7
Q ss_pred ceecccCceEEEEEEE-cCCeEEEEEeeccCC---cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEecCCC
Q 017558 208 NLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNK 283 (369)
Q Consensus 208 ~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 283 (369)
+.||+|+||.||++.. .+++.||+|.++... ......+.+|++++..++|+||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999985 467899999997532 223346778999999999999999999999999999999999999
Q ss_pred cHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 284 TLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHE-DCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 284 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
+|..++... ..+++..+..++.||+.||.|||+ + +|+||||||+|||+++++.+||+|||+++....
T Consensus 81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~ 148 (325)
T cd05594 81 ELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 148 (325)
T ss_pred cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCC
Confidence 999988654 358999999999999999999997 5 899999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-28 Score=231.35 Aligned_cols=157 Identities=27% Similarity=0.468 Sum_probs=134.3
Q ss_pred HHHhhcCCcccceecccCceEEEEEEE------cCCeEEEEEeeccCCc-ccHHHHHHHHHHHHhc-CCCccccEeeEEE
Q 017558 197 LKIATDNFSEANLLGQGGFGYVHKGVL------TNGKVVAIKQLKAGSG-QGEREFQAEIEIISQV-HHRHLVSLVGYCT 268 (369)
Q Consensus 197 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~g~~~ 268 (369)
+.+..++|++.+.||+|+||.||+|++ .++..||||+++.... ...+.+.+|+++|..+ +||||++++++|.
T Consensus 30 ~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~ 109 (375)
T cd05104 30 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACT 109 (375)
T ss_pred cccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeec
Confidence 344566788899999999999999974 2356899999975432 3345788999999999 8999999999999
Q ss_pred eCCeeEEEEEecCCCcHhhhhcCCC-------------------------------------------------------
Q 017558 269 FGSQRLLVYEFVPNKTLEFHLHGKD------------------------------------------------------- 293 (369)
Q Consensus 269 ~~~~~~lv~e~~~~g~L~~~l~~~~------------------------------------------------------- 293 (369)
..+..++||||+++|+|.++++...
T Consensus 110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 189 (375)
T cd05104 110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV 189 (375)
T ss_pred cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence 9999999999999999999986421
Q ss_pred ------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 294 ------------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 294 ------------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
...+++..++.++.||+.||.|||++ +++||||||+|||+++++.+||+|||+++....
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 266 (375)
T cd05104 190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRN 266 (375)
T ss_pred ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccC
Confidence 12478889999999999999999998 999999999999999999999999999987654
Q ss_pred C
Q 017558 356 T 356 (369)
Q Consensus 356 ~ 356 (369)
.
T Consensus 267 ~ 267 (375)
T cd05104 267 D 267 (375)
T ss_pred c
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=233.59 Aligned_cols=148 Identities=28% Similarity=0.358 Sum_probs=132.0
Q ss_pred cCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCCcc---cHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEE
Q 017558 202 DNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQ---GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 277 (369)
.-|++++.||.|+-|.|.+|++ .+|+.+|||++.+.... ....+.+||-||+.+.||||++|++++++..++|+|+
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 3467789999999999999994 57999999999665221 2246889999999999999999999999999999999
Q ss_pred EecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 278 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
||+++|.|+++|..++ .+.+.+..+++.||+.|+.|+|.. +|+||||||+|+|||..+++||+|||||-.-.
T Consensus 92 Eyv~gGELFdylv~kG--~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~ 163 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKG--PLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEV 163 (786)
T ss_pred EecCCchhHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeeccc
Confidence 9999999999997664 488899999999999999999998 99999999999999999999999999997543
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-28 Score=228.53 Aligned_cols=150 Identities=30% Similarity=0.353 Sum_probs=134.4
Q ss_pred cCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC---cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEE
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 277 (369)
++|.+.+.||+|+||.||+|+.. +++.||||+++... ......+.+|++++..++|+||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46888999999999999999965 58899999987542 233457889999999999999999999999999999999
Q ss_pred EecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCC
Q 017558 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 278 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~ 356 (369)
||+++++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999999765 4588999999999999999999998 9999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.6e-28 Score=224.15 Aligned_cols=141 Identities=26% Similarity=0.321 Sum_probs=125.3
Q ss_pred ecccCceEEEEEEEc-CCeEEEEEeeccCC---cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEecCCCcH
Q 017558 210 LGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTL 285 (369)
Q Consensus 210 lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g~L 285 (369)
||+|+||.||+++.. +++.||+|+++... ......+.+|++++.+++||||++++++|...+..|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999965 47889999986532 22345678899999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 286 EFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 286 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~ 145 (312)
T cd05585 81 FHHLQRE--GRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMK 145 (312)
T ss_pred HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCcc
Confidence 9999754 3488999999999999999999998 999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.5e-28 Score=235.55 Aligned_cols=164 Identities=20% Similarity=0.213 Sum_probs=137.1
Q ss_pred CCcccceecccCceEEEEEEEc-C-CeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEec
Q 017558 203 NFSEANLLGQGGFGYVHKGVLT-N-GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 280 (369)
Q Consensus 203 ~~~~~~~lg~G~fg~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 280 (369)
.|.+.+.||+|+||.||++... + +..||+|.+..........+.+|+++|++++||||++++++|...+..||||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 3888899999999999999853 3 5678888776554444457888999999999999999999999999999999999
Q ss_pred CCCcHhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCCCc
Q 017558 281 PNKTLEFHLHGK--DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 358 (369)
Q Consensus 281 ~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~~~ 358 (369)
++|+|.++|+.. ....+++..+..++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++.+.+...
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999988642 234588899999999999999999998 999999999999999999999999999998654322
Q ss_pred -eeeeeecccCC
Q 017558 359 -HVSTRVMGTFG 369 (369)
Q Consensus 359 -~~~~~~~gt~g 369 (369)
......+||++
T Consensus 225 ~~~~~~~~gt~~ 236 (478)
T PTZ00267 225 LDVASSFCGTPY 236 (478)
T ss_pred cccccccCCCcc
Confidence 12333456653
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-27 Score=223.64 Aligned_cols=145 Identities=28% Similarity=0.434 Sum_probs=126.2
Q ss_pred cCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcc-cHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEe
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 279 (369)
++|+..+.||+|+||.||+++.. +++.||||++...... ..+.+.+|++++++++|+||+++++++...+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 34556788999999999999964 5789999998654332 345789999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
+++|+|.... ...+.....++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++....
T Consensus 154 ~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~ 220 (353)
T PLN00034 154 MDGGSLEGTH------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQ 220 (353)
T ss_pred CCCCcccccc------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceeccc
Confidence 9999986532 255777889999999999999998 999999999999999999999999999987643
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=223.82 Aligned_cols=143 Identities=32% Similarity=0.464 Sum_probs=125.6
Q ss_pred ceecccCceEEEEEEE----cCCeEEEEEeeccCC----cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEe
Q 017558 208 NLLGQGGFGYVHKGVL----TNGKVVAIKQLKAGS----GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (369)
Q Consensus 208 ~~lg~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 279 (369)
+.||+|+||.||+++. ..++.||||.++... ......+.+|+++|.+++||||+++++++..++..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999985 357889999987532 12234678899999999999999999999999999999999
Q ss_pred cCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
+++++|.+++... ..+.+..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 152 (323)
T cd05584 82 LSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIH 152 (323)
T ss_pred CCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeeccc
Confidence 9999999999654 3478888889999999999999998 999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-28 Score=218.45 Aligned_cols=149 Identities=23% Similarity=0.415 Sum_probs=129.9
Q ss_pred hcCCcccceecccCceEEEEEEE-cCCeEEEEEeecc--CCcccHHHHHHHHHHHHhcCCCccccEeeEEEe-----CCe
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKA--GSGQGEREFQAEIEIISQVHHRHLVSLVGYCTF-----GSQ 272 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-----~~~ 272 (369)
...|...+.||+|+||.|+.+.. .+|+.||||++.. .+....+...+|+++|+.++|+||+.+++.+.. -..
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 44566678999999999999985 4689999999973 334455678899999999999999999998865 357
Q ss_pred eEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeecccee
Q 017558 273 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (369)
Q Consensus 273 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~ 352 (369)
.|+|+|+| ..+|...++.+. .|+.+++..+.+||++||+|+|+. +|+||||||+|+|++.+..+|||||||||.
T Consensus 101 vYiV~elM-etDL~~iik~~~--~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR~ 174 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIKSQQ--DLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLARY 174 (359)
T ss_pred eEEehhHH-hhHHHHHHHcCc--cccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccceee
Confidence 89999999 788998887543 489999999999999999999998 999999999999999999999999999999
Q ss_pred eCC
Q 017558 353 SLD 355 (369)
Q Consensus 353 ~~~ 355 (369)
...
T Consensus 175 ~~~ 177 (359)
T KOG0660|consen 175 LDK 177 (359)
T ss_pred ccc
Confidence 864
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=228.83 Aligned_cols=157 Identities=25% Similarity=0.344 Sum_probs=132.3
Q ss_pred hhcCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEE
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 278 (369)
...+|++.+.||+|+||.||+|.. .+++.||+|... ...+.+|+++|++++||||+++++++......++|||
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e 163 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP 163 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence 346799999999999999999985 457889999654 2457899999999999999999999999999999999
Q ss_pred ecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCCCc
Q 017558 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 358 (369)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~~~ 358 (369)
|+. ++|..++... ..+++..++.|+.||+.||.|||++ +|+||||||+|||++.++.+||+|||+|+...+...
T Consensus 164 ~~~-~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 164 RYK-TDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA 237 (391)
T ss_pred cCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence 995 7888888654 3488999999999999999999998 999999999999999999999999999976443322
Q ss_pred eeeeeecccC
Q 017558 359 HVSTRVMGTF 368 (369)
Q Consensus 359 ~~~~~~~gt~ 368 (369)
.......||+
T Consensus 238 ~~~~~~~gt~ 247 (391)
T PHA03212 238 NKYYGWAGTI 247 (391)
T ss_pred cccccccCcc
Confidence 2223345554
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=218.87 Aligned_cols=150 Identities=23% Similarity=0.369 Sum_probs=130.9
Q ss_pred cCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCc--ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEE
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 278 (369)
++|++.+.||+|+||.||+++.. +++.||||+++.... ...+.+.+|++++.+++|+||+++++++..++..|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46888999999999999999975 578899999875432 234578899999999999999999999999999999999
Q ss_pred ecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCC
Q 017558 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~ 356 (369)
|++++.|..+... ...+++..+..++.||+.||.|||+. +++||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 81 YVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred cCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 9999877665533 23588999999999999999999998 9999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=226.75 Aligned_cols=148 Identities=25% Similarity=0.358 Sum_probs=131.8
Q ss_pred cCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC---cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEE
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 277 (369)
++|+..+.||+|+||.||+++.. +++.||+|+++... ......+.+|++++.+++|+||+++++++.+.+..|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999964 57899999986432 223456888999999999999999999999999999999
Q ss_pred EecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 278 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
||+++|+|.+++... ..+++.....++.|++.||.|||++ +|+||||||+||||+.++.+||+|||+++...
T Consensus 81 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~ 152 (360)
T cd05627 81 EFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK 152 (360)
T ss_pred eCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCcccc
Confidence 999999999999754 3488999999999999999999998 99999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=216.19 Aligned_cols=149 Identities=27% Similarity=0.448 Sum_probs=132.0
Q ss_pred hcCCcccceecccCceEEEEEEEc----CCeEEEEEeeccCCcc-cHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEE
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT----NGKVVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 275 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 275 (369)
.++|++.+.||+|+||.||+|.+. .+..||+|.++..... ....|.+|+.++.+++||||++++|++..++..+|
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 456888999999999999999853 3568999998765432 33578999999999999999999999999999999
Q ss_pred EEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceee
Q 017558 276 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (369)
Q Consensus 276 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~ 353 (369)
||||+++|+|.+++.... ..+++..++.++.||+.||+|||++ +++||||||+|||++.++.+|++|||++...
T Consensus 84 v~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 84 VTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 999999999999997643 3588999999999999999999998 9999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-28 Score=223.76 Aligned_cols=170 Identities=29% Similarity=0.396 Sum_probs=149.0
Q ss_pred HHHHHhhcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC---cccHHHHHHHHHHHHhcCCCccccEeeEEEeC
Q 017558 195 EELKIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFG 270 (369)
Q Consensus 195 ~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~ 270 (369)
+...+..+.|+.-++||+|+||+||-|+.+ +|+.+|+|++.+.. ...+...++|-.+|.+++.+.||.|--.|+..
T Consensus 178 E~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTk 257 (591)
T KOG0986|consen 178 ELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETK 257 (591)
T ss_pred HhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCC
Confidence 333444567888999999999999999954 58999999986543 23445678999999999999999999889999
Q ss_pred CeeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccc
Q 017558 271 SQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLA 350 (369)
Q Consensus 271 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla 350 (369)
+.+||||..|.||+|..+|.+.+.+.|+++..++++.+|+.||++||.. +||+|||||+|||||+.|+++|+|+|||
T Consensus 258 d~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLA 334 (591)
T KOG0986|consen 258 DALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLA 334 (591)
T ss_pred CceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceE
Confidence 9999999999999999999988878899999999999999999999999 9999999999999999999999999999
Q ss_pred eeeCCCCceeeeeecccCC
Q 017558 351 KHSLDTDTHVSTRVMGTFG 369 (369)
Q Consensus 351 ~~~~~~~~~~~~~~~gt~g 369 (369)
..+.+.+.... .+||.|
T Consensus 335 vei~~g~~~~~--rvGT~G 351 (591)
T KOG0986|consen 335 VEIPEGKPIRG--RVGTVG 351 (591)
T ss_pred EecCCCCcccc--ccCccc
Confidence 99987765433 388877
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=214.13 Aligned_cols=149 Identities=30% Similarity=0.489 Sum_probs=133.6
Q ss_pred cCCcccceecccCceEEEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEecC
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVP 281 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 281 (369)
++|++.+.||+|+||.||++.+.++..+|+|.++... ...+++.+|++++++++|+||++++++|...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 4577889999999999999998887889999886443 334678999999999999999999999999999999999999
Q ss_pred CCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 282 NKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 282 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
+|+|.++++... ..+++..+..++.|++.||+|||++ +++||||||+||++++++.+||+|||+++....
T Consensus 83 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~ 152 (256)
T cd05114 83 NGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLD 152 (256)
T ss_pred CCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCC
Confidence 999999997543 3488999999999999999999998 999999999999999999999999999987644
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=216.90 Aligned_cols=164 Identities=29% Similarity=0.370 Sum_probs=142.6
Q ss_pred HhhcCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCCcccHHH---HHHHHHHHHhcCCCccccEeeEEEeCCeeE
Q 017558 199 IATDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGERE---FQAEIEIISQVHHRHLVSLVGYCTFGSQRL 274 (369)
Q Consensus 199 ~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~---~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 274 (369)
+..++|...++||+|.||+|-+|+. ..++.+|+|++++.......+ -+.|-++|...+||.+..|--.|+..+.+|
T Consensus 165 vTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlC 244 (516)
T KOG0690|consen 165 VTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLC 244 (516)
T ss_pred eccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEE
Confidence 3457888999999999999999984 468999999998765444433 467999999999999999988889999999
Q ss_pred EEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 275 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 275 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
+||||..||.|+.+|.+. ..+++....++...|..||.|||++ +||+||||.+|.|+|++|++||+|||||+...
T Consensus 245 FVMeyanGGeLf~HLsre--r~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I 319 (516)
T KOG0690|consen 245 FVMEYANGGELFFHLSRE--RVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEI 319 (516)
T ss_pred EEEEEccCceEeeehhhh--hcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhcc
Confidence 999999999999998764 4589999999999999999999998 99999999999999999999999999999876
Q ss_pred CCCceeeeeecccC
Q 017558 355 DTDTHVSTRVMGTF 368 (369)
Q Consensus 355 ~~~~~~~~~~~gt~ 368 (369)
..... ..+.+||+
T Consensus 320 ~~g~t-~kTFCGTP 332 (516)
T KOG0690|consen 320 KYGDT-TKTFCGTP 332 (516)
T ss_pred cccce-eccccCCh
Confidence 55443 34578886
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-27 Score=221.22 Aligned_cols=147 Identities=28% Similarity=0.378 Sum_probs=128.0
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC---cccHHHHHHHHHHHHhcCC-CccccEeeEEEeCCeeEEEE
Q 017558 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHH-RHLVSLVGYCTFGSQRLLVY 277 (369)
Q Consensus 203 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lv~ 277 (369)
+|++.+.||+|+||.||+|+.. +++.||||+++... ....+.+..|++++..++| ++|+.+++++...+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5788899999999999999965 46789999987532 2334567889999999976 56888999999999999999
Q ss_pred EecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 278 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
||+++|+|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 81 E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05587 81 EYVNGGDLMYHIQQVG--KFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENI 152 (324)
T ss_pred cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecC
Confidence 9999999999986543 488999999999999999999998 99999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=215.60 Aligned_cols=152 Identities=30% Similarity=0.488 Sum_probs=137.1
Q ss_pred hhcCCcccceecccCceEEEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEe
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 279 (369)
..++|++.+.||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++|+||+++++++...+..+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 456788999999999999999998888889999886543 2356889999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
+++++|.++++......+++..++.++.|++.||+|||++ +++||||||+||++++++.+||+|||+++...+
T Consensus 83 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05072 83 MAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIED 155 (261)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCC
Confidence 9999999999765555688999999999999999999998 999999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-27 Score=218.63 Aligned_cols=149 Identities=29% Similarity=0.433 Sum_probs=130.0
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcc-cHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEE
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 278 (369)
.++|++.+.||+|+||.||+|+.. +++.||||+++..... ....+.+|++++++++|+||+++++++..+...++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 467999999999999999999965 5789999998754322 23467889999999999999999999999999999999
Q ss_pred ecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
|+. ++|.+++.... ..+.+..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++...
T Consensus 84 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 154 (303)
T cd07869 84 YVH-TDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKS 154 (303)
T ss_pred CCC-cCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence 995 67777776433 3478889999999999999999998 99999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=218.33 Aligned_cols=148 Identities=27% Similarity=0.453 Sum_probs=129.9
Q ss_pred cCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCc-ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEe
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 279 (369)
++|+..+.||+|+||.||+|... ++..||+|.++.... .....+.+|++++++++|+||+++++++..+...++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 57888999999999999999864 578999999875432 2334678999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
+++ +|.+++.... ..+++..+..++.||+.||.|||++ +|+||||||+|||+++++.+||+|||+++...
T Consensus 85 ~~~-~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~ 154 (288)
T cd07871 85 LDS-DLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKS 154 (288)
T ss_pred CCc-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeecc
Confidence 974 8988886543 3478889999999999999999998 99999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-27 Score=214.37 Aligned_cols=147 Identities=34% Similarity=0.595 Sum_probs=128.6
Q ss_pred ccceecccCceEEEEEEEc-----CCeEEEEEeeccCCcc-cHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEe
Q 017558 206 EANLLGQGGFGYVHKGVLT-----NGKVVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (369)
Q Consensus 206 ~~~~lg~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 279 (369)
..+.||.|.||.||+|.+. .+..|+||.++..... ..++|.+|++.+.+++|+||++++|+|...+..++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4678999999999999987 2568999999664333 357899999999999999999999999988889999999
Q ss_pred cCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
+++|+|.++|+......+++..++.|+.||+.||.|||++ +++|+||+++|||+++++.+||+|||+++....
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~ 155 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISE 155 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTT
T ss_pred cccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc
Confidence 9999999999887556699999999999999999999998 899999999999999999999999999998743
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.9e-28 Score=216.76 Aligned_cols=153 Identities=33% Similarity=0.561 Sum_probs=139.7
Q ss_pred hhcCCcccceecccCceEEEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEe
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 279 (369)
...+|...+.||.|+||.||+|...++..+++|.+.........++.+|++++..++|+||+++++++......++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 44678889999999999999999888899999999876655567899999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
+++++|.+++.......+++..+++++.||+.||.|||++ +++|+|||++|||+++++.+||+|||+++...+
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~ 156 (261)
T cd05148 84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKE 156 (261)
T ss_pred cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCC
Confidence 9999999999876556689999999999999999999998 899999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-27 Score=220.57 Aligned_cols=144 Identities=31% Similarity=0.372 Sum_probs=126.8
Q ss_pred ceecccCceEEEEEEE----cCCeEEEEEeeccCCc--ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEecC
Q 017558 208 NLLGQGGFGYVHKGVL----TNGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVP 281 (369)
Q Consensus 208 ~~lg~G~fg~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 281 (369)
+.||+|+||.||+++. .+++.||+|+++.... .....+..|++++.+++|+||+++++++...+..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999874 3578999999975422 223457789999999999999999999999999999999999
Q ss_pred CCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCC
Q 017558 282 NKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 282 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~ 356 (369)
+|+|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 82 ~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 151 (318)
T cd05582 82 GGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 151 (318)
T ss_pred CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCC
Confidence 99999999654 3589999999999999999999998 9999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-27 Score=221.80 Aligned_cols=141 Identities=27% Similarity=0.381 Sum_probs=125.1
Q ss_pred ceecccCceEEEEEEEc-CCeEEEEEeeccCC---cccHHHHHHHHHHHHhc-CCCccccEeeEEEeCCeeEEEEEecCC
Q 017558 208 NLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLVYEFVPN 282 (369)
Q Consensus 208 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~~ 282 (369)
++||+|+||.||+++.. +++.||||.++... ....+.+.+|+.++.++ +||||++++++|...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999964 57899999997542 22334678899999998 699999999999999999999999999
Q ss_pred CcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceee
Q 017558 283 KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (369)
Q Consensus 283 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~ 353 (369)
|+|.+++... ..+++..+..++.||+.||.|||++ +++||||||+|||++.++.+||+|||+++..
T Consensus 81 g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~ 146 (329)
T cd05588 81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 146 (329)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCcccccc
Confidence 9999988654 3589999999999999999999998 9999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=227.73 Aligned_cols=155 Identities=26% Similarity=0.448 Sum_probs=133.1
Q ss_pred HHhhcCCcccceecccCceEEEEEEEcC------CeEEEEEeeccCCcc-cHHHHHHHHHHHHhcC-CCccccEeeEEEe
Q 017558 198 KIATDNFSEANLLGQGGFGYVHKGVLTN------GKVVAIKQLKAGSGQ-GEREFQAEIEIISQVH-HRHLVSLVGYCTF 269 (369)
Q Consensus 198 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-h~niv~l~g~~~~ 269 (369)
....++|.+.+.||+|+||.||+|+... +..||||+++..... ..+.+.+|+++|.+++ ||||++++++|..
T Consensus 33 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~ 112 (400)
T cd05105 33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK 112 (400)
T ss_pred eccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence 3456788899999999999999998531 347999999754433 3457899999999996 9999999999999
Q ss_pred CCeeEEEEEecCCCcHhhhhcCCC--------------------------------------------------------
Q 017558 270 GSQRLLVYEFVPNKTLEFHLHGKD-------------------------------------------------------- 293 (369)
Q Consensus 270 ~~~~~lv~e~~~~g~L~~~l~~~~-------------------------------------------------------- 293 (369)
.+..||||||+++|+|.++|+...
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (400)
T cd05105 113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML 192 (400)
T ss_pred CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence 999999999999999999886421
Q ss_pred --------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEE
Q 017558 294 --------------------------------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANIL 335 (369)
Q Consensus 294 --------------------------------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nil 335 (369)
...+++.+++.++.||+.||.|||++ +++||||||+|||
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nil 269 (400)
T cd05105 193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEE
Confidence 12477888899999999999999998 9999999999999
Q ss_pred ECCCCcEEEeeeccceeeCC
Q 017558 336 LDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 336 l~~~~~~ki~DFGla~~~~~ 355 (369)
+++++.+||+|||+++....
T Consensus 270 l~~~~~~kL~DfGla~~~~~ 289 (400)
T cd05105 270 LAQGKIVKICDFGLARDIMH 289 (400)
T ss_pred EeCCCEEEEEeCCcceeccc
Confidence 99999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.7e-28 Score=228.80 Aligned_cols=155 Identities=31% Similarity=0.507 Sum_probs=133.0
Q ss_pred HHhhcCCcccceecccCceEEEEEEEc------CCeEEEEEeeccCCcc-cHHHHHHHHHHHHhc-CCCccccEeeEEEe
Q 017558 198 KIATDNFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLKAGSGQ-GEREFQAEIEIISQV-HHRHLVSLVGYCTF 269 (369)
Q Consensus 198 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~l~g~~~~ 269 (369)
....++|++.+.||+|+||.||+|... ++..||||+++..... ..+.+.+|+++++.+ +|+||++++++|..
T Consensus 34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~ 113 (374)
T cd05106 34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH 113 (374)
T ss_pred cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence 345568889999999999999998842 2357999999765433 335688999999999 89999999999999
Q ss_pred CCeeEEEEEecCCCcHhhhhcCCC--------------------------------------------------------
Q 017558 270 GSQRLLVYEFVPNKTLEFHLHGKD-------------------------------------------------------- 293 (369)
Q Consensus 270 ~~~~~lv~e~~~~g~L~~~l~~~~-------------------------------------------------------- 293 (369)
.+..++||||+++|+|.++++...
T Consensus 114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (374)
T cd05106 114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ 193 (374)
T ss_pred CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence 999999999999999999985421
Q ss_pred ------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 294 ------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 294 ------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
...+++.+.++|+.||+.||.|||++ +|+||||||+|||+++++.+||+|||+++....
T Consensus 194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~ 264 (374)
T cd05106 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMN 264 (374)
T ss_pred cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccC
Confidence 12378888999999999999999998 999999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-28 Score=212.17 Aligned_cols=163 Identities=28% Similarity=0.412 Sum_probs=140.1
Q ss_pred hhcCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCCcc----c----HHHHHHHHHHHHhc-CCCccccEeeEEEe
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQ----G----EREFQAEIEIISQV-HHRHLVSLVGYCTF 269 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~----~----~~~~~~E~~~l~~l-~h~niv~l~g~~~~ 269 (369)
.-++|...+.||+|..+.|.+|.. .+++.+|+|++...... . .++-..|+.||+++ .||||+.|.++|+.
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 446788889999999999999875 46788999998643211 1 23456799999998 59999999999999
Q ss_pred CCeeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeecc
Q 017558 270 GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGL 349 (369)
Q Consensus 270 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGl 349 (369)
+...++|+|.|+.|.|+++|... -.++++...+|+.|+.+|++|||.+ +||||||||+|||+|++.++||+|||+
T Consensus 95 ~sF~FlVFdl~prGELFDyLts~--VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGF 169 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTSK--VTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGF 169 (411)
T ss_pred cchhhhhhhhcccchHHHHhhhh--eeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccce
Confidence 99999999999999999999654 4589999999999999999999998 999999999999999999999999999
Q ss_pred ceeeCCCCceeeeeecccCC
Q 017558 350 AKHSLDTDTHVSTRVMGTFG 369 (369)
Q Consensus 350 a~~~~~~~~~~~~~~~gt~g 369 (369)
|..+...+ ....++||+|
T Consensus 170 a~~l~~Ge--kLrelCGTPg 187 (411)
T KOG0599|consen 170 ACQLEPGE--KLRELCGTPG 187 (411)
T ss_pred eeccCCch--hHHHhcCCCc
Confidence 99987655 3355899987
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-27 Score=220.88 Aligned_cols=142 Identities=28% Similarity=0.393 Sum_probs=124.7
Q ss_pred ceecccCceEEEEEEEc-CCeEEEEEeeccCC---cccHHHHHHHHHHHHhc-CCCccccEeeEEEeCCeeEEEEEecCC
Q 017558 208 NLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLVYEFVPN 282 (369)
Q Consensus 208 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~~ 282 (369)
+.||+|+||.||+++.. +++.||+|.++... ....+.+.+|+.++.++ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999964 57889999997542 22334677899988877 799999999999999999999999999
Q ss_pred CcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 283 KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 283 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
|+|..++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~ 147 (329)
T cd05618 81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 147 (329)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCcccccc
Confidence 9999888654 3588999999999999999999998 99999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-27 Score=220.11 Aligned_cols=143 Identities=29% Similarity=0.419 Sum_probs=123.0
Q ss_pred ceecccCceEEEEEEEc-CCeEEEEEeeccCC---cccHHHHHHHHHHHHhc-CCCccccEeeEEEeCCeeEEEEEecCC
Q 017558 208 NLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLVYEFVPN 282 (369)
Q Consensus 208 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~~ 282 (369)
++||+|+||.||+|+.. +++.||||.++... ....+.+..|..++..+ +|+||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999964 47789999987532 22334556677777654 899999999999999999999999999
Q ss_pred CcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 283 KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 283 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
|+|..++... ..+++.....++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~ 148 (316)
T cd05592 81 GDLMFHIQSS--GRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMN 148 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCC
Confidence 9999998654 3488899999999999999999998 999999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-27 Score=212.63 Aligned_cols=152 Identities=32% Similarity=0.524 Sum_probs=137.3
Q ss_pred hhcCCcccceecccCceEEEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEe
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 279 (369)
..++|++.+.||+|+||.||+|...+++.||+|.++... ...+++.+|++++++++|+||+++++++...+..|++|||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 456788899999999999999998778889999987543 3356799999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
+++++|.+++.......+++..+..++.|++.||.|||++ +++||||||+||++++++.+||+|||+++...+
T Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05068 83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKE 155 (261)
T ss_pred ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence 9999999999765545689999999999999999999998 999999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-27 Score=216.48 Aligned_cols=150 Identities=31% Similarity=0.431 Sum_probs=132.0
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCc---ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEE
Q 017558 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG---QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (369)
Q Consensus 203 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 278 (369)
.|+..+.||+|+||.||++... +++.||||++..... .....+.+|+.++++++|+||+.+++++..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 3777899999999999999964 578999999865422 223457789999999999999999999999999999999
Q ss_pred ecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
|+++|+|.+++.......+++..+..++.|++.||.|||++ +++||||||+||++++++.++|+|||+++....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPE 154 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence 99999999988755445689999999999999999999998 999999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-28 Score=217.62 Aligned_cols=149 Identities=31% Similarity=0.443 Sum_probs=120.9
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCC-----eeEEE
Q 017558 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGS-----QRLLV 276 (369)
Q Consensus 203 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~lv 276 (369)
.|...+++|.|+||.||+|... +++.||||+.-.+. +.-.+|+++|++++|||||+|+-+|.... ...+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~----r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK----RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC----CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 4566899999999999999964 46899999986543 33457999999999999999999886532 33589
Q ss_pred EEecCCCcHhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCC-CcEEEeeeccceee
Q 017558 277 YEFVPNKTLEFHLHGK--DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS-FEAKVADFGLAKHS 353 (369)
Q Consensus 277 ~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~-~~~ki~DFGla~~~ 353 (369)
||||+. +|..+++.. .+..++.-...-+..||.+||.|||+. +|+||||||.|+|+|.+ |.+||||||-|+.+
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999964 677777631 123466666778999999999999997 99999999999999965 99999999999998
Q ss_pred CCCCce
Q 017558 354 LDTDTH 359 (369)
Q Consensus 354 ~~~~~~ 359 (369)
...+-.
T Consensus 177 ~~~epn 182 (364)
T KOG0658|consen 177 VKGEPN 182 (364)
T ss_pred ccCCCc
Confidence 766543
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-27 Score=221.43 Aligned_cols=151 Identities=25% Similarity=0.373 Sum_probs=133.0
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCc-ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEE
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 277 (369)
..++|+..+.||+|+||.||++... ++..+|+|.++.... ...+.+.+|++++.+++|+||++++++|..++..++||
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 3578999999999999999999975 577899998875432 23457899999999999999999999999999999999
Q ss_pred EecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 278 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
||+++|+|.+++.... .+++.....++.|++.||.|||++. +++||||||+|||+++++.+||+|||+++...
T Consensus 83 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~ 155 (333)
T cd06650 83 EHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (333)
T ss_pred ecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence 9999999999997543 4788889999999999999999742 69999999999999999999999999998654
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-27 Score=221.02 Aligned_cols=145 Identities=34% Similarity=0.500 Sum_probs=125.4
Q ss_pred CcccceecccCceEEEEEEEc-CCeEEEEEeeccCC---cccHHHHHHHHHHH---HhcCCCccccEeeEEEeCCeeEEE
Q 017558 204 FSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEII---SQVHHRHLVSLVGYCTFGSQRLLV 276 (369)
Q Consensus 204 ~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~g~~~~~~~~~lv 276 (369)
|++.+.||+|+||.||++... +++.||||+++... ....+.+.+|++++ .+++||||+++++++...+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567889999999999999864 57899999997532 12234566776655 566899999999999999999999
Q ss_pred EEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 277 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
|||+++++|..+++. ..+++..+..++.||+.||.|||++ +++||||||+|||+++++.+||+|||+++...
T Consensus 81 ~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 81 MEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 999999999988864 3589999999999999999999998 99999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-27 Score=219.89 Aligned_cols=151 Identities=26% Similarity=0.385 Sum_probs=133.7
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCc-ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEE
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 278 (369)
.++|+..+.||+|+||.||+++.. ++..+|+|.++.... ...+.+.+|+++|.+++|+||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 578999999999999999999965 577899998875432 234578999999999999999999999999999999999
Q ss_pred ecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
|+++|+|.+++.... .+++..+..++.|++.||.|||+++ +|+||||||+|||++.++.+||+|||+++...+
T Consensus 84 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 156 (331)
T cd06649 84 HMDGGSLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (331)
T ss_pred cCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence 999999999997543 4889999999999999999999852 699999999999999999999999999987643
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.9e-27 Score=211.99 Aligned_cols=150 Identities=33% Similarity=0.501 Sum_probs=134.0
Q ss_pred cCCcccceecccCceEEEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEecC
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVP 281 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 281 (369)
++|.+.+.||+|+||.||++.+.++..+|+|.++... ...+++.+|+.++.+++||||++++++|......++||||+.
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4677889999999999999998777779999987543 334679999999999999999999999998889999999999
Q ss_pred CCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCC
Q 017558 282 NKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 282 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~ 356 (369)
+|+|.+++..... .+++..++.++.||+.||.|||++ +++|+||||+|||+++++.+||+|||+++...+.
T Consensus 83 ~~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05113 83 NGCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD 153 (256)
T ss_pred CCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCC
Confidence 9999999975433 589999999999999999999998 9999999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-27 Score=219.73 Aligned_cols=143 Identities=30% Similarity=0.405 Sum_probs=124.8
Q ss_pred ceecccCceEEEEEEEc-CCeEEEEEeeccCC---cccHHHHHHHHHHHHhc-CCCccccEeeEEEeCCeeEEEEEecCC
Q 017558 208 NLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLVYEFVPN 282 (369)
Q Consensus 208 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~~ 282 (369)
++||+|+||.||+|+.. +++.||||+++... ....+.+..|++++..+ +|+||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999965 46899999987542 22334677899998876 799999999999999999999999999
Q ss_pred CcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 283 KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 283 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
|+|..++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~ 148 (321)
T cd05591 81 GDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGIL 148 (321)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceeccc
Confidence 9999988654 3488999999999999999999998 999999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-28 Score=228.59 Aligned_cols=156 Identities=31% Similarity=0.472 Sum_probs=133.2
Q ss_pred HHhhcCCcccceecccCceEEEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEE
Q 017558 198 KIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (369)
Q Consensus 198 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 277 (369)
++..+....++-||.|+.|.||+|+++ ++.||||+++.-+ ..+|+.|++|+|+||+.|.|+|.....+||||
T Consensus 120 eiPFe~IsELeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiM 191 (904)
T KOG4721|consen 120 EIPFEEISELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIM 191 (904)
T ss_pred cCCHHHhhhhhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEee
Confidence 333344445678999999999999995 6889999886422 34788899999999999999999999999999
Q ss_pred EecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCCC
Q 017558 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (369)
Q Consensus 278 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~~ 357 (369)
|||..|.|...|+.. ..+.....+.+..+||.||.|||.+ .|||||||+-||||..+..+||+|||-++.+.+..
T Consensus 192 EfCa~GqL~~VLka~--~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S 266 (904)
T KOG4721|consen 192 EFCAQGQLYEVLKAG--RPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDKS 266 (904)
T ss_pred eccccccHHHHHhcc--CccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhhh
Confidence 999999999999754 3578888999999999999999998 99999999999999999999999999999988764
Q ss_pred ceeeeeecccC
Q 017558 358 THVSTRVMGTF 368 (369)
Q Consensus 358 ~~~~~~~~gt~ 368 (369)
+.+ .++||.
T Consensus 267 TkM--SFaGTV 275 (904)
T KOG4721|consen 267 TKM--SFAGTV 275 (904)
T ss_pred hhh--hhhhhH
Confidence 433 256663
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-28 Score=234.61 Aligned_cols=147 Identities=29% Similarity=0.465 Sum_probs=129.2
Q ss_pred ccceecccCceEEEEEEE-cCC----eEEEEEeeccCCcc-cHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEe
Q 017558 206 EANLLGQGGFGYVHKGVL-TNG----KVVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (369)
Q Consensus 206 ~~~~lg~G~fg~Vy~~~~-~~~----~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 279 (369)
..++||.|+||+||+|.| ..| -+||+|++...... ...++++|+-+|++++|||+++|+|+|.... ..||++|
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~ 778 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQL 778 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHh
Confidence 368899999999999985 233 36899998776544 4468999999999999999999999998765 8899999
Q ss_pred cCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCCC
Q 017558 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (369)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~~ 357 (369)
|+.|.|.+|++.+. ..+-.+..+.|..|||+||.|||++ +++||||..+||||.+-..+||.|||+|+.+..++
T Consensus 779 mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 779 MPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred cccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 99999999998754 4577888999999999999999999 99999999999999999999999999999876544
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-27 Score=219.14 Aligned_cols=147 Identities=27% Similarity=0.363 Sum_probs=127.9
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCc---ccHHHHHHHHHHHHhc-CCCccccEeeEEEeCCeeEEEE
Q 017558 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG---QGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLVY 277 (369)
Q Consensus 203 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~ 277 (369)
+|.+.+.||+|+||.||+|+.. +++.||||.++.... ...+.+..|..++..+ +|++|+.+++++...+..|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5788899999999999999865 467899999875422 2234567788888877 5899999999999999999999
Q ss_pred EecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 278 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
||+++|+|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||+++++.+||+|||+++...
T Consensus 81 E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~ 152 (323)
T cd05616 81 EYVNGGDLMYQIQQVG--RFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENM 152 (323)
T ss_pred cCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecC
Confidence 9999999999986543 488999999999999999999998 99999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.9e-27 Score=219.11 Aligned_cols=142 Identities=31% Similarity=0.440 Sum_probs=124.6
Q ss_pred ceecccCceEEEEEEEc-CCeEEEEEeeccCC---cccHHHHHHHHHHHHhc-CCCccccEeeEEEeCCeeEEEEEecCC
Q 017558 208 NLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLVYEFVPN 282 (369)
Q Consensus 208 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~~ 282 (369)
+.||+|+||.||+++.. +++.||||+++... ....+.+..|+.++..+ +|+||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999965 57899999987532 22345677888888876 699999999999999999999999999
Q ss_pred CcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 283 KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 283 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
|+|.+++... ..+++..+..++.|++.||.|||++ +++||||||+|||+++++.+||+|||+++...
T Consensus 81 g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~ 147 (320)
T cd05590 81 GDLMFHIQKS--RRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 147 (320)
T ss_pred chHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecC
Confidence 9999988654 3488999999999999999999998 99999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.1e-28 Score=226.96 Aligned_cols=158 Identities=30% Similarity=0.465 Sum_probs=137.6
Q ss_pred HHhhcCCcccceecccCceEEEEEEEcC---C--eEEEEEeeccCC-cccHHHHHHHHHHHHhcCCCccccEeeEEEeCC
Q 017558 198 KIATDNFSEANLLGQGGFGYVHKGVLTN---G--KVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGS 271 (369)
Q Consensus 198 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~---~--~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~ 271 (369)
++..+.....++||+|.||.||+|.+.+ | --||||..+.+. ..+.+.|+.|.-+|++++||||++|+|+|. ..
T Consensus 385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~-e~ 463 (974)
T KOG4257|consen 385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCV-EQ 463 (974)
T ss_pred eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeee-cc
Confidence 3445556667899999999999999643 2 358999998754 345678999999999999999999999998 46
Q ss_pred eeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccce
Q 017558 272 QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351 (369)
Q Consensus 272 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~ 351 (369)
..|||||.++-|.|..||+.+. ..++......+++||+.+|.|||+. ++|||||..+|||+....-+||+||||+|
T Consensus 464 P~WivmEL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR 539 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSR 539 (974)
T ss_pred ceeEEEecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhh
Confidence 7899999999999999998765 4588889999999999999999999 99999999999999999999999999999
Q ss_pred eeCCCCcee
Q 017558 352 HSLDTDTHV 360 (369)
Q Consensus 352 ~~~~~~~~~ 360 (369)
.+.+.++..
T Consensus 540 ~~ed~~yYk 548 (974)
T KOG4257|consen 540 YLEDDAYYK 548 (974)
T ss_pred hccccchhh
Confidence 988776543
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=220.31 Aligned_cols=156 Identities=25% Similarity=0.361 Sum_probs=136.1
Q ss_pred cceecccCceEEEEEEE-cCCeEEEEEeeccCC--cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEecCCC
Q 017558 207 ANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNK 283 (369)
Q Consensus 207 ~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 283 (369)
.++||.|.||+||-|.. ++|+.||||.+.+.. ...+..+++|+.||.+++||.||.|...|+..+..++|||-+ +|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 58899999999999985 579999999997643 334568999999999999999999999999999999999999 67
Q ss_pred cHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCC---CcEEEeeeccceeeCCCCcee
Q 017558 284 TLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS---FEAKVADFGLAKHSLDTDTHV 360 (369)
Q Consensus 284 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~---~~~ki~DFGla~~~~~~~~~~ 360 (369)
++.++|...+...|++..-.++..||+.||.|||.+ +|+|.||||+|||+.+. -.+||||||+||...+...+
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR- 723 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR- 723 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhhhh-
Confidence 777777766667799888889999999999999998 99999999999999653 47999999999999876654
Q ss_pred eeeecccC
Q 017558 361 STRVMGTF 368 (369)
Q Consensus 361 ~~~~~gt~ 368 (369)
..++||+
T Consensus 724 -rsVVGTP 730 (888)
T KOG4236|consen 724 -RSVVGTP 730 (888)
T ss_pred -hhhcCCc
Confidence 3488886
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-27 Score=219.43 Aligned_cols=142 Identities=32% Similarity=0.450 Sum_probs=122.0
Q ss_pred ceecccCceEEEEEEEc-CCeEEEEEeeccCC---cccHHHHHHHHH-HHHhcCCCccccEeeEEEeCCeeEEEEEecCC
Q 017558 208 NLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIE-IISQVHHRHLVSLVGYCTFGSQRLLVYEFVPN 282 (369)
Q Consensus 208 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 282 (369)
+.||+|+||+||+++.. +++.||+|++.... ......+..|.. +++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999854 57899999986532 122345555655 46778999999999999999999999999999
Q ss_pred CcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 283 KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 283 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
|+|..++... ..+++..+..++.||+.||.|||++ +|+||||||+|||+++++.+||+|||+++...
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~ 147 (325)
T cd05604 81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGI 147 (325)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCC
Confidence 9999988654 3588999999999999999999998 99999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.8e-27 Score=218.86 Aligned_cols=142 Identities=32% Similarity=0.459 Sum_probs=122.1
Q ss_pred ceecccCceEEEEEEEc-CCeEEEEEeeccCC---cccHHHHHHHHH-HHHhcCCCccccEeeEEEeCCeeEEEEEecCC
Q 017558 208 NLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIE-IISQVHHRHLVSLVGYCTFGSQRLLVYEFVPN 282 (369)
Q Consensus 208 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 282 (369)
+.||+|+||.||+|+.. +++.||||++.... ....+++..|.. ++..++||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999964 58899999986532 122234555554 56789999999999999999999999999999
Q ss_pred CcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 283 KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 283 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
|+|..++... ..+.+.....++.||+.||.|||++ +|+||||||+|||+++++.+||+|||+++...
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~ 147 (323)
T cd05575 81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGI 147 (323)
T ss_pred CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccc
Confidence 9999998754 3588899999999999999999998 99999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.2e-27 Score=218.48 Aligned_cols=150 Identities=28% Similarity=0.500 Sum_probs=129.8
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCe----EEEEEeeccCCc-ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeE
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGK----VVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRL 274 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 274 (369)
..+|+..+.||+|+||.||+|++. ++. .||+|.++.... ...+++.+|+.++..++|+||++++|+|... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 356888999999999999999863 333 489999875432 3346789999999999999999999999764 578
Q ss_pred EEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 275 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 275 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
+++||+++|+|.+++.... ..+++...++++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++...
T Consensus 85 ~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 85 LITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccccccccc
Confidence 9999999999999997643 3488999999999999999999998 99999999999999999999999999999765
Q ss_pred C
Q 017558 355 D 355 (369)
Q Consensus 355 ~ 355 (369)
.
T Consensus 161 ~ 161 (316)
T cd05108 161 A 161 (316)
T ss_pred C
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.9e-27 Score=218.61 Aligned_cols=143 Identities=29% Similarity=0.439 Sum_probs=121.9
Q ss_pred ceecccCceEEEEEEEc-CCeEEEEEeeccCC---cccHHHHHHHHH-HHHhcCCCccccEeeEEEeCCeeEEEEEecCC
Q 017558 208 NLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIE-IISQVHHRHLVSLVGYCTFGSQRLLVYEFVPN 282 (369)
Q Consensus 208 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 282 (369)
++||+|+||.||+|+.. +++.||+|++.... ......+.+|.. +++.++|+||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999964 57899999986532 122234555554 67889999999999999999999999999999
Q ss_pred CcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 283 KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 283 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
|+|..++... ..+.+.....++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++....
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 148 (321)
T cd05603 81 GELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVE 148 (321)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCC
Confidence 9999888653 3478888899999999999999998 999999999999999999999999999986433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.3e-27 Score=218.65 Aligned_cols=147 Identities=27% Similarity=0.372 Sum_probs=127.8
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC---cccHHHHHHHHHHHHhcC-CCccccEeeEEEeCCeeEEEE
Q 017558 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVH-HRHLVSLVGYCTFGSQRLLVY 277 (369)
Q Consensus 203 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~ 277 (369)
+|+..+.||+|+||.||+++.. +++.||+|+++... ....+.+..|+.++..+. |++|+++++++...+..|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4677899999999999999864 57899999987532 223356778999998886 577888999999999999999
Q ss_pred EecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 278 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
||+++|+|.+++... ..+++.+++.++.||+.||.|||++ +++||||||+|||+++++.+||+|||+++...
T Consensus 81 Ey~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~ 152 (323)
T cd05615 81 EYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHM 152 (323)
T ss_pred cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccC
Confidence 999999999998654 3489999999999999999999998 99999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-25 Score=216.34 Aligned_cols=144 Identities=22% Similarity=0.261 Sum_probs=127.1
Q ss_pred hcCCcccceecccCceEEEEEEEcC-CeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEe
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 279 (369)
...|.+.+.||+|+||.||++.... ++.||||... ...+.+|+++|++++|+|||++++++...+..++||||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 4578999999999999999999754 6789999643 23467899999999999999999999999999999999
Q ss_pred cCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
+ .++|..++.... ..++|.+++.|+.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++....
T Consensus 242 ~-~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~ 312 (461)
T PHA03211 242 Y-RSDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARG 312 (461)
T ss_pred c-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccc
Confidence 9 478888886543 3589999999999999999999998 999999999999999999999999999987644
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-26 Score=213.21 Aligned_cols=150 Identities=29% Similarity=0.479 Sum_probs=125.9
Q ss_pred cCCcccceecccCceEEEEEEEc--CCeEEEEEeeccCCcc--cHHHHHHHHHHHHhc---CCCccccEeeEEEe-----
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLT--NGKVVAIKQLKAGSGQ--GEREFQAEIEIISQV---HHRHLVSLVGYCTF----- 269 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~--~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~h~niv~l~g~~~~----- 269 (369)
++|++.+.||+|+||.||+|+.. ++..||+|+++..... ....+.+|++++..+ +||||++++++|..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 46888999999999999999863 4678999998754322 234566788777665 69999999999853
Q ss_pred CCeeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeecc
Q 017558 270 GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGL 349 (369)
Q Consensus 270 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGl 349 (369)
....++||||++ ++|.+++.......+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 356899999996 6899998765555689999999999999999999998 999999999999999999999999999
Q ss_pred ceeeCC
Q 017558 350 AKHSLD 355 (369)
Q Consensus 350 a~~~~~ 355 (369)
++....
T Consensus 157 ~~~~~~ 162 (290)
T cd07862 157 ARIYSF 162 (290)
T ss_pred eEeccC
Confidence 987643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.7e-27 Score=210.58 Aligned_cols=149 Identities=30% Similarity=0.472 Sum_probs=133.1
Q ss_pred cCCcccceecccCceEEEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEecC
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVP 281 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 281 (369)
.+|++.+.||+|+||.||++.+.++..+|+|.+..... ...++.+|++++.+++|+||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 35777899999999999999987777899998865432 34578899999999999999999999999999999999999
Q ss_pred CCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 282 NKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 282 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
+++|.+++..... .+++...+.++.|++.||.|||++ +++||||||+||++++++.+||+|||+++...+
T Consensus 83 ~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~ 152 (256)
T cd05059 83 NGCLLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLD 152 (256)
T ss_pred CCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccc
Confidence 9999999975433 589999999999999999999998 899999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-26 Score=212.41 Aligned_cols=150 Identities=29% Similarity=0.497 Sum_probs=132.0
Q ss_pred cCCcccceecccCceEEEEEEEc-----CCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEe--CCeeE
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLT-----NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTF--GSQRL 274 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~ 274 (369)
++|++.+.||+|+||.||++... ++..||+|++........+.+.+|++++.+++|+||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 56888899999999999999853 477899999877655556789999999999999999999998754 34678
Q ss_pred EEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 275 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 275 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
+||||+++++|.+++.... ..+++..++.++.|++.||.|||++ +++||||||+|||+++++.+||+|||+++...
T Consensus 84 lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred EEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 9999999999999996543 3489999999999999999999998 99999999999999999999999999999764
Q ss_pred C
Q 017558 355 D 355 (369)
Q Consensus 355 ~ 355 (369)
.
T Consensus 160 ~ 160 (284)
T cd05081 160 Q 160 (284)
T ss_pred C
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.8e-27 Score=217.83 Aligned_cols=143 Identities=29% Similarity=0.429 Sum_probs=121.1
Q ss_pred ceecccCceEEEEEEEc-CCeEEEEEeeccCC---cccHHHHHHHHH-HHHhcCCCccccEeeEEEeCCeeEEEEEecCC
Q 017558 208 NLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIE-IISQVHHRHLVSLVGYCTFGSQRLLVYEFVPN 282 (369)
Q Consensus 208 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 282 (369)
+.||+|+||.||+++.. +++.||+|++.... ......+..|.. ++..++|+||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999965 46789999986532 122234444444 56788999999999999999999999999999
Q ss_pred CcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 283 KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 283 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
|+|.+++... ..+.+.....++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~L~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~ 148 (325)
T cd05602 81 GELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIE 148 (325)
T ss_pred CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCccccc
Confidence 9999999754 3477888889999999999999998 999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=212.13 Aligned_cols=148 Identities=30% Similarity=0.403 Sum_probs=130.9
Q ss_pred CcccceecccCceEEEEEEEc-CCeEEEEEeeccCCc---ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEe
Q 017558 204 FSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG---QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (369)
Q Consensus 204 ~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 279 (369)
|+..+.||+|+||+||++... +++.+|+|.+..... .....+.+|+++|.+++|+||+.+.+++..++..+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 666789999999999999864 578999999865432 2234578899999999999999999999999999999999
Q ss_pred cCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
+++++|.+++.......+++..+..++.|++.||.|||++ +|+||||||+||++++++.+||+|||+++...
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~ 153 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIP 153 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecC
Confidence 9999999988765445699999999999999999999998 99999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=217.53 Aligned_cols=142 Identities=29% Similarity=0.375 Sum_probs=125.1
Q ss_pred ceecccCceEEEEEEEc-CCeEEEEEeeccCCc---ccHHHHHHHHHHHHhc-CCCccccEeeEEEeCCeeEEEEEecCC
Q 017558 208 NLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG---QGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLVYEFVPN 282 (369)
Q Consensus 208 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~~ 282 (369)
+.||+|+||.||++... +++.||+|+++.... ...+.+.+|+.++.++ +|+||+.+++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999964 568899999976432 2334678899999888 699999999999999999999999999
Q ss_pred CcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 283 KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 283 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
|+|..++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~ 147 (327)
T cd05617 81 GDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGL 147 (327)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceecc
Confidence 9999888654 3489999999999999999999998 99999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=212.75 Aligned_cols=144 Identities=31% Similarity=0.447 Sum_probs=125.4
Q ss_pred ecccCceEEEEEEEc-CCeEEEEEeeccCCc---ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEecCCCcH
Q 017558 210 LGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG---QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTL 285 (369)
Q Consensus 210 lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g~L 285 (369)
||+|+||.||++... +++.||||++..... ...+.+..|++++.+++|+||+++.+++..+...|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999864 678999999865422 2234677899999999999999999999999999999999999999
Q ss_pred hhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCC
Q 017558 286 EFHLHGK--DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 286 ~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~ 356 (369)
.+++... ....+++..+..++.||+.||.|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 150 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG 150 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCC
Confidence 9887532 234589999999999999999999998 9999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.2e-27 Score=218.57 Aligned_cols=146 Identities=23% Similarity=0.402 Sum_probs=125.9
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC--cccHHHHHHHHHHHHhcCCCccccEeeEEEeC-----CeeE
Q 017558 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFG-----SQRL 274 (369)
Q Consensus 203 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~ 274 (369)
+|++.+.||+|+||.||+|+.. ++..||||+++... ......+.+|++++++++||||+++++++... ...|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4788899999999999999954 57899999987432 22335688999999999999999999988643 2479
Q ss_pred EEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 275 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 275 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
+||||+. ++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 81 lv~e~~~-~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 81 VVFELME-SDLHQVIKAN--DDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEecCC-CCHHHHHHhc--ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 9999995 6898888654 3489999999999999999999998 99999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.4e-27 Score=210.84 Aligned_cols=151 Identities=29% Similarity=0.448 Sum_probs=134.8
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEe
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 279 (369)
..+|...+.||+|+||.||+|... .++.||+|.++... ....++.+|++++.+++|+||++++++|..++..+++|||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 83 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence 345778899999999999999965 47889999987543 3356789999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
+++++|.+++.......+++..++.++.|++.||.|||++ +++||||||+|||+++++.+||+|||+++...+
T Consensus 84 ~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~ 156 (263)
T cd05052 84 MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 156 (263)
T ss_pred CCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence 9999999999765555689999999999999999999998 999999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=216.51 Aligned_cols=141 Identities=29% Similarity=0.418 Sum_probs=123.2
Q ss_pred ceecccCceEEEEEEEc-CCeEEEEEeeccCC---cccHHHHHHHHHHHHhc-CCCccccEeeEEEeCCeeEEEEEecCC
Q 017558 208 NLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLVYEFVPN 282 (369)
Q Consensus 208 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~~ 282 (369)
++||+|+||.||+|+.. +++.||+|.++... ....+.+..|..++... +|+||+++++++...+..|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999965 57899999997542 22334567788888764 899999999999999999999999999
Q ss_pred CcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceee
Q 017558 283 KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (369)
Q Consensus 283 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~ 353 (369)
|+|..++... ..+++.....++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 81 g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~ 146 (316)
T cd05620 81 GDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKEN 146 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeec
Confidence 9999998654 3488999999999999999999998 9999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-26 Score=209.32 Aligned_cols=149 Identities=28% Similarity=0.400 Sum_probs=134.2
Q ss_pred hcCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEe
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 279 (369)
.++|++.+.||+|+||.||+|+. .+++.||+|+++.........+.+|+.++.+++|+||+++++++..++..|+||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 35788899999999999999996 46789999998765544556788999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
+++++|.++++.. ..+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||+++...
T Consensus 88 ~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06646 88 CGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKIT 157 (267)
T ss_pred CCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeec
Confidence 9999999998654 3488999999999999999999998 99999999999999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.7e-29 Score=211.03 Aligned_cols=163 Identities=28% Similarity=0.377 Sum_probs=139.7
Q ss_pred hhcCCcccceecccCceEEEEEEE-cCCeEEEEEeeccC--CcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEE
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 276 (369)
..+.|++.++||+|.|+.||++.. .+|+.+|+|.+... ...+.+++.+|++|.+.|+|||||+|.+.+......|||
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 346788889999999999999984 46888999887543 344678899999999999999999999999999999999
Q ss_pred EEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEC---CCCcEEEeeeccceee
Q 017558 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLD---DSFEAKVADFGLAKHS 353 (369)
Q Consensus 277 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~---~~~~~ki~DFGla~~~ 353 (369)
+|+|.|++|..-+-.+ ..+++...-.+..||+++|.|+|.+ +|||||+||.|+|+. ..--+||+|||+|..+
T Consensus 89 Fe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred EecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 9999999998777543 3477888889999999999999999 999999999999995 4557999999999999
Q ss_pred CCCCceeeeeecccCC
Q 017558 354 LDTDTHVSTRVMGTFG 369 (369)
Q Consensus 354 ~~~~~~~~~~~~gt~g 369 (369)
. +.......+||+|
T Consensus 164 ~--~g~~~~G~~GtP~ 177 (355)
T KOG0033|consen 164 N--DGEAWHGFAGTPG 177 (355)
T ss_pred C--CccccccccCCCc
Confidence 8 4345555788876
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.9e-27 Score=221.84 Aligned_cols=161 Identities=24% Similarity=0.338 Sum_probs=138.8
Q ss_pred hhcCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCCcc--cHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEE
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQ--GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 276 (369)
....|.+...||+|.|++|.+++. -++..||+|.+.+..-. ....+.+|+++|..++|||||+|+.+...+..+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 345688899999999999999995 35889999999775432 334688999999999999999999999999999999
Q ss_pred EEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCC
Q 017558 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 277 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~ 356 (369)
|||+.+|.+++||...++ ..+.....++.|+..+++|||++ .|||||||.+||||+.+.++||+|||++..+...
T Consensus 134 ~eya~~ge~~~yl~~~gr--~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~ 208 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHGR--MKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDYG 208 (596)
T ss_pred EEeccCchhHHHHHhccc--chhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeeccc
Confidence 999999999999987764 55577888999999999999999 9999999999999999999999999999987643
Q ss_pred Cceeeeeeccc
Q 017558 357 DTHVSTRVMGT 367 (369)
Q Consensus 357 ~~~~~~~~~gt 367 (369)
. .....+|+
T Consensus 209 ~--~lqt~cgs 217 (596)
T KOG0586|consen 209 L--MLQTFCGS 217 (596)
T ss_pred c--cccccCCC
Confidence 2 33445554
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=221.53 Aligned_cols=147 Identities=24% Similarity=0.341 Sum_probs=127.7
Q ss_pred CCcccceecccCceEEEEEEE-cCCeEEEEEeeccCC--cccHHHHHHHHHHHHhcCCCccccEeeEEEeCC-----eeE
Q 017558 203 NFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGS-----QRL 274 (369)
Q Consensus 203 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~ 274 (369)
+|+..+.||+|+||.||++.. .+++.||||++.... ....+.+.+|++++..++|+||+++++++...+ ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477889999999999999995 468899999986532 223457889999999999999999999998766 789
Q ss_pred EEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 275 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 275 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
+||||+. ++|.+++... ..+++..+..++.||+.||.|||++ +++||||||+|||+++++.+||+|||+++...
T Consensus 81 lv~e~~~-~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEE 154 (372)
T ss_pred EEeeccc-cCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeecc
Confidence 9999996 5787777543 3589999999999999999999998 99999999999999999999999999998754
Q ss_pred C
Q 017558 355 D 355 (369)
Q Consensus 355 ~ 355 (369)
.
T Consensus 155 ~ 155 (372)
T cd07853 155 P 155 (372)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=209.74 Aligned_cols=151 Identities=32% Similarity=0.509 Sum_probs=134.0
Q ss_pred hhcCCcccceecccCceEEEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEe
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 279 (369)
..++|++.+.||+|+||.||++...++..+|+|.++.... ..+.+.+|+.++++++|+||+++++++. ....+++|||
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY 81 (260)
T ss_pred chHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence 3457888999999999999999988888899999876443 3467999999999999999999999885 5568999999
Q ss_pred cCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
+++++|.++++......+++.+++.++.|++.||.|||++ +++||||||+||++++++.+||+|||+++....
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05070 82 MSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIED 154 (260)
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence 9999999999765545689999999999999999999998 899999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-27 Score=194.32 Aligned_cols=150 Identities=25% Similarity=0.409 Sum_probs=128.9
Q ss_pred cCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCCccc--HHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEE
Q 017558 202 DNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQG--EREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 278 (369)
++|...+.||+|.||+||+++. ..++.||+|+++.+...+ -....+||-+|+.++|.|||+|+++...+..+-+|+|
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 3566678999999999999995 457899999997654322 2467899999999999999999999999999999999
Q ss_pred ecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCC
Q 017558 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~ 356 (369)
||+ -+|..|...-+ ..++.+.+..++.|+++||.|+|++ +++||||||.|.||+.+|++|++|||++|.+.-.
T Consensus 82 ~cd-qdlkkyfdsln-g~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgip 154 (292)
T KOG0662|consen 82 FCD-QDLKKYFDSLN-GDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIP 154 (292)
T ss_pred Hhh-HHHHHHHHhcC-CcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCc
Confidence 994 56777765433 3478888999999999999999998 9999999999999999999999999999976543
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=209.74 Aligned_cols=152 Identities=32% Similarity=0.493 Sum_probs=133.0
Q ss_pred hhcCCcccceecccCceEEEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEe
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 279 (369)
..++|.+.+.||+|+||.||+|...+...||+|+++.... ..+.+.+|++++.+++|+||+++++++. ....|+||||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY 81 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEc
Confidence 3467889999999999999999987767799999875332 3467899999999999999999999875 4568999999
Q ss_pred cCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCC
Q 017558 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~ 356 (369)
+++|+|.+++.......+++..++.++.|++.||.|||+. +++||||||+||++++++.+||+|||+++.....
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~ 155 (262)
T cd05071 82 MSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN 155 (262)
T ss_pred CCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence 9999999999765444588999999999999999999998 9999999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-26 Score=214.90 Aligned_cols=142 Identities=30% Similarity=0.435 Sum_probs=123.4
Q ss_pred ceecccCceEEEEEEEc-CCeEEEEEeeccCC---cccHHHHHHHHHHHHh-cCCCccccEeeEEEeCCeeEEEEEecCC
Q 017558 208 NLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQ-VHHRHLVSLVGYCTFGSQRLLVYEFVPN 282 (369)
Q Consensus 208 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~h~niv~l~g~~~~~~~~~lv~e~~~~ 282 (369)
+.||+|+||.||+|+.. +++.||||.++... ....+.+..|..++.. ++||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999965 46889999987542 2233456678888876 4899999999999999999999999999
Q ss_pred CcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 283 KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 283 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
|+|.+++... ..+++.+...++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~ 147 (316)
T cd05619 81 GDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENM 147 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECC
Confidence 9999998653 3488999999999999999999998 99999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=212.08 Aligned_cols=144 Identities=18% Similarity=0.277 Sum_probs=126.0
Q ss_pred cceecccCceEEEEEEEcCCeEEEEEeeccCCccc---HHHHHHHHHHHHhcCCCccccEeeEEEe----CCeeEEEEEe
Q 017558 207 ANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQG---EREFQAEIEIISQVHHRHLVSLVGYCTF----GSQRLLVYEF 279 (369)
Q Consensus 207 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~~lv~e~ 279 (369)
...|++|++|.||+|.+ +|+.||||.++...... .+.|.+|+++|.+++||||++++|++.+ ....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 36799999999999998 68899999997654333 3567899999999999999999999976 3467899999
Q ss_pred cCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
+++|+|.+++... ..+++...+.++.+++.||.|||+.. +++||||||+|||+++++.+||+|||+++....
T Consensus 104 ~~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~ 175 (283)
T PHA02988 104 CTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSS 175 (283)
T ss_pred CCCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcc
Confidence 9999999999764 35889999999999999999999742 788999999999999999999999999986543
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=234.96 Aligned_cols=151 Identities=28% Similarity=0.366 Sum_probs=134.0
Q ss_pred cCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcc---cHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEE
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ---GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 277 (369)
++|.+.+.||+|+||.||+|... +++.||||+++..... ....+.+|++++..++|+||+++++++......||||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 67888999999999999999975 5789999999754322 2357889999999999999999999999999999999
Q ss_pred EecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCCC
Q 017558 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (369)
Q Consensus 278 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~~ 357 (369)
||+.+++|.++++... .+.+...+.|+.||+.||.|||.+ +|+||||||+||||+.++.+||+|||+++.....+
T Consensus 84 Ey~~g~~L~~li~~~~--~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~~~~~~~ 158 (669)
T cd05610 84 EYLIGGDVKSLLHIYG--YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRE 158 (669)
T ss_pred eCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCccccCCc
Confidence 9999999999997543 478889999999999999999998 99999999999999999999999999999765443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=209.23 Aligned_cols=151 Identities=31% Similarity=0.479 Sum_probs=135.3
Q ss_pred HhhcCCcccceecccCceEEEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEE
Q 017558 199 IATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (369)
Q Consensus 199 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 278 (369)
+..++|++.+.||+|+||.||+|...+++.||+|.+..... ...++.+|+.++++++|+||+++++++. .+..+++||
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE 80 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence 45678899999999999999999988889999999875443 3468899999999999999999999874 567899999
Q ss_pred ecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
|+.+++|.+++.......+++.+++.++.|++.||+|||+. +++||||||+||++++++.++|+|||+++...
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 153 (260)
T cd05067 81 YMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIE 153 (260)
T ss_pred cCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecC
Confidence 99999999998765555689999999999999999999988 99999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-27 Score=227.21 Aligned_cols=159 Identities=28% Similarity=0.401 Sum_probs=133.1
Q ss_pred cccceecccCceEEEEEE-EcCCeEEEEEeeccCCc-ccHHHHHHHHHHHHhcCCCccccEeeEEEeCC------eeEEE
Q 017558 205 SEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGS------QRLLV 276 (369)
Q Consensus 205 ~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~~~lv 276 (369)
...+.||+|+||.||+|+ .+.|+.||||.++.... ...+...+|+++|++++|+|||++++.=+... ...+|
T Consensus 16 ~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlv 95 (732)
T KOG4250|consen 16 EMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLV 95 (732)
T ss_pred eehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEE
Confidence 345789999999999999 45799999999987542 34456789999999999999999998765433 56899
Q ss_pred EEecCCCcHhhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEC--CCC--cEEEeeeccce
Q 017558 277 YEFVPNKTLEFHLHGKD-RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLD--DSF--EAKVADFGLAK 351 (369)
Q Consensus 277 ~e~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~--~~~--~~ki~DFGla~ 351 (369)
||||.+|+|+..|...+ ...|++.+.+.+..+++.||.|||++ +|+||||||.||++- .+| --||+|||.||
T Consensus 96 mEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar 172 (732)
T KOG4250|consen 96 MEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR 172 (732)
T ss_pred EeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence 99999999999998643 35699999999999999999999998 999999999999983 333 46899999999
Q ss_pred eeCCCCceeeeeecccC
Q 017558 352 HSLDTDTHVSTRVMGTF 368 (369)
Q Consensus 352 ~~~~~~~~~~~~~~gt~ 368 (369)
.+.++. .-+.++||.
T Consensus 173 el~d~s--~~~S~vGT~ 187 (732)
T KOG4250|consen 173 ELDDNS--LFTSLVGTE 187 (732)
T ss_pred cCCCCC--eeeeecCch
Confidence 987665 445578884
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.2e-27 Score=223.46 Aligned_cols=156 Identities=27% Similarity=0.485 Sum_probs=133.1
Q ss_pred HHHhhcCCcccceecccCceEEEEEEEc------CCeEEEEEeeccCCcc-cHHHHHHHHHHHHhcC-CCccccEeeEEE
Q 017558 197 LKIATDNFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLKAGSGQ-GEREFQAEIEIISQVH-HRHLVSLVGYCT 268 (369)
Q Consensus 197 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-h~niv~l~g~~~ 268 (369)
+.+..++|.+.+.||+|+||.||+|++. .+..||+|+++..... ..+.+.+|+++|.++. |+||++++++|.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 3445567888899999999999999864 2467999999765333 2346889999999997 999999999999
Q ss_pred eCCeeEEEEEecCCCcHhhhhcCCC-------------------------------------------------------
Q 017558 269 FGSQRLLVYEFVPNKTLEFHLHGKD------------------------------------------------------- 293 (369)
Q Consensus 269 ~~~~~~lv~e~~~~g~L~~~l~~~~------------------------------------------------------- 293 (369)
..+..++||||+++|+|.++|+...
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 9999999999999999999996432
Q ss_pred -----------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCC
Q 017558 294 -----------------------------------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSA 332 (369)
Q Consensus 294 -----------------------------------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~ 332 (369)
...+++...+.|+.||+.||+|||+. +++||||||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~ 268 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAAR 268 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcc
Confidence 12367788899999999999999988 9999999999
Q ss_pred cEEECCCCcEEEeeeccceeeCC
Q 017558 333 NILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 333 Nill~~~~~~ki~DFGla~~~~~ 355 (369)
|||+++++.+||+|||+++....
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~ 291 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMR 291 (401)
T ss_pred eEEEeCCCEEEEEecCcceeccc
Confidence 99999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=211.59 Aligned_cols=151 Identities=28% Similarity=0.483 Sum_probs=131.1
Q ss_pred cCCcccceecccCceEEEEEEE-----cCCeEEEEEeeccCCc-ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEE
Q 017558 202 DNFSEANLLGQGGFGYVHKGVL-----TNGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 275 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 275 (369)
++|++.+.||+|+||.||+|.+ ..+..+++|.++.... ....++.+|++++++++|+||+++++++......|+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 5678889999999999999984 2457899999975432 334578899999999999999999999999999999
Q ss_pred EEEecCCCcHhhhhcCCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCC
Q 017558 276 VYEFVPNKTLEFHLHGKD---------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF 340 (369)
Q Consensus 276 v~e~~~~g~L~~~l~~~~---------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~ 340 (369)
||||+++++|.+++.... ...+++.+.+.++.|++.||.|||++ +++||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence 999999999999985321 12478888999999999999999998 999999999999999999
Q ss_pred cEEEeeeccceeeCC
Q 017558 341 EAKVADFGLAKHSLD 355 (369)
Q Consensus 341 ~~ki~DFGla~~~~~ 355 (369)
.+||+|||+++....
T Consensus 162 ~~kl~dfg~~~~~~~ 176 (283)
T cd05090 162 HVKISDLGLSREIYS 176 (283)
T ss_pred cEEeccccccccccC
Confidence 999999999987643
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-26 Score=208.04 Aligned_cols=152 Identities=31% Similarity=0.506 Sum_probs=137.9
Q ss_pred HhhcCCcccceecccCceEEEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEE
Q 017558 199 IATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (369)
Q Consensus 199 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 278 (369)
+..++|.+.+.||+|+||.||++...+++.+|||.+.... ...+++.+|+.++++++|+||+++++++......++|||
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 4567899999999999999999998778889999987543 335689999999999999999999999998899999999
Q ss_pred ecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
|+++++|.+++.......+++.++..++.|++.||.|||++ +++|+||||+||++++++.+||+|||+++...
T Consensus 82 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~ 154 (261)
T cd05034 82 YMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIE 154 (261)
T ss_pred ccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceecc
Confidence 99999999999876545689999999999999999999998 99999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.6e-26 Score=208.87 Aligned_cols=143 Identities=29% Similarity=0.400 Sum_probs=125.9
Q ss_pred ecccCceEEEEEEEc-CCeEEEEEeeccCCc---ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEecCCCcH
Q 017558 210 LGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG---QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTL 285 (369)
Q Consensus 210 lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g~L 285 (369)
||+|+||.||+++.. +++.||+|++..... .....+..|++++.+++|+||+++++++..+...|+||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999864 588999999864321 2234566799999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 286 EFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 286 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
.+++.......+++..+..++.||+.||+|||+. +++||||||+|||+++++.+||+|||++....+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~ 147 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKD 147 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCC
Confidence 9988765555689999999999999999999998 999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-26 Score=210.23 Aligned_cols=148 Identities=32% Similarity=0.429 Sum_probs=130.7
Q ss_pred CcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcc---cHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEe
Q 017558 204 FSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ---GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (369)
Q Consensus 204 ~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 279 (369)
|+..+.||+|+||.||++... +++.||||.+...... ....+.+|+.++.+++|+||+.+++.+...+..|+||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667889999999999999964 5789999998654322 224577899999999999999999999999999999999
Q ss_pred cCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
+++++|.+++.......+++.+++.++.|++.||.|||+. +++||||||+||++++++.++|+|||+++...
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 153 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVP 153 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecC
Confidence 9999999998655445689999999999999999999998 99999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-26 Score=207.76 Aligned_cols=150 Identities=31% Similarity=0.493 Sum_probs=133.2
Q ss_pred hcCCcccceecccCceEEEEEEEcC----CeEEEEEeeccCCcc-cHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEE
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLTN----GKVVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 275 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 275 (369)
.++|+..+.||+|+||.||+|.+.. ...||||.++..... ...+|.+|+.++.+++|+||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 3578889999999999999999743 357999988754332 34578999999999999999999999999999999
Q ss_pred EEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 276 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 276 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
+|||+++++|.+++.... ..+++..++.++.|++.||.|||++ +++|+||||+|||+++++.+||+|||+++...
T Consensus 83 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 83 ITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 999999999999997643 3589999999999999999999998 99999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=211.18 Aligned_cols=155 Identities=27% Similarity=0.506 Sum_probs=132.9
Q ss_pred HhhcCCcccceecccCceEEEEEEEc------CCeEEEEEeeccCCc-ccHHHHHHHHHHHHhcCCCccccEeeEEEeCC
Q 017558 199 IATDNFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGS 271 (369)
Q Consensus 199 ~~~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~ 271 (369)
+..++|+..+.||+|+||.||+|... .+..||||++..... ....++.+|+.++..++|+||+++++++....
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 35678999999999999999999853 246799998865432 23457889999999999999999999999999
Q ss_pred eeEEEEEecCCCcHhhhhcCCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEE
Q 017558 272 QRLLVYEFVPNKTLEFHLHGKD--------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAK 343 (369)
Q Consensus 272 ~~~lv~e~~~~g~L~~~l~~~~--------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~k 343 (369)
..++||||+++++|.+++.... ...+++..++.++.|++.||.|||+. +++||||||+|||+++++.+|
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEE
Confidence 9999999999999999986532 12367888999999999999999998 999999999999999999999
Q ss_pred EeeeccceeeCCC
Q 017558 344 VADFGLAKHSLDT 356 (369)
Q Consensus 344 i~DFGla~~~~~~ 356 (369)
|+|||+++.....
T Consensus 160 l~dfg~~~~~~~~ 172 (277)
T cd05062 160 IGDFGMTRDIYET 172 (277)
T ss_pred ECCCCCccccCCc
Confidence 9999999866543
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-27 Score=239.03 Aligned_cols=170 Identities=27% Similarity=0.269 Sum_probs=151.5
Q ss_pred HHHHHHhhcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC---cccHHHHHHHHHHHHhcCCCccccEeeEEEe
Q 017558 194 YEELKIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTF 269 (369)
Q Consensus 194 ~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~ 269 (369)
..+++...++|.+.++||+|+||.|.+++.+ ++++||+|++.++. ..+..-|.+|-++|.-.+.+-|++|.-.|++
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 4567778899999999999999999999964 57899999998753 2233468999999999999999999999999
Q ss_pred CCeeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeecc
Q 017558 270 GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGL 349 (369)
Q Consensus 270 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGl 349 (369)
+.++|||||||+||||..++.+.+ .+++.-+.++...|..||.-||+. |+|||||||.|||||.+|++||+|||-
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGs 221 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGS 221 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchh
Confidence 999999999999999999998765 588888889999999999999998 999999999999999999999999999
Q ss_pred ceeeCCCCceeeeeecccC
Q 017558 350 AKHSLDTDTHVSTRVMGTF 368 (369)
Q Consensus 350 a~~~~~~~~~~~~~~~gt~ 368 (369)
|-.+..+..-.+...+|||
T Consensus 222 Clkm~~dG~V~s~~aVGTP 240 (1317)
T KOG0612|consen 222 CLKMDADGTVRSSVAVGTP 240 (1317)
T ss_pred HHhcCCCCcEEeccccCCC
Confidence 9998877766666788987
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-26 Score=208.21 Aligned_cols=152 Identities=32% Similarity=0.496 Sum_probs=132.9
Q ss_pred hcCCcccceecccCceEEEEEEEc----CCeEEEEEeeccCCc-ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEE
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT----NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 275 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 275 (369)
.++|++.+.||+|+||.||+|... .+..+|+|.++.... ...+.+.+|+.++.+++||||+++++++..++..|+
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 356888899999999999999863 234799998875432 234578999999999999999999999999999999
Q ss_pred EEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 276 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 276 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
||||+++++|.+++.... ..+++.+.+.++.|++.||.|||++ +++||||||+|||++.++.+||+|||+++....
T Consensus 83 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 83 VTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 999999999999997653 3588999999999999999999998 999999999999999999999999999987654
Q ss_pred C
Q 017558 356 T 356 (369)
Q Consensus 356 ~ 356 (369)
.
T Consensus 159 ~ 159 (267)
T cd05066 159 D 159 (267)
T ss_pred c
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-26 Score=207.07 Aligned_cols=150 Identities=34% Similarity=0.500 Sum_probs=132.1
Q ss_pred hcCCcccceecccCceEEEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEec
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 280 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 280 (369)
.++|++.+.||+|+||.||++....+..+|+|.+.... ...+.+.+|++++++++|+|++++++++. .+..+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM 82 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence 45688889999999999999998777789999886543 23467889999999999999999999875 55689999999
Q ss_pred CCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 281 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 281 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
.+++|.++++......+++..+..++.|++.||.|||+. +++|+|||++||++++++.+||+|||+++....
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05069 83 GKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIED 154 (260)
T ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccC
Confidence 999999999765545589999999999999999999998 899999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-26 Score=206.79 Aligned_cols=150 Identities=32% Similarity=0.555 Sum_probs=135.9
Q ss_pred hcCCcccceecccCceEEEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEec
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 280 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 280 (369)
.++|++.+.||.|+||.||+|... ++.||+|.++.... ..+.+.+|+.++.+++|+||+++++++......++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 457888999999999999999974 78899999976544 4568899999999999999999999999899999999999
Q ss_pred CCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 281 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 281 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
++++|.+++.......+++.....++.|++.||.|||++ +++|+||||+||+++.++.+||+|||+++....
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~ 154 (256)
T cd05039 83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQ 154 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEccccccccccc
Confidence 999999999766544689999999999999999999998 999999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-26 Score=232.85 Aligned_cols=149 Identities=23% Similarity=0.331 Sum_probs=130.8
Q ss_pred cCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCc---ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEE
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG---QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 277 (369)
++|++.+.||+|+||.||+|... +++.||+|+++.... ...+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57889999999999999999964 578999999975422 22357899999999999999999999999999999999
Q ss_pred EecCCCcHhhhhcCCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeec
Q 017558 278 EFVPNKTLEFHLHGKD---------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFG 348 (369)
Q Consensus 278 e~~~~g~L~~~l~~~~---------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFG 348 (369)
||+++|+|.+++.... ...+++...+.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999986321 12356677889999999999999998 99999999999999999999999999
Q ss_pred cceee
Q 017558 349 LAKHS 353 (369)
Q Consensus 349 la~~~ 353 (369)
+++..
T Consensus 159 LAk~i 163 (932)
T PRK13184 159 AAIFK 163 (932)
T ss_pred cceec
Confidence 99876
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-26 Score=208.09 Aligned_cols=144 Identities=27% Similarity=0.414 Sum_probs=123.1
Q ss_pred eecccCceEEEEEEEcC---CeEEEEEeeccCCc-ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEecCCCc
Q 017558 209 LLGQGGFGYVHKGVLTN---GKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKT 284 (369)
Q Consensus 209 ~lg~G~fg~Vy~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g~ 284 (369)
.||+|+||.||+|...+ ...+++|.+..... .....+.+|+.+++.++|+||++++++|......|+||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997543 34688888765432 234578899999999999999999999999999999999999999
Q ss_pred HhhhhcCCCC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 285 LEFHLHGKDR---PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 285 L~~~l~~~~~---~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
|.+++..... ..+.+...+.++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++....
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 152 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYP 152 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEecccccccccc
Confidence 9999975432 2346778889999999999999998 999999999999999999999999999976443
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=227.44 Aligned_cols=156 Identities=22% Similarity=0.247 Sum_probs=132.7
Q ss_pred HHHhhcCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCC--cccHHHHHHHHHHHHhcCCCccccEeeEEEeCC--
Q 017558 197 LKIATDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGS-- 271 (369)
Q Consensus 197 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-- 271 (369)
.....++|.+.+.||+|+||.||+++. .+++.||||++.... ......+.+|+.++..++|+||+++.+.+...+
T Consensus 27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence 344567999999999999999999985 468899999986543 233456889999999999999999988775432
Q ss_pred ------eeEEEEEecCCCcHhhhhcCCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEE
Q 017558 272 ------QRLLVYEFVPNKTLEFHLHGKD--RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAK 343 (369)
Q Consensus 272 ------~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~k 343 (369)
..++||||+++|+|.++|.... ...+.+..+..++.|++.||.|||++ +|+||||||+||||+.++.+|
T Consensus 107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vk 183 (496)
T PTZ00283 107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVK 183 (496)
T ss_pred CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEE
Confidence 3689999999999999986432 34588999999999999999999998 999999999999999999999
Q ss_pred EeeeccceeeCC
Q 017558 344 VADFGLAKHSLD 355 (369)
Q Consensus 344 i~DFGla~~~~~ 355 (369)
|+|||+++.+..
T Consensus 184 L~DFGls~~~~~ 195 (496)
T PTZ00283 184 LGDFGFSKMYAA 195 (496)
T ss_pred EEecccCeeccc
Confidence 999999987654
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-26 Score=213.87 Aligned_cols=142 Identities=30% Similarity=0.441 Sum_probs=124.9
Q ss_pred ceecccCceEEEEEEEc-CCeEEEEEeeccCC---cccHHHHHHHHHHHHhc-CCCccccEeeEEEeCCeeEEEEEecCC
Q 017558 208 NLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLVYEFVPN 282 (369)
Q Consensus 208 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~~ 282 (369)
+.||+|+||.||++... +++.||||.++... ......+..|++++..+ +|+||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999965 46789999997542 22345677899999888 699999999999999999999999999
Q ss_pred CcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 283 KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 283 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
|+|..++... ..+++.....++.||+.||.|||++ +++||||||+|||+++++.+||+|||+++...
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 147 (318)
T cd05570 81 GDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGI 147 (318)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecC
Confidence 9999988654 3589999999999999999999998 99999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=4e-26 Score=211.77 Aligned_cols=150 Identities=27% Similarity=0.389 Sum_probs=131.7
Q ss_pred cCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCc-ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEe
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 279 (369)
++|++.+.||+|+||.||++... ++..+|+|.++.... ...+++.+|++++.+++|+||++++++|..++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46888999999999999999864 578899998865432 2335688999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
+++++|.++++.. ..+++..+..++.||+.||.|||++. +++||||||+|||+++++.+||+|||+++...+
T Consensus 81 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 152 (308)
T cd06615 81 MDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 152 (308)
T ss_pred cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccc
Confidence 9999999999754 34889999999999999999999732 899999999999999999999999999986543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-25 Score=239.26 Aligned_cols=142 Identities=26% Similarity=0.495 Sum_probs=123.2
Q ss_pred cCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEec
Q 017558 202 DNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 280 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 280 (369)
..|...++||+|+||.||+|+. .++..||||+++..... ..+|++++++++|||||+++|+|.+.+..|+|||||
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~ 765 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI 765 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence 4577788999999999999996 46889999998754322 234688999999999999999999999999999999
Q ss_pred CCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceee
Q 017558 281 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (369)
Q Consensus 281 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~ 353 (369)
++|+|.++++. ++|..+.+|+.||+.||+|||..+.++|+||||||+||+++.++..++. ||+.+..
T Consensus 766 ~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~ 832 (968)
T PLN00113 766 EGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL 832 (968)
T ss_pred CCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccc
Confidence 99999999953 8899999999999999999996656699999999999999999888876 7766543
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-26 Score=211.16 Aligned_cols=154 Identities=27% Similarity=0.495 Sum_probs=131.6
Q ss_pred HhhcCCcccceecccCceEEEEEEEc------CCeEEEEEeeccCCc-ccHHHHHHHHHHHHhcCCCccccEeeEEEeCC
Q 017558 199 IATDNFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGS 271 (369)
Q Consensus 199 ~~~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~ 271 (369)
+..++|++.+.||+|+||.||+|..+ .+..||+|.+..... .....+.+|+.++.+++|+||+++++++...+
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 35678999999999999999999753 245799998865432 22346788999999999999999999999999
Q ss_pred eeEEEEEecCCCcHhhhhcCCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEE
Q 017558 272 QRLLVYEFVPNKTLEFHLHGKD--------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAK 343 (369)
Q Consensus 272 ~~~lv~e~~~~g~L~~~l~~~~--------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~k 343 (369)
..|+||||+++|+|.+++.... ...+.+.....++.|++.||.|||++ +++||||||+|||+++++.+|
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEE
Confidence 9999999999999999997432 23356778889999999999999998 999999999999999999999
Q ss_pred EeeeccceeeCC
Q 017558 344 VADFGLAKHSLD 355 (369)
Q Consensus 344 i~DFGla~~~~~ 355 (369)
|+|||+++....
T Consensus 160 L~Dfg~~~~~~~ 171 (288)
T cd05061 160 IGDFGMTRDIYE 171 (288)
T ss_pred ECcCCccccccc
Confidence 999999986543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.6e-26 Score=212.10 Aligned_cols=149 Identities=26% Similarity=0.449 Sum_probs=129.6
Q ss_pred cCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcc-cHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEe
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 279 (369)
++|...+.||+|+||.||+|+.. +++.||+|.++..... ....+.+|++++++++|+||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56888999999999999999864 5678999998754322 234678899999999999999999999999999999999
Q ss_pred cCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
+++ +|.+++.... ..+++..+..++.||+.||.|||++ +|+||||||+|||+++++.+||+|||+++....
T Consensus 86 ~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 156 (309)
T cd07872 86 LDK-DLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSV 156 (309)
T ss_pred CCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCC
Confidence 975 7878776543 3478889999999999999999998 999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-26 Score=210.41 Aligned_cols=153 Identities=27% Similarity=0.531 Sum_probs=134.4
Q ss_pred hcCCcccceecccCceEEEEEEEc------CCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeE
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRL 274 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 274 (369)
.++|.+.+.||+|+||.||++... ++..+|+|.++.......+.+.+|++++.+++|+||++++++|...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 467888999999999999999842 24568999987665555668999999999999999999999999999999
Q ss_pred EEEEecCCCcHhhhhcCCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEE
Q 017558 275 LVYEFVPNKTLEFHLHGKD-----------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAK 343 (369)
Q Consensus 275 lv~e~~~~g~L~~~l~~~~-----------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~k 343 (369)
+||||+++++|.+++.... ...+++..++.++.|++.||+|||++ +++||||||+|||+++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEE
Confidence 9999999999999986432 13489999999999999999999998 999999999999999999999
Q ss_pred EeeeccceeeCCC
Q 017558 344 VADFGLAKHSLDT 356 (369)
Q Consensus 344 i~DFGla~~~~~~ 356 (369)
|+|||+++.....
T Consensus 161 l~dfg~~~~~~~~ 173 (288)
T cd05093 161 IGDFGMSRDVYST 173 (288)
T ss_pred eccCCccccccCC
Confidence 9999999876443
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-27 Score=218.41 Aligned_cols=161 Identities=31% Similarity=0.432 Sum_probs=141.5
Q ss_pred cCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCCcc-cHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEe
Q 017558 202 DNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 279 (369)
..|...+.||+|.||.||+|.. +.++.||+|.+...... +.+++..|+.+|++++++||.+++|.+..+..+|++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 3466678999999999999994 56889999999776543 457899999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCCCce
Q 017558 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 359 (369)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~~~~ 359 (369)
|.+|++.+.|... ..+.+.....|..+++.||.|||.+ +.+|||||+.|||+..+|.+||+|||++..+.+....
T Consensus 93 ~~gGsv~~lL~~~--~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r 167 (467)
T KOG0201|consen 93 CGGGSVLDLLKSG--NILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR 167 (467)
T ss_pred hcCcchhhhhccC--CCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhhc
Confidence 9999999999654 3357778888999999999999999 9999999999999999999999999999998876655
Q ss_pred eeeeecccC
Q 017558 360 VSTRVMGTF 368 (369)
Q Consensus 360 ~~~~~~gt~ 368 (369)
. .+.+||+
T Consensus 168 r-~tfvGTP 175 (467)
T KOG0201|consen 168 R-KTFVGTP 175 (467)
T ss_pred c-ccccccc
Confidence 4 5578875
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-26 Score=216.77 Aligned_cols=152 Identities=31% Similarity=0.525 Sum_probs=129.2
Q ss_pred hhcCCcccceecccCceEEEEEEE------cCCeEEEEEeeccCCcc-cHHHHHHHHHHHHhc-CCCccccEeeEEEeC-
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVL------TNGKVVAIKQLKAGSGQ-GEREFQAEIEIISQV-HHRHLVSLVGYCTFG- 270 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~- 270 (369)
..++|++.+.||+|+||.||+|.. .+++.||||+++..... ....+.+|+.+|.++ +|+||++++++|...
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 456789999999999999999973 34678999999764432 335688999999999 689999999988654
Q ss_pred CeeEEEEEecCCCcHhhhhcCCC---------------------------------------------------------
Q 017558 271 SQRLLVYEFVPNKTLEFHLHGKD--------------------------------------------------------- 293 (369)
Q Consensus 271 ~~~~lv~e~~~~g~L~~~l~~~~--------------------------------------------------------- 293 (369)
...+++|||+++|+|.++++...
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 56789999999999999986421
Q ss_pred --------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 294 --------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 294 --------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
...+++.....++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~ 230 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIY 230 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccc
Confidence 12367888899999999999999998 99999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-26 Score=212.27 Aligned_cols=152 Identities=26% Similarity=0.500 Sum_probs=131.1
Q ss_pred hcCCcccceecccCceEEEEEEEcC---------------CeEEEEEeeccCCcc-cHHHHHHHHHHHHhcCCCccccEe
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLTN---------------GKVVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVSLV 264 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~~---------------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~ 264 (369)
.++|++.+.||+|+||.||+++..+ ...||+|.++..... ....|.+|++++.+++|+||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 4578889999999999999987532 235899998765322 345789999999999999999999
Q ss_pred eEEEeCCeeEEEEEecCCCcHhhhhcCCC----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcE
Q 017558 265 GYCTFGSQRLLVYEFVPNKTLEFHLHGKD----------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANI 334 (369)
Q Consensus 265 g~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Ni 334 (369)
+++...+..++||||+++++|.+++.... ...+.+..++.++.|++.||.|||++ +++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhE
Confidence 99999999999999999999999986432 12368889999999999999999998 999999999999
Q ss_pred EECCCCcEEEeeeccceeeCC
Q 017558 335 LLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 335 ll~~~~~~ki~DFGla~~~~~ 355 (369)
|+++++.+||+|||+++....
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~ 181 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYS 181 (295)
T ss_pred EEcCCCcEEeccccccccccc
Confidence 999999999999999987644
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-26 Score=209.06 Aligned_cols=152 Identities=27% Similarity=0.535 Sum_probs=133.6
Q ss_pred hcCCcccceecccCceEEEEEEEcC------CeEEEEEeeccCCcc-cHHHHHHHHHHHHhcCCCccccEeeEEEeCCee
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLTN------GKVVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQR 273 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 273 (369)
.++|.+.+.||+|+||.||+|...+ +..||||.++..... ..+.+.+|+++|.+++|+||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 3567778999999999999998633 478999999765444 456899999999999999999999999999999
Q ss_pred EEEEEecCCCcHhhhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCc
Q 017558 274 LLVYEFVPNKTLEFHLHGKD------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFE 341 (369)
Q Consensus 274 ~lv~e~~~~g~L~~~l~~~~------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~ 341 (369)
++||||+++++|.+++.... ...+++.....++.|++.||.|||++ +++||||||+|||++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCe
Confidence 99999999999999997532 23478889999999999999999998 9999999999999999999
Q ss_pred EEEeeeccceeeCC
Q 017558 342 AKVADFGLAKHSLD 355 (369)
Q Consensus 342 ~ki~DFGla~~~~~ 355 (369)
+||+|||+++....
T Consensus 161 ~kl~d~g~~~~~~~ 174 (280)
T cd05049 161 VKIGDFGMSRDVYT 174 (280)
T ss_pred EEECCcccceeccc
Confidence 99999999987544
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.94 E-value=5e-26 Score=204.61 Aligned_cols=143 Identities=27% Similarity=0.473 Sum_probs=126.9
Q ss_pred ceecccCceEEEEEEEc-CCeEEEEEeeccCCc-ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEecCCCcH
Q 017558 208 NLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTL 285 (369)
Q Consensus 208 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g~L 285 (369)
+.||+|+||.||+|... +++.+|+|.++.... .....+.+|++++++++|+||++++++|......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999964 688999998865432 3345789999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 286 EFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 286 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
.+++.... ..+++..++.++.|++.||.|||++ +++||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 145 (252)
T cd05084 81 LTFLRTEG-PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEE 145 (252)
T ss_pred HHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccc
Confidence 99996543 3588999999999999999999998 99999999999999999999999999998644
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-26 Score=214.34 Aligned_cols=141 Identities=26% Similarity=0.302 Sum_probs=120.4
Q ss_pred ecccCceEEEEEEEc-CCeEEEEEeeccCCc---ccHHHHHHHHHHHHhc---CCCccccEeeEEEeCCeeEEEEEecCC
Q 017558 210 LGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG---QGEREFQAEIEIISQV---HHRHLVSLVGYCTFGSQRLLVYEFVPN 282 (369)
Q Consensus 210 lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l---~h~niv~l~g~~~~~~~~~lv~e~~~~ 282 (369)
||+|+||.||+|+.. +++.||||++..... .....+..|..++.++ +||||+.+++++......|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999964 578999999864321 1223445667776655 699999999999999999999999999
Q ss_pred CcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 283 KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 283 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
|+|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||+++++.+||+|||+++....
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~ 148 (330)
T cd05586 81 GELFWHLQKE--GRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLT 148 (330)
T ss_pred ChHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCC
Confidence 9999998754 3588999999999999999999998 999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.9e-26 Score=208.22 Aligned_cols=152 Identities=30% Similarity=0.548 Sum_probs=132.1
Q ss_pred cCCcccceecccCceEEEEEEEcC------CeEEEEEeeccCCc-ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeE
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLTN------GKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRL 274 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 274 (369)
++|++.+.||+|+||.||+|.... ...|++|.++.... ....+|.+|++++.+++|+||+++++++......|
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 568888999999999999998643 25799999875433 23457899999999999999999999999989999
Q ss_pred EEEEecCCCcHhhhhcCCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCC
Q 017558 275 LVYEFVPNKTLEFHLHGKDR--------------PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF 340 (369)
Q Consensus 275 lv~e~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~ 340 (369)
++|||+++++|.+++..... ..+++...+.++.|++.||.|||++ +++||||||+|||+++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence 99999999999999975321 3578889999999999999999998 999999999999999999
Q ss_pred cEEEeeeccceeeCCC
Q 017558 341 EAKVADFGLAKHSLDT 356 (369)
Q Consensus 341 ~~ki~DFGla~~~~~~ 356 (369)
.+||+|||+++.....
T Consensus 162 ~~~L~dfg~~~~~~~~ 177 (283)
T cd05048 162 TVKISDFGLSRDIYSA 177 (283)
T ss_pred cEEECCCcceeecccc
Confidence 9999999999876543
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.7e-26 Score=205.37 Aligned_cols=152 Identities=30% Similarity=0.478 Sum_probs=134.8
Q ss_pred HhhcCCcccceecccCceEEEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEE
Q 017558 199 IATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (369)
Q Consensus 199 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 278 (369)
+..++|++.+.||+|+||.||++...++..+++|.++... ...+.+.+|++++++++|+||+++++++.. ...+++||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 3457889999999999999999998777889999887543 234678899999999999999999999887 77899999
Q ss_pred ecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
|+++++|.+++.......+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||+++...+
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 81 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred eCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 99999999999765555688999999999999999999998 999999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-26 Score=216.08 Aligned_cols=154 Identities=30% Similarity=0.513 Sum_probs=130.2
Q ss_pred HhhcCCcccceecccCceEEEEEEEc------CCeEEEEEeeccCCcc-cHHHHHHHHHHHHhc-CCCccccEeeEEEe-
Q 017558 199 IATDNFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLKAGSGQ-GEREFQAEIEIISQV-HHRHLVSLVGYCTF- 269 (369)
Q Consensus 199 ~~~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~l~g~~~~- 269 (369)
+..++|++.+.||+|+||.||+|... +++.||+|+++..... ..+.+..|++++.++ +|+||++++++|..
T Consensus 4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~ 83 (337)
T cd05054 4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP 83 (337)
T ss_pred cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence 34567889999999999999999742 2478999998754322 235678899999999 79999999998865
Q ss_pred CCeeEEEEEecCCCcHhhhhcCCCC-------------------------------------------------------
Q 017558 270 GSQRLLVYEFVPNKTLEFHLHGKDR------------------------------------------------------- 294 (369)
Q Consensus 270 ~~~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------- 294 (369)
+...+++|||+++++|.++|.....
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 4568899999999999999864211
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 295 ----PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 295 ----~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
..++|..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.+..
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~ 225 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYK 225 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhccc
Confidence 2578999999999999999999998 999999999999999999999999999987644
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.6e-26 Score=202.43 Aligned_cols=143 Identities=34% Similarity=0.536 Sum_probs=127.9
Q ss_pred ceecccCceEEEEEEEcCCeEEEEEeeccCCcc-cHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEecCCCcHh
Q 017558 208 NLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLE 286 (369)
Q Consensus 208 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g~L~ 286 (369)
++||+|+||.||+|...++..+|+|.++..... ....+.+|++++.+++|+||++++++|...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 469999999999999888889999998765432 2346889999999999999999999999999999999999999999
Q ss_pred hhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 287 FHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 287 ~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
+++.... ..+++..++.++.|++.+|.|||++ +++||||||+||++++++.+||+|||+++...
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 144 (250)
T cd05085 81 SFLRKKK-DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQED 144 (250)
T ss_pred HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceecc
Confidence 9987543 3578999999999999999999998 99999999999999999999999999997643
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.2e-26 Score=209.83 Aligned_cols=157 Identities=27% Similarity=0.496 Sum_probs=135.3
Q ss_pred HHHhhcCCcccceecccCceEEEEEEEcC------CeEEEEEeeccCCc-ccHHHHHHHHHHHHhc-CCCccccEeeEEE
Q 017558 197 LKIATDNFSEANLLGQGGFGYVHKGVLTN------GKVVAIKQLKAGSG-QGEREFQAEIEIISQV-HHRHLVSLVGYCT 268 (369)
Q Consensus 197 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~g~~~ 268 (369)
+.+..++|+..+.||+|+||.||++.... ...+|+|.++.... ....++.+|++++.++ +|+||++++++|.
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 34556778889999999999999998642 36799999875432 2345688999999999 7999999999999
Q ss_pred eCCeeEEEEEecCCCcHhhhhcCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcE
Q 017558 269 FGSQRLLVYEFVPNKTLEFHLHGK--------------DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANI 334 (369)
Q Consensus 269 ~~~~~~lv~e~~~~g~L~~~l~~~--------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Ni 334 (369)
.++..+++|||+++|+|..+++.. ....+++..++.++.|++.||.|||++ +|+||||||+||
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Ni 163 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNV 163 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeE
Confidence 999999999999999999998642 234588999999999999999999998 999999999999
Q ss_pred EECCCCcEEEeeeccceeeCCC
Q 017558 335 LLDDSFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 335 ll~~~~~~ki~DFGla~~~~~~ 356 (369)
|+++++.+||+|||+++.....
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~ 185 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHI 185 (293)
T ss_pred EEcCCCeEEeCccccccccccc
Confidence 9999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.7e-26 Score=205.34 Aligned_cols=145 Identities=33% Similarity=0.480 Sum_probs=129.2
Q ss_pred CcccceecccCceEEEEEEEcC-CeEEEEEeeccCCcccHH--HHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEec
Q 017558 204 FSEANLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGSGQGER--EFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 280 (369)
Q Consensus 204 ~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 280 (369)
|+..+.||+|+||.||++.... ++.+|+|.+......... ...+|+.++.+++|+||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 5678999999999999999754 568999999876544322 3456999999999999999999999999999999999
Q ss_pred CCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceee
Q 017558 281 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (369)
Q Consensus 281 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~ 353 (369)
++++|.+++.. ...+++..+..++.|++.||.|||++ +++|+||||+||++++++.++|+|||++...
T Consensus 81 ~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~ 148 (260)
T PF00069_consen 81 PGGSLQDYLQK--NKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKL 148 (260)
T ss_dssp TTEBHHHHHHH--HSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEES
T ss_pred ccccccccccc--cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc
Confidence 99999999972 23589999999999999999999998 9999999999999999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.7e-26 Score=206.92 Aligned_cols=150 Identities=24% Similarity=0.443 Sum_probs=132.1
Q ss_pred cCCcccceecccCceEEEEEEEcC------CeEEEEEeeccCCcc-cHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeE
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLTN------GKVVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRL 274 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 274 (369)
++|+..+.||+|+||.||+|+... .+.+++|.+...... ..+++.+|++++++++|+||+++++++.+....|
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 678889999999999999999642 457899988654433 3467999999999999999999999999989999
Q ss_pred EEEEecCCCcHhhhhcCCCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeee
Q 017558 275 LVYEFVPNKTLEFHLHGKDR-------PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADF 347 (369)
Q Consensus 275 lv~e~~~~g~L~~~l~~~~~-------~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DF 347 (369)
+||||+++|+|.+++..... ..+++..+..++.|++.||.|||++ +++||||||+|||++.++.+||+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence 99999999999999975441 2589999999999999999999998 9999999999999999999999999
Q ss_pred ccceeeC
Q 017558 348 GLAKHSL 354 (369)
Q Consensus 348 Gla~~~~ 354 (369)
|+++...
T Consensus 162 ~~~~~~~ 168 (275)
T cd05046 162 SLSKDVY 168 (275)
T ss_pred ccccccC
Confidence 9987643
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=4e-26 Score=211.18 Aligned_cols=154 Identities=29% Similarity=0.494 Sum_probs=134.4
Q ss_pred HhhcCCcccceecccCceEEEEEEEc------CCeEEEEEeeccCCcc-cHHHHHHHHHHHHhc-CCCccccEeeEEEeC
Q 017558 199 IATDNFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLKAGSGQ-GEREFQAEIEIISQV-HHRHLVSLVGYCTFG 270 (369)
Q Consensus 199 ~~~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~ 270 (369)
...++|.+.+.||+|+||.||++... .+..+|||+++..... ..+.+.+|+++++++ +|+||++++++|...
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 44567889999999999999999742 2457999988765332 335789999999999 799999999999999
Q ss_pred CeeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccc
Q 017558 271 SQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLA 350 (369)
Q Consensus 271 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla 350 (369)
+..|+||||+.+|+|.++++......+++.+...++.|++.||+|||++ +++|+||||+|||++.++.+||+|||++
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCccc
Confidence 9999999999999999999765444589999999999999999999998 9999999999999999999999999999
Q ss_pred eeeCC
Q 017558 351 KHSLD 355 (369)
Q Consensus 351 ~~~~~ 355 (369)
+....
T Consensus 189 ~~~~~ 193 (302)
T cd05055 189 RDIMN 193 (302)
T ss_pred ccccC
Confidence 87654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.7e-26 Score=205.95 Aligned_cols=146 Identities=28% Similarity=0.406 Sum_probs=125.2
Q ss_pred ceecccCceEEEEEEEcC---CeEEEEEeeccCCcc-cHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEecCCC
Q 017558 208 NLLGQGGFGYVHKGVLTN---GKVVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNK 283 (369)
Q Consensus 208 ~~lg~G~fg~Vy~~~~~~---~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 283 (369)
+.||+|+||.||+|...+ +..+|+|.++..... ....+.+|+.++.+++|+||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 358999999999998643 357899988765432 3347889999999999999999999999989999999999999
Q ss_pred cHhhhhcCCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCC
Q 017558 284 TLEFHLHGKD---RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 284 ~L~~~l~~~~---~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~ 356 (369)
+|.++++... ...+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||+++...+.
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~ 153 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKE 153 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCc
Confidence 9999997532 22456778889999999999999998 9999999999999999999999999999765443
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.9e-27 Score=224.90 Aligned_cols=153 Identities=27% Similarity=0.467 Sum_probs=135.1
Q ss_pred cCCcccceecccCceEEEEEEEcC--C--eEEEEEeeccCCcc-cHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEE
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLTN--G--KVVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~~--~--~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 276 (369)
++....++||+|.||.|++|.|.. | ..||||+++.+... ...+|++|+.+|.+|+|+|+++|+|+..+ ....||
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV 188 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV 188 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence 344456889999999999999864 3 36899999887654 56799999999999999999999999986 778999
Q ss_pred EEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCC
Q 017558 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 277 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~ 356 (369)
||.++.|+|.+.|++.....|--...-.++.|||.||.||.++ ++|||||..+|+||-.-..+||+||||.|-+...
T Consensus 189 ~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 189 FELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred hhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 9999999999999985555677778889999999999999999 9999999999999999999999999999998776
Q ss_pred Cc
Q 017558 357 DT 358 (369)
Q Consensus 357 ~~ 358 (369)
+.
T Consensus 266 ed 267 (1039)
T KOG0199|consen 266 ED 267 (1039)
T ss_pred Cc
Confidence 54
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.5e-28 Score=210.59 Aligned_cols=160 Identities=32% Similarity=0.454 Sum_probs=140.6
Q ss_pred cCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEec
Q 017558 202 DNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 280 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 280 (369)
+-|.+.+.||+|+||.||++.. +.|+++|||.+-.+ .+.+++..||.+|.+++.++||+++|.|.....+|+|||||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 3456678999999999999985 45899999988643 45689999999999999999999999999999999999999
Q ss_pred CCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCCCcee
Q 017558 281 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 360 (369)
Q Consensus 281 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~~~~~ 360 (369)
.-|++.+.++.+. ..|.++++..++...++||+|||.. .-||||||+.||||+.+|.+||+|||.|..+.+.-..
T Consensus 111 GAGSiSDI~R~R~-K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK- 185 (502)
T KOG0574|consen 111 GAGSISDIMRARR-KPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK- 185 (502)
T ss_pred CCCcHHHHHHHhc-CCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHHh-
Confidence 9999999998654 4699999999999999999999998 8999999999999999999999999999988764333
Q ss_pred eeeecccC
Q 017558 361 STRVMGTF 368 (369)
Q Consensus 361 ~~~~~gt~ 368 (369)
..++.||+
T Consensus 186 RNTVIGTP 193 (502)
T KOG0574|consen 186 RNTVIGTP 193 (502)
T ss_pred hCccccCc
Confidence 34578875
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=8e-26 Score=207.84 Aligned_cols=150 Identities=33% Similarity=0.398 Sum_probs=133.4
Q ss_pred cCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC---cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEE
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 277 (369)
++|.+.+.||+|+||.||++... +++.+|+|.+.... ....+.+.+|++++++++|+||+++++++......|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46888999999999999999964 57899999986532 223456889999999999999999999999999999999
Q ss_pred EecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCC
Q 017558 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 278 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~ 356 (369)
||+++++|.+++... ..+++..+..++.|++.||.|||++ +++|+||+|+|||++.++.+||+|||+++...+.
T Consensus 81 e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 999999999999765 3588999999999999999999998 9999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.6e-26 Score=206.07 Aligned_cols=148 Identities=29% Similarity=0.421 Sum_probs=133.0
Q ss_pred cCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEec
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 280 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 280 (369)
++|...+.||+|+||.||+++.. +++.||+|.++.........+.+|+.++..++|+||+++++++...+..|+||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 46777889999999999999864 57899999987665444567889999999999999999999999999999999999
Q ss_pred CCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 281 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 281 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
++++|.+++.... .+++.+.+.++.|++.||.|||++ +++|+||||+||+++.++.+||+|||+++...
T Consensus 89 ~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06645 89 GGGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQIT 157 (267)
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEcc
Confidence 9999999986543 488999999999999999999998 99999999999999999999999999997654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-25 Score=202.51 Aligned_cols=152 Identities=22% Similarity=0.309 Sum_probs=134.2
Q ss_pred CCcccceecccCceEEEEEEE-cCCeEEEEEeeccCC--cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEe
Q 017558 203 NFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (369)
Q Consensus 203 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 279 (369)
+|+..+.||.|+||.||.++. .+++.+++|.+.... ....+++.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 478899999999999999885 457889999886542 23345788999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCCC
Q 017558 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (369)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~~ 357 (369)
+++++|.+++.......+++..+..++.|++.||.|||++ +++|+||+|+||++++++.+||+|||+++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 9999999999765445689999999999999999999998 99999999999999999999999999998765433
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.1e-26 Score=210.05 Aligned_cols=149 Identities=30% Similarity=0.583 Sum_probs=128.7
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCe--EEEEEeeccCC-cccHHHHHHHHHHHHhc-CCCccccEeeEEEeCCeeEE
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGK--VVAIKQLKAGS-GQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLL 275 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~l 275 (369)
.++|++.+.||+|+||.||+|... ++. .+++|.++... ....+.+.+|++++.++ +|+||+++++++..++..|+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 357888899999999999999964 343 46788776533 23345788999999999 89999999999999999999
Q ss_pred EEEecCCCcHhhhhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCc
Q 017558 276 VYEFVPNKTLEFHLHGKD--------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFE 341 (369)
Q Consensus 276 v~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~ 341 (369)
||||+++++|.++++... ...+++.+++.++.|++.||+|||++ +++||||||+|||+++++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCc
Confidence 999999999999997532 13578999999999999999999998 9999999999999999999
Q ss_pred EEEeeecccee
Q 017558 342 AKVADFGLAKH 352 (369)
Q Consensus 342 ~ki~DFGla~~ 352 (369)
+||+|||+++.
T Consensus 163 ~kl~dfg~~~~ 173 (303)
T cd05088 163 AKIADFGLSRG 173 (303)
T ss_pred EEeCccccCcc
Confidence 99999999964
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-25 Score=202.81 Aligned_cols=151 Identities=28% Similarity=0.364 Sum_probs=134.4
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEeeccC--CcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEe
Q 017558 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (369)
Q Consensus 203 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 279 (369)
+|...+.||+|+||.||++... +++.|++|.+... ......++.+|++++++++|+||+++++++..++..|+||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4777899999999999999964 5789999998643 233456788999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCC
Q 017558 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~ 356 (369)
+++++|.++++......+++...+.++.|++.||.|||++ +++|+|||++||++++++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~ 154 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN 154 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence 9999999999875445689999999999999999999998 9999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-25 Score=207.03 Aligned_cols=150 Identities=29% Similarity=0.457 Sum_probs=134.2
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEe
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 279 (369)
.++|++.+.||.|+||.||+|+.. ++..+++|.+........+.+.+|++++++++|+||+++++++..++..|+||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 467888999999999999999965 4789999998766555566789999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
+++++|..++.... ..+++..+..++.|++.+|.|||++ +++||||||+||+++.++.+||+|||+++...
T Consensus 91 ~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 161 (292)
T cd06644 91 CPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNV 161 (292)
T ss_pred CCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceecc
Confidence 99999988876433 3589999999999999999999998 99999999999999999999999999987643
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.8e-26 Score=206.44 Aligned_cols=150 Identities=30% Similarity=0.519 Sum_probs=127.1
Q ss_pred cCCcccceecccCceEEEEEEEc-CCe----EEEEEeeccCCcc-cHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEE
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLT-NGK----VVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 275 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~----~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 275 (369)
++|++.+.||+|+||.||+|.+. +++ .+++|.+...... ...++..|+.++++++|+||+++++++. ....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 56778899999999999999964 333 4778887544322 2357788888999999999999999885 456789
Q ss_pred EEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 276 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 276 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
++||+++|+|.+++.... ..+++.....++.||+.||.|||++ +++||||||+|||+++++.+||+|||+++....
T Consensus 86 i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred EEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 999999999999997543 3589999999999999999999998 899999999999999999999999999987654
Q ss_pred C
Q 017558 356 T 356 (369)
Q Consensus 356 ~ 356 (369)
.
T Consensus 162 ~ 162 (279)
T cd05111 162 D 162 (279)
T ss_pred C
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.4e-26 Score=206.15 Aligned_cols=152 Identities=30% Similarity=0.456 Sum_probs=131.9
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcccHHHHHHHHHHHHhc-CCCccccEeeEEEeC------C
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHRHLVSLVGYCTFG------S 271 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~------~ 271 (369)
+.+.|+..+.||+|+||.||+|... +++.||+|.+.... .....+..|+.++.++ +|+||++++++|... .
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 4566888899999999999999864 47889999986543 3346788999999998 699999999998753 4
Q ss_pred eeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccce
Q 017558 272 QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351 (369)
Q Consensus 272 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~ 351 (369)
..|++|||+.+++|.+++.......+++..+..++.|++.||.|||++ +|+|+|||++||++++++.+||+|||+++
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~~ 159 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSA 159 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCce
Confidence 679999999999999999865445689999999999999999999998 99999999999999999999999999998
Q ss_pred eeCC
Q 017558 352 HSLD 355 (369)
Q Consensus 352 ~~~~ 355 (369)
....
T Consensus 160 ~~~~ 163 (272)
T cd06637 160 QLDR 163 (272)
T ss_pred eccc
Confidence 7543
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.3e-26 Score=208.62 Aligned_cols=152 Identities=27% Similarity=0.513 Sum_probs=133.4
Q ss_pred cCCcccceecccCceEEEEEEEc------CCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEE
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 275 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 275 (369)
.+|.+.+.||+|+||.||+++.. ++..+++|.++.......+.+.+|++++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 45778899999999999999842 345689999876655555689999999999999999999999999999999
Q ss_pred EEEecCCCcHhhhhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCc
Q 017558 276 VYEFVPNKTLEFHLHGKD--------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFE 341 (369)
Q Consensus 276 v~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~ 341 (369)
||||+++++|.+++.... ...+++..++.++.||+.||+|||++ +++||||||+|||+++++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCc
Confidence 999999999999996532 23478999999999999999999998 9999999999999999999
Q ss_pred EEEeeeccceeeCCC
Q 017558 342 AKVADFGLAKHSLDT 356 (369)
Q Consensus 342 ~ki~DFGla~~~~~~ 356 (369)
+||+|||+++.....
T Consensus 162 ~~l~dfg~a~~~~~~ 176 (291)
T cd05094 162 VKIGDFGMSRDVYST 176 (291)
T ss_pred EEECCCCcccccCCC
Confidence 999999999876543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-25 Score=204.50 Aligned_cols=149 Identities=26% Similarity=0.434 Sum_probs=124.6
Q ss_pred cccceecccCceEEEEEEEcCC---eEEEEEeeccCC--cccHHHHHHHHHHHHhcCCCccccEeeEEEeC------Cee
Q 017558 205 SEANLLGQGGFGYVHKGVLTNG---KVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFG------SQR 273 (369)
Q Consensus 205 ~~~~~lg~G~fg~Vy~~~~~~~---~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~ 273 (369)
.+.+.||+|+||.||+|++... ..+|+|.++... ....+.+.+|++++.+++|+||++++++|... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 4568899999999999997543 258999886542 23345788999999999999999999988532 246
Q ss_pred EEEEEecCCCcHhhhhcCC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeecc
Q 017558 274 LLVYEFVPNKTLEFHLHGK----DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGL 349 (369)
Q Consensus 274 ~lv~e~~~~g~L~~~l~~~----~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGl 349 (369)
+++|||+++|+|.+++... ....+++.....++.|++.||.|||++ +|+||||||+|||+++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCc
Confidence 8999999999999887422 223478999999999999999999998 999999999999999999999999999
Q ss_pred ceeeCCC
Q 017558 350 AKHSLDT 356 (369)
Q Consensus 350 a~~~~~~ 356 (369)
++.....
T Consensus 159 ~~~~~~~ 165 (272)
T cd05075 159 SKKIYNG 165 (272)
T ss_pred ccccCcc
Confidence 9876543
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.8e-26 Score=210.17 Aligned_cols=154 Identities=27% Similarity=0.492 Sum_probs=133.0
Q ss_pred HhhcCCcccceecccCceEEEEEEEc--------CCeEEEEEeeccCC-cccHHHHHHHHHHHHhc-CCCccccEeeEEE
Q 017558 199 IATDNFSEANLLGQGGFGYVHKGVLT--------NGKVVAIKQLKAGS-GQGEREFQAEIEIISQV-HHRHLVSLVGYCT 268 (369)
Q Consensus 199 ~~~~~~~~~~~lg~G~fg~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~ 268 (369)
+..++|.+.+.||+|+||.||+++.. ++..||+|.++... ....+++.+|+.++..+ +|+||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 45677888999999999999999742 23579999887543 23346789999999999 7999999999999
Q ss_pred eCCeeEEEEEecCCCcHhhhhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcE
Q 017558 269 FGSQRLLVYEFVPNKTLEFHLHGKD--------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANI 334 (369)
Q Consensus 269 ~~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Ni 334 (369)
.....|+||||+++|+|.+++.... ...+++..++.++.||+.||.|||++ +++||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceE
Confidence 9999999999999999999997532 13478888999999999999999998 999999999999
Q ss_pred EECCCCcEEEeeeccceeeCC
Q 017558 335 LLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 335 ll~~~~~~ki~DFGla~~~~~ 355 (369)
|+++++.+||+|||+++....
T Consensus 169 li~~~~~~kl~D~g~~~~~~~ 189 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNN 189 (304)
T ss_pred EEcCCCcEEECCCccceeccc
Confidence 999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.3e-26 Score=208.33 Aligned_cols=152 Identities=25% Similarity=0.476 Sum_probs=131.4
Q ss_pred hcCCcccceecccCceEEEEEEEc-----------------CCeEEEEEeeccCCc-ccHHHHHHHHHHHHhcCCCcccc
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-----------------NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVS 262 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-----------------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~ 262 (369)
.++|++.+.||+|+||.||++... +...+|+|.++.... ...+++.+|++++.+++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 457889999999999999998642 234689999876532 33467999999999999999999
Q ss_pred EeeEEEeCCeeEEEEEecCCCcHhhhhcCCCC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCc
Q 017558 263 LVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDR---------PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSAN 333 (369)
Q Consensus 263 l~g~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~N 333 (369)
+++++...+..++||||+++++|.+++..... ..+++...+.++.|++.||+|||++ +++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhe
Confidence 99999999999999999999999999875321 2367888999999999999999998 99999999999
Q ss_pred EEECCCCcEEEeeeccceeeCC
Q 017558 334 ILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 334 ill~~~~~~ki~DFGla~~~~~ 355 (369)
||+++++.+||+|||+++.+..
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~ 182 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYS 182 (296)
T ss_pred EEEcCCCCEEeccCcccccccC
Confidence 9999999999999999987544
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-25 Score=202.68 Aligned_cols=149 Identities=29% Similarity=0.484 Sum_probs=131.1
Q ss_pred hcCCcccceecccCceEEEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEE-eCCeeEEEEEe
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCT-FGSQRLLVYEF 279 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~~~lv~e~ 279 (369)
.++|.+.+.||+|+||.||++... +..+++|.++... ..+.+.+|+.++++++|+||+++++++. .++..+++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 457888999999999999999874 7789999886543 3457899999999999999999999865 45678999999
Q ss_pred cCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
+++++|.+++.......+++..++.++.||+.||+|||++ +++||||||+||++++++.+||+|||+++....
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 154 (256)
T cd05082 82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 154 (256)
T ss_pred CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccc
Confidence 9999999999866555688999999999999999999998 999999999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.1e-26 Score=210.87 Aligned_cols=154 Identities=27% Similarity=0.480 Sum_probs=132.8
Q ss_pred HhhcCCcccceecccCceEEEEEEEc--------CCeEEEEEeeccCC-cccHHHHHHHHHHHHhc-CCCccccEeeEEE
Q 017558 199 IATDNFSEANLLGQGGFGYVHKGVLT--------NGKVVAIKQLKAGS-GQGEREFQAEIEIISQV-HHRHLVSLVGYCT 268 (369)
Q Consensus 199 ~~~~~~~~~~~lg~G~fg~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~ 268 (369)
+..++|.+.+.||+|+||.||++... ....+|+|.++... .....++.+|++++.++ +|+||++++++|.
T Consensus 15 ~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (307)
T cd05098 15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 94 (307)
T ss_pred eehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 34567899999999999999999752 23469999987643 23345788899999999 7999999999999
Q ss_pred eCCeeEEEEEecCCCcHhhhhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcE
Q 017558 269 FGSQRLLVYEFVPNKTLEFHLHGKD--------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANI 334 (369)
Q Consensus 269 ~~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Ni 334 (369)
..+..|+||||+++|+|.+++.... ...+++.++++++.|++.||+|||++ +++||||||+||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Ni 171 (307)
T cd05098 95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV 171 (307)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHhe
Confidence 9999999999999999999997532 13488999999999999999999998 999999999999
Q ss_pred EECCCCcEEEeeeccceeeCC
Q 017558 335 LLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 335 ll~~~~~~ki~DFGla~~~~~ 355 (369)
|++.++.+||+|||+++....
T Consensus 172 ll~~~~~~kL~dfg~a~~~~~ 192 (307)
T cd05098 172 LVTEDNVMKIADFGLARDIHH 192 (307)
T ss_pred EEcCCCcEEECCCcccccccc
Confidence 999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-27 Score=226.54 Aligned_cols=150 Identities=27% Similarity=0.411 Sum_probs=132.4
Q ss_pred cCCcccceecccCceEEEEEEEcCC-eEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEec
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLTNG-KVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 280 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 280 (369)
+-|.++..||.|+||+||+++.++. ...|.|.+........++|.-||+||+.++||+||+|++.|+.++.+||++|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 3455567799999999999997653 456788887777777889999999999999999999999999999999999999
Q ss_pred CCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 281 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 281 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
.||-.+..+..-+ ..|.+.++..+++|++.||.|||++ +|||||||+.|||++-+|.++|+|||.+.....
T Consensus 112 ~GGAVDaimlEL~-r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~ 182 (1187)
T KOG0579|consen 112 GGGAVDAIMLELG-RVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS 182 (1187)
T ss_pred CCchHhHHHHHhc-cccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchh
Confidence 9999887765444 4699999999999999999999999 999999999999999999999999999876544
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-25 Score=200.99 Aligned_cols=150 Identities=20% Similarity=0.332 Sum_probs=133.3
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC-cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEec
Q 017558 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 280 (369)
Q Consensus 203 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 280 (369)
+|++.+.||+|+||.||++... +++.+|+|.++... ....+.+.+|+.++++++|+||+++++++..++..|++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4778899999999999999964 57889999986533 234467889999999999999999999999999999999999
Q ss_pred CCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 281 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 281 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
++++|.+++.......+++...+.++.|++.||.|||++ +++|+||||+||++++++.++|+|||+++....
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 152 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS 152 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeecc
Confidence 999999998755445688999999999999999999998 999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5e-26 Score=207.59 Aligned_cols=142 Identities=28% Similarity=0.377 Sum_probs=120.8
Q ss_pred eecccCceEEEEEEEcC-------------------------CeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccE
Q 017558 209 LLGQGGFGYVHKGVLTN-------------------------GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSL 263 (369)
Q Consensus 209 ~lg~G~fg~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 263 (369)
.||+|+||.||+|.+.. ...|++|.+.........+|.+|+.++++++|+||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 59999999999997421 13588898865544444578899999999999999999
Q ss_pred eeEEEeCCeeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCC---
Q 017558 264 VGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF--- 340 (369)
Q Consensus 264 ~g~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~--- 340 (369)
+++|......++||||+++|+|..++.... ..+++..++.++.||++||+|||++ +|+||||||+|||+++++
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK-GRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCccc
Confidence 999999999999999999999999986533 3588999999999999999999998 999999999999997643
Q ss_pred ----cEEEeeeccceeeC
Q 017558 341 ----EAKVADFGLAKHSL 354 (369)
Q Consensus 341 ----~~ki~DFGla~~~~ 354 (369)
.+|++|||+++...
T Consensus 158 ~~~~~~kl~d~g~~~~~~ 175 (274)
T cd05076 158 GTSPFIKLSDPGVSFTAL 175 (274)
T ss_pred CccceeeecCCccccccc
Confidence 48999999986543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.2e-26 Score=204.13 Aligned_cols=142 Identities=30% Similarity=0.453 Sum_probs=123.7
Q ss_pred ceecccCceEEEEEEEcCCe-----------EEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEE
Q 017558 208 NLLGQGGFGYVHKGVLTNGK-----------VVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (369)
Q Consensus 208 ~~lg~G~fg~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 276 (369)
+.||+|+||.||+|...+.. .+++|.+...... ...+.+|+.++++++|+||++++++|.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999975432 4778877654433 5788999999999999999999999988 778999
Q ss_pred EEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCC-------cEEEeeecc
Q 017558 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF-------EAKVADFGL 349 (369)
Q Consensus 277 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~-------~~ki~DFGl 349 (369)
|||+++|+|.+++..... .+++..++.++.||+.||+|||++ +++||||||+|||++.++ .+||+|||+
T Consensus 79 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 999999999999976542 588999999999999999999998 999999999999999887 799999999
Q ss_pred ceeeCC
Q 017558 350 AKHSLD 355 (369)
Q Consensus 350 a~~~~~ 355 (369)
++....
T Consensus 155 a~~~~~ 160 (259)
T cd05037 155 PITVLS 160 (259)
T ss_pred cccccc
Confidence 987554
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.94 E-value=9e-26 Score=206.24 Aligned_cols=155 Identities=22% Similarity=0.436 Sum_probs=134.5
Q ss_pred hhcCCcccceecccCceEEEEEEEcC-----CeEEEEEeeccCCc-ccHHHHHHHHHHHHhcCCCccccEeeEEEe-CCe
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVLTN-----GKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTF-GSQ 272 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~ 272 (369)
..++|.+.+.||+|+||.||+|.... +..|++|.++.... ...+.+.+|+.++.+++|+||+++++++.. ...
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 45788889999999999999999765 68899998875432 334578899999999999999999999876 467
Q ss_pred eEEEEEecCCCcHhhhhcCCCC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEee
Q 017558 273 RLLVYEFVPNKTLEFHLHGKDR------PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVAD 346 (369)
Q Consensus 273 ~~lv~e~~~~g~L~~~l~~~~~------~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~D 346 (369)
.++++||+++++|.+++..... ..+++..++.++.|++.||+|||++ +++||||||+|||+++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECC
Confidence 8999999999999999865322 4588999999999999999999998 999999999999999999999999
Q ss_pred eccceeeCCCC
Q 017558 347 FGLAKHSLDTD 357 (369)
Q Consensus 347 FGla~~~~~~~ 357 (369)
||+++.+...+
T Consensus 161 ~g~~~~~~~~~ 171 (280)
T cd05043 161 NALSRDLFPMD 171 (280)
T ss_pred CCCcccccCCc
Confidence 99998765443
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-25 Score=203.90 Aligned_cols=151 Identities=28% Similarity=0.459 Sum_probs=128.4
Q ss_pred CcccceecccCceEEEEEEEcC----CeEEEEEeeccCCc--ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCe-----
Q 017558 204 FSEANLLGQGGFGYVHKGVLTN----GKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQ----- 272 (369)
Q Consensus 204 ~~~~~~lg~G~fg~Vy~~~~~~----~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~----- 272 (369)
|.+.+.||+|+||.||+|.... +..||+|+++.... .....+.+|+++++.++|+||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4567899999999999998642 36799999875432 234578999999999999999999999876554
Q ss_pred -eEEEEEecCCCcHhhhhcCC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeee
Q 017558 273 -RLLVYEFVPNKTLEFHLHGK----DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADF 347 (369)
Q Consensus 273 -~~lv~e~~~~g~L~~~l~~~----~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DF 347 (369)
.+++|||+++|+|..++... ....+++.....++.|++.||.|||++ +++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 78999999999999988543 223588999999999999999999998 9999999999999999999999999
Q ss_pred ccceeeCCCC
Q 017558 348 GLAKHSLDTD 357 (369)
Q Consensus 348 Gla~~~~~~~ 357 (369)
|+++.....+
T Consensus 158 g~~~~~~~~~ 167 (273)
T cd05035 158 GLSKKIYSGD 167 (273)
T ss_pred cceeeccccc
Confidence 9999765443
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.9e-26 Score=207.00 Aligned_cols=151 Identities=28% Similarity=0.418 Sum_probs=135.2
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEe
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 279 (369)
.++|++.+.||.|+||.||++... ++..+|+|.++.......+.+.+|++++++++|+||+++++++..+...|+||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 456888899999999999999964 5789999998766555556899999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
+++++|.+++.... ..+++..+..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++.....
T Consensus 84 ~~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~ 155 (280)
T cd06611 84 CDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKS 155 (280)
T ss_pred cCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhcc
Confidence 99999999986543 3589999999999999999999998 999999999999999999999999999876543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-26 Score=219.01 Aligned_cols=145 Identities=23% Similarity=0.283 Sum_probs=128.6
Q ss_pred CcccceecccCceEEEEEEE-cCCeEEEEEeeccCCcc---cHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEe
Q 017558 204 FSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQ---GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (369)
Q Consensus 204 ~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 279 (369)
|..++.||-|+||+|+++.. .+...||.|.+++.+.. .....+.|-+||+..+.+-||+|+-.|.+++.+|+||||
T Consensus 631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdY 710 (1034)
T KOG0608|consen 631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY 710 (1034)
T ss_pred eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEec
Confidence 66788999999999999984 44678999999875432 223567899999999999999999999999999999999
Q ss_pred cCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceee
Q 017558 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (369)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~ 353 (369)
++||++..+|.+.+ .|.++.+.+++.+++.|+++.|.. |+|||||||.|||||.+|++||+|||||--+
T Consensus 711 IPGGDmMSLLIrmg--IFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGf 779 (1034)
T KOG0608|consen 711 IPGGDMMSLLIRMG--IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGF 779 (1034)
T ss_pred cCCccHHHHHHHhc--cCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccc
Confidence 99999999997654 588889999999999999999998 9999999999999999999999999999644
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=206.95 Aligned_cols=149 Identities=31% Similarity=0.471 Sum_probs=131.8
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcc-----cHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEE
Q 017558 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ-----GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (369)
Q Consensus 203 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 276 (369)
+|...+.||+|+||.||+|... +++.|+||+++..... ....+..|++++.+++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4777889999999999999964 5789999999765322 234577899999999999999999999999999999
Q ss_pred EEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCC
Q 017558 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 277 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~ 356 (369)
|||+ +++|.+++.... ..+++..++.++.||++||.|||++ +++|+||||+|||++.++.+||+|||+++.....
T Consensus 81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 9999 999999997654 3589999999999999999999998 9999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.6e-26 Score=206.90 Aligned_cols=152 Identities=28% Similarity=0.500 Sum_probs=133.7
Q ss_pred hcCCcccceecccCceEEEEEEEc------CCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeE
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRL 274 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 274 (369)
..+|...+.||+|+||.||++... ++..+++|.++.......+.+.+|++++.+++|+||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 356777899999999999999742 35678999887666555678999999999999999999999999999999
Q ss_pred EEEEecCCCcHhhhhcCCCC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCc
Q 017558 275 LVYEFVPNKTLEFHLHGKDR-------------PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFE 341 (369)
Q Consensus 275 lv~e~~~~g~L~~~l~~~~~-------------~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~ 341 (369)
++|||+++++|.++++.... ..+++..++.++.|++.||+|||++ +++||||||+|||+++++.
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCC
Confidence 99999999999999875421 2478999999999999999999998 9999999999999999999
Q ss_pred EEEeeeccceeeCC
Q 017558 342 AKVADFGLAKHSLD 355 (369)
Q Consensus 342 ~ki~DFGla~~~~~ 355 (369)
+||+|||+++....
T Consensus 161 ~kL~dfg~~~~~~~ 174 (280)
T cd05092 161 VKIGDFGMSRDIYS 174 (280)
T ss_pred EEECCCCceeEcCC
Confidence 99999999986643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-25 Score=204.69 Aligned_cols=150 Identities=33% Similarity=0.526 Sum_probs=131.5
Q ss_pred cCCcccceecccCceEEEEEEEcC-C---eEEEEEeeccCC-cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEE
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLTN-G---KVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~~-~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 276 (369)
.+|++.+.||+|+||.||+|.... + ..||||.++... ....++|..|++++++++||||+++++++..+...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 457788999999999999999643 2 369999987543 23346899999999999999999999999999999999
Q ss_pred EEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 277 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
|||+++++|.+++.... ..+++.+++.++.|++.||.|||++ +++|+||||+|||++.++.+||+|||+++....
T Consensus 84 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 84 TEFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCcccccccc
Confidence 99999999999987543 3588999999999999999999998 999999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-25 Score=204.19 Aligned_cols=150 Identities=25% Similarity=0.379 Sum_probs=132.2
Q ss_pred cCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCc--ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEE
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 278 (369)
++|+..+.||+|+||.||++... +++.||+|++..... ...+.+.+|++++.+++|+||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888899999999999999975 578999999865432 233568899999999999999999999999999999999
Q ss_pred ecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCC
Q 017558 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~ 356 (369)
|++++.|..++... ..+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEKNP--RGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 99999998877543 3489999999999999999999998 9999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.5e-26 Score=210.12 Aligned_cols=155 Identities=27% Similarity=0.494 Sum_probs=132.8
Q ss_pred HHhhcCCcccceecccCceEEEEEEEc--------CCeEEEEEeeccCCc-ccHHHHHHHHHHHHhc-CCCccccEeeEE
Q 017558 198 KIATDNFSEANLLGQGGFGYVHKGVLT--------NGKVVAIKQLKAGSG-QGEREFQAEIEIISQV-HHRHLVSLVGYC 267 (369)
Q Consensus 198 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~g~~ 267 (369)
....++|.+.+.||+|+||.||+++.. ....+|+|.++.... ....++..|++++.++ +|+||++++++|
T Consensus 8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (314)
T cd05099 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVC 87 (314)
T ss_pred cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence 344567888999999999999999742 245789998875432 3345788999999999 699999999999
Q ss_pred EeCCeeEEEEEecCCCcHhhhhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCc
Q 017558 268 TFGSQRLLVYEFVPNKTLEFHLHGKD--------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSAN 333 (369)
Q Consensus 268 ~~~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~N 333 (369)
...+..|++|||+++|+|.+++.... ...+++.+++.++.||+.||.|||++ +++||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~N 164 (314)
T cd05099 88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARN 164 (314)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeecccccee
Confidence 99999999999999999999996532 23488999999999999999999998 99999999999
Q ss_pred EEECCCCcEEEeeeccceeeCC
Q 017558 334 ILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 334 ill~~~~~~ki~DFGla~~~~~ 355 (369)
||+++++.+||+|||+++....
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~ 186 (314)
T cd05099 165 VLVTEDNVMKIADFGLARGVHD 186 (314)
T ss_pred EEEcCCCcEEEccccccccccc
Confidence 9999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=204.90 Aligned_cols=147 Identities=27% Similarity=0.446 Sum_probs=130.9
Q ss_pred CcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEecCC
Q 017558 204 FSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPN 282 (369)
Q Consensus 204 ~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 282 (369)
|+..+.||+|+||.||++... ++..+++|.+........+.+.+|++++..++|+||++++++|..++..|+||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 566788999999999999965 4678899988765555556788999999999999999999999999999999999999
Q ss_pred CcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 283 KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 283 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
++|..++.... ..+++..+..++.|++.||.|||+. +++||||||+|||++.++.+||+|||+++...
T Consensus 87 ~~l~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~ 154 (282)
T cd06643 87 GAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNT 154 (282)
T ss_pred CcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccc
Confidence 99998886533 3589999999999999999999998 99999999999999999999999999997654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.8e-26 Score=206.54 Aligned_cols=154 Identities=27% Similarity=0.478 Sum_probs=133.5
Q ss_pred hhcCCcccceecccCceEEEEEEEcC------CeEEEEEeeccCCc-ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCe
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVLTN------GKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQ 272 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 272 (369)
..++|.+.+.||+|+||.||+|.... +..||+|.+..... .....+.+|+.++..++|+||+++++++.....
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 45688889999999999999998642 36799999865432 334578899999999999999999999999999
Q ss_pred eEEEEEecCCCcHhhhhcCCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEE
Q 017558 273 RLLVYEFVPNKTLEFHLHGKD--------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKV 344 (369)
Q Consensus 273 ~~lv~e~~~~g~L~~~l~~~~--------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki 344 (369)
.++||||+++|+|.+++.... ...+.+..++.++.||+.||.|||+. +++||||||+|||++.++.+||
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEE
Confidence 999999999999999986432 22468889999999999999999998 9999999999999999999999
Q ss_pred eeeccceeeCCC
Q 017558 345 ADFGLAKHSLDT 356 (369)
Q Consensus 345 ~DFGla~~~~~~ 356 (369)
+|||+++.....
T Consensus 161 ~dfg~~~~~~~~ 172 (277)
T cd05032 161 GDFGMTRDIYET 172 (277)
T ss_pred CCcccchhhccC
Confidence 999999876544
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-25 Score=204.17 Aligned_cols=145 Identities=23% Similarity=0.387 Sum_probs=128.0
Q ss_pred cCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCC-cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEe
Q 017558 202 DNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 279 (369)
++|+..++||+|+||.||+|.. .+++.||+|.+.... ....+++.+|++++.+++|+||++++++|...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 4678889999999999999985 467889999986543 23345788999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
+++++|..+. .+++.....++.|++.||.|||++ +++|+||||+|||++.++.+||+|||+++....
T Consensus 81 ~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~ 147 (279)
T cd06619 81 MDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN 147 (279)
T ss_pred CCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccc
Confidence 9999997653 367888899999999999999998 999999999999999999999999999987543
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-25 Score=201.60 Aligned_cols=148 Identities=28% Similarity=0.449 Sum_probs=130.9
Q ss_pred cCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCCcc-----cHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEE
Q 017558 202 DNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQ-----GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 275 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 275 (369)
++|...+.||+|+||.||++.. .+++.+++|.+...... ....+.+|++++.+++|+||+++++++..++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5688899999999999999985 45789999988643211 23468899999999999999999999999999999
Q ss_pred EEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 276 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 276 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
||||+++++|.+++... ..+++.....++.|++.||.|||+. +++||||+|+||++++++.+||+|||+++...
T Consensus 82 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 99999999999998654 3478889999999999999999998 99999999999999999999999999998654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=204.74 Aligned_cols=150 Identities=27% Similarity=0.465 Sum_probs=129.5
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCe----EEEEEeeccCCc-ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeE
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGK----VVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRL 274 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 274 (369)
.++|+..+.||+|+||.||+|++. ++. .||+|.++.... ...+++.+|+.++..++|+||++++++|.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 467888999999999999999853 343 489999875433 334578899999999999999999999975 4578
Q ss_pred EEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 275 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 275 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
++|||+++|+|.++++... ..+++...+.++.||+.||.|||++ +++||||||+|||+++++.+||+|||+++...
T Consensus 85 l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred EEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeecc
Confidence 9999999999999997543 3589999999999999999999998 99999999999999999999999999998765
Q ss_pred C
Q 017558 355 D 355 (369)
Q Consensus 355 ~ 355 (369)
.
T Consensus 161 ~ 161 (279)
T cd05109 161 I 161 (279)
T ss_pred c
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=206.78 Aligned_cols=154 Identities=26% Similarity=0.495 Sum_probs=133.8
Q ss_pred hcCCcccceecccCceEEEEEEEcC-----------------CeEEEEEeeccCCc-ccHHHHHHHHHHHHhcCCCcccc
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLTN-----------------GKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVS 262 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~~-----------------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~ 262 (369)
.++|++.+.||+|+||.||++.... +..||+|.+..... ...+.+.+|++++.+++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4678889999999999999988532 24689999876543 33467899999999999999999
Q ss_pred EeeEEEeCCeeEEEEEecCCCcHhhhhcCCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCc
Q 017558 263 LVGYCTFGSQRLLVYEFVPNKTLEFHLHGKD---------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSAN 333 (369)
Q Consensus 263 l~g~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~N 333 (369)
++++|..++..+++|||+++++|.+++.... ...+++..++.++.|++.||.|||++ +++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence 9999999999999999999999999987543 12588999999999999999999998 99999999999
Q ss_pred EEECCCCcEEEeeeccceeeCCCC
Q 017558 334 ILLDDSFEAKVADFGLAKHSLDTD 357 (369)
Q Consensus 334 ill~~~~~~ki~DFGla~~~~~~~ 357 (369)
|++++++.+||+|||+++.....+
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~ 184 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSD 184 (296)
T ss_pred eeecCCCceEEccccceeecccCc
Confidence 999999999999999998765443
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=206.92 Aligned_cols=149 Identities=25% Similarity=0.380 Sum_probs=134.4
Q ss_pred hcCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEe
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 279 (369)
..+|...+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.+++.++|+||++++++|...+..|+||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 36788899999999999999995 46889999999766555556788999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
+++++|.+++.. ..+++..+..++.|++.||.|||+. +++||||||+|||++.++.+||+|||+++....
T Consensus 98 ~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~ 167 (297)
T cd06656 98 LAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (297)
T ss_pred cCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccC
Confidence 999999999864 2478899999999999999999998 999999999999999999999999999987543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.6e-25 Score=210.59 Aligned_cols=145 Identities=23% Similarity=0.328 Sum_probs=126.2
Q ss_pred HhhcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEE
Q 017558 199 IATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (369)
Q Consensus 199 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 277 (369)
....+|++.+.||+|+||.||+|+.. ++..||+|..... ....|+.++.+++|+||+++++++......++||
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 34567999999999999999999975 4578899975432 3456999999999999999999999999999999
Q ss_pred EecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 278 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
||+. ++|.+++.... ..+++..++.|+.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 137 e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 208 (357)
T PHA03209 137 PHYS-SDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPV 208 (357)
T ss_pred EccC-CcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccc
Confidence 9994 68888886543 3589999999999999999999998 99999999999999999999999999998543
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=206.19 Aligned_cols=151 Identities=29% Similarity=0.511 Sum_probs=129.7
Q ss_pred CCcccceecccCceEEEEEEEc------CCeEEEEEeeccCCc-ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEE
Q 017558 203 NFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 275 (369)
Q Consensus 203 ~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 275 (369)
+|++.+.||+|+||.||+|+.. ....+++|.+..... ...+++.+|++++++++||||+++++.|..++..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4777899999999999999853 235788888865443 234578899999999999999999999999999999
Q ss_pred EEEecCCCcHhhhhcCCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCc
Q 017558 276 VYEFVPNKTLEFHLHGKD----------------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSAN 333 (369)
Q Consensus 276 v~e~~~~g~L~~~l~~~~----------------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~N 333 (369)
+|||+.+++|.+++.... ...+++...+.++.|++.||+|||++ +++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence 999999999999986421 12478899999999999999999998 99999999999
Q ss_pred EEECCCCcEEEeeeccceeeCCC
Q 017558 334 ILLDDSFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 334 ill~~~~~~ki~DFGla~~~~~~ 356 (369)
||+++++.+||+|||+++.....
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~ 180 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEE 180 (290)
T ss_pred EEEcCCCcEEeccccccccccCc
Confidence 99999999999999999876443
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=215.92 Aligned_cols=146 Identities=26% Similarity=0.321 Sum_probs=127.6
Q ss_pred hhcCCcccceecccCceEEEEEEEc---CCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEE
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVLT---NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 276 (369)
...+|.+.+.||+|+||.||++... .+..|++|.+... +.+.+|+++|++++|+||+++++++......|+|
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 164 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV 164 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence 3467999999999999999999753 3567899987643 3456899999999999999999999999999999
Q ss_pred EEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCC
Q 017558 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 277 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~ 356 (369)
|||+. ++|.+++... ..+++..++.|+.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 165 ~e~~~-~~l~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 165 MPKYK-CDLFTYVDRS--GPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred ehhcC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 99995 6888888432 4589999999999999999999998 9999999999999999999999999999876543
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=207.13 Aligned_cols=148 Identities=28% Similarity=0.567 Sum_probs=128.3
Q ss_pred cCCcccceecccCceEEEEEEEcC-C--eEEEEEeeccCC-cccHHHHHHHHHHHHhc-CCCccccEeeEEEeCCeeEEE
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLTN-G--KVVAIKQLKAGS-GQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLV 276 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~~-~--~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv 276 (369)
++|++.+.||+|+||.||+|...+ + ..+++|.++... ....+.+.+|++++.++ +||||+++++++...+..|+|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578889999999999999998754 3 247888887532 23345789999999999 799999999999999999999
Q ss_pred EEecCCCcHhhhhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcE
Q 017558 277 YEFVPNKTLEFHLHGKD--------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEA 342 (369)
Q Consensus 277 ~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ 342 (369)
|||+++++|.++++... ...+++..++.++.|++.||+|||++ +++||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence 99999999999996532 12478899999999999999999998 99999999999999999999
Q ss_pred EEeeecccee
Q 017558 343 KVADFGLAKH 352 (369)
Q Consensus 343 ki~DFGla~~ 352 (369)
||+|||+++.
T Consensus 159 kl~dfg~~~~ 168 (297)
T cd05089 159 KIADFGLSRG 168 (297)
T ss_pred EECCcCCCcc
Confidence 9999999874
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-25 Score=201.98 Aligned_cols=151 Identities=21% Similarity=0.329 Sum_probs=131.6
Q ss_pred cCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC---cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEE
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 277 (369)
++|++.+.||+|+||.||+|+.. +++.||||.++... ......+.+|++++++++|+||+++++++...+..+++|
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57888999999999999999954 67899999876432 222346889999999999999999999999999999999
Q ss_pred EecCCCcHhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 278 EFVPNKTLEFHLHGK--DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 278 e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
||+++++|.+++... ....+++...+.++.|++.||.|||++ +++|+||||+|||++.++.++|+|||+++....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 999999999888532 223478889999999999999999998 999999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=203.30 Aligned_cols=154 Identities=29% Similarity=0.377 Sum_probs=133.7
Q ss_pred HHHhhcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEE
Q 017558 197 LKIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 275 (369)
Q Consensus 197 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 275 (369)
++..++++.....||+|+||.||+|... ++..|++|.+........+.+.+|++++++++|+||+++++++..++..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 3445666766788999999999999954 567899999877665566789999999999999999999999999999999
Q ss_pred EEEecCCCcHhhhhcCCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECC-CCcEEEeeecccee
Q 017558 276 VYEFVPNKTLEFHLHGKDRPVM--NWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD-SFEAKVADFGLAKH 352 (369)
Q Consensus 276 v~e~~~~g~L~~~l~~~~~~~l--~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~-~~~~ki~DFGla~~ 352 (369)
||||+++++|.+++..... .+ .+..+..++.||+.||.|||++ +|+||||||+||+++. ++.+||+|||+++.
T Consensus 83 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~ 158 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWG-PLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKR 158 (268)
T ss_pred EEecCCCCCHHHHHHHhcc-cCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence 9999999999999975422 24 7788889999999999999998 9999999999999986 67999999999976
Q ss_pred eC
Q 017558 353 SL 354 (369)
Q Consensus 353 ~~ 354 (369)
..
T Consensus 159 ~~ 160 (268)
T cd06624 159 LA 160 (268)
T ss_pred cc
Confidence 54
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.7e-25 Score=201.25 Aligned_cols=151 Identities=23% Similarity=0.379 Sum_probs=133.4
Q ss_pred cCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC---cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEE
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 277 (369)
++|++.+.||+|+||.||+|... +++.||+|.++... ....+.+.+|++++++++|+||+++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888999999999999999976 78899999886432 223457899999999999999999999999999999999
Q ss_pred EecCCCcHhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 278 EFVPNKTLEFHLHGK--DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 278 e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
||+++++|..++... ....+++.+++.++.+++.||.|||+. +++||||+|+||+++.++.+||+|||+++....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999988642 234588999999999999999999998 999999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=203.50 Aligned_cols=151 Identities=31% Similarity=0.539 Sum_probs=132.6
Q ss_pred hcCCcccceecccCceEEEEEEEcC-C---eEEEEEeeccCC-cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEE
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLTN-G---KVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 275 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~~-~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 275 (369)
.++|...+.||+|+||.||+|.... + ..+++|.++... ....+++..|++++.+++|+||+++++++...+..|+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 4577888999999999999999642 2 378999887553 2334578999999999999999999999999999999
Q ss_pred EEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 276 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 276 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
||||+++++|.+++.... ..+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++....
T Consensus 84 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 84 ITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 999999999999997543 3589999999999999999999998 999999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.6e-26 Score=206.70 Aligned_cols=152 Identities=25% Similarity=0.410 Sum_probs=130.6
Q ss_pred cCCcccceecccCceEEEEEEEcC------CeEEEEEeeccCCcc-cHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeE
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLTN------GKVVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRL 274 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 274 (369)
.+|++.+.||+|+||.||+|...+ +..||+|+++..... ..+.+.+|+.++.+++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 346678899999999999998632 478999999755433 2356889999999999999999999999999999
Q ss_pred EEEEecCCCcHhhhhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCC
Q 017558 275 LVYEFVPNKTLEFHLHGKD--------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF 340 (369)
Q Consensus 275 lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~ 340 (369)
+++||+.+++|.+++.... ...+++..+++++.|++.||.|||++ +++||||||+|||+++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCC
Confidence 9999999999999985321 23478888999999999999999998 999999999999999999
Q ss_pred cEEEeeeccceeeCCC
Q 017558 341 EAKVADFGLAKHSLDT 356 (369)
Q Consensus 341 ~~ki~DFGla~~~~~~ 356 (369)
.+||+|||+++.....
T Consensus 162 ~~kl~Dfg~~~~~~~~ 177 (283)
T cd05091 162 NVKISDLGLFREVYAA 177 (283)
T ss_pred ceEecccccccccccc
Confidence 9999999999876543
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=206.22 Aligned_cols=151 Identities=23% Similarity=0.386 Sum_probs=132.1
Q ss_pred cCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC-cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEe
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 279 (369)
++|++.+.||+|+||.||++... ++..||+|.++... ......+.+|++++.+++|+||+++++++...+..|+||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 46788899999999999999975 67899999887542 23345788999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 280 VPNKTLEFHLHGKD-RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 280 ~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
+++++|..++.... ...+++..+..++.|++.||.|||++. +++||||||+||+++.++.+||+|||+++.+.
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 154 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV 154 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 99999999886532 235899999999999999999999642 89999999999999999999999999997653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-25 Score=200.75 Aligned_cols=149 Identities=32% Similarity=0.544 Sum_probs=133.0
Q ss_pred cCCcccceecccCceEEEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEecC
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVP 281 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 281 (369)
.+|++.+.||+|+||.||++.+.++..+|+|.++... ....++.+|++++.+++|+||+++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 4677889999999999999998778889999887543 234678999999999999999999999999999999999999
Q ss_pred CCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 282 NKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 282 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
+++|.+++.... ..+.++.+..++.|++.+|+|||++ +++|+||||+||+++.++.+||+|||+++...+
T Consensus 83 ~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 152 (256)
T cd05112 83 HGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLD 152 (256)
T ss_pred CCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeeccc
Confidence 999999987543 3478999999999999999999998 899999999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=205.09 Aligned_cols=149 Identities=31% Similarity=0.519 Sum_probs=129.7
Q ss_pred CCcccceecccCceEEEEEEE-----cCCeEEEEEeeccCC-cccHHHHHHHHHHHHhcCCCccccEeeEEEeC--CeeE
Q 017558 203 NFSEANLLGQGGFGYVHKGVL-----TNGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFG--SQRL 274 (369)
Q Consensus 203 ~~~~~~~lg~G~fg~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~ 274 (369)
.|+..+.||+|+||.||++.+ .++..||+|.++... ....+.+.+|++++++++|+||+++++++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 467788999999999999984 246789999987553 23345789999999999999999999999775 5688
Q ss_pred EEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 275 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 275 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
+||||+++++|.+++.... ..+++..++.++.|++.||+|||++ +++||||||+|||++.++.+||+|||+++...
T Consensus 85 lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred EEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccccccc
Confidence 9999999999999986543 3589999999999999999999998 99999999999999999999999999998764
Q ss_pred C
Q 017558 355 D 355 (369)
Q Consensus 355 ~ 355 (369)
.
T Consensus 161 ~ 161 (284)
T cd05079 161 T 161 (284)
T ss_pred c
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.6e-25 Score=200.86 Aligned_cols=143 Identities=32% Similarity=0.499 Sum_probs=123.5
Q ss_pred eecccCceEEEEEEEc---CCeEEEEEeeccCCc-ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEecCCCc
Q 017558 209 LLGQGGFGYVHKGVLT---NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKT 284 (369)
Q Consensus 209 ~lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g~ 284 (369)
.||+|+||.||+|.+. .+..||+|.+..... ...+.+.+|+.++++++|+||++++++|. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999864 355799999876533 23457899999999999999999999986 457899999999999
Q ss_pred HhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCC
Q 017558 285 LEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 285 L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~ 356 (369)
|.+++.... ..+++..+++++.|++.||.|||++ +++||||||+|||++.++.+||+|||+++.....
T Consensus 81 L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 148 (257)
T cd05115 81 LNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGAD 148 (257)
T ss_pred HHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCC
Confidence 999987533 3589999999999999999999998 9999999999999999999999999999865443
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.7e-25 Score=203.43 Aligned_cols=148 Identities=26% Similarity=0.435 Sum_probs=129.5
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCc--ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEe
Q 017558 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (369)
Q Consensus 203 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 279 (369)
+|+..+.||+|+||.||+|+.. ++..||||+++.... ...+.+.+|+.++.+++|+||+++++++..++..|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4778899999999999999964 578999999865422 2335788999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 280 VPNKTLEFHLHGKD-RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 280 ~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
++ ++|.+++.... ...+++..+..++.||+.||.|||++ +++||||||+|||+++++.+||+|||+++...
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 152 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFG 152 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecC
Confidence 97 68888876533 24588999999999999999999998 99999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.9e-25 Score=199.97 Aligned_cols=148 Identities=30% Similarity=0.506 Sum_probs=131.4
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCc-----ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEE
Q 017558 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG-----QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (369)
Q Consensus 203 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 276 (369)
+|+..+.||+|+||.||+|... ++..|++|.+..... ...+.+.+|++++++++|+||+++++++......+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677889999999999999976 688999998865431 2345788999999999999999999999999999999
Q ss_pred EEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 277 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
|||+++++|.+++... ..+++..+..++.||+.||.|||+. +++|+||+++||+++.++.+||+|||+++....
T Consensus 81 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 9999999999999754 3478999999999999999999998 999999999999999999999999999987543
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=217.68 Aligned_cols=148 Identities=27% Similarity=0.430 Sum_probs=121.9
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeC--------
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFG-------- 270 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-------- 270 (369)
...+|.+.+.||+|+||.||+|... +++.||||++.... ....+|+.+|++++|+||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 4467999999999999999999964 57899999886432 2345799999999999999999987532
Q ss_pred CeeEEEEEecCCCcHhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCC-CcEEEeee
Q 017558 271 SQRLLVYEFVPNKTLEFHLHG--KDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS-FEAKVADF 347 (369)
Q Consensus 271 ~~~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~-~~~ki~DF 347 (369)
...++||||+++ +|.+++.. .....+++.....++.||+.||.|||++ +|+||||||+||||+.+ +.+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeecc
Confidence 246789999975 56665542 2234588999999999999999999998 99999999999999965 47999999
Q ss_pred ccceeeCC
Q 017558 348 GLAKHSLD 355 (369)
Q Consensus 348 Gla~~~~~ 355 (369)
|+|+.+..
T Consensus 216 Gla~~~~~ 223 (440)
T PTZ00036 216 GSAKNLLA 223 (440)
T ss_pred ccchhccC
Confidence 99987654
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.7e-25 Score=206.80 Aligned_cols=150 Identities=29% Similarity=0.339 Sum_probs=134.2
Q ss_pred cCCcccceecccCceEEEEEEEcC-CeEEEEEeeccCCcc---cHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEE
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGSGQ---GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 277 (369)
++|+..+.||+|+||.||+|...+ ++.+|+|.+...... ..+.+.+|++++.+++|+||+++++.+......|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 468889999999999999999754 889999999765322 3457889999999999999999999999999999999
Q ss_pred EecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 278 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
||+.+++|.+++.......+++.....++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++....
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 154 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSD 154 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhccc
Confidence 999999999999765555689999999999999999999998 99999999999999999999999999988654
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-25 Score=200.18 Aligned_cols=150 Identities=31% Similarity=0.527 Sum_probs=133.3
Q ss_pred CcccceecccCceEEEEEEEcC-----CeEEEEEeeccCCcc-cHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEE
Q 017558 204 FSEANLLGQGGFGYVHKGVLTN-----GKVVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (369)
Q Consensus 204 ~~~~~~lg~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 277 (369)
|.+.+.||+|+||.||++.... +..||+|.++..... ..+.+..|++++.+++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3457889999999999999754 378999999766543 4568999999999999999999999999999999999
Q ss_pred EecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCC
Q 017558 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 278 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~ 356 (369)
||+++++|.+++.......+++..+..++.|++.||.|||+. +++|+||||+||++++++.+||+|||+++...+.
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceecccc
Confidence 999999999999765433389999999999999999999998 9999999999999999999999999999887654
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.6e-25 Score=203.55 Aligned_cols=146 Identities=34% Similarity=0.542 Sum_probs=127.0
Q ss_pred CcccceecccCceEEEEEEE-----cCCeEEEEEeeccCCc-ccHHHHHHHHHHHHhcCCCccccEeeEEEeC--CeeEE
Q 017558 204 FSEANLLGQGGFGYVHKGVL-----TNGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFG--SQRLL 275 (369)
Q Consensus 204 ~~~~~~lg~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~l 275 (369)
|+..+.||+|+||.||++.+ .++..||+|.++.... .....+.+|++++++++|+||++++++|... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37789999999999988763 2467899999876533 2346788999999999999999999998763 35789
Q ss_pred EEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 276 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 276 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
+|||+++++|.+++... .+++..+..++.|++.||.|||++ +++||||||+|||+++++.+||+|||+++....
T Consensus 86 v~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred EecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccCC
Confidence 99999999999999653 489999999999999999999998 999999999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-25 Score=204.47 Aligned_cols=148 Identities=27% Similarity=0.332 Sum_probs=129.7
Q ss_pred CCcccceecccCceEEEEEEE----cCCeEEEEEeeccCCc----ccHHHHHHHHHHHHhc-CCCccccEeeEEEeCCee
Q 017558 203 NFSEANLLGQGGFGYVHKGVL----TNGKVVAIKQLKAGSG----QGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQR 273 (369)
Q Consensus 203 ~~~~~~~lg~G~fg~Vy~~~~----~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 273 (369)
+|++.+.||+|+||.||++.. .+|..||+|+++.... ...+.+.+|++++.++ +|+||+.+++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477789999999999999986 3678999999875322 2235678899999999 599999999999999999
Q ss_pred EEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceee
Q 017558 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (369)
Q Consensus 274 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~ 353 (369)
|+||||+++++|.+++... ..+.+.....++.|++.||.|||++ +++||||+|+|||++.++.+||+|||+++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 81 HLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred EEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 9999999999999999754 3478889999999999999999998 9999999999999999999999999999876
Q ss_pred CC
Q 017558 354 LD 355 (369)
Q Consensus 354 ~~ 355 (369)
..
T Consensus 156 ~~ 157 (290)
T cd05613 156 HE 157 (290)
T ss_pred cc
Confidence 44
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=205.42 Aligned_cols=147 Identities=26% Similarity=0.456 Sum_probs=129.9
Q ss_pred cCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcc-cHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEe
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 279 (369)
++|+..+.||+|+||.||+|... +++.||+|.+...... ....+.+|++++++++|+||+++++++..++..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 67888999999999999999965 5789999998754322 234577899999999999999999999999999999999
Q ss_pred cCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceee
Q 017558 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (369)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~ 353 (369)
+.+ +|.+++..... .+++.....++.|++.||.|||++ +++||||||+|||++.++.+||+|||+++..
T Consensus 85 ~~~-~L~~~~~~~~~-~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 153 (291)
T cd07844 85 LDT-DLKQYMDDCGG-GLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAK 153 (291)
T ss_pred CCC-CHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECcccccccc
Confidence 974 89998875443 588999999999999999999998 9999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-25 Score=208.34 Aligned_cols=142 Identities=23% Similarity=0.228 Sum_probs=114.5
Q ss_pred HhhcCCcccceecccCceEEEEEEEc--CCeEEEEEeeccCC-----cccHHHHHHHHHHHHhcCCCccccEeeEEEeCC
Q 017558 199 IATDNFSEANLLGQGGFGYVHKGVLT--NGKVVAIKQLKAGS-----GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGS 271 (369)
Q Consensus 199 ~~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~ 271 (369)
...++|...+.||+|+||+||+|... +++.+|||++.... ....+.|.+|+++|.+++|+||+..+.. .+
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~ 91 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TG 91 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cC
Confidence 35678999999999999999999864 57788999875331 1124568999999999999999853322 24
Q ss_pred eeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCC-CCCcEEECCCCcEEEeeeccc
Q 017558 272 QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDI-KSANILLDDSFEAKVADFGLA 350 (369)
Q Consensus 272 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdl-k~~Nill~~~~~~ki~DFGla 350 (369)
..||||||+++++|.. +.. .. ...++.+++.+|.|||++ +|+|||| ||+|||++.++.+||+|||+|
T Consensus 92 ~~~LVmE~~~G~~L~~-~~~-----~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGlA 159 (365)
T PRK09188 92 KDGLVRGWTEGVPLHL-ARP-----HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQLA 159 (365)
T ss_pred CcEEEEEccCCCCHHH-hCc-----cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECccc
Confidence 6799999999999963 211 11 146788999999999998 9999999 999999999999999999999
Q ss_pred eeeCC
Q 017558 351 KHSLD 355 (369)
Q Consensus 351 ~~~~~ 355 (369)
+.+..
T Consensus 160 ~~~~~ 164 (365)
T PRK09188 160 SVFRR 164 (365)
T ss_pred eeccc
Confidence 97654
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-25 Score=220.61 Aligned_cols=164 Identities=20% Similarity=0.244 Sum_probs=124.1
Q ss_pred hhcCCcccceecccCceEEEEEEEcC--CeEEEEE------------------eeccCCcccHHHHHHHHHHHHhcCCCc
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVLTN--GKVVAIK------------------QLKAGSGQGEREFQAEIEIISQVHHRH 259 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~~~--~~~vavK------------------~~~~~~~~~~~~~~~E~~~l~~l~h~n 259 (369)
..++|++.+.||+|+||+||+|..+. +..+++| .++. .......+.+|+++|.+++|+|
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKA-GSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhc-chHHHHHHHHHHHHHHhCCCCC
Confidence 45789999999999999999987532 1112212 1111 1122346889999999999999
Q ss_pred cccEeeEEEeCCeeEEEEEecCCCcHhhhhcCCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEE
Q 017558 260 LVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKD---RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILL 336 (369)
Q Consensus 260 iv~l~g~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill 336 (369)
|+++++++...+..|+|+|++. ++|..++.... ...........|+.||+.||.|||++ +|+||||||+||||
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence 9999999999999999999995 56766664322 11233456778999999999999998 99999999999999
Q ss_pred CCCCcEEEeeeccceeeCCCCceeeeeecccC
Q 017558 337 DDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF 368 (369)
Q Consensus 337 ~~~~~~ki~DFGla~~~~~~~~~~~~~~~gt~ 368 (369)
+.++.+||+|||+++.+.+..........||+
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~ 332 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTV 332 (501)
T ss_pred CCCCCEEEEeCCCceecCcccccccccccCCc
Confidence 99999999999999987654333233345553
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=203.99 Aligned_cols=153 Identities=30% Similarity=0.453 Sum_probs=131.8
Q ss_pred hhcCCcccceecccCceEEEEEEEcC------CeEEEEEeeccCCcc-cHHHHHHHHHHHHhcCCCccccEeeEEEeCCe
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVLTN------GKVVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQ 272 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 272 (369)
..++|.+.+.||+|+||.||+|.+.. +..|++|.+...... ...+|.+|+.++++++|+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 34678889999999999999999753 567899988654332 34578999999999999999999999999999
Q ss_pred eEEEEEecCCCcHhhhhcCCCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCC---cEEE
Q 017558 273 RLLVYEFVPNKTLEFHLHGKDR-----PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF---EAKV 344 (369)
Q Consensus 273 ~~lv~e~~~~g~L~~~l~~~~~-----~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~---~~ki 344 (369)
.++||||+++++|.+++..... ..+++..+++++.||+.||+|||++ +++||||||+|||++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEe
Confidence 9999999999999999875421 2589999999999999999999998 899999999999998654 6999
Q ss_pred eeeccceeeCC
Q 017558 345 ADFGLAKHSLD 355 (369)
Q Consensus 345 ~DFGla~~~~~ 355 (369)
+|||+++....
T Consensus 161 ~dfg~~~~~~~ 171 (277)
T cd05036 161 ADFGMARDIYR 171 (277)
T ss_pred ccCccccccCC
Confidence 99999987643
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-26 Score=196.27 Aligned_cols=156 Identities=29% Similarity=0.389 Sum_probs=137.7
Q ss_pred HHHhhcCCcccceecccCceEEEEEE-EcCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeC-----
Q 017558 197 LKIATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFG----- 270 (369)
Q Consensus 197 ~~~~~~~~~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~----- 270 (369)
+.+..++|++.+.||+|+|..||+++ ..+++.||+|++.-...++.+..++|++..++++||||+++++++..+
T Consensus 16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~ 95 (302)
T KOG2345|consen 16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGK 95 (302)
T ss_pred EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence 34566789999999999999999999 567899999999877777788899999999999999999999987543
Q ss_pred CeeEEEEEecCCCcHhhhhcCCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeec
Q 017558 271 SQRLLVYEFVPNKTLEFHLHGKD--RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFG 348 (369)
Q Consensus 271 ~~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFG 348 (369)
...||++.|...|+|.+.+.... ...+++.+.++|+.+|++||++||+. .+.+.||||||.|||+.+.+.++|.|||
T Consensus 96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~G 174 (302)
T KOG2345|consen 96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLG 174 (302)
T ss_pred eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEecc
Confidence 35899999999999999987543 34689999999999999999999998 3469999999999999999999999999
Q ss_pred cceee
Q 017558 349 LAKHS 353 (369)
Q Consensus 349 la~~~ 353 (369)
-+...
T Consensus 175 S~~~a 179 (302)
T KOG2345|consen 175 SATQA 179 (302)
T ss_pred Ccccc
Confidence 88653
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-25 Score=202.39 Aligned_cols=144 Identities=28% Similarity=0.438 Sum_probs=123.3
Q ss_pred ceecccCceEEEEEEEcC-------------CeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeE
Q 017558 208 NLLGQGGFGYVHKGVLTN-------------GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRL 274 (369)
Q Consensus 208 ~~lg~G~fg~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 274 (369)
+.||+|+||.||+|.+.. ...+++|.+..........+.+|+.++..++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998532 2358889876654444557889999999999999999999999999999
Q ss_pred EEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCc-------EEEeee
Q 017558 275 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFE-------AKVADF 347 (369)
Q Consensus 275 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~-------~ki~DF 347 (369)
+||||+++|+|..+++... ..+++..+++++.||+.||.|||++ +|+||||||+|||++.++. +|++||
T Consensus 81 lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred EEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 9999999999999887543 3489999999999999999999998 9999999999999987654 899999
Q ss_pred ccceeeCC
Q 017558 348 GLAKHSLD 355 (369)
Q Consensus 348 Gla~~~~~ 355 (369)
|++.....
T Consensus 157 g~~~~~~~ 164 (262)
T cd05077 157 GIPITVLS 164 (262)
T ss_pred CCCccccC
Confidence 99876543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-25 Score=205.47 Aligned_cols=147 Identities=24% Similarity=0.383 Sum_probs=133.0
Q ss_pred cCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEec
Q 017558 202 DNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 280 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 280 (369)
.+|+..+.||+|+||.||++.. .+++.|++|.+........+.+.+|+.++..++|+||++++++|......|+||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 5788889999999999999985 457899999987665555677899999999999999999999999999999999999
Q ss_pred CCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 281 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 281 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
++++|.+++... .+++.++..++.|++.||.|||++ +++||||||+|||++.++.+||+|||+++...
T Consensus 100 ~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~ 167 (296)
T cd06654 100 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167 (296)
T ss_pred CCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcc
Confidence 999999998642 478999999999999999999998 99999999999999999999999999988654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=211.80 Aligned_cols=147 Identities=26% Similarity=0.367 Sum_probs=125.1
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC--cccHHHHHHHHHHHHhcCCCccccEeeEEEeCC-----
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGS----- 271 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----- 271 (369)
..++|+..+.||+|+||.||++... ++..||||++.... ......+.+|+.++..++|+||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 4578999999999999999999864 57899999986542 223457889999999999999999999986543
Q ss_pred -eeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccc
Q 017558 272 -QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLA 350 (369)
Q Consensus 272 -~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla 350 (369)
..|+||||+++ +|..+++. .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a 170 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 170 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCCc
Confidence 57999999975 56566542 378888999999999999999998 9999999999999999999999999999
Q ss_pred eeeC
Q 017558 351 KHSL 354 (369)
Q Consensus 351 ~~~~ 354 (369)
+...
T Consensus 171 ~~~~ 174 (359)
T cd07876 171 RTAC 174 (359)
T ss_pred cccc
Confidence 8654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.7e-25 Score=201.39 Aligned_cols=146 Identities=27% Similarity=0.506 Sum_probs=130.1
Q ss_pred CCcccceecccCceEEEEEEEcCCeEEEEEeeccCCc------ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEE
Q 017558 203 NFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSG------QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (369)
Q Consensus 203 ~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 276 (369)
+|...+.||+|+||.||+|...+++.+|+|.++.... .....+.+|++++++++|+||++++++|.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 4677899999999999999987889999998865321 1124588999999999999999999999999999999
Q ss_pred EEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceee
Q 017558 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (369)
Q Consensus 277 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~ 353 (369)
|||+++++|.+++.... .+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||+++..
T Consensus 81 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 152 (265)
T cd06631 81 MEFVPGGSISSILNRFG--PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152 (265)
T ss_pred EecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence 99999999999996543 478899999999999999999998 8999999999999999999999999998764
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.2e-25 Score=202.92 Aligned_cols=149 Identities=28% Similarity=0.401 Sum_probs=132.9
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC--cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEe
Q 017558 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (369)
Q Consensus 203 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 279 (369)
+|++.+.||+|+||.||+|... ++..|++|++.... ....+.+.+|+.++++++|+||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4778899999999999999964 67899999987654 22345789999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCC
Q 017558 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~ 356 (369)
+ +++|.+++.... ..+++.+++.++.||+.||.|||++ +++|+||||+||+++.++.++|+|||+++.....
T Consensus 81 ~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (286)
T cd07832 81 M-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEE 152 (286)
T ss_pred c-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCC
Confidence 9 999999987544 4589999999999999999999998 9999999999999999999999999999876544
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=205.16 Aligned_cols=149 Identities=30% Similarity=0.455 Sum_probs=131.6
Q ss_pred cCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcc--cHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEE
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ--GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 278 (369)
++|+..+.||+|+||.||+|... +++.||+|++...... ..+.+.+|++++.+++|+||++++++|..+...|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888999999999999999975 4789999988654322 24578899999999999999999999999999999999
Q ss_pred ecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
|++++.|..+.... ..+++..++.++.||+.||.|||+. +++|+||+|+||++++++.+||+|||+++....
T Consensus 81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07846 81 FVDHTVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 152 (286)
T ss_pred cCCccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence 99999998877543 2489999999999999999999998 999999999999999999999999999987544
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=209.77 Aligned_cols=155 Identities=26% Similarity=0.480 Sum_probs=132.4
Q ss_pred HHhhcCCcccceecccCceEEEEEEEcC--------CeEEEEEeeccCCc-ccHHHHHHHHHHHHhc-CCCccccEeeEE
Q 017558 198 KIATDNFSEANLLGQGGFGYVHKGVLTN--------GKVVAIKQLKAGSG-QGEREFQAEIEIISQV-HHRHLVSLVGYC 267 (369)
Q Consensus 198 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~g~~ 267 (369)
++...+|.+.+.||+|+||.||++.... ...||+|.++.... ...+++.+|++++.++ +|+||++++++|
T Consensus 8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (334)
T cd05100 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC 87 (334)
T ss_pred ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence 3344578889999999999999997421 23689998875432 2346789999999999 799999999999
Q ss_pred EeCCeeEEEEEecCCCcHhhhhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCc
Q 017558 268 TFGSQRLLVYEFVPNKTLEFHLHGKD--------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSAN 333 (369)
Q Consensus 268 ~~~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~N 333 (369)
..++..+++|||+++|+|.+++.... ...+.+.+++.++.|++.||.|||++ +++||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~N 164 (334)
T cd05100 88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARN 164 (334)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccce
Confidence 99999999999999999999986432 23478899999999999999999998 99999999999
Q ss_pred EEECCCCcEEEeeeccceeeCC
Q 017558 334 ILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 334 ill~~~~~~ki~DFGla~~~~~ 355 (369)
||++.++.+||+|||+++...+
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~ 186 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHN 186 (334)
T ss_pred EEEcCCCcEEECCcccceeccc
Confidence 9999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-25 Score=202.95 Aligned_cols=141 Identities=24% Similarity=0.391 Sum_probs=120.5
Q ss_pred eecccCceEEEEEEEcCC---eEEEEEeeccCCc-ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEecCCCc
Q 017558 209 LLGQGGFGYVHKGVLTNG---KVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKT 284 (369)
Q Consensus 209 ~lg~G~fg~Vy~~~~~~~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g~ 284 (369)
.||+|+||.||++...++ ..+++|.++.... ...+.+.+|+.+++.++||||++++++|......|+||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 599999999999985443 3456776655432 344689999999999999999999999999999999999999999
Q ss_pred HhhhhcCCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeecccee
Q 017558 285 LEFHLHGKD--RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (369)
Q Consensus 285 L~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~ 352 (369)
|.++++... ...+.+.....++.||+.||+|||++ +++||||||+|||++.++.+||+|||+++.
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~ 148 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPS 148 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccc
Confidence 999997542 23356677789999999999999998 999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.2e-25 Score=204.96 Aligned_cols=148 Identities=27% Similarity=0.447 Sum_probs=129.8
Q ss_pred cCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCc-ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEe
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 279 (369)
++|...+.||+|+||.||+|... +++.||+|.++.... .....+.+|+.++.+++|+||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 57888999999999999999864 578899999875432 2334678899999999999999999999999999999999
Q ss_pred cCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
++ ++|..++.... ..+++.....++.||+.||.|||++ +++|+||||+|||+++++.+||+|||+++...
T Consensus 86 ~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 155 (301)
T cd07873 86 LD-KDLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKS 155 (301)
T ss_pred cc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccC
Confidence 97 58888886543 3578899999999999999999998 99999999999999999999999999997644
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-25 Score=202.43 Aligned_cols=151 Identities=28% Similarity=0.419 Sum_probs=130.2
Q ss_pred hcCCcccceecccCceEEEEEEEcCC----eEEEEEeeccCC-cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEE
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLTNG----KVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 275 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~~~----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 275 (369)
.++|.+.+.||+|+||.||+|...+. ..|+||...... ....+.+.+|+.++.+++|+||++++++|.. ...|+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 35677889999999999999986432 468999887554 3344678999999999999999999999875 56789
Q ss_pred EEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 276 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 276 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
||||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +++|+||||+|||++.++.+||+|||+++....
T Consensus 84 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 84 VMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeeccc
Confidence 999999999999997543 3589999999999999999999998 999999999999999999999999999987654
Q ss_pred C
Q 017558 356 T 356 (369)
Q Consensus 356 ~ 356 (369)
.
T Consensus 160 ~ 160 (270)
T cd05056 160 E 160 (270)
T ss_pred c
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-25 Score=204.54 Aligned_cols=158 Identities=28% Similarity=0.402 Sum_probs=133.5
Q ss_pred HHHHHHhhcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcccHHHHHHHHHHHHhc-CCCccccEeeEEE---
Q 017558 194 YEELKIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHRHLVSLVGYCT--- 268 (369)
Q Consensus 194 ~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~--- 268 (369)
++.+....++|++.+.||+|+||.||++... +++.+|+|.++... ....++.+|+.++.++ +|+||++++++|.
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 3445567789999999999999999999864 57889999876432 2235788999999999 6999999999884
Q ss_pred --eCCeeEEEEEecCCCcHhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEE
Q 017558 269 --FGSQRLLVYEFVPNKTLEFHLHGK--DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKV 344 (369)
Q Consensus 269 --~~~~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki 344 (369)
.++..++||||+++++|.+++... ....+++..+..++.|++.||.|||++ +++||||||+||++++++.+||
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl 165 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKL 165 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEE
Confidence 345689999999999999887532 234578889999999999999999998 9999999999999999999999
Q ss_pred eeeccceeeCC
Q 017558 345 ADFGLAKHSLD 355 (369)
Q Consensus 345 ~DFGla~~~~~ 355 (369)
+|||+++....
T Consensus 166 ~dfg~~~~~~~ 176 (286)
T cd06638 166 VDFGVSAQLTS 176 (286)
T ss_pred ccCCceeeccc
Confidence 99999987654
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.93 E-value=3e-25 Score=207.62 Aligned_cols=145 Identities=15% Similarity=0.193 Sum_probs=126.5
Q ss_pred ccceeccc--CceEEEEEEE-cCCeEEEEEeeccCCc--ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEec
Q 017558 206 EANLLGQG--GFGYVHKGVL-TNGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 280 (369)
Q Consensus 206 ~~~~lg~G--~fg~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 280 (369)
+.++||+| +|++||++.. .+++.||+|+++.... ...+.+.+|+++++.++||||++++++|..++..|+||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 7889999986 4678999999975432 23346788999999999999999999999999999999999
Q ss_pred CCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceee
Q 017558 281 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (369)
Q Consensus 281 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~ 353 (369)
++|+|.+++.......+++..++.++.|++.||.|||++ +|+||||||+|||++.++.++++|||.+...
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~ 151 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSM 151 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhcc
Confidence 999999999654444589999999999999999999998 9999999999999999999999999875543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.2e-25 Score=202.56 Aligned_cols=150 Identities=31% Similarity=0.502 Sum_probs=130.6
Q ss_pred hcCCcccceecccCceEEEEEEEcC-C----eEEEEEeeccCCc-ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeE
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLTN-G----KVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRL 274 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~~-~----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 274 (369)
..+|+..+.||+|+||.||+|.+.. + ..+|+|.+..... ....++.+|+.++.+++|+||++++++|.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 3567888999999999999998643 3 2589998876543 234578899999999999999999999987 7889
Q ss_pred EEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 275 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 275 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
+||||+++|+|.+++..... .+++...+.++.||+.||+|||++ +++||||||+|||+++++.+||+|||+++...
T Consensus 85 ~v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 85 LITQLMPLGCLLDYVRNHKD-NIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEEecCCCCcHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCccccccc
Confidence 99999999999999976433 489999999999999999999998 99999999999999999999999999998765
Q ss_pred C
Q 017558 355 D 355 (369)
Q Consensus 355 ~ 355 (369)
.
T Consensus 161 ~ 161 (279)
T cd05057 161 V 161 (279)
T ss_pred C
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-25 Score=204.24 Aligned_cols=153 Identities=29% Similarity=0.521 Sum_probs=133.0
Q ss_pred hhcCCcccceecccCceEEEEEEEc------CCeEEEEEeeccCCc-ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCe
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQ 272 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 272 (369)
..++|+..+.||+|+||.||++... ++..+|+|.+..... ...+++.+|+.++++++|+||++++++|..+..
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 3467888999999999999999853 357899999875433 334578999999999999999999999999999
Q ss_pred eEEEEEecCCCcHhhhhcCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCC
Q 017558 273 RLLVYEFVPNKTLEFHLHGKD--------------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSA 332 (369)
Q Consensus 273 ~~lv~e~~~~g~L~~~l~~~~--------------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~ 332 (369)
.++||||+++|+|.+++.... ...+++..++.++.|++.||.|||++ +++||||||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHh
Confidence 999999999999999996421 12477888999999999999999998 9999999999
Q ss_pred cEEECCCCcEEEeeeccceeeCC
Q 017558 333 NILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 333 Nill~~~~~~ki~DFGla~~~~~ 355 (369)
|||+++++.+||+|||+++....
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~ 182 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYS 182 (288)
T ss_pred heEecCCCceEECccccceeccc
Confidence 99999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.1e-25 Score=199.96 Aligned_cols=144 Identities=31% Similarity=0.442 Sum_probs=128.0
Q ss_pred ceecccCceEEEEEEEcC--C--eEEEEEeeccCCc-ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEecCC
Q 017558 208 NLLGQGGFGYVHKGVLTN--G--KVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPN 282 (369)
Q Consensus 208 ~~lg~G~fg~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 282 (369)
+.||+|+||.||+|.+.+ + ..||||.++.... ...+.+.+|++++.+++|+||+++++++.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998643 2 3689999987655 445689999999999999999999999988 889999999999
Q ss_pred CcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 283 KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 283 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
++|.+++.......+++...+.++.|++.||.|||++ +++|+||||+||+++.++.+||+|||+++....
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~ 149 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQ 149 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccc
Confidence 9999999765434589999999999999999999998 999999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.4e-25 Score=199.34 Aligned_cols=151 Identities=29% Similarity=0.423 Sum_probs=135.4
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEe
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 279 (369)
.++|+..+.||+|+||.||++... +++.+++|.+........+.+.+|++++++++|+||+++++++......|++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 367888999999999999999964 4678999999766555567899999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
+++++|.+++.... ..+++.....++.|++.||.|||++ +++|+||+|+||++++++.+||+|||++.....
T Consensus 82 ~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 153 (262)
T cd06613 82 CGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTA 153 (262)
T ss_pred CCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhh
Confidence 99999999987542 3588999999999999999999998 999999999999999999999999999876543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-26 Score=218.43 Aligned_cols=157 Identities=27% Similarity=0.366 Sum_probs=131.2
Q ss_pred ccceecccCceEEEEEEEc-CCeEEEEEeeccC----CcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCe--eEEEEE
Q 017558 206 EANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG----SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQ--RLLVYE 278 (369)
Q Consensus 206 ~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~--~~lv~e 278 (369)
..++||+|.|-+||+|... +|..||.-.++.. .....+.|..|+++|+.|+|+||++++.+|.+... +.+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 3578999999999999953 4667775544322 22334689999999999999999999999987654 678999
Q ss_pred ecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECC-CCcEEEeeeccceeeCCCC
Q 017558 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD-SFEAKVADFGLAKHSLDTD 357 (369)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~-~~~~ki~DFGla~~~~~~~ 357 (369)
.|..|+|+.|+.+..+ .+......|+.||++||.|||++ .|+|||||||..||+|+. .|.+||+|+|||.......
T Consensus 124 L~TSGtLr~Y~kk~~~--vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ 200 (632)
T KOG0584|consen 124 LFTSGTLREYRKKHRR--VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH 200 (632)
T ss_pred cccCCcHHHHHHHhcc--CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence 9999999999987654 77888999999999999999997 789999999999999985 5899999999999877654
Q ss_pred ceeeeeecccC
Q 017558 358 THVSTRVMGTF 368 (369)
Q Consensus 358 ~~~~~~~~gt~ 368 (369)
. ..++||+
T Consensus 201 a---ksvIGTP 208 (632)
T KOG0584|consen 201 A---KSVIGTP 208 (632)
T ss_pred c---ceeccCc
Confidence 3 3389987
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=5e-25 Score=198.84 Aligned_cols=143 Identities=29% Similarity=0.474 Sum_probs=124.1
Q ss_pred eecccCceEEEEEEEc---CCeEEEEEeeccCCc--ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEecCCC
Q 017558 209 LLGQGGFGYVHKGVLT---NGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNK 283 (369)
Q Consensus 209 ~lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 283 (369)
.||+|+||.||+|.+. ++..+|+|+++.... ...+++.+|+.++++++|+||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999753 468899999865432 23457899999999999999999999986 45678999999999
Q ss_pred cHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCCC
Q 017558 284 TLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (369)
Q Consensus 284 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~~ 357 (369)
+|.+++... ..+++.....++.|++.||+|||++ +++||||||+|||+++++.+||+|||+++......
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~ 149 (257)
T cd05116 81 PLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADE 149 (257)
T ss_pred cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCC
Confidence 999999654 3488999999999999999999998 99999999999999999999999999998765443
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-25 Score=201.96 Aligned_cols=151 Identities=21% Similarity=0.322 Sum_probs=132.0
Q ss_pred cCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCCc---ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEE
Q 017558 202 DNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSG---QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 277 (369)
++|.+.+.||+|+||.||++.. .++..++||.+..... ....++.+|++++..++|+||+++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4677889999999999999995 4788999998865322 23357889999999999999999999999999999999
Q ss_pred EecCCCcHhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 278 EFVPNKTLEFHLHGK--DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 278 e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
||+++++|.+++... ....+++...+.++.||+.||.|||++ +++|+||||+||+++.++.+||+|||+++....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999988632 234588999999999999999999998 999999999999999999999999999886543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-25 Score=200.40 Aligned_cols=146 Identities=30% Similarity=0.556 Sum_probs=129.3
Q ss_pred cCCcccceecccCceEEEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEecC
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVP 281 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 281 (369)
++|.+.+.||+|+||.||++.. +++.+|+|.++... ..+.+.+|+.++.+++|+||+++++++..+ ..+++|||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 5688899999999999999986 67789999886532 235788999999999999999999998654 5799999999
Q ss_pred CCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 282 NKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 282 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
+++|.+++.......+++..++.++.|++.||.|||++ +++||||||+|||++.++.+||+|||+++...
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~ 151 (254)
T cd05083 82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGS 151 (254)
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceecc
Confidence 99999999766555688999999999999999999998 99999999999999999999999999998644
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.6e-25 Score=204.75 Aligned_cols=143 Identities=22% Similarity=0.335 Sum_probs=118.7
Q ss_pred cceecccCceEEEEEEEc---CCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEe--CCeeEEEEEecC
Q 017558 207 ANLLGQGGFGYVHKGVLT---NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTF--GSQRLLVYEFVP 281 (369)
Q Consensus 207 ~~~lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lv~e~~~ 281 (369)
.+.||+|+||.||+|+.. +++.||+|.++.... ...+.+|+++|++++||||+++++++.. +...|++|||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999864 457899999865422 3467889999999999999999998854 456789999995
Q ss_pred CCcHhhhhcCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEE----CCCCcEEEeeeccc
Q 017558 282 NKTLEFHLHGK-------DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILL----DDSFEAKVADFGLA 350 (369)
Q Consensus 282 ~g~L~~~l~~~-------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill----~~~~~~ki~DFGla 350 (369)
++|.+++... ....+++..+..++.||+.||.|||++ +|+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5777776422 122478889999999999999999998 99999999999999 45679999999999
Q ss_pred eeeCC
Q 017558 351 KHSLD 355 (369)
Q Consensus 351 ~~~~~ 355 (369)
+....
T Consensus 160 ~~~~~ 164 (317)
T cd07868 160 RLFNS 164 (317)
T ss_pred eccCC
Confidence 87654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.3e-25 Score=198.29 Aligned_cols=146 Identities=30% Similarity=0.545 Sum_probs=130.9
Q ss_pred ceecccCceEEEEEEEcC----CeEEEEEeeccCCccc-HHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEecCC
Q 017558 208 NLLGQGGFGYVHKGVLTN----GKVVAIKQLKAGSGQG-EREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPN 282 (369)
Q Consensus 208 ~~lg~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 282 (369)
+.||+|+||.||+|.... +..|++|.+....... .+.+.+|++++..++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999754 7789999997654433 56889999999999999999999999999999999999999
Q ss_pred CcHhhhhcCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 283 KTLEFHLHGKD-------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 283 g~L~~~l~~~~-------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
++|.+++.... ...+++..+..++.|++.||.|||++ +++||||||+||++++++.+||+|||+++....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 99999997642 24589999999999999999999998 999999999999999999999999999998765
Q ss_pred C
Q 017558 356 T 356 (369)
Q Consensus 356 ~ 356 (369)
.
T Consensus 158 ~ 158 (262)
T cd00192 158 D 158 (262)
T ss_pred c
Confidence 4
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.1e-25 Score=202.66 Aligned_cols=149 Identities=28% Similarity=0.439 Sum_probs=124.7
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcc--cHHHHHHHHHHHHhc---CCCccccEeeEEEe-----CC
Q 017558 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ--GEREFQAEIEIISQV---HHRHLVSLVGYCTF-----GS 271 (369)
Q Consensus 203 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~h~niv~l~g~~~~-----~~ 271 (369)
+|+..+.||+|+||.||+|+.. +++.||+|.++..... ....+.+|++++.++ +|+||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4778899999999999999865 5789999998754322 223566777777655 79999999999864 24
Q ss_pred eeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccce
Q 017558 272 QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351 (369)
Q Consensus 272 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~ 351 (369)
..+++|||+. ++|.+++.......+++..+..++.||+.||.|||++ +++||||||+|||+++++.+||+|||+++
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCccc
Confidence 5789999997 5888888765555689999999999999999999998 99999999999999999999999999998
Q ss_pred eeCC
Q 017558 352 HSLD 355 (369)
Q Consensus 352 ~~~~ 355 (369)
....
T Consensus 157 ~~~~ 160 (288)
T cd07863 157 IYSC 160 (288)
T ss_pred cccC
Confidence 7643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.2e-25 Score=204.54 Aligned_cols=146 Identities=22% Similarity=0.298 Sum_probs=130.0
Q ss_pred cCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCc---ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEE
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG---QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 277 (369)
++|+..+.||+|+||.||++... .++.|++|.+..... ...+.+.+|++++..++|+||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46888999999999999999964 467899999876532 22356889999999999999999999999999999999
Q ss_pred EecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeecccee
Q 017558 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (369)
Q Consensus 278 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~ 352 (369)
||+++++|.+++... ..+++.....++.|++.||.|||++ +++||||||+||+++.++.+||+|||+++.
T Consensus 81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~ 150 (305)
T cd05609 81 EYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKI 150 (305)
T ss_pred ecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccc
Confidence 999999999999654 3488999999999999999999998 999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=214.36 Aligned_cols=150 Identities=32% Similarity=0.445 Sum_probs=132.3
Q ss_pred cCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCCcccHHHHHHHHHHHHhcC-C-----CccccEeeEEEeCCeeE
Q 017558 202 DNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVH-H-----RHLVSLVGYCTFGSQRL 274 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~g~~~~~~~~~ 274 (369)
-+|++.++||+|+||+|-+|.. .+++.||||+++..... .++...|+.+|..++ | -|+|++++||...+++|
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f-~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc 264 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRF-LRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC 264 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHH-HHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence 3789999999999999999995 56899999999875433 356678999999997 4 48999999999999999
Q ss_pred EEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECC--CCcEEEeeecccee
Q 017558 275 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD--SFEAKVADFGLAKH 352 (369)
Q Consensus 275 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~--~~~~ki~DFGla~~ 352 (369)
||+|.+ .-+|.++|..+....|+......|+.||+.||.+||+. +|||.||||+||||.+ ...+||+|||.|..
T Consensus 265 iVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 265 IVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecccccc
Confidence 999998 68999999988877899999999999999999999998 9999999999999964 34899999999987
Q ss_pred eCCC
Q 017558 353 SLDT 356 (369)
Q Consensus 353 ~~~~ 356 (369)
..+.
T Consensus 341 ~~q~ 344 (586)
T KOG0667|consen 341 ESQR 344 (586)
T ss_pred cCCc
Confidence 6543
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.5e-25 Score=201.09 Aligned_cols=149 Identities=30% Similarity=0.493 Sum_probs=131.9
Q ss_pred cCCcccceecccCceEEEEEEEc-----CCeEEEEEeeccCCcc-cHHHHHHHHHHHHhcCCCccccEeeEEEe--CCee
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLT-----NGKVVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVSLVGYCTF--GSQR 273 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~ 273 (369)
++|+..+.||+|+||.||++.+. .+..+|||.++..... ..++|.+|++++++++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45677899999999999999864 3678999999765443 45689999999999999999999999987 5578
Q ss_pred EEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceee
Q 017558 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (369)
Q Consensus 274 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~ 353 (369)
+++|||+++++|.+++.... ..+++..++.++.|++.||+|||++ +++|+||||+|||++.++.+||+|||+++..
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 99999999999999997644 2589999999999999999999998 9999999999999999999999999999876
Q ss_pred C
Q 017558 354 L 354 (369)
Q Consensus 354 ~ 354 (369)
.
T Consensus 160 ~ 160 (284)
T cd05038 160 P 160 (284)
T ss_pred c
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.2e-25 Score=199.62 Aligned_cols=147 Identities=29% Similarity=0.478 Sum_probs=129.4
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCccc---------HHHHHHHHHHHHhcCCCccccEeeEEEeCCe
Q 017558 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQG---------EREFQAEIEIISQVHHRHLVSLVGYCTFGSQ 272 (369)
Q Consensus 203 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~---------~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 272 (369)
+|.+.+.||+|+||.||+|... +++.+|+|.+....... .+.+.+|++++.+++|+||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3667889999999999999864 57889999886543211 2467899999999999999999999999999
Q ss_pred eEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeecccee
Q 017558 273 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (369)
Q Consensus 273 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~ 352 (369)
.++||||+++++|.+++... ..+++.....++.|++.||+|||++ +++||||+|+||++++++.+||+|||+++.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 99999999999999999654 3478889999999999999999998 999999999999999999999999999987
Q ss_pred eC
Q 017558 353 SL 354 (369)
Q Consensus 353 ~~ 354 (369)
..
T Consensus 156 ~~ 157 (267)
T cd06628 156 LE 157 (267)
T ss_pred cc
Confidence 65
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.4e-25 Score=200.14 Aligned_cols=147 Identities=27% Similarity=0.452 Sum_probs=129.0
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCc---c-------cHHHHHHHHHHHHhcCCCccccEeeEEEeCC
Q 017558 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG---Q-------GEREFQAEIEIISQVHHRHLVSLVGYCTFGS 271 (369)
Q Consensus 203 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~-------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~ 271 (369)
+|...+.||+|+||.||+|... +++.+|+|.++.... . ..+.+.+|+.++.+++|+||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4667889999999999999854 578999998864211 0 1235788999999999999999999999999
Q ss_pred eeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccce
Q 017558 272 QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351 (369)
Q Consensus 272 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~ 351 (369)
..++||||+++++|.+++... ..+++..+..++.||+.||.|||++ +++||||+++||+++.++.+||+|||+++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccccc
Confidence 999999999999999999765 3588999999999999999999998 99999999999999999999999999998
Q ss_pred eeC
Q 017558 352 HSL 354 (369)
Q Consensus 352 ~~~ 354 (369)
...
T Consensus 157 ~~~ 159 (272)
T cd06629 157 KSD 159 (272)
T ss_pred ccc
Confidence 654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.1e-25 Score=199.64 Aligned_cols=148 Identities=28% Similarity=0.427 Sum_probs=127.7
Q ss_pred cCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCc-----ccHHHHHHHHHHHHhcCCCccccEeeEEEeC--Cee
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG-----QGEREFQAEIEIISQVHHRHLVSLVGYCTFG--SQR 273 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~ 273 (369)
++|+..+.||+|+||.||++... ++..||||.++.... ...+.+.+|++++.+++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 57888999999999999999864 578999998854321 1234688899999999999999999988663 467
Q ss_pred EEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceee
Q 017558 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (369)
Q Consensus 274 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~ 353 (369)
+++|||+++++|.+++.... .+++...++++.|++.||+|||++ +++|+||||+||+++.++.+||+|||+++..
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~ 156 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRL 156 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence 89999999999999986543 478888999999999999999998 8999999999999999999999999999865
Q ss_pred C
Q 017558 354 L 354 (369)
Q Consensus 354 ~ 354 (369)
.
T Consensus 157 ~ 157 (265)
T cd06652 157 Q 157 (265)
T ss_pred c
Confidence 3
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.7e-25 Score=197.65 Aligned_cols=150 Identities=22% Similarity=0.343 Sum_probs=133.1
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC--cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEe
Q 017558 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (369)
Q Consensus 203 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 279 (369)
+|+..+.||+|+||.||++... +++.|++|++.... ....+++.+|++++++++|+||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4788899999999999999854 57899999986532 23345789999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
+.+++|.+++.......+++.+.+.++.|++.||.|||++ +++|+||+++|||++.++.++|+|||+++....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~ 153 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS 153 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCc
Confidence 9999999999765444578999999999999999999998 999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=8e-25 Score=197.84 Aligned_cols=149 Identities=30% Similarity=0.452 Sum_probs=133.3
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcc--cHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEe
Q 017558 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ--GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (369)
Q Consensus 203 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 279 (369)
+|...+.||+|+||.||++... +++.|++|.++..... ..+.+.+|++++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4777899999999999999864 6789999998765443 456889999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCC
Q 017558 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~ 356 (369)
+++++|.+++... ..+++..+..|+.+++.||.|||+. +++|+||+++||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~ 152 (264)
T cd06626 81 CSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN 152 (264)
T ss_pred CCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCC
Confidence 9999999999754 3478889999999999999999998 9999999999999999999999999999876543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.6e-25 Score=202.95 Aligned_cols=148 Identities=24% Similarity=0.409 Sum_probs=133.9
Q ss_pred cCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEec
Q 017558 202 DNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 280 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 280 (369)
.+|+..+.||.|.||.||++.. .+++.|++|.+........+.+.+|+.+++.++|+||+++++++...+..|+||||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4688899999999999999985 468899999997655555678899999999999999999999999999999999999
Q ss_pred CCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 281 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 281 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
++++|..++... .+++.++..++.|++.||.|||++ +++||||||+||+++.++.+||+|||+++....
T Consensus 99 ~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~ 167 (296)
T cd06655 99 AGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP 167 (296)
T ss_pred CCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccc
Confidence 999999988642 488999999999999999999998 999999999999999999999999999887544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.8e-26 Score=199.03 Aligned_cols=149 Identities=27% Similarity=0.459 Sum_probs=132.6
Q ss_pred HHHHHHhhcCCcccceecccCceEEEEEE-EcCCeEEEEEeeccCCcccHHHHHHHHHHHHhcC-CCccccEeeEEEeCC
Q 017558 194 YEELKIATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVH-HRHLVSLVGYCTFGS 271 (369)
Q Consensus 194 ~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~ 271 (369)
++++...+ .+.||+|+|+.|.-|. +.++..||||++.+.....+..+.+|++++.+++ |+||++|++||+++.
T Consensus 75 F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~ 149 (463)
T KOG0607|consen 75 FEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT 149 (463)
T ss_pred HHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc
Confidence 45555555 4789999999999998 6789999999998887777788999999999995 999999999999999
Q ss_pred eeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCC---CcEEEeeec
Q 017558 272 QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS---FEAKVADFG 348 (369)
Q Consensus 272 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~---~~~ki~DFG 348 (369)
..|||||-|.||.|..+|+.+. .|++.++.++..+|+.||.|||.+ ||.||||||+|||..+- .-+|||||.
T Consensus 150 ~FYLVfEKm~GGplLshI~~~~--~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfD 224 (463)
T KOG0607|consen 150 RFYLVFEKMRGGPLLSHIQKRK--HFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFD 224 (463)
T ss_pred eEEEEEecccCchHHHHHHHhh--hccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccc
Confidence 9999999999999999998654 499999999999999999999999 99999999999999654 358999998
Q ss_pred ccee
Q 017558 349 LAKH 352 (369)
Q Consensus 349 la~~ 352 (369)
|.-.
T Consensus 225 LgSg 228 (463)
T KOG0607|consen 225 LGSG 228 (463)
T ss_pred cccc
Confidence 8754
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.4e-25 Score=208.58 Aligned_cols=150 Identities=23% Similarity=0.383 Sum_probs=128.1
Q ss_pred HhhcCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCCc--ccHHHHHHHHHHHHhcCCCccccEeeEEEeC-----
Q 017558 199 IATDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFG----- 270 (369)
Q Consensus 199 ~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~----- 270 (369)
...++|...+.||+|+||.||+|.. .+++.||||++..... ...+.+.+|+++|.+++|+||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 3457899999999999999999985 4578999999865422 2335677899999999999999999987543
Q ss_pred -CeeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeecc
Q 017558 271 -SQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGL 349 (369)
Q Consensus 271 -~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGl 349 (369)
...|+++|++ +++|.+++.. ..+++..+..++.||+.||.|||++ +|+||||||+|||+++++.+||+|||+
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCcc
Confidence 3568999988 7889888753 2488999999999999999999998 999999999999999999999999999
Q ss_pred ceeeCC
Q 017558 350 AKHSLD 355 (369)
Q Consensus 350 a~~~~~ 355 (369)
++....
T Consensus 165 ~~~~~~ 170 (343)
T cd07878 165 ARQADD 170 (343)
T ss_pred ceecCC
Confidence 987654
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.8e-25 Score=201.42 Aligned_cols=151 Identities=27% Similarity=0.407 Sum_probs=131.9
Q ss_pred cCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC--cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEE
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 278 (369)
++|+..+.||+|+||.||+|... +++.|+||+++... ....+.+.+|++++++++|+||+++++++..++..+++||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888999999999999999965 47899999987542 2234678999999999999999999999999999999999
Q ss_pred ecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCCC
Q 017558 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (369)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~~ 357 (369)
|++++.|..++... ..+++.....++.||+.||.|||++ +++|+||+++||++++++.+||+|||+++......
T Consensus 81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 99988887666443 3488999999999999999999998 99999999999999999999999999998765543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.9e-25 Score=199.45 Aligned_cols=142 Identities=32% Similarity=0.613 Sum_probs=123.0
Q ss_pred ceecccCceEEEEEEEcC-Ce--EEEEEeeccCC-cccHHHHHHHHHHHHhc-CCCccccEeeEEEeCCeeEEEEEecCC
Q 017558 208 NLLGQGGFGYVHKGVLTN-GK--VVAIKQLKAGS-GQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLVYEFVPN 282 (369)
Q Consensus 208 ~~lg~G~fg~Vy~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~~ 282 (369)
+.||+|+||.||+|+..+ +. .+++|.++... ....+.+.+|++++.++ +|+||++++++|...+..|+||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 468999999999999754 33 46888887543 23345788999999999 799999999999999999999999999
Q ss_pred CcHhhhhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeec
Q 017558 283 KTLEFHLHGKD--------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFG 348 (369)
Q Consensus 283 g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFG 348 (369)
|+|.++++... ...+++.+++.++.|++.||+|||++ +++||||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 99999987532 12478999999999999999999998 99999999999999999999999999
Q ss_pred ccee
Q 017558 349 LAKH 352 (369)
Q Consensus 349 la~~ 352 (369)
+++.
T Consensus 158 l~~~ 161 (270)
T cd05047 158 LSRG 161 (270)
T ss_pred Cccc
Confidence 9864
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-26 Score=216.39 Aligned_cols=149 Identities=31% Similarity=0.399 Sum_probs=127.7
Q ss_pred CcccceecccCceEEEEEEE-cCCeEEEEEeeccCCcc---cHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEe
Q 017558 204 FSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQ---GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (369)
Q Consensus 204 ~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 279 (369)
|...+.||.|+||.||.++. .+.++||||++.-...+ .-.++..|+..|.+++|||++.+-|+|..+...||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 66678899999999999994 56789999998643322 335899999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCCC
Q 017558 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (369)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~~ 357 (369)
| -|+-.++|.-.. .++.+-.+..|+.+.+.||.|||+. +.||||||+.||||++.|.|||+|||-|-......
T Consensus 108 C-lGSAsDlleVhk-KplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAn 180 (948)
T KOG0577|consen 108 C-LGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPAN 180 (948)
T ss_pred H-hccHHHHHHHHh-ccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCchh
Confidence 9 566666664433 3588889999999999999999998 99999999999999999999999999987765443
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.6e-25 Score=197.64 Aligned_cols=144 Identities=31% Similarity=0.505 Sum_probs=122.5
Q ss_pred ceecccCceEEEEEEEcC----CeEEEEEeeccCC-cccHHHHHHHHHHHHhcCCCccccEeeEEEe-CCeeEEEEEecC
Q 017558 208 NLLGQGGFGYVHKGVLTN----GKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTF-GSQRLLVYEFVP 281 (369)
Q Consensus 208 ~~lg~G~fg~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lv~e~~~ 281 (369)
+.||+|+||.||+|.+.+ ...+|+|++.... ....+.+.+|+.+++.++|+||++++++|.. ++..+++|||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998642 3579999885432 2334678899999999999999999998864 556899999999
Q ss_pred CCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 282 NKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 282 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
+|+|.+++.... ..+.+...+.++.||+.||.|||+. +++||||||+|||+++++.+||+|||+++...+
T Consensus 81 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~ 150 (262)
T cd05058 81 HGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYD 150 (262)
T ss_pred CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccC
Confidence 999999997543 2467788889999999999999998 999999999999999999999999999986544
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.2e-25 Score=196.86 Aligned_cols=143 Identities=31% Similarity=0.532 Sum_probs=128.6
Q ss_pred ceecccCceEEEEEEEcCCeEEEEEeeccCCcc-cHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEecCCCcHh
Q 017558 208 NLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLE 286 (369)
Q Consensus 208 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g~L~ 286 (369)
+.||+|+||.||++...+++.|++|.++..... ..+.+.+|++++++++|+||+++++++......++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 469999999999999877899999998765443 4467999999999999999999999999999999999999999999
Q ss_pred hhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 287 FHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 287 ~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
+++.... ..+++..++.++.+++.+|.|||++ +++||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~ 144 (251)
T cd05041 81 TFLRKKK-NRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEE 144 (251)
T ss_pred HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeecccccccc
Confidence 9997543 3578899999999999999999998 99999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.3e-25 Score=197.20 Aligned_cols=149 Identities=32% Similarity=0.456 Sum_probs=134.5
Q ss_pred cCCcccceecccCceEEEEEEEcC-CeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEec
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 280 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 280 (369)
++|+..+.||+|.||.||++.... +..+++|.++.... .+++.+|++++++++|+||+++++++......|+++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 678889999999999999999765 78999999875432 568999999999999999999999999999999999999
Q ss_pred CCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCC
Q 017558 281 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 281 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~ 356 (369)
++++|.+++.... ..+++.....++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (256)
T cd06612 81 GAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT 152 (256)
T ss_pred CCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence 9999999986543 4589999999999999999999998 9999999999999999999999999999876543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-24 Score=196.68 Aligned_cols=143 Identities=34% Similarity=0.532 Sum_probs=124.9
Q ss_pred ceecccCceEEEEEEEcC----CeEEEEEeeccCCcc-cHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEecCC
Q 017558 208 NLLGQGGFGYVHKGVLTN----GKVVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPN 282 (369)
Q Consensus 208 ~~lg~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 282 (369)
+.||+|+||.||+|.+.. +..+|+|.+...... ..+++.+|++++++++|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 469999999999998532 268999998765542 4457899999999999999999999886 4567999999999
Q ss_pred CcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCC
Q 017558 283 KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 283 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~ 356 (369)
|+|.+++.... .+++..++.++.|++.||+|||++ +++|+||||+|||++.++.+||+|||+++.....
T Consensus 80 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~ 148 (257)
T cd05060 80 GPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAG 148 (257)
T ss_pred CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecC
Confidence 99999997653 589999999999999999999998 8999999999999999999999999999876443
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.9e-25 Score=209.19 Aligned_cols=148 Identities=24% Similarity=0.336 Sum_probs=125.5
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCc--ccHHHHHHHHHHHHhcCCCccccEeeEEEeC------
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFG------ 270 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------ 270 (369)
..++|+..+.||+|+||.||++... .++.||||++..... ...+.+.+|+.+++.++|+||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578999999999999999999853 578899999875422 2335678899999999999999999988643
Q ss_pred CeeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccc
Q 017558 271 SQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLA 350 (369)
Q Consensus 271 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla 350 (369)
...|+||||+++ +|..++.. .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~~ 166 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCccc
Confidence 356999999965 56666643 378889999999999999999998 9999999999999999999999999999
Q ss_pred eeeCC
Q 017558 351 KHSLD 355 (369)
Q Consensus 351 ~~~~~ 355 (369)
+....
T Consensus 167 ~~~~~ 171 (355)
T cd07874 167 RTAGT 171 (355)
T ss_pred ccCCC
Confidence 87543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.1e-25 Score=214.49 Aligned_cols=171 Identities=29% Similarity=0.423 Sum_probs=145.4
Q ss_pred CHHHHHHhhcCCcccceecccCceEEEEEE-EcCCeEEEEEeeccCCcccHHHHHHHHHHHHhc-CCCccccEeeEEEe-
Q 017558 193 TYEELKIATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHRHLVSLVGYCTF- 269 (369)
Q Consensus 193 ~~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~- 269 (369)
.++.+...++.|++.++||.|.+|.||+++ .++++.+|+|++..+... .+++..|.++|... +|||++.++|++..
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 344455567889999999999999999999 456888999988765444 35788899998877 69999999999864
Q ss_pred ----CCeeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEe
Q 017558 270 ----GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVA 345 (369)
Q Consensus 270 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~ 345 (369)
++++|||||||.+|+.-+++.+.....+.|+....|+..+++||.+||.+ .++|||||-.|||++.++.+|++
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLv 165 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLV 165 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEe
Confidence 57899999999999999999876667799999999999999999999998 89999999999999999999999
Q ss_pred eeccceeeCCCCceeeeeecccC
Q 017558 346 DFGLAKHSLDTDTHVSTRVMGTF 368 (369)
Q Consensus 346 DFGla~~~~~~~~~~~~~~~gt~ 368 (369)
|||++..+...-. ...+.+||+
T Consensus 166 DFGvSaQldsT~g-rRnT~iGtP 187 (953)
T KOG0587|consen 166 DFGVSAQLDSTVG-RRNTFIGTP 187 (953)
T ss_pred eeeeeeeeecccc-cccCcCCCc
Confidence 9999999865432 334467765
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.5e-25 Score=200.66 Aligned_cols=149 Identities=27% Similarity=0.407 Sum_probs=128.3
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCccc-HHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEE
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQG-EREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 278 (369)
.++|...+.||+|+||.||+|... ++..||+|.++...... ...+.+|++++.+++|+||+++++++..++..|+|||
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 467889999999999999999864 57899999987554332 3467899999999999999999999999999999999
Q ss_pred ecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
|+. ++|.+++.... ..+.+..+..++.||+.||.|||++ +++|+||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 154 (291)
T cd07870 84 YMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKS 154 (291)
T ss_pred ccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccC
Confidence 996 66766665432 3477888889999999999999998 99999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-24 Score=195.49 Aligned_cols=150 Identities=24% Similarity=0.366 Sum_probs=130.4
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCc--ccHHHHHHHHHHHHhcCCCccccEeeEEEe-CCeeEEEEE
Q 017558 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTF-GSQRLLVYE 278 (369)
Q Consensus 203 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lv~e 278 (369)
.|++.+.||+|+||.||++... +++.+|+|++..... ...+.+.+|++++++++|+||+++++.+.. +...|++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788999999999999999964 467899999865432 334578899999999999999999998764 446789999
Q ss_pred ecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
|+++++|.+++.......+++.++..++.+++.||.|||++ +++||||||+||++++++.+||+|||+++....
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~ 154 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN 154 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecc
Confidence 99999999999765445689999999999999999999998 999999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=196.63 Aligned_cols=152 Identities=26% Similarity=0.393 Sum_probs=134.7
Q ss_pred cCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC-cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEe
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 279 (369)
++|++.+.||.|+||.||+|... ++..+++|++.... ....+.+.+|+++++.++|+||+++++.+...+..|+||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47888999999999999999954 57789999986543 23456899999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcCCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCC
Q 017558 280 VPNKTLEFHLHGKDR-PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 280 ~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~ 356 (369)
+++++|.+++..... ..+++.....++.|++.||.|||++ +++||||+|+||++++++.+||+|||++..+...
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~ 155 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADG 155 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence 999999999975432 4588999999999999999999998 9999999999999999999999999999876553
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.1e-25 Score=200.64 Aligned_cols=148 Identities=27% Similarity=0.464 Sum_probs=130.8
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCc--ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEe
Q 017558 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (369)
Q Consensus 203 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 279 (369)
+|+..+.||.|+||.||+|+.. +++.||||+++.... .....+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999864 578999998865432 2235788999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
+. ++|..++.......+++..+..++.|++.||+|||++ +++|+||+|+||++++++.+||+|||+++...
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~ 151 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 151 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcc
Confidence 95 6898888765556689999999999999999999998 99999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.6e-25 Score=225.59 Aligned_cols=158 Identities=20% Similarity=0.294 Sum_probs=130.0
Q ss_pred HHhhcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC--cccHHHHHHHHHHHHhcCCCccccEeeEEEe--CCe
Q 017558 198 KIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTF--GSQ 272 (369)
Q Consensus 198 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~ 272 (369)
....++|.+.+.||+|+||.||++... .+..+|+|.+.... ......|..|+.+|.+++|||||+++++|.. ...
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 345578999999999999999999964 46788999886542 2234578899999999999999999998855 356
Q ss_pred eEEEEEecCCCcHhhhhcCCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCC----CCeeecCCCCCcEEECC--------
Q 017558 273 RLLVYEFVPNKTLEFHLHGKD--RPVMNWPTRMKIALGSARGLAYLHEDCQ----PKIIHRDIKSANILLDD-------- 338 (369)
Q Consensus 273 ~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~yLH~~~~----~~ivHrdlk~~Nill~~-------- 338 (369)
.||||||+++|+|.++|.... ...+++..++.|+.||+.||.|||+... .+||||||||+||||+.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 899999999999999986521 2358999999999999999999998521 25999999999999964
Q ss_pred ---------CCcEEEeeeccceeeCC
Q 017558 339 ---------SFEAKVADFGLAKHSLD 355 (369)
Q Consensus 339 ---------~~~~ki~DFGla~~~~~ 355 (369)
...+||+|||+++....
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~ 194 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGI 194 (1021)
T ss_pred cccccccCCCCceEEccCCccccccc
Confidence 23489999999987643
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-25 Score=207.15 Aligned_cols=152 Identities=20% Similarity=0.269 Sum_probs=134.0
Q ss_pred cCCcccceecccCceEEEEEE-EcCCeEEEEEeeccCCcccH--HHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEE
Q 017558 202 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGE--REFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 278 (369)
.-|.+.+.||+|.|..|-+++ .-+|..||||++.+.+..+. ..+..|++.|+.++|||||+|+.+...+..+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 346777899999999999998 34799999999987654433 468899999999999999999999999999999999
Q ss_pred ecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEE-CCCCcEEEeeeccceeeCCCC
Q 017558 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILL-DDSFEAKVADFGLAKHSLDTD 357 (369)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill-~~~~~~ki~DFGla~~~~~~~ 357 (369)
.=++|+|++||-+.+. .+.++...+++.||+.|+.|+|.. .+|||||||+||++ .+-|-+||.|||++..+....
T Consensus 98 LGD~GDl~DyImKHe~-Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~ 173 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEE-GLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK 173 (864)
T ss_pred ecCCchHHHHHHhhhc-cccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence 9999999999987654 589999999999999999999988 79999999999976 567899999999998876543
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.9e-25 Score=203.60 Aligned_cols=145 Identities=29% Similarity=0.421 Sum_probs=128.6
Q ss_pred CcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEecCC
Q 017558 204 FSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPN 282 (369)
Q Consensus 204 ~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 282 (369)
|.....||+|+||.||++... ++..||||++........+.+.+|+.++.+++|+||+++++.+...+..|+||||+++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 344567999999999999864 5789999998765545556789999999999999999999999999999999999999
Q ss_pred CcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 283 KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 283 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
++|.+++... .+++.....++.||+.||.|||++ +++||||||+||++++++.+||+|||+++...
T Consensus 104 ~~L~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~ 169 (292)
T cd06658 104 GALTDIVTHT---RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVS 169 (292)
T ss_pred CcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcc
Confidence 9999988542 478999999999999999999998 99999999999999999999999999997654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.3e-25 Score=198.30 Aligned_cols=148 Identities=26% Similarity=0.435 Sum_probs=129.5
Q ss_pred CCcccceecccCceEEEEEEE-cCCeEEEEEeeccCCc------ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEE
Q 017558 203 NFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSG------QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 275 (369)
Q Consensus 203 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 275 (369)
+|+..+.||+|+||.||++.. .+++.+|+|.+..... ...+.+.+|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477789999999999999985 5678999999864321 123578899999999999999999999999999999
Q ss_pred EEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCC-cEEEeeeccceeeC
Q 017558 276 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF-EAKVADFGLAKHSL 354 (369)
Q Consensus 276 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~-~~ki~DFGla~~~~ 354 (369)
||||+++++|.+++... ..+++.....++.|++.||.|||++ +++|+||+++||+++.++ .+||+|||+++...
T Consensus 81 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred EEeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 99999999999999754 3488999999999999999999998 999999999999998765 59999999998765
Q ss_pred C
Q 017558 355 D 355 (369)
Q Consensus 355 ~ 355 (369)
.
T Consensus 156 ~ 156 (268)
T cd06630 156 A 156 (268)
T ss_pred c
Confidence 3
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.7e-25 Score=207.57 Aligned_cols=148 Identities=23% Similarity=0.327 Sum_probs=125.5
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC--cccHHHHHHHHHHHHhcCCCccccEeeEEEeC------
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFG------ 270 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------ 270 (369)
..++|...+.||+|+||.||++... .++.||||++.... ....+.+.+|+.+++.++|+||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3578999999999999999999853 57889999987542 22345788999999999999999999987543
Q ss_pred CeeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccc
Q 017558 271 SQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLA 350 (369)
Q Consensus 271 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla 350 (369)
...|+||||+++ +|..++.. .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 357999999965 66666642 378889999999999999999998 9999999999999999999999999999
Q ss_pred eeeCC
Q 017558 351 KHSLD 355 (369)
Q Consensus 351 ~~~~~ 355 (369)
+....
T Consensus 174 ~~~~~ 178 (364)
T cd07875 174 RTAGT 178 (364)
T ss_pred cccCC
Confidence 87543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.9e-25 Score=198.34 Aligned_cols=149 Identities=28% Similarity=0.353 Sum_probs=133.0
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCc---ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEE
Q 017558 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG---QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (369)
Q Consensus 203 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 278 (369)
+|+..+.||.|+||.||++... +++.||+|.+..... ...+.+.+|++++++++||||+++++++......++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788899999999999999975 588999999875432 234678999999999999999999999999999999999
Q ss_pred ecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCC
Q 017558 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~ 356 (369)
|+.+++|.+++... ..+.+.....++.|++.||.|||++ +++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 99999999999754 3588999999999999999999998 9999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.2e-25 Score=202.31 Aligned_cols=144 Identities=25% Similarity=0.356 Sum_probs=128.2
Q ss_pred ccceecccCceEEEEEEEc-CCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEecCCCc
Q 017558 206 EANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKT 284 (369)
Q Consensus 206 ~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g~ 284 (369)
....||+|+||.||++... ++..||+|.+........+.+.+|+.++..++|+||+++++++..++..|+||||+++++
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence 3457999999999999864 578999999876554555678899999999999999999999999999999999999999
Q ss_pred HhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 285 LEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 285 L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
|..++.. ..+++..++.++.|++.||.|||++ +++|||||++|||++.++.+||+|||+++....
T Consensus 105 L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~ 169 (297)
T cd06659 105 LTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK 169 (297)
T ss_pred HHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccc
Confidence 9988754 3488999999999999999999998 999999999999999999999999999976543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.1e-25 Score=202.50 Aligned_cols=150 Identities=31% Similarity=0.531 Sum_probs=127.3
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCe----EEEEEeeccCCcc-cHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeE
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGK----VVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRL 274 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~----~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 274 (369)
.++|+..+.||+|+||.||+|.+. ++. .+|+|.+...... ...++.+|+.++.+++|+||++++|+|... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 456778899999999999999863 343 4788888654332 234688999999999999999999999754 567
Q ss_pred EEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 275 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 275 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
+++||+++|+|.+++.... ..+++..++.++.|++.||.|||++ +++||||||+|||+++++.+||+|||+++...
T Consensus 85 ~v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eeehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcccccccccc
Confidence 9999999999999987543 3478999999999999999999998 99999999999999999999999999998754
Q ss_pred C
Q 017558 355 D 355 (369)
Q Consensus 355 ~ 355 (369)
.
T Consensus 161 ~ 161 (303)
T cd05110 161 G 161 (303)
T ss_pred C
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-24 Score=200.81 Aligned_cols=143 Identities=22% Similarity=0.338 Sum_probs=118.4
Q ss_pred cceecccCceEEEEEEEcC---CeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEe--CCeeEEEEEecC
Q 017558 207 ANLLGQGGFGYVHKGVLTN---GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTF--GSQRLLVYEFVP 281 (369)
Q Consensus 207 ~~~lg~G~fg~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lv~e~~~ 281 (369)
.+.||+|+||.||+|+..+ +..||+|.++.... ...+.+|++++.+++|+||+++++++.. +...|+||||+.
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 4679999999999999653 46899998865432 2467899999999999999999999854 567899999996
Q ss_pred CCcHhhhhcCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEE----CCCCcEEEeeeccc
Q 017558 282 NKTLEFHLHGK-------DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILL----DDSFEAKVADFGLA 350 (369)
Q Consensus 282 ~g~L~~~l~~~-------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill----~~~~~~ki~DFGla 350 (369)
+ +|.+++... ....+++..+..++.||+.||.|||++ +|+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 4 676666421 123478889999999999999999998 99999999999999 56779999999999
Q ss_pred eeeCC
Q 017558 351 KHSLD 355 (369)
Q Consensus 351 ~~~~~ 355 (369)
+....
T Consensus 160 ~~~~~ 164 (317)
T cd07867 160 RLFNS 164 (317)
T ss_pred eccCC
Confidence 87654
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=198.71 Aligned_cols=150 Identities=24% Similarity=0.405 Sum_probs=126.0
Q ss_pred cCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCc-ccHHHHHHHHHH-HHhcCCCccccEeeEEEeCCeeEEEEE
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG-QGEREFQAEIEI-ISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~-l~~l~h~niv~l~g~~~~~~~~~lv~e 278 (369)
++|++.+.||+|+||.||+++.. +++.||+|+++.... ....++..|+.+ ++.++|+||+++++++..+...|++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 47888999999999999999965 588999999876432 233456666665 566789999999999999999999999
Q ss_pred ecCCCcHhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 279 FVPNKTLEFHLHGK--DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 279 ~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
|++ |+|.+++... ....+++..++.++.||+.||.|||++. +++||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~ 155 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 996 6787776532 2345899999999999999999999753 79999999999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-24 Score=197.41 Aligned_cols=149 Identities=25% Similarity=0.415 Sum_probs=132.0
Q ss_pred CCcccceecccCceEEEEEEE-cCCeEEEEEeeccCC-cccHHHHHHHHHHHHhcC---CCccccEeeEEEeCCeeEEEE
Q 017558 203 NFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGS-GQGEREFQAEIEIISQVH---HRHLVSLVGYCTFGSQRLLVY 277 (369)
Q Consensus 203 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~lv~ 277 (369)
.|+..+.||+|+||.||+|.. .+++.+++|.++... ....+++.+|++++++++ |+||++++++|......|+||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 467788999999999999996 467899999987543 334467889999999996 999999999999999999999
Q ss_pred EecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCCC
Q 017558 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (369)
Q Consensus 278 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~~ 357 (369)
||+++++|.+++... .+++...+.++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++......+
T Consensus 82 e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 82 EYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred ecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence 999999999998653 588999999999999999999998 99999999999999999999999999998765543
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.1e-25 Score=200.40 Aligned_cols=144 Identities=26% Similarity=0.425 Sum_probs=123.8
Q ss_pred ceecccCceEEEEEEEcC--------CeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEe
Q 017558 208 NLLGQGGFGYVHKGVLTN--------GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (369)
Q Consensus 208 ~~lg~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 279 (369)
+.||+|+||.||+|.... ...+++|.+........+.+.+|+.++..++|+||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999998632 234788887655444456788999999999999999999999998999999999
Q ss_pred cCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCc--------EEEeeeccce
Q 017558 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFE--------AKVADFGLAK 351 (369)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~--------~ki~DFGla~ 351 (369)
+++|+|..+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++. +|++|||++.
T Consensus 81 ~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 81 VKFGSLDTYLKKNKN-LINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred CCCCcHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 999999999976543 588999999999999999999998 9999999999999987765 6999999987
Q ss_pred eeCC
Q 017558 352 HSLD 355 (369)
Q Consensus 352 ~~~~ 355 (369)
....
T Consensus 157 ~~~~ 160 (258)
T cd05078 157 TVLP 160 (258)
T ss_pred ccCC
Confidence 6543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.3e-25 Score=200.42 Aligned_cols=150 Identities=26% Similarity=0.367 Sum_probs=131.7
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC-cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEE
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 278 (369)
.++|++.+.||+|+||.||++... +++.||+|.+.... ....+.+.+|++++..++|+||+++++++...+..++|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 356778899999999999999964 57889999886543 2334678999999999999999999999999999999999
Q ss_pred ecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
|+++++|.+++... ..+++..+..++.+++.+|.|||+.. +++||||||+||++++++.++|+|||+++...
T Consensus 84 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~ 155 (284)
T cd06620 84 FMDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELI 155 (284)
T ss_pred cCCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchh
Confidence 99999999998654 34889999999999999999999732 79999999999999999999999999987653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-24 Score=196.39 Aligned_cols=148 Identities=28% Similarity=0.445 Sum_probs=128.0
Q ss_pred cCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCc-----ccHHHHHHHHHHHHhcCCCccccEeeEEEe--CCee
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG-----QGEREFQAEIEIISQVHHRHLVSLVGYCTF--GSQR 273 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~ 273 (369)
.+|...+.||+|+||.||++... ++..|++|+++.... ...+.+.+|+.++++++|+||+++++++.. ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 46888999999999999999864 578999998864321 123468889999999999999999998875 3577
Q ss_pred EEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceee
Q 017558 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (369)
Q Consensus 274 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~ 353 (369)
+++|||+++++|.+++.... .+++...+.++.|++.||.|||++ +++||||||+||+++.++.+||+|||+++..
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~ 156 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL 156 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence 89999999999999997543 478899999999999999999998 9999999999999999999999999999865
Q ss_pred C
Q 017558 354 L 354 (369)
Q Consensus 354 ~ 354 (369)
.
T Consensus 157 ~ 157 (266)
T cd06651 157 Q 157 (266)
T ss_pred c
Confidence 3
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=199.73 Aligned_cols=159 Identities=29% Similarity=0.398 Sum_probs=134.7
Q ss_pred CHHHHHHhhcCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCCcccHHHHHHHHHHHHhc-CCCccccEeeEEEeC
Q 017558 193 TYEELKIATDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHRHLVSLVGYCTFG 270 (369)
Q Consensus 193 ~~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~ 270 (369)
.++++..+.++|...+.||+|+||.||++.. .+++.+|+|.+..... ....+.+|+.++.++ +|+||++++++|...
T Consensus 13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 3445556678999999999999999999996 4578999998865422 235678899999999 799999999998754
Q ss_pred -----CeeEEEEEecCCCcHhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEE
Q 017558 271 -----SQRLLVYEFVPNKTLEFHLHGK--DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAK 343 (369)
Q Consensus 271 -----~~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~k 343 (369)
+..|+||||+++++|.++++.. ....+.+..++.++.|++.||+|||+. +++||||||+||++++++.+|
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~k 168 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVK 168 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEE
Confidence 3579999999999999988632 234588999999999999999999998 999999999999999999999
Q ss_pred EeeeccceeeCC
Q 017558 344 VADFGLAKHSLD 355 (369)
Q Consensus 344 i~DFGla~~~~~ 355 (369)
|+|||+++....
T Consensus 169 l~dfg~~~~~~~ 180 (291)
T cd06639 169 LVDFGVSAQLTS 180 (291)
T ss_pred Eeecccchhccc
Confidence 999999886543
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-24 Score=199.84 Aligned_cols=150 Identities=26% Similarity=0.384 Sum_probs=130.2
Q ss_pred cCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcc--cHHHHHHHHHHHHhcCCCccccEeeEEEeC--CeeEEE
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ--GEREFQAEIEIISQVHHRHLVSLVGYCTFG--SQRLLV 276 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lv 276 (369)
++|+..+.||+|.||.||+|... +++.+++|.++..... ....+.+|++++.+++|+||+++++++... ...|+|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888899999999999999975 4788999999754322 223567899999999999999999999877 889999
Q ss_pred EEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCC
Q 017558 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 277 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~ 356 (369)
|||++ ++|.+++.... ..+++...+.++.||+.||+|||++ +++|+||||+|||+++++.+||+|||+++.....
T Consensus 85 ~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 85 MEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159 (293)
T ss_pred ehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence 99997 58988886543 3589999999999999999999998 9999999999999999999999999999876554
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.3e-24 Score=195.32 Aligned_cols=148 Identities=27% Similarity=0.438 Sum_probs=128.2
Q ss_pred cCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC-----cccHHHHHHHHHHHHhcCCCccccEeeEEEeC--Cee
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS-----GQGEREFQAEIEIISQVHHRHLVSLVGYCTFG--SQR 273 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~ 273 (369)
++|++.+.||+|+||.||++... +++.||+|.+.... ....+.+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 57888999999999999999864 58899999874321 12335788999999999999999999998764 467
Q ss_pred EEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceee
Q 017558 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (369)
Q Consensus 274 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~ 353 (369)
+++|||+++++|.+++.... .+.+.....++.||+.||.|||++ +++|+||||+||+++.++.++|+|||+++..
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 156 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRI 156 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccccc
Confidence 89999999999999987543 378888999999999999999998 9999999999999999999999999999865
Q ss_pred C
Q 017558 354 L 354 (369)
Q Consensus 354 ~ 354 (369)
.
T Consensus 157 ~ 157 (264)
T cd06653 157 Q 157 (264)
T ss_pred c
Confidence 3
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-24 Score=196.90 Aligned_cols=149 Identities=31% Similarity=0.404 Sum_probs=133.5
Q ss_pred cCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC-cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEe
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 279 (369)
++|+..+.||.|+||.||+|... +++.+++|.+.... ......+.+|+++++.++|+||+++++++.++...|+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 46788899999999999999964 57899999987543 33345788999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCC
Q 017558 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~ 356 (369)
+++++|.+++... .+++.....++.|++.||.|||++ +++|+||+|+||++++++.++|+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 151 (274)
T cd06609 81 CGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTST 151 (274)
T ss_pred eCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccc
Confidence 9999999999754 588999999999999999999998 8999999999999999999999999999887543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-24 Score=199.90 Aligned_cols=149 Identities=26% Similarity=0.391 Sum_probs=132.9
Q ss_pred cCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEec
Q 017558 202 DNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 280 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 280 (369)
++|...+.||+|+||.||++.. .++..|++|.+........+.+.+|+.++++++|+||++++++|...+..|+|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 6788889999999999999985 357889999986554444567899999999999999999999999999999999999
Q ss_pred CCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCC
Q 017558 281 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 281 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~ 356 (369)
++++|.+++... .+++..+..++.|++.||.|||++ +++|+|||++||+++.++.+||+|||++......
T Consensus 99 ~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~ 168 (293)
T cd06647 99 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (293)
T ss_pred CCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccc
Confidence 999999998643 478899999999999999999998 9999999999999999999999999998765443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.4e-25 Score=193.11 Aligned_cols=148 Identities=26% Similarity=0.333 Sum_probs=128.6
Q ss_pred hhcCCcc-cceecccCceEEEEEEE-cCCeEEEEEeeccCCcccHHHHHHHHHHHHhc-CCCccccEeeEEEe----CCe
Q 017558 200 ATDNFSE-ANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHRHLVSLVGYCTF----GSQ 272 (369)
Q Consensus 200 ~~~~~~~-~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~----~~~ 272 (369)
.+++|.+ .++||-|-.|+|..|.. .+++.+|+|++.+ ....++|+++.... .|+|||.++++|++ ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 4566655 46799999999999985 4688999999864 35678899987776 59999999999864 457
Q ss_pred eEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEC---CCCcEEEeeecc
Q 017558 273 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLD---DSFEAKVADFGL 349 (369)
Q Consensus 273 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~---~~~~~ki~DFGl 349 (369)
+++|||+|+||.|+..++.++...|++.++..|..||+.|+.|||+. +|.||||||+|+|.. .|..+||+|||+
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEeccccc
Confidence 78999999999999999998888899999999999999999999998 999999999999996 456899999999
Q ss_pred ceeeCC
Q 017558 350 AKHSLD 355 (369)
Q Consensus 350 a~~~~~ 355 (369)
|+....
T Consensus 211 AK~t~~ 216 (400)
T KOG0604|consen 211 AKETQE 216 (400)
T ss_pred ccccCC
Confidence 998664
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.6e-24 Score=194.33 Aligned_cols=150 Identities=29% Similarity=0.405 Sum_probs=135.1
Q ss_pred cCCcccceecccCceEEEEEEEcC-CeEEEEEeeccCCc-ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEe
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 279 (369)
++|++.+.||+|+||.||+++... ++.|+||++..... ...+.+.+|++++.+++|+||+++++++......++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 468888999999999999999764 88999999876543 3456899999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCC
Q 017558 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHE-DCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~ 356 (369)
+++++|.+++... ..+++...+.++.|+++||.|||+ + +++|+||+|+||+++.++.++|+|||+++.....
T Consensus 81 ~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~ 153 (264)
T cd06623 81 MDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENT 153 (264)
T ss_pred cCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence 9999999999754 458999999999999999999999 8 9999999999999999999999999999876543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.3e-24 Score=193.91 Aligned_cols=150 Identities=25% Similarity=0.401 Sum_probs=131.5
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC--cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEe
Q 017558 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (369)
Q Consensus 203 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 279 (369)
+|+..+.||+|+||.||++... +++.+|+|.+.... ....+.+.+|++++++++|+||+++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 5788899999999999999863 57889999986542 22345789999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCC-CcEEEeeeccceeeCC
Q 017558 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS-FEAKVADFGLAKHSLD 355 (369)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~-~~~ki~DFGla~~~~~ 355 (369)
+++++|.+++.......+++..+..++.+++.+|.|||++ +++|+||+|+||+++++ +.+||+|||+++...+
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSS 154 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCC
Confidence 9999999999765545689999999999999999999998 99999999999999854 4689999999987654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.9e-24 Score=196.12 Aligned_cols=147 Identities=32% Similarity=0.447 Sum_probs=130.2
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCc-ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEec
Q 017558 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 280 (369)
Q Consensus 203 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 280 (369)
-|+..+.||+|+||.||+|... ++..+|+|.+..... ...+.+.+|++++.+++|+||+++++++..+...|+||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 4667789999999999999864 578999998865432 23457889999999999999999999999999999999999
Q ss_pred CCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 281 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 281 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
++++|.+++.. ..+++.....++.|++.+|.|||++ +++|+||+++||+++.++.++|+|||+++....
T Consensus 85 ~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06641 85 GGGSALDLLEP---GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 153 (277)
T ss_pred CCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceeccc
Confidence 99999999864 2488999999999999999999998 999999999999999999999999999987654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.4e-25 Score=199.57 Aligned_cols=147 Identities=31% Similarity=0.441 Sum_probs=129.7
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC-cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEec
Q 017558 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 280 (369)
Q Consensus 203 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 280 (369)
.|+..+.||+|+||.||+|... ++..||+|.++... ....+.+.+|++++++++|+||+++++++..+...|+||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 3556788999999999999854 57889999887543 233457889999999999999999999999999999999999
Q ss_pred CCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 281 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 281 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
++++|.+++.. ..+++..+..++.|++.||.|||++ +++|+||+|+||++++++.+||+|||+++....
T Consensus 85 ~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06642 85 GGGSALDLLKP---GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred CCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccC
Confidence 99999998864 3488999999999999999999998 999999999999999999999999999987654
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-24 Score=211.21 Aligned_cols=152 Identities=26% Similarity=0.381 Sum_probs=121.2
Q ss_pred hhcCCcccceecccCceEEEEEEE-----------------cCCeEEEEEeeccCCcccHHH--------------HHHH
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVL-----------------TNGKVVAIKQLKAGSGQGERE--------------FQAE 248 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~E 248 (369)
..++|++.++||+|+||.||+|.. ..++.||||+++.......++ ...|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999964 234679999987543322223 3346
Q ss_pred HHHHHhcCCCcc-----ccEeeEEEe--------CCeeEEEEEecCCCcHhhhhcCCC----------------------
Q 017558 249 IEIISQVHHRHL-----VSLVGYCTF--------GSQRLLVYEFVPNKTLEFHLHGKD---------------------- 293 (369)
Q Consensus 249 ~~~l~~l~h~ni-----v~l~g~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~---------------------- 293 (369)
+.++.+++|.|+ ++++++|.. ++..||||||+++++|.++|+...
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777766554 778888753 356899999999999999987421
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 294 RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 294 ~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
...++|..+..++.|++.+|.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~ 360 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMC 360 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccc
Confidence 11246778889999999999999998 89999999999999999999999999997654
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.6e-24 Score=207.61 Aligned_cols=153 Identities=22% Similarity=0.333 Sum_probs=122.9
Q ss_pred HHHHHhhcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcccHHHHHHHHHHHHhcCC------CccccEeeEE
Q 017558 195 EELKIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHH------RHLVSLVGYC 267 (369)
Q Consensus 195 ~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~g~~ 267 (369)
+++....++|++.++||+|+||.||+|... .++.||||+++.... ..+++..|++++..++| .+|+.+++++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK-YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh-hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 344556788999999999999999999864 578899999965322 23456677777777654 4588999988
Q ss_pred EeC-CeeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCC------
Q 017558 268 TFG-SQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF------ 340 (369)
Q Consensus 268 ~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~------ 340 (369)
... ...|+|||++ +++|.+++... ..+.+..+..|+.||+.||.|||++. +||||||||+|||++.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~--gIiHrDlKP~NILl~~~~~~~~~~ 275 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHTEL--HLMHTDLKPENILMETSDTVVDPV 275 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcC--CeecCCCCHHHEEEecCCcccccc
Confidence 764 5778999988 77888888654 35899999999999999999999731 899999999999998765
Q ss_pred ----------cEEEeeeccceee
Q 017558 341 ----------EAKVADFGLAKHS 353 (369)
Q Consensus 341 ----------~~ki~DFGla~~~ 353 (369)
.+||+|||++...
T Consensus 276 ~~~~~~~~~~~vkl~DfG~~~~~ 298 (467)
T PTZ00284 276 TNRALPPDPCRVRICDLGGCCDE 298 (467)
T ss_pred cccccCCCCceEEECCCCccccC
Confidence 4999999998654
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-24 Score=196.34 Aligned_cols=149 Identities=28% Similarity=0.464 Sum_probs=125.2
Q ss_pred CcccceecccCceEEEEEEEc----CCeEEEEEeeccCC--cccHHHHHHHHHHHHhcCCCccccEeeEEEeCC------
Q 017558 204 FSEANLLGQGGFGYVHKGVLT----NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGS------ 271 (369)
Q Consensus 204 ~~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------ 271 (369)
|.+.+.||+|+||.||+|.+. .++.||||.++... ....+++.+|++++++++|+||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 556789999999999999854 35789999987543 223457889999999999999999999886532
Q ss_pred eeEEEEEecCCCcHhhhhcCC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeee
Q 017558 272 QRLLVYEFVPNKTLEFHLHGK----DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADF 347 (369)
Q Consensus 272 ~~~lv~e~~~~g~L~~~l~~~----~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DF 347 (369)
..++++||+.+|+|.+++... ....+++...+.++.||+.||+|||++ +++||||||+|||+++++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 247889999999998887532 122478889999999999999999998 9999999999999999999999999
Q ss_pred ccceeeCC
Q 017558 348 GLAKHSLD 355 (369)
Q Consensus 348 Gla~~~~~ 355 (369)
|+++....
T Consensus 158 g~~~~~~~ 165 (273)
T cd05074 158 GLSKKIYS 165 (273)
T ss_pred cccccccC
Confidence 99987643
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.8e-24 Score=196.16 Aligned_cols=149 Identities=31% Similarity=0.451 Sum_probs=131.7
Q ss_pred cCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC-cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEe
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 279 (369)
..|+..+.||.|+||.||+|... ++..||+|.+.... ......+.+|+.++++++|+||+++++++......|+||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 34667788999999999999964 57899999987543 23345788999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCC
Q 017558 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~ 356 (369)
+++++|.+++... .+++.....++.|++.||+|||++ +++|+||+|+||+++.++.++|+|||+++.....
T Consensus 84 ~~~~~L~~~i~~~---~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06640 84 LGGGSALDLLRAG---PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT 154 (277)
T ss_pred CCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCC
Confidence 9999999998642 478889999999999999999998 9999999999999999999999999999876543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-24 Score=199.41 Aligned_cols=153 Identities=29% Similarity=0.394 Sum_probs=130.5
Q ss_pred HhhcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCc--ccHHHHHHHHHHHHhcCCCccccEeeEEEeCC----
Q 017558 199 IATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFGS---- 271 (369)
Q Consensus 199 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~---- 271 (369)
...++|++.+.||+|.||.||+|... +++.||+|+++.... .....+.+|++++++++|+||+++++++....
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678999999999999999999975 478999999875432 23346788999999999999999999987654
Q ss_pred ------eeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEe
Q 017558 272 ------QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVA 345 (369)
Q Consensus 272 ------~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~ 345 (369)
..++|+||+++ +|..++... ...+++..++.++.||+.||.|||+. +|+|+|||++||++++++.+||+
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeC
Confidence 78999999976 666666543 23589999999999999999999998 99999999999999999999999
Q ss_pred eeccceeeCCC
Q 017558 346 DFGLAKHSLDT 356 (369)
Q Consensus 346 DFGla~~~~~~ 356 (369)
|||+++.....
T Consensus 159 dfg~~~~~~~~ 169 (302)
T cd07864 159 DFGLARLYNSE 169 (302)
T ss_pred cccccccccCC
Confidence 99999876543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.5e-25 Score=218.96 Aligned_cols=162 Identities=27% Similarity=0.462 Sum_probs=139.6
Q ss_pred HHHHhhcCCcccceecccCceEEEEEEEc--------CCeEEEEEeeccCCcc-cHHHHHHHHHHHHhc-CCCccccEee
Q 017558 196 ELKIATDNFSEANLLGQGGFGYVHKGVLT--------NGKVVAIKQLKAGSGQ-GEREFQAEIEIISQV-HHRHLVSLVG 265 (369)
Q Consensus 196 ~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~l~g 265 (369)
.+++..+++.+.+.||+|.||.|++|... ....||||.++..... +.+++..|+++|..+ +|+||+.|+|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 34555666666779999999999999843 1357999999876544 556899999999998 5999999999
Q ss_pred EEEeCCeeEEEEEecCCCcHhhhhcCCC------C--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCC
Q 017558 266 YCTFGSQRLLVYEFVPNKTLEFHLHGKD------R--------PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKS 331 (369)
Q Consensus 266 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~------~--------~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~ 331 (369)
+|..++..++|+||+..|+|..+|+... . ..+...+.+.++.|||.||+||++. ++|||||.+
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhh
Confidence 9999999999999999999999998654 0 1388889999999999999999998 899999999
Q ss_pred CcEEECCCCcEEEeeeccceeeCCCCcee
Q 017558 332 ANILLDDSFEAKVADFGLAKHSLDTDTHV 360 (369)
Q Consensus 332 ~Nill~~~~~~ki~DFGla~~~~~~~~~~ 360 (369)
||||+.++..+||+||||||...+.+...
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~ 475 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYR 475 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceE
Confidence 99999999999999999999877766554
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-24 Score=197.73 Aligned_cols=142 Identities=31% Similarity=0.433 Sum_probs=125.7
Q ss_pred ecccCceEEEEEEEc-CCeEEEEEeeccCC---cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEecCCCcH
Q 017558 210 LGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTL 285 (369)
Q Consensus 210 lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g~L 285 (369)
||+|+||.||++... +++.||+|.+.... ....+.+.+|++++.+++|+||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999854 57899999986532 22334677899999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 286 EFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 286 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
.+++.......+++..++.++.|++.||.|||++ +++||||+|+||++++++.+||+|||+++...
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~ 146 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELK 146 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhc
Confidence 9999765545689999999999999999999998 99999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-25 Score=204.04 Aligned_cols=165 Identities=32% Similarity=0.452 Sum_probs=134.4
Q ss_pred cCCcccceecccCceEEEEEE-EcCCeEEEEEeeccCC-cccH------HHHHHHHHHHHhcCCCccccEeeEEEeC-Ce
Q 017558 202 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGS-GQGE------REFQAEIEIISQVHHRHLVSLVGYCTFG-SQ 272 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~-~~~~------~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~ 272 (369)
++|-.+.+||+|+|++||++. +...+.||||+-..+. +.++ +...+|.+|.+.|+||.||++++|+.-+ +.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 457778899999999999998 5567889999864332 2221 2356899999999999999999999654 56
Q ss_pred eEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEC---CCCcEEEeeecc
Q 017558 273 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLD---DSFEAKVADFGL 349 (369)
Q Consensus 273 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~---~~~~~ki~DFGl 349 (369)
.|-|+|||+|.+|+.||... ..+++.++..|+.||..||.||.+. .++|||-||||.||||. ..|.+||+||||
T Consensus 543 FCTVLEYceGNDLDFYLKQh--klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGL 619 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQH--KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGL 619 (775)
T ss_pred ceeeeeecCCCchhHHHHhh--hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecch
Confidence 78899999999999999755 3589999999999999999999987 77999999999999995 458999999999
Q ss_pred ceeeCCCCce------eeeeecccCC
Q 017558 350 AKHSLDTDTH------VSTRVMGTFG 369 (369)
Q Consensus 350 a~~~~~~~~~------~~~~~~gt~g 369 (369)
++.+.++.+. .+...+||++
T Consensus 620 SKIMdddSy~~vdGmeLTSQgAGTYW 645 (775)
T KOG1151|consen 620 SKIMDDDSYNSVDGMELTSQGAGTYW 645 (775)
T ss_pred hhhccCCccCcccceeeecccCceee
Confidence 9988765432 2344567754
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-24 Score=199.60 Aligned_cols=147 Identities=24% Similarity=0.406 Sum_probs=127.8
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCc--ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEe
Q 017558 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (369)
Q Consensus 203 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 279 (369)
+|+..+.||+|.||.||+|... +|+.+|+|+++.... .....+.+|++++++++|+||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4778899999999999999964 588999999865322 2234678899999999999999999999999999999999
Q ss_pred cCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
++ ++|.+++.... ..+++...+.++.||+.||.|||++ +++||||||+||+++.++.+||+|||+++...
T Consensus 81 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 150 (284)
T cd07839 81 CD-QDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFG 150 (284)
T ss_pred CC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccC
Confidence 97 57777775432 3489999999999999999999998 99999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=4e-24 Score=196.80 Aligned_cols=149 Identities=26% Similarity=0.417 Sum_probs=127.6
Q ss_pred cCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCc--ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEE
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 278 (369)
++|+..+.||+|.||.||+|... +++.||+|+++.... ...+.+.+|++++++++|+||+++++++......|+|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57888999999999999999965 578999999865432 223578899999999999999999999999999999999
Q ss_pred ecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECC-CCcEEEeeeccceeeC
Q 017558 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD-SFEAKVADFGLAKHSL 354 (369)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~-~~~~ki~DFGla~~~~ 354 (369)
|++ ++|.+++.......+++.....++.||+.||+|||++ +++||||+|+||++++ ++.+||+|||+++...
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~ 154 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence 996 5787777654444467888889999999999999998 9999999999999985 5679999999997653
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-25 Score=196.90 Aligned_cols=151 Identities=26% Similarity=0.382 Sum_probs=124.6
Q ss_pred cCCcccceecccCceEEEEEEEcC-----CeEEEEEeeccCCcc-c-HHHHHHHHHHHHhcCCCccccEeeEEEe-CCee
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLTN-----GKVVAIKQLKAGSGQ-G-EREFQAEIEIISQVHHRHLVSLVGYCTF-GSQR 273 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~-~-~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~ 273 (369)
..|+....||+|+||.||++.-++ .+.+|+|+++..++. . .....+|+.+++.++|+||+.|+.++.. +...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 468888999999999999996432 247899999765432 1 1356789999999999999999999877 8899
Q ss_pred EEEEEecCCCcHhhhhcCCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCC----CcEEEee
Q 017558 274 LLVYEFVPNKTLEFHLHGKD---RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS----FEAKVAD 346 (369)
Q Consensus 274 ~lv~e~~~~g~L~~~l~~~~---~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~----~~~ki~D 346 (369)
||++||.+. +|...|+... ...++......|+.||+.|+.|||++ =|+||||||.||||..+ |.+||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeec
Confidence 999999965 5666665322 23577778889999999999999999 49999999999999877 9999999
Q ss_pred eccceeeCCC
Q 017558 347 FGLAKHSLDT 356 (369)
Q Consensus 347 FGla~~~~~~ 356 (369)
|||+|.+.+.
T Consensus 180 lGlaR~~~~p 189 (438)
T KOG0666|consen 180 LGLARLFNNP 189 (438)
T ss_pred ccHHHHhhcc
Confidence 9999987654
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.7e-24 Score=197.38 Aligned_cols=149 Identities=29% Similarity=0.324 Sum_probs=129.1
Q ss_pred CCcccceecccCceEEEEEEEc----CCeEEEEEeeccCCc----ccHHHHHHHHHHHHhc-CCCccccEeeEEEeCCee
Q 017558 203 NFSEANLLGQGGFGYVHKGVLT----NGKVVAIKQLKAGSG----QGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQR 273 (369)
Q Consensus 203 ~~~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 273 (369)
+|+..+.||+|+||.||+++.. ++..||||.++.... ...+.+.+|++++.++ +|+||+.+++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4677899999999999999843 467899999875321 2234678999999999 599999999999999999
Q ss_pred EEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceee
Q 017558 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (369)
Q Consensus 274 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~ 353 (369)
++||||+++|+|.+++... ..+++.....++.|++.+|.|||+. +++||||||+||+++.++.+||+|||+++..
T Consensus 81 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred EEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 9999999999999998654 3488889999999999999999998 9999999999999999999999999999876
Q ss_pred CCC
Q 017558 354 LDT 356 (369)
Q Consensus 354 ~~~ 356 (369)
...
T Consensus 156 ~~~ 158 (288)
T cd05583 156 LAE 158 (288)
T ss_pred ccc
Confidence 543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.2e-24 Score=190.66 Aligned_cols=150 Identities=31% Similarity=0.476 Sum_probs=134.0
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCc--ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEe
Q 017558 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (369)
Q Consensus 203 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 279 (369)
+|+..+.||+|.||.||++... +++.|++|.+..... ...+.+.+|++++.+++|+||+++++++..++..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4777899999999999999865 578899999976543 3446789999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCCC
Q 017558 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (369)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~~ 357 (369)
+++++|.+++... ..+++..+..++.|++.||.|||++ +++||||+|+||+++.++.+||+|||+++......
T Consensus 81 ~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 81 AENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred CCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 9999999998754 4589999999999999999999998 99999999999999999999999999998765543
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.2e-24 Score=197.36 Aligned_cols=149 Identities=23% Similarity=0.349 Sum_probs=127.1
Q ss_pred cCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCc--ccHHHHHHHHHHHHhcC-CCccccEeeEEEeCCe-----
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG--QGEREFQAEIEIISQVH-HRHLVSLVGYCTFGSQ----- 272 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~----- 272 (369)
++|+..+.||+|+||.||+|... +++.||+|.++.... .....+.+|+.++.++. |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888999999999999999964 578999998865432 22357888999999995 6999999999987665
Q ss_pred eEEEEEecCCCcHhhhhcCCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECC-CCcEEEeeec
Q 017558 273 RLLVYEFVPNKTLEFHLHGKD---RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD-SFEAKVADFG 348 (369)
Q Consensus 273 ~~lv~e~~~~g~L~~~l~~~~---~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~-~~~~ki~DFG 348 (369)
.|+||||+++ +|.+++.... ...+++..++.++.||+.||.|||++ +++||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999985 7888876432 23579999999999999999999998 9999999999999998 8999999999
Q ss_pred cceeeC
Q 017558 349 LAKHSL 354 (369)
Q Consensus 349 la~~~~ 354 (369)
+++.+.
T Consensus 157 ~~~~~~ 162 (295)
T cd07837 157 LGRAFS 162 (295)
T ss_pred cceecC
Confidence 998654
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.9e-24 Score=189.35 Aligned_cols=150 Identities=35% Similarity=0.486 Sum_probs=135.2
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEecC
Q 017558 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVP 281 (369)
Q Consensus 203 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 281 (369)
+|...+.||+|+||.||++... ++..+++|++........+.+.+|++++++++|+||+++++++..+...++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4777899999999999999975 578899999977655456789999999999999999999999999999999999999
Q ss_pred CCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCC
Q 017558 282 NKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 282 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~ 356 (369)
+++|.+++.... ..+++.....++.|++.+|.|||++ +++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 151 (253)
T cd05122 81 GGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT 151 (253)
T ss_pred CCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccc
Confidence 999999987653 3589999999999999999999998 9999999999999999999999999999876654
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.4e-24 Score=198.33 Aligned_cols=149 Identities=26% Similarity=0.361 Sum_probs=126.6
Q ss_pred CCcccceecccCceEEEEEEEcC---CeEEEEEeeccCC---cccHHHHHHHHHHHHhcCCCccccEeeEEEeC--CeeE
Q 017558 203 NFSEANLLGQGGFGYVHKGVLTN---GKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFG--SQRL 274 (369)
Q Consensus 203 ~~~~~~~lg~G~fg~Vy~~~~~~---~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~ 274 (369)
+|++.+.||+|+||.||+|.... +..||+|.+.... ....+.+.+|+.++.+++||||+++++++.+. ...|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 47778999999999999999754 6899999997643 23335778899999999999999999999887 7899
Q ss_pred EEEEecCCCcHhhhhcCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECC----CCcEEEeee
Q 017558 275 LVYEFVPNKTLEFHLHGK---DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD----SFEAKVADF 347 (369)
Q Consensus 275 lv~e~~~~g~L~~~l~~~---~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~----~~~~ki~DF 347 (369)
+||||+++ +|.+++... ....+++.....++.||+.||.|||++ +++||||||+|||++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 566655422 123578889999999999999999998 8999999999999999 999999999
Q ss_pred ccceeeCC
Q 017558 348 GLAKHSLD 355 (369)
Q Consensus 348 Gla~~~~~ 355 (369)
|+++....
T Consensus 157 g~~~~~~~ 164 (316)
T cd07842 157 GLARLFNA 164 (316)
T ss_pred ccccccCC
Confidence 99987543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=5e-24 Score=194.91 Aligned_cols=148 Identities=27% Similarity=0.409 Sum_probs=129.9
Q ss_pred CcccceecccCceEEEEEEEc-CCeEEEEEeeccCC--cccHHHHHHHHHHHHhcCCCccccEeeEEEeC--CeeEEEEE
Q 017558 204 FSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFG--SQRLLVYE 278 (369)
Q Consensus 204 ~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lv~e 278 (369)
|++.+.||+|+||.||+|... +++.+|+|++.... ....+.+.+|++++.+++|+||+++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 566789999999999999975 47899999997653 23345788999999999999999999999887 88999999
Q ss_pred ecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCC
Q 017558 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~ 356 (369)
|+++ +|.+++.... ..+++..++.++.||+.||+|||++ +++|+||+|+|||+++++.+||+|||+++.....
T Consensus 81 ~~~~-~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMDH-DLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred cccc-cHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 9974 8888886543 3589999999999999999999998 9999999999999999999999999999877654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=197.35 Aligned_cols=145 Identities=32% Similarity=0.566 Sum_probs=125.2
Q ss_pred ceecccCceEEEEEEEcC-------CeEEEEEeeccCCc-ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEe
Q 017558 208 NLLGQGGFGYVHKGVLTN-------GKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (369)
Q Consensus 208 ~~lg~G~fg~Vy~~~~~~-------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 279 (369)
+.||+|+||.||+|+..+ +..+++|.+..... ....++.+|++++++++|+||++++++|...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998643 25789998865432 3346788999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcCC-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCC-----cEEEeeecc
Q 017558 280 VPNKTLEFHLHGK-----DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF-----EAKVADFGL 349 (369)
Q Consensus 280 ~~~g~L~~~l~~~-----~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~-----~~ki~DFGl 349 (369)
+++++|.+++... ....+++.+++.++.|++.||.|||+. +++|+||||+|||++.++ .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999999753 223478899999999999999999998 899999999999999877 899999999
Q ss_pred ceeeCC
Q 017558 350 AKHSLD 355 (369)
Q Consensus 350 a~~~~~ 355 (369)
++....
T Consensus 158 ~~~~~~ 163 (269)
T cd05044 158 ARDIYK 163 (269)
T ss_pred cccccc
Confidence 986543
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.6e-24 Score=193.69 Aligned_cols=165 Identities=22% Similarity=0.313 Sum_probs=140.8
Q ss_pred CHHHHHHhhcCCcccceecccCceEEEEEEEcC------CeEEEEEeeccCCcc-cHHHHHHHHHHHHhcCCCccccEee
Q 017558 193 TYEELKIATDNFSEANLLGQGGFGYVHKGVLTN------GKVVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVSLVG 265 (369)
Q Consensus 193 ~~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g 265 (369)
..+++.+..++++...++.+|+||+||+|.|.+ .+.|.||.++....+ ....++.|..++..+.|+|+..+.+
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence 356777888889999999999999999997653 345778888776544 4457889999999999999999999
Q ss_pred EEEeC-CeeEEEEEecCCCcHhhhhcC------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECC
Q 017558 266 YCTFG-SQRLLVYEFVPNKTLEFHLHG------KDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD 338 (369)
Q Consensus 266 ~~~~~-~~~~lv~e~~~~g~L~~~l~~------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~ 338 (369)
++.++ ...+.+|.++..|+|..||.. .....++..+...++.|++.||+|||.+ ++||.||..+|++||+
T Consensus 355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd 431 (563)
T KOG1024|consen 355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDD 431 (563)
T ss_pred EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehh
Confidence 99764 566889999999999999972 1223477788899999999999999998 9999999999999999
Q ss_pred CCcEEEeeeccceeeCCCCcee
Q 017558 339 SFEAKVADFGLAKHSLDTDTHV 360 (369)
Q Consensus 339 ~~~~ki~DFGla~~~~~~~~~~ 360 (369)
...+||+|-.|+|++...|++.
T Consensus 432 ~LqVkltDsaLSRDLFP~DYhc 453 (563)
T KOG1024|consen 432 QLQVKLTDSALSRDLFPGDYHC 453 (563)
T ss_pred heeEEeccchhccccCcccccc
Confidence 9999999999999999888764
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.7e-24 Score=195.08 Aligned_cols=148 Identities=28% Similarity=0.484 Sum_probs=129.8
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcc-cHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEec
Q 017558 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 280 (369)
Q Consensus 203 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 280 (369)
+|+..+.||.|++|.||+|+.. ++..||||+++..... ....+.+|++++++++|+||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5788899999999999999974 5789999998765432 3456788999999999999999999999999999999999
Q ss_pred CCCcHhhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 281 PNKTLEFHLHGKD-RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 281 ~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
++ +|.+++.... ...+++..+..++.||+.||.|||++ +++||||||+||++++++.+||+|||+++...
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~ 151 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFG 151 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhc
Confidence 85 7888876433 23589999999999999999999998 99999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.4e-24 Score=193.83 Aligned_cols=152 Identities=24% Similarity=0.415 Sum_probs=127.7
Q ss_pred CCcccceecccCceEEEEEEEcC--CeEEEEEeeccCC----------cccHHHHHHHHHHHHh-cCCCccccEeeEEEe
Q 017558 203 NFSEANLLGQGGFGYVHKGVLTN--GKVVAIKQLKAGS----------GQGEREFQAEIEIISQ-VHHRHLVSLVGYCTF 269 (369)
Q Consensus 203 ~~~~~~~lg~G~fg~Vy~~~~~~--~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~-l~h~niv~l~g~~~~ 269 (369)
+|++.+.||+|+||.||++.... ++.+|+|.+.... .....++..|+.++.+ ++|+||++++++|..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 46778899999999999999765 6789999875321 1122456788888865 799999999999999
Q ss_pred CCeeEEEEEecCCCcHhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeee
Q 017558 270 GSQRLLVYEFVPNKTLEFHLHG--KDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADF 347 (369)
Q Consensus 270 ~~~~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DF 347 (369)
++..+++|||+++++|.+++.. .....+++..++.++.|++.||.|||+.. +++|+||+++|||+++++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence 9999999999999999988743 12345888999999999999999999631 7999999999999999999999999
Q ss_pred ccceeeCCC
Q 017558 348 GLAKHSLDT 356 (369)
Q Consensus 348 Gla~~~~~~ 356 (369)
|+++.....
T Consensus 159 g~~~~~~~~ 167 (269)
T cd08528 159 GLAKQKQPE 167 (269)
T ss_pred cceeecccc
Confidence 999876544
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.4e-24 Score=195.34 Aligned_cols=150 Identities=29% Similarity=0.387 Sum_probs=129.1
Q ss_pred cCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCc-ccHHHHHHHHHHHHhcCCCccccEeeEEEeC--CeeEEEE
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFG--SQRLLVY 277 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lv~ 277 (369)
++|+..+.||.|.+|.||++... +++.+|+|.+..... ....++.+|++++++++|+||++++++|... ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46788899999999999999974 578899999875433 3345789999999999999999999998653 4689999
Q ss_pred EecCCCcHhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 278 EFVPNKTLEFHLHG--KDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 278 e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
||+++++|.+++.. .....+++.....++.||+.||.|||+. +++|+||+++||++++++.+||+|||++....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 99999999988753 2234578889999999999999999998 99999999999999999999999999987644
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.7e-25 Score=223.77 Aligned_cols=150 Identities=27% Similarity=0.415 Sum_probs=124.6
Q ss_pred HhhcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC-cccHHHHHHHHHHHHhcCCCccccEeeEEE--------
Q 017558 199 IATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCT-------- 268 (369)
Q Consensus 199 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-------- 268 (369)
....+|+..++||+|+||.||+++.+ +|+.||||++.... ......+.+|+++|++|+|||||+++..+.
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 45567888999999999999999954 79999999997654 223357889999999999999999876321
Q ss_pred --------------------------------------------------------------------------------
Q 017558 269 -------------------------------------------------------------------------------- 268 (369)
Q Consensus 269 -------------------------------------------------------------------------------- 268 (369)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred -----------------------eC--------CeeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 017558 269 -----------------------FG--------SQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLH 317 (369)
Q Consensus 269 -----------------------~~--------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH 317 (369)
.+ ..+||-||||+...|.++++.+... -.....++++.+|++||.|+|
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~-~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN-SQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc-hhhHHHHHHHHHHHHHHHHHH
Confidence 00 1357889999999998888754321 135677899999999999999
Q ss_pred hCCCCCeeecCCCCCcEEECCCCcEEEeeecccee
Q 017558 318 EDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (369)
Q Consensus 318 ~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~ 352 (369)
++ +||||||||.||+||++..+||+|||+|..
T Consensus 715 ~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~ 746 (1351)
T KOG1035|consen 715 DQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATD 746 (1351)
T ss_pred hC---ceeeccCCcceeEEcCCCCeeecccccchh
Confidence 99 899999999999999999999999999987
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.9e-24 Score=193.40 Aligned_cols=150 Identities=22% Similarity=0.373 Sum_probs=131.7
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC--cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEe
Q 017558 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (369)
Q Consensus 203 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 279 (369)
+|...+.||+|+||.||++... ++..+|+|.+.... ....+.+.+|++++++++|+||+++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4778899999999999999965 47889999986542 22345788999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCC-cEEEeeeccceeeCC
Q 017558 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF-EAKVADFGLAKHSLD 355 (369)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~-~~ki~DFGla~~~~~ 355 (369)
+++++|.+++.......+++..+..++.|++.||.|||++ +++|+||||+||++++++ .+||+|||++....+
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND 154 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccC
Confidence 9999999999765555689999999999999999999998 999999999999999875 469999999987654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.8e-25 Score=209.07 Aligned_cols=156 Identities=29% Similarity=0.398 Sum_probs=132.3
Q ss_pred ceecccCceEEEEEEEcC-CeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEecCCCcHh
Q 017558 208 NLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLE 286 (369)
Q Consensus 208 ~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g~L~ 286 (369)
-+||+|+||+||-|+..+ ...+|||.+........+-+.+||.+.++++|.|||+++|.|..++..-|.||.++||+|.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 359999999999999654 4578999998777666678899999999999999999999999999999999999999999
Q ss_pred hhhcCCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECC-CCcEEEeeeccceeeCCCCceeeee
Q 017558 287 FHLHGKDRPVM--NWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD-SFEAKVADFGLAKHSLDTDTHVSTR 363 (369)
Q Consensus 287 ~~l~~~~~~~l--~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~-~~~~ki~DFGla~~~~~~~~~~~~~ 363 (369)
.+|+..=. ++ ++.+.-++-+||++||+|||++ .|||||||-.||||+. .|.+||+|||-++.+..-. -++.+
T Consensus 661 sLLrskWG-PlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin-P~TET 735 (1226)
T KOG4279|consen 661 SLLRSKWG-PLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN-PCTET 735 (1226)
T ss_pred HHHHhccC-CCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCC-ccccc
Confidence 99976432 24 6778889999999999999999 8999999999999974 7899999999998865432 23344
Q ss_pred ecccC
Q 017558 364 VMGTF 368 (369)
Q Consensus 364 ~~gt~ 368 (369)
..||+
T Consensus 736 FTGTL 740 (1226)
T KOG4279|consen 736 FTGTL 740 (1226)
T ss_pred cccch
Confidence 55553
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.1e-24 Score=194.24 Aligned_cols=149 Identities=28% Similarity=0.430 Sum_probs=132.3
Q ss_pred cCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCc-ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEe
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 279 (369)
++|+..+.||+|+||.||++... +++.+++|.+..... ...+++.+|++++++++|+||+++++++..+...++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 36777889999999999999975 578999999876533 3345789999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHE-DCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
+++++|.+++.... ..+++.....++.|++.||.|||+ . +++|+|||++||++++++.+||+|||+++...
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~ 152 (265)
T cd06605 81 MDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLV 152 (265)
T ss_pred cCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhH
Confidence 99999999997543 458889999999999999999998 7 99999999999999999999999999987653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.8e-24 Score=193.70 Aligned_cols=151 Identities=32% Similarity=0.445 Sum_probs=131.7
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcccHHHHHHHHHHHHhc-CCCccccEeeEEEeCC------
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGS------ 271 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~------ 271 (369)
..++|+..+.||+|+||.||+|... +++.+++|.+..... ..+++.+|++++.++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 4578999999999999999999974 567899998875443 346789999999999 6999999999997644
Q ss_pred eeEEEEEecCCCcHhhhhcCCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeecc
Q 017558 272 QRLLVYEFVPNKTLEFHLHGKD--RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGL 349 (369)
Q Consensus 272 ~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGl 349 (369)
..|+||||+++++|.+++.... ...+++..+..++.|++.||.|||++ +++|+||+|+||++++++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCcc
Confidence 4899999999999999986533 34688999999999999999999998 999999999999999999999999999
Q ss_pred ceeeC
Q 017558 350 AKHSL 354 (369)
Q Consensus 350 a~~~~ 354 (369)
++...
T Consensus 160 ~~~~~ 164 (275)
T cd06608 160 SAQLD 164 (275)
T ss_pred ceecc
Confidence 87654
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-24 Score=185.77 Aligned_cols=142 Identities=15% Similarity=0.140 Sum_probs=109.9
Q ss_pred cceecccCceEEEEEEEcCCeEEEEEeeccCCcc--c-------H-----------------HHHHHHHHHHHhcCCCcc
Q 017558 207 ANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQ--G-------E-----------------REFQAEIEIISQVHHRHL 260 (369)
Q Consensus 207 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~E~~~l~~l~h~ni 260 (369)
.+.||+|+||.||+|...+|+.||||+++..... . . .....|+++|.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4679999999999999878999999999754211 1 0 122359999999988776
Q ss_pred ccEeeEEEeCCeeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeeecCCCCCcEEECCC
Q 017558 261 VSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYL-HEDCQPKIIHRDIKSANILLDDS 339 (369)
Q Consensus 261 v~l~g~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yL-H~~~~~~ivHrdlk~~Nill~~~ 339 (369)
.....+.. ...+|||||+++++|...+... ..+++.....++.|++.+|.|| |+. +|+||||||+|||+++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~~- 153 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYHD- 153 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEEC-
Confidence 44333222 2348999999988776543222 3588889999999999999999 687 8999999999999984
Q ss_pred CcEEEeeeccceeeCCC
Q 017558 340 FEAKVADFGLAKHSLDT 356 (369)
Q Consensus 340 ~~~ki~DFGla~~~~~~ 356 (369)
+.++|+|||+|....+.
T Consensus 154 ~~v~LiDFG~a~~~~~~ 170 (190)
T cd05147 154 GKLYIIDVSQSVEHDHP 170 (190)
T ss_pred CcEEEEEccccccCCCc
Confidence 78999999999865543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.4e-24 Score=201.31 Aligned_cols=150 Identities=26% Similarity=0.455 Sum_probs=128.2
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccC--CcccHHHHHHHHHHHHhc-CCCccccEeeEEEeC--Cee
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG--SGQGEREFQAEIEIISQV-HHRHLVSLVGYCTFG--SQR 273 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~--~~~ 273 (369)
..++|+..+.||+|+||.||+|... +++.+|+|++... .......+.+|+.++.++ +|+||++++++|... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3567888999999999999999965 5789999988543 222334677899999999 999999999998653 367
Q ss_pred EEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceee
Q 017558 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (369)
Q Consensus 274 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~ 353 (369)
|+||||++ ++|..++... .+.+..+..++.||+.||.|||++ +++||||||+|||++.++.+||+|||+++..
T Consensus 85 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred EEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 99999997 5898888653 578999999999999999999998 9999999999999999999999999999876
Q ss_pred CCC
Q 017558 354 LDT 356 (369)
Q Consensus 354 ~~~ 356 (369)
...
T Consensus 158 ~~~ 160 (337)
T cd07852 158 SEL 160 (337)
T ss_pred ccc
Confidence 543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.7e-24 Score=194.18 Aligned_cols=141 Identities=29% Similarity=0.380 Sum_probs=126.1
Q ss_pred ecccCceEEEEEEEcC-CeEEEEEeeccCCc---ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEecCCCcH
Q 017558 210 LGQGGFGYVHKGVLTN-GKVVAIKQLKAGSG---QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTL 285 (369)
Q Consensus 210 lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g~L 285 (369)
||.|+||.||+++... ++.+++|.+..... ...+.+.+|++++.+++|+||+++++.+......|++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999764 88999999865433 3345788999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 286 EFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 286 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
.+++.... .+++..++.++.||+.||.|||++ +++|+||+++||++++++.+||+|||++.....
T Consensus 81 ~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~ 145 (265)
T cd05579 81 ASLLENVG--SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLV 145 (265)
T ss_pred HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhccc
Confidence 99997643 589999999999999999999998 999999999999999999999999999886543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.4e-24 Score=194.71 Aligned_cols=147 Identities=26% Similarity=0.438 Sum_probs=129.5
Q ss_pred CcccceecccCceEEEEEEEc-CCeEEEEEeeccCCc--ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEec
Q 017558 204 FSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 280 (369)
Q Consensus 204 ~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 280 (369)
|+..+.||.|.+|.||+|... ++..||+|++..... ...+.+.+|++++++++|+|++++++++.+.+..|++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 566789999999999999864 688999999865432 22356889999999999999999999999999999999999
Q ss_pred CCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 281 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 281 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
+ ++|.+++.......+++..++.++.|+++||+|||++ +++||||+|+||++++++.+||+|||+++...
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~ 150 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFG 150 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccC
Confidence 5 6899998765544689999999999999999999998 99999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.5e-24 Score=195.50 Aligned_cols=143 Identities=27% Similarity=0.406 Sum_probs=127.6
Q ss_pred cceecccCceEEEEEEE-cCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEecCCCcH
Q 017558 207 ANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTL 285 (369)
Q Consensus 207 ~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g~L 285 (369)
...||+|+||.||++.. .+++.||||++..........+.+|+.++++++|+||+++++++...+..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 35799999999999986 46889999998655444456789999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 286 EFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 286 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
.+++... .+++.....++.|++.||+|||++ +++|+||+|+||++++++.++|+|||+++....
T Consensus 105 ~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~ 168 (292)
T cd06657 105 TDIVTHT---RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 168 (292)
T ss_pred HHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccc
Confidence 9987542 478999999999999999999998 999999999999999999999999999886644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.2e-24 Score=195.39 Aligned_cols=158 Identities=30% Similarity=0.439 Sum_probs=134.4
Q ss_pred CHHHHHHhhcCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCCcccHHHHHHHHHHHHhc-CCCccccEeeEEEe-
Q 017558 193 TYEELKIATDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHRHLVSLVGYCTF- 269 (369)
Q Consensus 193 ~~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~- 269 (369)
++.++....+.|+..+.||.|+||.||+|.. .+++.+|+|.+.... ....++..|+.++.++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 3444555667889999999999999999996 457889999886543 2335788899999998 69999999999853
Q ss_pred -----CCeeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEE
Q 017558 270 -----GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKV 344 (369)
Q Consensus 270 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki 344 (369)
....|++|||+++|+|.+++.......+++..+..++.||+.||.|||++ +++|+|||++||++++++.+||
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l 162 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKL 162 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEE
Confidence 45789999999999999999765545688888899999999999999998 9999999999999999999999
Q ss_pred eeeccceeeC
Q 017558 345 ADFGLAKHSL 354 (369)
Q Consensus 345 ~DFGla~~~~ 354 (369)
+|||+++...
T Consensus 163 ~dfg~~~~~~ 172 (282)
T cd06636 163 VDFGVSAQLD 172 (282)
T ss_pred eeCcchhhhh
Confidence 9999987653
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.9e-24 Score=194.44 Aligned_cols=150 Identities=30% Similarity=0.420 Sum_probs=134.7
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEE
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 278 (369)
..+.|+..+.||+|.||.||++... ++..+++|.++.... ..+.+.+|++++.+++|+||+++++++......|+++|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4566788899999999999999975 578899999976544 45678999999999999999999999999999999999
Q ss_pred ecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
|+++++|.+++.... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++....
T Consensus 96 ~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 167 (286)
T cd06614 96 YMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLT 167 (286)
T ss_pred ccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhc
Confidence 999999999998654 3589999999999999999999998 99999999999999999999999999887544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.3e-24 Score=196.06 Aligned_cols=148 Identities=29% Similarity=0.387 Sum_probs=127.7
Q ss_pred cCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCc---ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEE
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG---QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 277 (369)
+.|+..+.||+|.||.||++... +++.||+|++..... ...+++.+|++++..++|+||++++++|...+..|+||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45778899999999999999864 578999999864332 22346889999999999999999999999999999999
Q ss_pred EecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 278 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
||++ |+|.+++.... ..+++..+..++.|++.||.|||++ +++||||+|+||++++++.+||+|||+++...
T Consensus 95 e~~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~ 166 (307)
T cd06607 95 EYCL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVS 166 (307)
T ss_pred HhhC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecC
Confidence 9997 56666665332 3589999999999999999999998 99999999999999999999999999997654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-23 Score=189.05 Aligned_cols=151 Identities=23% Similarity=0.353 Sum_probs=134.5
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCc--ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEe
Q 017558 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (369)
Q Consensus 203 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 279 (369)
+|...+.||+|+||.||++... ++..+++|++..... ...+.+.+|++++++++|+|++++++.+......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4778899999999999999965 578999999876533 3456789999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcCCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCC
Q 017558 280 VPNKTLEFHLHGKD--RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 280 ~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~ 356 (369)
+++++|.+++.... ...+++.....++.+++.||.|||++ +++|+||+++||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 99999999997642 35689999999999999999999998 9999999999999999999999999999876544
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=8e-24 Score=194.13 Aligned_cols=145 Identities=26% Similarity=0.400 Sum_probs=129.4
Q ss_pred CcccceecccCceEEEEEEE-cCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEecCC
Q 017558 204 FSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPN 282 (369)
Q Consensus 204 ~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 282 (369)
|...+.||+|+||.||++.. .+++.+++|++........+.+.+|+.++.+++|+||+++++++...+..++++||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 44567899999999999985 46788999998755444456788999999999999999999999999999999999999
Q ss_pred CcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 283 KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 283 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
++|.+++.. ..+++..+..++.|++.||+|||++ +++||||+|+||+++.++.+||+|||+++...
T Consensus 101 ~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~ 166 (285)
T cd06648 101 GALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVS 166 (285)
T ss_pred CCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhc
Confidence 999999875 3488999999999999999999998 99999999999999999999999999987644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=3e-24 Score=195.64 Aligned_cols=150 Identities=28% Similarity=0.367 Sum_probs=133.3
Q ss_pred cCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC---cccHHHHHHHHHHHHhcC-CCccccEeeEEEeCCeeEEE
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVH-HRHLVSLVGYCTFGSQRLLV 276 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv 276 (369)
++|...+.||+|+||.||++... +++.|++|.+.... ....+.+.+|++++.+++ |+||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888999999999999999964 68899999886532 223457889999999998 99999999999999999999
Q ss_pred EEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCC
Q 017558 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 277 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~ 356 (369)
|||+++++|.+++.... .+++...+.++.|++.||.|||++ +++|+||+++||+++.++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 81 LEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred EcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 99999999999997643 589999999999999999999998 9999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.8e-24 Score=191.11 Aligned_cols=142 Identities=27% Similarity=0.323 Sum_probs=126.4
Q ss_pred ecccCceEEEEEEEc-CCeEEEEEeeccCCc---ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEecCCCcH
Q 017558 210 LGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG---QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTL 285 (369)
Q Consensus 210 lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g~L 285 (369)
||.|+||.||+++.. +++.+++|.+..... ...+.+.+|++++++++|+||+++++++.++...|++|||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999975 378999999865432 2345789999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCC
Q 017558 286 EFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 286 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~ 356 (369)
.+++... ..+++..+..++.||+.||.|||++ +++|+||+++||+++.++.+||+|||+++...+.
T Consensus 81 ~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~ 146 (262)
T cd05572 81 WTILRDR--GLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG 146 (262)
T ss_pred HHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCcc
Confidence 9999764 3488899999999999999999998 9999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.3e-24 Score=196.58 Aligned_cols=151 Identities=30% Similarity=0.420 Sum_probs=129.0
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcc--cHHHHHHHHHHHHhcCCCccccEeeEEEeC--CeeEE
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ--GEREFQAEIEIISQVHHRHLVSLVGYCTFG--SQRLL 275 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~l 275 (369)
.++|+..+.||+|+||.||+|... +++.||+|.++..... ....+.+|++++.+++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467889999999999999999964 5889999998754322 123567899999999999999999998765 56899
Q ss_pred EEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 276 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 276 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
||||+. ++|.+++.... ..+++.++..++.||+.||.|||+. +++||||||+||++++++.+||+|||+++....
T Consensus 86 v~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 86 VMEYCE-QDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160 (309)
T ss_pred EEecCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence 999996 47888876533 4589999999999999999999998 999999999999999999999999999987654
Q ss_pred C
Q 017558 356 T 356 (369)
Q Consensus 356 ~ 356 (369)
.
T Consensus 161 ~ 161 (309)
T cd07845 161 P 161 (309)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=7e-24 Score=193.92 Aligned_cols=141 Identities=26% Similarity=0.334 Sum_probs=118.4
Q ss_pred eecccCceEEEEEEEc-CCeEEEEEeeccCCcc---cHHHHHHHHHHHH---hcCCCccccEeeEEEeCCeeEEEEEecC
Q 017558 209 LLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ---GEREFQAEIEIIS---QVHHRHLVSLVGYCTFGSQRLLVYEFVP 281 (369)
Q Consensus 209 ~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~---~l~h~niv~l~g~~~~~~~~~lv~e~~~ 281 (369)
.||+|+||.||++... +++.+|+|.+...... ....+.+|..++. ..+|+||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999964 5789999988654321 1223444544333 3479999999999999999999999999
Q ss_pred CCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 282 NKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 282 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
+++|.+++.... .+++.....++.|++.||.|||++ +++||||||+|||+++++.+||+|||+++...
T Consensus 81 ~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~ 148 (279)
T cd05633 81 GGDLHYHLSQHG--VFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFS 148 (279)
T ss_pred CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceecc
Confidence 999999987543 489999999999999999999998 89999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.6e-24 Score=191.62 Aligned_cols=152 Identities=24% Similarity=0.390 Sum_probs=129.8
Q ss_pred CCcccceecccCceEEEEEEE-cCCeEEEEEeeccCC--cccHHHHHHHHHHHHhcCCCccccEeeEEEe--CCeeEEEE
Q 017558 203 NFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTF--GSQRLLVY 277 (369)
Q Consensus 203 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lv~ 277 (369)
+|++.+.||.|+||.||++.. .++..+|+|.+.... ....+.+..|++++++++|+||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 477889999999999999985 457889999886543 2234578899999999999999999998764 45679999
Q ss_pred EecCCCcHhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCCeeecCCCCCcEEECCCCcEEEeeeccc
Q 017558 278 EFVPNKTLEFHLHGK--DRPVMNWPTRMKIALGSARGLAYLH-----EDCQPKIIHRDIKSANILLDDSFEAKVADFGLA 350 (369)
Q Consensus 278 e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~yLH-----~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla 350 (369)
||+++++|.+++... ....+++..++.++.||+.||.||| +. +++|+||||+||++++++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999998643 2345899999999999999999999 66 8999999999999999999999999999
Q ss_pred eeeCCCC
Q 017558 351 KHSLDTD 357 (369)
Q Consensus 351 ~~~~~~~ 357 (369)
+......
T Consensus 158 ~~~~~~~ 164 (265)
T cd08217 158 KILGHDS 164 (265)
T ss_pred ccccCCc
Confidence 9876543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-23 Score=188.57 Aligned_cols=150 Identities=32% Similarity=0.465 Sum_probs=134.3
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCc--ccHHHHHHHHHHHHhcCCCccccEeeEEEeC--CeeEEEE
Q 017558 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFG--SQRLLVY 277 (369)
Q Consensus 203 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lv~ 277 (369)
+|...+.||+|++|.||+|... +++.+++|++..... ...+.+.+|++++++++|+||+++++.+... ...+++|
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677899999999999999976 688999999876543 3456889999999999999999999999988 8899999
Q ss_pred EecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCCC
Q 017558 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (369)
Q Consensus 278 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~~ 357 (369)
||+++++|.+++.... .+++..+..++.|++.+|.|||+. +++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 81 EYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred EecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence 9999999999997654 689999999999999999999998 99999999999999999999999999998876543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3e-25 Score=200.91 Aligned_cols=164 Identities=27% Similarity=0.344 Sum_probs=138.4
Q ss_pred HhhcCCcccceecccCceEEEEEEEcC-CeEEEEEeeccCCcc---cHHHHHHHHHHHHhc-CCCccccEeeEEEeCCee
Q 017558 199 IATDNFSEANLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGSGQ---GEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQR 273 (369)
Q Consensus 199 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 273 (369)
+...+|.+..+||+|+||+|.++..++ .+.+|||+++++... +.+--+.|-++|+.. +-|.+++|...++..+.+
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL 425 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL 425 (683)
T ss_pred eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence 345678889999999999999998654 568999999876432 223345677888776 468899999999999999
Q ss_pred EEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceee
Q 017558 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (369)
Q Consensus 274 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~ 353 (369)
|+||||+.||+|..+++.-+ .+.+..++.+|.+||-||-|||++ +||+||||..||+||.+|++||+||||++..
T Consensus 426 yFVMEyvnGGDLMyhiQQ~G--kFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 426 YFVMEYVNGGDLMYHIQQVG--KFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred eeEEEEecCchhhhHHHHhc--ccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccccccc
Confidence 99999999999999997654 488889999999999999999999 9999999999999999999999999999986
Q ss_pred CCCCceeeeeecccC
Q 017558 354 LDTDTHVSTRVMGTF 368 (369)
Q Consensus 354 ~~~~~~~~~~~~gt~ 368 (369)
.-.+. .+.+.+||+
T Consensus 501 i~~~~-TTkTFCGTP 514 (683)
T KOG0696|consen 501 IFDGV-TTKTFCGTP 514 (683)
T ss_pred ccCCc-ceeeecCCC
Confidence 65554 344578886
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.2e-25 Score=181.81 Aligned_cols=157 Identities=24% Similarity=0.420 Sum_probs=128.3
Q ss_pred HHHhhcCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCC-cccHHHHHHHHHHHHhc-CCCccccEeeEEEeCCee
Q 017558 197 LKIATDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGS-GQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQR 273 (369)
Q Consensus 197 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 273 (369)
+++..+++..++.||+|++|.|-+-++ .+|...|+|+++..- .+..+..++|+++..+. ..|.+|.++|.+......
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 344555666678899999999888774 478999999997653 34445788999986665 699999999999999999
Q ss_pred EEEEEecCCCcHhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccce
Q 017558 274 LLVYEFVPNKTLEFHLHG--KDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351 (369)
Q Consensus 274 ~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~ 351 (369)
|+.||.|+ .+|+.+... .......+.-.-+|+..|..||.|||++. .+||||+||+||||+.+|++||||||++.
T Consensus 121 wIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 121 WICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred EEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccce
Confidence 99999994 566555432 12345778888899999999999999985 89999999999999999999999999998
Q ss_pred eeCCC
Q 017558 352 HSLDT 356 (369)
Q Consensus 352 ~~~~~ 356 (369)
.+.+.
T Consensus 198 ~L~dS 202 (282)
T KOG0984|consen 198 YLVDS 202 (282)
T ss_pred eehhh
Confidence 87654
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-23 Score=199.44 Aligned_cols=148 Identities=25% Similarity=0.358 Sum_probs=126.7
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC--cccHHHHHHHHHHHHhcCCCccccEeeEEEeC------
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFG------ 270 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------ 270 (369)
..++|+..+.||+|+||.||++... +++.||+|.+.... ......+.+|+.++.+++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999954 68899999986432 22335677899999999999999999988643
Q ss_pred CeeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccc
Q 017558 271 SQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLA 350 (369)
Q Consensus 271 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla 350 (369)
...|+||||+. ++|.+++... +++.....++.|++.||+|||++ +++||||||+|||++.++.+||+|||++
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~~ 165 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 165 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCccc
Confidence 35699999995 5788877532 78889999999999999999998 9999999999999999999999999999
Q ss_pred eeeCC
Q 017558 351 KHSLD 355 (369)
Q Consensus 351 ~~~~~ 355 (369)
+....
T Consensus 166 ~~~~~ 170 (353)
T cd07850 166 RTAGT 170 (353)
T ss_pred eeCCC
Confidence 87654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-23 Score=194.80 Aligned_cols=150 Identities=31% Similarity=0.439 Sum_probs=127.0
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcc--cHHHHHHHHHHHHhcCCCccccEeeEEEeCC------
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ--GEREFQAEIEIISQVHHRHLVSLVGYCTFGS------ 271 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------ 271 (369)
.++|+..+.||+|+||.||++... +++.||||++...... ....+.+|++++++++|+||++++++|....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 457889999999999999999964 5789999988654322 2235678999999999999999999987654
Q ss_pred --eeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeecc
Q 017558 272 --QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGL 349 (369)
Q Consensus 272 --~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGl 349 (369)
..++||||+. ++|.+++.... ..+++.+.+.++.||+.||.|||++ +++|+||||+||+++.++.+||+|||+
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCC
Confidence 3499999996 47877776543 3589999999999999999999998 999999999999999999999999999
Q ss_pred ceeeCC
Q 017558 350 AKHSLD 355 (369)
Q Consensus 350 a~~~~~ 355 (369)
++....
T Consensus 166 ~~~~~~ 171 (310)
T cd07865 166 ARAFSL 171 (310)
T ss_pred cccccC
Confidence 987643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-23 Score=180.27 Aligned_cols=143 Identities=13% Similarity=0.078 Sum_probs=112.9
Q ss_pred cceecccCceEEEEEEEcCCeEEEEEeeccCCcc---------------------c-----HHHHHHHHHHHHhcCCCcc
Q 017558 207 ANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQ---------------------G-----EREFQAEIEIISQVHHRHL 260 (369)
Q Consensus 207 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---------------------~-----~~~~~~E~~~l~~l~h~ni 260 (369)
.+.||+|+||.||+|...+|+.||||+++..... . ...+..|.+.+.++.|++|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999999878999999998765211 0 1123578999999999987
Q ss_pred ccEeeEEEeCCeeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCcEEECCC
Q 017558 261 VSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHE-DCQPKIIHRDIKSANILLDDS 339 (369)
Q Consensus 261 v~l~g~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivHrdlk~~Nill~~~ 339 (369)
.....+... ..||||||++++++....... ..++......++.|++.+|.|||+ + +|+||||||+|||++ +
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~-~ 153 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH-D 153 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-C
Confidence 554444332 348999999988554332222 246778889999999999999999 7 999999999999999 7
Q ss_pred CcEEEeeeccceeeCCCC
Q 017558 340 FEAKVADFGLAKHSLDTD 357 (369)
Q Consensus 340 ~~~ki~DFGla~~~~~~~ 357 (369)
+.++|+|||+|+...+..
T Consensus 154 ~~~~liDFG~a~~~~~~~ 171 (190)
T cd05145 154 GKPYIIDVSQAVELDHPN 171 (190)
T ss_pred CCEEEEEcccceecCCCC
Confidence 899999999999876653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.4e-24 Score=199.25 Aligned_cols=149 Identities=23% Similarity=0.419 Sum_probs=128.4
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCc--ccHHHHHHHHHHHHhcCCCccccEeeEEEe----CCee
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTF----GSQR 273 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~ 273 (369)
.++|+..+.||+|+||.||+|... ++..||+|++..... ...+.+.+|+.+|.+++|+||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 368888999999999999999954 588999999875422 234567889999999999999999998753 3467
Q ss_pred EEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceee
Q 017558 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (369)
Q Consensus 274 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~ 353 (369)
|+||||+. ++|.+++.... .+++..+..++.||+.||.|||++ +++||||||+|||+++++.+||+|||+++..
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQ--PLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEEehhh-hhHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceee
Confidence 99999995 68988886543 489999999999999999999998 9999999999999999999999999999876
Q ss_pred CC
Q 017558 354 LD 355 (369)
Q Consensus 354 ~~ 355 (369)
..
T Consensus 158 ~~ 159 (334)
T cd07855 158 SS 159 (334)
T ss_pred cc
Confidence 43
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-24 Score=192.07 Aligned_cols=164 Identities=25% Similarity=0.361 Sum_probs=142.0
Q ss_pred HhhcCCcccceecccCceEEEEEEE-cCCeEEEEEeeccC---CcccHHHHHHHHHHHHhc-CCCccccEeeEEEeCCee
Q 017558 199 IATDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAG---SGQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQR 273 (369)
Q Consensus 199 ~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 273 (369)
...++|.+.++||+|+|.+|.++++ ++.+.+|+|++++. ..++..-.+.|-.++.+. +||.+|.|..+|+.+..+
T Consensus 247 l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrl 326 (593)
T KOG0695|consen 247 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRL 326 (593)
T ss_pred cccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceE
Confidence 4567899999999999999999995 45789999998764 333445567888888877 699999999999999999
Q ss_pred EEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceee
Q 017558 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (369)
Q Consensus 274 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~ 353 (369)
++|.||++||+|..+++.+. .++++.+.++...|+.||.|||+. |||+||||..|||||..|++||+|+||++..
T Consensus 327 ffvieyv~ggdlmfhmqrqr--klpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 327 FFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred EEEEEEecCcceeeehhhhh--cCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcC
Confidence 99999999999998887654 489999999999999999999999 9999999999999999999999999999997
Q ss_pred CCCCceeeeeecccC
Q 017558 354 LDTDTHVSTRVMGTF 368 (369)
Q Consensus 354 ~~~~~~~~~~~~gt~ 368 (369)
..... .+.+.+||+
T Consensus 402 l~~gd-~tstfcgtp 415 (593)
T KOG0695|consen 402 LGPGD-TTSTFCGTP 415 (593)
T ss_pred CCCCc-ccccccCCC
Confidence 76543 345578886
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-23 Score=197.66 Aligned_cols=155 Identities=24% Similarity=0.391 Sum_probs=131.7
Q ss_pred HHHHHHhhcCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCC--cccHHHHHHHHHHHHhcCCCccccEeeEEEeC
Q 017558 194 YEELKIATDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFG 270 (369)
Q Consensus 194 ~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~ 270 (369)
.+++....++|...+.||+|+||.||++.. .+++.||+|+++... ....+.+.+|++++.+++|+||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 455667789999999999999999999985 468899999987542 22345678899999999999999999988643
Q ss_pred ------CeeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEE
Q 017558 271 ------SQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKV 344 (369)
Q Consensus 271 ------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki 344 (369)
...|++++++ +++|.+++... .+++..+..++.||+.||.|||++ +++||||||+||++++++.+||
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl 161 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKI 161 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEE
Confidence 3467888887 78998887542 488999999999999999999998 9999999999999999999999
Q ss_pred eeeccceeeCC
Q 017558 345 ADFGLAKHSLD 355 (369)
Q Consensus 345 ~DFGla~~~~~ 355 (369)
+|||+++....
T Consensus 162 ~dfg~~~~~~~ 172 (345)
T cd07877 162 LDFGLARHTDD 172 (345)
T ss_pred ecccccccccc
Confidence 99999987543
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.3e-24 Score=196.19 Aligned_cols=146 Identities=18% Similarity=0.168 Sum_probs=125.1
Q ss_pred ccceecccCceEEEEEEEcCCeEEEEEeeccC--CcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEecCCC
Q 017558 206 EANLLGQGGFGYVHKGVLTNGKVVAIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNK 283 (369)
Q Consensus 206 ~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 283 (369)
+.+.+|.|+++.||++.. +++.||||+++.. .....+.+.+|++++++++|+||+++++++...+..+++|||+++|
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 345556666666666665 6889999998754 2334467999999999999999999999999999999999999999
Q ss_pred cHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 284 TLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 284 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
+|.+++.......+++.....++.|++.||+|||++ +|+|||||++|||++.++.+||+|||++.....
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~ 153 (314)
T cd08216 85 SCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIK 153 (314)
T ss_pred CHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecc
Confidence 999999765444588899999999999999999998 999999999999999999999999999876543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=197.92 Aligned_cols=149 Identities=25% Similarity=0.404 Sum_probs=127.9
Q ss_pred hhcCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCCc--ccHHHHHHHHHHHHhcCCCccccEeeEEEeCC-----
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFGS----- 271 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----- 271 (369)
..++|+..+.||+|+||.||++.. .++..||||++..... ...+.+.+|+++|.+++|+||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 467899999999999999999985 4688999999864322 22346889999999999999999999987543
Q ss_pred -eeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccc
Q 017558 272 -QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLA 350 (369)
Q Consensus 272 -~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla 350 (369)
..++||||+ +++|.+++.. ..+++..++.++.||+.||.|||++ +|+||||||+||++++++.+||+|||++
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~~ 165 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLA 165 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccc
Confidence 458999999 7799888754 3488999999999999999999998 9999999999999999999999999999
Q ss_pred eeeCC
Q 017558 351 KHSLD 355 (369)
Q Consensus 351 ~~~~~ 355 (369)
+....
T Consensus 166 ~~~~~ 170 (343)
T cd07880 166 RQTDS 170 (343)
T ss_pred ccccc
Confidence 87543
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.4e-24 Score=202.15 Aligned_cols=150 Identities=25% Similarity=0.352 Sum_probs=128.3
Q ss_pred cCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCc--------ccHHHHHHHHHHHHhcC---CCccccEeeEEEe
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG--------QGEREFQAEIEIISQVH---HRHLVSLVGYCTF 269 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~ 269 (369)
.+|...+.+|+|+||.|++|..+ +...|+||.+.+.+. .+.-.+-.||+||+.++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 45788899999999999999965 456889998865421 11123457999999997 9999999999999
Q ss_pred CCeeEEEEEec-CCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeec
Q 017558 270 GSQRLLVYEFV-PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFG 348 (369)
Q Consensus 270 ~~~~~lv~e~~-~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFG 348 (369)
++..||+||-- ++-+|++++..+ +.+++.+...|++||+.|+++||++ +|||||||-+||.++.+|-+||+|||
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~k--p~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidfg 715 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFK--PRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFG 715 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhcc--CccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeecc
Confidence 99999999976 567999999765 4589999999999999999999999 99999999999999999999999999
Q ss_pred cceeeCCC
Q 017558 349 LAKHSLDT 356 (369)
Q Consensus 349 la~~~~~~ 356 (369)
-|....+.
T Consensus 716 saa~~ksg 723 (772)
T KOG1152|consen 716 SAAYTKSG 723 (772)
T ss_pred chhhhcCC
Confidence 98765443
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.1e-24 Score=198.36 Aligned_cols=148 Identities=23% Similarity=0.391 Sum_probs=126.8
Q ss_pred hcCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCC-cccHHHHHHHHHHHHhcCCCccccEeeEEEeC-----Cee
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFG-----SQR 273 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~ 273 (369)
.++|++.+.||+|+||.||+|.. .+++.||||++.... ......+.+|+.++.+++|+||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 46899999999999999999985 457899999986432 22345688899999999999999999987654 357
Q ss_pred EEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceee
Q 017558 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (369)
Q Consensus 274 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~ 353 (369)
|+|+||+. ++|..++.. ..+++..+..++.|++.||.|||++ +++||||||+|||++.++.+||+|||+++..
T Consensus 84 ~lv~e~~~-~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 156 (336)
T cd07849 84 YIVQELME-TDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIA 156 (336)
T ss_pred EEEehhcc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceeec
Confidence 99999996 478777754 3488999999999999999999998 9999999999999999999999999999876
Q ss_pred CC
Q 017558 354 LD 355 (369)
Q Consensus 354 ~~ 355 (369)
..
T Consensus 157 ~~ 158 (336)
T cd07849 157 DP 158 (336)
T ss_pred cc
Confidence 43
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.1e-23 Score=194.27 Aligned_cols=148 Identities=28% Similarity=0.404 Sum_probs=127.0
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCc---ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEE
Q 017558 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG---QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (369)
Q Consensus 203 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 278 (369)
.|...+.||+|+||.||+++.. ++..+|+|++..... .....+.+|++++++++|+|+++++++|..+...|+|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 3667889999999999999964 578999999864322 223468899999999999999999999999999999999
Q ss_pred ecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
|+. |+|.+++.... ..+++..+..++.|++.||.|||++ +++||||+|+||+++.++.+||+|||+++....
T Consensus 106 ~~~-g~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (317)
T cd06635 106 YCL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASP 177 (317)
T ss_pred CCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence 996 57777765433 3489999999999999999999998 999999999999999999999999999876543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.3e-23 Score=190.35 Aligned_cols=141 Identities=26% Similarity=0.330 Sum_probs=118.4
Q ss_pred eecccCceEEEEEEEc-CCeEEEEEeeccCCcc---cHHHHHHHHH---HHHhcCCCccccEeeEEEeCCeeEEEEEecC
Q 017558 209 LLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ---GEREFQAEIE---IISQVHHRHLVSLVGYCTFGSQRLLVYEFVP 281 (369)
Q Consensus 209 ~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~---~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 281 (369)
.||+|+||.||++... +++.||+|.+...... ....+..|.. ++...+|+||+.+++++...+..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999864 5789999998654221 1122344433 4445679999999999999999999999999
Q ss_pred CCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 282 NKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 282 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
+++|.+++... ..+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+|||+++...
T Consensus 81 g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~ 148 (278)
T cd05606 81 GGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFS 148 (278)
T ss_pred CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccC
Confidence 99999988653 3589999999999999999999998 89999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-23 Score=190.36 Aligned_cols=146 Identities=25% Similarity=0.322 Sum_probs=124.0
Q ss_pred CcccceecccCceEEEEEEEc-CCeEEEEEeeccCCc-ccHHHHHHHHHHHHhcC-CCccccEeeEEEeC--CeeEEEEE
Q 017558 204 FSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVH-HRHLVSLVGYCTFG--SQRLLVYE 278 (369)
Q Consensus 204 ~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~--~~~~lv~e 278 (369)
|+..+.||+|.||.||++... ++..||+|+++.... .......+|+.++.++. |+||+++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 566789999999999999954 578999999875422 22234557899999885 99999999999887 88999999
Q ss_pred ecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
|++ ++|.+++.... ..+++.++..++.|++.||+|||++ +++||||||+||+++. +.+||+|||+++....
T Consensus 81 ~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~ 151 (282)
T cd07831 81 LMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYS 151 (282)
T ss_pred cCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence 997 57777776533 3589999999999999999999998 9999999999999999 9999999999987643
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=192.11 Aligned_cols=148 Identities=26% Similarity=0.363 Sum_probs=129.3
Q ss_pred CcccceecccCceEEEEEEEc-CCeEEEEEeeccCCc-ccHHHHHHHHHHHHhcC-CCccccEeeEEEeCCeeEEEEEec
Q 017558 204 FSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVH-HRHLVSLVGYCTFGSQRLLVYEFV 280 (369)
Q Consensus 204 ~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~~ 280 (369)
|.+.+.||+|+||.||+|... +++.|+||++..... .......+|+..+.+++ |+||+++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 566789999999999999975 478899999865432 22234567999999999 999999999999999999999999
Q ss_pred CCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 281 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 281 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
+|+|.+++.......+++..+..++.|++.+|.|||++ +++|+||+++||++++++.++|+|||+++....
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~ 151 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRS 151 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccC
Confidence 88999988765544689999999999999999999998 999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=193.26 Aligned_cols=151 Identities=25% Similarity=0.449 Sum_probs=124.7
Q ss_pred cCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCc-ccHHHHHHHHHHHHhcC-CCccccEeeEEEeCCeeEEEEE
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVH-HRHLVSLVGYCTFGSQRLLVYE 278 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e 278 (369)
++|...+.||+|+||.||++... +++.+|+|.+..... .....+.+|+.++.++. |+||+++++++..+...+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 35566788999999999999964 578999999875432 33457889999999996 9999999999999999999999
Q ss_pred ecCCCcHhh---hhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 279 FVPNKTLEF---HLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 279 ~~~~g~L~~---~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
|+.. +|.+ ++.......+++.....++.|++.||+|||+.. +++||||||+|||++.++.+||+|||+++...+
T Consensus 84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 9864 4433 333333345899999999999999999999742 899999999999999999999999999986543
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.7e-23 Score=189.27 Aligned_cols=148 Identities=30% Similarity=0.447 Sum_probs=126.0
Q ss_pred CcccceecccCceEEEEEEEcC-CeEEEEEeeccCCcc--cHHHHHHHHHHHHhc---CCCccccEeeEEEeCCe-----
Q 017558 204 FSEANLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGSGQ--GEREFQAEIEIISQV---HHRHLVSLVGYCTFGSQ----- 272 (369)
Q Consensus 204 ~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~h~niv~l~g~~~~~~~----- 272 (369)
|++.+.||+|+||.||+++... ++.||+|+++..... ....+.+|++++.++ +|+||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 5678899999999999999764 789999999754322 234566788777665 69999999999988776
Q ss_pred eEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeecccee
Q 017558 273 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (369)
Q Consensus 273 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~ 352 (369)
.+++|||+. ++|.+++.......+++..++.++.|++.||.|||++ +++|+||+++||+++.++.+||+|||+++.
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCccee
Confidence 899999997 4788888765444689999999999999999999998 899999999999999999999999999987
Q ss_pred eCC
Q 017558 353 SLD 355 (369)
Q Consensus 353 ~~~ 355 (369)
...
T Consensus 157 ~~~ 159 (287)
T cd07838 157 YSF 159 (287)
T ss_pred ccC
Confidence 644
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.1e-23 Score=195.75 Aligned_cols=147 Identities=29% Similarity=0.395 Sum_probs=126.5
Q ss_pred cCCc-ccceecccCceEEEEEEEc-CCeEEEEEeeccCCccc--------------HHHHHHHHHHHHhcCCCccccEee
Q 017558 202 DNFS-EANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQG--------------EREFQAEIEIISQVHHRHLVSLVG 265 (369)
Q Consensus 202 ~~~~-~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~g 265 (369)
++|. +.+.||.|+||.||+|... .++.||||+++...... ...+.+|++++.+++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4554 3577999999999999954 58899999986543221 124778999999999999999999
Q ss_pred EEEeCCeeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEe
Q 017558 266 YCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVA 345 (369)
Q Consensus 266 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~ 345 (369)
++...+..++||||+. |+|.+++... ..+++.....++.|++.||.|||+. +++|+||+++|||++.++.+||+
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~ 161 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRK--IRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIA 161 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEEC
Confidence 9999999999999996 6898888643 3488999999999999999999998 99999999999999999999999
Q ss_pred eeccceeeC
Q 017558 346 DFGLAKHSL 354 (369)
Q Consensus 346 DFGla~~~~ 354 (369)
|||+++...
T Consensus 162 dfg~~~~~~ 170 (335)
T PTZ00024 162 DFGLARRYG 170 (335)
T ss_pred Cccceeecc
Confidence 999998765
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-23 Score=196.61 Aligned_cols=150 Identities=22% Similarity=0.435 Sum_probs=128.2
Q ss_pred hcCCcccceecccCceEEEEEEE-cCCeEEEEEeeccC--CcccHHHHHHHHHHHHhcCCCccccEeeEEEeC-----Ce
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFG-----SQ 272 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~ 272 (369)
.++|...+.||+|+||.||++.. .+++.||||.++.. .......+.+|+.++..++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 45788899999999999999985 45789999998753 222345677899999999999999999988654 34
Q ss_pred eEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeecccee
Q 017558 273 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (369)
Q Consensus 273 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~ 352 (369)
.|+||||+. ++|.+++... ..+++.....++.|++.||.|||++ +++||||||+||+++.++.+||+|||+++.
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 157 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLART 157 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence 799999995 6888888654 3489999999999999999999998 999999999999999999999999999987
Q ss_pred eCCC
Q 017558 353 SLDT 356 (369)
Q Consensus 353 ~~~~ 356 (369)
....
T Consensus 158 ~~~~ 161 (337)
T cd07858 158 TSEK 161 (337)
T ss_pred cCCC
Confidence 6543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.9e-25 Score=221.94 Aligned_cols=151 Identities=30% Similarity=0.416 Sum_probs=132.1
Q ss_pred hcCCcccceecccCceEEEEEE-EcCCeEEEEEeeccCC--cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEE
Q 017558 201 TDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 277 (369)
+-++.....||.|.||.||-|. ..+|+..|+|.++-.. ....+.+.+|+.+|..++|||+|+++|+-.+.+..+|.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 4457778899999999999998 5678999999886543 333457889999999999999999999999999999999
Q ss_pred EecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCC
Q 017558 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 278 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~ 356 (369)
|||++|+|.+.+.... .+++.....+-.|++.|+.|||++ ||||||||+.||||+.+|.+|++|||.|+.....
T Consensus 1314 EyC~~GsLa~ll~~gr--i~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGR--IEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred HHhccCcHHHHHHhcc--hhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCc
Confidence 9999999999997543 356666667889999999999999 9999999999999999999999999999987665
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-23 Score=195.50 Aligned_cols=142 Identities=20% Similarity=0.249 Sum_probs=123.5
Q ss_pred ceeccc--CceEEEEEEE-cCCeEEEEEeeccCCcc--cHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEecCC
Q 017558 208 NLLGQG--GFGYVHKGVL-TNGKVVAIKQLKAGSGQ--GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPN 282 (369)
Q Consensus 208 ~~lg~G--~fg~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 282 (369)
+.||+| +||.||+++. .+++.||+|.+...... ..+.+.+|+.+++.++|+||++++++|..++..++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 9999999996 46899999998754322 235788999999999999999999999999999999999999
Q ss_pred CcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeecccee
Q 017558 283 KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (369)
Q Consensus 283 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~ 352 (369)
++|.+++.......+++..+..++.|++.||+|||++ +++||||||+|||++.++.+|++||+.+..
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~ 150 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYS 150 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhh
Confidence 9999998765444588999999999999999999998 999999999999999999999999986543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=9e-24 Score=182.19 Aligned_cols=153 Identities=25% Similarity=0.435 Sum_probs=127.4
Q ss_pred CcccceecccCceEEEEEEEc-CCeEEEEEeeccC-CcccHHHHHHHHHHHHhcC-CCccccEeeEEEeCCeeEEEEEec
Q 017558 204 FSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG-SGQGEREFQAEIEIISQVH-HRHLVSLVGYCTFGSQRLLVYEFV 280 (369)
Q Consensus 204 ~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~~ 280 (369)
.+....||.|+.|.|++++++ .|..+|||.++.. +.+..+.++..++++.+.+ .|.||+.+|||..+...++.||.|
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM 173 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM 173 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence 334567999999999999965 5899999999765 4445567888999877764 899999999999999999999999
Q ss_pred CCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCCCcee
Q 017558 281 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 360 (369)
Q Consensus 281 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~~~~~ 360 (369)
...++.+|..- ...+.+.-+-++...+..||.||.+++ +|+|||+||+|||+|+.|++|+||||++..+.+...+.
T Consensus 174 -s~C~ekLlkri-k~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAht 249 (391)
T KOG0983|consen 174 -STCAEKLLKRI-KGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAHT 249 (391)
T ss_pred -HHHHHHHHHHh-cCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecccccc
Confidence 34455555443 345778777899999999999999986 99999999999999999999999999999887765543
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-23 Score=195.60 Aligned_cols=148 Identities=26% Similarity=0.415 Sum_probs=130.1
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC--cccHHHHHHHHHHHHhcCCCccccEeeEEEeCC-----eeE
Q 017558 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGS-----QRL 274 (369)
Q Consensus 203 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~ 274 (369)
+|.+.+.||+|+||.||+|+.. +++.|+||++.... ....+.+.+|+.++..++|+||+++++++.... ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4778899999999999999975 47899999987643 334467899999999999999999999998765 789
Q ss_pred EEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 275 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 275 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
++|||+. ++|.+++.... .+++..++.++.|++.||.|||++ +++||||||+|||++.++.++|+|||++....
T Consensus 81 lv~e~~~-~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred EEecchh-hhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 9999997 58888886543 689999999999999999999998 99999999999999999999999999998865
Q ss_pred CC
Q 017558 355 DT 356 (369)
Q Consensus 355 ~~ 356 (369)
..
T Consensus 155 ~~ 156 (330)
T cd07834 155 PD 156 (330)
T ss_pred cc
Confidence 54
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.5e-23 Score=187.10 Aligned_cols=150 Identities=31% Similarity=0.440 Sum_probs=131.2
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC--cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEe
Q 017558 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (369)
Q Consensus 203 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 279 (369)
+|++.+.||+|+||.||+++.. +++.+++|.+.... .....++.+|++++++++|+||+++++++......++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4778899999999999999854 57889999987543 22345778999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcCCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 280 VPNKTLEFHLHGKD--RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 280 ~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
+++++|.+++.... ...+++...+.++.|++.||.|||+. +++|+||+++||++++++.+||+|||+++....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~ 155 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKK 155 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhcc
Confidence 99999999986521 24588999999999999999999998 999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.7e-23 Score=191.56 Aligned_cols=153 Identities=25% Similarity=0.425 Sum_probs=127.2
Q ss_pred HhhcCCcccceecccCceEEEEEEEcC-CeEEEEEeeccCCc-ccHHHHHHHHHHHHhcC-CCccccEeeEEEeCCeeEE
Q 017558 199 IATDNFSEANLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGSG-QGEREFQAEIEIISQVH-HRHLVSLVGYCTFGSQRLL 275 (369)
Q Consensus 199 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~l 275 (369)
...++|++.+.||+|.||.||+|.... ++.||||.++.... ....++.+|+.++.+.. |+||++++++|......|+
T Consensus 12 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 91 (296)
T cd06618 12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFI 91 (296)
T ss_pred CCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEE
Confidence 345778889999999999999999764 88999999975432 23346677887776664 9999999999999999999
Q ss_pred EEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 276 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 276 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
||||+. ++|.+++.... ..+++..+..++.||+.||.|||+.. +++||||+|+||++++++.+||+|||+++.+.+
T Consensus 92 v~e~~~-~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 92 CMELMS-TCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred EeeccC-cCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 999985 46666654432 35899999999999999999999732 899999999999999999999999999986543
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.6e-23 Score=186.15 Aligned_cols=142 Identities=26% Similarity=0.287 Sum_probs=120.1
Q ss_pred ceecccCceEEEEEEEc-CCeEEEEEeeccCCcc---cHHHHHHHHHHH-HhcCCCccccEeeEEEeCCeeEEEEEecCC
Q 017558 208 NLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ---GEREFQAEIEII-SQVHHRHLVSLVGYCTFGSQRLLVYEFVPN 282 (369)
Q Consensus 208 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l-~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 282 (369)
+.||+|+||.||+|... +++.||+|.++..... ....+..|..++ ...+|+||+++++++..++..|+||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 56999999999999864 5789999998654321 122344555544 455899999999999999999999999999
Q ss_pred CcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 283 KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 283 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
++|.+++.... .+++..+..++.||+.||.|||+. +++||||+|+||++++++.+||+|||+++...
T Consensus 82 ~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 148 (260)
T cd05611 82 GDCASLIKTLG--GLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGL 148 (260)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceecc
Confidence 99999996543 478889999999999999999998 99999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.4e-23 Score=192.80 Aligned_cols=147 Identities=22% Similarity=0.343 Sum_probs=123.2
Q ss_pred CCcccceecccCceEEEEEEEcC---CeEEEEEeeccCC--cccHHHHHHHHHHHHhc-CCCccccEeeEEEeC----Ce
Q 017558 203 NFSEANLLGQGGFGYVHKGVLTN---GKVVAIKQLKAGS--GQGEREFQAEIEIISQV-HHRHLVSLVGYCTFG----SQ 272 (369)
Q Consensus 203 ~~~~~~~lg~G~fg~Vy~~~~~~---~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~----~~ 272 (369)
+|.+.+.||+|+||.||++.... +..||+|++.... ....+.+.+|++++.++ +|+||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 47778999999999999999643 6789999986532 22245788899999999 599999999976432 35
Q ss_pred eEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeecccee
Q 017558 273 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (369)
Q Consensus 273 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~ 352 (369)
.|+++||+. ++|.+++... ..+++..+..++.||+.||+|||++ +++||||||+|||+++++.+||+|||+++.
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 688899885 6898888643 3588999999999999999999998 999999999999999999999999999987
Q ss_pred eCC
Q 017558 353 SLD 355 (369)
Q Consensus 353 ~~~ 355 (369)
...
T Consensus 155 ~~~ 157 (332)
T cd07857 155 FSE 157 (332)
T ss_pred ccc
Confidence 543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.3e-23 Score=185.61 Aligned_cols=150 Identities=24% Similarity=0.227 Sum_probs=122.8
Q ss_pred HHHHhhcCCccccee--cccCceEEEEEEE-cCCeEEEEEeeccCCcccHHHHHHHHHHHHhc-CCCccccEeeEEEeCC
Q 017558 196 ELKIATDNFSEANLL--GQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGS 271 (369)
Q Consensus 196 ~~~~~~~~~~~~~~l--g~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~ 271 (369)
+.....++|++.+.+ |+|+||.||++.. .++..+|+|.+....... . |+.....+ +|+||+++++++...+
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---~--e~~~~~~~~~h~~iv~~~~~~~~~~ 82 (267)
T PHA03390 8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA---I--EPMVHQLMKDNPNFIKLYYSVTTLK 82 (267)
T ss_pred HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch---h--hHHHHHHhhcCCCEEEEEEEEecCC
Confidence 334445667776666 9999999999995 457889999886532111 1 22222222 7999999999999999
Q ss_pred eeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCC-cEEEeeeccc
Q 017558 272 QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF-EAKVADFGLA 350 (369)
Q Consensus 272 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~-~~ki~DFGla 350 (369)
..|+||||+++++|.+++.... .+++.++..++.||+.||.|||+. +++||||||+||+++.++ .++|+|||++
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~ 157 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLC 157 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccc
Confidence 9999999999999999997653 589999999999999999999998 899999999999999988 9999999999
Q ss_pred eeeCC
Q 017558 351 KHSLD 355 (369)
Q Consensus 351 ~~~~~ 355 (369)
+....
T Consensus 158 ~~~~~ 162 (267)
T PHA03390 158 KIIGT 162 (267)
T ss_pred eecCC
Confidence 87654
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3e-25 Score=190.51 Aligned_cols=151 Identities=26% Similarity=0.436 Sum_probs=123.7
Q ss_pred cCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCc-ccHHHHHHHHHHH-HhcCCCccccEeeEEEeCCeeEEEEE
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG-QGEREFQAEIEII-SQVHHRHLVSLVGYCTFGSQRLLVYE 278 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l-~~l~h~niv~l~g~~~~~~~~~lv~e 278 (369)
++.+....||.|.||.|++-.++ .|+..|||+++.... .+.++++.|.+.. +.-+.||||+++|.+..++..||.||
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME 143 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME 143 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence 44455678999999999998854 589999999988765 4456788888864 45579999999999999999999999
Q ss_pred ecCCCcHhhhh---cCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 279 FVPNKTLEFHL---HGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 279 ~~~~g~L~~~l---~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
.|+ .+|+.+. +.-....+++.-.-+|...+..||.||.+.. .|||||+||+|||||..|.+||||||++..+.+
T Consensus 144 LMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~ 220 (361)
T KOG1006|consen 144 LMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD 220 (361)
T ss_pred HHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence 994 4554332 2223345788888889999999999999875 899999999999999999999999999987654
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-22 Score=188.44 Aligned_cols=146 Identities=29% Similarity=0.424 Sum_probs=125.4
Q ss_pred CcccceecccCceEEEEEEEc-CCeEEEEEeeccCCc---ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEe
Q 017558 204 FSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG---QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (369)
Q Consensus 204 ~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 279 (369)
|...+.||+|+||.||+|+.. ++..|++|++..... ...+.+.+|++++++++|+|++++++++.+....|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 555678999999999999863 578999999865332 2234688899999999999999999999999999999999
Q ss_pred cCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
+. |+|.+++.... ..+++.+++.++.||+.+|.|||++ +++|+||+|+||++++++.+||+|||++....
T Consensus 103 ~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~ 172 (313)
T cd06633 103 CL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSS 172 (313)
T ss_pred CC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccC
Confidence 95 57777775433 3589999999999999999999998 99999999999999999999999999987543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.2e-23 Score=192.62 Aligned_cols=150 Identities=25% Similarity=0.384 Sum_probs=128.5
Q ss_pred HHhhcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC--cccHHHHHHHHHHHHhcCCCccccEeeEEEe-CCee
Q 017558 198 KIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTF-GSQR 273 (369)
Q Consensus 198 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~ 273 (369)
....++|+..+.||+|+||.||++... +++.||||++.... ....+.+.+|++++.+++||||++++++|.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 346788999999999999999999854 68899999886432 2234578899999999999999999999865 5578
Q ss_pred EEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceee
Q 017558 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (369)
Q Consensus 274 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~ 353 (369)
|++|||+ +++|..++... .+.+.....++.|++.||.|||++ +++||||+|+|||+++++.+||+|||+++..
T Consensus 86 ~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~ 158 (328)
T cd07856 86 YFVTELL-GTDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQ 158 (328)
T ss_pred EEEeehh-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcccccccc
Confidence 9999999 56898888642 477888889999999999999998 9999999999999999999999999999865
Q ss_pred C
Q 017558 354 L 354 (369)
Q Consensus 354 ~ 354 (369)
.
T Consensus 159 ~ 159 (328)
T cd07856 159 D 159 (328)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.6e-23 Score=187.67 Aligned_cols=148 Identities=26% Similarity=0.407 Sum_probs=129.3
Q ss_pred CcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcc--cHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEec
Q 017558 204 FSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ--GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 280 (369)
Q Consensus 204 ~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 280 (369)
|+..+.||+|++|.||++... +++.+++|+++..... ....+.+|++++++++|+||+++++++..+...++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 456788999999999999864 6788999998754332 3457889999999999999999999999999999999999
Q ss_pred CCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCC
Q 017558 281 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 281 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~ 356 (369)
++ +|.+++.... ..+++..+..++.||+.||.|||++ +++|+||||+||++++++.+||+|||++......
T Consensus 81 ~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~ 151 (283)
T cd05118 81 DT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSP 151 (283)
T ss_pred CC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCC
Confidence 75 8888876543 3589999999999999999999998 9999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.3e-23 Score=188.35 Aligned_cols=148 Identities=28% Similarity=0.419 Sum_probs=129.9
Q ss_pred CcccceecccCceEEEEEEEc-CCeEEEEEeeccCC--cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEec
Q 017558 204 FSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 280 (369)
Q Consensus 204 ~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 280 (369)
|+..+.||+|.||.||+|+.. +++.+++|.+.... ....+.+..|++++++++|+||+++++++...+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 456788999999999999965 48899999987653 223457889999999999999999999999999999999999
Q ss_pred CCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCC
Q 017558 281 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 281 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~ 356 (369)
+ ++|.+++.... ..+++..+..++.|++.||.|||++ +++||||+++||++++++.+||+|||+++.....
T Consensus 81 ~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~ 151 (282)
T cd07829 81 D-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIP 151 (282)
T ss_pred C-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCC
Confidence 7 58999997643 3589999999999999999999998 9999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=188.35 Aligned_cols=148 Identities=28% Similarity=0.392 Sum_probs=126.5
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC---cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEE
Q 017558 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (369)
Q Consensus 203 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 278 (369)
.|...+.||+|+||.||+|... ++..+++|.+.... ....+++.+|+++++.++|+|++++++++......|+|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 3666788999999999999964 57889999886432 2233468899999999999999999999999999999999
Q ss_pred ecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
|+. |+|.+++.... ..+++..+..++.|++.||.|||++ +++||||+|+|||++.++.+||+|||++.....
T Consensus 96 ~~~-~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 96 YCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred ccC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence 996 67777765433 3478999999999999999999998 999999999999999999999999999987554
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=182.20 Aligned_cols=141 Identities=33% Similarity=0.367 Sum_probs=126.2
Q ss_pred ecccCceEEEEEEEc-CCeEEEEEeeccCCcc---cHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEecCCCcH
Q 017558 210 LGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ---GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTL 285 (369)
Q Consensus 210 lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g~L 285 (369)
||+|+||.||++... +++.+++|.++..... ....+..|++++++++|+||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999975 4789999998765332 345788999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 286 EFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 286 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
.+++.... .+++.....++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++.....
T Consensus 81 ~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~ 145 (250)
T cd05123 81 FSHLSKEG--RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSS 145 (250)
T ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceeccc
Confidence 99997543 488999999999999999999998 999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.89 E-value=7e-23 Score=192.84 Aligned_cols=147 Identities=26% Similarity=0.389 Sum_probs=126.3
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeC---------
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFG--------- 270 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--------- 270 (369)
..+|...+.||.|+||.||+|... +++.||+|++........+.+.+|++++++++|+||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 367889999999999999999864 5789999998766555567789999999999999999999876543
Q ss_pred -----CeeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEC-CCCcEEE
Q 017558 271 -----SQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLD-DSFEAKV 344 (369)
Q Consensus 271 -----~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~-~~~~~ki 344 (369)
...|+||||++ ++|.+++.. ..+.+.....++.||+.||.|||++ +++|||||++|||++ +++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEE
Confidence 35789999997 588888753 2488999999999999999999998 999999999999997 4567899
Q ss_pred eeeccceeeC
Q 017558 345 ADFGLAKHSL 354 (369)
Q Consensus 345 ~DFGla~~~~ 354 (369)
+|||+++...
T Consensus 157 ~dfg~~~~~~ 166 (342)
T cd07854 157 GDFGLARIVD 166 (342)
T ss_pred CCcccceecC
Confidence 9999998654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=190.89 Aligned_cols=146 Identities=25% Similarity=0.422 Sum_probs=124.3
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC--cccHHHHHHHHHHHHhcCCCccccEeeEEEeCC------
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGS------ 271 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------ 271 (369)
.++|...+.||+|+||.||+|+.. +++.||||+++... ......+.+|++++.+++|+||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 478999999999999999999964 68899999986532 222346889999999999999999999986542
Q ss_pred eeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccce
Q 017558 272 QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351 (369)
Q Consensus 272 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~ 351 (369)
..|+|+||+. .+|..++. ..+.+..+..++.|++.||.|||++ +++||||||+|||++.++.+||+|||+++
T Consensus 94 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~ 165 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLAR 165 (342)
T ss_pred eEEEEecccc-cCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence 4689999996 46766652 2488999999999999999999998 89999999999999999999999999998
Q ss_pred eeC
Q 017558 352 HSL 354 (369)
Q Consensus 352 ~~~ 354 (369)
...
T Consensus 166 ~~~ 168 (342)
T cd07879 166 HAD 168 (342)
T ss_pred CCC
Confidence 653
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.8e-23 Score=189.42 Aligned_cols=150 Identities=30% Similarity=0.413 Sum_probs=126.3
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcc--cHHHHHHHHHHHHhcCCCccccEeeEEEeCC------
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ--GEREFQAEIEIISQVHHRHLVSLVGYCTFGS------ 271 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------ 271 (369)
.++|++.+.||+|+||.||+++.. +++.+|||++...... ....+.+|++++.+++|+||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 478999999999999999999964 5788999998654322 2246788999999999999999999875433
Q ss_pred --eeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeecc
Q 017558 272 --QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGL 349 (369)
Q Consensus 272 --~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGl 349 (369)
..++||||+.+ +|..++.... ..+++..+..++.|+++||.|||++ +++|+||||+|||+++++.+||+|||+
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~-~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPS-VKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCcc
Confidence 46999999965 6766665432 3589999999999999999999998 999999999999999999999999999
Q ss_pred ceeeCC
Q 017558 350 AKHSLD 355 (369)
Q Consensus 350 a~~~~~ 355 (369)
++....
T Consensus 162 ~~~~~~ 167 (311)
T cd07866 162 ARPYDG 167 (311)
T ss_pred chhccC
Confidence 986543
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.8e-22 Score=184.79 Aligned_cols=151 Identities=23% Similarity=0.290 Sum_probs=111.6
Q ss_pred HhhcCCcccceecccCceEEEEEEEcCC----eEEEEEeeccCCccc--H---------HHHHHHHHHHHhcCCCccccE
Q 017558 199 IATDNFSEANLLGQGGFGYVHKGVLTNG----KVVAIKQLKAGSGQG--E---------REFQAEIEIISQVHHRHLVSL 263 (369)
Q Consensus 199 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~~----~~vavK~~~~~~~~~--~---------~~~~~E~~~l~~l~h~niv~l 263 (369)
+..++|++.+.||+|+||.||+|...++ ..+|+|......... + .....+...+..++|+||+++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 3456899999999999999999996543 456666543222111 0 011233344566789999999
Q ss_pred eeEEEeCC----eeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCC
Q 017558 264 VGYCTFGS----QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS 339 (369)
Q Consensus 264 ~g~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~ 339 (369)
++++.... ..++++|++. .++.+.+... ..+++..+..|+.|++.||.|||++ +++||||||+|||++.+
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~ 162 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGN 162 (294)
T ss_pred EEeeeEecCCceEEEEEEehhc-cCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCC
Confidence 99776543 3467788764 3555555432 2356788889999999999999998 99999999999999999
Q ss_pred CcEEEeeeccceeeCC
Q 017558 340 FEAKVADFGLAKHSLD 355 (369)
Q Consensus 340 ~~~ki~DFGla~~~~~ 355 (369)
+.+||+|||+|+.+..
T Consensus 163 ~~~~l~DFGla~~~~~ 178 (294)
T PHA02882 163 NRGYIIDYGIASHFII 178 (294)
T ss_pred CcEEEEEcCCceeecc
Confidence 9999999999987653
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.2e-23 Score=184.53 Aligned_cols=149 Identities=21% Similarity=0.316 Sum_probs=123.3
Q ss_pred CCcccceecccCceEEEEEEEcC-CeEEEEEeeccC-----CcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEE
Q 017558 203 NFSEANLLGQGGFGYVHKGVLTN-GKVVAIKQLKAG-----SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (369)
Q Consensus 203 ~~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 276 (369)
+|.+.+.||+|+||.||++.... +..+++|.++.. ......++..|+.++++++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47788999999999999998643 344555554432 112234577899999999999999999999988999999
Q ss_pred EEecCCCcHhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 277 YEFVPNKTLEFHLHG--KDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 277 ~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
|||+++++|.+++.. .....+++..++.++.|++.||.|||++ +++|+|||++||++++ +.+||+|||+++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999998864 2234689999999999999999999998 9999999999999976 469999999998764
Q ss_pred C
Q 017558 355 D 355 (369)
Q Consensus 355 ~ 355 (369)
.
T Consensus 157 ~ 157 (260)
T cd08222 157 G 157 (260)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.9e-25 Score=187.01 Aligned_cols=151 Identities=31% Similarity=0.499 Sum_probs=122.9
Q ss_pred cCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC-ccc-HHHHHHHHHHHHhcCCCccccEeeEEEe--------C
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS-GQG-EREFQAEIEIISQVHHRHLVSLVGYCTF--------G 270 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~-~~~~~~E~~~l~~l~h~niv~l~g~~~~--------~ 270 (369)
..|+...+||+|.||+||+++.. +|+.||+|++.-.+ ... -....+|+++|..++|+|++.|+..|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 45666778999999999999954 46778888764322 111 2356799999999999999999998853 2
Q ss_pred CeeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccc
Q 017558 271 SQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLA 350 (369)
Q Consensus 271 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla 350 (369)
...||||++|+ -+|.-+|.... ..++..++.+++.++..||.|+|.. .|+|||+|+.|+||+.++.+||+|||++
T Consensus 97 ~t~ylVf~~ce-hDLaGlLsn~~-vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 97 ATFYLVFDFCE-HDLAGLLSNRK-VRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred ceeeeeHHHhh-hhHHHHhcCcc-ccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccccc
Confidence 35799999996 46777775442 3588889999999999999999998 9999999999999999999999999999
Q ss_pred eeeCCCC
Q 017558 351 KHSLDTD 357 (369)
Q Consensus 351 ~~~~~~~ 357 (369)
|.+...+
T Consensus 172 r~fs~~~ 178 (376)
T KOG0669|consen 172 RAFSTSK 178 (376)
T ss_pred cceeccc
Confidence 8765443
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=3e-22 Score=173.94 Aligned_cols=139 Identities=18% Similarity=0.182 Sum_probs=108.4
Q ss_pred cccceecccCceEEEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHhc-----CCCccccEeeEEEeCC---eeE-E
Q 017558 205 SEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQV-----HHRHLVSLVGYCTFGS---QRL-L 275 (369)
Q Consensus 205 ~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~g~~~~~~---~~~-l 275 (369)
...+.||+|+||.||. .......+||++........+++.+|++++..+ +||||++++|+++++. ..+ +
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 4467899999999996 333333468988765445567899999999999 5799999999998863 434 7
Q ss_pred EEEe--cCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCeeecCCCCCcEEECC----CCcEEEeeec
Q 017558 276 VYEF--VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGL-AYLHEDCQPKIIHRDIKSANILLDD----SFEAKVADFG 348 (369)
Q Consensus 276 v~e~--~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l-~yLH~~~~~~ivHrdlk~~Nill~~----~~~~ki~DFG 348 (369)
|+|| +.+|+|.+++... .+++. ..++.+++.++ +|||++ +|+||||||+|||++. ++.++|+||+
T Consensus 83 I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 8999 5579999999652 25554 35677888788 899999 9999999999999974 3489999955
Q ss_pred cceee
Q 017558 349 LAKHS 353 (369)
Q Consensus 349 la~~~ 353 (369)
-++.+
T Consensus 155 G~~~~ 159 (210)
T PRK10345 155 GESTF 159 (210)
T ss_pred CCcce
Confidence 55544
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.3e-22 Score=201.78 Aligned_cols=150 Identities=24% Similarity=0.265 Sum_probs=107.4
Q ss_pred hhcCCcccceecccCceEEEEEEEcC-----CeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeE------EE
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVLTN-----GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGY------CT 268 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~------~~ 268 (369)
..++|++.+.||+|+||.||+|+..+ +..||||++...... +....| .+....+.++..++.. +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 45789999999999999999999754 578999987643211 111111 1122222222222211 24
Q ss_pred eCCeeEEEEEecCCCcHhhhhcCCCCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCC
Q 017558 269 FGSQRLLVYEFVPNKTLEFHLHGKDRP------------------VMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIK 330 (369)
Q Consensus 269 ~~~~~~lv~e~~~~g~L~~~l~~~~~~------------------~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk 330 (369)
.+...+|||||+.+++|.++++..... ...+..+..|+.||+.||.|||++ +|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence 567889999999999999998753211 011234557999999999999998 99999999
Q ss_pred CCcEEECC-CCcEEEeeeccceeeCCC
Q 017558 331 SANILLDD-SFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 331 ~~Nill~~-~~~~ki~DFGla~~~~~~ 356 (369)
|+|||+++ ++.+||+|||+|+.+...
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~ 309 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVG 309 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccc
Confidence 99999985 679999999999876443
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.3e-22 Score=191.10 Aligned_cols=149 Identities=28% Similarity=0.449 Sum_probs=128.7
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC--cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCe----
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQ---- 272 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~---- 272 (369)
..++|...+.||+|+||.||+|+.. ++..||||++.... ....+.+.+|+.++++++|+||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4678999999999999999999975 47889999886532 2233567789999999999999999998866554
Q ss_pred --eEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccc
Q 017558 273 --RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLA 350 (369)
Q Consensus 273 --~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla 350 (369)
.++|+||+ +++|.+++.. ..+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+|||++
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~ 165 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLA 165 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccccc
Confidence 89999999 6799998864 3489999999999999999999998 9999999999999999999999999999
Q ss_pred eeeCC
Q 017558 351 KHSLD 355 (369)
Q Consensus 351 ~~~~~ 355 (369)
+....
T Consensus 166 ~~~~~ 170 (343)
T cd07851 166 RHTDD 170 (343)
T ss_pred ccccc
Confidence 87643
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.2e-22 Score=190.08 Aligned_cols=166 Identities=22% Similarity=0.324 Sum_probs=138.6
Q ss_pred HHHhhcCCcccceecccCceEEEEEEEcCCeEEEEEeeccC--CcccHHHHHHHHHHHHhcC-CCccccEeeEEEeCCee
Q 017558 197 LKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAG--SGQGEREFQAEIEIISQVH-HRHLVSLVGYCTFGSQR 273 (369)
Q Consensus 197 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~ 273 (369)
+.+....|++.++||+|+.++||++...+...||+|++... +.....-|..|+..|.+|+ |.+||+|++|-..++.+
T Consensus 356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l 435 (677)
T KOG0596|consen 356 IKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL 435 (677)
T ss_pred EEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence 34556678899999999999999999988889999987543 3334567999999999995 99999999999999999
Q ss_pred EEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceee
Q 017558 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (369)
Q Consensus 274 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~ 353 (369)
||||||= .-+|..+|.........| .+..+..|++.++.++|.+ ||||.||||.|+|+-++ .+||+|||+|+..
T Consensus 436 YmvmE~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVkG-~LKLIDFGIA~aI 509 (677)
T KOG0596|consen 436 YMVMECG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVKG-RLKLIDFGIANAI 509 (677)
T ss_pred EEEeecc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEee-eEEeeeechhccc
Confidence 9999975 678999998776655556 6678999999999999999 99999999999999765 7999999999987
Q ss_pred CCCCcee-eeeecccC
Q 017558 354 LDTDTHV-STRVMGTF 368 (369)
Q Consensus 354 ~~~~~~~-~~~~~gt~ 368 (369)
..+.+.+ ...-+||+
T Consensus 510 ~~DTTsI~kdsQvGT~ 525 (677)
T KOG0596|consen 510 QPDTTSIVKDSQVGTV 525 (677)
T ss_pred CccccceeeccccCcc
Confidence 6654332 23357775
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.2e-23 Score=177.16 Aligned_cols=143 Identities=24% Similarity=0.419 Sum_probs=124.4
Q ss_pred hcCCcccceecccCceEEEEEE-EcCCeEEEEEeeccCCcccHHHHHHHHHHHHhcC-CCccccEeeEEEeC--CeeEEE
Q 017558 201 TDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVH-HRHLVSLVGYCTFG--SQRLLV 276 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~--~~~~lv 276 (369)
.++|++.+.+|+|.|++||.|. ..+++.++||.++.- ..+.+.+|+.||..+. |+||+.|++...+. ....||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 4679999999999999999998 456788999999764 3568999999999997 99999999998764 355799
Q ss_pred EEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECC-CCcEEEeeeccceeeC
Q 017558 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD-SFEAKVADFGLAKHSL 354 (369)
Q Consensus 277 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~-~~~~ki~DFGla~~~~ 354 (369)
+||+++.+...+. +.|+...+..++.+++.||.|+|+. ||+|||+||.|++||. .-.++|+|+|||..+.
T Consensus 114 FE~v~n~Dfk~ly-----~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY-----PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hhhhccccHHHHh-----hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcC
Confidence 9999999987665 3477788899999999999999999 9999999999999995 5679999999998654
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.6e-24 Score=197.61 Aligned_cols=161 Identities=25% Similarity=0.257 Sum_probs=138.6
Q ss_pred hcCCcccceecccCceEEEEEEEcCCe-EEEEEeeccCCc---ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEE
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLTNGK-VVAIKQLKAGSG---QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~-~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 276 (369)
..+++.+..||-|+||.|-++...... .+|+|++++... ...+.+..|-++|..++.+.||+|+..|.++.+.||+
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL 498 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML 498 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence 345666778999999999999875433 489999876543 2345678899999999999999999999999999999
Q ss_pred EEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCC
Q 017558 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 277 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~ 356 (369)
||-|-||.|...|+.++ .|+..+..+++..+.+|++|||.+ +||+|||||+|++||.+|-+||.|||+|+.+...
T Consensus 499 mEaClGGElWTiLrdRg--~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 499 MEACLGGELWTILRDRG--SFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred HHhhcCchhhhhhhhcC--CcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 99999999999997654 488899999999999999999999 9999999999999999999999999999998755
Q ss_pred CceeeeeecccC
Q 017558 357 DTHVSTRVMGTF 368 (369)
Q Consensus 357 ~~~~~~~~~gt~ 368 (369)
. .+-+.+||+
T Consensus 574 ~--KTwTFcGTp 583 (732)
T KOG0614|consen 574 R--KTWTFCGTP 583 (732)
T ss_pred C--ceeeecCCc
Confidence 4 334578886
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.6e-21 Score=171.47 Aligned_cols=149 Identities=32% Similarity=0.387 Sum_probs=133.4
Q ss_pred CcccceecccCceEEEEEEEcC-CeEEEEEeeccCCcc-cHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEecC
Q 017558 204 FSEANLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVP 281 (369)
Q Consensus 204 ~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 281 (369)
|...+.||+|++|.||++...+ ++.+++|.+...... ..+.+.+|++.+.+++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567899999999999999765 789999999866544 56789999999999999999999999999899999999999
Q ss_pred CCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCC
Q 017558 282 NKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 282 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~ 356 (369)
+++|.+++..... .+++.....++.+++.++.|||++ +++|+||+++||+++.++.++|+|||+++.....
T Consensus 81 ~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~ 151 (225)
T smart00221 81 GGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRD 151 (225)
T ss_pred CCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCc
Confidence 9999999976432 178999999999999999999998 9999999999999999999999999999987654
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.6e-24 Score=201.40 Aligned_cols=151 Identities=28% Similarity=0.407 Sum_probs=138.0
Q ss_pred hhcCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEE
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 278 (369)
..++|+....+|.|+||.|||++. ..++..|+|.++.....+..-+..|+-+++.++|+||+.++|.|...+..|++||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 457888899999999999999994 5688999999998877777888999999999999999999999999999999999
Q ss_pred ecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
||.+|+|.+.-+.. ..+++.+..+.+...++||+|||++ +-+|||||-.|||+++.|.+|++|||.+..+..
T Consensus 93 ycgggslQdiy~~T--gplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqita 164 (829)
T KOG0576|consen 93 YCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITA 164 (829)
T ss_pred ecCCCcccceeeec--ccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhh
Confidence 99999999887654 4589999999999999999999999 889999999999999999999999999877643
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.88 E-value=4e-22 Score=177.85 Aligned_cols=133 Identities=23% Similarity=0.188 Sum_probs=115.6
Q ss_pred cCceEEEEEEE-cCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEecCCCcHhhhhcC
Q 017558 213 GGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHG 291 (369)
Q Consensus 213 G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g~L~~~l~~ 291 (369)
|.||.||+++. .+++.||+|+++... .+.+|...+....|+||+++++++...+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 88999999995 467899999987542 344555556667799999999999999999999999999999999865
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 292 KDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 292 ~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
.. .+++.....++.|++.||.|||++ +++||||||+||+++.++.++++|||+++....
T Consensus 79 ~~--~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~ 137 (237)
T cd05576 79 FL--NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVED 137 (237)
T ss_pred hc--CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccc
Confidence 43 489999999999999999999998 999999999999999999999999998876543
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.5e-24 Score=182.65 Aligned_cols=148 Identities=26% Similarity=0.376 Sum_probs=121.3
Q ss_pred CcccceecccCceEEEEEEE-cCCeEEEEEeeccCC--cccHHHHHHHHHHHHhcCCCccccEeeEEEeC-----CeeEE
Q 017558 204 FSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFG-----SQRLL 275 (369)
Q Consensus 204 ~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~l 275 (369)
.+..+.||-|.||.||.+.. ++|+.||+|++-.-- -...+.+-+|+++|.-++|.||+.+++...-. .++|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 34468899999999999884 578999999885421 22345778999999999999999999877543 25678
Q ss_pred EEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 276 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 276 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
+.|.| ..+|...+-. ...++.+...-+.+||++||+|||+. +|+||||||.|.|++.|..+|||||||||....
T Consensus 135 ~TELm-QSDLHKIIVS--PQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 135 LTELM-QSDLHKIIVS--PQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHH-Hhhhhheecc--CCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccch
Confidence 88888 5667666643 34578888888999999999999998 999999999999999999999999999998665
Q ss_pred CC
Q 017558 356 TD 357 (369)
Q Consensus 356 ~~ 357 (369)
.+
T Consensus 209 d~ 210 (449)
T KOG0664|consen 209 RD 210 (449)
T ss_pred hh
Confidence 44
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.6e-21 Score=170.36 Aligned_cols=145 Identities=14% Similarity=0.114 Sum_probs=113.2
Q ss_pred CCcccceecccCceEEEEEE--EcCCeEEEEEeeccCCcc------------------------cHHHHHHHHHHHHhcC
Q 017558 203 NFSEANLLGQGGFGYVHKGV--LTNGKVVAIKQLKAGSGQ------------------------GEREFQAEIEIISQVH 256 (369)
Q Consensus 203 ~~~~~~~lg~G~fg~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 256 (369)
.|.+.+.||+|+||.||+|. ..+|+.||||+++..... ....+.+|++++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47788999999999999998 567999999998754210 0123568999999997
Q ss_pred CCc--cccEeeEEEeCCeeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-eeecCCCCCc
Q 017558 257 HRH--LVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPK-IIHRDIKSAN 333 (369)
Q Consensus 257 h~n--iv~l~g~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~-ivHrdlk~~N 333 (369)
+.+ +..++++ ...+|||||+++++|..++... ..+.......++.||+.+|.|||++ + ++||||||+|
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~N 179 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEYN 179 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChhh
Confidence 533 3444433 2358999999998887665322 2355556778999999999999998 8 9999999999
Q ss_pred EEECCCCcEEEeeeccceeeCCCC
Q 017558 334 ILLDDSFEAKVADFGLAKHSLDTD 357 (369)
Q Consensus 334 ill~~~~~~ki~DFGla~~~~~~~ 357 (369)
|+++ ++.++|+|||+|....+..
T Consensus 180 Ili~-~~~i~LiDFg~a~~~~~~~ 202 (237)
T smart00090 180 ILVH-DGKVVIIDVSQSVELDHPM 202 (237)
T ss_pred EEEE-CCCEEEEEChhhhccCCcc
Confidence 9999 7899999999998765544
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.7e-21 Score=166.62 Aligned_cols=143 Identities=12% Similarity=0.130 Sum_probs=118.2
Q ss_pred HHhhcCCcccceecccCceEEEEEEEcCCeEEEEEeeccCCcccHHH---------HHHHHHHHHhcCCCccccEeeEEE
Q 017558 198 KIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGERE---------FQAEIEIISQVHHRHLVSLVGYCT 268 (369)
Q Consensus 198 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~h~niv~l~g~~~ 268 (369)
.+...+|+..++||.|+||.||+... ++..+|+|.++.......+. +.+|++.+.+++|++|..+..++.
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 46678999999999999999999766 56789999997654333222 678999999999999999998866
Q ss_pred eC--------CeeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCC
Q 017558 269 FG--------SQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF 340 (369)
Q Consensus 269 ~~--------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~ 340 (369)
.. ...+|+|||++|.+|.++.. ++. ....+++.+|..||.. +++|||+||+||+++.++
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g 172 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG 172 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC
Confidence 43 35789999999999987742 222 2456899999999998 999999999999999988
Q ss_pred cEEEeeeccceeeCC
Q 017558 341 EAKVADFGLAKHSLD 355 (369)
Q Consensus 341 ~~ki~DFGla~~~~~ 355 (369)
++|+|||..+...+
T Consensus 173 -i~liDfg~~~~~~e 186 (232)
T PRK10359 173 -LRIIDLSGKRCTAQ 186 (232)
T ss_pred -EEEEECCCcccccc
Confidence 99999999887643
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.8e-20 Score=162.19 Aligned_cols=143 Identities=37% Similarity=0.517 Sum_probs=127.2
Q ss_pred ecccCceEEEEEEEcC-CeEEEEEeeccCCcc-cHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEecCCCcHhh
Q 017558 210 LGQGGFGYVHKGVLTN-GKVVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEF 287 (369)
Q Consensus 210 lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g~L~~ 287 (369)
||+|.+|.||++...+ ++.+++|++...... ..+.+.+|++.+..++|++|+++++++......+++|||+.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999754 789999999765432 34679999999999999999999999999899999999999999999
Q ss_pred hhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECC-CCcEEEeeeccceeeCCC
Q 017558 288 HLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD-SFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 288 ~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~-~~~~ki~DFGla~~~~~~ 356 (369)
++.... ..+++..+..++.+++++|.|||++ +++|+||++.||+++. ++.++|+|||++......
T Consensus 81 ~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~ 146 (215)
T cd00180 81 LLKENE-GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSD 146 (215)
T ss_pred HHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCC
Confidence 987542 3488999999999999999999998 9999999999999999 899999999999876543
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=1e-20 Score=164.21 Aligned_cols=148 Identities=18% Similarity=0.125 Sum_probs=115.3
Q ss_pred HHHHHhhcCCcccceecccCceEEEEEEEcCCeEEEEEeeccCCcc----------------------cHHHHHHHHHHH
Q 017558 195 EELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQ----------------------GEREFQAEIEII 252 (369)
Q Consensus 195 ~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l 252 (369)
+++......|...+.||+|+||.||++...+|+.||||+++..... ....+..|+.++
T Consensus 8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 87 (198)
T cd05144 8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL 87 (198)
T ss_pred HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence 3444444458888999999999999999888999999987643200 012356789999
Q ss_pred HhcCCCc--cccEeeEEEeCCeeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCC
Q 017558 253 SQVHHRH--LVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIK 330 (369)
Q Consensus 253 ~~l~h~n--iv~l~g~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk 330 (369)
..+.|.+ +...++ ....++||||+++++|..+... .....++.+++.++.++|+. +++|||||
T Consensus 88 ~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~ 152 (198)
T cd05144 88 KALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKH---GIIHGDLS 152 (198)
T ss_pred HHHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHC---CCCcCCCC
Confidence 9998774 444443 2456899999999999765421 23457889999999999998 99999999
Q ss_pred CCcEEECCCCcEEEeeeccceeeCCCC
Q 017558 331 SANILLDDSFEAKVADFGLAKHSLDTD 357 (369)
Q Consensus 331 ~~Nill~~~~~~ki~DFGla~~~~~~~ 357 (369)
|+||++++++.++|+|||++.......
T Consensus 153 p~Nill~~~~~~~liDfg~~~~~~~~~ 179 (198)
T cd05144 153 EFNILVDDDEKIYIIDWPQMVSTDHPN 179 (198)
T ss_pred cccEEEcCCCcEEEEECCccccCCCcc
Confidence 999999999999999999998766543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.2e-20 Score=165.35 Aligned_cols=136 Identities=21% Similarity=0.269 Sum_probs=114.6
Q ss_pred ceecccCceEEEEEEEcCCeEEEEEeeccCCcc--------cHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEe
Q 017558 208 NLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQ--------GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (369)
Q Consensus 208 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 279 (369)
+.||+|++|.||+|.+ .+..+++|+....... ....+.+|++++..+.|+||.....++......+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999998 6677888976543211 123577899999999999998888788778889999999
Q ss_pred cCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
++|++|.+++... .+ .+..++.+++.+|.+||+. +++|+|++|.|||++ ++.++|+|||+++...
T Consensus 81 ~~G~~L~~~~~~~-----~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~~ 145 (211)
T PRK14879 81 IEGEPLKDLINSN-----GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEFSK 145 (211)
T ss_pred eCCcCHHHHHHhc-----cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccCCC
Confidence 9999999998542 22 7789999999999999998 999999999999999 7899999999998643
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-21 Score=190.98 Aligned_cols=158 Identities=29% Similarity=0.380 Sum_probs=123.5
Q ss_pred CcccceecccCceE-EEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHhc-CCCccccEeeEEEeCCeeEEEEEecC
Q 017558 204 FSEANLLGQGGFGY-VHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLVYEFVP 281 (369)
Q Consensus 204 ~~~~~~lg~G~fg~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~ 281 (369)
|...+++|.|.-|+ ||+|.+ +++.||||++.... ..-..+|+..|..- +|||||++++.-.++...||..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC- 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC- 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence 44467899998875 999999 57899999986432 23567999999988 4999999988888888999999999
Q ss_pred CCcHhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECC-----CCcEEEeeeccceeeC
Q 017558 282 NKTLEFHLHGK--DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD-----SFEAKVADFGLAKHSL 354 (369)
Q Consensus 282 ~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~-----~~~~ki~DFGla~~~~ 354 (369)
.-+|.+++... +.........+.+..|++.||.+||+. +||||||||.||||+. ..+++|+|||+|+++.
T Consensus 586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 57899999763 211122134467889999999999997 9999999999999975 3589999999999987
Q ss_pred CCCcee--eeeecccCC
Q 017558 355 DTDTHV--STRVMGTFG 369 (369)
Q Consensus 355 ~~~~~~--~~~~~gt~g 369 (369)
...+.. ...+.||-|
T Consensus 663 ~~~sS~~r~s~~sGt~G 679 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSG 679 (903)
T ss_pred CCcchhhcccCCCCccc
Confidence 654322 334566654
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.4e-20 Score=167.01 Aligned_cols=138 Identities=33% Similarity=0.399 Sum_probs=124.6
Q ss_pred CceEEEEEEEcC-CeEEEEEeeccCCccc-HHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEecCCCcHhhhhcC
Q 017558 214 GFGYVHKGVLTN-GKVVAIKQLKAGSGQG-EREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHG 291 (369)
Q Consensus 214 ~fg~Vy~~~~~~-~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g~L~~~l~~ 291 (369)
+||.||+|.... ++.+++|++....... .+.+.+|++.+++++|+||+++++++......+++|||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999864 7899999997765544 67899999999999999999999999999999999999999999999875
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCC
Q 017558 292 KDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 292 ~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~ 356 (369)
... +++...+.++.+++.++.|||+. +++|+||+++||++++++.++|+|||++......
T Consensus 81 ~~~--~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~ 140 (244)
T smart00220 81 RGR--LSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPG 140 (244)
T ss_pred ccC--CCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeeccc
Confidence 432 88999999999999999999998 9999999999999999999999999999887654
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=5e-21 Score=162.57 Aligned_cols=152 Identities=26% Similarity=0.343 Sum_probs=128.8
Q ss_pred HhhcCCcccceecccCceEEEEEE-EcCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCC-CccccEeeEEEeCCeeEEE
Q 017558 199 IATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHH-RHLVSLVGYCTFGSQRLLV 276 (369)
Q Consensus 199 ~~~~~~~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lv 276 (369)
+...+|.+.+.||.|+||.+|.|. ..+|+.||||.-..... ...+..|.++...+++ ..|..+..|..+.....||
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV 89 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV 89 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence 345789999999999999999998 56799999997654433 2478889999999975 6788888888888899999
Q ss_pred EEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECC---CCcEEEeeeccceee
Q 017558 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD---SFEAKVADFGLAKHS 353 (369)
Q Consensus 277 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~---~~~~ki~DFGla~~~ 353 (369)
||.+ |-+|++++.-..+ .++-.+.+-++-|++.-++|+|.+ ++|||||||+|+|+.- ...+.++|||||+.+
T Consensus 90 MdLL-GPsLEdLfnfC~R-~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 90 MDLL-GPSLEDLFNFCSR-RFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred eecc-CccHHHHHHHHhh-hhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhh
Confidence 9998 8899888865443 488899999999999999999998 8999999999999963 457889999999998
Q ss_pred CCCC
Q 017558 354 LDTD 357 (369)
Q Consensus 354 ~~~~ 357 (369)
.+..
T Consensus 165 ~d~~ 168 (341)
T KOG1163|consen 165 RDIR 168 (341)
T ss_pred cccc
Confidence 7654
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1e-20 Score=170.30 Aligned_cols=161 Identities=24% Similarity=0.336 Sum_probs=135.1
Q ss_pred CHHHHHHhhcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcccHHHHHHHHHHHHhcC--CCc----cccEee
Q 017558 193 TYEELKIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVH--HRH----LVSLVG 265 (369)
Q Consensus 193 ~~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~n----iv~l~g 265 (369)
.++......++|.+...+|+|+||.|.++... .+..||||+++.-... .+..+-|+++|.++. .|| +|++.+
T Consensus 80 v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY-reAa~iEi~vLqki~~~DP~g~~rcv~m~~ 158 (415)
T KOG0671|consen 80 VYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY-REAALIEIEVLQKINESDPNGKFRCVQMRD 158 (415)
T ss_pred EEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH-hhHHHHHHHHHHHHHhcCCCCceEEEeeeh
Confidence 34444556889999999999999999999854 3688999999864433 346677999999994 233 788999
Q ss_pred EEEeCCeeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECC-------
Q 017558 266 YCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD------- 338 (369)
Q Consensus 266 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~------- 338 (369)
||...++.|||+|.| |-+++++|..++...+...+...|+.|++++++|||+. +++|-||||+|||+.+
T Consensus 159 wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~ 234 (415)
T KOG0671|consen 159 WFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTY 234 (415)
T ss_pred hhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEe
Confidence 999999999999998 77999999988877899999999999999999999999 9999999999999831
Q ss_pred -------------CCcEEEeeeccceeeCCCCc
Q 017558 339 -------------SFEAKVADFGLAKHSLDTDT 358 (369)
Q Consensus 339 -------------~~~~ki~DFGla~~~~~~~~ 358 (369)
+..+||+|||-|....+..+
T Consensus 235 ~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~hs 267 (415)
T KOG0671|consen 235 NPKKKVCFIRPLKSTAIKVIDFGSATFDHEHHS 267 (415)
T ss_pred ccCCccceeccCCCcceEEEecCCcceeccCcc
Confidence 34689999999998776653
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.6e-20 Score=186.63 Aligned_cols=139 Identities=22% Similarity=0.297 Sum_probs=113.2
Q ss_pred hcCCcccceecccCceEEEEEEEcCCeEEEEEe-eccC-Cc------ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCe
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQ-LKAG-SG------QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQ 272 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~-~~~~-~~------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 272 (369)
...|...+.||+|+||.||++.+.+.. +++|+ +... .. ...+.+.+|++++.+++|+||+....++.....
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 344566789999999999999985544 33333 2211 11 112468899999999999999988888888788
Q ss_pred eEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeecccee
Q 017558 273 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (369)
Q Consensus 273 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~ 352 (369)
.++||||+++++|.+++. ....++.+++.+|.|||+. +++||||||+|||+ +++.++|+|||+++.
T Consensus 411 ~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 899999999999998874 3567899999999999998 99999999999999 677999999999987
Q ss_pred eC
Q 017558 353 SL 354 (369)
Q Consensus 353 ~~ 354 (369)
..
T Consensus 477 ~~ 478 (535)
T PRK09605 477 SD 478 (535)
T ss_pred CC
Confidence 54
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.8e-20 Score=161.44 Aligned_cols=132 Identities=22% Similarity=0.290 Sum_probs=107.8
Q ss_pred eecccCceEEEEEEEcCCeEEEEEeeccCCcc--------cHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEec
Q 017558 209 LLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQ--------GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 280 (369)
Q Consensus 209 ~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 280 (369)
.||+|+||.||+|.+ ++..+++|........ ..+.+.+|++++..++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999996 5678899986543211 1245778999999999887665555666677789999999
Q ss_pred CCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 281 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 281 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
+|++|.+++.... . .++.+++.+|.+||+. +++|+|++|+||+++ ++.++++|||+++...
T Consensus 80 ~g~~l~~~~~~~~--------~-~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~ 140 (199)
T TIGR03724 80 EGKPLKDVIEEGN--------D-ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYSD 140 (199)
T ss_pred CCccHHHHHhhcH--------H-HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcCCC
Confidence 9999998875321 0 7899999999999998 999999999999999 7899999999998754
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.3e-20 Score=157.37 Aligned_cols=132 Identities=19% Similarity=0.131 Sum_probs=105.9
Q ss_pred ccceecccCceEEEEEEEcCCeEEEEEeeccCCccc----HHHHHHHHHHHHhcC-CCccccEeeEEEeCCeeEEEEEec
Q 017558 206 EANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQG----EREFQAEIEIISQVH-HRHLVSLVGYCTFGSQRLLVYEFV 280 (369)
Q Consensus 206 ~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~----~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~~ 280 (369)
....|++|+||+||++.- .+..++.+.+.....-. ...+.+|+++|.+++ |++|++++++ +..+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 357899999999997766 66778777776543311 125789999999995 5889999886 3469999999
Q ss_pred CCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCC-CCCcEEECCCCcEEEeeeccceeeC
Q 017558 281 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDI-KSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 281 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdl-k~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
.|.+|...+.. ....++.|++.+|+|+|++ ||+|||| |+.|||++.++.++|+|||+|....
T Consensus 81 ~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~ 143 (218)
T PRK12274 81 AGAAMYQRPPR---------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGN 143 (218)
T ss_pred cCccHHhhhhh---------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecC
Confidence 99998654321 1135778999999999999 9999999 7999999999999999999998644
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.7e-21 Score=164.37 Aligned_cols=148 Identities=21% Similarity=0.369 Sum_probs=120.1
Q ss_pred hhcCCcccceecccCceEEEEEEEcC-CeEEEEEeeccCCcccHHHHHHHHHHHHhc-CCCccccEeeE-EEeCCeeEEE
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHRHLVSLVGY-CTFGSQRLLV 276 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~-~~~~~~~~lv 276 (369)
..+.|.+.+.||+|.||.+.+++.+. ...+++|-+... ....++|.+|..---.| .|.||+.-+++ |+..+..+++
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 34678888999999999999999765 457788876543 23457899998764445 48999877664 5667788899
Q ss_pred EEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEC--CCCcEEEeeeccceeeC
Q 017558 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLD--DSFEAKVADFGLAKHSL 354 (369)
Q Consensus 277 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~--~~~~~ki~DFGla~~~~ 354 (369)
+||++.|+|..-+.. ..+-+....+++.|++.|+.|||++ ++||||||.+||||- +..++||||||+.+...
T Consensus 101 qE~aP~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred eccCccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccC
Confidence 999999999887744 3477888889999999999999999 999999999999993 44589999999987643
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.1e-20 Score=180.24 Aligned_cols=146 Identities=25% Similarity=0.325 Sum_probs=124.4
Q ss_pred hcCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCCcccHHHHHHHHHHHHhc-CCCccccEeeEEEeCCeeEEEEE
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLVYE 278 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e 278 (369)
.+.|.....+|.|+|+.|-++.. .+++..+||++.+.. .+..+|+.++... +|+||+.+.+.|.+..+.|+|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 56778888899999999999985 457889999997652 3455677776666 69999999999999999999999
Q ss_pred ecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEE-CCCCcEEEeeeccceeeCCC
Q 017558 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILL-DDSFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill-~~~~~~ki~DFGla~~~~~~ 356 (369)
++.++-|.+.+..... +. ..+..|+.+|+.++.|||++ ++|||||||+|||+ ++.++++|+|||.++.....
T Consensus 397 ~l~g~ell~ri~~~~~--~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKPE--FC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred hccccHHHHHHHhcch--hH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 9999999888865432 33 66778999999999999998 99999999999999 68999999999999987654
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.6e-20 Score=162.87 Aligned_cols=152 Identities=25% Similarity=0.337 Sum_probs=125.6
Q ss_pred hhcCCcccceecccCceEEEEEE-EcCCeEEEEEeeccCCcccHHHHHHHHHHHHhcC-CCccccEeeEEEeCCeeEEEE
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVH-HRHLVSLVGYCTFGSQRLLVY 277 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~ 277 (369)
..-.|++++.||+|+||.++.|+ +-+++.||||.--. . .+.-++..|.+..+.|. .++|...+-|...+.+-.|||
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr-k-S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR-K-SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred ecccceeccccccCcceeeecccccccCceEEEEeccc-c-CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 34578899999999999999999 45789999995322 1 22347888888888885 688888876666677778999
Q ss_pred EecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECC-----CCcEEEeeecccee
Q 017558 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD-----SFEAKVADFGLAKH 352 (369)
Q Consensus 278 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~-----~~~~ki~DFGla~~ 352 (369)
|.+ |-+|++++.-.++ .|+.++.+-||.|++.-++|+|++ .+|+|||||+|+||.. ...+.|+|||||+.
T Consensus 104 dLL-GPSLEDLFD~CgR-~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 104 DLL-GPSLEDLFDLCGR-RFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hhh-CcCHHHHHHHhcC-cccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 998 8888888765543 599999999999999999999999 8999999999999963 44689999999999
Q ss_pred eCCCCc
Q 017558 353 SLDTDT 358 (369)
Q Consensus 353 ~~~~~~ 358 (369)
+.+.++
T Consensus 179 YrDp~T 184 (449)
T KOG1165|consen 179 YRDPKT 184 (449)
T ss_pred hcCccc
Confidence 988764
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.4e-19 Score=168.89 Aligned_cols=145 Identities=26% Similarity=0.351 Sum_probs=122.6
Q ss_pred CCcccceecccCceEEEEEEEcCC--eEEEEEeeccCCcccHHHHHHHHHHHHhcCC----CccccEeeEE-EeCCeeEE
Q 017558 203 NFSEANLLGQGGFGYVHKGVLTNG--KVVAIKQLKAGSGQGEREFQAEIEIISQVHH----RHLVSLVGYC-TFGSQRLL 275 (369)
Q Consensus 203 ~~~~~~~lg~G~fg~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~g~~-~~~~~~~l 275 (369)
+|.+.+.||+|+||.||++..... ..+|+|............+..|+.++..+.. .++..+++.. ......||
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999996553 4788887665433322378889999988873 6889999888 47778899
Q ss_pred EEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCC-----CcEEEeeeccc
Q 017558 276 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS-----FEAKVADFGLA 350 (369)
Q Consensus 276 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~-----~~~ki~DFGla 350 (369)
||+.+ |.+|.++........++..+.++|+.|++.+|++||+. |++||||||.|+++... ..+.|.|||+|
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99988 89999988655556799999999999999999999998 99999999999999854 46999999999
Q ss_pred e
Q 017558 351 K 351 (369)
Q Consensus 351 ~ 351 (369)
|
T Consensus 175 r 175 (322)
T KOG1164|consen 175 R 175 (322)
T ss_pred c
Confidence 9
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.9e-19 Score=166.56 Aligned_cols=135 Identities=27% Similarity=0.381 Sum_probs=115.1
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcccHHHHHHHHHHHHhcC-----C---CccccEeeEEEe--
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVH-----H---RHLVSLVGYCTF-- 269 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~g~~~~-- 269 (369)
..+|-+.++||-|.|++||+|... +.+.||+|+.+..... .+....||++|.+++ | .+||+|++.|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhY-tEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHY-TEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHH-HHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 367889999999999999999954 5678999998764333 356788999999884 3 369999999975
Q ss_pred --CCeeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCC
Q 017558 270 --GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS 339 (369)
Q Consensus 270 --~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~ 339 (369)
+.++|||+|++ |-+|..+|.......+......+|+.||+.||.|||.+| +|||-||||+|||+..+
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~ 224 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCST 224 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeecc
Confidence 45889999999 788888998877778999999999999999999999987 99999999999999644
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.2e-19 Score=165.45 Aligned_cols=147 Identities=22% Similarity=0.372 Sum_probs=128.2
Q ss_pred HHHHhhcCCcccceecccCceEEEEEEEc----CCeEEEEEeeccCCcccHHHHHHHHHHHHhcC-CCccccEeeEEEeC
Q 017558 196 ELKIATDNFSEANLLGQGGFGYVHKGVLT----NGKVVAIKQLKAGSGQGEREFQAEIEIISQVH-HRHLVSLVGYCTFG 270 (369)
Q Consensus 196 ~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~ 270 (369)
.+....+.|...+.||+|.|+.||++... ..+.||+|.+...... ..+.+|+++|..+. +.||+++.+++-..
T Consensus 30 ~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 30 DIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhccC
Confidence 34556678899999999999999999843 3578999998765433 46899999999995 99999999999999
Q ss_pred CeeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECC-CCcEEEeeecc
Q 017558 271 SQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD-SFEAKVADFGL 349 (369)
Q Consensus 271 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~-~~~~ki~DFGl 349 (369)
+...+||||++.....+++.. ++...+..++..+..||.|+|.+ |||||||||+|+|.+. .+.-.|.||||
T Consensus 108 d~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGL 179 (418)
T ss_pred CeeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechh
Confidence 999999999999999888854 66788889999999999999999 9999999999999984 56778999999
Q ss_pred cee
Q 017558 350 AKH 352 (369)
Q Consensus 350 a~~ 352 (369)
|..
T Consensus 180 A~~ 182 (418)
T KOG1167|consen 180 AQR 182 (418)
T ss_pred HHH
Confidence 984
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.3e-18 Score=141.77 Aligned_cols=135 Identities=20% Similarity=0.146 Sum_probs=115.0
Q ss_pred cceecccCceEEEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCC--CccccEeeEEEeCCeeEEEEEecCCCc
Q 017558 207 ANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHH--RHLVSLVGYCTFGSQRLLVYEFVPNKT 284 (369)
Q Consensus 207 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~g~~~~~~~~~lv~e~~~~g~ 284 (369)
.+.||+|.++.||++...+ ..+++|....... ...+.+|+.++..++| .++.++++++...+..+++|||++++.
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 5779999999999999854 7789998865443 4578999999999976 589999998888888999999999887
Q ss_pred HhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceee
Q 017558 285 LEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (369)
Q Consensus 285 L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~ 353 (369)
+..+ +......++.+++.+|.+||.....+++|+|++++||++++++.++++|||+++..
T Consensus 80 ~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 80 LDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred cccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 7543 45667788999999999999864347999999999999999899999999999863
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.8e-18 Score=148.55 Aligned_cols=140 Identities=16% Similarity=0.174 Sum_probs=100.8
Q ss_pred cceecccCceEEEEEEEcCCeEEEEEeeccCCccc--HHH----------------------HHHHHHHHHhcCCC--cc
Q 017558 207 ANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQG--ERE----------------------FQAEIEIISQVHHR--HL 260 (369)
Q Consensus 207 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~--~~~----------------------~~~E~~~l~~l~h~--ni 260 (369)
.+.||+|+||.||+|...+++.||||+++...... ... ...|.+.+.++.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999998788999999987542211 111 13566666666443 24
Q ss_pred ccEeeEEEeCCeeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCcEEECCC
Q 017558 261 VSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHE-DCQPKIIHRDIKSANILLDDS 339 (369)
Q Consensus 261 v~l~g~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivHrdlk~~Nill~~~ 339 (369)
...+++ ...++||||++++.+......... .. .....++.+++.++.++|. . +|+|+||||+||+++ +
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~-~ 150 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD-D 150 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE-C
Confidence 444443 246899999999654321111100 11 5567899999999999998 6 999999999999999 8
Q ss_pred CcEEEeeeccceeeCCCC
Q 017558 340 FEAKVADFGLAKHSLDTD 357 (369)
Q Consensus 340 ~~~ki~DFGla~~~~~~~ 357 (369)
+.++|+|||+++....++
T Consensus 151 ~~~~liDfg~a~~~~~~~ 168 (187)
T cd05119 151 GKVYIIDVPQAVEIDHPN 168 (187)
T ss_pred CcEEEEECcccccccCcc
Confidence 899999999998776543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.7e-19 Score=159.05 Aligned_cols=144 Identities=26% Similarity=0.378 Sum_probs=117.8
Q ss_pred cCCcccceecccCceEEEEEE-EcCCeEEEEEeeccC--CcccHHHHHHHHHHHHhcCCCccccEeeEEEeC------Ce
Q 017558 202 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFG------SQ 272 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~ 272 (369)
.+|...+.+|.|.- .|.-+. .-.++.||+|++... .....+...+|..++..++|+||++++.++.-. .+
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 35556677888876 555554 234788999987543 223345678999999999999999999998654 36
Q ss_pred eEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeecccee
Q 017558 273 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (369)
Q Consensus 273 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~ 352 (369)
.|+||||| ..+|...++. .++..+..+|.+|++.|++|||+. +|+||||||+||++..++.+||.|||+|+.
T Consensus 96 ~y~v~e~m-~~nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 96 VYLVMELM-DANLCQVILM----ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLART 167 (369)
T ss_pred HHHHHHhh-hhHHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcc
Confidence 79999999 6788888873 367788899999999999999999 999999999999999999999999999987
Q ss_pred eC
Q 017558 353 SL 354 (369)
Q Consensus 353 ~~ 354 (369)
-.
T Consensus 168 e~ 169 (369)
T KOG0665|consen 168 ED 169 (369)
T ss_pred cC
Confidence 43
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.1e-18 Score=159.56 Aligned_cols=162 Identities=22% Similarity=0.268 Sum_probs=135.0
Q ss_pred ccCHHHHHHhhcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcccHHHHHHHHHHHHhcC------CCccccE
Q 017558 191 TFTYEELKIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVH------HRHLVSL 263 (369)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l 263 (369)
.|.+.-.+....+|.+....|+|-|+.|.+|... .|..||||+|+.+... .+.=+.|++||.+|+ --|+++|
T Consensus 421 YYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl 499 (752)
T KOG0670|consen 421 YYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRL 499 (752)
T ss_pred eEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHH
Confidence 3445555677889999999999999999999853 4779999999875432 244568999999996 3579999
Q ss_pred eeEEEeCCeeEEEEEecCCCcHhhhhcCCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCC-Cc
Q 017558 264 VGYCTFGSQRLLVYEFVPNKTLEFHLHGKDR-PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS-FE 341 (369)
Q Consensus 264 ~g~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~-~~ 341 (369)
+-.|...+++|||+|-+ .-+|.+.|...+. -.|.......++.|+..||..|... +|+|.||||.|||+++. ..
T Consensus 500 ~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~i 575 (752)
T KOG0670|consen 500 FRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNI 575 (752)
T ss_pred HHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcce
Confidence 99999999999999988 6789999986543 3578888899999999999999976 99999999999999864 57
Q ss_pred EEEeeeccceeeCCCC
Q 017558 342 AKVADFGLAKHSLDTD 357 (369)
Q Consensus 342 ~ki~DFGla~~~~~~~ 357 (369)
+||||||-|-...+++
T Consensus 576 LKLCDfGSA~~~~ene 591 (752)
T KOG0670|consen 576 LKLCDFGSASFASENE 591 (752)
T ss_pred eeeccCcccccccccc
Confidence 8999999998776655
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.75 E-value=2e-17 Score=147.26 Aligned_cols=137 Identities=18% Similarity=0.201 Sum_probs=106.0
Q ss_pred cceec-ccCceEEEEEEEcCCeEEEEEeeccCC-------------cccHHHHHHHHHHHHhcCCCcc--ccEeeEEEeC
Q 017558 207 ANLLG-QGGFGYVHKGVLTNGKVVAIKQLKAGS-------------GQGEREFQAEIEIISQVHHRHL--VSLVGYCTFG 270 (369)
Q Consensus 207 ~~~lg-~G~fg~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~l~g~~~~~ 270 (369)
...|| .|+.|.||++... +..++||+++... ......+.+|++++.+++|++| +..++++...
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 45687 8888899998874 6778899885421 0122457889999999998774 7777775443
Q ss_pred C----eeEEEEEecCC-CcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEe
Q 017558 271 S----QRLLVYEFVPN-KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVA 345 (369)
Q Consensus 271 ~----~~~lv~e~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~ 345 (369)
. ..++||||+++ .+|.+++... .++.. .+.+|+.+|.+||++ ||+||||||.|||++.++.++|+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEEE
Confidence 2 23599999997 6898888542 24443 356899999999998 99999999999999998899999
Q ss_pred eeccceeeC
Q 017558 346 DFGLAKHSL 354 (369)
Q Consensus 346 DFGla~~~~ 354 (369)
|||.++...
T Consensus 185 Dfg~~~~~~ 193 (239)
T PRK01723 185 DFDRGELRT 193 (239)
T ss_pred ECCCcccCC
Confidence 999998754
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.6e-17 Score=150.05 Aligned_cols=149 Identities=34% Similarity=0.427 Sum_probs=128.1
Q ss_pred CcccceecccCceEEEEEEEcCCeEEEEEeeccCCcc---cHHHHHHHHHHHHhcCCC-ccccEeeEEEeCCeeEEEEEe
Q 017558 204 FSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQ---GEREFQAEIEIISQVHHR-HLVSLVGYCTFGSQRLLVYEF 279 (369)
Q Consensus 204 ~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~l~g~~~~~~~~~lv~e~ 279 (369)
|...+.||.|.||.||++... ..+++|.+...... ....+.+|+.++..+.|+ +|+.+.+++......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 566788999999999999986 77899998765433 256899999999999988 799999999777778999999
Q ss_pred cCCCcHhhhhcCCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCC-cEEEeeeccceeeCCCC
Q 017558 280 VPNKTLEFHLHGKDR-PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF-EAKVADFGLAKHSLDTD 357 (369)
Q Consensus 280 ~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~-~~ki~DFGla~~~~~~~ 357 (369)
+.+++|.+++..... ..+.......+..|++.++.|+|+. +++|||+||+||+++..+ .++++|||+++.+....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999977754332 2588889999999999999999998 899999999999999988 79999999998665543
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.3e-16 Score=152.31 Aligned_cols=142 Identities=23% Similarity=0.246 Sum_probs=101.9
Q ss_pred cceecccCceEEEEEEEcCCeEEEEEeeccCCcccH----------------------------------------HHHH
Q 017558 207 ANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGE----------------------------------------REFQ 246 (369)
Q Consensus 207 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~~ 246 (369)
.+.||.|++|+||+|++.+|+.||||+.+....... -+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 367999999999999999999999999875421100 0244
Q ss_pred HHHHHHHhcC----CCccccEeeEEE-eCCeeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHH-HHHHHHhCC
Q 017558 247 AEIEIISQVH----HRHLVSLVGYCT-FGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSAR-GLAYLHEDC 320 (369)
Q Consensus 247 ~E~~~l~~l~----h~niv~l~g~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~-~l~yLH~~~ 320 (369)
+|++.+.++. |.+-+.+-.+|. .....+|||||++|++|.+++..... .. .+..++..++. .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~---~~~~ia~~~~~~~l~ql~~~- 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GL---DRKALAENLARSFLNQVLRD- 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CC---CHHHHHHHHHHHHHHHHHhC-
Confidence 5665555552 333333333332 24567999999999999887643211 12 23456666665 46788887
Q ss_pred CCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 321 QPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 321 ~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
|++|+|+||.||+++.++.++++|||+++.+.+
T Consensus 277 --g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 277 --GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred --CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 999999999999999999999999999988754
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.7e-16 Score=161.57 Aligned_cols=150 Identities=27% Similarity=0.364 Sum_probs=116.6
Q ss_pred HHHHHhhcCCcccceecccCceEEEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHhcC---CCccccEeeEEEeCC
Q 017558 195 EELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVH---HRHLVSLVGYCTFGS 271 (369)
Q Consensus 195 ~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~ 271 (369)
.+++...++|.+.+.||+|+||.||+|...+++.||+|.=+....-+ |--=.+++.+|+ -+.|+.+...+...+
T Consensus 691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~ 767 (974)
T KOG1166|consen 691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQN 767 (974)
T ss_pred ceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCC
Confidence 34556678899999999999999999998889999999876543221 111112223332 234445555555677
Q ss_pred eeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEC-------CCCcEEE
Q 017558 272 QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLD-------DSFEAKV 344 (369)
Q Consensus 272 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~-------~~~~~ki 344 (369)
.-+||+||.+.|+|.+++... ..++|...+.+..|+++-+++||.. +|||+||||+|+||. +...++|
T Consensus 768 ~S~lv~ey~~~Gtlld~~N~~--~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~l 842 (974)
T KOG1166|consen 768 ASVLVSEYSPYGTLLDLINTN--KVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYL 842 (974)
T ss_pred cceeeeeccccccHHHhhccC--CCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEE
Confidence 788999999999999999743 4589999999999999999999998 999999999999994 3457999
Q ss_pred eeecccee
Q 017558 345 ADFGLAKH 352 (369)
Q Consensus 345 ~DFGla~~ 352 (369)
+|||-+-+
T Consensus 843 IDfG~siD 850 (974)
T KOG1166|consen 843 IDFGRSID 850 (974)
T ss_pred Eeccccee
Confidence 99998865
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.7e-14 Score=121.60 Aligned_cols=132 Identities=17% Similarity=0.081 Sum_probs=97.8
Q ss_pred cceecccCceEEEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCcc-ccEeeEEEeCCeeEEEEEecCCCcH
Q 017558 207 ANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHL-VSLVGYCTFGSQRLLVYEFVPNKTL 285 (369)
Q Consensus 207 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lv~e~~~~g~L 285 (369)
.+.|+.|.++.||+++.. +..+++|....... ....+..|++++..+.+.++ .+++.+. ....++||||+++.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 467899999999999974 77899998765432 12356789999998865554 4455443 3346899999999887
Q ss_pred hhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeeecCCCCCcEEECCCCcEEEeeeccceee
Q 017558 286 EFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDC--QPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (369)
Q Consensus 286 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~--~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~ 353 (369)
.... . ....++.+++++|..||... ...++|+|+++.||+++ ++.++++|||.+...
T Consensus 79 ~~~~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~ 137 (170)
T cd05151 79 LTED-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMN 137 (170)
T ss_pred cccc-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCC
Confidence 5430 1 11245678999999999872 12369999999999999 568999999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.57 E-value=3.1e-15 Score=146.31 Aligned_cols=147 Identities=18% Similarity=0.185 Sum_probs=94.8
Q ss_pred cCCcccceecccCceEEEEEEEcC-CeEEEEEeeccCCcc--------------------------c--------HH---
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGSGQ--------------------------G--------ER--- 243 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~--------------------------~--------~~--- 243 (369)
.+|+. +.||.|++|+||+|++++ |+.||||+++.+... + .+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 44665 789999999999999987 999999999754210 0 01
Q ss_pred ---HHHHHHHHHHhcC----CCccccEeeEEEe-CCeeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHH-HHH
Q 017558 244 ---EFQAEIEIISQVH----HRHLVSLVGYCTF-GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSAR-GLA 314 (369)
Q Consensus 244 ---~~~~E~~~l~~l~----h~niv~l~g~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~-~l~ 314 (369)
+|.+|+..+.++. +.+.+.+-.++++ ....+|||||++|+.|.++-.... ...+... ++...+. -+.
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~-~g~d~~~---la~~~v~~~~~ 274 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRA-AGTDMKL---LAERGVEVFFT 274 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHh-cCCCHHH---HHHHHHHHHHH
Confidence 2344554444442 3444444444433 456789999999999976422111 1122111 1111111 122
Q ss_pred HHHhCCCCCeeecCCCCCcEEECCCC----cEEEeeeccceeeCCC
Q 017558 315 YLHEDCQPKIIHRDIKSANILLDDSF----EAKVADFGLAKHSLDT 356 (369)
Q Consensus 315 yLH~~~~~~ivHrdlk~~Nill~~~~----~~ki~DFGla~~~~~~ 356 (369)
-+... |++|+|+||.||+++.++ .++++|||++..+.+.
T Consensus 275 Qif~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 275 QVFRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred HHHhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 23344 899999999999999888 9999999999987654
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.51 E-value=3.7e-13 Score=115.05 Aligned_cols=139 Identities=15% Similarity=0.147 Sum_probs=102.2
Q ss_pred ceecccCceEEEEEEEcC-------CeEEEEEeeccCCc----------------------ccHHHHH----HHHHHHHh
Q 017558 208 NLLGQGGFGYVHKGVLTN-------GKVVAIKQLKAGSG----------------------QGEREFQ----AEIEIISQ 254 (369)
Q Consensus 208 ~~lg~G~fg~Vy~~~~~~-------~~~vavK~~~~~~~----------------------~~~~~~~----~E~~~l~~ 254 (369)
..||.|.-+.||.|...+ +..+|||..+.... ...+.+. +|.+.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 469999999999998543 47899998763210 0012233 79999999
Q ss_pred cC--CCccccEeeEEEeCCeeEEEEEecCCCcHhh-hhcCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeeecCCC
Q 017558 255 VH--HRHLVSLVGYCTFGSQRLLVYEFVPNKTLEF-HLHGKDRPVMNWPTRMKIALGSARGLAYL-HEDCQPKIIHRDIK 330 (369)
Q Consensus 255 l~--h~niv~l~g~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~l~~~~~~~i~~~i~~~l~yL-H~~~~~~ivHrdlk 330 (369)
+. .-++...+++ ...+|||||+.+..+.. .|.. ..++.++...+..+++.+|.+| |.. ++||+||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDLs 152 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADLS 152 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCCC
Confidence 85 3577777764 46789999997654422 2221 1244556677889999999999 777 99999999
Q ss_pred CCcEEECCCCcEEEeeeccceeeCCCC
Q 017558 331 SANILLDDSFEAKVADFGLAKHSLDTD 357 (369)
Q Consensus 331 ~~Nill~~~~~~ki~DFGla~~~~~~~ 357 (369)
+.|||+++ +.+.|+|||.+-...++.
T Consensus 153 ~~NIL~~~-~~v~iIDF~qav~~~hp~ 178 (197)
T cd05146 153 EYNMLWHD-GKVWFIDVSQSVEPTHPH 178 (197)
T ss_pred HHHEEEEC-CcEEEEECCCceeCCCCC
Confidence 99999974 579999999998876554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.5e-14 Score=150.72 Aligned_cols=92 Identities=11% Similarity=0.092 Sum_probs=71.3
Q ss_pred hcCC-CccccEeeEE-------EeCCeeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCee
Q 017558 254 QVHH-RHLVSLVGYC-------TFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKII 325 (369)
Q Consensus 254 ~l~h-~niv~l~g~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iv 325 (369)
.++| .||.+++++| ......+++|||+ +++|.++|.... ..+++.+++.|+.||++||.|||++ +|+
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---gIv 102 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD-RSVDAFECFHVFRQIVEIVNAAHSQ---GIV 102 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc-ccccHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence 3445 5888888887 2334567789988 669999997533 4589999999999999999999998 999
Q ss_pred ecCCCCCcEEECCCCcEEEeeeccc
Q 017558 326 HRDIKSANILLDDSFEAKVADFGLA 350 (369)
Q Consensus 326 Hrdlk~~Nill~~~~~~ki~DFGla 350 (369)
||||||+||||+..+.+|++|||++
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~ 127 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASC 127 (793)
T ss_pred eccCCchhEEEcccCcEEEeecccc
Confidence 9999999999965444444444433
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.5e-14 Score=144.23 Aligned_cols=145 Identities=23% Similarity=0.266 Sum_probs=111.6
Q ss_pred cccceecccCceEEEEEEEc-CCeEEEEEeeccC--CcccHH----HHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEE
Q 017558 205 SEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG--SGQGER----EFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (369)
Q Consensus 205 ~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~----~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 277 (369)
...+++|.|.+|.|+..... ..+..+.|.++.. .....+ .+..|.-+-..+.|+|++..+..+.+....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 35688999999977776632 3344455544311 111122 2556777778889999988888777766666679
Q ss_pred EecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 278 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
||+++ +|+.++... ..+...++..++.|++.|++|||+. ||.|||||++|++++.++.+||+|||.+..+.-
T Consensus 401 E~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred hcccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeecc
Confidence 99999 999998654 2477778889999999999999998 999999999999999999999999999876543
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.47 E-value=8.9e-15 Score=126.81 Aligned_cols=137 Identities=21% Similarity=0.417 Sum_probs=115.7
Q ss_pred cceecccCceEEEEEEEcCCeEEEEEeecc--CCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEecCCCc
Q 017558 207 ANLLGQGGFGYVHKGVLTNGKVVAIKQLKA--GSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKT 284 (369)
Q Consensus 207 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g~ 284 (369)
.-+|.+...|+.|+|+|.++. +++|++.. ......++|.+|.-.|+-+.||||+.++|.|.......++..||+.|+
T Consensus 195 ~tkl~e~hsgelwrgrwqgnd-ivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQGND-IVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhhccCCCcccccccccCcc-hhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 345888889999999996554 55576643 333444689999999999999999999999999999999999999999
Q ss_pred HhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEe
Q 017558 285 LEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVA 345 (369)
Q Consensus 285 L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~ 345 (369)
|+..||....-..+..+.++++.+|++||.|||+. .+-|.--.|.++.|+||++.+++|+
T Consensus 274 lynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltaris 333 (448)
T KOG0195|consen 274 LYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARIS 333 (448)
T ss_pred HHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhhee
Confidence 99999988766678889999999999999999986 4445556799999999999998875
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.47 E-value=8.5e-13 Score=116.10 Aligned_cols=144 Identities=19% Similarity=0.253 Sum_probs=112.3
Q ss_pred cceecccCceEEEEEEEcCCeEEEEEeeccCCc-ccHHHHHHHHHHHHhcCC--CccccEeeEEEeC---CeeEEEEEec
Q 017558 207 ANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHH--RHLVSLVGYCTFG---SQRLLVYEFV 280 (369)
Q Consensus 207 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--~niv~l~g~~~~~---~~~~lv~e~~ 280 (369)
.+.|+.|.++.||++...+|..+++|....... ....++..|++++..+.+ .++.+++.++... +..++||||+
T Consensus 3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred ceecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 367899999999999987668899998765432 134578899999999975 4567788877654 2568999999
Q ss_pred CCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------------
Q 017558 281 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHED----------------------------------------- 319 (369)
Q Consensus 281 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~----------------------------------------- 319 (369)
++.+|.+.+.. ..++..+...++.++++.|.+||+.
T Consensus 83 ~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 83 DGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 99988776532 2367777778888888888888852
Q ss_pred ------------CCCCeeecCCCCCcEEECC--CCcEEEeeeccceee
Q 017558 320 ------------CQPKIIHRDIKSANILLDD--SFEAKVADFGLAKHS 353 (369)
Q Consensus 320 ------------~~~~ivHrdlk~~Nill~~--~~~~ki~DFGla~~~ 353 (369)
....++|+|+++.|||++. ++.+.|+||+.+...
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g 207 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG 207 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence 1246799999999999998 667899999988754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.42 E-value=3.3e-12 Score=105.91 Aligned_cols=134 Identities=20% Similarity=0.276 Sum_probs=99.2
Q ss_pred ceecccCceEEEEEEEcCCeEEEEEe-eccCCc-c--c----HHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEe
Q 017558 208 NLLGQGGFGYVHKGVLTNGKVVAIKQ-LKAGSG-Q--G----EREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (369)
Q Consensus 208 ~~lg~G~fg~Vy~~~~~~~~~vavK~-~~~~~~-~--~----~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 279 (369)
..+++|+-..+|.+.+.+ ..+++|. +.+.-. . + .+...+|+++++++.--.|..-+=|..+.....|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~g-~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLG-LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeeccC-cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 357899999999998754 3455553 222111 1 1 13457899999998754444444455567778899999
Q ss_pred cCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
++|..|.++|... ...++..|..-+.-||.. +|+|+||.++||++..+. +.++||||++....
T Consensus 81 I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~s~~ 143 (204)
T COG3642 81 IEGELLKDALEEA---------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEFSDE 143 (204)
T ss_pred eCChhHHHHHHhc---------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCccccccc
Confidence 9999999888543 246777888889999998 999999999999998774 99999999986543
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.42 E-value=3.7e-12 Score=105.11 Aligned_cols=144 Identities=19% Similarity=0.225 Sum_probs=106.1
Q ss_pred ccceecccCceEEEEEEEcCCeEEEEEee-ccC-C------cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEE
Q 017558 206 EANLLGQGGFGYVHKGVLTNGKVVAIKQL-KAG-S------GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (369)
Q Consensus 206 ~~~~lg~G~fg~Vy~~~~~~~~~vavK~~-~~~-~------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 277 (369)
....|-+|+-+.|+++.+ .|+.+.||.= .+. . .-..+..++|+++|.++.--.|.--.-++.+.....|+|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 467899999999999999 4666666642 211 1 112346788999999987544443334565666778999
Q ss_pred EecCC-CcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCC---cEEEeeeccceee
Q 017558 278 EFVPN-KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF---EAKVADFGLAKHS 353 (369)
Q Consensus 278 e~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~---~~ki~DFGla~~~ 353 (369)
||+++ .++.+++..........+....++..|.+.+.-||.+ .+||+||..+||+|..++ .+.++||||+...
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 99977 4788888765444344444478899999999999999 999999999999996543 4589999998654
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.42 E-value=2.4e-14 Score=144.29 Aligned_cols=143 Identities=22% Similarity=0.227 Sum_probs=118.1
Q ss_pred CCcccceecccCceEEEEEEEcCCeEEEEEeeccCC-cccHHHHHHHHHH--HHhcCCCccccEeeEEEeCCeeEEEEEe
Q 017558 203 NFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGS-GQGEREFQAEIEI--ISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (369)
Q Consensus 203 ~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~--l~~l~h~niv~l~g~~~~~~~~~lv~e~ 279 (369)
+|...+.||++.|=+|.+|+.++|. |+||++-+.. ....+.|.++++- +..++|||++.+..+...+...|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5667789999999999999998887 8889875443 4445555443332 5566899999998887777788999999
Q ss_pred cCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeecccee
Q 017558 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (369)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~ 352 (369)
+ .-+|+|.|.. ++.+..-+...|++|++.||..+|.. +|+|+|||.+||||+...-+.|+||.--|-
T Consensus 103 v-khnLyDRlST--RPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKP 169 (1431)
T KOG1240|consen 103 V-KHNLYDRLST--RPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKP 169 (1431)
T ss_pred H-hhhhhhhhcc--chHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCC
Confidence 8 5678888855 35678888899999999999999998 999999999999999999999999987664
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.41 E-value=2.3e-14 Score=137.48 Aligned_cols=144 Identities=27% Similarity=0.274 Sum_probs=119.6
Q ss_pred eecccCceEEEEEEE----cCCeEEEEEeeccCCcc--cHHHHHHHHHHHHhcC-CCccccEeeEEEeCCeeEEEEEecC
Q 017558 209 LLGQGGFGYVHKGVL----TNGKVVAIKQLKAGSGQ--GEREFQAEIEIISQVH-HRHLVSLVGYCTFGSQRLLVYEFVP 281 (369)
Q Consensus 209 ~lg~G~fg~Vy~~~~----~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~~~ 281 (369)
++|+|.||.|+++.. ..+..+|+|.+++.... .......|..++..++ |+.+|++.-.++.+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 379999999998763 34677888888664322 1124456788888887 9999999988999999999999999
Q ss_pred CCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCCC
Q 017558 282 NKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (369)
Q Consensus 282 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~~ 357 (369)
+|+|...+.... .+.+.....+...++.+++++|.. +++|||+|++||+++.+|++|+.|||+++...+..
T Consensus 81 gg~lft~l~~~~--~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~ 151 (612)
T KOG0603|consen 81 GGDLFTRLSKEV--MFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK 151 (612)
T ss_pred cchhhhccccCC--chHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhh
Confidence 999998886543 467777778888999999999998 99999999999999999999999999999876544
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.33 E-value=5.2e-11 Score=107.41 Aligned_cols=142 Identities=15% Similarity=0.050 Sum_probs=104.6
Q ss_pred cceecccCceEEEEEEEcCCeEEEEEeeccCCcc-----------cHHHHHHHHHHHHhcC--CCccccEeeEEEe----
Q 017558 207 ANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQ-----------GEREFQAEIEIISQVH--HRHLVSLVGYCTF---- 269 (369)
Q Consensus 207 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~--h~niv~l~g~~~~---- 269 (369)
++.+-.-....|++..+ +|+.|.||+....... ....+.+|.+.+.+|. .-.+..++++...
T Consensus 27 ~e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~ 105 (268)
T PRK15123 27 GEVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP 105 (268)
T ss_pred CcEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence 35555555556778776 6788999977443211 1114779999998885 3445566666643
Q ss_pred -CCeeEEEEEecCCC-cHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECC-------CC
Q 017558 270 -GSQRLLVYEFVPNK-TLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD-------SF 340 (369)
Q Consensus 270 -~~~~~lv~e~~~~g-~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~-------~~ 340 (369)
...-+||+|++++. +|.+++............+..++.+++..+.-||.. ||+|+||+++|||++. +.
T Consensus 106 ~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~ 182 (268)
T PRK15123 106 ATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDL 182 (268)
T ss_pred ccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCc
Confidence 23568999999986 898888532222345667778999999999999999 9999999999999975 57
Q ss_pred cEEEeeecccee
Q 017558 341 EAKVADFGLAKH 352 (369)
Q Consensus 341 ~~ki~DFGla~~ 352 (369)
.+.++||+.++.
T Consensus 183 ~~~LIDl~r~~~ 194 (268)
T PRK15123 183 KLSVIDLHRAQI 194 (268)
T ss_pred eEEEEECCcccc
Confidence 899999998864
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.31 E-value=1.2e-12 Score=119.39 Aligned_cols=89 Identities=30% Similarity=0.338 Sum_probs=70.3
Q ss_pred CCCccccEeeEEEe---------------------------CCeeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHH
Q 017558 256 HHRHLVSLVGYCTF---------------------------GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALG 308 (369)
Q Consensus 256 ~h~niv~l~g~~~~---------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ 308 (369)
+|||||++.++|.+ ...+|+||.-+ .-+|..||..+. .+.....-|..|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~---~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH---RSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC---CchHHHHHHHHH
Confidence 59999999987642 23568888777 457888886543 445566678899
Q ss_pred HHHHHHHHHhCCCCCeeecCCCCCcEEE--CCCC--cEEEeeeccce
Q 017558 309 SARGLAYLHEDCQPKIIHRDIKSANILL--DDSF--EAKVADFGLAK 351 (369)
Q Consensus 309 i~~~l~yLH~~~~~~ivHrdlk~~Nill--~~~~--~~ki~DFGla~ 351 (369)
+++|+.|||.+ +|.|||||++|||| |+|+ .+.|+|||.|-
T Consensus 350 lLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcL 393 (598)
T KOG4158|consen 350 LLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCL 393 (598)
T ss_pred HHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceee
Confidence 99999999998 99999999999998 4443 46799999874
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.26 E-value=3.4e-11 Score=108.61 Aligned_cols=148 Identities=20% Similarity=0.295 Sum_probs=93.8
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC---cccHHHHHHHHHHHHhcCC----------CccccEeeEEE
Q 017558 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHH----------RHLVSLVGYCT 268 (369)
Q Consensus 203 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h----------~niv~l~g~~~ 268 (369)
.+...+.||.|+|+.||.++.. +++.+|||.+.... ....+++++|.-....+.+ -.++--++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 3455789999999999999975 48999999875433 2234567777655544332 11111112111
Q ss_pred ---------eC--C------eeEEEEEecCCCcHhhhhcC---CCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeee
Q 017558 269 ---------FG--S------QRLLVYEFVPNKTLEFHLHG---KDR--PVMNWPTRMKIALGSARGLAYLHEDCQPKIIH 326 (369)
Q Consensus 269 ---------~~--~------~~~lv~e~~~~g~L~~~l~~---~~~--~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH 326 (369)
.. . ..+++|+-+ .++|.+++.. ... ..+....++.+-.|+.+.+++||.+ |++|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEe
Confidence 11 1 225667666 6788777542 111 1233344566778999999999999 9999
Q ss_pred cCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 327 RDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 327 rdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
+||+++|+|++.+|.++|+||+..+...
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g 196 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAG 196 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETT
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecC
Confidence 9999999999999999999999877644
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.25 E-value=8.5e-11 Score=100.15 Aligned_cols=129 Identities=19% Similarity=0.265 Sum_probs=85.9
Q ss_pred EEEEEEEcCCeEEEEEeeccCCc-------------c---------c----HHHHHHHHHHHHhcCCC--ccccEeeEEE
Q 017558 217 YVHKGVLTNGKVVAIKQLKAGSG-------------Q---------G----EREFQAEIEIISQVHHR--HLVSLVGYCT 268 (369)
Q Consensus 217 ~Vy~~~~~~~~~vavK~~~~~~~-------------~---------~----~~~~~~E~~~l~~l~h~--niv~l~g~~~ 268 (369)
.||.|...+|..+|||..+.... . . .....+|.+.|.++..- ++.+.+++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 48999988899999998763210 0 0 12356899999999755 567776542
Q ss_pred eCCeeEEEEEecC--CCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeeecCCCCCcEEECCCCcEEEe
Q 017558 269 FGSQRLLVYEFVP--NKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYL-HEDCQPKIIHRDIKSANILLDDSFEAKVA 345 (369)
Q Consensus 269 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yL-H~~~~~~ivHrdlk~~Nill~~~~~~ki~ 345 (369)
..+|||||++ +..+..+.... ++......++.+++..+..+ |.. +++|+||...|||++++ .+.|+
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE-
T ss_pred ---CCEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEEE
Confidence 4579999998 65554433221 11334556778888866664 566 99999999999999988 99999
Q ss_pred eeccceeeCCCC
Q 017558 346 DFGLAKHSLDTD 357 (369)
Q Consensus 346 DFGla~~~~~~~ 357 (369)
|||.+....++.
T Consensus 149 Df~qav~~~~p~ 160 (188)
T PF01163_consen 149 DFGQAVDSSHPN 160 (188)
T ss_dssp -GTTEEETTSTT
T ss_pred ecCcceecCCcc
Confidence 999998876543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.18 E-value=3.5e-11 Score=115.36 Aligned_cols=100 Identities=26% Similarity=0.426 Sum_probs=89.5
Q ss_pred HHhcCCCccccEeeEEEeCCeeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCC
Q 017558 252 ISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKS 331 (369)
Q Consensus 252 l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~ 331 (369)
|+.+.|.|+.+++|.|.++...++|.+|+..|+|.+.+.... ..++|.-...+..+|+.||.|||+- . -..|+.|++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~-~~~d~~F~~s~~rdi~~Gl~ylh~s-~-i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED-IKLDYFFILSFIRDISKGLAYLHNS-P-IGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc-cCccHHHHHHHHHHHHHHHHHHhcC-c-ceeeeeecc
Confidence 356889999999999999999999999999999999998743 4588888899999999999999976 2 339999999
Q ss_pred CcEEECCCCcEEEeeeccceeeC
Q 017558 332 ANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 332 ~Nill~~~~~~ki~DFGla~~~~ 354 (369)
+|+++|..+.+||+|||+.....
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~ 100 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLE 100 (484)
T ss_pred ccceeeeeEEEEechhhhccccc
Confidence 99999999999999999987764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.06 E-value=2.5e-11 Score=121.19 Aligned_cols=151 Identities=24% Similarity=0.339 Sum_probs=120.6
Q ss_pred cCCcccceecccCceEEEEEEEcC--CeEEEEEeeccCC--cccHHHHHHHHHHHHhcC-CCccccEeeEEEeCCeeEEE
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLTN--GKVVAIKQLKAGS--GQGEREFQAEIEIISQVH-HRHLVSLVGYCTFGSQRLLV 276 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv 276 (369)
..|.+.+.||+|.|+.|-...... ...+|+|.+.... ....+....|..+-..+. |.|++.+++.....+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 345566779999999999887533 3456777665443 122234556777777776 99999999999999999999
Q ss_pred EEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeeecCCCCCcEEECCCC-cEEEeeeccceeeC
Q 017558 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLH-EDCQPKIIHRDIKSANILLDDSF-EAKVADFGLAKHSL 354 (369)
Q Consensus 277 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH-~~~~~~ivHrdlk~~Nill~~~~-~~ki~DFGla~~~~ 354 (369)
+||.+++++++.+........+......+..|+..++.|+| .. ++.|||+||+|.+++..+ ..|++|||+|..+.
T Consensus 100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAYR 176 (601)
T ss_pred cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence 99999999998883222223555667789999999999999 76 899999999999999999 99999999998877
Q ss_pred C
Q 017558 355 D 355 (369)
Q Consensus 355 ~ 355 (369)
.
T Consensus 177 ~ 177 (601)
T KOG0590|consen 177 N 177 (601)
T ss_pred c
Confidence 6
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.1e-09 Score=106.57 Aligned_cols=123 Identities=18% Similarity=0.262 Sum_probs=100.3
Q ss_pred EcCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEecCCCcHhhhhcCCCCCCCCHHHH
Q 017558 223 LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTR 302 (369)
Q Consensus 223 ~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~ 302 (369)
..++..|.|..++...........+-++.|+.++||||++++..++.++..|||+|-+. .|..++.. +.....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-----l~~~~v 106 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-----LGKEEV 106 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-----hHHHHH
Confidence 34577788887776555334567788889999999999999999999999999999883 56666643 224455
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 303 MKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 303 ~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
-..+.||+.||.|||+.+ +++|++|.-..|+|+..|+.||++|-++....
T Consensus 107 ~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~ 156 (690)
T KOG1243|consen 107 CLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKAS 156 (690)
T ss_pred HHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccc
Confidence 667899999999999765 89999999999999999999999999886543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.01 E-value=6e-09 Score=90.78 Aligned_cols=107 Identities=21% Similarity=0.229 Sum_probs=86.4
Q ss_pred HHHHHHHHHHHhcC--CCccccEeeEEEeCC----eeEEEEEecCCC-cHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHH
Q 017558 243 REFQAEIEIISQVH--HRHLVSLVGYCTFGS----QRLLVYEFVPNK-TLEFHLHGKDRPVMNWPTRMKIALGSARGLAY 315 (369)
Q Consensus 243 ~~~~~E~~~l~~l~--h~niv~l~g~~~~~~----~~~lv~e~~~~g-~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~y 315 (369)
....+|.+.+.+|. .-.+...+++.+... ..+||+|++++. +|.+++..... ++......++.+++..+.-
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIAK 133 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHHH
Confidence 46788888888775 445677777776532 458999999884 89999875332 5566778899999999999
Q ss_pred HHhCCCCCeeecCCCCCcEEECCCC---cEEEeeeccceeeC
Q 017558 316 LHEDCQPKIIHRDIKSANILLDDSF---EAKVADFGLAKHSL 354 (369)
Q Consensus 316 LH~~~~~~ivHrdlk~~Nill~~~~---~~ki~DFGla~~~~ 354 (369)
||++ ||+|+|+++.|||++.+. .+.++||+-++...
T Consensus 134 lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 134 LHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 9999 999999999999999887 89999999888654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.00 E-value=3.5e-09 Score=100.20 Aligned_cols=139 Identities=14% Similarity=0.158 Sum_probs=110.5
Q ss_pred eEEEEEE-EcCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEE----eCCeeEEEEEecCC-CcHhhhh
Q 017558 216 GYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCT----FGSQRLLVYEFVPN-KTLEFHL 289 (369)
Q Consensus 216 g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~----~~~~~~lv~e~~~~-g~L~~~l 289 (369)
.+.|++. ..+|..|++|++..+..........-+++++++.|.|||.|..++. .+..+++||+|.++ ++|.++.
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 5688887 4578899999995544443344556788899999999999999886 35578999999986 5776654
Q ss_pred cCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCC
Q 017558 290 HGK-------------DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 290 ~~~-------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~ 356 (369)
... ......+...+.++.|++.||.++|+. |+..+-|.+++||++.+.+++|+..|+...+..+
T Consensus 370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 321 122366788999999999999999998 8999999999999999999999998888776555
Q ss_pred C
Q 017558 357 D 357 (369)
Q Consensus 357 ~ 357 (369)
+
T Consensus 447 ~ 447 (655)
T KOG3741|consen 447 P 447 (655)
T ss_pred C
Confidence 4
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.00 E-value=1.3e-08 Score=87.39 Aligned_cols=140 Identities=15% Similarity=0.119 Sum_probs=105.6
Q ss_pred ecccCceEEEEEEEcCCeEEEEEeeccCC------cccHHHHHHHHHHHHhcC--CCccccEeeEEE-e----CCeeEEE
Q 017558 210 LGQGGFGYVHKGVLTNGKVVAIKQLKAGS------GQGEREFQAEIEIISQVH--HRHLVSLVGYCT-F----GSQRLLV 276 (369)
Q Consensus 210 lg~G~fg~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~--h~niv~l~g~~~-~----~~~~~lv 276 (369)
-|+|+.+-|++..+. |+.+-+|+-...- ......|.+|+..|.++. .-.+.+.+ ++. . .-..+||
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 467888889998874 4578888765221 224567999999999985 33355555 442 2 1246799
Q ss_pred EEecCC-CcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCc--EEEeeeccceee
Q 017558 277 YEFVPN-KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFE--AKVADFGLAKHS 353 (369)
Q Consensus 277 ~e~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~--~ki~DFGla~~~ 353 (369)
+|-+++ -+|.+++........+...+..+..+|+..+.-||.. ++.|+|+-+.|||++.++. ++++||.-+|..
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~~ 180 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRRR 180 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccchh
Confidence 998864 6898888665444567777889999999999999998 9999999999999986666 999999877754
Q ss_pred C
Q 017558 354 L 354 (369)
Q Consensus 354 ~ 354 (369)
.
T Consensus 181 l 181 (216)
T PRK09902 181 L 181 (216)
T ss_pred h
Confidence 3
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.99 E-value=1.6e-09 Score=105.78 Aligned_cols=142 Identities=17% Similarity=0.230 Sum_probs=96.4
Q ss_pred ceecccCceEEEEEEEcCCeEEEEEeeccCCccc----------------------------------------HHHHHH
Q 017558 208 NLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQG----------------------------------------EREFQA 247 (369)
Q Consensus 208 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~----------------------------------------~~~~~~ 247 (369)
+-|+.++-|+||+|++.+|+.||||+.+.+-... +-++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 6799999999999999999999999987542111 002345
Q ss_pred HHHHHHhcC-----CCccccEeeEEE-eCCeeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 017558 248 EIEIISQVH-----HRHLVSLVGYCT-FGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQ 321 (369)
Q Consensus 248 E~~~l~~l~-----h~niv~l~g~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~ 321 (369)
|..-+.+++ .++| .+=.+|+ ......|+|||++|-.+.+...... ..++.........++..-.-+- .
T Consensus 211 EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f~~q~~~--d-- 284 (517)
T COG0661 211 EAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAFLRQLLR--D-- 284 (517)
T ss_pred HHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHHHHHHHh--c--
Confidence 555555542 2332 2333343 3567899999999999988753332 2355434333333333222233 3
Q ss_pred CCeeecCCCCCcEEECCCCcEEEeeeccceeeCCC
Q 017558 322 PKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 322 ~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~ 356 (369)
|++|.|..|.||+++.++++-+.|||+...+.+.
T Consensus 285 -gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 285 -GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred -CccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 8999999999999999999999999999887653
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.97 E-value=3e-10 Score=109.22 Aligned_cols=149 Identities=19% Similarity=0.264 Sum_probs=121.3
Q ss_pred HhhcCCcccceecccCceEEEEEEEc--CCeEEEEEeeccCCcccHHHH--HHHHHHHHhc-CCCccccEeeEEEeCCee
Q 017558 199 IATDNFSEANLLGQGGFGYVHKGVLT--NGKVVAIKQLKAGSGQGEREF--QAEIEIISQV-HHRHLVSLVGYCTFGSQR 273 (369)
Q Consensus 199 ~~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~--~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 273 (369)
....+|.....||.|.|+.|+....+ ++..|++|.+.+.......++ ..|+-+...+ .|.++++++..+......
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 34567888999999999999998753 578899999877654433332 4577666666 499999988888878888
Q ss_pred EEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCC-CcEEEeeecccee
Q 017558 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS-FEAKVADFGLAKH 352 (369)
Q Consensus 274 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~-~~~ki~DFGla~~ 352 (369)
|+-.||++++++...+.. ...+++..++++..|++.++.++|+. .++|+|+||+||++.++ +..++.|||.+..
T Consensus 342 ~ip~e~~~~~s~~l~~~~--~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSVT--SQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred cCchhhhcCcchhhhhHH--HHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccccc
Confidence 899999999998877632 23477788899999999999999988 89999999999999875 8899999998853
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.95 E-value=6.3e-09 Score=91.60 Aligned_cols=140 Identities=17% Similarity=0.163 Sum_probs=99.5
Q ss_pred CcccceecccCceEEEEEEEcCCeEEEEEeeccCCc----------c------------cHHHHHHHHHHHHhcCCC--c
Q 017558 204 FSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSG----------Q------------GEREFQAEIEIISQVHHR--H 259 (369)
Q Consensus 204 ~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~----------~------------~~~~~~~E~~~l~~l~h~--n 259 (369)
..+++.||-|.-+.||.|....|..+|||.=+.... . .....++|.++|.+|.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 456789999999999999998899999996432210 0 112456899999998644 6
Q ss_pred cccEeeEEEeCCeeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCC
Q 017558 260 LVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS 339 (369)
Q Consensus 260 iv~l~g~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~ 339 (369)
|..-+++ +...+||||+++-.|...-. +.+..-.|+..|++-+.-+-.. |+||+|+..=|||++++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r~-------~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~d 238 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLRL-------DVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTED 238 (304)
T ss_pred CCCcccc----ccceeeeehcccceeecccC-------cccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEecC
Confidence 6666553 56789999999877653321 1222233444455555544455 89999999999999999
Q ss_pred CcEEEeeeccceeeCCCC
Q 017558 340 FEAKVADFGLAKHSLDTD 357 (369)
Q Consensus 340 ~~~ki~DFGla~~~~~~~ 357 (369)
|.+.++||==+-...+++
T Consensus 239 g~~~vIDwPQ~v~~~hp~ 256 (304)
T COG0478 239 GDIVVIDWPQAVPISHPD 256 (304)
T ss_pred CCEEEEeCcccccCCCCC
Confidence 999999997766555444
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.86 E-value=5.8e-08 Score=85.75 Aligned_cols=141 Identities=17% Similarity=0.172 Sum_probs=87.8
Q ss_pred cceecccCceEEEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCC--ccccEeeEEEeCCeeEEEEEecCCCc
Q 017558 207 ANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHR--HLVSLVGYCTFGSQRLLVYEFVPNKT 284 (369)
Q Consensus 207 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~g~~~~~~~~~lv~e~~~~g~ 284 (369)
...||+|..+.||+. .+..+++|...... ......+|.+++..+..- .+.+.++++...+...+|||+++|..
T Consensus 6 ~~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 6 WTQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred heeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 467999999999984 24457788776533 335678999999988643 35777888877778889999999863
Q ss_pred -Hhhh---------------------hcCCCCCCCCHHHHH-HHHH----------HHHH-HHHHHHhC-CCCCeeecCC
Q 017558 285 -LEFH---------------------LHGKDRPVMNWPTRM-KIAL----------GSAR-GLAYLHED-CQPKIIHRDI 329 (369)
Q Consensus 285 -L~~~---------------------l~~~~~~~l~~~~~~-~i~~----------~i~~-~l~yLH~~-~~~~ivHrdl 329 (369)
+... ||.-........... ++.. .+.. ...+|... ....++|+|+
T Consensus 81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 2111 121110111111100 0100 0011 12222211 1336799999
Q ss_pred CCCcEEECCCCcEEEeeeccceee
Q 017558 330 KSANILLDDSFEAKVADFGLAKHS 353 (369)
Q Consensus 330 k~~Nill~~~~~~ki~DFGla~~~ 353 (369)
.+.||++++++ +.|+||+.+...
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~~G 183 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFGYG 183 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcCcC
Confidence 99999999887 999999988653
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.85 E-value=8.9e-08 Score=82.64 Aligned_cols=141 Identities=18% Similarity=0.235 Sum_probs=96.1
Q ss_pred HHhhcCCcccceecccCceEEEEEEEcCCeEEEEEeeccCCcccHHHH---------HHHHHHHHhcC---CCccccEee
Q 017558 198 KIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREF---------QAEIEIISQVH---HRHLVSLVG 265 (369)
Q Consensus 198 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~---------~~E~~~l~~l~---h~niv~l~g 265 (369)
.+...+|...+++-......|.+-.. +|..+++|..+......++.| .+++..+.++. .-....++.
T Consensus 27 ~i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 27 KILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 35567788888888877777888777 568899998876543333322 34444444443 223333333
Q ss_pred EEE-----eCCeeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCC
Q 017558 266 YCT-----FGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF 340 (369)
Q Consensus 266 ~~~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~ 340 (369)
++. .....+|+|||++|-.|.++.. +.+ .++..+..+|.-||.. |++|+|..|.|++++++
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~- 171 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNN- 171 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECC-
Confidence 322 2235568999999998866542 222 3455677889999998 99999999999999866
Q ss_pred cEEEeeeccceee
Q 017558 341 EAKVADFGLAKHS 353 (369)
Q Consensus 341 ~~ki~DFGla~~~ 353 (369)
.++++||+..+..
T Consensus 172 ~i~iID~~~k~~~ 184 (229)
T PF06176_consen 172 GIRIIDTQGKRMS 184 (229)
T ss_pred cEEEEECcccccc
Confidence 4999999987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.80 E-value=3.4e-09 Score=107.59 Aligned_cols=111 Identities=23% Similarity=0.359 Sum_probs=76.2
Q ss_pred hcCCcccceecccCceEEEEEEEcC-CeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEe
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 279 (369)
.++|..++.|..|+||.||..+.+. .+.+|+| +.+++ .+.+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~-----lilRn--ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQN-----LILRN--ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhc-ccccc-----hhhhc--cccccCCccee------------------
Confidence 4678889999999999999998653 4567773 43321 11111 22222334333
Q ss_pred cCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceee
Q 017558 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (369)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~ 353 (369)
||-...+...+ .+.-+ .+.+++|||+. +|+|||+|++|.||+.-|++|+.||||.+..
T Consensus 136 ---gDc~tllk~~g--~lPvd--------mvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~G 193 (1205)
T KOG0606|consen 136 ---GDCATLLKNIG--PLPVD--------MVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKG 193 (1205)
T ss_pred ---chhhhhcccCC--CCcch--------hhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhh
Confidence 44444444322 22221 17889999998 9999999999999999999999999998864
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.76 E-value=2.6e-08 Score=96.03 Aligned_cols=151 Identities=21% Similarity=0.196 Sum_probs=118.5
Q ss_pred cCCcccceecc--cCceEEEEEEE---cCCeEEEEEeeccCCc--ccHHHHHHHHHHHHhcC-CCccccEeeEEEeCCee
Q 017558 202 DNFSEANLLGQ--GGFGYVHKGVL---TNGKVVAIKQLKAGSG--QGEREFQAEIEIISQVH-HRHLVSLVGYCTFGSQR 273 (369)
Q Consensus 202 ~~~~~~~~lg~--G~fg~Vy~~~~---~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~ 273 (369)
..|.....+|. |.+|.||.+.. .++..+|+|+-+.... .....=.+|+....+++ |+|.++....++..+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 34555677999 99999999886 3467888887433222 22233346777777775 99999998899999999
Q ss_pred EEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCCeeecCCCCCcEEECCC-CcEEEeeec
Q 017558 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSAR----GLAYLHEDCQPKIIHRDIKSANILLDDS-FEAKVADFG 348 (369)
Q Consensus 274 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~----~l~yLH~~~~~~ivHrdlk~~Nill~~~-~~~ki~DFG 348 (369)
++-+|++. .+|..+.+... ..+.....+.+..+... ||.++|+. +++|-|+|+.||++..+ ..++++|||
T Consensus 194 fiqtE~~~-~sl~~~~~~~~-~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHTPC-NFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred eeeecccc-chhHHhhhccc-ccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCcc
Confidence 99999984 78888876543 23666677777888888 99999998 99999999999999988 899999999
Q ss_pred cceeeCCCC
Q 017558 349 LAKHSLDTD 357 (369)
Q Consensus 349 la~~~~~~~ 357 (369)
+...+.+.+
T Consensus 269 ~v~~i~~~~ 277 (524)
T KOG0601|consen 269 LVSKISDGN 277 (524)
T ss_pred eeEEccCCc
Confidence 999877655
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=98.76 E-value=2.3e-08 Score=84.57 Aligned_cols=61 Identities=26% Similarity=0.161 Sum_probs=53.8
Q ss_pred CcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 283 KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 283 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
|+|.++++... ..++|.+++.|+.||+.||.|||++ + ||+|||++.++.+|+ ||+++....
T Consensus 1 GsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~ 61 (176)
T smart00750 1 VSLADILEVRG-RPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTP 61 (176)
T ss_pred CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecc
Confidence 78999997543 3599999999999999999999988 4 999999999999999 999987654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.73 E-value=8.9e-09 Score=92.27 Aligned_cols=95 Identities=22% Similarity=0.375 Sum_probs=79.7
Q ss_pred HHHHhcCCCccccEeeEEEeC-----CeeEEEEEecCCCcHhhhhcCCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 017558 250 EIISQVHHRHLVSLVGYCTFG-----SQRLLVYEFVPNKTLEFHLHGKD--RPVMNWPTRMKIALGSARGLAYLHEDCQP 322 (369)
Q Consensus 250 ~~l~~l~h~niv~l~g~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~yLH~~~~~ 322 (369)
+-|-++.|-|||++..|+.+. ....++.|||..|+|..+|++.. ...+......+|+.||..||.|||+ +.+
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCC
Confidence 345566799999999998653 35678999999999999998643 3346667778999999999999998 488
Q ss_pred CeeecCCCCCcEEECCCCcEEEe
Q 017558 323 KIIHRDIKSANILLDDSFEAKVA 345 (369)
Q Consensus 323 ~ivHrdlk~~Nill~~~~~~ki~ 345 (369)
.|+|+++..+-|++..++-+||.
T Consensus 198 piihgnlTc~tifiq~ngLIkig 220 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIG 220 (458)
T ss_pred ccccCCcchhheeecCCceEEec
Confidence 99999999999999999988885
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.70 E-value=4.2e-07 Score=80.26 Aligned_cols=144 Identities=18% Similarity=0.176 Sum_probs=87.0
Q ss_pred cceecccCceEEEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCC--ccccEeeEEEe---CCeeEEEEEecC
Q 017558 207 ANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHR--HLVSLVGYCTF---GSQRLLVYEFVP 281 (369)
Q Consensus 207 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~g~~~~---~~~~~lv~e~~~ 281 (369)
++.|+.|..+.||+....+ ..+++|..... .....+.+|..++..+... .+.+++.++.. ....+++|+|++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 4679999999999999876 58889987654 3446788899998888532 46677775533 345689999999
Q ss_pred CCcHhh----------------hh---cCC--CCCCCCHHH---------HHHH------------HHHHHH-HHHHHHh
Q 017558 282 NKTLEF----------------HL---HGK--DRPVMNWPT---------RMKI------------ALGSAR-GLAYLHE 318 (369)
Q Consensus 282 ~g~L~~----------------~l---~~~--~~~~l~~~~---------~~~i------------~~~i~~-~l~yLH~ 318 (369)
+..+.. .+ |.. ....+.+.. .... ...+.. .++.++.
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 998877 11 111 111111110 0000 111222 2333332
Q ss_pred C----CCCCeeecCCCCCcEEEC-CCCcEEEeeeccceee
Q 017558 319 D----CQPKIIHRDIKSANILLD-DSFEAKVADFGLAKHS 353 (369)
Q Consensus 319 ~----~~~~ivHrdlk~~Nill~-~~~~~ki~DFGla~~~ 353 (369)
. ....++|+|+.+.|||++ +++.+-|+||+.+...
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~~ 198 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGWG 198 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EEE
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccceEC
Confidence 1 234799999999999999 6666789999988754
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.68 E-value=3.3e-09 Score=100.53 Aligned_cols=80 Identities=25% Similarity=0.368 Sum_probs=69.6
Q ss_pred eeEEEEEecCCCcHhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccc
Q 017558 272 QRLLVYEFVPNKTLEFHLHGK-DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLA 350 (369)
Q Consensus 272 ~~~lv~e~~~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla 350 (369)
..||.|+++...+|.+||.+. .....++...+.++.|++.|++| + +.+|||+||.||+...+..+||.||||.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence 578999999999999999743 34456788899999999999999 5 8999999999999999999999999998
Q ss_pred eeeCCCC
Q 017558 351 KHSLDTD 357 (369)
Q Consensus 351 ~~~~~~~ 357 (369)
-...+..
T Consensus 404 ts~~~~~ 410 (516)
T KOG1033|consen 404 TSQDKDE 410 (516)
T ss_pred eecccCC
Confidence 7765544
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.67 E-value=3.4e-07 Score=81.92 Aligned_cols=140 Identities=16% Similarity=0.106 Sum_probs=87.4
Q ss_pred eecccCc-eEEEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHhcC-CCccccEeeEEEeCCeeEEEEEecCCCcHh
Q 017558 209 LLGQGGF-GYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVH-HRHLVSLVGYCTFGSQRLLVYEFVPNKTLE 286 (369)
Q Consensus 209 ~lg~G~f-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~~~~g~L~ 286 (369)
.|..|.. ..||+.... +..+.||+..... ...+.+|++++..+. +--+.++++++...+..++||||++|..|.
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 4555655 779998764 4678888775432 345778999888874 455677888777666789999999998776
Q ss_pred hhh-------------------cCCCCC--CCCH--HHHHHH-HH-------------------HHHHHHHHHHhC----
Q 017558 287 FHL-------------------HGKDRP--VMNW--PTRMKI-AL-------------------GSARGLAYLHED---- 319 (369)
Q Consensus 287 ~~l-------------------~~~~~~--~l~~--~~~~~i-~~-------------------~i~~~l~yLH~~---- 319 (369)
... |..... .+.. ...+.. .. .+...+..|-..
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 432 111100 1110 000000 00 011112222211
Q ss_pred CCCCeeecCCCCCcEEECCCCcEEEeeecccee
Q 017558 320 CQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (369)
Q Consensus 320 ~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~ 352 (369)
..+.++|+|+.+.|||++++....|+||+.|..
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 234699999999999999987788999998864
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.65 E-value=1.6e-07 Score=91.54 Aligned_cols=143 Identities=19% Similarity=0.170 Sum_probs=92.2
Q ss_pred cceecccCceEEEEEEEcCCeEEEEEeeccCCccc-------------------------------------HHHHHHHH
Q 017558 207 ANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQG-------------------------------------EREFQAEI 249 (369)
Q Consensus 207 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~-------------------------------------~~~~~~E~ 249 (369)
.+.|+.-+.|+||+|++++|+.||||+-+..-... +=+|..|+
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 36799999999999999999999999876432110 01244555
Q ss_pred HHHHh----cCCCcc---ccEeeEEEe-CCeeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 017558 250 EIISQ----VHHRHL---VSLVGYCTF-GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQ 321 (369)
Q Consensus 250 ~~l~~----l~h~ni---v~l~g~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~ 321 (369)
+-..+ +.|-+. |.+=.++++ .....|+||||+|..+.+...-.. ..++......-+.+...-+-+.|
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~-~gi~~~~i~~~l~~~~~~qIf~~---- 320 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDK-RGISPHDILNKLVEAYLEQIFKT---- 320 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHH-cCCCHHHHHHHHHHHHHHHHHhc----
Confidence 43333 345551 112223332 457789999999987766533222 23555444433333332222222
Q ss_pred CCeeecCCCCCcEEEC----CCCcEEEeeeccceeeCC
Q 017558 322 PKIIHRDIKSANILLD----DSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 322 ~~ivHrdlk~~Nill~----~~~~~ki~DFGla~~~~~ 355 (369)
|++|.|-.|.||+++ .++++.+-|||+.+...+
T Consensus 321 -GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 321 -GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred -CCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 899999999999998 478999999999987654
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.60 E-value=1e-06 Score=77.01 Aligned_cols=155 Identities=17% Similarity=0.200 Sum_probs=101.5
Q ss_pred CHHHHHHhhcCCcccce---ecccCceEEEEEEEcCCeEEEEEeeccCCccc-------------------HHH-----H
Q 017558 193 TYEELKIATDNFSEANL---LGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQG-------------------ERE-----F 245 (369)
Q Consensus 193 ~~~~~~~~~~~~~~~~~---lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~-------------------~~~-----~ 245 (369)
+++.+....+...+.+. |..|.-..||+|...++..+|||+++...... .++ .
T Consensus 36 t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~ 115 (268)
T COG1718 36 TLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWA 115 (268)
T ss_pred HHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHH
Confidence 34555555555554444 55677778999998788999999987532211 111 2
Q ss_pred HHHHHHHHhcC--CCccccEeeEEEeCCeeEEEEEecCCCcH-hhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 017558 246 QAEIEIISQVH--HRHLVSLVGYCTFGSQRLLVYEFVPNKTL-EFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQP 322 (369)
Q Consensus 246 ~~E~~~l~~l~--h~niv~l~g~~~~~~~~~lv~e~~~~g~L-~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~ 322 (369)
.+|..-|.++. +-.+.+-+++. ...|||||+....+ .=.|.. ..+.......+..++++.|.-|...+
T Consensus 116 ~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD---v~~e~~e~~~~~~~~v~~~~~l~~~a-- 186 (268)
T COG1718 116 RKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKD---VPLELEEAEGLYEDVVEYMRRLYKEA-- 186 (268)
T ss_pred HHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCccc---CCcCchhHHHHHHHHHHHHHHHHHhc--
Confidence 35666666663 44455555443 34699999954411 111111 12233356677888888888887632
Q ss_pred CeeecCCCCCcEEECCCCcEEEeeeccceeeCCCC
Q 017558 323 KIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (369)
Q Consensus 323 ~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~~ 357 (369)
++||+||..=|||+. ++.+.|+|||=|....++.
T Consensus 187 ~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~hp~ 220 (268)
T COG1718 187 GLVHGDLSEYNILVH-DGEPYIIDVSQAVTIDHPN 220 (268)
T ss_pred CcccccchhhheEEE-CCeEEEEECccccccCCCc
Confidence 899999999999999 7799999999887766543
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.54 E-value=1.6e-06 Score=90.97 Aligned_cols=146 Identities=17% Similarity=0.264 Sum_probs=92.5
Q ss_pred cceecccCceEEEEEEEcCC---eEEEEEeeccCCc-ccHHHHHHHHHHHHhcC-CCcc--ccEeeEEEeC---CeeEEE
Q 017558 207 ANLLGQGGFGYVHKGVLTNG---KVVAIKQLKAGSG-QGEREFQAEIEIISQVH-HRHL--VSLVGYCTFG---SQRLLV 276 (369)
Q Consensus 207 ~~~lg~G~fg~Vy~~~~~~~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~ni--v~l~g~~~~~---~~~~lv 276 (369)
.+.|+.|.+..+|+....++ ..+++|+...... .....+.+|.++|..+. |.+| .+++++|.+. +..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 57789999999999887554 3577776543321 23357889999999995 6654 8888888764 467899
Q ss_pred EEecCCCcHhh-----------------------hhcCCCCC---------CCCH--HHHHHHH---------------H
Q 017558 277 YEFVPNKTLEF-----------------------HLHGKDRP---------VMNW--PTRMKIA---------------L 307 (369)
Q Consensus 277 ~e~~~~g~L~~-----------------------~l~~~~~~---------~l~~--~~~~~i~---------------~ 307 (369)
|||+++..+.+ .||.-... ...+ .+..++. -
T Consensus 123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 202 (822)
T PLN02876 123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP 202 (822)
T ss_pred EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence 99998765321 12221100 0011 0111111 1
Q ss_pred HHHHHHHHHHhCCC--------CCeeecCCCCCcEEECC-CCc-EEEeeecccee
Q 017558 308 GSARGLAYLHEDCQ--------PKIIHRDIKSANILLDD-SFE-AKVADFGLAKH 352 (369)
Q Consensus 308 ~i~~~l~yLH~~~~--------~~ivHrdlk~~Nill~~-~~~-~ki~DFGla~~ 352 (369)
.+...+.||..+.. +.+||+|+++.|||++. +.. +-|.||.++..
T Consensus 203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 12334567755422 35999999999999985 333 56999998764
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.53 E-value=4.5e-07 Score=77.57 Aligned_cols=103 Identities=21% Similarity=0.191 Sum_probs=80.6
Q ss_pred HHHHHHHHhcCC-CccccEeeEEEeCCeeEEEEEecCCCcHhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 017558 246 QAEIEIISQVHH-RHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHG-KDRPVMNWPTRMKIALGSARGLAYLHEDCQPK 323 (369)
Q Consensus 246 ~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ 323 (369)
..|.-+|..+++ +++.+++|+|- .+++.||+..+++...-.. ..-...+|..+.+||.++++.+++|+......
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 357888888876 69999999994 3789999987765321000 01123689999999999999999999864446
Q ss_pred eeecCCCCCcEEECCCCcEEEeeecccee
Q 017558 324 IIHRDIKSANILLDDSFEAKVADFGLAKH 352 (369)
Q Consensus 324 ivHrdlk~~Nill~~~~~~ki~DFGla~~ 352 (369)
+...|++++|+-+++++++|++|...+-.
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcch
Confidence 77799999999999999999999886543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.40 E-value=4e-06 Score=71.67 Aligned_cols=125 Identities=28% Similarity=0.456 Sum_probs=90.4
Q ss_pred cCCcccceecccCc-eEEEEEEEcCCeEEEEEeeccCC------------c---------ccHHHHHHHHHHHHhcC---
Q 017558 202 DNFSEANLLGQGGF-GYVHKGVLTNGKVVAIKQLKAGS------------G---------QGEREFQAEIEIISQVH--- 256 (369)
Q Consensus 202 ~~~~~~~~lg~G~f-g~Vy~~~~~~~~~vavK~~~~~~------------~---------~~~~~~~~E~~~l~~l~--- 256 (369)
.+++..+.||.|.- |.||++++ +|+.+|+|.++... . .-...|..|.+.+.+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 67888999999999 99999999 67899999943210 0 00124788999988885
Q ss_pred CCcc--ccEeeEEEeCC------------------eeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 017558 257 HRHL--VSLVGYCTFGS------------------QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYL 316 (369)
Q Consensus 257 h~ni--v~l~g~~~~~~------------------~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yL 316 (369)
+.++ |+.+||..-.. ..-||.||++... .+.. .-+.+|.+-|..+
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~----~~~~~~~~dl~~~ 180 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQI----RDIPQMLRDLKIL 180 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccch----hHHHHHHHHHHHH
Confidence 4455 88888873221 2246778775443 1222 3345677788999
Q ss_pred HhCCCCCeeecCCCCCcEEECCCCcEEEeeeccc
Q 017558 317 HEDCQPKIIHRDIKSANILLDDSFEAKVADFGLA 350 (369)
Q Consensus 317 H~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla 350 (369)
|.. +|+-+|++++|.. .-||+|||.+
T Consensus 181 ~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 181 HKL---GIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHC---CeeeccCcccccc-----CCEEEecccC
Confidence 988 9999999999986 4599999964
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.37 E-value=1e-05 Score=74.51 Aligned_cols=80 Identities=11% Similarity=0.071 Sum_probs=59.2
Q ss_pred CCcccceecccCceEEEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCC---CccccEeeEEEe---CCeeEEE
Q 017558 203 NFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHH---RHLVSLVGYCTF---GSQRLLV 276 (369)
Q Consensus 203 ~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~g~~~~---~~~~~lv 276 (369)
.....+.||.|..+.||+....+++ +++|..+.. .....+..|.+.|+.+.. -.|.+++++|.. .+..+||
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV 91 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYDSQGN-PMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL 91 (297)
T ss_pred hhheeeecCCccceeEEEEEcCCCC-EEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence 3444678999999999998875554 666764331 123588999999998853 468899988864 3668999
Q ss_pred EEecCCCcH
Q 017558 277 YEFVPNKTL 285 (369)
Q Consensus 277 ~e~~~~g~L 285 (369)
||+++++++
T Consensus 92 mE~i~G~~~ 100 (297)
T PRK10593 92 LERLRGVSV 100 (297)
T ss_pred EeccCCEec
Confidence 999998754
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.36 E-value=4.2e-06 Score=69.38 Aligned_cols=127 Identities=20% Similarity=0.262 Sum_probs=85.0
Q ss_pred cceecccCceEEEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCcccc-EeeEEEeCCeeEEEEEecCCCcH
Q 017558 207 ANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVS-LVGYCTFGSQRLLVYEFVPNKTL 285 (369)
Q Consensus 207 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-l~g~~~~~~~~~lv~e~~~~g~L 285 (369)
.+.|++|++|.||+|.+. |..+|+|+-+.+. ....+..|+++|..++-.++-. ++.|. ..++.|||+.|-.|
T Consensus 27 ~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~~L 99 (201)
T COG2112 27 EKELAKGTTSVVYLGEWR-GGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGRPL 99 (201)
T ss_pred hhhhhcccccEEEEeecc-CceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCcch
Confidence 577999999999999996 4578888766543 3468899999999988666543 33332 33466999999888
Q ss_pred hhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCC-C-CcEEECCCCcEEEeeeccceee
Q 017558 286 EFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIK-S-ANILLDDSFEAKVADFGLAKHS 353 (369)
Q Consensus 286 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk-~-~Nill~~~~~~ki~DFGla~~~ 353 (369)
.++-... +-++... +++.---|-.. ||-|+.|. + .||++.+ ..+.|+||--|..-
T Consensus 100 ~~~~~~~-----~rk~l~~----vlE~a~~LD~~---GI~H~El~~~~k~vlv~~-~~~~iIDFd~At~k 156 (201)
T COG2112 100 GKLEIGG-----DRKHLLR----VLEKAYKLDRL---GIEHGELSRPWKNVLVND-RDVYIIDFDSATFK 156 (201)
T ss_pred hhhhhcc-----cHHHHHH----HHHHHHHHHHh---ccchhhhcCCceeEEecC-CcEEEEEccchhhc
Confidence 7665321 2233333 33332233333 78888775 3 4555544 48999999988743
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.31 E-value=6.6e-06 Score=73.19 Aligned_cols=140 Identities=19% Similarity=0.222 Sum_probs=77.6
Q ss_pred ceecccCce-EEEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCC---ccccEeeEEEeC---CeeEEEEEec
Q 017558 208 NLLGQGGFG-YVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHR---HLVSLVGYCTFG---SQRLLVYEFV 280 (369)
Q Consensus 208 ~~lg~G~fg-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~g~~~~~---~~~~lv~e~~ 280 (369)
+.|+.|+.. .||+. +..+++|..+.. ....++.+|.++|..+... .+...++.+... ...|++||++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 457766665 58875 234667765542 2235788999999887532 345555444332 2348899999
Q ss_pred CCCcHhhh------------------hcCCCCCC--------------C-CHHHHH--HHH-------HHHHHH-HH-HH
Q 017558 281 PNKTLEFH------------------LHGKDRPV--------------M-NWPTRM--KIA-------LGSARG-LA-YL 316 (369)
Q Consensus 281 ~~g~L~~~------------------l~~~~~~~--------------l-~~~~~~--~i~-------~~i~~~-l~-yL 316 (369)
+|.++... ||.-.... + .|.... .+. .+.... ++ ++
T Consensus 77 ~G~~l~~~~~~~~~~l~~~la~~l~~LH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 156 (235)
T cd05155 77 EGETATAAALSDPSEFAEDLADFLAALRQIDPSGGPPAGRHNFLRGGDLAVRDAETREAIEALEGVIDVDAARALWEAAL 156 (235)
T ss_pred cCCCCCccccCCHHHHHHHHHHHHHHHhCCCcccCCccCCccccCCCChhHhhHHHHHHHHHcccccChHHHHHHHHHHh
Confidence 98776422 12111000 0 111110 000 011111 11 11
Q ss_pred Hh--CCCCCeeecCCCCCcEEECCCCcEEEeeeccceee
Q 017558 317 HE--DCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (369)
Q Consensus 317 H~--~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~ 353 (369)
+. .....++|+|+.+.|||++++...-|+||+.|...
T Consensus 157 ~~~~~~~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~g 195 (235)
T cd05155 157 RAPWWGPPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGVG 195 (235)
T ss_pred cccccCCceEEeCCCCCCcEEEECCCEEEEEeCcccCcC
Confidence 11 12345999999999999987755679999987643
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.29 E-value=2.9e-05 Score=66.82 Aligned_cols=128 Identities=20% Similarity=0.254 Sum_probs=89.5
Q ss_pred cceecccCceEEEEEEEcCCeEEEEEeeccCC----------------cccHHHHHHHHHHHHhcC------CCccccEe
Q 017558 207 ANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGS----------------GQGEREFQAEIEIISQVH------HRHLVSLV 264 (369)
Q Consensus 207 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------h~niv~l~ 264 (369)
...||+|+.-.||.- .++....||+++... ....++..+|+.-...+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 567999999999983 334556778776554 122356667776655554 88999999
Q ss_pred eEEEeCCeeEEEEEecCC------CcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECC
Q 017558 265 GYCTFGSQRLLVYEFVPN------KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD 338 (369)
Q Consensus 265 g~~~~~~~~~lv~e~~~~------g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~ 338 (369)
|+.+.+.-.-+|+|.+-+ -+|.+++... .++. . +...+-+-.+||-++ .|+.+||+|.||++..
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~---~~~~-~---~~~~L~~f~~~l~~~---~Iv~~dl~~~NIv~~~ 153 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEG---GLTE-E---LRQALDEFKRYLLDH---HIVIRDLNPHNIVVQR 153 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcC---CccH-H---HHHHHHHHHHHHHHc---CCeecCCCcccEEEEe
Confidence 999999888999998843 3577777433 2444 2 223333445677777 8999999999999953
Q ss_pred C---C-cEEEee
Q 017558 339 S---F-EAKVAD 346 (369)
Q Consensus 339 ~---~-~~ki~D 346 (369)
. . .+.|+|
T Consensus 154 ~~~~~~~lvlID 165 (199)
T PF10707_consen 154 RDSGEFRLVLID 165 (199)
T ss_pred cCCCceEEEEEe
Confidence 2 2 588888
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.24 E-value=2.1e-05 Score=69.86 Aligned_cols=142 Identities=21% Similarity=0.234 Sum_probs=83.1
Q ss_pred cceecccCceEEEEEEEcC--CeEEEEEeeccCCcccHHHHHHHHHHHHhcCC-CccccEeeEEEeCCeeEEEEEecCCC
Q 017558 207 ANLLGQGGFGYVHKGVLTN--GKVVAIKQLKAGSGQGEREFQAEIEIISQVHH-RHLVSLVGYCTFGSQRLLVYEFVPNK 283 (369)
Q Consensus 207 ~~~lg~G~fg~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lv~e~~~~g 283 (369)
.+.|..|-...+|+....+ +..|++|........ .-+..+|+.++..+.. .-+.++++.+. ..++|||++|.
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~ 77 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGR 77 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCC
Confidence 3567788888999998754 567888877543221 1234578888888853 33445544332 24899999987
Q ss_pred cHhhh-----------------hcCCCC---------CCC-CHHHHHHHHH----------------------HHHHHHH
Q 017558 284 TLEFH-----------------LHGKDR---------PVM-NWPTRMKIAL----------------------GSARGLA 314 (369)
Q Consensus 284 ~L~~~-----------------l~~~~~---------~~l-~~~~~~~i~~----------------------~i~~~l~ 314 (369)
++... ||.... ... -|+....+.. .+..-+.
T Consensus 78 ~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 157 (235)
T cd05157 78 TLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEIS 157 (235)
T ss_pred cCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHH
Confidence 66321 111110 011 1222111111 1111112
Q ss_pred HH----HhC-CCCCeeecCCCCCcEEECC-CCcEEEeeeccceee
Q 017558 315 YL----HED-CQPKIIHRDIKSANILLDD-SFEAKVADFGLAKHS 353 (369)
Q Consensus 315 yL----H~~-~~~~ivHrdlk~~Nill~~-~~~~ki~DFGla~~~ 353 (369)
.| ... ....++|+|+.+.|||+++ ++.+.|+||..|...
T Consensus 158 ~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~~ 202 (235)
T cd05157 158 WLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGYN 202 (235)
T ss_pred HHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCcC
Confidence 22 111 2346999999999999997 578999999988653
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.16 E-value=1.5e-05 Score=71.76 Aligned_cols=138 Identities=14% Similarity=0.097 Sum_probs=79.7
Q ss_pred ecccCceEEEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCc-cccEeeEEEeCCeeEEEEEecCCCcHhhh
Q 017558 210 LGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRH-LVSLVGYCTFGSQRLLVYEFVPNKTLEFH 288 (369)
Q Consensus 210 lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~g~~~~~~~~~lv~e~~~~g~L~~~ 288 (369)
+..|-...+|+... ++..+++|........-.-+..+|.+++..+.... ..++++.+. .++||||++|..+...
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence 55677788998874 56678888754432221124577888888886433 344444432 3799999998765421
Q ss_pred -----------------hcCCCC--CCCCHHH-HHHHHHHH---------HHHHHHHHhC-----CCCCeeecCCCCCcE
Q 017558 289 -----------------LHGKDR--PVMNWPT-RMKIALGS---------ARGLAYLHED-----CQPKIIHRDIKSANI 334 (369)
Q Consensus 289 -----------------l~~~~~--~~l~~~~-~~~i~~~i---------~~~l~yLH~~-----~~~~ivHrdlk~~Ni 334 (369)
||.... ..++... ...+..++ ...++.+-.. ....++|+|+.+.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 222111 1122111 11111111 1112222211 123689999999999
Q ss_pred EECCCCcEEEeeeccceee
Q 017558 335 LLDDSFEAKVADFGLAKHS 353 (369)
Q Consensus 335 ll~~~~~~ki~DFGla~~~ 353 (369)
++++++ ++|+||..|...
T Consensus 159 l~~~~~-~~lIDwE~a~~g 176 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYASDG 176 (256)
T ss_pred EEeCCC-CEEEeccccCcC
Confidence 999876 789999988653
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=98.13 E-value=6.5e-05 Score=69.62 Aligned_cols=143 Identities=16% Similarity=0.165 Sum_probs=84.5
Q ss_pred cceecccCceEEEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCC--CccccEeeEE------EeCCeeEEEEE
Q 017558 207 ANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHH--RHLVSLVGYC------TFGSQRLLVYE 278 (369)
Q Consensus 207 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~g~~------~~~~~~~lv~e 278 (369)
.+.++.|....+|+....++ .+++|+..... ...++..|.+++..|.. -+|.+++... ...+..++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 45677777788999886555 57788765422 23455667777776632 2345554422 22456789999
Q ss_pred ecCCCcHhh--------------hhcCCCC----C------CCCHHHHH------------HHHHHHHHHHHHHHh----
Q 017558 279 FVPNKTLEF--------------HLHGKDR----P------VMNWPTRM------------KIALGSARGLAYLHE---- 318 (369)
Q Consensus 279 ~~~~g~L~~--------------~l~~~~~----~------~l~~~~~~------------~i~~~i~~~l~yLH~---- 318 (369)
|++|..+.. .+|.... . ...|.... .....+...++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 998855421 1121100 0 01121110 011123345555542
Q ss_pred CCCCCeeecCCCCCcEEECCCCcEEEeeecccee
Q 017558 319 DCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (369)
Q Consensus 319 ~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~ 352 (369)
....++||+|+.+.||++++++...|+||+.+..
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 2345899999999999999887678999998843
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.13 E-value=5.9e-05 Score=70.26 Aligned_cols=142 Identities=14% Similarity=0.141 Sum_probs=79.1
Q ss_pred cceecccCceEEEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHhcC--CCccccEee------EEEeCCeeEEEEE
Q 017558 207 ANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVH--HRHLVSLVG------YCTFGSQRLLVYE 278 (369)
Q Consensus 207 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~g------~~~~~~~~~lv~e 278 (369)
.+.|+.|....+|+....+| .+++|++.. ...+.+..|+.++..|. .-.|.+.+. +....+..++++|
T Consensus 27 ~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~---~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTTQG-EYVLTLFER---LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred cchhccccccceEEEEeCCC-cEEEEEecc---CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 35566777778999887555 588888752 12334445556555553 122444442 1233566789999
Q ss_pred ecCCCcHhh-----------h---hcCCC---------CCCCCH-HHHHH-H-----------H-HHHHHHHHHHHh---
Q 017558 279 FVPNKTLEF-----------H---LHGKD---------RPVMNW-PTRMK-I-----------A-LGSARGLAYLHE--- 318 (369)
Q Consensus 279 ~~~~g~L~~-----------~---l~~~~---------~~~l~~-~~~~~-i-----------~-~~i~~~l~yLH~--- 318 (369)
|++|..+.. . +|... ...+.| ..... + . ..+...++++..
T Consensus 103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 182 (319)
T PRK05231 103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW 182 (319)
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence 999875421 1 11110 001112 11111 0 1 111122233321
Q ss_pred -CCCCCeeecCCCCCcEEECCCCcEEEeeecccee
Q 017558 319 -DCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (369)
Q Consensus 319 -~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~ 352 (369)
....++||+|+.+.|||++++...-|+||+.+..
T Consensus 183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred ccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 1345899999999999999775568999998854
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=98.09 E-value=4.7e-05 Score=70.11 Aligned_cols=142 Identities=17% Similarity=0.157 Sum_probs=87.2
Q ss_pred cceecccCceEEEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCC--ccccEeeE------EEeCCeeEEEEE
Q 017558 207 ANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHR--HLVSLVGY------CTFGSQRLLVYE 278 (369)
Q Consensus 207 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~g~------~~~~~~~~lv~e 278 (369)
.+.|..|....+|+....+ ..+++|+... ....++..|++++..+.+. .+.+++.. ....+..++|++
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 5567778778899987644 4688888764 2335677788888777432 34555442 233456789999
Q ss_pred ecCCCcHhh----h----------hcCC----C-----CCCCCHHHHH----------HHHHHHHHHHHHHHh----CCC
Q 017558 279 FVPNKTLEF----H----------LHGK----D-----RPVMNWPTRM----------KIALGSARGLAYLHE----DCQ 321 (369)
Q Consensus 279 ~~~~g~L~~----~----------l~~~----~-----~~~l~~~~~~----------~i~~~i~~~l~yLH~----~~~ 321 (369)
|++|..+.. . ||.. . .....|.... .....+...+.++.. ...
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 999876532 0 1110 0 0112222211 011223344555543 123
Q ss_pred CCeeecCCCCCcEEECCCCcEEEeeecccee
Q 017558 322 PKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (369)
Q Consensus 322 ~~ivHrdlk~~Nill~~~~~~ki~DFGla~~ 352 (369)
.+++|+|+.+.|||++++..+.|+||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 4799999999999999987778999988764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.09 E-value=0.00013 Score=69.58 Aligned_cols=76 Identities=20% Similarity=0.153 Sum_probs=54.4
Q ss_pred cceecccCceEEEEEEEcCC-eEEEEEeeccC-----C--cccHHHHHHHHHHHHhcC---CCccccEeeEEEeCCeeEE
Q 017558 207 ANLLGQGGFGYVHKGVLTNG-KVVAIKQLKAG-----S--GQGEREFQAEIEIISQVH---HRHLVSLVGYCTFGSQRLL 275 (369)
Q Consensus 207 ~~~lg~G~fg~Vy~~~~~~~-~~vavK~~~~~-----~--~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~l 275 (369)
.+.||.|.+..||++...+| +.++||.-... . ....+.+..|.+.|..+. -.++.+++.+ +.+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 46799999999999998776 48999975321 1 123456777888887763 3467777766 3456789
Q ss_pred EEEecCCCc
Q 017558 276 VYEFVPNKT 284 (369)
Q Consensus 276 v~e~~~~g~ 284 (369)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998643
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.99 E-value=7e-05 Score=69.20 Aligned_cols=142 Identities=22% Similarity=0.256 Sum_probs=85.2
Q ss_pred cceecccCceEEEEEEEcC-------CeEEEEEeeccCCcccHHHHHHHHHHHHhcCCC-ccccEeeEEEeCCeeEEEEE
Q 017558 207 ANLLGQGGFGYVHKGVLTN-------GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHR-HLVSLVGYCTFGSQRLLVYE 278 (369)
Q Consensus 207 ~~~lg~G~fg~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~-niv~l~g~~~~~~~~~lv~e 278 (369)
.+.|..|-.-.+|+....+ ++.+++|....... ...+..+|.+++..+... -..++++++. -.+|+|
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~v~e 77 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE-LLIDRERELVVFARLSERNLGPKLYGIFP----NGRIEE 77 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc-ceechHHHHHHHHHHHhCCCCCceEEEeC----CCchhh
Confidence 3556677777899988654 47888998765432 223567788888877532 2345555553 246899
Q ss_pred ecCCCcHhhh-----------------hcCCCCC-------CC--CHHHHHH--------------------------HH
Q 017558 279 FVPNKTLEFH-----------------LHGKDRP-------VM--NWPTRMK--------------------------IA 306 (369)
Q Consensus 279 ~~~~g~L~~~-----------------l~~~~~~-------~l--~~~~~~~--------------------------i~ 306 (369)
|++|..+... ||..... .. -|..... +.
T Consensus 78 ~i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (302)
T cd05156 78 FIPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFL 157 (302)
T ss_pred eeCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHH
Confidence 9998776431 1111111 00 0111100 11
Q ss_pred HHHHHHHHHHHh------CCCCCeeecCCCCCcEEECCC----CcEEEeeeccceee
Q 017558 307 LGSARGLAYLHE------DCQPKIIHRDIKSANILLDDS----FEAKVADFGLAKHS 353 (369)
Q Consensus 307 ~~i~~~l~yLH~------~~~~~ivHrdlk~~Nill~~~----~~~ki~DFGla~~~ 353 (369)
..+..-+++|.. .....++|+|+.+.|||++++ +.++++||..|...
T Consensus 158 ~~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~~ 214 (302)
T cd05156 158 EDEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASYN 214 (302)
T ss_pred HHHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCCC
Confidence 122233344432 134579999999999999974 78999999988753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PF01102 Glycophorin_A: Glycophorin A; InterPro: IPR001195 Proteins in this group are responsible for the molecular basis of the blood group antigens, surface markers on the outside of the red blood cell membrane | Back alignment and domain information |
|---|
Probab=97.92 E-value=6.9e-06 Score=63.91 Aligned_cols=37 Identities=22% Similarity=0.239 Sum_probs=22.0
Q ss_pred CCCCCCCceeeeehHHHHHHHHHHHHHHHHHHHHhhhhh
Q 017558 65 NGYLPPGALAGMVVGVVIGAGIVLAAVGIFLIFYKRRKR 103 (369)
Q Consensus 65 ~~~~~~~~~~~ivvg~~~~~~~~l~~~~~~~~~~rrr~~ 103 (369)
...++.+++++|++|+++|+++ ++++++||++|||||
T Consensus 58 ~h~fs~~~i~~Ii~gv~aGvIg--~Illi~y~irR~~Kk 94 (122)
T PF01102_consen 58 VHRFSEPAIIGIIFGVMAGVIG--IILLISYCIRRLRKK 94 (122)
T ss_dssp SSSSS-TCHHHHHHHHHHHHHH--HHHHHHHHHHHHS--
T ss_pred ccCccccceeehhHHHHHHHHH--HHHHHHHHHHHHhcc
Confidence 3467888999999999976533 333444444444444
|
Most of these markers are proteins, but some are carbohydrates attached to lipids or proteins [Reid M.E., Lomas-Francis C. The Blood Group Antigen FactsBook Academic Press, London / San Diego, (1997)]. Glycophorin A (PAS-2) and glycophorin B (PAS-3) belong to the MNS blood group system and are associated with antigens that include M/N, S/s, U, He, Mi(a), M(c), Vw, Mur, M(g), Vr, M(e), Mt(a), St(a), Ri(a), Cl(a), Ny(a), Hut, Hil, M(v), Far, Mit, Dantu, Hop, Nob, En(a), ENKT, amongst others. Glycophorin A is the major sialoglycoprotein of the erythrocyte membrane []. Structurally, glycophorin A consists of an N-terminal extracellular domain, heavily glycosylated on serine and threonine residues, followed by a transmembrane region and a C-terminal cytoplasmic domain. Other glycophorins in this entry such as Glycophorin B and Glycophorin E represent minor sialoglycoproteins in the erythrocyte membrane.; GO: 0016021 integral to membrane; PDB: 2KPF_B 1AFO_B 2KPE_A. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.00091 Score=61.67 Aligned_cols=146 Identities=18% Similarity=0.271 Sum_probs=83.8
Q ss_pred cceecccCceEEEEEEEcCCeEEEEEeec-cCCcccHHHHHHHHHHHHhcC--CCccccEeeEEEeCC--eeEEEEEecC
Q 017558 207 ANLLGQGGFGYVHKGVLTNGKVVAIKQLK-AGSGQGEREFQAEIEIISQVH--HRHLVSLVGYCTFGS--QRLLVYEFVP 281 (369)
Q Consensus 207 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~-~~~~~~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~~--~~~lv~e~~~ 281 (369)
.+.+..|.--.+|+.... ++.+++.+=. ...........+|.++|+.+. .--+...+++|.++. ..|.||+|++
T Consensus 30 v~~~~~G~sn~t~~~~~~-~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~ve 108 (321)
T COG3173 30 VEEISGGWSNDTFRLGDT-GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVE 108 (321)
T ss_pred eeeccCCcccceEEEecC-CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEec
Confidence 344434433345554433 6667777211 112223356678888888874 334556677787665 6799999998
Q ss_pred CCcHhhhhcCCC------------------------------------CCCCCHHHHHHHHH--------HHHHHHHHHH
Q 017558 282 NKTLEFHLHGKD------------------------------------RPVMNWPTRMKIAL--------GSARGLAYLH 317 (369)
Q Consensus 282 ~g~L~~~l~~~~------------------------------------~~~l~~~~~~~i~~--------~i~~~l~yLH 317 (369)
|..+...+.... ++...|...++.+. ....-..||+
T Consensus 109 Ge~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~ 188 (321)
T COG3173 109 GEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLE 188 (321)
T ss_pred ceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHH
Confidence 843322221100 00111211111010 1223344555
Q ss_pred hC-----CCCCeeecCCCCCcEEECCCCcEEEeeeccceee
Q 017558 318 ED-----CQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (369)
Q Consensus 318 ~~-----~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~ 353 (369)
.+ ....++|+|+.+.|++++.+..+=|.||+++...
T Consensus 189 ~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 189 ANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred hcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 44 2357999999999999999888999999998754
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.63 E-value=9.9e-05 Score=67.15 Aligned_cols=134 Identities=19% Similarity=0.132 Sum_probs=91.9
Q ss_pred CCcccceecccCceEEEEEEEcCCeEEEEEeeccCCc--------------------cc--HHHHHHHHHHHHhcC-CC-
Q 017558 203 NFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSG--------------------QG--EREFQAEIEIISQVH-HR- 258 (369)
Q Consensus 203 ~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~--------------------~~--~~~~~~E~~~l~~l~-h~- 258 (369)
-+..+++||-|.-+.||.+...+|...++|.-+.... .- .-...+|...|..|. |.
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 3677899999999999999998899888885432110 00 113457888888874 32
Q ss_pred ccccEeeEEEeCCeeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECC
Q 017558 259 HLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD 338 (369)
Q Consensus 259 niv~l~g~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~ 338 (369)
-|..-++ .+..++|||++.+-.|...-+- .+..++ ...+..-+.-|..+ |+||+|..==||+|++
T Consensus 173 pVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v-----~d~~~l---y~~lm~~Iv~la~~---GlIHgDFNEFNimv~d 237 (465)
T KOG2268|consen 173 PVPKPID----HNRHCVVMELVDGYPLRQVRHV-----EDPPTL---YDDLMGLIVRLANH---GLIHGDFNEFNIMVKD 237 (465)
T ss_pred CCCCccc----ccceeeHHHhhcccceeeeeec-----CChHHH---HHHHHHHHHHHHHc---CceecccchheeEEec
Confidence 2444443 3567899999998888654332 222232 23333334556566 9999999999999999
Q ss_pred CCcEEEeeeccce
Q 017558 339 SFEAKVADFGLAK 351 (369)
Q Consensus 339 ~~~~ki~DFGla~ 351 (369)
++.++++||==+-
T Consensus 238 d~~i~vIDFPQmv 250 (465)
T KOG2268|consen 238 DDKIVVIDFPQMV 250 (465)
T ss_pred CCCEEEeechHhh
Confidence 9999999996443
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.00083 Score=61.21 Aligned_cols=32 Identities=25% Similarity=0.472 Sum_probs=26.5
Q ss_pred CCeeecCCCCCcEEECCCCc-EEEeeeccceee
Q 017558 322 PKIIHRDIKSANILLDDSFE-AKVADFGLAKHS 353 (369)
Q Consensus 322 ~~ivHrdlk~~Nill~~~~~-~ki~DFGla~~~ 353 (369)
+.++|+|+.+.|||+++++. .-|+||+.+...
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 46899999999999997555 469999988653
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.53 E-value=8.3e-06 Score=83.64 Aligned_cols=146 Identities=17% Similarity=0.167 Sum_probs=98.4
Q ss_pred cCCcccceecccCceEEEEEEEc-CCeEEEEEeeccC---CcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEE
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG---SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 277 (369)
+.|.+.+-+.+|.|+.++.+.-. .+...+.|..... ...+.+..+.+-.++..-.+|-+++..--+.-....+|++
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~ 883 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVG 883 (1205)
T ss_pred ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhh
Confidence 44555666777888888776632 2333333333221 1112233344444444445566666554444567889999
Q ss_pred EecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeecccee
Q 017558 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (369)
Q Consensus 278 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~ 352 (369)
+|+.+++|...||.-. ..+.+-.......+..+++|||.. .++|||+++.|.|+..++..+++|||+.+.
T Consensus 884 ~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~ 953 (1205)
T KOG0606|consen 884 HYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSK 953 (1205)
T ss_pred HHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccc
Confidence 9999999999998654 344444445566678899999987 689999999999999999999999995443
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.0026 Score=58.91 Aligned_cols=30 Identities=37% Similarity=0.430 Sum_probs=26.0
Q ss_pred CCeeecCCCCCcEEECCCCcEEEeeecccee
Q 017558 322 PKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (369)
Q Consensus 322 ~~ivHrdlk~~Nill~~~~~~ki~DFGla~~ 352 (369)
.+++|+|+.+.||+++. +.+.|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 47999999999999987 5789999997653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PTZ00382 Variant-specific surface protein (VSP); Provisional | Back alignment and domain information |
|---|
Probab=97.48 E-value=6.2e-05 Score=56.46 Aligned_cols=18 Identities=44% Similarity=0.619 Sum_probs=15.0
Q ss_pred CCCCCCCceeeeehHHHH
Q 017558 65 NGYLPPGALAGMVVGVVI 82 (369)
Q Consensus 65 ~~~~~~~~~~~ivvg~~~ 82 (369)
++++++++|+||+||+++
T Consensus 60 ~~~ls~gaiagi~vg~~~ 77 (96)
T PTZ00382 60 RSGLSTGAIAGISVAVVA 77 (96)
T ss_pred CCCcccccEEEEEeehhh
Confidence 357889999999998875
|
|
| >PF08693 SKG6: Transmembrane alpha-helix domain; InterPro: IPR014805 SKG6 and AXL2 are membrane proteins that show polarised intracellular localisation [, ] | Back alignment and domain information |
|---|
Probab=97.48 E-value=3.9e-05 Score=46.65 Aligned_cols=29 Identities=41% Similarity=0.893 Sum_probs=15.6
Q ss_pred eeeehHHHHHHHHHHHHHHHHHHHHhhhh
Q 017558 74 AGMVVGVVIGAGIVLAAVGIFLIFYKRRK 102 (369)
Q Consensus 74 ~~ivvg~~~~~~~~l~~~~~~~~~~rrr~ 102 (369)
++|.+|+++.++++++++++++++++||+
T Consensus 11 vaIa~~VvVPV~vI~~vl~~~l~~~~rR~ 39 (40)
T PF08693_consen 11 VAIAVGVVVPVGVIIIVLGAFLFFWYRRK 39 (40)
T ss_pred EEEEEEEEechHHHHHHHHHHhheEEecc
Confidence 34555555555555555555555444443
|
This entry represents the highly conserved transmembrane alpha-helical domain found in these proteins [, ]. The full-length AXL2 protein has a negative regulatory function in cytokinesis []. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.0032 Score=59.30 Aligned_cols=142 Identities=19% Similarity=0.207 Sum_probs=82.3
Q ss_pred cceecccCceEEEEEEEcC-----CeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCcc-ccEeeEEEeCCeeEEEEEec
Q 017558 207 ANLLGQGGFGYVHKGVLTN-----GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHL-VSLVGYCTFGSQRLLVYEFV 280 (369)
Q Consensus 207 ~~~lg~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lv~e~~ 280 (369)
.+.|-.|-.-.+|+..+.+ ++.|++|......... -+-..|..++..+..-++ .++++.+.. + .|+||+
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~-idR~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~efi 115 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELF-FDRDDEIRTFECMSRHGQGPRLLGRFPN-G---RVEEFI 115 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCee-echHHHHHHHHHHHHcCCCCceEEEECC-c---eEEEee
Confidence 3456567777899987543 3578889876544222 233678888888753333 455555532 2 689999
Q ss_pred CCCcHhhh-----------------hcCCCC---C-CCCHHHHHHHHHH-----------------HHHHHHHHH----h
Q 017558 281 PNKTLEFH-----------------LHGKDR---P-VMNWPTRMKIALG-----------------SARGLAYLH----E 318 (369)
Q Consensus 281 ~~g~L~~~-----------------l~~~~~---~-~l~~~~~~~i~~~-----------------i~~~l~yLH----~ 318 (369)
++.+|... +|.... . ..-|++..++..+ +..-+..|. .
T Consensus 116 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~ 195 (344)
T PLN02236 116 HARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG 195 (344)
T ss_pred CCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence 87776421 222110 0 1112222222211 111122222 1
Q ss_pred -CCCCCeeecCCCCCcEEECC-CCcEEEeeeccceee
Q 017558 319 -DCQPKIIHRDIKSANILLDD-SFEAKVADFGLAKHS 353 (369)
Q Consensus 319 -~~~~~ivHrdlk~~Nill~~-~~~~ki~DFGla~~~ 353 (369)
.....++|+|+++.|||+++ ++.++|+||..|...
T Consensus 196 ~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~ 232 (344)
T PLN02236 196 DDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYN 232 (344)
T ss_pred cCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcccc
Confidence 22346899999999999986 468999999988753
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.0028 Score=59.39 Aligned_cols=79 Identities=15% Similarity=0.053 Sum_probs=50.7
Q ss_pred eecccCceEEEEEEEcCC-eEEEEEeeccC------C-cccHHHHHHHHHHHHhcC--CC-ccccEeeEEEeCCeeEEEE
Q 017558 209 LLGQGGFGYVHKGVLTNG-KVVAIKQLKAG------S-GQGEREFQAEIEIISQVH--HR-HLVSLVGYCTFGSQRLLVY 277 (369)
Q Consensus 209 ~lg~G~fg~Vy~~~~~~~-~~vavK~~~~~------~-~~~~~~~~~E~~~l~~l~--h~-niv~l~g~~~~~~~~~lv~ 277 (369)
.||.|..-.||++...++ +.|+||.-... . .-..+....|.+.|.... -| .+.+++ +.+.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy--~~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIF--HFDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEE--EEccccceehH
Confidence 479999999999997654 57889875321 1 123345567777776653 24 455553 33456667999
Q ss_pred EecCC-CcHhhhh
Q 017558 278 EFVPN-KTLEFHL 289 (369)
Q Consensus 278 e~~~~-g~L~~~l 289 (369)
|+++. ..|...|
T Consensus 80 EdL~~~~ilR~~L 92 (370)
T TIGR01767 80 EDLSHHKIARKGL 92 (370)
T ss_pred hhCccchHHHHHH
Confidence 99954 3444444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.004 Score=59.35 Aligned_cols=80 Identities=15% Similarity=0.129 Sum_probs=53.1
Q ss_pred cceecccCceEEEEEEEcCCeEEEEEeeccCCc-------ccHHHHHHHHHHHHhcC---CCccccEeeEEEeCCeeEEE
Q 017558 207 ANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSG-------QGEREFQAEIEIISQVH---HRHLVSLVGYCTFGSQRLLV 276 (369)
Q Consensus 207 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~lv 276 (369)
.+.||.|..-.||+.... +..++||.-..... ........|.+.|..+. -.+|.+++.+|. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 567999999999998864 45688887542111 12233344566666553 357888988886 456889
Q ss_pred EEecCC--CcHhhhh
Q 017558 277 YEFVPN--KTLEFHL 289 (369)
Q Consensus 277 ~e~~~~--g~L~~~l 289 (369)
|||+++ ..+.+.|
T Consensus 114 ME~L~~~~~ilr~~L 128 (418)
T PLN02756 114 MRYLEPPHIILRKGL 128 (418)
T ss_pred EeecCCcceehhhhh
Confidence 999977 3454444
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.0026 Score=59.22 Aligned_cols=136 Identities=22% Similarity=0.336 Sum_probs=81.4
Q ss_pred CceEEEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCc------cccEeeEE--EeCC--eeEEEEEecCCC
Q 017558 214 GFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRH------LVSLVGYC--TFGS--QRLLVYEFVPNK 283 (369)
Q Consensus 214 ~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~g~~--~~~~--~~~lv~e~~~~g 283 (369)
.--.+|+....+++. ++|..+.. ....++..|+..|..+.-.+ |..+-|-. .... ..+-+++|++|.
T Consensus 37 ~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~ 113 (331)
T COG2334 37 EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGR 113 (331)
T ss_pred ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCc
Confidence 345699998877765 88888765 33456777777777663211 22222221 1133 778899999998
Q ss_pred cHhh-h--------------hcC--CC--------CCCCCHHH-------------HHHHHHHHHHHHHHHHhC----CC
Q 017558 284 TLEF-H--------------LHG--KD--------RPVMNWPT-------------RMKIALGSARGLAYLHED----CQ 321 (369)
Q Consensus 284 ~L~~-~--------------l~~--~~--------~~~l~~~~-------------~~~i~~~i~~~l~yLH~~----~~ 321 (369)
.+.. . ||. ++ .....|.. ......++...+..+.+. ..
T Consensus 114 ~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp 193 (331)
T COG2334 114 PLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLP 193 (331)
T ss_pred CcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCC
Confidence 8873 1 110 11 11233430 011233344444444442 22
Q ss_pred CC---eeecCCCCCcEEECCCCc-EEEeeecccee
Q 017558 322 PK---IIHRDIKSANILLDDSFE-AKVADFGLAKH 352 (369)
Q Consensus 322 ~~---ivHrdlk~~Nill~~~~~-~ki~DFGla~~ 352 (369)
.. +||+|+.+.|||++.+.. +.++||+-|..
T Consensus 194 ~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 194 ALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred cccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 23 899999999999998875 88999998764
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.0036 Score=58.18 Aligned_cols=143 Identities=15% Similarity=0.177 Sum_probs=93.6
Q ss_pred ccceecccCceEEEEEEEcCCeEEEEEeeccCC----c------------------ccHHH----HHHHHHHHHhcCCCc
Q 017558 206 EANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGS----G------------------QGERE----FQAEIEIISQVHHRH 259 (369)
Q Consensus 206 ~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~----~------------------~~~~~----~~~E~~~l~~l~h~n 259 (369)
+-.+|..|.-..||.+...+|..+|||+++..- . ..++. ...|++-|.+++...
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 346688899999999999999999999886320 0 01111 235777777776444
Q ss_pred cccEeeEEEeCCeeEEEEEecCCCcH-hhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECC
Q 017558 260 LVSLVGYCTFGSQRLLVYEFVPNKTL-EFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD 338 (369)
Q Consensus 260 iv~l~g~~~~~~~~~lv~e~~~~g~L-~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~ 338 (369)
|.----.. =....|||+|+..... .-.|. ...++...+..+-.+++.-|.-|...| ++||.||.==|+|+-
T Consensus 228 IP~PePIl--Lk~hVLVM~FlGrdgw~aPkLK---d~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh- 299 (520)
T KOG2270|consen 228 IPCPEPIL--LKNHVLVMEFLGRDGWAAPKLK---DASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH- 299 (520)
T ss_pred CCCCCcee--eecceEeeeeccCCCCcCcccc---cccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE-
Confidence 32110001 0234699999952211 11111 123666667777788888888888776 899999999999885
Q ss_pred CCcEEEeeeccceeeCCC
Q 017558 339 SFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 339 ~~~~ki~DFGla~~~~~~ 356 (369)
+|.+.|+|-+=+....++
T Consensus 300 dG~lyiIDVSQSVE~DHP 317 (520)
T KOG2270|consen 300 DGKLYIIDVSQSVEHDHP 317 (520)
T ss_pred CCEEEEEEccccccCCCh
Confidence 458999998877655443
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.00073 Score=61.77 Aligned_cols=76 Identities=14% Similarity=0.242 Sum_probs=49.3
Q ss_pred CcccceecccCceEEEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHhcC---CCccccEeeEEEeCCeeEEEEEec
Q 017558 204 FSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVH---HRHLVSLVGYCTFGSQRLLVYEFV 280 (369)
Q Consensus 204 ~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~lv~e~~ 280 (369)
....+.|+.|....+|+.. .+++.+.||.-.. .....|..|.+-|+.|. --.|.+.+++...++..||||||+
T Consensus 19 i~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l 94 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD-TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL 94 (288)
T ss_dssp --EEEEE--SSSSEEEEEE-TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred eeeeEecCCCChhheEEEE-CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence 3446779999999999988 5678899997652 22357888888888773 456889999888888889999999
Q ss_pred CCC
Q 017558 281 PNK 283 (369)
Q Consensus 281 ~~g 283 (369)
+.+
T Consensus 95 ~~~ 97 (288)
T PF03881_consen 95 EMG 97 (288)
T ss_dssp ---
T ss_pred cCC
Confidence 877
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PF02439 Adeno_E3_CR2: Adenovirus E3 region protein CR2; InterPro: IPR003470 Early region 3 (E3) of human adenoviruses (Ads) codes for proteins that appear to control viral interactions with the host [] | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.00023 Score=42.42 Aligned_cols=18 Identities=28% Similarity=0.680 Sum_probs=10.4
Q ss_pred eeeehHHHHHHHHHHHHH
Q 017558 74 AGMVVGVVIGAGIVLAAV 91 (369)
Q Consensus 74 ~~ivvg~~~~~~~~l~~~ 91 (369)
++|++|+++|.+++++.+
T Consensus 6 IaIIv~V~vg~~iiii~~ 23 (38)
T PF02439_consen 6 IAIIVAVVVGMAIIIICM 23 (38)
T ss_pred hhHHHHHHHHHHHHHHHH
Confidence 567777776554444333
|
This region called CR1 (conserved region 1) [] is found three times in Human adenovirus 19 (a subgroup D adenovirus) 49 kDa protein in the E3 region. CR1 is also found in the 20.1 Kd protein of subgroup B adenoviruses. The function of this 80 amino acid region is unknown. This region is probably a divergent immunoglobulin domain. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.28 E-value=3.6e-05 Score=75.40 Aligned_cols=140 Identities=17% Similarity=0.114 Sum_probs=96.8
Q ss_pred CCcccceecccCceEEEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCc-cccEeeEEEeCCeeEEEEEecC
Q 017558 203 NFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRH-LVSLVGYCTFGSQRLLVYEFVP 281 (369)
Q Consensus 203 ~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~g~~~~~~~~~lv~e~~~ 281 (369)
.+.....+++|+++++||.+-...+...++.+... ....-++++|.+++||| .+..++-++.+...+++++|+.
T Consensus 243 ws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s 317 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICS 317 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhc
Confidence 34445667899999999987544444445555322 45667899999999999 8888888888889999999998
Q ss_pred CC-cHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCC
Q 017558 282 NK-TLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 282 ~g-~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~ 356 (369)
.+ +-..... .....+..-+...+...-+++++|||+. .-+|+| ||+..+ +..|..||+....+...
T Consensus 318 ~~rs~~~~~~-~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~ 384 (829)
T KOG0576|consen 318 TGRSSALEMT-VSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRT 384 (829)
T ss_pred CCccccccCC-hhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCcc
Confidence 77 2211110 0111233333345556667899999976 458998 777665 57899999998877654
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.0037 Score=57.95 Aligned_cols=32 Identities=16% Similarity=0.321 Sum_probs=28.7
Q ss_pred CCCeeecCCCCCcEEECCCCcEEEeeecccee
Q 017558 321 QPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (369)
Q Consensus 321 ~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~ 352 (369)
..++||+|+...|||++.++.+.|+||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 44799999999999999999999999988765
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF04478 Mid2: Mid2 like cell wall stress sensor; InterPro: IPR007567 This family represents a region near the C terminus of Mid2, which contains a transmembrane region | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.00025 Score=56.80 Aligned_cols=32 Identities=38% Similarity=0.591 Sum_probs=16.1
Q ss_pred CceeeeehHHHHHHHHHHHHHHHHHHHHhhhhhh
Q 017558 71 GALAGMVVGVVIGAGIVLAAVGIFLIFYKRRKRK 104 (369)
Q Consensus 71 ~~~~~ivvg~~~~~~~~l~~~~~~~~~~rrr~~~ 104 (369)
.+++|+||||.++ ++|++++++|+||+|+||+
T Consensus 49 nIVIGvVVGVGg~--ill~il~lvf~~c~r~kkt 80 (154)
T PF04478_consen 49 NIVIGVVVGVGGP--ILLGILALVFIFCIRRKKT 80 (154)
T ss_pred cEEEEEEecccHH--HHHHHHHhheeEEEecccC
Confidence 3577777776543 2333333444444444443
|
The remainder of the protein sequence is serine-rich and of low complexity, and is therefore impossible to align accurately. Mid2 is thought to act as a mechanosensor of cell wall stress. The C-terminal cytoplasmic region of Mid2 is known to interact with Rom2, a guanine nucleotide exchange factor (GEF) for Rho1, which is part of the cell wall integrity signalling pathway []. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.016 Score=54.15 Aligned_cols=70 Identities=11% Similarity=0.069 Sum_probs=45.1
Q ss_pred ceEEEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCC--Ccccc---Eee--EEEeCCeeEEEEEecCCCcH
Q 017558 215 FGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHH--RHLVS---LVG--YCTFGSQRLLVYEFVPNKTL 285 (369)
Q Consensus 215 fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~---l~g--~~~~~~~~~lv~e~~~~g~L 285 (369)
--.||+....++..+++|..+... ....++..|++.+..+.. -.|+. .-| +...++..+.+++|++|...
T Consensus 38 eN~vy~v~~~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~~ 114 (325)
T PRK11768 38 ENRVYQFGDEDGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRAP 114 (325)
T ss_pred cceEEEEecCCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence 356999988778889999876432 345677788888776632 12222 122 22335677889999987643
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.02 E-value=0.0071 Score=56.65 Aligned_cols=141 Identities=17% Similarity=0.236 Sum_probs=79.2
Q ss_pred ceecccCceEEEEEEEcC----CeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCcc-ccEeeEEEeCCeeEEEEEecCC
Q 017558 208 NLLGQGGFGYVHKGVLTN----GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHL-VSLVGYCTFGSQRLLVYEFVPN 282 (369)
Q Consensus 208 ~~lg~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lv~e~~~~ 282 (369)
+.|..|=.-.+|+....+ +..|++|........ .-+-.+|..++..+..-++ .++++++. .+ +|.+|+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcC
Confidence 456556667799887543 237888887654332 1234578888888764444 45565553 22 58999977
Q ss_pred CcHhh-----------------hhcCCCC---C-CCCHHHHHHHHHHH----------------------HHHHHHHHh-
Q 017558 283 KTLEF-----------------HLHGKDR---P-VMNWPTRMKIALGS----------------------ARGLAYLHE- 318 (369)
Q Consensus 283 g~L~~-----------------~l~~~~~---~-~l~~~~~~~i~~~i----------------------~~~l~yLH~- 318 (369)
..|.. .||.... . .--|....++..++ ..-+..+..
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 65521 1122111 0 11122222222111 111222211
Q ss_pred ----CCCCCeeecCCCCCcEEECC-CCcEEEeeeccceee
Q 017558 319 ----DCQPKIIHRDIKSANILLDD-SFEAKVADFGLAKHS 353 (369)
Q Consensus 319 ----~~~~~ivHrdlk~~Nill~~-~~~~ki~DFGla~~~ 353 (369)
....-++|.|+.+.|||+++ ++.++++||..|...
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~n 214 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSYS 214 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCCC
Confidence 11224799999999999974 578999999988653
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.0034 Score=54.68 Aligned_cols=31 Identities=32% Similarity=0.486 Sum_probs=22.2
Q ss_pred CeeecCCCCCcEEE-CCCCcEEEeeeccceee
Q 017558 323 KIIHRDIKSANILL-DDSFEAKVADFGLAKHS 353 (369)
Q Consensus 323 ~ivHrdlk~~Nill-~~~~~~ki~DFGla~~~ 353 (369)
-++|+||.+.|||+ +.++.++++||..|...
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~n 175 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGYN 175 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EEE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhhc
Confidence 58999999999999 88899999999988753
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.98 E-value=0.0059 Score=57.94 Aligned_cols=81 Identities=15% Similarity=0.133 Sum_probs=52.7
Q ss_pred cceecccCceEEEEEEEcC-CeEEEEEeeccC-----C-cccHHHHHHHHHHHHhcC--CC-ccccEeeEEEeCCeeEEE
Q 017558 207 ANLLGQGGFGYVHKGVLTN-GKVVAIKQLKAG-----S-GQGEREFQAEIEIISQVH--HR-HLVSLVGYCTFGSQRLLV 276 (369)
Q Consensus 207 ~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~-----~-~~~~~~~~~E~~~l~~l~--h~-niv~l~g~~~~~~~~~lv 276 (369)
.+.||.|.-..||++...+ ++.|+||.-... . .-..+...-|.++|.... -| .+.+++ +.+.+...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy--~~D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVY--LFDSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEE--EECcHHhhHH
Confidence 4679999999999999743 567888865321 1 123456677888887663 24 455564 3345666789
Q ss_pred EEecCC-CcHhhhh
Q 017558 277 YEFVPN-KTLEFHL 289 (369)
Q Consensus 277 ~e~~~~-g~L~~~l 289 (369)
||+++. ..|+..|
T Consensus 112 MEdL~~~~ilR~~L 125 (409)
T PRK12396 112 MEDLSDHTILRTAL 125 (409)
T ss_pred HHhCcccHHHHHHH
Confidence 999954 3344444
|
|
| >PF04478 Mid2: Mid2 like cell wall stress sensor; InterPro: IPR007567 This family represents a region near the C terminus of Mid2, which contains a transmembrane region | Back alignment and domain information |
|---|
Probab=96.98 E-value=0.00025 Score=56.74 Aligned_cols=40 Identities=23% Similarity=0.267 Sum_probs=29.1
Q ss_pred CCCCCCceeeeehHHHHHHHHHHHHHHHHHHHHhhhhhhhhh
Q 017558 66 GYLPPGALAGMVVGVVIGAGIVLAAVGIFLIFYKRRKRKLAA 107 (369)
Q Consensus 66 ~~~~~~~~~~ivvg~~~~~~~~l~~~~~~~~~~rrr~~~~~~ 107 (369)
.+++.... -|||||++| +.+.++++++++++...+|++..
T Consensus 41 sGlS~knk-nIVIGvVVG-VGg~ill~il~lvf~~c~r~kkt 80 (154)
T PF04478_consen 41 SGLSSKNK-NIVIGVVVG-VGGPILLGILALVFIFCIRRKKT 80 (154)
T ss_pred CCCCcCCc-cEEEEEEec-ccHHHHHHHHHhheeEEEecccC
Confidence 35555555 588999875 46777778888888888888664
|
The remainder of the protein sequence is serine-rich and of low complexity, and is therefore impossible to align accurately. Mid2 is thought to act as a mechanosensor of cell wall stress. The C-terminal cytoplasmic region of Mid2 is known to interact with Rom2, a guanine nucleotide exchange factor (GEF) for Rho1, which is part of the cell wall integrity signalling pathway []. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.92 E-value=0.019 Score=61.80 Aligned_cols=141 Identities=17% Similarity=0.210 Sum_probs=78.0
Q ss_pred ceecccCceEEEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHhcC-------CCccccEe-e----EEEe-CC--e
Q 017558 208 NLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVH-------HRHLVSLV-G----YCTF-GS--Q 272 (369)
Q Consensus 208 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-------h~niv~l~-g----~~~~-~~--~ 272 (369)
+.|+ |..-.+|+....++..+++|+.+... ....+..|.++|..|. -|.++.-. | .... ++ .
T Consensus 31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~--~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~ 107 (1013)
T PRK06148 31 TPLD-GERDLNFRLTTDDGADYILKIVNPSE--PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR 107 (1013)
T ss_pred eecC-CcCCceEEEEeCCCCeEEEEEcCCcc--chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence 4454 34567899887778889999987643 2234444555554442 22333221 1 1111 22 4
Q ss_pred eEEEEEecCCCcHhhhh-----------------cC----C----CCCCCCHHH-----------------HHHHHHHHH
Q 017558 273 RLLVYEFVPNKTLEFHL-----------------HG----K----DRPVMNWPT-----------------RMKIALGSA 310 (369)
Q Consensus 273 ~~lv~e~~~~g~L~~~l-----------------~~----~----~~~~l~~~~-----------------~~~i~~~i~ 310 (369)
.+-+|+|++|..|.+.. |. . ....+.|.. ...++.++.
T Consensus 108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~ 187 (1013)
T PRK06148 108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL 187 (1013)
T ss_pred EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence 56789999998776511 10 0 011233321 112222222
Q ss_pred HHHH-----HHHhCCCCCeeecCCCCCcEEECCCC--cEE-Eeeecccee
Q 017558 311 RGLA-----YLHEDCQPKIIHRDIKSANILLDDSF--EAK-VADFGLAKH 352 (369)
Q Consensus 311 ~~l~-----yLH~~~~~~ivHrdlk~~Nill~~~~--~~k-i~DFGla~~ 352 (369)
..++ .| .....++||+|+.+.|||++.+. ++. |+|||-+..
T Consensus 188 ~~~~~~v~p~l-~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 188 ARFERNVAPRL-AALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred HHHHHHHHHHH-hcCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 2221 12 22344799999999999999775 565 999997754
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.0056 Score=56.86 Aligned_cols=74 Identities=18% Similarity=0.201 Sum_probs=55.8
Q ss_pred eeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccce
Q 017558 272 QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351 (369)
Q Consensus 272 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~ 351 (369)
+.|++|++- |+.|.. ...-.|++.+.|+.+.+.-+.-+..++ .+=|||+.-.||||+ +|++-|+||-++|
T Consensus 300 y~yl~~kdh-gt~is~------ik~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfklsR 369 (488)
T COG5072 300 YLYLHFKDH-GTPISI------IKADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKLSR 369 (488)
T ss_pred EEEEEEecC-Cceeee------eecccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeeeee
Confidence 445666654 455432 123568888999988777777776654 789999999999999 8899999999999
Q ss_pred eeCC
Q 017558 352 HSLD 355 (369)
Q Consensus 352 ~~~~ 355 (369)
....
T Consensus 370 l~~~ 373 (488)
T COG5072 370 LSYS 373 (488)
T ss_pred cccC
Confidence 6443
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.53 E-value=0.015 Score=50.69 Aligned_cols=76 Identities=13% Similarity=0.146 Sum_probs=52.4
Q ss_pred cceecccCceEEEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHhc---CCCccccEeeEEEeCCeeEEEEEecCCC
Q 017558 207 ANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQV---HHRHLVSLVGYCTFGSQRLLVYEFVPNK 283 (369)
Q Consensus 207 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~g~~~~~~~~~lv~e~~~~g 283 (369)
.+.+..|..-+.|.... +...+.||+=. ......|..|+.-|..| +--+|.+.+.+-...+..|+||||++-|
T Consensus 21 r~~v~gG~inea~~v~d-g~~~~FvK~n~---~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~ 96 (286)
T COG3001 21 REEVSGGDINEAWRLRD-GTDPFFVKCNQ---REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTG 96 (286)
T ss_pred ccccCCccccceeEeec-CCcceEEEecc---hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCC
Confidence 34555555555555443 45678888532 23346788888766666 4466888888888899999999999986
Q ss_pred cHh
Q 017558 284 TLE 286 (369)
Q Consensus 284 ~L~ 286 (369)
.+.
T Consensus 97 ~~d 99 (286)
T COG3001 97 PLD 99 (286)
T ss_pred CCC
Confidence 664
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.41 E-value=0.035 Score=52.98 Aligned_cols=75 Identities=16% Similarity=0.221 Sum_probs=44.9
Q ss_pred cceecccCceEEEEEEEcCC--eE-----EEEEeeccCCcccHHHHHHHHHHHHhcCCCcc-ccEeeEEEeCCeeEEEEE
Q 017558 207 ANLLGQGGFGYVHKGVLTNG--KV-----VAIKQLKAGSGQGEREFQAEIEIISQVHHRHL-VSLVGYCTFGSQRLLVYE 278 (369)
Q Consensus 207 ~~~lg~G~fg~Vy~~~~~~~--~~-----vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lv~e 278 (369)
.+.|..|-...+|++...++ .. |.++........ .-+-.+|++++..+...++ .++++.+. -++++|
T Consensus 55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l-~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l~e 129 (383)
T PTZ00384 55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSL-VIDNDLQYNIAKLLGDNNFGPKIIGRFG----DFTIQE 129 (383)
T ss_pred EEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCce-EeccHHHHHHHHHHHhCCCCCeEEEecC----CEEEEE
Confidence 34565677789999986443 12 333332221111 1134578889988865444 45555553 369999
Q ss_pred ecCCCcHh
Q 017558 279 FVPNKTLE 286 (369)
Q Consensus 279 ~~~~g~L~ 286 (369)
|++|..|.
T Consensus 130 fIeGr~l~ 137 (383)
T PTZ00384 130 WVEGNTMG 137 (383)
T ss_pred EeccccCC
Confidence 99987764
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.21 E-value=0.017 Score=54.62 Aligned_cols=61 Identities=16% Similarity=0.144 Sum_probs=42.4
Q ss_pred eeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEC
Q 017558 272 QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLD 337 (369)
Q Consensus 272 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~ 337 (369)
...|+=+|+.|-++..++...+ ..++.+.+++.--++|+.-|--- .+++|.|+.|.||++.
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~~~~---~pe~l~kkva~lg~~AllkMl~v--DNFvHaDlHPGNVlir 379 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVKWKS---QPEALVKKVAKLGVNALLKMLIV--DNFVHADLHPGNVLIR 379 (565)
T ss_pred cceeeeeccccccHHhhhhccc---ChHHHHHHHHHHHHHHHHHHHHh--hcceecccCCCcEEEE
Confidence 3456778888989988887544 33445556666556666544322 1799999999999995
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 369 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 4e-50 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 6e-49 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 7e-35 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 5e-34 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-32 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-31 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-31 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-30 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-20 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 8e-20 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 8e-20 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-18 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 8e-18 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 9e-18 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 9e-18 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-17 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 8e-17 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 8e-16 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-15 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-15 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-15 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-15 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-15 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 5e-15 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 6e-15 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 6e-15 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 6e-15 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 7e-15 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 8e-15 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 9e-15 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-14 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-14 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-14 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 5e-14 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 5e-14 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 6e-14 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 6e-14 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-14 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 7e-14 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 7e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 7e-14 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 7e-14 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 7e-14 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 8e-14 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 8e-14 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 8e-14 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 9e-14 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 9e-14 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-13 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-13 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-13 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-13 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-13 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-13 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-13 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-13 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-13 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-13 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-13 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-13 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-13 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-13 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-13 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-13 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-13 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-13 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-13 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-13 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-13 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-13 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-13 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-13 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-13 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-13 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-13 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-13 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-13 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-13 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 5e-13 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 6e-13 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 6e-13 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-13 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 6e-13 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 6e-13 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 6e-13 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 6e-13 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 6e-13 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 6e-13 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 6e-13 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 7e-13 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 7e-13 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 7e-13 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 7e-13 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 8e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 8e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 8e-13 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-13 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-13 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 9e-13 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-12 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-12 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-12 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-12 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-12 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-12 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-12 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-12 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-12 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-12 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-12 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-12 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-12 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-12 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-12 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-12 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-12 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-12 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-12 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-12 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-12 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-12 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-12 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-12 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-12 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-12 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-12 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-12 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-12 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-12 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-12 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-12 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-12 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-12 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-12 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-12 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-12 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-12 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-12 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-12 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-12 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-12 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-12 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-12 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-12 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 4e-12 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-12 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-12 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-12 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-12 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 5e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 6e-12 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 7e-12 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 7e-12 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 7e-12 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 8e-12 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 8e-12 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 9e-12 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 9e-12 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-11 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-11 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-11 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-11 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-11 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-11 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-11 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-11 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-11 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-11 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-11 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-11 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-11 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-11 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-11 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-11 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-11 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-11 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-11 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-11 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-11 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-11 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-11 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-11 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-11 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-11 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-11 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-11 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-11 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-11 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-11 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-11 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-11 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-11 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-11 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-11 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-11 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-11 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-11 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-11 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-11 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-11 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-11 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-11 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-11 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-11 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-11 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-11 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-11 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-11 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-11 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-11 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-11 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-11 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-11 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 4e-11 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 5e-11 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-11 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 5e-11 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-11 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 5e-11 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 5e-11 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 5e-11 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 6e-11 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 6e-11 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-11 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 6e-11 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 6e-11 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 6e-11 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-11 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 6e-11 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 6e-11 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 7e-11 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 7e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 7e-11 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 7e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 8e-11 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 8e-11 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 8e-11 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 8e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 9e-11 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 9e-11 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 9e-11 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-10 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-10 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-10 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-10 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-10 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-10 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-10 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-10 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-10 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-10 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-10 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-10 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-10 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-10 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-10 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-10 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-10 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-10 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-10 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-10 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-10 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-10 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-10 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-10 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-10 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-10 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-10 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-10 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-10 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-10 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-10 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-10 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-10 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-10 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-10 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-10 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-10 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-10 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-10 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-10 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-10 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-10 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-10 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-10 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-10 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-10 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-10 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-10 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-10 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-10 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-10 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-10 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-10 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-10 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-10 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-10 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-10 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-10 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-10 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-10 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-10 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 5e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-10 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 5e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 5e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-10 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-10 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 6e-10 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 7e-10 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 7e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-10 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-10 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 8e-10 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 8e-10 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 8e-10 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 8e-10 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 8e-10 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 9e-10 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 9e-10 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-10 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-10 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-09 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-09 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-09 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-09 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-09 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-09 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-09 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-09 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-09 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-09 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-09 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-09 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-09 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-09 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-09 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-09 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-09 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-09 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-09 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-09 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-09 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-09 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-09 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-09 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-09 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-09 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-09 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-09 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-09 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-09 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 4e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-09 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-09 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-09 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-09 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-09 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 4e-09 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-09 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 5e-09 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 5e-09 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-09 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 5e-09 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-09 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-09 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-09 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-09 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-09 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 5e-09 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-09 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-09 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-09 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-09 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 5e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 5e-09 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-09 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 6e-09 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 6e-09 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 6e-09 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 6e-09 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 6e-09 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-09 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 7e-09 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-09 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 7e-09 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 7e-09 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-09 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 8e-09 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 8e-09 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-09 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-09 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 8e-09 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 8e-09 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 8e-09 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 9e-09 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 9e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 9e-09 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 9e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 9e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 9e-09 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-08 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-08 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-08 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-08 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-08 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-08 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-08 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-08 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-08 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-08 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-08 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-08 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-08 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-08 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-08 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-08 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-08 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-08 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-08 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-08 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-08 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-08 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-08 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-08 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-08 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-08 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-08 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-08 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-08 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-08 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-08 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-08 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-08 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-08 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 4e-08 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-08 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-08 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 5e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-08 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-08 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-08 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 5e-08 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-08 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 6e-08 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 6e-08 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 6e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 6e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 7e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 7e-08 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-08 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 8e-08 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-07 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-07 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-07 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-07 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-07 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-07 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-07 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-07 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-07 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-07 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-07 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-07 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-07 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-07 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-07 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 4e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 4e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-07 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 5e-07 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 5e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-07 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-07 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 6e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 6e-07 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 6e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 6e-07 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 6e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-07 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 6e-07 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 6e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 6e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 6e-07 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 6e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 7e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 8e-07 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 9e-07 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 9e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-06 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-06 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-06 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-06 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-06 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-06 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-06 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-06 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-06 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-06 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-06 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-06 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-06 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-06 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-06 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-06 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-06 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-06 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-06 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-06 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-06 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-06 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-06 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 5e-06 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 5e-06 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-06 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 6e-06 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 6e-06 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-06 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 6e-06 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 7e-06 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-06 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 8e-06 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 8e-06 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 8e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 9e-06 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-05 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-05 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-05 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-05 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-05 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-05 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-05 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-05 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-05 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-05 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-05 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-05 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-05 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-05 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-05 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-05 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-05 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-05 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-05 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-05 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-05 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-05 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-05 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-05 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-05 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-05 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-05 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-05 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-05 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-05 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-05 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-05 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-05 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-05 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-05 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-05 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-05 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-05 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-05 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-05 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-05 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-05 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-05 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-05 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-05 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-05 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-05 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-05 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-05 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-05 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-05 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-05 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-05 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-05 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-05 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-05 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-05 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-05 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-05 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-05 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-05 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-05 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-05 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-05 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-05 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-05 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-05 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-05 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-05 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-05 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-05 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 5e-05 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-05 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 5e-05 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-05 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 5e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-05 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-05 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 6e-05 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 6e-05 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-05 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 6e-05 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 6e-05 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 6e-05 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 6e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 7e-05 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 7e-05 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 7e-05 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-05 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 8e-05 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 8e-05 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 8e-05 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-05 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 9e-05 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-04 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-04 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-04 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-04 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-04 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-04 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-04 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-04 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-04 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-04 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-04 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-04 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-04 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-04 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-04 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-04 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-04 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-04 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-04 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-04 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-04 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-04 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-04 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-04 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-04 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-04 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-04 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-04 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-04 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-04 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-04 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-04 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-04 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-04 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-04 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-04 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-04 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-04 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-04 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-04 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-04 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-04 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-04 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-04 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-04 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-04 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 5e-04 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-04 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 5e-04 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-04 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 5e-04 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 5e-04 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-04 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-04 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-04 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 6e-04 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 6e-04 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 6e-04 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 6e-04 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 6e-04 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-04 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-04 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 7e-04 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 7e-04 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-04 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 7e-04 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 7e-04 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 7e-04 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 7e-04 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 7e-04 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 7e-04 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 7e-04 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 7e-04 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 7e-04 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 7e-04 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 7e-04 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 7e-04 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 8e-04 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 8e-04 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-04 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 8e-04 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 8e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 383 bits (987), Expect = e-133
Identities = 101/194 (52%), Positives = 137/194 (70%), Gaps = 4/194 (2%)
Query: 179 QSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGS 238
+ P + +G K F+ EL++A+DNFS N+LG+GGFG V+KG L +G +VA+K+LK
Sbjct: 8 EDPEVHLGQLK-RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEER 66
Query: 239 GQG-EREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGK--DRP 295
QG E +FQ E+E+IS HR+L+ L G+C ++RLLVY ++ N ++ L + +P
Sbjct: 67 TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQP 126
Query: 296 VMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355
++WP R +IALGSARGLAYLH+ C PKIIHRD+K+ANILLD+ FEA V DFGLAK
Sbjct: 127 PLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 186
Query: 356 TDTHVSTRVMGTFG 369
DTHV+T V GT G
Sbjct: 187 KDTHVTTAVRGTIG 200
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 361 bits (929), Expect = e-125
Identities = 87/209 (41%), Positives = 125/209 (59%), Gaps = 6/209 (2%)
Query: 164 LSTSGSLDSDKPFPRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVL 223
+ + S ++ S V +L+ AT+NF L+G G FG V+KGVL
Sbjct: 1 MGSKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVL 60
Query: 224 TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNK 283
+G VA+K+ S QG EF+ EIE +S H HLVSL+G+C ++ +L+Y+++ N
Sbjct: 61 RDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENG 120
Query: 284 TLEFHLHGKDRPV--MNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFE 341
L+ HL+G D P M+W R++I +G+ARGL YLH IIHRD+KS NILLD++F
Sbjct: 121 NLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFV 177
Query: 342 AKVADFGLAKHSLDTD-THVSTRVMGTFG 369
K+ DFG++K + D TH+ST V GT G
Sbjct: 178 PKITDFGISKKGTELDQTHLSTVVKGTLG 206
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 344 bits (885), Expect = e-118
Identities = 80/203 (39%), Positives = 125/203 (61%), Gaps = 17/203 (8%)
Query: 179 QSPGMPVGNFKSTFTYEELKIATDNFSE------ANLLGQGGFGYVHKGVLTNGKVVAIK 232
+S + F +F++ ELK T+NF E N +G+GGFG V+KG + N VA+K
Sbjct: 3 KSLEVSDTRFH-SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVK 60
Query: 233 QLKAG----SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFH 288
+L A + + +++F EI+++++ H +LV L+G+ + G LVY ++PN +L
Sbjct: 61 KLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR 120
Query: 289 LHGKD-RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADF 347
L D P ++W R KIA G+A G+ +LHE+ IHRDIKSANILLD++F AK++DF
Sbjct: 121 LSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDF 177
Query: 348 GLAKHS-LDTDTHVSTRVMGTFG 369
GLA+ S T +++R++GT
Sbjct: 178 GLARASEKFAQTVMTSRIVGTTA 200
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 219 bits (561), Expect = 2e-69
Identities = 54/192 (28%), Positives = 80/192 (41%), Gaps = 17/192 (8%)
Query: 190 STFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEI 249
E L + + +G FG V K L + VA+K Q + + E+
Sbjct: 12 VDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSW-QNEYEV 69
Query: 250 EIISQVHHRHLVSLVGYCTFGS----QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKI 305
+ + H +++ +G G+ L+ F +L L V++W I
Sbjct: 70 YSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK---ANVVSWNELCHI 126
Query: 306 ALGSARGLAYLHED-------CQPKIIHRDIKSANILLDDSFEAKVADFGLAK-HSLDTD 357
A ARGLAYLHED +P I HRDIKS N+LL ++ A +ADFGLA
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186
Query: 358 THVSTRVMGTFG 369
+ +GT
Sbjct: 187 AGDTHGQVGTRR 198
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 7e-57
Identities = 49/198 (24%), Positives = 86/198 (43%), Gaps = 27/198 (13%)
Query: 192 FTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEI 251
E + DN L+G+G +G V+KG L + + VA+K + + F E I
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNI 58
Query: 252 --ISQVHHRHLVSLVGYCTFGS-----QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMK 304
+ + H ++ + + + LLV E+ PN +L +L +W + +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS---LHTSDWVSSCR 115
Query: 305 IALGSARGLAYLHED------CQPKIIHRDIKSANILLDDSFEAKVADFGLAK------- 351
+A RGLAYLH + +P I HRD+ S N+L+ + ++DFGL+
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRL 175
Query: 352 HSLDTDTHVSTRVMGTFG 369
+ + + +GT
Sbjct: 176 VRPGEEDNAAISEVGTIR 193
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 6e-51
Identities = 54/202 (26%), Positives = 91/202 (45%), Gaps = 7/202 (3%)
Query: 171 DSDKPFPRQS-PGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVV 229
P P F+ +++ I + + +G G FG VH+ +G V
Sbjct: 5 HHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDV 63
Query: 230 AIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEF 287
A+K L + EF E+ I+ ++ H ++V +G T +V E++ +L
Sbjct: 64 AVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYR 123
Query: 288 HLHGKD-RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVAD 346
LH R ++ R+ +A A+G+ YLH P I+HR++KS N+L+D + KV D
Sbjct: 124 LLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCD 182
Query: 347 FGLAKHSLDTDTHVSTRVMGTF 368
FGL++ + S GT
Sbjct: 183 FGLSR-LKASTFLSSKSAAGTP 203
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 3e-49
Identities = 64/189 (33%), Positives = 96/189 (50%), Gaps = 21/189 (11%)
Query: 193 TYEELKIATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGE-------RE 244
+A + +G+GGFG VHKG + + VVAIK L G +GE +E
Sbjct: 10 KSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQE 69
Query: 245 FQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMK 304
FQ E+ I+S ++H ++V L G + +V EFVP L L K P + W +++
Sbjct: 70 FQREVFIMSNLNHPNIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLDKAHP-IKWSVKLR 126
Query: 305 IALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFE-----AKVADFGLAKHSLDTDTH 359
+ L A G+ Y+ + P I+HRD++S NI L E AKVADFGL++ H
Sbjct: 127 LMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ----SVH 181
Query: 360 VSTRVMGTF 368
+ ++G F
Sbjct: 182 SVSGLLGNF 190
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 2e-47
Identities = 37/179 (20%), Positives = 73/179 (40%), Gaps = 19/179 (10%)
Query: 194 YEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAG--SGQGEREFQAEIEI 251
+++L L + G + KG G + +K LK S + R+F E
Sbjct: 9 FKQLNFL-------TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPR 60
Query: 252 ISQVHHRHLVSLVGYCTFGSQRLL--VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGS 309
+ H +++ ++G C + ++P +L LH V++ +K AL
Sbjct: 61 LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDM 120
Query: 310 ARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF 368
ARG+A+LH +P I + S ++++D+ A+++ + + S M
Sbjct: 121 ARGMAFLH-TLEPLIPRHALNSRSVMIDEDMTARISMADVKF------SFQSPGRMYAP 172
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 1e-46
Identities = 45/160 (28%), Positives = 74/160 (46%), Gaps = 5/160 (3%)
Query: 210 LGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCT 268
LG+G FG K G+V+ +K+L + +R F E++++ + H +++ +G
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 269 FGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRD 328
+ + E++ TL + D W R+ A A G+AYLH IIHRD
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIKSMDSQ-YPWSQRVSFAKDIASGMAYLH---SMNIIHRD 133
Query: 329 IKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF 368
+ S N L+ ++ VADFGLA+ +D T
Sbjct: 134 LNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKK 173
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 2e-46
Identities = 54/177 (30%), Positives = 82/177 (46%), Gaps = 18/177 (10%)
Query: 194 YEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIIS 253
Y+E+++ ++G+G FG V K K VAIKQ++ S + F E+ +S
Sbjct: 7 YKEIEVE-------EVVGRGAFGVVCKAKW-RAKDVAIKQIE--SESERKAFIVELRQLS 56
Query: 254 QVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDR-PVMNWPTRMKIALGSARG 312
+V+H ++V L G C + LV E+ +L LHG + P M L ++G
Sbjct: 57 RVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQG 114
Query: 313 LAYLHEDCQPKIIHRDIKSANILLDDSFE-AKVADFGLAKHSLDTDTHVSTRVMGTF 368
+AYLH +IHRD+K N+LL K+ DFG A T G+
Sbjct: 115 VAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI----QTHMTNNKGSA 167
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 2e-45
Identities = 53/187 (28%), Positives = 81/187 (43%), Gaps = 26/187 (13%)
Query: 194 YEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAG----SGQGEREFQAEI 249
+ EL + ++G GGFG V++ G VA+K + Q + E
Sbjct: 6 FAELTLE-------EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEA 57
Query: 250 EIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGS 309
++ + + H ++++L G C LV EF L L GK P + A+
Sbjct: 58 KLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIP---PDILVNWAVQI 114
Query: 310 ARGLAYLHEDCQPKIIHRDIKSANILLDDSFE--------AKVADFGLAKHSLDTDTHVS 361
ARG+ YLH++ IIHRD+KS+NIL+ E K+ DFGLA+ T
Sbjct: 115 ARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK--- 171
Query: 362 TRVMGTF 368
G +
Sbjct: 172 MSAAGAY 178
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 2e-44
Identities = 43/175 (24%), Positives = 79/175 (45%), Gaps = 21/175 (12%)
Query: 208 NLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEI--ISQVHHRHLVSLVG 265
+G+G +G V +G G+ VA+K + + E+ + E E+ + H +++ +
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 266 YCTFGS----QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHED-- 319
Q L+ + +L +L ++ + ++I L A GLA+LH +
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYLQ---LTTLDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 320 ---CQPKIIHRDIKSANILLDDSFEAKVADFGLAK---HSLDTDTHVSTRVMGTF 368
+P I HRD+KS NIL+ + + +AD GLA S + + +GT
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTK 181
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 3e-44
Identities = 47/203 (23%), Positives = 88/203 (43%), Gaps = 16/203 (7%)
Query: 165 STSGSLDSDKPFPRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLT 224
+ SL S + FPR++ +++ +E I + L+G+G FG V+ G
Sbjct: 3 EMNLSLLSARSFPRKAS-------QTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRW- 54
Query: 225 NGKVVAIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPN 282
+G+V AI+ + + + F+ E+ Q H ++V +G C ++
Sbjct: 55 HGEV-AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKG 113
Query: 283 KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEA 342
+TL + + V++ +IA +G+ YLH I+H+D+KS N+ D+ +
Sbjct: 114 RTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYDN-GKV 168
Query: 343 KVADFGLAKHSLDTDTHVSTRVM 365
+ DFGL S +
Sbjct: 169 VITDFGLFSISGVLQAGRREDKL 191
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 1e-43
Identities = 48/223 (21%), Positives = 83/223 (37%), Gaps = 30/223 (13%)
Query: 160 FNEPLSTSGSLDSDKPFPRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVH 219
+ P + L G+P+ +G+G +G V
Sbjct: 4 YIPPGESLRDLIEQSQSSGSGSGLPL------LVQR---TIAKQIQMVKQIGKGRYGEVW 54
Query: 220 KGVLTNGKVVAIKQLKAGSGQGEREFQAEIEI--ISQVHHRHLVSLVGYCTFGS----QR 273
G G+ VA+K E + E EI + H +++ + G+ Q
Sbjct: 55 MGKW-RGEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL 110
Query: 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHED-----CQPKIIHRD 328
L+ ++ N +L +L ++ + +K+A S GL +LH + +P I HRD
Sbjct: 111 YLITDYHENGSLYDYLK---STTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRD 167
Query: 329 IKSANILLDDSFEAKVADFGLAK---HSLDTDTHVSTRVMGTF 368
+KS NIL+ + +AD GLA + +GT
Sbjct: 168 LKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTK 210
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-43
Identities = 53/178 (29%), Positives = 88/178 (49%), Gaps = 10/178 (5%)
Query: 193 TYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAG--SGQGEREFQAEIE 250
++ +I + +G G FG V+KG +G V A+K L + Q + F+ E+
Sbjct: 15 AADDWEIPDGQITVGQRIGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQAFKNEVG 72
Query: 251 IISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSA 310
++ + H +++ +GY T Q +V ++ +L HLH + + IA +A
Sbjct: 73 VLRKTRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHASETK-FEMKKLIDIARQTA 130
Query: 311 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK-HSLDTDTHVSTRVMGT 367
RG+ YLH IIHRD+KS NI L + K+ DFGLA S + +H ++ G+
Sbjct: 131 RGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGS 185
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 5e-42
Identities = 50/175 (28%), Positives = 83/175 (47%), Gaps = 21/175 (12%)
Query: 208 NLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEI--ISQVHHRHLVSLVG 265
+G+G FG V +G G+ VA+K + + ER + E EI + H +++ +
Sbjct: 48 ESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIA 103
Query: 266 YCT----FGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHED-- 319
+Q LV ++ + +L +L+ R + +K+AL +A GLA+LH +
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASGLAHLHMEIV 160
Query: 320 ---CQPKIIHRDIKSANILLDDSFEAKVADFGLAK---HSLDTDTHVSTRVMGTF 368
+P I HRD+KS NIL+ + +AD GLA + DT +GT
Sbjct: 161 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 215
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 6e-38
Identities = 40/150 (26%), Positives = 67/150 (44%), Gaps = 6/150 (4%)
Query: 210 LGQGGFGYVHKGVLTNGKV-VAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVSLVGYC 267
+G+G FG V G L VA+K + + +F E I+ Q H ++V L+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 268 TFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHR 327
T +V E V L + + T +++ +A G+ YL IHR
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARL-RVKTLLQMVGDAAAGMEYLESK---CCIHR 237
Query: 328 DIKSANILLDDSFEAKVADFGLAKHSLDTD 357
D+ + N L+ + K++DFG+++ D
Sbjct: 238 DLAARNCLVTEKNVLKISDFGMSREEADGV 267
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-34
Identities = 45/149 (30%), Positives = 78/149 (52%), Gaps = 11/149 (7%)
Query: 210 LGQGGFGYVHKGVLT-----NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLV 264
LG+G FG V G+VVA+K+L+ + + R+F+ EIEI+ + H ++V
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 265 GYCTFGSQR--LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQP 322
G C +R L+ E++P +L +L K + ++ ++ +G+ YL
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGTK--- 133
Query: 323 KIIHRDIKSANILLDDSFEAKVADFGLAK 351
+ IHRD+ + NIL+++ K+ DFGL K
Sbjct: 134 RYIHRDLATRNILVENENRVKIGDFGLTK 162
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 2e-34
Identities = 45/161 (27%), Positives = 76/161 (47%), Gaps = 7/161 (4%)
Query: 192 FTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEI 251
F + +G+G FG V G G VA+K +K + + F AE +
Sbjct: 11 FYRSGWALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASV 67
Query: 252 ISQVHHRHLVSLVGYCTFGSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSA 310
++Q+ H +LV L+G L +V E++ +L +L + R V+ +K +L
Sbjct: 68 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVC 127
Query: 311 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351
+ YL + +HRD+ + N+L+ + AKV+DFGL K
Sbjct: 128 EAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK 165
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-34
Identities = 51/184 (27%), Positives = 75/184 (40%), Gaps = 12/184 (6%)
Query: 174 KPFPRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQ 233
P P P E LK+ LG G FG V VA+K
Sbjct: 167 VPCMSSKPQKPWEKDAWEIPRESLKLE-------KKLGAGQFGEVWMATYNKHTKVAVKT 219
Query: 234 LKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKD 293
+K GS F AE ++ + H LV L T ++ EF+ +L L +
Sbjct: 220 MKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDE 277
Query: 294 RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353
P + + A G+A++ + IHRD+++ANIL+ S K+ADFGLA+
Sbjct: 278 GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVI 334
Query: 354 LDTD 357
D +
Sbjct: 335 EDNE 338
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-34
Identities = 47/180 (26%), Positives = 79/180 (43%), Gaps = 11/180 (6%)
Query: 174 KPFPRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQ 233
KP + F + +G+G FG V G G VA+K
Sbjct: 169 KPKVMEGTVAAQ----DEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKC 223
Query: 234 LKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRL-LVYEFVPNKTLEFHLHGK 292
+K + + F AE +++Q+ H +LV L+G L +V E++ +L +L +
Sbjct: 224 IKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR 281
Query: 293 DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352
R V+ +K +L + YL + +HRD+ + N+L+ + AKV+DFGL K
Sbjct: 282 GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKE 338
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-34
Identities = 44/148 (29%), Positives = 69/148 (46%), Gaps = 5/148 (3%)
Query: 210 LGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTF 269
LG G FG V G VA+K +K GS E EF E + + ++ H LV G C+
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 270 GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDI 329
+V E++ N L +L + +++ G+A+L + IHRD+
Sbjct: 75 EYPIYIVTEYISNGCLLNYLR-SHGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDL 130
Query: 330 KSANILLDDSFEAKVADFGLAKHSLDTD 357
+ N L+D KV+DFG+ ++ LD
Sbjct: 131 AARNCLVDRDLCVKVSDFGMTRYVLDDQ 158
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 5e-34
Identities = 45/149 (30%), Positives = 78/149 (52%), Gaps = 11/149 (7%)
Query: 210 LGQGGFGYVHKGVLT-----NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLV 264
LG+G FG V G+VVA+K+L+ + + R+F+ EIEI+ + H ++V
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 265 GYCTFGSQR--LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQP 322
G C +R L+ E++P +L +L K + ++ ++ +G+ YL
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGTK--- 164
Query: 323 KIIHRDIKSANILLDDSFEAKVADFGLAK 351
+ IHRD+ + NIL+++ K+ DFGL K
Sbjct: 165 RYIHRDLATRNILVENENRVKIGDFGLTK 193
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-33
Identities = 44/147 (29%), Positives = 76/147 (51%), Gaps = 5/147 (3%)
Query: 210 LGQGGFGYVHKGVLTNGKV-VAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCT 268
LG G +G V++GV + VA+K LK + + E EF E ++ ++ H +LV L+G CT
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 269 FGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRD 328
++ EF+ L +L +R ++ + +A + + YL + IHRD
Sbjct: 80 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRD 136
Query: 329 IKSANILLDDSFEAKVADFGLAKHSLD 355
+ + N L+ ++ KVADFGL++
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTG 163
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-33
Identities = 50/148 (33%), Positives = 76/148 (51%), Gaps = 5/148 (3%)
Query: 210 LGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTF 269
+G G FG VH G N VAIK ++ G+ E +F E E++ ++ H LV L G C
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 270 GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDI 329
+ LV EF+ + L +L R + T + + L G+AYL E +IHRD+
Sbjct: 75 QAPICLVTEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDL 130
Query: 330 KSANILLDDSFEAKVADFGLAKHSLDTD 357
+ N L+ ++ KV+DFG+ + LD
Sbjct: 131 AARNCLVGENQVIKVSDFGMTRFVLDDQ 158
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 1e-33
Identities = 47/183 (25%), Positives = 89/183 (48%), Gaps = 8/183 (4%)
Query: 174 KPFPRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKV-VAIK 232
P P+++ G + +E + + + + LG G +G V++GV + VA+K
Sbjct: 195 YPAPKRNKPTIYGVSPNYDKWE---MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK 251
Query: 233 QLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGK 292
LK + + E EF E ++ ++ H +LV L+G CT ++ EF+ L +L
Sbjct: 252 TLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC 310
Query: 293 DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352
+R ++ + +A + + YL + IHR++ + N L+ ++ KVADFGL++
Sbjct: 311 NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRL 367
Query: 353 SLD 355
Sbjct: 368 MTG 370
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-33
Identities = 49/148 (33%), Positives = 74/148 (50%), Gaps = 5/148 (3%)
Query: 210 LGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTF 269
LG G FG V G VA+K LK GS + F AE ++ Q+ H+ LV L T
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVT- 78
Query: 270 GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDI 329
++ E++ N +L L + + +A A G+A++ E IHRD+
Sbjct: 79 QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDL 135
Query: 330 KSANILLDDSFEAKVADFGLAKHSLDTD 357
++ANIL+ D+ K+ADFGLA+ D +
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIEDNE 163
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-33
Identities = 47/150 (31%), Positives = 80/150 (53%), Gaps = 12/150 (8%)
Query: 210 LGQGGFGYVHKGVLT-----NGKVVAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVSL 263
LG+G FG V G+ VA+K LK SG + + EIEI+ ++H ++V
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 264 VGYCTFGSQR--LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQ 321
G CT L+ EF+P+ +L+ +L K++ +N ++K A+ +G+ YL
Sbjct: 89 KGICTEDGGNGIKLIMEFLPSGSLKEYLP-KNKNKINLKQQLKYAVQICKGMDYLGSR-- 145
Query: 322 PKIIHRDIKSANILLDDSFEAKVADFGLAK 351
+ +HRD+ + N+L++ + K+ DFGL K
Sbjct: 146 -QYVHRDLAARNVLVESEHQVKIGDFGLTK 174
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-33
Identities = 45/149 (30%), Positives = 74/149 (49%), Gaps = 11/149 (7%)
Query: 210 LGQGGFGYVHKGVLT-----NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLV 264
LG+G FG V G +VA+KQL+ +R+FQ EI+I+ +H +V
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 265 GYCTFGSQR--LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQP 322
G ++ LV E++P+ L L + R ++ + + +G+ YL
Sbjct: 91 GVSYGPGRQSLRLVMEYLPSGCLRDFLQ-RHRARLDASRLLLYSSQICKGMEYLGSR--- 146
Query: 323 KIIHRDIKSANILLDDSFEAKVADFGLAK 351
+ +HRD+ + NIL++ K+ADFGLAK
Sbjct: 147 RCVHRDLAARNILVESEAHVKIADFGLAK 175
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 3e-33
Identities = 48/166 (28%), Positives = 77/166 (46%), Gaps = 5/166 (3%)
Query: 192 FTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEI 251
Y +I + + LG G FG V G VAIK +K GS E EF E ++
Sbjct: 14 LGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKV 72
Query: 252 ISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSAR 311
+ + H LV L G CT ++ E++ N L +L + R +++
Sbjct: 73 MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCE 131
Query: 312 GLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357
+ YL + +HRD+ + N L++D KV+DFGL+++ LD +
Sbjct: 132 AMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 4e-33
Identities = 41/148 (27%), Positives = 74/148 (50%), Gaps = 11/148 (7%)
Query: 210 LGQGGFGYVHKGVLT----NGKV-VAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVSL 263
LG G FG V+KG+ K+ VAIK+L+ + E E +++ V + H+ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 264 VGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPK 323
+G C S L+ + +P L ++ + + + + + A+G+ YL + +
Sbjct: 83 LGICL-TSTVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNYLEDR---R 137
Query: 324 IIHRDIKSANILLDDSFEAKVADFGLAK 351
++HRD+ + N+L+ K+ DFGLAK
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAK 165
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 5e-33
Identities = 51/163 (31%), Positives = 80/163 (49%), Gaps = 9/163 (5%)
Query: 210 LGQGGFGYVHKGVLTNGKV---VAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVSLVG 265
LG G FG V +GV K VAIK LK G+ + + E E +I+ Q+ + ++V L+G
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 266 YCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKII 325
C +LV E L L GK + ++ + G+ YL E +
Sbjct: 78 VCQ-AEALMLVMEMAGGGPLHKFLVGKREEI-PVSNVAELLHQVSMGMKYLEEK---NFV 132
Query: 326 HRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF 368
HRD+ + N+LL + AK++DFGL+K D++ + R G +
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 175
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 7e-33
Identities = 49/150 (32%), Positives = 75/150 (50%), Gaps = 5/150 (3%)
Query: 208 NLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYC 267
LGQG FG V G VAIK LK G+ E F E +++ ++ H LV L
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 268 TFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHR 327
+ +V E++ +L L G+ + P + +A A G+AY+ +HR
Sbjct: 249 S-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHR 304
Query: 328 DIKSANILLDDSFEAKVADFGLAKHSLDTD 357
D+++ANIL+ ++ KVADFGLA+ D +
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNE 334
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 7e-33
Identities = 46/153 (30%), Positives = 74/153 (48%), Gaps = 10/153 (6%)
Query: 210 LGQGGFGYVHKGVLTNGKV----VAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVSLV 264
LG+G FG V++GV TN K VA+K K + +F +E I+ + H H+V L+
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 265 GYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKI 324
G ++ E P L +L +++ + T + +L + +AYL
Sbjct: 80 GIIE-EEPTWIIMELYPYGELGHYLE-RNKNSLKVLTLVLYSLQICKAMAYLESI---NC 134
Query: 325 IHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357
+HRDI NIL+ K+ DFGL+++ D D
Sbjct: 135 VHRDIAVRNILVASPECVKLGDFGLSRYIEDED 167
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-32
Identities = 48/165 (29%), Positives = 79/165 (47%), Gaps = 10/165 (6%)
Query: 210 LGQGGFGYVHKGVLTNGKV-----VAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVSL 263
+G G FG V+KG+L VAIK LKAG + +R +F E I+ Q H +++ L
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 264 VGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPK 323
G + +++ E++ N L+ L + + + + G A G+ YL
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLR-EKDGEFSVLQLVGMLRGIAAGMKYLANM---N 167
Query: 324 IIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF 368
+HRD+ + NIL++ + KV+DFGL++ D T G
Sbjct: 168 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 212
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-32
Identities = 42/153 (27%), Positives = 73/153 (47%), Gaps = 10/153 (6%)
Query: 210 LGQGGFGYVHKGVLTNGK----VVAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVSLV 264
+G+G FG VH+G+ + + VAIK K + R +F E + Q H H+V L+
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 265 GYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKI 324
G T + ++ E L L + ++ + + A + LAYL +
Sbjct: 83 GVIT-ENPVWIIMELCTLGELRSFLQ-VRKYSLDLASLILYAYQLSTALAYLESK---RF 137
Query: 325 IHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357
+HRDI + N+L+ + K+ DFGL+++ D+
Sbjct: 138 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 170
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-32
Identities = 54/200 (27%), Positives = 83/200 (41%), Gaps = 16/200 (8%)
Query: 174 KPFPRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGK----VV 229
P + P V F + I ++G G FG V G L V
Sbjct: 24 DPHTFEDPTQTVHEFAKELDATNISID-------KVVGAGEFGEVCSGRLKLPSKKEISV 76
Query: 230 AIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFH 288
AIK LK G + +R +F E I+ Q H +++ L G T ++V E++ N +L+
Sbjct: 77 AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 136
Query: 289 LHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFG 348
L K + + G A G+ YL + +HRD+ + NIL++ + KV+DFG
Sbjct: 137 LR-KHDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFG 192
Query: 349 LAKHSLDTDTHVSTRVMGTF 368
L + D T G
Sbjct: 193 LGRVLEDDPEAAYTTRGGKI 212
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 3e-32
Identities = 45/156 (28%), Positives = 74/156 (47%), Gaps = 10/156 (6%)
Query: 208 NLLGQGGFGYVHKGVLTNGK----VVAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVS 262
++G+G FG V+ G L + A+K L + GE +F E I+ H +++S
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 263 LVGYCTFG-SQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQ 321
L+G C L+V ++ + L + + + L A+G+ YL
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIR-NETHNPTVKDLIGFGLQVAKGMKYLASK-- 147
Query: 322 PKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357
K +HRD+ + N +LD+ F KVADFGLA+ D +
Sbjct: 148 -KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 182
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-32
Identities = 51/245 (20%), Positives = 92/245 (37%), Gaps = 11/245 (4%)
Query: 119 GKPHHWQQNVSAPSDYQELPKPSLPPSNGPTAPLPTVPVSAFNEPLSTSGSLDSDKPFPR 178
HH S + P P + + S + + S +
Sbjct: 7 MGHHHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHI 66
Query: 179 QSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGK----VVAIKQL 234
+ + + ++ ++G+G FG V+ G L + A+K L
Sbjct: 67 DLSALN-PELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL 125
Query: 235 KAGSGQGER-EFQAEIEIISQVHHRHLVSLVGYCT-FGSQRLLVYEFVPNKTLEFHLHGK 292
+ GE +F E I+ H +++SL+G C L+V ++ + L +
Sbjct: 126 NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR-N 184
Query: 293 DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352
+ + L A+G+ +L K +HRD+ + N +LD+ F KVADFGLA+
Sbjct: 185 ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARD 241
Query: 353 SLDTD 357
D +
Sbjct: 242 MYDKE 246
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-32
Identities = 44/164 (26%), Positives = 75/164 (45%), Gaps = 20/164 (12%)
Query: 210 LGQGGFGYVHKGVLTNGKV--------VAIKQLKAGSGQGEREFQAEIEIISQVHHRHLV 261
LGQG F + KGV V +K L F ++S++ H+HLV
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 262 SLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQ 321
G C G + +LV EFV +L+ +L K++ +N ++++A A + +L E+
Sbjct: 76 LNYGVCVCGDENILVQEFVKFGSLDTYLK-KNKNCINILWKLEVAKQLAAAMHFLEEN-- 132
Query: 322 PKIIHRDIKSANILLDDSFE--------AKVADFGLAKHSLDTD 357
+IH ++ + NILL + K++D G++ L D
Sbjct: 133 -TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD 175
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 4e-32
Identities = 45/164 (27%), Positives = 75/164 (45%), Gaps = 11/164 (6%)
Query: 210 LGQGGFGYVHKGVLTNGKV---VAIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSLV 264
LG G FG V KG KV VA+K LK + E AE ++ Q+ + ++V ++
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 265 GYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKI 324
G C +LV E L +L + + +++ + G+ YL E
Sbjct: 85 GICE-AESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLEES---NF 138
Query: 325 IHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF 368
+HRD+ + N+LL AK++DFGL+K + + + G +
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 182
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 5e-32
Identities = 55/200 (27%), Positives = 88/200 (44%), Gaps = 16/200 (8%)
Query: 174 KPFPRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLT---NGKV-V 229
+P + PG +F + I ++G G G V G L V V
Sbjct: 28 EPHTYEEPGRAGRSFTREIEASRIHIE-------KIIGSGDSGEVCYGRLRVPGQRDVPV 80
Query: 230 AIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFH 288
AIK LKAG + +R +F +E I+ Q H +++ L G T G ++V E++ N +L+
Sbjct: 81 AIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTF 140
Query: 289 LHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFG 348
L D + + G G+ YL + +HRD+ + N+L+D + KV+DFG
Sbjct: 141 LRTHDGQF-TIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFG 196
Query: 349 LAKHSLDTDTHVSTRVMGTF 368
L++ D T G
Sbjct: 197 LSRVLEDDPDAAYTTTGGKI 216
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 8e-32
Identities = 42/156 (26%), Positives = 74/156 (47%), Gaps = 10/156 (6%)
Query: 208 NLLGQGGFGYVHKGVLTNGK----VVAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVS 262
++G+G FG V+ G + AIK L + + F E ++ ++H ++++
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 263 LVGYCTFGS-QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQ 321
L+G ++ ++ + L + + + L ARG+ YL E
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFIR-SPQRNPTVKDLISFGLQVARGMEYLAEQ-- 143
Query: 322 PKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357
K +HRD+ + N +LD+SF KVADFGLA+ LD +
Sbjct: 144 -KFVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 51/219 (23%), Positives = 92/219 (42%), Gaps = 10/219 (4%)
Query: 144 PSNGPTAPLPTVPVSAFNEPLSTSGSLDSDKPFPRQSPGMPVGNFKSTFTYEELKIATDN 203
P LP++P A NE S + + + + + + +I +
Sbjct: 332 PQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRER 391
Query: 204 FSEANLLGQGGFGYVHKGVLTNGK----VVAIKQLKAGSGQGER-EFQAEIEIISQVHHR 258
+G+G FG VH+G+ + + VAIK K + R +F E + Q H
Sbjct: 392 IELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 451
Query: 259 HLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHE 318
H+V L+G T + ++ E L L + ++ + + A + LAYL
Sbjct: 452 HIVKLIGVIT-ENPVWIIMELCTLGELRSFLQ-VRKFSLDLASLILYAYQLSTALAYLES 509
Query: 319 DCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357
+ +HRDI + N+L+ + K+ DFGL+++ D+
Sbjct: 510 K---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 545
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-31
Identities = 50/150 (33%), Positives = 74/150 (49%), Gaps = 14/150 (9%)
Query: 210 LGQGGFGYVHKGVLTN-----GKVVAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVSL 263
LG+G FG V G++VA+K LKA +G R ++ EI+I+ ++H H++
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 264 VGYCTFGSQR--LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQ 321
G C LV E+VP +L +L + + A G+AYLH
Sbjct: 99 KGCCEDAGAASLQLVMEYVPLGSLRDYLP-RHSI--GLAQLLLFAQQICEGMAYLHAQ-- 153
Query: 322 PKIIHRDIKSANILLDDSFEAKVADFGLAK 351
IHRD+ + N+LLD+ K+ DFGLAK
Sbjct: 154 -HYIHRDLAARNVLLDNDRLVKIGDFGLAK 182
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-31
Identities = 48/160 (30%), Positives = 78/160 (48%), Gaps = 11/160 (6%)
Query: 210 LGQGGFGYVHKGVLT----NGKV-VAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVSL 263
LG G FG VHKGV + K+ V IK ++ SG+ + I + H H+V L
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 264 VGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPK 323
+G C GS LV +++P +L H+ + R + + + A+G+ YL E
Sbjct: 81 LGLCP-GSSLQLVTQYLPLGSLLDHVR-QHRGALGPQLLLNWGVQIAKGMYYLEEH---G 135
Query: 324 IIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTR 363
++HR++ + N+LL + +VADFG+A D +
Sbjct: 136 MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYS 175
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 49/163 (30%), Positives = 79/163 (48%), Gaps = 9/163 (5%)
Query: 210 LGQGGFGYVHKGVLTNGKV---VAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVSLVG 265
LG G FG V +GV K VAIK LK G+ + + E E +I+ Q+ + ++V L+G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 266 YCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKII 325
C +LV E L L R + ++ + G+ YL E +
Sbjct: 404 VCQ-AEALMLVMEMAGGGPLHKFLV-GKREEIPVSNVAELLHQVSMGMKYLEEK---NFV 458
Query: 326 HRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF 368
HR++ + N+LL + AK++DFGL+K D++ + R G +
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 501
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-31
Identities = 41/148 (27%), Positives = 74/148 (50%), Gaps = 11/148 (7%)
Query: 210 LGQGGFGYVHKGVLT----NGKV-VAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVSL 263
LG G FG V+KG+ K+ VAIK+L+ + E E +++ V + H+ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 264 VGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPK 323
+G C S L+ + +P L ++ + + + + + A+G+ YL + +
Sbjct: 83 LGICL-TSTVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNYLEDR---R 137
Query: 324 IIHRDIKSANILLDDSFEAKVADFGLAK 351
++HRD+ + N+L+ K+ DFGLAK
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAK 165
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 7e-31
Identities = 48/163 (29%), Positives = 83/163 (50%), Gaps = 18/163 (11%)
Query: 210 LGQGGFGYVHKGVLTNGK------VVAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVS 262
LGQG FG V++GV VAIK + + ER EF E ++ + + H+V
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 263 LVGYCTFGSQRLLVYEFVPNKTLEFHL-----HGKDRPVMNWPTR---MKIALGSARGLA 314
L+G + G L++ E + L+ +L + PV+ P+ +++A A G+A
Sbjct: 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 315 YLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357
YL+ + K +HRD+ + N ++ + F K+ DFG+ + +TD
Sbjct: 153 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 192
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 49/150 (32%), Positives = 75/150 (50%), Gaps = 5/150 (3%)
Query: 208 NLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYC 267
LGQG FG V G VAIK LK G+ E F E +++ ++ H LV L
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 268 TFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHR 327
+ +V E++ +L L G+ + P + +A A G+AY+ +HR
Sbjct: 332 S-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHR 387
Query: 328 DIKSANILLDDSFEAKVADFGLAKHSLDTD 357
D+++ANIL+ ++ KVADFGLA+ D +
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIEDNE 417
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-30
Identities = 42/170 (24%), Positives = 74/170 (43%), Gaps = 23/170 (13%)
Query: 210 LGQGGFGYVHKGVLTNGK------VVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSL 263
LG+G FG V N +VA+K LK + ++FQ E E+++ + H H+V
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 264 VGYCTFGSQRLLVYEFVPN--------------KTLEFHLHGKDRPVMNWPTRMKIALGS 309
G C G ++V+E++ + L + + + + IA
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 310 ARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 359
A G+ YL +HRD+ + N L+ + K+ DFG+++ TD +
Sbjct: 143 ASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY 189
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 3e-30
Identities = 43/175 (24%), Positives = 85/175 (48%), Gaps = 25/175 (14%)
Query: 208 NLLGQGGFGYVHKGVLTNGKV---VAIKQLKAGSGQGER-EFQAEIEIISQV-HHRHLVS 262
+++G+G FG V K + + AIK++K + + + +F E+E++ ++ HH ++++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 263 LVGYCTFGSQRLLVYEFVPN--------------KTLEFHLHGKDRPVMNWPTRMKIALG 308
L+G C L E+ P+ F + ++ + A
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 309 SARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTR 363
ARG+ YL + + IHRD+ + NIL+ +++ AK+ADFGL++ + +V
Sbjct: 151 VARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKT 199
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-30
Identities = 44/182 (24%), Positives = 66/182 (36%), Gaps = 10/182 (5%)
Query: 177 PRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLK 235
G F + I ++ LG+GGF YV L +G A+K++
Sbjct: 4 SHHHHHHSSGRENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRIL 63
Query: 236 AGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQR----LLVYEFVPNKTLEFHLHG 291
Q E Q E ++ +H +++ LV YC L+ F TL +
Sbjct: 64 CHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIER 123
Query: 292 KDRPVMNWPTR--MKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGL 349
+ + LG RGL +H HRD+K NILL D + + D G
Sbjct: 124 LKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGS 180
Query: 350 AK 351
Sbjct: 181 MN 182
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 5e-30
Identities = 43/149 (28%), Positives = 64/149 (42%), Gaps = 12/149 (8%)
Query: 210 LGQGGFGYVHKGVLTNGKV----VAIKQLKAG---SGQGEREFQAEIEIISQVHHRHLVS 262
LG G FG V +G VA+K LK + +F E+ + + HR+L+
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 263 LVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQP 322
L G +V E P +L L K + T + A+ A G+ YL
Sbjct: 86 LYGVVL-TPPMKMVTELAPLGSLLDRLR-KHQGHFLLGTLSRYAVQVAEGMGYLESK--- 140
Query: 323 KIIHRDIKSANILLDDSFEAKVADFGLAK 351
+ IHRD+ + N+LL K+ DFGL +
Sbjct: 141 RFIHRDLAARNLLLATRDLVKIGDFGLMR 169
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 5e-30
Identities = 45/167 (26%), Positives = 72/167 (43%), Gaps = 22/167 (13%)
Query: 210 LGQGGFGYVHKGVLTNGK------VVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSL 263
LG+G FG V N +VA+K LK S ++FQ E E+++ + H+H+V
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 264 VGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTR-------------MKIALGSA 310
G CT G L+V+E++ + L L + +A A
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 311 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357
G+ YL +HRD+ + N L+ K+ DFG+++ TD
Sbjct: 169 AGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD 212
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-29
Identities = 47/162 (29%), Positives = 78/162 (48%), Gaps = 7/162 (4%)
Query: 209 LLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYC 267
+LG+G +G V+ G L+N +AIK++ + + EI + + H+++V +G
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 268 TFGSQRLLVYEFVPNKTLEFHLHGKDRPV-MNWPTRMKIALGSARGLAYLHEDCQPKIIH 326
+ + E VP +L L K P+ N T GL YLH++ +I+H
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVH 145
Query: 327 RDIKSANILLD-DSFEAKVADFGLAKHSLDTDTHVSTRVMGT 367
RDIK N+L++ S K++DFG +K + T GT
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGT 186
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-29
Identities = 40/170 (23%), Positives = 70/170 (41%), Gaps = 24/170 (14%)
Query: 210 LGQGGFGYVHKGVLTNGK------VVAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVS 262
LG+ FG V+KG L VAIK LK + R EF+ E + +++ H ++V
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 263 LVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTR--------------MKIALG 308
L+G T +++ + + L L + T + +
Sbjct: 77 LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 309 SARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 358
A G+ YL ++H+D+ + N+L+ D K++D GL + D
Sbjct: 137 IAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADY 183
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 4e-29
Identities = 39/169 (23%), Positives = 68/169 (40%), Gaps = 18/169 (10%)
Query: 209 LLGQGGFGYVHKGV-LTNGKVVAIKQ--LKAGSGQGEREFQAEIEIISQVHHRHLVSLVG 265
+G+G F V+KG+ VA + + + + F+ E E++ + H ++V
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 266 YCTFGSQ---RLLVY-EFVPNKTLEFHL--HGKDRPVMNWPTRMKIALGSARGLAYLHED 319
+ +++ E + + TL+ +L M +GL +LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV----MKIKVLRSWCRQILKGLQFLHT- 147
Query: 320 CQPKIIHRDIKSANILLDDSF-EAKVADFGLAKHSLDTDTHVSTRVMGT 367
P IIHRD+K NI + K+ D GLA + V+GT
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK--RASFAKA-VIGT 193
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 6e-29
Identities = 47/163 (28%), Positives = 75/163 (46%), Gaps = 23/163 (14%)
Query: 208 NLLGQGGFGYVHKGVLT------NGKVVAIKQLKAGSGQGER-EFQAEIEIISQV-HHRH 259
LG G FG V + VA+K LK+ + E+ +E++I+S + H +
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 260 LVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTR------------MKIAL 307
+V+L+G CT G L++ E+ L L K R + P + +
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 308 GSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLA 350
A+G+A+L IHRD+ + N+LL + AK+ DFGLA
Sbjct: 172 QVAQGMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGLA 211
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-28
Identities = 50/210 (23%), Positives = 85/210 (40%), Gaps = 19/210 (9%)
Query: 170 LDSDKPFPRQSPGM-PVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGK- 227
+ S S G+ P G+ + E++ I + +LG+G FG V +G L
Sbjct: 1 MGSSHHHHHHSSGLVPRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDG 60
Query: 228 ---VVAIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSLVGYCT-----FGSQRLLVY 277
VA+K +K S + EF +E + H +++ L+G C + +++
Sbjct: 61 TSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVIL 120
Query: 278 EFVPNKTL-EF---HLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSAN 333
F+ L + + T +K + A G+ YL +HRD+ + N
Sbjct: 121 PFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARN 177
Query: 334 ILLDDSFEAKVADFGLAKHSLDTDTHVSTR 363
+L D VADFGL+K D + R
Sbjct: 178 CMLRDDMTVCVADFGLSKKIYSGDYYRQGR 207
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-28
Identities = 43/164 (26%), Positives = 68/164 (41%), Gaps = 19/164 (11%)
Query: 210 LGQGGFGYVHKGVLTNGK----VVAIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSL 263
LG+G FG V + L VA+K LKA + EF E + + H H+ L
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 264 VGYCT------FGSQRLLVYEFVPNKTL-EF---HLHGKDRPVMNWPTRMKIALGSARGL 313
VG +++ F+ + L F G++ + T ++ + A G+
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 314 AYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357
YL IHRD+ + N +L + VADFGL++ D
Sbjct: 151 EYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD 191
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-28
Identities = 45/177 (25%), Positives = 76/177 (42%), Gaps = 32/177 (18%)
Query: 210 LGQGGFGYVHKGVLTNGK------VVAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVS 262
LG+G FG V K + K VA+K LK + E + +E ++ QV+H H++
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 263 LVGYCTFGSQRLLVYEFVPN----------------------KTLEFHLHGKDRPVMNWP 300
L G C+ LL+ E+ L D +
Sbjct: 91 LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 301 TRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357
+ A ++G+ YL E K++HRD+ + NIL+ + + K++DFGL++ + D
Sbjct: 151 DLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-28
Identities = 43/163 (26%), Positives = 69/163 (42%), Gaps = 18/163 (11%)
Query: 210 LGQGGFGYVHKGVLTNGK------VVAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVS 262
LG G FG V++G ++ VA+K L + + +F E IIS+ +H+++V
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 263 LVGYCTFGSQRLLVYEFVPNKTLEFHL-----HGKDRPVMNWPTRMKIALGSARGLAYLH 317
+G R ++ E + L+ L + + +A A G YL
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 318 EDCQPKIIHRDIKSANILLDDSFE---AKVADFGLAKHSLDTD 357
E+ IHRDI + N LL AK+ DFG+A+
Sbjct: 158 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS 197
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 8e-28
Identities = 39/166 (23%), Positives = 73/166 (43%), Gaps = 27/166 (16%)
Query: 210 LGQGGFGYVHKGVLTNGK--------VVAIKQLKAGSGQGER-EFQAEIEIISQV-HHRH 259
LG+G FG V VA+K LK + + + + +E+E++ + H++
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 260 LVSLVGYCTFGSQRLLVYEFVPN--------------KTLEFHLHGKDRPVMNWPTRMKI 305
+++L+G CT ++ E+ + ++ M + +
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 306 ALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351
ARG+ YL K IHRD+ + N+L+ ++ K+ADFGLA+
Sbjct: 163 TYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLAR 205
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 8e-28
Identities = 47/183 (25%), Positives = 84/183 (45%), Gaps = 26/183 (14%)
Query: 202 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHL 260
+F E L+G GGFG V K +GK IK++K + + E++ ++++ H ++
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK----YNNEKAEREVKALAKLDHVNI 66
Query: 261 VSLVGY-------------CTFGSQRLLVY---EFVPNKTLEFHLHGKDRPVMNWPTRMK 304
V G + S+ ++ EF TLE + + ++ ++
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126
Query: 305 IALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRV 364
+ +G+ Y+H K+I+RD+K +NI L D+ + K+ DFGL SL D +
Sbjct: 127 LFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVT-SLKNDGKRTRSK 182
Query: 365 MGT 367
GT
Sbjct: 183 -GT 184
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-27
Identities = 43/165 (26%), Positives = 71/165 (43%), Gaps = 27/165 (16%)
Query: 210 LGQGGFGYVHKGVLTNGK------VVAIKQLKAGSGQGER-EFQAEIEIISQV-HHRHLV 261
LG G FG V + VA+K LK + ER +E++++S + +H ++V
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 262 SLVGYCTFGSQRLLVYEFVPN----------------KTLEFHLHGKDRPVMNWPTRMKI 305
+L+G CT G L++ E+ + D ++ +
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 306 ALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLA 350
+ A+G+A+L IHRD+ + NILL K+ DFGLA
Sbjct: 151 SYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLA 192
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 39/166 (23%), Positives = 73/166 (43%), Gaps = 27/166 (16%)
Query: 210 LGQGGFGYVHKGVLTNGK--------VVAIKQLKAGSGQGER-EFQAEIEIISQV-HHRH 259
LG+G FG V VA+K LK + + + + +E+E++ + H++
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 260 LVSLVGYCTFGSQRLLVYEFVPN--------------KTLEFHLHGKDRPVMNWPTRMKI 305
+++L+G CT ++ E+ + ++ M + +
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 306 ALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351
ARG+ YL K IHRD+ + N+L+ ++ K+ADFGLA+
Sbjct: 209 TYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLAR 251
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-27
Identities = 44/165 (26%), Positives = 74/165 (44%), Gaps = 26/165 (15%)
Query: 210 LGQGGFGYVHKGVLTN------GKVVAIKQLKAGSGQGER-EFQAEIEIISQV-HHRHLV 261
LG+G FG V + + VA+K LK G+ E +E++I+ + HH ++V
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 262 SLVGYCT-FGSQRLLVYEFVPNKTL--------------EFHLHGKDRPVMNWPTRMKIA 306
+L+G CT G +++ EF L + + + + +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 307 LGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351
A+G+ +L K IHRD+ + NILL + K+ DFGLA+
Sbjct: 155 FQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLAR 196
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-27
Identities = 42/203 (20%), Positives = 80/203 (39%), Gaps = 14/203 (6%)
Query: 171 DSDKPFPRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGV-LTNGKVV 229
P P + Y L NF +G+G F V++ L +G V
Sbjct: 5 SQGMQGPPVPQFQPQKALRPDMGYNTL----ANFRIEKKIGRGQFSEVYRAACLLDGVPV 60
Query: 230 AIKQLKAGSGQGEREFQA---EIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLE 286
A+K+++ + EI+++ Q++H +++ ++ +V E L
Sbjct: 61 ALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLS 120
Query: 287 FHL--HGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKV 344
+ K + ++ T K + L ++H +++HRDIK AN+ + + K+
Sbjct: 121 RMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKL 177
Query: 345 ADFGLAKHSLDTDTHVSTRVMGT 367
D GL + T + V GT
Sbjct: 178 GDLGLGRFFSSKTTAAHSLV-GT 199
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 4e-27
Identities = 42/177 (23%), Positives = 79/177 (44%), Gaps = 32/177 (18%)
Query: 210 LGQGGFGYVHKGVLTNGK------VVAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVS 262
+G+G FG V + +VA+K LK + + +FQ E ++++ + ++V
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 263 LVGYCTFGSQRLLVYEFVPN----------------------KTLEFHLHGKDRPVMNWP 300
L+G C G L++E++ + + P ++
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 301 TRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357
++ IA A G+AYL E K +HRD+ + N L+ ++ K+ADFGL+++ D
Sbjct: 175 EQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 228
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 4e-27
Identities = 40/177 (22%), Positives = 73/177 (41%), Gaps = 32/177 (18%)
Query: 210 LGQGGFGYVHKGVLTNGK------VVAIKQLKAGSGQGER-EFQAEIEIISQV-HHRHLV 261
LG G FG V VA+K LK + ER +E+++++Q+ H ++V
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 262 SLVGYCTFGSQRLLVYEFVPN------------KTLEFHLHGKDRPVMNWPTR------- 302
+L+G CT L++E+ K E + +++ +
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172
Query: 303 --MKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357
+ A A+G+ +L +HRD+ + N+L+ K+ DFGLA+ +
Sbjct: 173 DLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 226
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 6e-27
Identities = 45/191 (23%), Positives = 80/191 (41%), Gaps = 35/191 (18%)
Query: 201 TDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRH 259
+F E +LGQG FG V K + + AIK+++ + +E+ +++ ++H++
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63
Query: 260 LVSLVGYCTFGSQRL---------------LVYEFVPNKTLEFHLHGKDRP-----VMNW 299
+V Y + +R + E+ N TL +H ++
Sbjct: 64 VVRY--YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121
Query: 300 PTRMK-IALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 358
+ I L+Y+H IIHRD+K NI +D+S K+ DFGLAK+ +
Sbjct: 122 ---FRQILEA----LSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLD 171
Query: 359 HVSTRVMGTFG 369
+ G
Sbjct: 172 ILKLDSQNLPG 182
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-27
Identities = 43/163 (26%), Positives = 69/163 (42%), Gaps = 18/163 (11%)
Query: 210 LGQGGFGYVHKGVLTNGK------VVAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVS 262
LG G FG V++G ++ VA+K L + + +F E IIS+ +H+++V
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 263 LVGYCTFGSQRLLVYEFVPNKTLEFHL-----HGKDRPVMNWPTRMKIALGSARGLAYLH 317
+G R ++ E + L+ L + + +A A G YL
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 318 EDCQPKIIHRDIKSANILLDDSFE---AKVADFGLAKHSLDTD 357
E+ IHRDI + N LL AK+ DFG+A+
Sbjct: 199 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG 238
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 8e-27
Identities = 42/184 (22%), Positives = 76/184 (41%), Gaps = 38/184 (20%)
Query: 201 TDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRH 259
+ + LG G FG V+K G + A K ++ S + ++ EIEI++ H +
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 260 LVSLVG-------------YCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIA 306
+V L+G +C G+ ++ + E I
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDAIM-LELDRGLTEPQ----------------IQ 120
Query: 307 L---GSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTR 363
+ L +LH +IIHRD+K+ N+L+ + ++ADFG++ +L T +
Sbjct: 121 VVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS- 176
Query: 364 VMGT 367
+GT
Sbjct: 177 FIGT 180
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-26
Identities = 45/182 (24%), Positives = 86/182 (47%), Gaps = 11/182 (6%)
Query: 179 QSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAG 237
S G G +S F + +++ +L +GGF +V++ + +G+ A+K+L +
Sbjct: 5 GSLGGASGRDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN 64
Query: 238 SGQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQR--------LLVYEFVPNKTLEFH 288
+ R E+ + ++ H ++V + G + LL+ E + +EF
Sbjct: 65 EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFL 124
Query: 289 LHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFG 348
+ R ++ T +KI + R + ++H +P IIHRD+K N+LL + K+ DFG
Sbjct: 125 KKMESRGPLSCDTVLKIFYQTCRAVQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFG 183
Query: 349 LA 350
A
Sbjct: 184 SA 185
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 40/172 (23%), Positives = 74/172 (43%), Gaps = 27/172 (15%)
Query: 210 LGQGGFGYVHKGVLTNGK--------VVAIKQLKAGSGQGER-EFQAEIEIISQV-HHRH 259
LG+G FG V VA+K LK+ + + + + +E+E++ + H++
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 260 LVSLVGYCTFGSQRLLVYEFVPN--------------KTLEFHLHGKDRPVMNWPTRMKI 305
+++L+G CT ++ E+ ++ ++ +
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 306 ALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357
A ARG+ YL K IHRD+ + N+L+ + K+ADFGLA+ D
Sbjct: 197 AYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 245
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-26
Identities = 39/176 (22%), Positives = 71/176 (40%), Gaps = 19/176 (10%)
Query: 202 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGERE-FQAEIEIISQVHHRH 259
+F LG+GGFG V + + AIK+++ + + RE E++ ++++ H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 260 LVSLVGY---------CTFGSQRLLVY---EFVPNKTL-EFHLHGKDRPVMNWPTRMKIA 306
+V S ++ +Y + + L ++ + I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 307 LGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 362
L A + +LH ++HRD+K +NI KV DFGL ++D D T
Sbjct: 125 LQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVT-AMDQDEEEQT 176
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-26
Identities = 48/230 (20%), Positives = 80/230 (34%), Gaps = 17/230 (7%)
Query: 141 SLPPSNGPTAPLPTVPVSAFNEPLSTSGSLDSDKPFPRQSPGMPVGNFKSTFTYEELKIA 200
S S+G L ++ S S L P + G+ + YE +
Sbjct: 2 SGSVSSGQAHSLASLA----KTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEY-REE 56
Query: 201 TDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRH 259
+ +G+G FG VH+ G A+K+++ E E+ + +
Sbjct: 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRL-----EVFRVEELVACAGLSSPR 111
Query: 260 LVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHED 319
+V L G G + E + +L + K + + + GL YLH
Sbjct: 112 IVPLYGAVREGPWVNIFMELLEGGSLGQLI--KQMGCLPEDRALYYLGQALEGLEYLHTR 169
Query: 320 CQPKIIHRDIKSANILLD-DSFEAKVADFGLAKHSLDTDTHVSTRVMGTF 368
+I+H D+K+ N+LL D A + DFG A S
Sbjct: 170 ---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYI 216
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-26
Identities = 53/191 (27%), Positives = 82/191 (42%), Gaps = 45/191 (23%)
Query: 201 TDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHR 258
F L+G G +G V+KG + G++ AIK + +G E E + EI ++ + HHR
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TGDEEEEIKQEINMLKKYSHHR 81
Query: 259 HLVSLVG-------------------YCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNW 299
++ + G +C GS L+ N E
Sbjct: 82 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW----------- 130
Query: 300 PTRMKIAL---GSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356
IA RGL++LH+ K+IHRDIK N+LL ++ E K+ DFG++ T
Sbjct: 131 -----IAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 182
Query: 357 DTHVSTRVMGT 367
+T +GT
Sbjct: 183 VGRRNT-FIGT 192
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-25
Identities = 50/206 (24%), Positives = 77/206 (37%), Gaps = 47/206 (22%)
Query: 171 DSDKPFPRQSPGMPVGNFKSTFTYEELKIA------TDNFSEANLLGQGGFGYVHKGV-L 223
+ F MP G + ++ FS+ +G G FG V+ +
Sbjct: 17 TENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDV 76
Query: 224 TNGKVVAIKQLKAGSGQGEREF---QAEIEIISQVHHRHLVSLVG-------------YC 267
N +VVAIK++ Q ++ E+ + ++ H + + G YC
Sbjct: 77 RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC 136
Query: 268 TFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIAL---GSARGLAYLHEDCQPKI 324
+ LL E E IA G+ +GLAYLH +
Sbjct: 137 LGSASDLL--EVHKKPLQEVE----------------IAAVTHGALQGLAYLHSH---NM 175
Query: 325 IHRDIKSANILLDDSFEAKVADFGLA 350
IHRD+K+ NILL + K+ DFG A
Sbjct: 176 IHRDVKAGNILLSEPGLVKLGDFGSA 201
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-25
Identities = 56/185 (30%), Positives = 81/185 (43%), Gaps = 41/185 (22%)
Query: 201 TDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGERE-FQAEIEIISQVHHR 258
+ F++ +G+G FG V KG+ KVVAIK + + E E Q EI ++SQ
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 259 HLVSLVG-------------YCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKI 305
++ G Y GS + + L+ +I
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLD---------------ETQI 121
Query: 306 AL---GSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 362
A +GL YLH + K IHRDIK+AN+LL + E K+ADFG+A DT +T
Sbjct: 122 ATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT 178
Query: 363 RVMGT 367
+GT
Sbjct: 179 -FVGT 182
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-25
Identities = 48/163 (29%), Positives = 76/163 (46%), Gaps = 15/163 (9%)
Query: 198 KIATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLK----AGSGQGEREFQAEIEII 252
+ A ++F LG+G FG V+ + ++A+K L +G + + E+EI
Sbjct: 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ-LRREVEIQ 63
Query: 253 SQVHHRHLVSLVGYCTFGSQR--LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSA 310
S + H +++ L Y F L+ E+ P T+ L K T I A
Sbjct: 64 SHLRHPNILRL--YGYFHDATRVYLILEYAPLGTVYRELQ-KLSKFDEQRTATYITE-LA 119
Query: 311 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353
L+Y H ++IHRDIK N+LL + E K+ADFG + H+
Sbjct: 120 NALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA 159
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-25
Identities = 47/217 (21%), Positives = 79/217 (36%), Gaps = 25/217 (11%)
Query: 161 NEPLSTSGSLDSDKPFPRQSPGMPVGNFKSTFTYEELKIATD---NFSEANLLGQGGFGY 217
+ +SG + QS + FK+ + D +G+G G
Sbjct: 3 HHHHHSSGVDLGTENLYFQSGVVTHEQFKAA--LRMVVDQGDPRLLLDSYVKIGEGSTGI 60
Query: 218 VHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276
V +G+ VA+K + Q E+ I+ H ++V + G + ++
Sbjct: 61 VCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVL 120
Query: 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMK------IALGSARGLAYLHEDCQPKIIHRDIK 330
EF+ G +++ R+ + + LAYLH +IHRDIK
Sbjct: 121 MEFLQG--------GALTDIVS-QVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIK 168
Query: 331 SANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGT 367
S +ILL K++DFG + V GT
Sbjct: 169 SDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GT 204
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 2e-25
Identities = 34/170 (20%), Positives = 73/170 (42%), Gaps = 9/170 (5%)
Query: 202 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQA---EIEIISQVHH 257
+ + +G+G FG +G+ IK++ S +E + E+ +++ + H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINI-SRMSSKEREESRREVAVLANMKH 82
Query: 258 RHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLH 317
++V +V ++ L ++ + + + + L ++H
Sbjct: 83 PNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH 142
Query: 318 EDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGT 367
+ KI+HRDIKS NI L ++ DFG+A+ L++ ++ +GT
Sbjct: 143 D---RKILHRDIKSQNIFLTKDGTVQLGDFGIAR-VLNSTVELARACIGT 188
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-25
Identities = 45/195 (23%), Positives = 78/195 (40%), Gaps = 14/195 (7%)
Query: 178 RQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQ--LK 235
S G+ +G F + + + +S +G GG V + + ++ AIK L+
Sbjct: 6 HHSSGVDLGTENLYF--QSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLE 63
Query: 236 AGSGQGEREFQAEIEIISQV--HHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKD 293
Q ++ EI ++++ H ++ L Y +V E N L L K
Sbjct: 64 EADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKK 122
Query: 294 RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH- 352
++ R + +H+ I+H D+K AN L+ D K+ DFG+A
Sbjct: 123 S--IDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQM 176
Query: 353 SLDTDTHVSTRVMGT 367
DT + V +GT
Sbjct: 177 QPDTTSVVKDSQVGT 191
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 5e-25
Identities = 46/153 (30%), Positives = 71/153 (46%), Gaps = 18/153 (11%)
Query: 209 LLGQGGFGYVHKGV-LTNGKVVAIK-----QLKAGSGQGEREFQAEIEIISQVHHRHLVS 262
LLG+G F V++ + G VAIK + +G +R Q E++I Q+ H ++
Sbjct: 18 LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYK-AGMVQR-VQNEVKIHCQLKHPSILE 75
Query: 263 LVGYCTFGSQR--LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIA-LGSARGLAYLHED 319
L Y F LV E N + +L + +P R + + G+ YLH
Sbjct: 76 LYNY--FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQI--ITGMLYLH-- 129
Query: 320 CQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352
I+HRD+ +N+LL + K+ADFGLA
Sbjct: 130 -SHGILHRDLTLSNLLLTRNMNIKIADFGLATQ 161
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 7e-25
Identities = 54/182 (29%), Positives = 77/182 (42%), Gaps = 36/182 (19%)
Query: 201 TDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRH 259
+ F LG+G +G V+K + G++VAIKQ+ +E EI I+ Q H
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPH 85
Query: 260 LVSLVG-------------YCTFGSQRLL-VYEFVPNKTLEFHLHGKDRPVMNWPTRMKI 305
+V G YC GS + + E + I
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGS--VSDIIRLRNKTLTEDEI-------------ATI 130
Query: 306 ALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVM 365
+ +GL YLH + IHRDIK+ NILL+ AK+ADFG+A DT +T +
Sbjct: 131 LQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI- 186
Query: 366 GT 367
GT
Sbjct: 187 GT 188
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 8e-25
Identities = 41/182 (22%), Positives = 71/182 (39%), Gaps = 36/182 (19%)
Query: 201 TDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRH 259
++ +GQG G V+ + + G+ VAI+Q+ + EI ++ + + +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 260 LVSLVG-------------YCTFGSQRLLVYEFVPNKTL-EFHLHGKDRPVMNWPTRMKI 305
+V+ + Y GS + + V + E + +
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGS----LTDVVTETCMDEGQI-------------AAV 121
Query: 306 ALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVM 365
+ L +LH + ++IHRDIKS NILL K+ DFG + ST V
Sbjct: 122 CRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV- 177
Query: 366 GT 367
GT
Sbjct: 178 GT 179
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 48/232 (20%), Positives = 79/232 (34%), Gaps = 26/232 (11%)
Query: 141 SLPPSNGPTAPLPTVPVSAFNEPLSTSGSLDSDKPFPRQSPGMPVGNFKSTFTYEELKIA 200
L P + G+ D DK + + V Y LK
Sbjct: 9 GLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRI----YSILK-- 62
Query: 201 TDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQ--LKAGSGQGEREFQAEIEIISQVHH- 257
+G GG V + + ++ AIK L+ Q ++ EI ++++
Sbjct: 63 --------QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 114
Query: 258 -RHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYL 316
++ L Y +V E N L L K ++ R + +
Sbjct: 115 SDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTI 171
Query: 317 HEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH-SLDTDTHVSTRVMGT 367
H+ I+H D+K AN L+ D K+ DFG+A DT + V +G
Sbjct: 172 HQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGA 219
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-24
Identities = 44/182 (24%), Positives = 72/182 (39%), Gaps = 25/182 (13%)
Query: 202 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGERE-FQAEIEIISQVHHRH 259
D++ ++G G V + VAIK++ Q + EI+ +SQ HH +
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 260 LVSLVG-------------YCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIA 306
+VS + GS ++ V + V++ T I
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHK-------SGVLDESTIATIL 127
Query: 307 LGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMG 366
GL YLH++ IHRD+K+ NILL + ++ADFG++ +V
Sbjct: 128 REVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRK 184
Query: 367 TF 368
TF
Sbjct: 185 TF 186
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 47/204 (23%), Positives = 78/204 (38%), Gaps = 21/204 (10%)
Query: 151 PLPTVPVSAFNEPLSTSGSLDSDKPFPRQSPGMPVGNFKSTFTYEELKIATDNFSEANLL 210
P P P A ++ G+ + P + + +S Y + L
Sbjct: 2 PAPADPGKAGVPGVAAPGAPAAAPPAKEIPE--VLVDPRSRRRYVRGR----------FL 49
Query: 211 GQGGFGYVHKGV-LTNGKVVAIKQL---KAGSGQGEREFQAEIEIISQVHHRHLVSLVGY 266
G+GGF + +V A K + + EI I + H+H+V G+
Sbjct: 50 GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF 109
Query: 267 CTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIH 326
+V E ++L LH + + + R G YLH + ++IH
Sbjct: 110 FEDNDFVFVVLELCRRRSL-LELHKRRKALTEPEAR-YYLRQIVLGCQYLH---RNRVIH 164
Query: 327 RDIKSANILLDDSFEAKVADFGLA 350
RD+K N+ L++ E K+ DFGLA
Sbjct: 165 RDLKLGNLFLNEDLEVKIGDFGLA 188
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 3e-24
Identities = 40/175 (22%), Positives = 80/175 (45%), Gaps = 10/175 (5%)
Query: 202 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQL-KAGSGQGEREF-QAEIEIISQVHHR 258
+++ +G G +G K ++GK++ K+L + E++ +E+ ++ ++ H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 259 HLVSLVG-YCTFGSQRL-LVYEFVPNKTLEFHL--HGKDRPVMNWPTRMKIALGSARGLA 314
++V + L +V E+ L + K+R ++ +++ L
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 315 YLHE--DCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGT 367
H D ++HRD+K AN+ LD K+ DFGLA+ L+ DT + +GT
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR-ILNHDTSFAKTFVGT 179
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-24
Identities = 48/204 (23%), Positives = 74/204 (36%), Gaps = 21/204 (10%)
Query: 169 SLDSDKPFPRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGV-LTNGK 227
S + QSPG +S F +F + LG G +G V K +G+
Sbjct: 32 SFRGEASETLQSPGYDPSRPESFFQ--------QSFQRLSRLGHGSYGEVFKVRSKEDGR 83
Query: 228 VVAIKQLKAGSGQGEREFQ---AEIEIISQV-HHRHLVSLVGYCTFGSQRLLVYEFVPNK 283
+ A+K+ + +G ++ AE+ +V H V L G L E
Sbjct: 84 LYAVKRSMS-PFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GP 141
Query: 284 TLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAK 343
+L+ H + + LA+LH ++H D+K ANI L K
Sbjct: 142 SLQQHCE-AWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCK 197
Query: 344 VADFGLAKHSLDTDTHVSTRVMGT 367
+ DFGL L T + G
Sbjct: 198 LGDFGLLVE-LGTAGAGEVQE-GD 219
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 6e-24
Identities = 42/178 (23%), Positives = 72/178 (40%), Gaps = 12/178 (6%)
Query: 195 EELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQ--LKAGSGQGEREFQAEIEII 252
E + + +S +G GG V + + ++ AIK L+ Q ++ EI +
Sbjct: 2 ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 61
Query: 253 SQV--HHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSA 310
+++ H ++ L Y +V E N L L K ++ R
Sbjct: 62 NKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKS--IDPWERKSYWKNML 118
Query: 311 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH-SLDTDTHVSTRVMGT 367
+ +H+ I+H D+K AN L+ D K+ DFG+A DT + V +GT
Sbjct: 119 EAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGT 172
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 6e-24
Identities = 39/146 (26%), Positives = 62/146 (42%), Gaps = 9/146 (6%)
Query: 209 LLGQGGFGYVHKGV-LTNGKVVAIKQL---KAGSGQGEREFQAEIEIISQVHHRHLVSLV 264
LG+GGF + +V A K + + EI I + H+H+V
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 265 GYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKI 324
G+ +V E ++L LH + + + R G YLH + ++
Sbjct: 82 GFFEDNDFVFVVLELCRRRSL-LELHKRRKALTEPEAR-YYLRQIVLGCQYLH---RNRV 136
Query: 325 IHRDIKSANILLDDSFEAKVADFGLA 350
IHRD+K N+ L++ E K+ DFGLA
Sbjct: 137 IHRDLKLGNLFLNEDLEVKIGDFGLA 162
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-23
Identities = 51/170 (30%), Positives = 75/170 (44%), Gaps = 17/170 (10%)
Query: 198 KIATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLK----AGSGQGEREFQAEIEII 252
K D+F LG+G FG V+ N ++A+K L G + + EIEI
Sbjct: 10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ-LRREIEIQ 68
Query: 253 SQVHHRHLVSLVGYCTFGSQR--LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIA-LGS 309
S + H +++ + Y F ++ L+ EF P L L K + + L
Sbjct: 69 SHLRHPNILRM--YNYFHDRKRIYLMLEFAPRGELYKELQ-KHGRFDEQRSATFMEELAD 125
Query: 310 ARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 359
A L Y HE K+IHRDIK N+L+ E K+ADFG + H+
Sbjct: 126 A--LHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR 170
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 2e-23
Identities = 41/181 (22%), Positives = 75/181 (41%), Gaps = 18/181 (9%)
Query: 198 KIATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQL-KAGSGQGEREFQAEIEIISQV 255
+ + +++LGQG V +G G + AIK + E E++ ++
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 256 HHRHLVSLVGYCTF----GSQRLLVYEFVPNKTLEFHLHGKDRPV-MNWPTRMKIALGSA 310
+H+++V L + ++L+ EF P +L L + + +
Sbjct: 65 NHKNIVKL--FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV 122
Query: 311 RGLAYLHEDCQPKIIHRDIKSANILL----DDSFEAKVADFGLAKHSLDTDTHVSTRVMG 366
G+ +L E+ I+HR+IK NI+ D K+ DFG A+ L+ D + G
Sbjct: 123 GGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE-LEDDEQFVSLY-G 177
Query: 367 T 367
T
Sbjct: 178 T 178
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 97.4 bits (242), Expect = 8e-23
Identities = 38/237 (16%), Positives = 72/237 (30%), Gaps = 29/237 (12%)
Query: 138 PKPSLPPSNGPTAPLPTVPVSAFNEPLSTSGSLDSDKPFPRQSPGMPV--GNFKSTFTYE 195
P+ S + + P +++ L L P +
Sbjct: 3 PQMSSLGTVDAPNFIVGNP---WDDKL-IFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKT 58
Query: 196 ELKIATDNFSEANLLGQGGFGYVHKGV------LTNGKVVAIKQLKAGSGQGEREFQAEI 249
E ++ + +LLG+G F V++ N + +K K + +
Sbjct: 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLM 118
Query: 250 EIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRP---VMNWPTRMKIA 306
E + + F + +LV E TL ++ VM + A
Sbjct: 119 ERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFA 178
Query: 307 LGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEA-----------KVADFGLAKH 352
+ + +H+ +IIH DIK N +L + F + D G +
Sbjct: 179 MRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSID 232
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 1e-22
Identities = 45/191 (23%), Positives = 84/191 (43%), Gaps = 35/191 (18%)
Query: 195 EELKIATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGERE-FQAEIEII 252
+ ++ + +G+G +G V+K V +G+++A+K++++ + E++ +++++
Sbjct: 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVV 74
Query: 253 -SQVHHRHLVSLVG-------------YCTFGSQRLL--VYEFVPNKTLEFHLHGKDRPV 296
++V G + + VY + + E L
Sbjct: 75 MRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEIL------- 127
Query: 297 MNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356
KI L + + L +L E KIIHRDIK +NILLD S K+ DFG++ L
Sbjct: 128 ------GKITLATVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQ-L-V 177
Query: 357 DTHVSTRVMGT 367
D+ TR G
Sbjct: 178 DSIAKTRDAGC 188
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-22
Identities = 45/163 (27%), Positives = 76/163 (46%), Gaps = 9/163 (5%)
Query: 209 LLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGE---REFQAEIEIISQVHHRHLVSLV 264
LG GG V+ VAIK + + E + F+ E+ SQ+ H+++VS++
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 265 GYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKI 324
LV E++ TL ++ ++ T + G+ + H+ +I
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYIE--SHGPLSVDTAINFTNQILDGIKHAHDM---RI 132
Query: 325 IHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGT 367
+HRDIK NIL+D + K+ DFG+AK +T + V+GT
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGT 175
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 96.5 bits (240), Expect = 2e-22
Identities = 41/181 (22%), Positives = 75/181 (41%), Gaps = 18/181 (9%)
Query: 198 KIATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQL-KAGSGQGEREFQAEIEIISQV 255
+ + +++LGQG V +G G + AIK + E E++ ++
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 256 HHRHLVSLVGYCTF----GSQRLLVYEFVPNKTLEFHLHGKDRPV-MNWPTRMKIALGSA 310
+H+++V L + ++L+ EF P +L L + + +
Sbjct: 65 NHKNIVKL--FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV 122
Query: 311 RGLAYLHEDCQPKIIHRDIKSANILL----DDSFEAKVADFGLAKHSLDTDTHVSTRVMG 366
G+ +L E+ I+HR+IK NI+ D K+ DFG A+ L+ D + G
Sbjct: 123 GGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE-LEDDEQFVSLY-G 177
Query: 367 T 367
T
Sbjct: 178 T 178
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 3e-22
Identities = 38/187 (20%), Positives = 63/187 (33%), Gaps = 28/187 (14%)
Query: 201 TDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLK-AGSGQGEREFQ-AEIEIISQV-H 256
T F E +G G FG V K V +G + AIK+ K +G + + E+ + +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 257 HRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHL--HGKDRPVMNWPTRMKIALGSARGLA 314
H H+V L+ E+ +L + + + + L RGL
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 315 YLHEDCQPKIIHRDIKSANILLD-------------------DSFEAKVADFGLAKHSLD 355
Y+H ++H DIK +NI + + K+ D G
Sbjct: 130 YIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186
Query: 356 TDTHVST 362
Sbjct: 187 PQVEEGD 193
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 3e-22
Identities = 33/175 (18%), Positives = 70/175 (40%), Gaps = 30/175 (17%)
Query: 210 LGQGGFGYVHKGVLTNGKVVAIKQL-----------------KAGSGQGEREFQAEIEII 252
L QG F + + K A+K+ K +F+ E++II
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 253 SQVHHRHLVSLVGYCTFGSQR--LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGS- 309
+ + + + ++ + ++YE++ N ++ N+ + I +
Sbjct: 98 TDIKNEYCLTC--EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKC 155
Query: 310 -----ARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 359
+Y+H + I HRD+K +NIL+D + K++DFG +++ +D
Sbjct: 156 IIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK 208
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 3e-22
Identities = 37/187 (19%), Positives = 77/187 (41%), Gaps = 35/187 (18%)
Query: 197 LKIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGERE-FQAEIEII-S 253
+++ D+ LG+G +G V K +G+++A+K+++A E++ +++I
Sbjct: 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMR 61
Query: 254 QVHHRHLVSLVG-------------YCTFGSQRLLVYEFVPNKTL-EFHLHGKDRPVMNW 299
V V+ G + +T+ E L
Sbjct: 62 TVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDIL---------- 111
Query: 300 PTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH---SLDT 356
KIA+ + L +LH + +IHRD+K +N+L++ + K+ DFG++ + +
Sbjct: 112 ---GKIAVSIVKALEHLHS--KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK 166
Query: 357 DTHVSTR 363
D +
Sbjct: 167 DIDAGCK 173
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 4e-22
Identities = 27/184 (14%), Positives = 60/184 (32%), Gaps = 40/184 (21%)
Query: 201 TDNFSEANLLGQG--GFGYVHKGV-LTNGKVVAIKQ--LKAGSGQGEREFQAEIEIISQV 255
+ ++G+G V+ G+ V +++ L+A S + Q E+ +
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 256 HHRHLVSLVG-------------YCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTR 302
+H ++V + +GS + L+ + E
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELA-------------- 129
Query: 303 MKIAL---GSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 359
IA G + L Y+H +HR +K+++IL+ + ++ +
Sbjct: 130 --IAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQR 184
Query: 360 VSTR 363
Sbjct: 185 QRVV 188
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 96.8 bits (241), Expect = 5e-22
Identities = 65/259 (25%), Positives = 105/259 (40%), Gaps = 31/259 (11%)
Query: 123 HWQQNVSAPSDYQELPKPSLPPSNGPTAPLPTVPVSAFNEPLSTSGSLDSDKPFPRQSPG 182
+ + P E+P+ + P F E + S PF
Sbjct: 107 QNFLSHTGPDLIPEVPRQLVTNCTQRLEQGP--CKDLFQELTRLTHEYLSVAPFADYLDS 164
Query: 183 MPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYV----HKGVLTNGKVVAIKQLKAG- 237
+ F E + + F + +LG+GGFG V + GK+ A K+L+
Sbjct: 165 IYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRA---TGKMYACKKLEKKR 221
Query: 238 --SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQ-RL-LVYEFVPNKTLEFHLHGKD 293
+GE E +I+ +V+ R +VSL + ++ L LV + L+FH++
Sbjct: 222 IKKRKGEAMALNEKQILEKVNSRFVVSL--AYAYETKDALCLVLTLMNGGDLKFHIYHMG 279
Query: 294 RPVMNWPTRMK-----IALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFG 348
+ R I G L LH + +I++RD+K NILLDD +++D G
Sbjct: 280 QAGFPEA-RAVFYAAEICCG----LEDLHRE---RIVYRDLKPENILLDDHGHIRISDLG 331
Query: 349 LAKHSLDTDTHVSTRVMGT 367
LA H + T + RV GT
Sbjct: 332 LAVHVPEGQT-IKGRV-GT 348
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 7e-22
Identities = 59/228 (25%), Positives = 90/228 (39%), Gaps = 28/228 (12%)
Query: 155 VPVSAFNEPLSTSGSLDSDKPFPRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGG 214
F L + PF + F E + D F + +LG+GG
Sbjct: 138 AGDGLFQPLLRAVLAHLGQAPFQEFLDSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGG 197
Query: 215 FGYV----HKGVLTNGKVVAIKQLKAG---SGQGEREFQAEIEIISQVHHRHLVSLVGYC 267
FG V K GK+ A K+L +G + E +I+++VH R +VSL
Sbjct: 198 FGEVFACQMKA---TGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL--AY 252
Query: 268 TFGSQ-RL-LVYEFVPNKTLEFHLHGKDRPVMNWP-TRMK-----IALGSARGLAYLHED 319
F ++ L LV + + +H++ D + R I G L +LH+
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG----LEHLHQR 308
Query: 320 CQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGT 367
II+RD+K N+LLDD +++D GLA T GT
Sbjct: 309 ---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GT 352
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 93.4 bits (232), Expect = 2e-21
Identities = 44/183 (24%), Positives = 81/183 (44%), Gaps = 34/183 (18%)
Query: 198 KIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREF-QAEIEIISQV 255
++ D+F + + LG G G V K +G V+A K + R E++++ +
Sbjct: 29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 88
Query: 256 HHRHLVSLVG-------------YCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTR 302
+ ++V G + GS ++ + + E L
Sbjct: 89 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK--AGRIPEQIL------------- 133
Query: 303 MKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT--DTHV 360
K+++ +GL YL E KI+HRD+K +NIL++ E K+ DFG++ +D+ ++ V
Sbjct: 134 GKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV 191
Query: 361 STR 363
TR
Sbjct: 192 GTR 194
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 95.1 bits (236), Expect = 2e-21
Identities = 51/179 (28%), Positives = 78/179 (43%), Gaps = 17/179 (9%)
Query: 201 TDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGERE-FQAEIEIISQVHHR 258
+ LG GGFGYV + + G+ VAIKQ + RE + EI+I+ +++H
Sbjct: 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHP 72
Query: 259 HLVSLV------GYCTFGSQRLLVYEFVPNKTLEFHLHGKDRP-VMNWPTRMKIALGSAR 311
++VS LL E+ L +L+ + + + +
Sbjct: 73 NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132
Query: 312 GLAYLHEDCQPKIIHRDIKSANILLDDSFEA---KVADFGLAKHSLDTDTHVSTRVMGT 367
L YLHE+ +IIHRD+K NI+L + K+ D G AK LD + V GT
Sbjct: 133 ALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE-LDQGELCTEFV-GT 186
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 4e-21
Identities = 51/265 (19%), Positives = 93/265 (35%), Gaps = 36/265 (13%)
Query: 122 HHWQQNVSAPSDYQELPKPSLPPSNGPTAPLPTVPVSAFNEPLSTSGSLDSDKPFPRQSP 181
HH + + S + + + + ++ L P +
Sbjct: 4 HHHHHSSGVDL----GTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRT 59
Query: 182 GMPVGNFKST---FTYEELKIATDNFSE------ANLLGQGGFGYVHKGV-LTNGKVVAI 231
+ + F + + + +LG G FG VHK G +A
Sbjct: 60 SALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAA 119
Query: 232 KQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTL------ 285
K +K + + E + EI +++Q+ H +L+ L + +LV E+V L
Sbjct: 120 KIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIID 179
Query: 286 -EFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEA-- 342
++L D + MK G+ ++H+ I+H D+K NIL +
Sbjct: 180 ESYNLTELDTILF-----MKQICE---GIRHMHQM---YILHLDLKPENILCVNRDAKQI 228
Query: 343 KVADFGLAKHSLDTDTHVSTRVMGT 367
K+ DFGLA+ + GT
Sbjct: 229 KIIDFGLARR-YKPREKLKVNF-GT 251
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 4e-21
Identities = 50/243 (20%), Positives = 86/243 (35%), Gaps = 29/243 (11%)
Query: 139 KPSLPPSNGPTAPLPTVPVSAFNEPLSTSGSLDSDKPFPRQSPGMPVGNFKSTFTYEELK 198
KP P + ++ G + K + V + + + ++
Sbjct: 92 KPCEPTAPVLIPGDERKRRRGYDVD--EQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVE 149
Query: 199 IATDNFSE----ANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIIS 253
I D+ + LG G FG VH+ G A K + + + EI+ +S
Sbjct: 150 IKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMS 209
Query: 254 QVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTL-------EFHLHGKDRPVMNWPTRMKIA 306
+ H LV+L ++ +++YEF+ L + + M+
Sbjct: 210 VLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEY-----MRQV 264
Query: 307 LGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEA--KVADFGLAKHSLDTDTHVSTRV 364
GL ++HE+ +H D+K NI+ K+ DFGL H LD V
Sbjct: 265 CK---GLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAH-LDPKQSVKVTT 317
Query: 365 MGT 367
GT
Sbjct: 318 -GT 319
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 8e-21
Identities = 44/155 (28%), Positives = 81/155 (52%), Gaps = 13/155 (8%)
Query: 202 DNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGERE---FQA--EIEIISQVH 256
+ + + +G+G +G V+K + G++VA+K+++ + E E A EI ++ ++H
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDA---EDEGIPSTAIREISLLKELH 77
Query: 257 HRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYL 316
H ++VSL+ LV+EF+ K L+ L + RG+A+
Sbjct: 78 HPNIVSLIDVIHSERCLTLVFEFME-KDLKKVLDENKTG-LQDSQIKIYLYQLLRGVAHC 135
Query: 317 HEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351
H+ +I+HRD+K N+L++ K+ADFGLA+
Sbjct: 136 HQH---RILHRDLKPQNLLINSDGALKLADFGLAR 167
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 8e-21
Identities = 43/156 (27%), Positives = 82/156 (52%), Gaps = 13/156 (8%)
Query: 202 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGERE---FQA--EIEIISQV 255
+NF + +G+G +G V+K G+VVA+K+++ + E E A EI ++ ++
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT---ETEGVPSTAIREISLLKEL 59
Query: 256 HHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAY 315
+H ++V L+ ++ LV+EF+ + L+ + + P +GLA+
Sbjct: 60 NHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 316 LHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351
H +++HRD+K N+L++ K+ADFGLA+
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR 151
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 1e-20
Identities = 47/169 (27%), Positives = 81/169 (47%), Gaps = 15/169 (8%)
Query: 209 LLGQGGFGYVHKGV-LTNGKVVAIKQLK---AGSGQGEREFQAEIEIISQVHHRHLVSL- 263
+LG GG VH L + + VA+K L+ A F+ E + + ++H +V++
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 264 -VGYCTFGSQRL--LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDC 320
G + L +V E+V TL +H M +++ + + L + H++
Sbjct: 79 DTGEAETPAGPLPYIVMEYVDGVTLRDIVH--TEGPMTPKRAIEVIADACQALNFSHQN- 135
Query: 321 QPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV--STRVMGT 367
IIHRD+K ANI++ + KV DFG+A+ D+ V + V+GT
Sbjct: 136 --GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 4e-20
Identities = 46/156 (29%), Positives = 80/156 (51%), Gaps = 11/156 (7%)
Query: 202 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGERE---FQA--EIEIISQV 255
+ + + LG+G F V+K ++VAIK++K G ++ A EI+++ ++
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69
Query: 256 HHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAY 315
H +++ L+ S LV++F+ LE + + L + +GL Y
Sbjct: 70 SHPNIIGLLDAFGHKSNISLVFDFME-TDLEVIIKDNSLV-LTPSHIKAYMLMTLQGLEY 127
Query: 316 LHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351
LH+ I+HRD+K N+LLD++ K+ADFGLAK
Sbjct: 128 LHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK 160
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 6e-20
Identities = 36/164 (21%), Positives = 62/164 (37%), Gaps = 11/164 (6%)
Query: 209 LLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGE---REFQAEIEIISQVHHRHLVSLV 264
L+G+GG G V++ ++VA+K + Q E ++ H+V +
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 265 GYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKI 324
+ Q + + L L + + + P + I L H
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAML--RRQGPLAPPRAVAIVRQIGSALDAAHAA---GA 155
Query: 325 IHRDIKSANILLDDSFEAKVADFGLAKHSLDTD-THVSTRVMGT 367
HRD+K NIL+ A + DFG+A + D T + +GT
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN-TVGT 198
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 6e-20
Identities = 35/188 (18%), Positives = 69/188 (36%), Gaps = 36/188 (19%)
Query: 195 EELKIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGERE-FQAEIEII 252
+ + ++ +G G G V K G V+A+KQ++ + E + +++++
Sbjct: 18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVV 77
Query: 253 -SQVHHRHLVSLVG-------------YCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMN 298
++V G + + + + E L
Sbjct: 78 LKSHDCPYIVQCFGTFITNTDVFIAMELMGTCA--EKLKKRMQGPIPERIL--------- 126
Query: 299 WPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH---SLD 355
K+ + + L YL E + +IHRD+K +NILLD+ + K+ DFG++
Sbjct: 127 ----GKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA 180
Query: 356 TDTHVSTR 363
D
Sbjct: 181 KDRSAGCA 188
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 7e-20
Identities = 36/156 (23%), Positives = 75/156 (48%), Gaps = 14/156 (8%)
Query: 202 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGERE---FQA--EIEIISQV 255
+ + +G+G +G V K ++VA+K+++ + E A EI ++ ++
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD---DDEGVPSSALREICLLKEL 58
Query: 256 HHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAY 315
H+++V L + LV+EF + L+ + + ++ +GL +
Sbjct: 59 KHKNIVRLHDVLHSDKKLTLVFEFCD-QDLKKYFDSCNGD-LDPEIVKSFLFQLLKGLGF 116
Query: 316 LHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351
H ++HRD+K N+L++ + E K+A+FGLA+
Sbjct: 117 CHSR---NVLHRDLKPQNLLINRNGELKLANFGLAR 149
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 1e-19
Identities = 41/155 (26%), Positives = 76/155 (49%), Gaps = 13/155 (8%)
Query: 202 DNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGERE---FQA--EIEIISQVH 256
+ + +G+G +G V+K G+ A+K+++ E E EI I+ ++
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEK---EDEGIPSTTIREISILKELK 58
Query: 257 HRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYL 316
H ++V L + +LV+E + + L+ L + + T L G+AY
Sbjct: 59 HSNIVKLYDVIHTKKRLVLVFEHLD-QDLKKLLDVCEGG-LESVTAKSFLLQLLNGIAYC 116
Query: 317 HEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351
H+ +++HRD+K N+L++ E K+ADFGLA+
Sbjct: 117 HDR---RVLHRDLKPQNLLINREGELKIADFGLAR 148
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 1e-19
Identities = 48/211 (22%), Positives = 83/211 (39%), Gaps = 28/211 (13%)
Query: 171 DSDKPFPRQSPGMPVGNFKSTFTYEELKIATDNFSE----ANLLGQGGFGYVHKGV-LTN 225
D P + + + +++ + + LG G FG VH+ V
Sbjct: 17 KYDGPKINDYDK-FYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKAT 75
Query: 226 GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTL 285
G+V K + + + EI I++Q+HH L++L + +L+ EF+ L
Sbjct: 76 GRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGEL 135
Query: 286 -------EFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD 338
++ + + M+ A GL ++HE I+H DIK NI+ +
Sbjct: 136 FDRIAAEDYKMSEAEVINY-----MRQACE---GLKHMHEH---SIVHLDIKPENIMCET 184
Query: 339 SFEA--KVADFGLAKHSLDTDTHVSTRVMGT 367
+ K+ DFGLA L+ D V T
Sbjct: 185 KKASSVKIIDFGLATK-LNPDEIVKVTT-AT 213
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 2e-19
Identities = 34/167 (20%), Positives = 65/167 (38%), Gaps = 21/167 (12%)
Query: 209 LLGQGGFGYVHKGV--LTNGKVVAIKQLKAGSGQGERE-FQAEIEIISQVHHRHLVSL-- 263
+ GG G+++ + NG+ V +K L + AE + +++V H +V +
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 264 VGYCTFGSQRLLVY---EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDC 320
T + Y E+V ++L+ K + + L L+YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK----LPVAEAIAYLLEILPALSYLHSI- 201
Query: 321 QPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGT 367
+++ D+K NI+L + + K+ D G + GT
Sbjct: 202 --GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGY-----LYGT 240
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 2e-19
Identities = 53/201 (26%), Positives = 87/201 (43%), Gaps = 24/201 (11%)
Query: 173 DKPFPRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAI 231
S G+ +G F + + + L+G+G +G V K G++VAI
Sbjct: 2 GHHHHHHSSGVDLGTENLYFQ------SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAI 55
Query: 232 KQLKAGSGQGERE---FQA--EIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLE 286
K+ + + A EI+++ Q+ H +LV+L+ C + LV+EFV + T+
Sbjct: 56 KKFLESD---DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFV-DHTIL 111
Query: 287 FHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVAD 346
L +++ K G+ + H IIHRDIK NIL+ S K+ D
Sbjct: 112 DDLELFPNG-LDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCD 167
Query: 347 FGLAKH---SLDTDTH-VSTR 363
FG A+ + V+TR
Sbjct: 168 FGFARTLAAPGEVYDDEVATR 188
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 3e-19
Identities = 47/160 (29%), Positives = 80/160 (50%), Gaps = 16/160 (10%)
Query: 200 ATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGE-----REFQAEIEIIS 253
++ F + LG G + V+KG+ T G VA+K++K S +G RE I ++
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIRE----ISLMK 58
Query: 254 QVHHRHLVSLVGYCTFGSQRLLVYEFVPN---KTLEFHLHGKDRPVMNWPTRMKIALGSA 310
++ H ++V L ++ LV+EF+ N K ++ G +
Sbjct: 59 ELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118
Query: 311 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLA 350
+GLA+ HE+ KI+HRD+K N+L++ + K+ DFGLA
Sbjct: 119 QGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLA 155
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 3e-19
Identities = 43/173 (24%), Positives = 75/173 (43%), Gaps = 20/173 (11%)
Query: 202 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGERE---FQA--EIEIISQV 255
+ + + +G+G +G V K G++VAIK+ + A EI ++ Q+
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE---DDPVIKKIALREIRMLKQL 59
Query: 256 HHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMK-IALGSARGLA 314
H +LV+L+ + LV+E+ + T+ L +K I + + +
Sbjct: 60 KHPNLVNLLEVFRRKRRLHLVFEYC-DHTVLHEL--DRYQRGVPEHLVKSITWQTLQAVN 116
Query: 315 YLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH---SLDTDTH-VSTR 363
+ H+ IHRD+K NIL+ K+ DFG A+ D V+TR
Sbjct: 117 FCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATR 166
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 5e-19
Identities = 41/180 (22%), Positives = 78/180 (43%), Gaps = 19/180 (10%)
Query: 198 KIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQV-H 256
+ +F ++LG G G + + + + VA+K++ + E++++ +
Sbjct: 20 IVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP---ECFSFADREVQLLRESDE 76
Query: 257 HRHLVSLVGYCTFGSQRL--LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLA 314
H +++ +CT ++ + E TL+ ++ KD + + + GLA
Sbjct: 77 HPNVIRY--FCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPI-TLLQQTTSGLA 132
Query: 315 YLHEDCQPKIIHRDIKSANILLDDSFE-----AKVADFGLAKHSLDTDTHVSTRVMGTFG 369
+LH I+HRD+K NIL+ A ++DFGL K L H +R G G
Sbjct: 133 HLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK-LAVGRHSFSRRSGVPG 188
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 5e-19
Identities = 59/242 (24%), Positives = 99/242 (40%), Gaps = 47/242 (19%)
Query: 143 PPSNGPTAPLPTVPVSAFNEPLSTSGSLDSDKPFPRQSPGMPVGNFKSTFTYEELKIATD 202
P + V + + S D K + + +Y + K+
Sbjct: 5 PRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKV--- 61
Query: 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLV 261
+G G FG V++ L +G++VAIK++ Q +R E++I+ ++ H ++V
Sbjct: 62 -------IGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIV 110
Query: 262 SLVGYCTFGSQRL------LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSA----- 310
L + ++ LV ++VP +T+ V +R K L
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVP-ETVY--------RVARHYSRAKQTLPVIYVKLY 161
Query: 311 -----RGLAYLHEDCQPKIIHRDIKSANILLD-DSFEAKVADFGLAKHSLDTDTHVS--- 361
R LAY+H I HRDIK N+LLD D+ K+ DFG AK + + +VS
Sbjct: 162 MYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 218
Query: 362 TR 363
+R
Sbjct: 219 SR 220
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 5e-19
Identities = 42/202 (20%), Positives = 82/202 (40%), Gaps = 30/202 (14%)
Query: 161 NEPLSTSGSLDSDKPFPRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHK 220
+ G+L++ P + S Y + LG+G +G V+K
Sbjct: 3 HHHHHHMGTLEAQTQGPGSMSVSAAPSATSIDRYRRI----------TKLGEGTYGEVYK 52
Query: 221 GV-LTNGKVVAIKQLKAGSGQGERE---FQA--EIEIISQVHHRHLVSLVGYCTFGSQRL 274
+ + VAIK+++ E E A E+ ++ ++ HR+++ L +
Sbjct: 53 AIDTVTNETVAIKRIRLEH---EEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109
Query: 275 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANI 334
L++E+ L+ ++ P ++ G+ + H + +HRD+K N+
Sbjct: 110 LIFEYA-ENDLKKYMD--KNPDVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNL 163
Query: 335 LLDDSFEA-----KVADFGLAK 351
LL S + K+ DFGLA+
Sbjct: 164 LLSVSDASETPVLKIGDFGLAR 185
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 9e-19
Identities = 54/209 (25%), Positives = 77/209 (36%), Gaps = 25/209 (11%)
Query: 170 LDSDKPFPRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYV----HKGVLTN 225
+D PR G + K ++F +LG+G F V
Sbjct: 1 MDGTAAEPRPGAGSLQHAQPPP---QPRKKRPEDFKFGKILGEGSFSTVVLARELA---T 54
Query: 226 GKVVAIKQLKAGSGQGEREFQ---AEIEIISQVHHRHLVSLVGYCTFGSQRLL--VYEFV 280
+ AIK L+ E + E +++S++ H V L Y TF L +
Sbjct: 55 SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL--YFTFQDDEKLYFGLSYA 112
Query: 281 PNKTLEFHLHGKDRPVMNWPTRMKIA-LGSARGLAYLHEDCQPKIIHRDIKSANILLDDS 339
N L ++ K TR A + SA L YLH IIHRD+K NILL++
Sbjct: 113 KNGELLKYIR-KIGSFDETCTRFYTAEIVSA--LEYLHGK---GIIHRDLKPENILLNED 166
Query: 340 FEAKVADFGLAKHSLDTDTHVSTRVM-GT 367
++ DFG AK GT
Sbjct: 167 MHIQITDFGTAKVLSPESKQARANSFVGT 195
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 1e-18
Identities = 50/198 (25%), Positives = 78/198 (39%), Gaps = 46/198 (23%)
Query: 186 GNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREF 245
+ Y K+ +G G FG V + L VAIK++ Q +R
Sbjct: 34 TGEQREIAYTNCKV----------IGNGSFGVVFQAKLVESDEVAIKKVL----QDKRFK 79
Query: 246 QAEIEIISQVHHRHLVSLVGYCTFGSQRL------LVYEFVPNKTLEFHLHGKDRPVMNW 299
E++I+ V H ++V L + + LV E+VP +T+
Sbjct: 80 NRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP-ETV--------YRASRH 130
Query: 300 PTRMKIALGSA----------RGLAYLHEDCQPKIIHRDIKSANILLD-DSFEAKVADFG 348
++K + R LAY+H I HRDIK N+LLD S K+ DFG
Sbjct: 131 YAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFG 187
Query: 349 LAKH--SLDTDTH-VSTR 363
AK + + + + +R
Sbjct: 188 SAKILIAGEPNVSYICSR 205
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 1e-18
Identities = 44/169 (26%), Positives = 73/169 (43%), Gaps = 24/169 (14%)
Query: 200 ATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEI------EI- 251
AT + +G G +G V+K +G VA+K ++ + + E+
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPN---GGGGGGGLPISTVREVA 63
Query: 252 ----ISQVHHRHLVSL----VGYCTFGSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTR 302
+ H ++V L T ++ LV+E V ++ L +L P + T
Sbjct: 64 LLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETI 122
Query: 303 MKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351
+ RGL +LH + I+HRD+K NIL+ K+ADFGLA+
Sbjct: 123 KDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLAR 168
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 86.5 bits (214), Expect = 1e-18
Identities = 54/231 (23%), Positives = 86/231 (37%), Gaps = 36/231 (15%)
Query: 155 VPVSAFNEPLSTSGSLDSDKPFPRQSPGMPVGNFKSTFTYE-ELKIATDNFSEANLLGQG 213
VP F + F + F E + + ++FS ++G+G
Sbjct: 141 VPPDLFQPYIEEICQNLRGDVFQKFIESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRG 200
Query: 214 GFGYV----HKGVLTNGKVVAIKQLKAG---SGQGEREFQAEIEIISQVH---HRHLVSL 263
GFG V GK+ A+K L QGE E ++S V +V +
Sbjct: 201 GFGEVYGCRKAD---TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCM 257
Query: 264 VGYCTFGSQ-RL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMK-----IALGSARGLAYL 316
F + +L + + + L +HL M+ I LG L ++
Sbjct: 258 --SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA---DMRFYAAEIILG----LEHM 308
Query: 317 HEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGT 367
H +++RD+K ANILLD+ +++D GLA H V GT
Sbjct: 309 HNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--ASV-GT 353
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 1e-18
Identities = 47/173 (27%), Positives = 80/173 (46%), Gaps = 42/173 (24%)
Query: 202 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGERE---FQA--EIEIISQV 255
+ + +GQG FG V K G+ VA+K++ + E+E A EI+I+ +
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN---EKEGFPITALREIKILQLL 73
Query: 256 HHRHLVSLVGYCTFGSQRL--------LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIAL 307
H ++V+L+ C + LV++F E L G +++ + +
Sbjct: 74 KHENVVNLIEICRTKASPYNRCKGSIYLVFDF-----CEHDLAG----LLS---NVLVKF 121
Query: 308 GSA----------RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLA 350
+ GL Y+H + KI+HRD+K+AN+L+ K+ADFGLA
Sbjct: 122 TLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLA 171
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 2e-18
Identities = 43/156 (27%), Positives = 80/156 (51%), Gaps = 15/156 (9%)
Query: 202 DNFSEANLLGQGGFGYVHKG-VLTNGKVVAIKQLKAGSGQGE-----REFQAEIEIISQV 255
+ + + + LG+G + V+KG +VA+K+++ +G RE + ++ +
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIRE----VSLLKDL 57
Query: 256 HHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAY 315
H ++V+L LV+E++ +K L+ +L +N RGLAY
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNI-INMHNVKLFLFQLLRGLAY 115
Query: 316 LHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351
H + K++HRD+K N+L+++ E K+ADFGLA+
Sbjct: 116 CH---RQKVLHRDLKPQNLLINERGELKLADFGLAR 148
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 2e-18
Identities = 44/183 (24%), Positives = 81/183 (44%), Gaps = 20/183 (10%)
Query: 195 EELKIATDNFSEANLLGQGGFGYV----HKGVLTNGKVVAIKQLKAGS--GQGERE-FQA 247
+++++ ++F ++G+G FG V K KV A+K L + E F+
Sbjct: 67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKN---ADKVFAMKILNKWEMLKRAETACFRE 123
Query: 248 EIEIISQVHHRHLVSLVGYCTF-GSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKI 305
E +++ + + +L + F L LV ++ L L + + R +
Sbjct: 124 ERDVLVNGDSKWITTL--HYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYL 181
Query: 306 A-LGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRV 364
A + A + +H Q +HRDIK NIL+D + ++ADFG ++ T S+
Sbjct: 182 AEMVIA--IDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA 236
Query: 365 MGT 367
+GT
Sbjct: 237 VGT 239
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 2e-18
Identities = 52/205 (25%), Positives = 82/205 (40%), Gaps = 33/205 (16%)
Query: 181 PGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG 239
PG + + E + D F + GQG FG V G G VAIK++
Sbjct: 2 PGSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR 61
Query: 240 QGEREFQAEIEIISQVHHRHLVSL------VGYCTFGSQRL-LVYEFVPNKTLEFHLHGK 292
RE Q ++ ++ +HH ++V L +G L +V E+VP+ LH
Sbjct: 62 FRNRELQ-IMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDT-----LH-- 113
Query: 293 DRPVMNWPTRMKIALGSA----------RGLAYLHEDCQPKIIHRDIKSANILLD-DSFE 341
R ++A R + LH + HRDIK N+L++
Sbjct: 114 --RCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGT 170
Query: 342 AKVADFGLAKHSLDTDTHVS---TR 363
K+ DFG AK ++ +V+ +R
Sbjct: 171 LKLCDFGSAKKLSPSEPNVAYICSR 195
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 3e-18
Identities = 38/182 (20%), Positives = 70/182 (38%), Gaps = 34/182 (18%)
Query: 201 TDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRH 259
+ + A LG+G FG VH+ V ++ K K +K G + + EI I++ HR+
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRN 62
Query: 260 LVSLVGYCTFGSQRLLVYEFVPNKTL-------EFHLHGKD-----RPVMNWPTRMKIAL 307
++ L + ++++EF+ + F L+ ++ V
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCE--------- 113
Query: 308 GSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEA--KVADFGLAKHSLDTDTHVSTRVM 365
L +LH I H DI+ NI+ + K+ +FG A+ L +
Sbjct: 114 ----ALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ-LKPGDNFRLLF- 164
Query: 366 GT 367
Sbjct: 165 TA 166
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 84.1 bits (208), Expect = 4e-18
Identities = 40/188 (21%), Positives = 74/188 (39%), Gaps = 31/188 (16%)
Query: 202 DNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHRHL 260
+ +LG G G V G+ VA+K++ EI+++++ H ++
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNV 71
Query: 261 VSLVGYCTFGSQRL--LVYEFVPNKTL-----EFHLHGKDRPVMNWPTRMKIALGSARGL 313
+ YC+ + R + E N L ++ ++ + + + A G+
Sbjct: 72 IRY--YCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGV 128
Query: 314 AYLHEDCQPKIIHRDIKSANILLD-------------DSFEAKVADFGLAKHSLDTDTHV 360
A+LH KIIHRD+K NIL+ ++ ++DFGL K LD+
Sbjct: 129 AHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK-LDSGQSS 184
Query: 361 STRVMGTF 368
+
Sbjct: 185 FRTNLNNP 192
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 7e-18
Identities = 46/183 (25%), Positives = 76/183 (41%), Gaps = 20/183 (10%)
Query: 195 EELKIATDNFSEANLLGQGGFGYV----HKGVLTNGKVVAIKQLKAGS--GQGERE-FQA 247
+E+++ D+F ++G+G F V K G+V A+K + +GE F+
Sbjct: 54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQ---TGQVYAMKIMNKWDMLKRGEVSCFRE 110
Query: 248 EIEIISQVHHRHLVSLVGYCTFGSQRLL--VYEFVPNKTLEFHLHGKDRPVMNWPTRMKI 305
E +++ R + L + F + L V E+ L L + R +
Sbjct: 111 ERDVLVNGDRRWITQL--HFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYL 168
Query: 306 A-LGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRV 364
A + A + +H + +HRDIK NILLD ++ADFG T S
Sbjct: 169 AEIVMA--IDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVA 223
Query: 365 MGT 367
+GT
Sbjct: 224 VGT 226
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 7e-18
Identities = 44/165 (26%), Positives = 76/165 (46%), Gaps = 22/165 (13%)
Query: 202 DNFSEANLLGQGGFGYVHKG--VLTNGKVVAIKQLKAGSGQGERE---FQA--EIEI--- 251
+ +G+G +G V K + G+ VA+K+++ + E E+ +
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT---GEEGMPLSTIREVAVLRH 67
Query: 252 ISQVHHRHLVSL----VGYCTFGSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIA 306
+ H ++V L T +L LV+E V ++ L +L P + T +
Sbjct: 68 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMM 126
Query: 307 LGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351
RGL +LH +++HRD+K NIL+ S + K+ADFGLA+
Sbjct: 127 FQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR 168
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 1e-17
Identities = 55/255 (21%), Positives = 97/255 (38%), Gaps = 31/255 (12%)
Query: 130 APSDYQELPKPSLPPSNGPTAPLPTVPVSAFNEPLSTSGSLDSDKPFPRQSPGMPVGNFK 189
A + + LP + L P + N D+ +G
Sbjct: 22 ARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPED 81
Query: 190 STFTYEELKIATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIK-------QLKAGSGQG 241
+ K + +++G+G V + V G A+K +L +
Sbjct: 82 ELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEE 141
Query: 242 ERE-FQAEIEIISQVH-HRHLVSLVGYCTFGSQRLLVYEFVPNKTLEF-------HLHGK 292
RE + E I+ QV H H+++L+ S LV++ + L F L K
Sbjct: 142 VREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL-FDYLTEKVALSEK 200
Query: 293 DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352
+ + M+ L +++LH + I+HRD+K NILLDD+ + +++DFG + H
Sbjct: 201 ETRSI-----MRSLLE---AVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCH 249
Query: 353 SLDTDTHVSTRVMGT 367
L+ + GT
Sbjct: 250 -LEPGEKLRELC-GT 262
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 1e-17
Identities = 46/202 (22%), Positives = 83/202 (41%), Gaps = 21/202 (10%)
Query: 180 SPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIK-----Q 233
SPG+ G ++ + D + ++G+G F V + + G+ A+K +
Sbjct: 2 SPGISGGGGGILDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAK 61
Query: 234 LKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKD 293
+ G + + E I + H H+V L+ + +V+EF+ L F + +
Sbjct: 62 FTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRA 121
Query: 294 RPVMNWPTR-----MKIALGSARGLAYLHEDCQPKIIHRDIKSANILL---DDSFEAKVA 345
+ M+ L L Y H++ IIHRD+K +LL ++S K+
Sbjct: 122 DAGFVYSEAVASHYMRQILE---ALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLG 175
Query: 346 DFGLAKHSLDTDTHVSTRVMGT 367
FG+A ++ RV GT
Sbjct: 176 GFGVAIQLGESGLVAGGRV-GT 196
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 82.0 bits (202), Expect = 2e-17
Identities = 18/178 (10%), Positives = 31/178 (17%), Gaps = 37/178 (20%)
Query: 209 LLGQGGFGYVHKGV-LTNGKVVAIKQL---KAGSGQGEREFQAEIEIISQVHHRHLVSLV 264
L G V + + A+K S +++
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 265 GYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGS--------------- 309
V + D V N+ M A
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 310 ---------------ARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352
R A L ++H N+ + + D
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWK 243
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 2e-17
Identities = 46/175 (26%), Positives = 68/175 (38%), Gaps = 30/175 (17%)
Query: 210 LGQGGFGYVHKGV-LTNGKVVAIK-----QLKAGSGQGERE-FQAEIEIISQVHHRHLVS 262
LG G F V K + G A K Q +A RE + E+ I+ QV H ++++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 263 LVGYCTFGSQRLLVYEFVPNKTL------EFHLHGKDRPVMNWPTRMKIALGSARGLAYL 316
L + +L+ E V L + L ++ +K L G+ YL
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF-----IKQILD---GVNYL 131
Query: 317 HEDCQPKIIHRDIKSANILL----DDSFEAKVADFGLAKHSLDTDTHVSTRVMGT 367
H KI H D+K NI+L K+ DFGLA ++ GT
Sbjct: 132 HTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE-IEDGVEFKNIF-GT 181
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 3e-17
Identities = 46/208 (22%), Positives = 83/208 (39%), Gaps = 39/208 (18%)
Query: 181 PGMPVGNFKST---FTYEELKIATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQL-- 234
PG + + +T F I +D + +LG+G FG V G+ A+K +
Sbjct: 2 PGSMMDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISK 61
Query: 235 -KAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKD 293
+ + E++++ Q+ H +++ L + LV E L F D
Sbjct: 62 RQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL-F-----D 115
Query: 294 RPVMNWPTR-----------MKIALGSARGLAYLHEDCQPKIIHRDIKSANILL---DDS 339
+ +R ++ L G+ Y+H++ KI+HRD+K N+LL
Sbjct: 116 EII----SRKRFSEVDAARIIRQVLS---GITYMHKN---KIVHRDLKPENLLLESKSKD 165
Query: 340 FEAKVADFGLAKHSLDTDTHVSTRVMGT 367
++ DFGL+ H + +GT
Sbjct: 166 ANIRIIDFGLSTHFEASKKM--KDKIGT 191
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 3e-17
Identities = 49/185 (26%), Positives = 77/185 (41%), Gaps = 26/185 (14%)
Query: 195 EELKIATDNFSEANLLGQGGFGYV----HKGVLTNGKVVAIKQLK----AGSGQGEREFQ 246
+L++ +++ ++G+G FG V HK KV A+K L F
Sbjct: 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKS---TRKVYAMKLLSKFEMIKRSDSAF-FW 117
Query: 247 AEIEIISQVHHRHLVSLVGYCTFGSQRLL--VYEFVPNKTLEFHLHGKDRPVMNWPTRMK 304
E +I++ + +V L + F R L V E++P L + + V R
Sbjct: 118 EERDIMAFANSPWVVQL--FYAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWARFY 173
Query: 305 IA-LGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTR 363
A + A L +H IHRD+K N+LLD S K+ADFG ++ + V
Sbjct: 174 TAEVVLA--LDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK-MNKEGMVRCD 227
Query: 364 VM-GT 367
GT
Sbjct: 228 TAVGT 232
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 3e-17
Identities = 68/308 (22%), Positives = 110/308 (35%), Gaps = 59/308 (19%)
Query: 87 VLAAVGIFLIFYKRRKRKLAAQNLPLKN----------------DPFAGKPHHW------ 124
+L G F+ YK R + + + PL N + F + W
Sbjct: 28 LLKNDGTFI-GYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIER 86
Query: 125 QQNVSAPSDYQELPKPSLPPSNGPTAPLPTVPVSAFNEPLSTSGSLDSDKPFPRQSPGMP 184
+V P + +E ++G P SG+ + + +
Sbjct: 87 TFHVETPEEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKH--- 143
Query: 185 VGNFKSTFTYEELKIATDNFSEANLLGQGGFGYV----HKGVLTNGKVVAIKQLKAGSGQ 240
++ + F LLG+G FG V K G+ A+K LK
Sbjct: 144 -------------RVTMNEFEYLKLLGKGTFGKVILVKEKA---TGRYYAMKILKKEVIV 187
Query: 241 GEREF---QAEIEIISQVHHRHLVSLVGYCTFGSQ-RL-LVYEFVPNKTLEFHLHGKDRP 295
+ E E ++ H L +L +F + RL V E+ L FHL ++R
Sbjct: 188 AKDEVAHTLTENRVLQNSRHPFLTAL--KYSFQTHDRLCFVMEYANGGELFFHLS-RERV 244
Query: 296 VMNWPTRMKIA-LGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354
R A + SA L YLH + +++RD+K N++LD K+ DFGL K +
Sbjct: 245 FSEDRARFYGAEIVSA--LDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300
Query: 355 DTDTHVST 362
+ T
Sbjct: 301 KDGATMKT 308
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 4e-17
Identities = 43/214 (20%), Positives = 73/214 (34%), Gaps = 38/214 (17%)
Query: 174 KPFPRQSPGMPVGNFKST---FTYEELKIATDNFSEANLLGQGGFGYVHKGV-LTNGKVV 229
+ G+ ++T F + ++ + LG G +G V
Sbjct: 6 HHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVER 65
Query: 230 AIKQL-KAGSGQGERE-FQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEF 287
AIK + K E+ ++ + H +++ L + LV E L F
Sbjct: 66 AIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGEL-F 124
Query: 288 HLHGKDRPVMNWPTR-----------MKIALGSARGLAYLHEDCQPKIIHRDIKSANILL 336
D + R +K L G+ YLH+ I+HRD+K N+LL
Sbjct: 125 -----DEII----HRMKFNEVDAAVIIKQVLS---GVTYLHKH---NIVHRDLKPENLLL 169
Query: 337 ---DDSFEAKVADFGLAKHSLDTDTHVSTRVMGT 367
+ K+ DFGL+ + +GT
Sbjct: 170 ESKEKDALIKIVDFGLSAVFENQKKM--KERLGT 201
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 79.1 bits (196), Expect = 5e-17
Identities = 42/175 (24%), Positives = 68/175 (38%), Gaps = 30/175 (17%)
Query: 210 LGQGGFGYVHKGV-LTNGKVVAIK-----QLKAGSGQGERE-FQAEIEIISQVHHRHLVS 262
LG G F V K GK A K +L + RE + E+ I+ ++ H ++++
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 263 LVGYCTFGSQRLLVYEFVPNKTL------EFHLHGKDRPVMNWPTRMKIALGSARGLAYL 316
L + +L+ E V L + L + +K L G+ YL
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQF-----LKQILD---GVHYL 124
Query: 317 HEDCQPKIIHRDIKSANILL----DDSFEAKVADFGLAKHSLDTDTHVSTRVMGT 367
H +I H D+K NI+L + K+ DFG+A ++ GT
Sbjct: 125 HSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK-IEAGNEFKNIF-GT 174
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 6e-17
Identities = 46/175 (26%), Positives = 74/175 (42%), Gaps = 30/175 (17%)
Query: 210 LGQGGFGYVHKGV-LTNGKVVAIKQL--KAGSGQGERE------FQAEIEIISQVHHRHL 260
LG G G V K VAI+ + + + RE + EIEI+ +++H +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 261 VSLVGYCTFGSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSAR----GLAY 315
+ + F ++ +V E + L F D+ V N + + Y
Sbjct: 203 IKIKN--FFDAEDYYIVLELMEGGEL-F-----DKVVGNKRLKEATCKLYFYQMLLAVQY 254
Query: 316 LHEDCQPKIIHRDIKSANILL---DDSFEAKVADFGLAKHSLDTDTHVSTRVMGT 367
LHE+ IIHRD+K N+LL ++ K+ DFG +K L + + T GT
Sbjct: 255 LHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI-LGETSLMRTLC-GT 304
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 1e-16
Identities = 39/206 (18%), Positives = 64/206 (31%), Gaps = 49/206 (23%)
Query: 210 LGQGGFGYVHKGV-LTNGKVVAIK-----QLKAGSGQGEREFQAEIEIISQVHHRHLVSL 263
+GQG +G V + + AIK +++ + + + E+ ++ ++HH ++ L
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 264 VG-------------YCTFGS--QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALG 308
C G +L V+ + I
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 309 SAR-----------------------GLAYLHEDCQPKIIHRDIKSANILL--DDSFEAK 343
L YLH I HRDIK N L + SFE K
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIK 210
Query: 344 VADFGLAKHSLDTDTHVSTRVMGTFG 369
+ DFGL+K + + G
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAG 236
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 1e-16
Identities = 42/184 (22%), Positives = 73/184 (39%), Gaps = 35/184 (19%)
Query: 201 TDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQL-KAGSGQGERE-FQAEIEIISQVHH 257
+ ++ +LG+G FG V K + A+K + KA + + E+E++ ++ H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 258 RHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTR-----------MKIA 306
+++ L S +V E L F D + R +K
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGEL-F-----DEII----KRKRFSEHDAARIIKQV 130
Query: 307 LGSARGLAYLHEDCQPKIIHRDIKSANILL---DDSFEAKVADFGLAKHSLDTDTHVSTR 363
G+ Y+H+ I+HRD+K NILL + + K+ DFGL+
Sbjct: 131 FS---GITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF--QQNTKMKD 182
Query: 364 VMGT 367
+GT
Sbjct: 183 RIGT 186
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 1e-16
Identities = 40/164 (24%), Positives = 62/164 (37%), Gaps = 41/164 (25%)
Query: 210 LGQGGFGYVHKGV-LTNGKVVAIK-----QLKAGSGQGEREFQA---EIEIISQVHHRHL 260
LG G FG+V V K V +K ++ + + EI I+S+V H ++
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 261 VSLVGYCTFGSQRLLVYEFVPNKT-----LEFHLHGK---DRPVMNWPTRMKIALGS--- 309
+ + + N+ +E H G + R+ L S
Sbjct: 92 IKV-------------LDIFENQGFFQLVMEKHGSGLDLFAFIDRH--PRLDEPLASYIF 136
Query: 310 ---ARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLA 350
+ YL IIHRDIK NI++ + F K+ DFG A
Sbjct: 137 RQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSA 177
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 1e-16
Identities = 46/175 (26%), Positives = 68/175 (38%), Gaps = 30/175 (17%)
Query: 210 LGQGGFGYVHKGV-LTNGKVVAIK-----QLKAGSGQGERE-FQAEIEIISQVHHRHLVS 262
LG G F V K + G A K Q +A RE + E+ I+ QV H ++++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 263 LVGYCTFGSQRLLVYEFVPNKTL------EFHLHGKDRPVMNWPTRMKIALGSARGLAYL 316
L + +L+ E V L + L ++ +K L G+ YL
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF-----IKQILD---GVNYL 131
Query: 317 HEDCQPKIIHRDIKSANILL----DDSFEAKVADFGLAKHSLDTDTHVSTRVMGT 367
H KI H D+K NI+L K+ DFGLA ++ GT
Sbjct: 132 HTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE-IEDGVEFKNIF-GT 181
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 1e-16
Identities = 42/178 (23%), Positives = 71/178 (39%), Gaps = 38/178 (21%)
Query: 209 LLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYC 267
+LG G F V GK+ A+K +K + + EI ++ ++ H ++V+L
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 268 TFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGS-------------ARGLA 314
+ LV + V L F DR + G +
Sbjct: 76 ESTTHYYLVMQLVSGGEL-F-----DRIL---------ERGVYTEKDASLVIQQVLSAVK 120
Query: 315 YLHEDCQPKIIHRDIKSANILL---DDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFG 369
YLHE+ I+HRD+K N+L +++ + + DFGL+K + + GT G
Sbjct: 121 YLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKME---QNGIMSTACGTPG 172
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 1e-16
Identities = 40/174 (22%), Positives = 70/174 (40%), Gaps = 30/174 (17%)
Query: 210 LGQGGFGYVHKGV-LTNGKVVAIKQL-KAGSGQGERE-FQAEIEIISQV-HHRHLVSLVG 265
LG+G F V + + + G+ A K L K GQ R EI ++ +++L
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 266 YCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTR---------MKIALGSARGLAYL 316
S+ +L+ E+ + F + +K L G+ YL
Sbjct: 97 VYENTSEIILILEYAAGGEI-F-----SLCLPELAEMVSENDVIRLIKQILE---GVYYL 147
Query: 317 HEDCQPKIIHRDIKSANILLDDSFEA---KVADFGLAKHSLDTDTHVSTRVMGT 367
H++ I+H D+K NILL + K+ DFG+++ + + + GT
Sbjct: 148 HQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK-IGHACELREIM-GT 196
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 78.9 bits (194), Expect = 2e-16
Identities = 33/281 (11%), Positives = 69/281 (24%), Gaps = 48/281 (17%)
Query: 122 HHWQQNVSAPSDYQELPKPSLPPSNGPTAPLPTVPVSAFNEPLSTSGSLDSDKPFPRQSP 181
HH + + Y + P + P V ++ + SL S + P
Sbjct: 3 HHHHHSSGRENLYFQGPGDVVIEELFNRIPQANVRTTSEYMQSAAD-SLVSTSLWNTGQP 61
Query: 182 GMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQ 240
+S +LGQ + G+ +
Sbjct: 62 F----RVESELGERPR-----TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERP 112
Query: 241 GERE----------------------------FQAEIEIISQVHHRHLVSLVGYC--TFG 270
F +++ + ++ + +
Sbjct: 113 PSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWV 172
Query: 271 SQRLLVYEFVPNKTLEF----HLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIH 326
R +Y + + F H + R+++ L R LA LH ++H
Sbjct: 173 LSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVH 229
Query: 327 RDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGT 367
++ +I+LD + F +R
Sbjct: 230 TYLRPVDIVLDQRGGVFLTGFEHLVRDGARVVSSVSRGFEP 270
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-16
Identities = 45/174 (25%), Positives = 69/174 (39%), Gaps = 30/174 (17%)
Query: 210 LGQGGFGYVHKGV-LTNGKVVAIKQL-KAGSGQGEREFQAEIEIISQVHHRHLVSLVGYC 267
LG G FG VH ++G IK + K S + +AEIE++ + H +++ +
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 268 TFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTR-----------MKIALGSARGLAYL 316
+V E L +R V MK + LAY
Sbjct: 90 EDYHNMYIVMETCEGGEL-L-----ERIVSAQARGKALSEGYVAELMKQMMN---ALAYF 140
Query: 317 HEDCQPKIIHRDIKSANILLDDSFEA---KVADFGLAKHSLDTDTHVSTRVMGT 367
H ++H+D+K NIL D+ K+ DFGLA+ +D H + GT
Sbjct: 141 HSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL-FKSDEHSTNAA-GT 189
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-16
Identities = 46/204 (22%), Positives = 80/204 (39%), Gaps = 35/204 (17%)
Query: 177 PRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQL- 234
S G F+ TF + ++ +LG+G FG V K + A+K +
Sbjct: 5 HHHSSGRENLYFQGTFA--------ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVIN 56
Query: 235 -KAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEF------ 287
+ + E+E++ ++ H +++ L S +V E L F
Sbjct: 57 KASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL-FDEIIKR 115
Query: 288 -HLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILL---DDSFEAK 343
D + +K G+ Y+H+ I+HRD+K NILL + + K
Sbjct: 116 KRFSEHDAARI-----IKQVFS---GITYMHKH---NIVHRDLKPENILLESKEKDCDIK 164
Query: 344 VADFGLAKHSLDTDTHVSTRVMGT 367
+ DFGL+ +T + R+ GT
Sbjct: 165 IIDFGLSTC-FQQNTKMKDRI-GT 186
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 2e-16
Identities = 51/178 (28%), Positives = 82/178 (46%), Gaps = 25/178 (14%)
Query: 198 KIATDNFSEANLLGQGGFGYV----HKGVLTNGKVVAIKQLKAGS--GQGEREFQAEIEI 251
K F +LGQG FG V ++ A+K LK + + + E +I
Sbjct: 20 KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI 79
Query: 252 ISQVHHRHLVSLVGYCTFGSQ-RL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMK----- 304
+ +V+H +V L + F ++ +L L+ +F+ L L + VM +K
Sbjct: 80 LVEVNHPFIVKL--HYAFQTEGKLYLILDFLRGGDLFTRLS---KEVMFTEEDVKFYLAE 134
Query: 305 IALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 362
+AL L +LH II+RD+K NILLD+ K+ DFGL+K S+D + +
Sbjct: 135 LALA----LDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS 185
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 3e-16
Identities = 42/174 (24%), Positives = 73/174 (41%), Gaps = 21/174 (12%)
Query: 198 KIATDNFSEANLLGQGGFGYV----HKGVLTNGKVVAIKQLKAGSGQGEREFQ---AEIE 250
+ D+F +G+G FG V K+ A+K + E + E++
Sbjct: 11 DVNFDHFEILRAIGKGSFGKVCIVQKND---TKKMYAMKYMNKQKCVERNEVRNVFKELQ 67
Query: 251 IISQVHHRHLVSLVGYCTF-GSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIA-L 307
I+ + H LV+L + +F + + +V + + L +HL ++ ++ I L
Sbjct: 68 IMQGLEHPFLVNL--WYSFQDEEDMFMVVDLLLGGDLRYHL-QQNVHFKEETVKLFICEL 124
Query: 308 GSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVS 361
A L YL +IIHRD+K NILLD+ + DF +A +
Sbjct: 125 VMA--LDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT 173
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 3e-16
Identities = 40/158 (25%), Positives = 65/158 (41%), Gaps = 29/158 (18%)
Query: 209 LLGQGGFGYVHKGV-LTNGKVVAIKQLK----AGSGQGEREFQAEIEIISQVHHRHLVSL 263
LLG+G +G V + + A+K LK GE + EI+++ ++ H++++ L
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 264 --VGYCTFGSQRLLVYEFVPNKTLE-FHLHGKDRPVMNWPTRMKIALGSAR--------G 312
V Y + +V E+ E D R + A G
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQEML-----DSVPEK---RFPVC--QAHGYFCQLIDG 121
Query: 313 LAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLA 350
L YLH I+H+DIK N+LL K++ G+A
Sbjct: 122 LEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVA 156
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 3e-16
Identities = 44/184 (23%), Positives = 70/184 (38%), Gaps = 30/184 (16%)
Query: 201 TDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIK-----QLKAGSGQGERE-FQAEIEIIS 253
D + LG G F V K + G A K + K+ RE + E+ I+
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 254 QVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTL------EFHLHGKDRPVMNWPTRMKIAL 307
++ H ++++L + +L+ E V L + L ++ +K L
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEF-----LKQIL 124
Query: 308 GSARGLAYLHEDCQPKIIHRDIKSANILL----DDSFEAKVADFGLAKHSLDTDTHVSTR 363
G+ YLH +I H D+K NI+L K+ DFGLA +D
Sbjct: 125 N---GVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK-IDFGNEFKNI 177
Query: 364 VMGT 367
GT
Sbjct: 178 F-GT 180
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 4e-16
Identities = 53/188 (28%), Positives = 87/188 (46%), Gaps = 19/188 (10%)
Query: 186 GNFKSTFTYEELKIATDNFSEANLLGQGGFGYV----HKGVLTNGKVVAIKQL-KAGSGQ 240
G+ +++ KI + F +LG+GG+G V GK+ A+K L KA +
Sbjct: 1 GSSETSVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVR 60
Query: 241 GEREF---QAEIEIISQVHHRHLVSLVGYCTFGSQ-RL-LVYEFVPNKTLEFHLHGKDRP 295
++ +AE I+ +V H +V L F + +L L+ E++ L L ++
Sbjct: 61 NAKDTAHTKAERNILEEVKHPFIVDL--IYAFQTGGKLYLILEYLSGGELFMQLE-REGI 117
Query: 296 VMNWPTRMKIA-LGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354
M +A + A L +LH+ II+RD+K NI+L+ K+ DFGL K S+
Sbjct: 118 FMEDTACFYLAEISMA--LGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESI 172
Query: 355 DTDTHVST 362
T T
Sbjct: 173 HDGTVTHT 180
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 6e-16
Identities = 39/177 (22%), Positives = 70/177 (39%), Gaps = 34/177 (19%)
Query: 210 LGQGGFGYVHKGV-LTNGKVVAIKQL--KAGSGQGEREFQAEIEIISQVHHRHLVSLVGY 266
LG+G F V + V + G+ A + K S + ++ + E I + H ++V L
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 267 CTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTR-----------MKIALGSARGLAY 315
+ L+++ V L F + V R ++ L + +
Sbjct: 79 ISEEGHHYLIFDLVTGGEL-F-----EDIV----AREYYSEADASHCIQQILE---AVLH 125
Query: 316 LHEDCQPKIIHRDIKSANILL---DDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFG 369
H+ ++HR++K N+LL K+ADFGLA ++ + GT G
Sbjct: 126 CHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIE-VEGEQQAWFGFAGTPG 178
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 9e-16
Identities = 45/195 (23%), Positives = 70/195 (35%), Gaps = 46/195 (23%)
Query: 201 TDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLK-------------AGSGQGEREFQ 246
+++ + LG G +G V AIK +K + E
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 247 AEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTR---- 302
EI ++ + H +++ L LV EF L F ++ + R
Sbjct: 95 NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL-F-----EQII----NRHKFD 144
Query: 303 -------MKIALGSARGLAYLHEDCQPKIIHRDIKSANILL---DDSFEAKVADFGLAKH 352
MK L G+ YLH+ I+HRDIK NILL + K+ DFGL+
Sbjct: 145 ECDAANIMKQILS---GICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSF 198
Query: 353 SLDTDTHVSTRVMGT 367
+ + +GT
Sbjct: 199 F--SKDYKLRDRLGT 211
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 77.0 bits (189), Expect = 9e-16
Identities = 22/194 (11%), Positives = 50/194 (25%), Gaps = 38/194 (19%)
Query: 209 LLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGE---REFQAEIEIISQ---------- 254
+LGQ + G+ + ++ + E+ +
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 255 ------------VHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHL---------HGKD 293
V ++ ++ F ++ +L H
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 294 RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353
+ R+++ L R LA LH ++H ++ +I+LD + F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 354 LDTDTHVSTRVMGT 367
+ R
Sbjct: 262 GASAVSPIGRGFAP 275
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 1e-15
Identities = 46/184 (25%), Positives = 73/184 (39%), Gaps = 31/184 (16%)
Query: 201 TDNFSEA----NLLGQGGFGYVHKGV-LTNGKVVAIKQL--KAGSGQGEREFQAEIEIIS 253
+ FS+ LG+G F V + V T G A K + K S + ++ + E I
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 254 QVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEF-------HLHGKDRPVMNWPTRMKIA 306
++ H ++V L S LV++ V L F D ++
Sbjct: 61 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL-FEDIVAREFYSEADASHC-----IQQI 114
Query: 307 LGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEA---KVADFGLAKHSLDTDTHVSTR 363
L +AY H + I+HR++K N+LL + K+ADFGLA ++
Sbjct: 115 LE---SIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE-VNDSEAWHGF 167
Query: 364 VMGT 367
GT
Sbjct: 168 A-GT 170
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-15
Identities = 47/175 (26%), Positives = 74/175 (42%), Gaps = 30/175 (17%)
Query: 210 LGQGGFGYVHKGV-LTNGKVVAIKQL--KAGSGQGERE------FQAEIEIISQVHHRHL 260
LG G G V K VAIK + + + RE + EIEI+ +++H +
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 261 VSLVGYCTFGSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSAR----GLAY 315
+ + F ++ +V E + L F D+ V N + + Y
Sbjct: 78 IKIKN--FFDAEDYYIVLELMEGGEL-F-----DKVVGNKRLKEATCKLYFYQMLLAVQY 129
Query: 316 LHEDCQPKIIHRDIKSANILL---DDSFEAKVADFGLAKHSLDTDTHVSTRVMGT 367
LHE+ IIHRD+K N+LL ++ K+ DFG +K L + + T GT
Sbjct: 130 LHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI-LGETSLMRTLC-GT 179
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 3e-15
Identities = 48/196 (24%), Positives = 74/196 (37%), Gaps = 61/196 (31%)
Query: 209 LLGQGGFGYVHKGV-LTNGKVVAIK-----QLKAGSGQGEREFQA--------------- 247
+G+G +G V + A+K +L +G R
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 248 ------EIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV--PNKT-----LEFHLHGKDR 294
EI I+ ++ H ++V L E + PN+ E G
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKL-------------VEVLDDPNEDHLYMVFELVNQG--- 123
Query: 295 PVMNWPTRMKIALGSAR--------GLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVAD 346
PVM PT ++ AR G+ YLH KIIHRDIK +N+L+ + K+AD
Sbjct: 124 PVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIAD 180
Query: 347 FGLAKHSLDTDTHVST 362
FG++ +D +S
Sbjct: 181 FGVSNEFKGSDALLSN 196
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 3e-15
Identities = 46/177 (25%), Positives = 71/177 (40%), Gaps = 34/177 (19%)
Query: 210 LGQGGFGYVHKGV-LTNGKVVAIK--------QLKAGSGQGERE-FQAEIEIISQV-HHR 258
LG+G V + + K A+K A Q RE E++I+ +V H
Sbjct: 25 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 259 HLVSLVGYCTFGSQRLLVYEFVPNKTLEF-------HLHGKD-RPVMNWPTRMKIALGSA 310
+++ L + LV++ + L F L K+ R +M + L
Sbjct: 85 NIIQLKDTYETNTFFFLVFDLMKKGEL-FDYLTEKVTLSEKETRKIM------RALLE-- 135
Query: 311 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGT 367
+ LH+ I+HRD+K NILLDD K+ DFG + LD + GT
Sbjct: 136 -VICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQ-LDPGEKLREVC-GT 186
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 5e-15
Identities = 51/210 (24%), Positives = 79/210 (37%), Gaps = 35/210 (16%)
Query: 175 PFPRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQ 233
P G S F +DN+ LG+G F V + V T G A K
Sbjct: 2 PHMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKI 61
Query: 234 L--KAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHG 291
+ K S + ++ + E I ++ H ++V L S LV++ V L F
Sbjct: 62 INTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL-F---- 116
Query: 292 KDRPVMNWPTR-----------MKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF 340
+ V R ++ L +AY H + I+HR++K N+LL
Sbjct: 117 -EDIV----AREFYSEADASHCIQQILE---SIAYCHSN---GIVHRNLKPENLLLASKA 165
Query: 341 EA---KVADFGLAKHSLDTDTHVSTRVMGT 367
+ K+ADFGLA ++ GT
Sbjct: 166 KGAAVKLADFGLAIE-VNDSEAWHGFA-GT 193
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 73.7 bits (182), Expect = 5e-15
Identities = 48/169 (28%), Positives = 78/169 (46%), Gaps = 21/169 (12%)
Query: 198 KIATDNFSEANLLGQGGFGYV----HKGVLTNGKVVAIKQLKAGSGQGEREFQ---AEIE 250
K + +F LG G FG V + NG+ A+K LK ++ + E
Sbjct: 2 KYSLQDFQILRTLGTGSFGRVHLIRSRH---NGRYYAMKVLKKEIVVRLKQVEHTNDERL 58
Query: 251 IISQVHHRHLVSLVGYCTF-GSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIA-L 307
++S V H ++ + + TF +Q++ ++ +++ L L K + N + A +
Sbjct: 59 MLSIVTHPFIIRM--WGTFQDAQQIFMIMDYIEGGELFSLLR-KSQRFPNPVAKFYAAEV 115
Query: 308 GSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356
A L YLH II+RD+K NILLD + K+ DFG AK+ D
Sbjct: 116 CLA--LEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 159
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 6e-15
Identities = 48/179 (26%), Positives = 71/179 (39%), Gaps = 29/179 (16%)
Query: 198 KIATDNFSEANLLGQGGFGYV----HKGVLTNGKVVAIKQLKAGSGQGEREF---QAEIE 250
K+ ++F LLG+G FG V K G+ A+K L+ + E E
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESR 57
Query: 251 IISQVHHRHLVSLVGYCTFGSQ-RL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMK---- 304
++ H L +L F + RL V E+ L FHL + R +
Sbjct: 58 VLQNTRHPFLTAL--KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE---RARFYGA 112
Query: 305 -IALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 362
I L YLH +++RDIK N++LD K+ DFGL K + + T
Sbjct: 113 EIVSA----LEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 164
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 7e-15
Identities = 45/169 (26%), Positives = 63/169 (37%), Gaps = 21/169 (12%)
Query: 198 KIATDNFSEANLLGQGGFGYV----HKGVLTNGKVVAIKQLKAGSGQGEREFQ---AEIE 250
D F LG G FG V HK +G A+K L ++ + E
Sbjct: 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKE---SGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 251 IISQVHHRHLVSLVGYCTFGSQRLL--VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIA-L 307
I+ V+ LV L +F L V E+V + HL + R A +
Sbjct: 94 ILQAVNFPFLVKL--EFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAAQI 150
Query: 308 GSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356
YLH +I+RD+K N+L+D +V DFG AK
Sbjct: 151 VLT--FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 73.8 bits (181), Expect = 7e-15
Identities = 20/126 (15%), Positives = 41/126 (32%), Gaps = 4/126 (3%)
Query: 238 SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTL-EFHLHGKDRPV 296
S +I + ++ V + + + + + L ++
Sbjct: 101 SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160
Query: 297 MNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356
+ I + A + +LH ++HRD+K +NI KV DFGL
Sbjct: 161 REHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 217
Query: 357 DTHVST 362
+ +
Sbjct: 218 EEEQTV 223
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 3e-05
Identities = 15/62 (24%), Positives = 32/62 (51%), Gaps = 2/62 (3%)
Query: 202 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGERE-FQAEIEIISQVHHRH 259
+F +G+GGFG V + + AIK+++ + + RE E++ ++++ H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 260 LV 261
+V
Sbjct: 66 IV 67
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 8e-15
Identities = 44/161 (27%), Positives = 66/161 (40%), Gaps = 31/161 (19%)
Query: 209 LLGQGGFGYVHKGV-LTNGKVVAIK-----QLKAGSGQGEREFQAEIEIISQVHHRHLVS 262
LG+G +G V V + VA+K + ++E I I ++H ++V
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKE----ICINKMLNHENVVK 69
Query: 263 LVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSAR--------GLA 314
G+ G+ + L E+ L F DR + M A+ G+
Sbjct: 70 FYGHRREGNIQYLFLEYCSGGEL-F-----DRIEPD--IGMPEP--DAQRFFHQLMAGVV 119
Query: 315 YLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355
YLH I HRDIK N+LLD+ K++DFGLA
Sbjct: 120 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRY 157
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 54/252 (21%), Positives = 94/252 (37%), Gaps = 23/252 (9%)
Query: 121 PHHWQQNVSAPSDYQELPKPSLPPSNGPTAPLPTVPVSAFNEPLSTSGSLDSDKPFPRQS 180
Q ++ L + N P P + + + + P +
Sbjct: 263 GISELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERA-KIGQGTKAPEEK 321
Query: 181 PGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYV----HKGVLTNGKVVAIKQLKA 236
+ F + + +K+ +F+ +LG+G FG V KG ++ A+K LK
Sbjct: 322 TANTISKFDNNGNRDRMKL--TDFNFLMVLGKGSFGKVMLSERKG---TDELYAVKILKK 376
Query: 237 GSGQGEREF---QAEIEIISQV-HHRHLVSLVGYCTFGSQ-RL-LVYEFVPNKTLEFHLH 290
+ + E +++ L L + F + RL V E+V L +H+
Sbjct: 377 DVVIQDDDVECTMVEKRVLALPGKPPFLTQL--HSCFQTMDRLYFVMEYVNGGDLMYHIQ 434
Query: 291 GKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLA 350
R P + A A GL +L II+RD+K N++LD K+ADFG+
Sbjct: 435 QVGR--FKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMC 489
Query: 351 KHSLDTDTHVST 362
K ++ T
Sbjct: 490 KENIWDGVTTKT 501
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 73.7 bits (181), Expect = 1e-14
Identities = 43/195 (22%), Positives = 78/195 (40%), Gaps = 38/195 (19%)
Query: 190 STFTYEELKIATDNFSEANLLGQGGFGYVHKGV---LTNGKVVAIKQLKAGSGQGEREFQ 246
F YE K+ G+G +G+V+K + K A+KQ++
Sbjct: 20 DLFEYEGCKV-----------GRGTYGHVYKAKRKDGKDDKDYALKQIEGTG----ISMS 64
Query: 247 A--EIEIISQVHHRHLVSLVGYCTFGSQRL--LVYEFVPN---KTLEFHLHGKDRP---V 296
A EI ++ ++ H +++SL + R L++++ + ++FH K
Sbjct: 65 ACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQ 124
Query: 297 MNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEA----KVADFGLAKH 352
+ + G+ YLH + ++HRD+K ANIL+ K+AD G A+
Sbjct: 125 LPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARL 181
Query: 353 ---SLDTDTHVSTRV 364
L + V
Sbjct: 182 FNSPLKPLADLDPVV 196
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 2e-14
Identities = 44/161 (27%), Positives = 66/161 (40%), Gaps = 31/161 (19%)
Query: 209 LLGQGGFGYVHKGV-LTNGKVVAIK-----QLKAGSGQGEREFQAEIEIISQVHHRHLVS 262
LG+G +G V V + VA+K + ++E I I ++H ++V
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKE----ICINKMLNHENVVK 69
Query: 263 LVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSAR--------GLA 314
G+ G+ + L E+ L F DR + M A+ G+
Sbjct: 70 FYGHRREGNIQYLFLEYCSGGEL-F-----DRIEPD--IGMPEP--DAQRFFHQLMAGVV 119
Query: 315 YLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355
YLH I HRDIK N+LLD+ K++DFGLA
Sbjct: 120 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRY 157
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 2e-14
Identities = 42/169 (24%), Positives = 63/169 (37%), Gaps = 25/169 (14%)
Query: 210 LGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCT 268
+G+G +G V V A K++ + F+ EIEI+ + H +++ L
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 269 FGSQRLLVYEFVPNKTLEF-------HLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQ 321
+ LV E L F D + MK L +AY H+
Sbjct: 77 DNTDIYLVMELCTGGEL-FERVVHKRVFRESDAARI-----MKDVLS---AVAYCHKL-- 125
Query: 322 PKIIHRDIKSANILL---DDSFEAKVADFGLAKHSLDTDTHVSTRVMGT 367
+ HRD+K N L K+ DFGLA + T+V GT
Sbjct: 126 -NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR-FKPGKMMRTKV-GT 171
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 5e-14
Identities = 46/174 (26%), Positives = 82/174 (47%), Gaps = 22/174 (12%)
Query: 186 GNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKG--VLTNGKVVAIKQL---KAGSGQ 240
GN ++ E+ I N+ +G+G F V +LT G+ VAIK + +
Sbjct: 1 GNSIASCADEQPHI--GNYRLLKTIGKGNFAKVKLARHILT-GREVAIKIIDKTQLNPTS 57
Query: 241 GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRL--LVYEFVPNKTLEFHLHGKDRPVMN 298
++ F+ E+ I+ ++H ++V L + +++ L+ E+ + +L R M
Sbjct: 58 LQKLFR-EVRIMKILNHPNIVKL--FEVIETEKTLYLIMEYASGGEVFDYLVAHGR--MK 112
Query: 299 WPTRMKIA--LGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLA 350
+ SA + Y H Q +I+HRD+K+ N+LLD K+ADFG +
Sbjct: 113 EKEARSKFRQIVSA--VQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFS 161
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 5e-14
Identities = 51/244 (20%), Positives = 85/244 (34%), Gaps = 51/244 (20%)
Query: 143 PPSNGPTAPLPTVPVSAFNEPLSTSGSLDSDKPFPRQSPGMPVGNFKSTFTYEELKIATD 202
S+G + + + +++ + G F E
Sbjct: 6 HHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESE----- 60
Query: 203 NFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLV 261
LG+G V++ K A+K LK ++ + EI ++ ++ H +++
Sbjct: 61 -------LGRGATSIVYRCKQKGTQKPYALKVLK--KTVDKKIVRTEIGVLLRLSHPNII 111
Query: 262 SLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGS------------ 309
L ++ LV E V L F DR V G
Sbjct: 112 KLKEIFETPTEISLVLELVTGGEL-F-----DRIV---------EKGYYSERDAADAVKQ 156
Query: 310 -ARGLAYLHEDCQPKIIHRDIKSANILLDDSFEA---KVADFGLAKHSLDTDTHVSTRVM 365
+AYLHE+ I+HRD+K N+L K+ADFGL+K ++ + T
Sbjct: 157 ILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKI-VEHQVLMKTVC- 211
Query: 366 GTFG 369
GT G
Sbjct: 212 GTPG 215
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 6e-14
Identities = 46/156 (29%), Positives = 67/156 (42%), Gaps = 29/156 (18%)
Query: 209 LLGQGGFGYVHKGV-LTNGKVVAIKQL---KAGSGQGEREFQAEIEIISQVHHRHLVSLV 264
LG G FG V G G VA+K L K S + + EI+ + H H++ L
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL- 76
Query: 265 GYCTFGSQR--LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSAR--------GLA 314
Y + +V E+V L F D + R++ AR +
Sbjct: 77 -YQVISTPTDFFMVMEYVSGGEL-F-----DYICKH--GRVEEM--EARRLFQQILSAVD 125
Query: 315 YLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLA 350
Y H + ++HRD+K N+LLD AK+ADFGL+
Sbjct: 126 YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLS 158
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 7e-14
Identities = 13/146 (8%), Positives = 41/146 (28%), Gaps = 11/146 (7%)
Query: 209 LLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGE---REFQAEIEIISQVHHRHLVSLV 264
G + + + VA+ + + +E + +S++ + ++
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97
Query: 265 GYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKI 324
+ L+V E++ +L+ P ++ A H +
Sbjct: 98 DVVHTRAGGLVVAEWIRGGSLQEVADTSPSP----VGAIRAMQSLAAAADAAHRA---GV 150
Query: 325 IHRDIKSANILLDDSFEAKVADFGLA 350
+ + + + +A
Sbjct: 151 ALSIDHPSRVRVSIDGDVVLAYPATM 176
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 1e-13
Identities = 39/174 (22%), Positives = 70/174 (40%), Gaps = 26/174 (14%)
Query: 209 LLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHRHLVSLVGY 266
+LG+G V + L + A+K ++ G E+E++ Q HR+++ L+ +
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 267 CTFGSQRLLVYEFVPNKTLEFHLHGKD-------RPVMNWPTRMKIALGSARGLAYLHED 319
+ LV+E + ++ H+H + V+ +A L +LH
Sbjct: 80 FEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQ-----DVA----SALDFLHN- 129
Query: 320 CQPKIIHRDIKSANILL---DDSFEAKVADFGLAK--HSLDTDTHVSTRVMGTF 368
I HRD+K NIL + K+ DF L + +ST + T
Sbjct: 130 --KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTP 181
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 2e-13
Identities = 42/223 (18%), Positives = 77/223 (34%), Gaps = 63/223 (28%)
Query: 186 GNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGERE 244
G S+ Y K LG G FG V + +GK A+K++ +
Sbjct: 1 GLETSSKKYSLGKT----------LGTGSFGIVCEVFDIESGKRFALKKVLQ-----DPR 45
Query: 245 FQA-EIEIISQVHHRHLVSL--VGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPT 301
++ E++I+ + H +++ L Y T + + L +G + +
Sbjct: 46 YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIV 105
Query: 302 R---------------------MKIALGSA----------------RGLAYLHEDCQPKI 324
+K + S R + ++H I
Sbjct: 106 NPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGI 162
Query: 325 IHRDIKSANILLD-DSFEAKVADFGLAKHSLDTDTHVS---TR 363
HRDIK N+L++ K+ DFG AK + ++ V+ +R
Sbjct: 163 CHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSR 205
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 2e-13
Identities = 47/182 (25%), Positives = 84/182 (46%), Gaps = 20/182 (10%)
Query: 198 KIATDNFSEANLLGQGGFGYV----HKGVLTNGKVVAIKQLKAGSGQGEREF----QAEI 249
K+ +NF +LG G +G V GK+ A+K LK + + + + E
Sbjct: 50 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTER 109
Query: 250 EIISQV-HHRHLVSLVGYCTFGSQ-RL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIA 306
+++ + LV+L + F ++ +L L+ +++ L HL + ++ +
Sbjct: 110 QVLEHIRQSPFLVTL--HYAFQTETKLHLILDYINGGELFTHLS-QRERFTEHEVQIYVG 166
Query: 307 -LGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVM 365
+ A L +LH+ II+RDIK NILLD + + DFGL+K + +T +
Sbjct: 167 EIVLA--LEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC 221
Query: 366 GT 367
GT
Sbjct: 222 GT 223
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 2e-13
Identities = 41/165 (24%), Positives = 63/165 (38%), Gaps = 39/165 (23%)
Query: 209 LLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYC 267
+G G FG ++VA+K ++ G+ E Q EI + H ++V
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN-VQREIINHRSLRHPNIVRF---- 81
Query: 268 TFGSQRLLVYEFVPNKT-----LEFHLHGK--DRPVMNWPTRMKIALGSAR--------G 312
E + T +E+ G+ +R R AR G
Sbjct: 82 ---------KEVILTPTHLAIIMEYASGGELYERICNA--GRFSED--EARFFFQQLLSG 128
Query: 313 LAYLHEDCQPKIIHRDIKSANILLDDSFEA--KVADFGLAKHSLD 355
++Y H +I HRD+K N LLD S K+ DFG +K S+
Sbjct: 129 VSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 3e-13
Identities = 47/156 (30%), Positives = 67/156 (42%), Gaps = 29/156 (18%)
Query: 209 LLGQGGFGYVHKGV-LTNGKVVAIKQL---KAGSGQGEREFQAEIEIISQVHHRHLVSLV 264
LG G FG V G G VA+K L K S + + EI+ + H H++ L
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL- 81
Query: 265 GYCTFGSQR--LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSAR--------GLA 314
Y + +V E+V L F D N R+ +R G+
Sbjct: 82 -YQVISTPSDIFMVMEYVSGGEL-F-----DYICKN--GRLDEKE--SRRLFQQILSGVD 130
Query: 315 YLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLA 350
Y H + ++HRD+K N+LLD AK+ADFGL+
Sbjct: 131 YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLS 163
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 4e-13
Identities = 51/214 (23%), Positives = 87/214 (40%), Gaps = 24/214 (11%)
Query: 160 FNEPLSTSGSLDSDKPFPRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYV- 218
++ P + + + + +S L + +F ++G+G + V
Sbjct: 12 YDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGL--QDFDLLRVIGRGSYAKVL 69
Query: 219 ---HKGVLTNGKVVAIKQLKAGSGQGEREF---QAEIEIISQV-HHRHLVSLVGYCTFGS 271
K ++ A++ +K + + Q E + Q +H LV L + F +
Sbjct: 70 LVRLKK---TDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL--HSCFQT 124
Query: 272 Q-RL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIA-LGSARGLAYLHEDCQPKIIHRD 328
+ RL V E+V L FH+ + R + R A + A L YLHE II+RD
Sbjct: 125 ESRLFFVIEYVNGGDLMFHMQ-RQRKLPEEHARFYSAEISLA--LNYLHER---GIIYRD 178
Query: 329 IKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 362
+K N+LLD K+ D+G+ K L ST
Sbjct: 179 LKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST 212
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 4e-13
Identities = 41/192 (21%), Positives = 70/192 (36%), Gaps = 44/192 (22%)
Query: 201 TDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQL--KAGSGQGEREFQA---------EI 249
++ + G +G V GV + G VAIK++ G+ EI
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 250 EIISQVHHRHLVSLVGYCTFGSQRL-----LVYEFVPNKTLEFHLHGKDRPVMNWPTRMK 304
+++ HH +++ L + LV E + L V++ +
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTEL-----MRTDLAQ----VIHDQ---R 128
Query: 305 IALGSA----------RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354
I + GL LHE ++HRD+ NILL D+ + + DF LA+
Sbjct: 129 IVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAREDT 185
Query: 355 DTDT---HVSTR 363
+V+ R
Sbjct: 186 ADANKTHYVTHR 197
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 5e-13
Identities = 54/215 (25%), Positives = 94/215 (43%), Gaps = 28/215 (13%)
Query: 159 AFNEPLSTSGSLDSDKPFPRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYV 218
++P + P P S + +G + +F ++G+G FG V
Sbjct: 1 GISQPQEPELMNANPAPPPAPSQQINLGPSSNP------HAKPSDFHFLKVIGKGSFGKV 54
Query: 219 ----HKGVLTNGKVVAIKQLKAGSGQGEREF---QAEIEIISQ-VHHRHLVSLVGYCTFG 270
HK A+K L+ + ++E +E ++ + V H LV L + +F
Sbjct: 55 LLARHKA---EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL--HFSFQ 109
Query: 271 SQ-RL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIA-LGSARGLAYLHEDCQPKIIHR 327
+ +L V +++ L +HL ++R + R A + SA L YLH I++R
Sbjct: 110 TADKLYFVLDYINGGELFYHLQ-RERCFLEPRARFYAAEIASA--LGYLHSL---NIVYR 163
Query: 328 DIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 362
D+K NILLD + DFGL K +++ ++ ST
Sbjct: 164 DLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST 198
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 5e-13
Identities = 49/176 (27%), Positives = 77/176 (43%), Gaps = 22/176 (12%)
Query: 198 KIATDNFSEANLLGQGGFGYV----HKGVLTNGKVVAIKQLKAGSGQGEREF---QAEIE 250
+ +F ++G+G + V K ++ A+K +K + + Q E
Sbjct: 5 PLGLQDFDLLRVIGRGSYAKVLLVRLKK---TDRIYAMKVVKKELVNDDEDIDWVQTEKH 61
Query: 251 IISQV-HHRHLVSLVGYCTFGSQ-RL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIA- 306
+ Q +H LV L + F ++ RL V E+V L FH+ + R + R A
Sbjct: 62 VFEQASNHPFLVGL--HSCFQTESRLFFVIEYVNGGDLMFHMQ-RQRKLPEEHARFYSAE 118
Query: 307 LGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 362
+ A L YLHE II+RD+K N+LLD K+ D+G+ K L ST
Sbjct: 119 ISLA--LNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST 169
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 7e-13
Identities = 45/180 (25%), Positives = 74/180 (41%), Gaps = 30/180 (16%)
Query: 198 KIATDNFSEANLLGQGGFGYV----HKGVLTNGKVVAIKQLKAGSGQGEREF---QAEIE 250
++ +F+ +LG+G FG V KG ++ A+K LK + + E
Sbjct: 16 RMKLTDFNFLMVLGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDDDVECTMVEKR 72
Query: 251 IISQV-HHRHLVSLVGYCTFGSQ-RL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMK--- 304
+++ L L + F + RL V E+V L +H+ R
Sbjct: 73 VLALPGKPPFLTQL--HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP---HAVFYA 127
Query: 305 --IALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 362
IA+G L +L II+RD+K N++LD K+ADFG+ K ++ T
Sbjct: 128 AEIAIG----LFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT 180
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 7e-13
Identities = 34/196 (17%), Positives = 66/196 (33%), Gaps = 46/196 (23%)
Query: 195 EELKIATDNFSEA----NLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEI 249
++L + F++ +G G + + + A+K + E I
Sbjct: 11 QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE----I 66
Query: 250 EIISQ-VHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALG 308
EI+ + H ++++L G +V E + L D+ +
Sbjct: 67 EILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGEL-L-----DKIL---------RQK 111
Query: 309 S-------------ARGLAYLHEDCQPKIIHRDIKSANILL----DDSFEAKVADFGLAK 351
+ + YLH ++HRD+K +NIL + ++ DFG AK
Sbjct: 112 FFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAK 168
Query: 352 HSLDTDTHVSTRVMGT 367
+ + T T
Sbjct: 169 QLRAENGLLMTPC-YT 183
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 7e-13
Identities = 50/181 (27%), Positives = 80/181 (44%), Gaps = 32/181 (17%)
Query: 198 KIATDNFSEANLLGQGGFGYV----HKGVLTNGKVVAIKQLKAGSGQGEREF---QAEIE 250
K+ ++F +LG+G FG V K + AIK LK + + E
Sbjct: 13 KLKIEDFILHKMLGKGSFGKVFLAEFKK---TNQFFAIKALKKDVVLMDDDVECTMVEKR 69
Query: 251 IISQV-HHRHLVSLVGYCTFGSQ-RL-LVYEFVPNKTLEFHLHGKDR-PVMNWPTRMK-- 304
++S H L + +CTF ++ L V E++ L +H+ + + +R
Sbjct: 70 VLSLAWEHPFLTHM--FCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDL----SRATFY 123
Query: 305 ---IALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVS 361
I LG L +LH I++RD+K NILLD K+ADFG+ K ++ D +
Sbjct: 124 AAEIILG----LQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTN 176
Query: 362 T 362
T
Sbjct: 177 T 177
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 1e-12
Identities = 54/248 (21%), Positives = 80/248 (32%), Gaps = 49/248 (19%)
Query: 143 PPSNGPTAPLPT-VPVSAFNEPLSTSGSLDSDKPFPRQSPGMPVGNFKSTFTYEELKIAT 201
P P P P P P P+Q P V KS ++ I
Sbjct: 5 SQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHV---KSGLQIKKNAIID 61
Query: 202 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHRH 259
D + +LG G G V + + A+K L+ + + E+E+ + H
Sbjct: 62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPH 116
Query: 260 LVSLVGYCTFGSQRLLVYEFVPNKTLEFHL-----HGK---DRPVMNWPTR--------- 302
+V +V VYE + + G R
Sbjct: 117 IVRIVD----------VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 166
Query: 303 MKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEA---KVADFGLAKHSLDTDTH 359
MK +G A + YLH I HRD+K N+L K+ DFG AK +
Sbjct: 167 MKS-IGEA--IQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-TTSHNS 219
Query: 360 VSTRVMGT 367
++T T
Sbjct: 220 LTTPC-YT 226
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 1e-12
Identities = 43/172 (25%), Positives = 65/172 (37%), Gaps = 62/172 (36%)
Query: 209 LLGQGGFGYVHKGV-LTNGKVVAIK-----QLKAGS--GQGEREFQAEIEIISQVHHRHL 260
LG+G FG V + VA+K LK + ERE I + + H H+
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVERE----ISYLKLLRHPHI 71
Query: 261 VSLVGYCTFGSQRLLVYEFVPNKT-----LEF-------HL--HGKDRPVMNWPTRMKIA 306
+ L Y+ + T +E+ ++ RM
Sbjct: 72 IKL-------------YDVITTPTDIVMVIEYAGGELFDYIVEKK----------RMTED 108
Query: 307 LGSAR--------GLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLA 350
R + Y H + KI+HRD+K N+LLDD+ K+ADFGL+
Sbjct: 109 E--GRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLS 155
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 2e-12
Identities = 37/175 (21%), Positives = 67/175 (38%), Gaps = 38/175 (21%)
Query: 210 LGQGGFGYVHKGV-LTNGKVVAIKQL-KAGSGQGEREFQAEIEIISQV-HHRHLVSLVGY 266
LG+G F K V + + A+K + K ++E I + H ++V L
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKE----ITALKLCEGHPNIVKLHEV 74
Query: 267 CTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTR-----------MKIALGSARGLAY 315
LV E + L F +R + M+ + +++
Sbjct: 75 FHDQLHTFLVMELLNGGEL-F-----ERIK----KKKHFSETEASYIMRKLVS---AVSH 121
Query: 316 LHEDCQPKIIHRDIKSANILL---DDSFEAKVADFGLAKHSLDTDTHVSTRVMGT 367
+H+ ++HRD+K N+L +D+ E K+ DFG A+ + + T T
Sbjct: 122 MHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FT 172
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 2e-12
Identities = 42/190 (22%), Positives = 66/190 (34%), Gaps = 43/190 (22%)
Query: 187 NFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREF 245
+ KS ++ I D + +LG G G V + + A+K L+ +
Sbjct: 3 HVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKA 57
Query: 246 QAEIEIISQV-HHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHL-----HG---KDRPV 296
+ E+E+ + H+V +V VYE + + G R
Sbjct: 58 RREVELHWRASQCPHIVRIVD----------VYENLYAGRKCLLIVMECLDGGELFSRIQ 107
Query: 297 MNWPTR---------MKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEA---KV 344
MK +G A + YLH I HRD+K N+L K+
Sbjct: 108 DRGDQAFTEREASEIMKS-IGEA--IQYLHSI---NIAHRDVKPENLLYTSKRPNAILKL 161
Query: 345 ADFGLAKHSL 354
DFG AK +
Sbjct: 162 TDFGFAKETT 171
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 2e-12
Identities = 54/183 (29%), Positives = 76/183 (41%), Gaps = 36/183 (19%)
Query: 198 KIATDNFSEANLLGQGGFGYV----HKGVLTNGKVVAIKQLKAGSGQGEREF---QAEIE 250
++ DNF +LG+G FG V K G + A+K LK + + E
Sbjct: 19 RLGIDNFEFIRVLGKGSFGKVMLARVKE---TGDLYAVKVLKKDVILQDDDVECTMTEKR 75
Query: 251 IISQV-HHRHLVSLVGYCTFGSQ-RL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIAL 307
I+S +H L L +C F + RL V EFV L FH+ R
Sbjct: 76 ILSLARNHPFLTQL--FCCFQTPDRLFFVMEFVNGGDLMFHIQKSRR----------FDE 123
Query: 308 GSAR--------GLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 359
AR L +LH+ II+RD+K N+LLD K+ADFG+ K +
Sbjct: 124 ARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT 180
Query: 360 VST 362
+T
Sbjct: 181 TAT 183
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 66.4 bits (161), Expect = 2e-12
Identities = 38/200 (19%), Positives = 59/200 (29%), Gaps = 49/200 (24%)
Query: 199 IATDNFSEANLLGQGGFGYVHKGVLTNG----KVVAIKQLKAGSG---QGEREFQAEIEI 251
+ T+ +G+G FG V + + + K++AI+ +G + E EI I
Sbjct: 17 LPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 252 ISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKT--------------------------- 284
++ L V T G L V
Sbjct: 77 SKELSL--LSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKD 134
Query: 285 ------LEFHLHGKD-----RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSAN 333
LEF G D + + T I LA + HRD+ N
Sbjct: 135 DQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGN 192
Query: 334 ILLDDSFEAKVADFGLAKHS 353
+LL + K+ K S
Sbjct: 193 VLLKKTSLKKLHYTLNGKSS 212
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 3e-12
Identities = 36/191 (18%), Positives = 64/191 (33%), Gaps = 48/191 (25%)
Query: 189 KSTFTYEELKIATDNFSE-----ANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGE 242
++ + ++ +LG G G V + G+ A+K L
Sbjct: 11 GLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYD-----S 65
Query: 243 REFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHL-----HGK---D 293
+ + E++ Q H+V ++ VYE + + + G
Sbjct: 66 PKARQEVDHHWQASGGPHIVCILD----------VYENMHHGKRCLLIIMECMEGGELFS 115
Query: 294 RPVMNWPTR---------MKIALGSARGLAYLHEDCQPKIIHRDIKSANILL---DDSFE 341
R M+ +G+A + +LH I HRD+K N+L +
Sbjct: 116 RIQERGDQAFTEREAAEIMRD-IGTA--IQFLHSH---NIAHRDVKPENLLYTSKEKDAV 169
Query: 342 AKVADFGLAKH 352
K+ DFG AK
Sbjct: 170 LKLTDFGFAKE 180
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 3e-12
Identities = 46/235 (19%), Positives = 72/235 (30%), Gaps = 68/235 (28%)
Query: 158 SAFNEPLS--TSGSLDSDKPFPRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGF 215
S +PL + P + Y LLG+GGF
Sbjct: 1 SMLTKPLQGPPAPPGTPTPPPGGKDREAFEAE------YRLGP----------LLGKGGF 44
Query: 216 GYVHKGV-LTNGKVVAIKQL------KAGSGQGEREFQAEIEIISQVH----HRHLVSLV 264
G V G LT+ VAIK + E+ ++ +V H ++ L
Sbjct: 45 GTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRL- 103
Query: 265 GYCTFGSQRLLVYEFVPNKT-----LEFHLHGK---DRPVMNWPTRMKIALGSAR----- 311
++ + LE L + D + +R
Sbjct: 104 ------------LDWFETQEGFMLVLERPLPAQDLFDYITEK--GPLGEGP--SRCFFGQ 147
Query: 312 ---GLAYLHEDCQPKIIHRDIKSANILLD-DSFEAKVADFGLAKHSLDTDTHVST 362
+ + H ++HRDIK NIL+D AK+ DFG +L D +
Sbjct: 148 VVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSG--ALLHDEPYTD 197
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 4e-12
Identities = 41/180 (22%), Positives = 67/180 (37%), Gaps = 48/180 (26%)
Query: 209 LLGQGGFGYVHKGV-LTNGKVVAIKQL------KAGSGQGEREFQAEIEIISQVHHR--H 259
LLG GGFG V+ G+ +++ VAIK + G E+ ++ +V
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 260 LVSLVGYCTFGSQRLLVYEFVPNKT-----LEFHLHGK---DRPVMNWPTRMKIALGSAR 311
++ L ++ LE + D ++ L AR
Sbjct: 110 VIRL-------------LDWFERPDSFVLILERPEPVQDLFDFITER--GALQEEL--AR 152
Query: 312 --------GLAYLHEDCQPKIIHRDIKSANILLD-DSFEAKVADFGLAKHSLDTDTHVST 362
+ + H ++HRDIK NIL+D + E K+ DFG +L DT +
Sbjct: 153 SFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSG--ALLKDTVYTD 207
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 4e-12
Identities = 45/211 (21%), Positives = 80/211 (37%), Gaps = 51/211 (24%)
Query: 165 STSGSLDSDKPFPRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGV-L 223
+ SGS + + P + + ++ D + +L+G G +G+V +
Sbjct: 19 TVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQI---PDRYEIRHLIGTGSYGHVCEAYDK 75
Query: 224 TNGKVVAIKQLKAGSGQGEREFQA---------EIEIISQVHHRHLVSLVGYCTFGSQRL 274
+VVAIK++ R F+ EI I+++++H H+V ++
Sbjct: 76 LEKRVVAIKKI-------LRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEK 128
Query: 275 -----LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSA----------RGLAYLHED 319
+V E + + R + L G+ Y+H
Sbjct: 129 FDELYVVLEI-----ADSDFKK----LF----RTPVYLTELHIKTLLYNLLVGVKYVHS- 174
Query: 320 CQPKIIHRDIKSANILLDDSFEAKVADFGLA 350
I+HRD+K AN L++ KV DFGLA
Sbjct: 175 --AGILHRDLKPANCLVNQDCSVKVCDFGLA 203
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 5e-12
Identities = 36/177 (20%), Positives = 69/177 (38%), Gaps = 32/177 (18%)
Query: 209 LLGQGGFGYVHKGVLTNGK------VVAIKQLKAGSGQGEREFQ-----AEIEIISQVHH 257
+GQGGFG ++ + + + +K + +G E + A+ E I +
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 258 RHLVSLVGYCT---FGSQ-------RLLVYEFVPNKTLE--FHLHGKDRPVMNWPTRMKI 305
+ +G G R ++ + L+ + + K + T +++
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAK---RFSRKTVLQL 157
Query: 306 ALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKV--ADFGLAKHSLDTDTHV 360
+L L Y+HE +H DIK++N+LL+ +V D+GLA H
Sbjct: 158 SLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHK 211
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 8e-12
Identities = 31/174 (17%), Positives = 68/174 (39%), Gaps = 28/174 (16%)
Query: 210 LGQGGFGYVHKGV---------LTNGKVVAIKQLKAGSGQGEREF-----QAEIEIISQV 255
+ G +++ + ++K L A G+ E A+ +++
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAAKPLQVNKW 108
Query: 256 HHRHLVSLVG---YCTFGSQ----RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALG 308
+ L+ FG R LV + ++L+ L + V++ + +++A
Sbjct: 109 KKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACR 167
Query: 309 SARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKV--ADFGLAKHSLDTDTHV 360
L +LHE+ +H ++ + NI +D +++V A +G A + HV
Sbjct: 168 LLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHV 218
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 1e-11
Identities = 39/175 (22%), Positives = 67/175 (38%), Gaps = 31/175 (17%)
Query: 209 LLGQGGFGYVHKGV-LTNGKVVAIKQLK---AGSGQGEREFQ-----AEIEIISQVHHRH 259
+G GGFG ++ + A +K +G E + A+ + I + R
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 260 LVSLVGYCTF----------GSQRLLVYEFVPNKTLE--FHLHGKDRPVMNWPTRMKIAL 307
+ +G F S R +V E + L+ +G T +++ +
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGT----FKKSTVLQLGI 158
Query: 308 GSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKV--ADFGLAKHSLDTDTHV 360
L Y+HE+ +H DIK+AN+LL +V AD+GL+ H
Sbjct: 159 RMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHK 210
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 63.8 bits (155), Expect = 2e-11
Identities = 34/153 (22%), Positives = 63/153 (41%), Gaps = 11/153 (7%)
Query: 183 MPVGNFKSTFTYEELK--IATDNFSEANLLGQGGFGYVHKGVLTN------GKVVAIKQL 234
+P+ Y+ K D LG+G FG V + + VA+K L
Sbjct: 1 LPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML 60
Query: 235 KAGSGQGER-EFQAEIEIISQV-HHRHLVSLVGYCT-FGSQRLLVYEFVPNKTLEFHLHG 291
K G+ E +E++I+ + HH ++V+L+G CT G +++ EF L +L
Sbjct: 61 KEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS 120
Query: 292 KDRPVMNWPTRMKIALGSARGLAYLHEDCQPKI 324
K + + T+ + + D + ++
Sbjct: 121 KRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRL 153
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 59.2 bits (143), Expect = 6e-10
Identities = 27/125 (21%), Positives = 49/125 (39%), Gaps = 3/125 (2%)
Query: 239 GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMN 298
G R+ + + I R L S+ + S + + + + E + +
Sbjct: 132 GARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLT 191
Query: 299 WPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 358
+ + A+G+ +L K IHRD+ + NILL + K+ DFGLA+
Sbjct: 192 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248
Query: 359 HVSTR 363
+V
Sbjct: 249 YVRKG 253
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 3e-11
Identities = 44/190 (23%), Positives = 75/190 (39%), Gaps = 52/190 (27%)
Query: 201 TDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQA---------EIE 250
+ +G G +G V + +G+ VAIK+L R FQ+ E+
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKL-------SRPFQSEIFAKRAYRELL 75
Query: 251 IISQVHHRHLVSLVGYCTFGSQRL------LVYEFVPNKTLEFHLHGKDRPVMNWPTRMK 304
++ + H +++ L+ T S LV F ++ L M
Sbjct: 76 LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPF-----MQTDLQ----------KIMG 120
Query: 305 IALGSA----------RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354
+ +GL Y+H ++HRD+K N+ +++ E K+ DFGLA+H+
Sbjct: 121 LKFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 177
Query: 355 DTDTH-VSTR 363
T V TR
Sbjct: 178 AEMTGYVVTR 187
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 9e-11
Identities = 42/189 (22%), Positives = 80/189 (42%), Gaps = 38/189 (20%)
Query: 194 YEELKIA---TDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEI 249
YE + D++ LG+G + V + + +TN + V +K LK +++ + EI
Sbjct: 25 YESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREI 81
Query: 250 EIISQV-HHRHLVSLVGYCTFGSQR----LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMK 304
+I+ + ++++L LV+E V N + + T
Sbjct: 82 KILENLRGGPNIITL--ADIVKDPVSRTPALVFEHVNNTDF--------KQLYQTLTDYD 131
Query: 305 IA------LGSARGLAYLHEDCQPKIIHRDIKSANILLD-DSFEAKVADFGLAK--HSLD 355
I L + L Y H I+HRD+K N+++D + + ++ D+GLA+ H
Sbjct: 132 IRFYMYEIL---KALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 185
Query: 356 TDTH-VSTR 363
V++R
Sbjct: 186 EYNVRVASR 194
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 2e-10
Identities = 42/182 (23%), Positives = 68/182 (37%), Gaps = 35/182 (19%)
Query: 209 LLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEI-------------ISQ 254
LG G F V + N VA+K ++ E AE EI
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE---AAEDEIKLLQRVNDADNTKEDS 82
Query: 255 VHHRHLVSLVGYCTF----GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSA 310
+ H++ L+ + G ++V+E + L + R + +I+
Sbjct: 83 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRG-IPLIYVKQISKQLL 141
Query: 311 RGLAYLHEDCQPKIIHRDIKSANILLDDS------FEAKVADFGLAKHSLDTDTH---VS 361
GL Y+H C IIH DIK N+L++ + K+AD G A + + +
Sbjct: 142 LGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CWYDEHYTNSIQ 197
Query: 362 TR 363
TR
Sbjct: 198 TR 199
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 3e-10
Identities = 44/175 (25%), Positives = 68/175 (38%), Gaps = 48/175 (27%)
Query: 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQA---------EIE 250
DN+ +L+G+G +GYV+ K VAIK++ R F+ EI
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKV-------NRMFEDLIDCKRILREIT 77
Query: 251 IISQVHHRHLVSLVGYCTFGSQRL-----LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKI 305
I++++ +++ L +V E + L + + I
Sbjct: 78 ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEI-----ADSDLKK----LF----KTPI 124
Query: 306 ALGSA----------RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLA 350
L G ++HE IIHRD+K AN LL+ KV DFGLA
Sbjct: 125 FLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLA 176
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 3e-10
Identities = 42/189 (22%), Positives = 79/189 (41%), Gaps = 45/189 (23%)
Query: 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQA---------EIE 250
++ + +G+G +G V N VAIK++ F+ EI+
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQRTLREIK 77
Query: 251 IISQVHHRHLVSLVGYCTFGSQRL-----LVYEFVPNKTLEFHLHG--KDRPVMNWPTRM 303
I+ + H +++ + + +V + +E L+ K + + N
Sbjct: 78 ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDL-----METDLYKLLKTQHLSNDHICY 132
Query: 304 KI--ALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH-- 359
+ L RGL Y+H ++HRD+K +N+LL+ + + K+ DFGLA+ + H
Sbjct: 133 FLYQIL---RGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG 186
Query: 360 -----VSTR 363
V+TR
Sbjct: 187 FLTEYVATR 195
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 6e-10
Identities = 22/54 (40%), Positives = 33/54 (61%), Gaps = 4/54 (7%)
Query: 311 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT-HVSTR 363
+GL Y+H IIHRD+K N+ +++ E K+ DFGLA+ + T +V TR
Sbjct: 139 KGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTR 189
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 8e-10
Identities = 38/158 (24%), Positives = 62/158 (39%), Gaps = 16/158 (10%)
Query: 210 LGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHH-RHLVSLVGYC 267
+G+G FG + +G L N + VAIK S + + E + + ++ +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFG 75
Query: 268 TFGSQRLLVYEFV-PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIH 326
G +LV + + P+ LE L R + T A + +HE +++
Sbjct: 76 QEGLHNVLVIDLLGPS--LEDLLDLCGR-KFSVKTVAMAAKQMLARVQSIHEKS---LVY 129
Query: 327 RDIKSANILLDDSFEAK-----VADFGLAKHSLDTDTH 359
RDIK N L+ V DFG+ K D T
Sbjct: 130 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK 167
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 9e-10
Identities = 25/54 (46%), Positives = 37/54 (68%), Gaps = 4/54 (7%)
Query: 311 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT-HVSTR 363
RGL Y+H IIHRD+K +N+ +++ E K+ DFGLA+H+ D T +V+TR
Sbjct: 143 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATR 193
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 1e-09
Identities = 39/158 (24%), Positives = 64/158 (40%), Gaps = 16/158 (10%)
Query: 210 LGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHH-RHLVSLVGYC 267
+G G FG + G L + VAIK S + E Q+ + + +
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHL--EYRFYKQLGSGDGIPQVYYFG 74
Query: 268 TFGSQRLLVYEFV-PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIH 326
G +V E + P+ LE DR + T + IA+ + Y+H +I+
Sbjct: 75 PCGKYNAMVLELLGPS--LEDLFDLCDR-TFSLKTVLMIAIQLISRMEYVHSKN---LIY 128
Query: 327 RDIKSANILL---DDSFEAKV--ADFGLAKHSLDTDTH 359
RD+K N L+ + + + DF LAK +D +T
Sbjct: 129 RDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETK 166
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 1e-09
Identities = 41/163 (25%), Positives = 62/163 (38%), Gaps = 26/163 (15%)
Query: 210 LGQGGFGYVHKGV-LTNGKVVAIKQ--LKAGSGQGEREFQ-----AEIEIISQVHHRHLV 261
+G G FG ++ G + G+ VAIK +K Q E + I +
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRW---- 72
Query: 262 SLVGYCTFGSQRLLVYEFV-PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDC 320
G ++V E + P+ LE + R + T + +A + Y+H
Sbjct: 73 ----CGAEGDYNVMVMELLGPS--LEDLFNFCSR-KFSLKTVLLLADQMISRIEYIHSKN 125
Query: 321 QPKIIHRDIKSANILL---DDSFEAKVADFGLAKHSLDTDTHV 360
IHRD+K N L+ + DFGLAK D TH
Sbjct: 126 ---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ 165
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 46/189 (24%), Positives = 73/189 (38%), Gaps = 48/189 (25%)
Query: 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQA---------EIE 250
+ +G G G V + VAIK+L R FQ E+
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKL-------SRPFQNQTHAKRAYRELV 76
Query: 251 IISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLE--------FHLHGKD-RPVMN--- 298
++ V+H++++ L+ F P K+LE L + V+
Sbjct: 77 LMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMEL 124
Query: 299 WPTRMKIALGSA-RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357
RM L G+ +LH IIHRD+K +NI++ K+ DFGLA+ + +
Sbjct: 125 DHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 181
Query: 358 T---HVSTR 363
+V TR
Sbjct: 182 MMTPYVVTR 190
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 2e-09
Identities = 45/183 (24%), Positives = 74/183 (40%), Gaps = 36/183 (19%)
Query: 201 TDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQA---------EIE 250
+ +G G G V + VAIK+L R FQ E+
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL-------SRPFQNQTHAKRAYRELV 113
Query: 251 IISQVHHRHLVSLVGYCTFGSQRL------LVYEFVPNKTLEFHLHGKDRPVMNWPTRMK 304
++ V+H++++SL+ T LV E ++ +L + + RM
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL-----MDANLCQVIQMEL-DHERMS 167
Query: 305 IALGSA-RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT---HV 360
L G+ +LH IIHRD+K +NI++ K+ DFGLA+ + + +V
Sbjct: 168 YLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV 224
Query: 361 STR 363
TR
Sbjct: 225 VTR 227
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 43/169 (25%), Positives = 73/169 (43%), Gaps = 23/169 (13%)
Query: 209 LLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREF--QA--EIEIISQVHHR----- 258
++G+G FG V K + VA+K ++ E+ F QA EI I+ + +
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRN-----EKRFHRQAAEEIRILEHLRKQDKDNT 158
Query: 259 -HLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLH 317
+++ ++ TF + + +E + E K + R K A + L LH
Sbjct: 159 MNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVR-KFAHSILQCLDALH 217
Query: 318 EDCQPKIIHRDIKSANILL--DDSFEAKVADFGLAKHSLDTD-THVSTR 363
+ +IIH D+K NILL KV DFG + + T++ +R
Sbjct: 218 ---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSR 263
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 1e-08
Identities = 37/170 (21%), Positives = 66/170 (38%), Gaps = 58/170 (34%)
Query: 210 LGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQA---------EIEIISQVHHRH 259
LG+G +G V G++VAIK+++ F EI+I+ H +
Sbjct: 19 LGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALRTLREIKILKHFKHEN 70
Query: 260 LVSLVGYCTFGSQRL-----LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKI----ALGSA 310
++++ S ++ E ++ LH ++ L
Sbjct: 71 IITIFNIQRPDSFENFNEVYIIQEL-----MQTDLH-------------RVISTQMLSDD 112
Query: 311 ----------RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLA 350
R + LH +IHRD+K +N+L++ + + KV DFGLA
Sbjct: 113 HIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLA 159
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 3e-08
Identities = 18/40 (45%), Positives = 26/40 (65%), Gaps = 3/40 (7%)
Query: 311 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLA 350
+ + YLH ++HRD+K +NILL+ KVADFGL+
Sbjct: 120 KVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLS 156
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 4e-08
Identities = 19/61 (31%), Positives = 31/61 (50%), Gaps = 11/61 (18%)
Query: 311 RGLAYLHEDCQPKIIHRDIKSANILLDDSF-EAKVADFGLAKHSLDTDTH-------VST 362
RGL Y+H ++HRD+K AN+ ++ K+ DFGLA+ +H + T
Sbjct: 131 RGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVT 187
Query: 363 R 363
+
Sbjct: 188 K 188
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 1e-07
Identities = 41/169 (24%), Positives = 68/169 (40%), Gaps = 19/169 (11%)
Query: 208 NLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQA---EIEIISQVHHR----- 258
+L+G+G FG V K + VAIK +K + E+ ++ ++
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMK 115
Query: 259 -HLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLH 317
++V L + F + LV+E + + + R V TR K A L +L
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTR-KFAQQMCTALLFLA 174
Query: 318 EDCQPKIIHRDIKSANILL--DDSFEAKVADFGLAKHSLDT-DTHVSTR 363
+ IIH D+K NILL K+ DFG + ++ +R
Sbjct: 175 TP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSR 222
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 51.9 bits (124), Expect = 1e-07
Identities = 37/156 (23%), Positives = 67/156 (42%), Gaps = 12/156 (7%)
Query: 210 LGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVH-HRHLVSLVGYC 267
+G G FG ++ G + + VAIK + + E +I + + ++ +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFG 72
Query: 268 TFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHR 327
G +LV + + +LE + R ++ T + +A + ++H +HR
Sbjct: 73 VEGDYNVLVMDLL-GPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKS---FLHR 127
Query: 328 DIKSANILL---DDSFEAKVADFGLAKHSLDTDTHV 360
DIK N L+ + + + DFGLAK DT TH
Sbjct: 128 DIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 1e-06
Identities = 39/140 (27%), Positives = 59/140 (42%), Gaps = 17/140 (12%)
Query: 210 LGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVH--------HRHL 260
LG G F V + K VA+K +K+ E EI ++ V +
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA-LDEIRLLKSVRNSDPNDPNREMV 103
Query: 261 VSLVGYCTF----GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYL 316
V L+ G+ +V+E + + L++ + + + P KI +GL YL
Sbjct: 104 VQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQG-LPLPCVKKIIQQVLQGLDYL 162
Query: 317 HEDCQPKIIHRDIKSANILL 336
H C+ IIH DIK NILL
Sbjct: 163 HTKCR--IIHTDIKPENILL 180
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 49.1 bits (116), Expect = 2e-06
Identities = 39/246 (15%), Positives = 72/246 (29%), Gaps = 62/246 (25%)
Query: 133 DYQELPKPSLPPSNGPTAPLPTVPVSAFNEPLSTSGSLDSDKPFPRQSPGMPVGNFKSTF 192
+Y+ L P P+ + T + L + + R P
Sbjct: 90 NYKFLMSPIKTEQRQPS--MMTRMYIEQRDRLYNDNQVFAKYNVSRLQP----------- 136
Query: 193 TYEELKIATDNFSEANLL---GQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEI 249
Y +L+ A A + G G G K + A+ + Q + +F+
Sbjct: 137 -YLKLRQALLELRPAKNVLIDGVLGSG---KTWV------ALDVCLSYKVQCKMDFKI-- 184
Query: 250 EIISQVHHRHLVSLVGYCTFGSQRL-----LVYEFVPNKTLEFHLHGKDRPVMNWPTRMK 304
++ + C L L+Y+ PN T D N R+
Sbjct: 185 ---------FWLN-LKNCNSPETVLEMLQKLLYQIDPNWT-----SRSDHSS-NIKLRIH 228
Query: 305 IALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVAD-FGLAKHSLDT--DTHVS 361
R L + + ++ ++L + AK + F L+ L T V+
Sbjct: 229 SIQAELRRL----------LKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVT 278
Query: 362 TRVMGT 367
+
Sbjct: 279 DFLSAA 284
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 4e-06
Identities = 52/200 (26%), Positives = 76/200 (38%), Gaps = 67/200 (33%)
Query: 209 LLGQGGFGYV-----HKGVLTNGKVVAIKQLKAGSGQGEREFQA---EIEIISQVHHR-- 258
LG+G FG V HK G+ VA+K +K +R +A EI+++ ++
Sbjct: 21 TLGEGAFGKVVECIDHK---AGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLNTTDP 73
Query: 259 ----HLVSLVGY-------C-TFGSQRLLVYEFV-PNKTLEFHLHGKDRPVMNWPTRMKI 305
V ++ + C F L Y+F+ N L F L R K+
Sbjct: 74 NSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDH---------IR-KM 123
Query: 306 ALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEA-------------------KVAD 346
A + + +LH K+ H D+K NIL S KV D
Sbjct: 124 AYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVD 180
Query: 347 FGLAKHSLDTDTH---VSTR 363
FG A + D + H VSTR
Sbjct: 181 FGSA--TYDDEHHSTLVSTR 198
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 5e-06
Identities = 43/188 (22%), Positives = 72/188 (38%), Gaps = 43/188 (22%)
Query: 209 LLGQGGFGYVHKGV--LTNGKVVAIKQLKAGSGQGEREFQA---EIEIISQVHHR----- 258
LG+G FG V + + VA+K ++ + +A EI ++ ++ +
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKIKEKDKENK 81
Query: 259 -HLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLH 317
V + + F + +E + T EF +P R +A L +LH
Sbjct: 82 FLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVR-HMAYQLCHALRFLH 140
Query: 318 EDCQPKIIHRDIKSANILLDDSFEA-------------------KVADFGLAKHSLDTDT 358
E ++ H D+K NIL +S +VADFG A + D +
Sbjct: 141 E---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA--TFDHEH 195
Query: 359 H---VSTR 363
H V+TR
Sbjct: 196 HTTIVATR 203
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 6e-06
Identities = 37/194 (19%), Positives = 69/194 (35%), Gaps = 51/194 (26%)
Query: 209 LLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQA---EIEIISQV-----HHRH 259
+G G FG V + N K A+K ++ ++ ++ E +I+ ++ ++ +
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNNN 97
Query: 260 LVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRM--KIALGSARGLAYLH 317
+V G + L++E + E + + L YL
Sbjct: 98 IVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGF---HIEDIKLYCIEILKALNYLR 154
Query: 318 EDCQPKIIHRDIKSANILLDDSFEA-------------------------KVADFGLAKH 352
+ + H D+K NILLDD + K+ DFG A
Sbjct: 155 KM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA-- 209
Query: 353 SLDTDTH---VSTR 363
+ +D H ++TR
Sbjct: 210 TFKSDYHGSIINTR 223
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 369 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.98 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 99.97 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.97 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.97 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.97 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 99.97 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 99.97 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 99.97 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 99.97 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.97 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 99.97 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 99.97 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.97 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.97 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.97 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.97 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.97 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.97 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.97 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.97 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.97 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.97 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.97 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 99.97 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.97 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.97 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.97 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.97 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.97 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.97 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.97 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.97 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.97 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.97 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.97 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.97 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.97 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.97 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.97 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.97 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.97 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.97 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.97 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.97 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.97 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.97 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.96 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.96 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.96 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.96 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.96 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.96 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.96 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.96 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.96 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.96 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.96 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.96 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.96 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.96 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.96 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.96 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.96 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.96 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.96 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.96 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.96 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.96 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.96 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.96 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.96 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.96 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.96 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.96 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.96 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.96 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.96 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.96 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.96 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.96 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.96 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.96 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.96 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.96 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.96 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.96 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.96 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.96 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.96 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.96 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.96 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.96 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.96 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.96 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.96 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.96 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.96 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.96 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.96 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.96 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.96 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.96 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.96 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.96 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.96 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.96 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.96 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.96 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.96 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.96 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.96 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.96 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.96 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.96 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.96 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.96 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.96 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.96 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.96 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.96 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.96 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.96 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.96 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.96 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.96 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.96 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.96 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.96 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.96 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.96 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.96 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.96 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.96 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.96 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.96 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.96 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.96 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.96 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.96 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.96 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.96 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.96 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.96 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.96 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.95 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.95 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.95 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.95 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.95 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.95 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.95 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.95 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.95 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.95 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.95 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.95 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.95 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.95 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.95 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.95 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.95 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.95 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.95 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.95 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.95 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.95 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.95 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.95 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.95 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.95 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.95 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.95 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.95 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.95 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.95 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.95 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.95 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.95 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.95 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.95 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.95 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.95 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.95 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.95 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.95 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.95 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.95 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.95 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.95 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.95 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.95 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.95 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.95 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.95 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.95 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.95 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.95 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.95 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.95 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.95 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.95 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.95 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.95 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.95 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.95 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.95 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.95 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.95 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.95 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.95 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.95 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.94 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.94 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.94 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.94 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.94 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.94 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.94 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.94 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.94 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.94 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.94 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.94 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.94 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.94 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.94 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.93 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.93 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.93 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.91 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.89 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.78 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.59 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.46 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.38 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 99.03 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.98 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.98 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.85 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.82 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.78 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.78 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.61 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.53 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.4 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.31 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.26 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 98.11 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.97 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.9 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.89 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.87 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 97.86 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.78 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 97.76 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.72 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 97.72 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.6 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.46 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.33 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 97.03 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.92 | |
| 2k9y_A | 41 | Ephrin type-A receptor 2; receptor tyrosine kinase | 96.78 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.92 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 94.62 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 94.31 | |
| 1iij_A | 35 | ERBB-2 receptor protein-tyrosine kinase; alpha-hel | 93.22 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 92.14 | |
| 2klu_A | 70 | T-cell surface glycoprotein CD4; cell membrane, di | 91.84 | |
| 2l34_A | 33 | TYRO protein tyrosine kinase-binding protein; immu | 91.63 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 91.36 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 91.23 | |
| 2l9u_A | 40 | Receptor tyrosine-protein kinase ERBB-3; transmenb | 91.15 | |
| 2l34_A | 33 | TYRO protein tyrosine kinase-binding protein; immu | 90.86 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 90.75 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 89.95 | |
| 2l8s_A | 54 | Integrin alpha-1; transmembrane region, detergent | 89.52 | |
| 2knc_B | 79 | Integrin beta-3; transmembrane signaling, protein | 87.52 | |
| 2knc_A | 54 | Integrin alpha-IIB; transmembrane signaling, prote | 84.1 | |
| 2jp3_A | 67 | FXYD domain-containing ION transport regulator 4; | 83.45 | |
| 2llm_A | 43 | Amyloid beta A4 protein; alzheimer'S disease, prot | 83.46 | |
| 1q55_A | 880 | EP-cadherin, C-cadherin; trans interaction, desmos | 82.68 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=305.56 Aligned_cols=166 Identities=27% Similarity=0.487 Sum_probs=143.1
Q ss_pred hhcCCcccceecccCceEEEEEEEc------CCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCee
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQR 273 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 273 (369)
..++|.+.+.||+|+||+||+|++. ++..||||+++.......++|.+|+++|++++|||||+++|+|.+++..
T Consensus 11 ~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 90 (299)
T 4asz_A 11 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 90 (299)
T ss_dssp CGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred CHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 3467888999999999999999864 4678999999876666667899999999999999999999999999999
Q ss_pred EEEEEecCCCcHhhhhcCCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcE
Q 017558 274 LLVYEFVPNKTLEFHLHGKD-----------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEA 342 (369)
Q Consensus 274 ~lv~e~~~~g~L~~~l~~~~-----------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ 342 (369)
|||||||++|+|.++|+... ...++|.++++|+.||+.||.|||++ +||||||||+||||++++.+
T Consensus 91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~ 167 (299)
T 4asz_A 91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLV 167 (299)
T ss_dssp EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCE
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcE
Confidence 99999999999999997532 34699999999999999999999998 99999999999999999999
Q ss_pred EEeeeccceeeCCCCcee-eeeecccC
Q 017558 343 KVADFGLAKHSLDTDTHV-STRVMGTF 368 (369)
Q Consensus 343 ki~DFGla~~~~~~~~~~-~~~~~gt~ 368 (369)
||+|||+|+.....+... .....||+
T Consensus 168 Ki~DFGla~~~~~~~~~~~~~~~~gt~ 194 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDYYRVGGHTMLPI 194 (299)
T ss_dssp EECCCSCHHHHTGGGCEEETTTEEECG
T ss_pred EECCcccceecCCCCceeecCceecCh
Confidence 999999999876655432 23355664
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=305.76 Aligned_cols=165 Identities=28% Similarity=0.482 Sum_probs=135.7
Q ss_pred hcCCcccceecccCceEEEEEEEc------CCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeE
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRL 274 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 274 (369)
.++|.+.+.||+|+||+||+|++. ++..||||+++.......++|.+|+++|++++|||||+|+|+|.+.+..|
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 119 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL 119 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 467788899999999999999864 46889999998766666678999999999999999999999999999999
Q ss_pred EEEEecCCCcHhhhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCc
Q 017558 275 LVYEFVPNKTLEFHLHGKD-------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFE 341 (369)
Q Consensus 275 lv~e~~~~g~L~~~l~~~~-------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~ 341 (369)
||||||++|+|.++|+... ...++|.++++|+.||+.||.|||++ +||||||||+||||++++.
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCc
Confidence 9999999999999997642 23589999999999999999999998 9999999999999999999
Q ss_pred EEEeeeccceeeCCCCce-eeeeecccC
Q 017558 342 AKVADFGLAKHSLDTDTH-VSTRVMGTF 368 (369)
Q Consensus 342 ~ki~DFGla~~~~~~~~~-~~~~~~gt~ 368 (369)
+||+|||+|+.....+.. ..+..+||+
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~ 224 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPI 224 (329)
T ss_dssp EEECCCC----------------CCCCG
T ss_pred EEEcccccceeccCCCcceecCcccccc
Confidence 999999999987655432 334466775
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=305.90 Aligned_cols=165 Identities=21% Similarity=0.327 Sum_probs=138.9
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC--cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEE
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 277 (369)
.++|++.+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+++|++++|||||++++++.+++..||||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 378999999999999999999964 58999999997653 233467999999999999999999999999999999999
Q ss_pred EecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCCC
Q 017558 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (369)
Q Consensus 278 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~~ 357 (369)
|||++|+|.++|..+....+++.+++.|+.||+.||+|||++ +||||||||+||||++++.+||+|||+|+.+.+..
T Consensus 103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 999999999999866656689999999999999999999999 99999999999999999999999999999875432
Q ss_pred ceeeeeecccCC
Q 017558 358 THVSTRVMGTFG 369 (369)
Q Consensus 358 ~~~~~~~~gt~g 369 (369)
...+.++||++
T Consensus 180 -~~~~~~~GT~~ 190 (350)
T 4b9d_A 180 -ELARACIGTPY 190 (350)
T ss_dssp -HHHHHHHSCCT
T ss_pred -ccccccCCCcc
Confidence 22344678864
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=299.82 Aligned_cols=165 Identities=24% Similarity=0.389 Sum_probs=140.3
Q ss_pred hcCCcccceecccCceEEEEEEEc------CCeEEEEEeeccCCc-ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCee
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQR 273 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 273 (369)
.+++++.+.||+|+||+||+|++. +++.||||+++.... ...++|.+|+.+|++++|||||+|+|+|..++..
T Consensus 25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~ 104 (308)
T 4gt4_A 25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPL 104 (308)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEE
Confidence 345677899999999999999963 467899999976543 3457899999999999999999999999999999
Q ss_pred EEEEEecCCCcHhhhhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCC
Q 017558 274 LLVYEFVPNKTLEFHLHGKD--------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS 339 (369)
Q Consensus 274 ~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~ 339 (369)
|||||||++|+|.++|+.+. ...++|.++++|+.|||.||+|||++ +||||||||+||||+++
T Consensus 105 ~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~ 181 (308)
T 4gt4_A 105 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDK 181 (308)
T ss_dssp EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGG
T ss_pred EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCC
Confidence 99999999999999997532 23589999999999999999999998 99999999999999999
Q ss_pred CcEEEeeeccceeeCCCCce-eeeeecccC
Q 017558 340 FEAKVADFGLAKHSLDTDTH-VSTRVMGTF 368 (369)
Q Consensus 340 ~~~ki~DFGla~~~~~~~~~-~~~~~~gt~ 368 (369)
+.+||+|||+||.....+.. ..+...||+
T Consensus 182 ~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~ 211 (308)
T 4gt4_A 182 LNVKISDLGLFREVYAADYYKLLGNSLLPI 211 (308)
T ss_dssp GCEEECCSCCBCGGGGGGCBCSSSSSCBCG
T ss_pred CCEEECCcccceeccCCCceeEecccccCC
Confidence 99999999999987654432 234456665
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=301.23 Aligned_cols=161 Identities=25% Similarity=0.359 Sum_probs=144.3
Q ss_pred cCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEec
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 280 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 280 (369)
+.|+..+.||+|+||.||+|+.. +|+.||||+++.......+.+.+|+++|++++|||||+|+++|.+++.+|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 56999999999999999999975 58999999997665555677899999999999999999999999999999999999
Q ss_pred CCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCCCcee
Q 017558 281 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 360 (369)
Q Consensus 281 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~~~~~ 360 (369)
++|+|.+++... .+++.++..|+.||+.||+|||++ +||||||||+||||+.++.+||+|||+|+.+.+... .
T Consensus 154 ~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-~ 226 (346)
T 4fih_A 154 EGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-R 226 (346)
T ss_dssp TTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-C
T ss_pred CCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCC-c
Confidence 999999999753 489999999999999999999999 999999999999999999999999999998765443 3
Q ss_pred eeeecccCC
Q 017558 361 STRVMGTFG 369 (369)
Q Consensus 361 ~~~~~gt~g 369 (369)
.+..+||++
T Consensus 227 ~~~~~GTp~ 235 (346)
T 4fih_A 227 RKSLVGTPY 235 (346)
T ss_dssp BCCCCSCGG
T ss_pred ccccccCcC
Confidence 345788863
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=296.09 Aligned_cols=163 Identities=23% Similarity=0.294 Sum_probs=143.7
Q ss_pred cCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCC---cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEE
Q 017558 202 DNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 277 (369)
++|++.++||+|+||+||+|+. .+++.||||++.+.. ....+.+.+|+++|++++|||||++++++++++..||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 6799999999999999999996 468899999996532 234567999999999999999999999999999999999
Q ss_pred EecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCCC
Q 017558 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (369)
Q Consensus 278 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~~ 357 (369)
|||++|+|.++|... ..+++..+..|+.||+.||+|||++ +|+||||||+||||++++.+||+|||+|+.+....
T Consensus 112 Ey~~gG~L~~~i~~~--~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp CCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence 999999999999764 3599999999999999999999999 99999999999999999999999999999876443
Q ss_pred c-eeeeeecccCC
Q 017558 358 T-HVSTRVMGTFG 369 (369)
Q Consensus 358 ~-~~~~~~~gt~g 369 (369)
. ......+||++
T Consensus 187 ~~~~~~~~~GTp~ 199 (311)
T 4aw0_A 187 KQARANSFVGTAQ 199 (311)
T ss_dssp TCCCBCCCCSCGG
T ss_pred CcccccCcccCcc
Confidence 2 23455788863
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=303.50 Aligned_cols=161 Identities=25% Similarity=0.359 Sum_probs=144.9
Q ss_pred cCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEec
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 280 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 280 (369)
++|+..+.||+|+||.||+|+.. +|+.||||++........+.+.+|+++|++++|||||+|+++|.+++.+|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 56999999999999999999964 58999999998766666678999999999999999999999999999999999999
Q ss_pred CCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCCCcee
Q 017558 281 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 360 (369)
Q Consensus 281 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~~~~~ 360 (369)
++|+|.+++... .+++.++..|+.||+.||+|||++ +||||||||+||||+.++.+||+|||+|+.+..... .
T Consensus 231 ~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~-~ 303 (423)
T 4fie_A 231 EGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-R 303 (423)
T ss_dssp TTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC-C
T ss_pred CCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCc-c
Confidence 999999999653 489999999999999999999999 999999999999999999999999999998765443 3
Q ss_pred eeeecccCC
Q 017558 361 STRVMGTFG 369 (369)
Q Consensus 361 ~~~~~gt~g 369 (369)
.+..+||++
T Consensus 304 ~~~~~GTp~ 312 (423)
T 4fie_A 304 RKSLVGTPY 312 (423)
T ss_dssp BCCCEECTT
T ss_pred ccccccCcC
Confidence 345788864
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=293.19 Aligned_cols=165 Identities=29% Similarity=0.460 Sum_probs=135.8
Q ss_pred HHhhcCCcccceecccCceEEEEEEEcCCeEEEEEeeccCC--cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEE
Q 017558 198 KIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 275 (369)
Q Consensus 198 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 275 (369)
++..++|.+.+.||+|+||+||+|++.+ .||||+++... ....++|.+|+++|++++|||||+++|+|.. +..||
T Consensus 32 ei~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~i 108 (307)
T 3omv_A 32 EIEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAI 108 (307)
T ss_dssp BCCTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred EEcHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEE
Confidence 3456788889999999999999999753 58999987543 2344689999999999999999999999864 56899
Q ss_pred EEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 276 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 276 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
|||||++|+|.++|+... ..++|.++++|+.||+.||.|||++ +||||||||+||||++++.+||+|||+|+....
T Consensus 109 VmEy~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 109 VTQWCEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp EEECCSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred EEEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 999999999999997654 3599999999999999999999998 999999999999999999999999999998654
Q ss_pred CCc-eeeeeecccCC
Q 017558 356 TDT-HVSTRVMGTFG 369 (369)
Q Consensus 356 ~~~-~~~~~~~gt~g 369 (369)
.+. ......+||++
T Consensus 185 ~~~~~~~~~~~GT~~ 199 (307)
T 3omv_A 185 WSGSQQVEQPTGSVL 199 (307)
T ss_dssp ---------CCCCTT
T ss_pred CCcceeecccccCCC
Confidence 332 23445678864
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=292.16 Aligned_cols=175 Identities=26% Similarity=0.423 Sum_probs=148.3
Q ss_pred ccCHHHHHHhhcCCcccceecccCceEEEEEEEcC------CeEEEEEeeccCCcc-cHHHHHHHHHHHHhcCC-Ccccc
Q 017558 191 TFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTN------GKVVAIKQLKAGSGQ-GEREFQAEIEIISQVHH-RHLVS 262 (369)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h-~niv~ 262 (369)
.++..++++..++|++.+.||+|+||+||+|++.. ++.||||+++..... ..++|.+|+++|.+++| ||||+
T Consensus 53 p~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~ 132 (353)
T 4ase_A 53 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 132 (353)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEE
Confidence 34556778888999999999999999999998643 368999999765443 34679999999999975 89999
Q ss_pred EeeEEEeC-CeeEEEEEecCCCcHhhhhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeec
Q 017558 263 LVGYCTFG-SQRLLVYEFVPNKTLEFHLHGKD--------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHR 327 (369)
Q Consensus 263 l~g~~~~~-~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHr 327 (369)
|+|+|... +..|||||||++|+|.++|+... ...++|.+++.|+.|||+||+|||++ +||||
T Consensus 133 l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHR 209 (353)
T 4ase_A 133 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHR 209 (353)
T ss_dssp EEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred EEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecC
Confidence 99999764 57899999999999999997532 23589999999999999999999999 99999
Q ss_pred CCCCCcEEECCCCcEEEeeeccceeeCCCCc-eeeeeecccC
Q 017558 328 DIKSANILLDDSFEAKVADFGLAKHSLDTDT-HVSTRVMGTF 368 (369)
Q Consensus 328 dlk~~Nill~~~~~~ki~DFGla~~~~~~~~-~~~~~~~gt~ 368 (369)
||||+||||++++.+||+|||+||....... ...+...||+
T Consensus 210 DLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~ 251 (353)
T 4ase_A 210 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 251 (353)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECG
T ss_pred ccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccc
Confidence 9999999999999999999999998765443 3444567775
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=279.55 Aligned_cols=160 Identities=26% Similarity=0.407 Sum_probs=127.4
Q ss_pred cCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCC---cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEE
Q 017558 202 DNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 277 (369)
++|++.+.||+|+||+||+|+. .+++.||||+++... ....+.+.+|+++|++++|||||++++++.+++..||||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 6899999999999999999995 468999999997543 223457999999999999999999999999999999999
Q ss_pred EecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCCC
Q 017558 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (369)
Q Consensus 278 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~~ 357 (369)
||+ +|+|.+++... ..+++.++..++.||+.||+|||++ +|+||||||+||||++++.+||+|||+|+...+..
T Consensus 93 Ey~-~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 166 (275)
T 3hyh_A 93 EYA-GNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN 166 (275)
T ss_dssp ECC-CEEHHHHHHHS--CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred eCC-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence 999 78999999764 3599999999999999999999999 99999999999999999999999999998765433
Q ss_pred ceeeeeecccCC
Q 017558 358 THVSTRVMGTFG 369 (369)
Q Consensus 358 ~~~~~~~~gt~g 369 (369)
.....+||++
T Consensus 167 --~~~~~~GT~~ 176 (275)
T 3hyh_A 167 --FLKTSCGSPN 176 (275)
T ss_dssp ----------CT
T ss_pred --ccCCeeECcc
Confidence 2334678864
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=290.34 Aligned_cols=161 Identities=29% Similarity=0.344 Sum_probs=132.9
Q ss_pred cCCcccceecccCceEEEEEEEc----CCeEEEEEeeccCC--cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEE
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLT----NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 275 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 275 (369)
++|++.+.||+|+||+||+|+.. .++.||||+++... ......+.+|+++|++++|||||++++++.+++..||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 67999999999999999999852 46789999997542 2233478899999999999999999999999999999
Q ss_pred EEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 276 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 276 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
|||||++|+|.++|.... .+++.++..|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+...+
T Consensus 104 vmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp EECCCTTCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred EEEcCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 999999999999997643 599999999999999999999999 999999999999999999999999999998655
Q ss_pred CCceeeeeecccC
Q 017558 356 TDTHVSTRVMGTF 368 (369)
Q Consensus 356 ~~~~~~~~~~gt~ 368 (369)
.+.. ....+||+
T Consensus 179 ~~~~-~~~~~GT~ 190 (304)
T 3ubd_A 179 HEKK-AYSFCGTV 190 (304)
T ss_dssp --CC-CCSCCCCG
T ss_pred CCcc-ccccccCc
Confidence 4432 34467886
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=285.44 Aligned_cols=163 Identities=28% Similarity=0.363 Sum_probs=132.0
Q ss_pred cCCcccceecccCceEEEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCC----eeEEEE
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGS----QRLLVY 277 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----~~~lv~ 277 (369)
.+|.+.+.||+|+||.||+|++ +|+.||||+++..... ...+..|+..+.+++|||||+++|+|..++ ..||||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 4577889999999999999998 6899999999653211 123345666677899999999999998754 579999
Q ss_pred EecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCeeecCCCCCcEEECCCCcEEEeeecccee
Q 017558 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHED-----CQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (369)
Q Consensus 278 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-----~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~ 352 (369)
|||++|+|.++|+.. .++|+.+++|+.|++.||.|||++ +.++||||||||+||||++++.+||+|||+|+.
T Consensus 81 Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 157 (303)
T 3hmm_A 81 DYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp ECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred cCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence 999999999999764 489999999999999999999975 245899999999999999999999999999998
Q ss_pred eCCCCcee---eeeecccCC
Q 017558 353 SLDTDTHV---STRVMGTFG 369 (369)
Q Consensus 353 ~~~~~~~~---~~~~~gt~g 369 (369)
........ ....+||++
T Consensus 158 ~~~~~~~~~~~~~~~~GT~~ 177 (303)
T 3hmm_A 158 HDSATDTIDIAPNHRVGTKR 177 (303)
T ss_dssp EETTTTEESCC-----CCGG
T ss_pred ccCCCCceeeeccccccccc
Confidence 76654332 233577763
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=282.09 Aligned_cols=159 Identities=28% Similarity=0.361 Sum_probs=133.6
Q ss_pred cccceecccCceEEEEEEEc-CCeEEEEEeeccCC--cccHHHHHHHHHHHHhcCCCccccEeeEEEe----CCeeEEEE
Q 017558 205 SEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTF----GSQRLLVY 277 (369)
Q Consensus 205 ~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~~lv~ 277 (369)
++.+.||+|+||.||+|... ++..||||++.... ....+.|.+|+++|++++|||||+++++|.. +..+||||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 56678999999999999964 57899999996542 2344679999999999999999999999865 34679999
Q ss_pred EecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECC-CCcEEEeeeccceeeCCC
Q 017558 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD-SFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 278 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~-~~~~ki~DFGla~~~~~~ 356 (369)
|||++|+|.++|... ..+++..+..|+.||+.||+|||++ .++||||||||+||||+. ++.+||+|||+|+.....
T Consensus 109 Ey~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~ 185 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 185 (290)
T ss_dssp ECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred eCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC
Confidence 999999999999764 3589999999999999999999998 113999999999999984 789999999999864332
Q ss_pred CceeeeeecccCC
Q 017558 357 DTHVSTRVMGTFG 369 (369)
Q Consensus 357 ~~~~~~~~~gt~g 369 (369)
....++||++
T Consensus 186 ---~~~~~~GTp~ 195 (290)
T 3fpq_A 186 ---FAKAVIGTPE 195 (290)
T ss_dssp ---SBEESCSSCC
T ss_pred ---ccCCcccCcc
Confidence 2345789874
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=288.80 Aligned_cols=159 Identities=22% Similarity=0.270 Sum_probs=134.6
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEe
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 279 (369)
.++|+..+.||+|+||.||+|+.. +|+.||||+++... .+.+|+++|++++|||||+++++|.+++..||||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 356888899999999999999964 58999999997543 224799999999999999999999999999999999
Q ss_pred cCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCC-cEEEeeeccceeeCCCCc
Q 017558 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF-EAKVADFGLAKHSLDTDT 358 (369)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~-~~ki~DFGla~~~~~~~~ 358 (369)
|++|+|.++|+... .+++.++..|+.||+.||+|||++ +||||||||+||||+.++ ++||+|||+|+.+.....
T Consensus 132 ~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 132 LEGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp CTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred cCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 99999999997643 599999999999999999999998 999999999999999887 699999999998765432
Q ss_pred e----eeeeecccCC
Q 017558 359 H----VSTRVMGTFG 369 (369)
Q Consensus 359 ~----~~~~~~gt~g 369 (369)
. ....++||++
T Consensus 207 ~~~~~~~~~~~GT~~ 221 (336)
T 4g3f_A 207 GKSLLTGDYIPGTET 221 (336)
T ss_dssp -------CCCCCCGG
T ss_pred ccceecCCccccCcc
Confidence 1 2234678863
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=282.74 Aligned_cols=152 Identities=22% Similarity=0.356 Sum_probs=126.2
Q ss_pred cCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcc-cHHHHHHHHHHHHhcCCCccccEeeEEEeCC--------
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVSLVGYCTFGS-------- 271 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-------- 271 (369)
++|++.+.||+|+||+||+|+.. +++.||||+++..... ..+.+.+|+++|++++|||||+++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 46899999999999999999964 6889999999765433 3457899999999999999999999987644
Q ss_pred ----eeEEEEEecCCCcHhhhhcCCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEee
Q 017558 272 ----QRLLVYEFVPNKTLEFHLHGKDR-PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVAD 346 (369)
Q Consensus 272 ----~~~lv~e~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~D 346 (369)
..|||||||++|+|.+++..... ....+..++.|+.||+.||+|||++ +|+||||||+||||+.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEcc
Confidence 36899999999999999976542 2355677889999999999999999 999999999999999999999999
Q ss_pred eccceeeCCC
Q 017558 347 FGLAKHSLDT 356 (369)
Q Consensus 347 FGla~~~~~~ 356 (369)
||+|+.+...
T Consensus 162 FGla~~~~~~ 171 (299)
T 4g31_A 162 FGLVTAMDQD 171 (299)
T ss_dssp CCCC------
T ss_pred CccceecCCC
Confidence 9999987654
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-35 Score=276.76 Aligned_cols=163 Identities=22% Similarity=0.386 Sum_probs=136.5
Q ss_pred hcCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCCc--ccHHHHHHHHHHHHhcCCCccccEeeEEEe------CC
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTF------GS 271 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~------~~ 271 (369)
.++|++.+.||+|+||.||+|+. .+|+.||||+++.... ...+.+.+|+++|++++|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 36799999999999999999996 4689999999975432 234578899999999999999999998764 35
Q ss_pred eeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccce
Q 017558 272 QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351 (369)
Q Consensus 272 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~ 351 (369)
.+|||||||+ |+|.+++... ..+++.++..|+.||+.||.|||++ +||||||||+|||++.++.+||+|||+|+
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~--~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMAR 206 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSS--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEEeCCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceee
Confidence 7899999995 7899999754 4599999999999999999999999 99999999999999999999999999999
Q ss_pred eeCCCCc---eeeeeecccCC
Q 017558 352 HSLDTDT---HVSTRVMGTFG 369 (369)
Q Consensus 352 ~~~~~~~---~~~~~~~gt~g 369 (369)
.+..... ......+||+.
T Consensus 207 ~~~~~~~~~~~~~~~~~GT~~ 227 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVATRW 227 (398)
T ss_dssp CC-------CCCCCSSCCCCT
T ss_pred ecccCccccccccccceeChH
Confidence 8654321 22344678763
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-34 Score=269.25 Aligned_cols=150 Identities=19% Similarity=0.306 Sum_probs=133.1
Q ss_pred HHHhhcCCcccceecccCceEEEEEEEc----CCeEEEEEeeccCCcccHHHHHHHHHHHHhc-CCCccccEeeEEEeCC
Q 017558 197 LKIATDNFSEANLLGQGGFGYVHKGVLT----NGKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGS 271 (369)
Q Consensus 197 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~ 271 (369)
+....++|++.+.||+|+||.||+|+.+ .++.||||++.... ....+.+|+++|..+ +|||||++++++.+.+
T Consensus 16 ~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~ 93 (361)
T 4f9c_A 16 VPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKND 93 (361)
T ss_dssp SGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETT
T ss_pred cCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECC
Confidence 3345688999999999999999999853 46789999986543 345788999999998 6999999999999999
Q ss_pred eeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCC-CcEEEeeeccc
Q 017558 272 QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS-FEAKVADFGLA 350 (369)
Q Consensus 272 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~-~~~ki~DFGla 350 (369)
..|||||||++|+|.+++. .+++.++..++.||+.||+|||++ +|+||||||+||||+.+ +.+||+|||+|
T Consensus 94 ~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla 165 (361)
T 4f9c_A 94 HVVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLA 165 (361)
T ss_dssp EEEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCC
Confidence 9999999999999999984 388999999999999999999999 99999999999999876 79999999999
Q ss_pred eeeCCC
Q 017558 351 KHSLDT 356 (369)
Q Consensus 351 ~~~~~~ 356 (369)
+...+.
T Consensus 166 ~~~~~~ 171 (361)
T 4f9c_A 166 QGTHDT 171 (361)
T ss_dssp EECTTC
T ss_pred cccCCc
Confidence 976543
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-34 Score=284.78 Aligned_cols=161 Identities=26% Similarity=0.361 Sum_probs=137.1
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC---cccHHHHHH---HHHHHHhcCCCccccEeeEEEeCCee
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQA---EIEIISQVHHRHLVSLVGYCTFGSQR 273 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~---E~~~l~~l~h~niv~l~g~~~~~~~~ 273 (369)
.++|++.++||+|+||+||+|+.. +|+.||||++++.. ......+.+ ++.++..++|||||+|++++.+.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 468999999999999999999964 58999999996432 122233333 45667778999999999999999999
Q ss_pred EEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceee
Q 017558 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (369)
Q Consensus 274 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~ 353 (369)
|||||||+||+|.++|... ..+++..+..|+.||+.||+|||++ +||||||||+||||+.+|++||+|||+|+.+
T Consensus 268 ylVmEy~~GGdL~~~l~~~--~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp EEEECCCCSCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeec
Confidence 9999999999999999764 3599999999999999999999998 9999999999999999999999999999987
Q ss_pred CCCCceeeeeecccCC
Q 017558 354 LDTDTHVSTRVMGTFG 369 (369)
Q Consensus 354 ~~~~~~~~~~~~gt~g 369 (369)
.+.. ....+||++
T Consensus 343 ~~~~---~~t~~GTp~ 355 (689)
T 3v5w_A 343 SKKK---PHASVGTHG 355 (689)
T ss_dssp SSCC---CCSCCSCGG
T ss_pred CCCC---CCCccCCcC
Confidence 6543 234678864
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-34 Score=282.81 Aligned_cols=162 Identities=25% Similarity=0.377 Sum_probs=143.5
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEe
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 279 (369)
.++|++.+.||+|+||.||+|+.+ +|+.||||+++.....+.+.+.+|+++|++++|||||+|+++|.+++.+||||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 468999999999999999999964 5899999999876656667899999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCC--CcEEEeeeccceeeCCCC
Q 017558 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS--FEAKVADFGLAKHSLDTD 357 (369)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~--~~~ki~DFGla~~~~~~~ 357 (369)
|++|+|.++|.... ..+++.++..|+.||+.||+|||++ +|+||||||+||||+.+ +.+||+|||+|+.+....
T Consensus 236 ~~gg~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~ 311 (573)
T 3uto_A 236 MSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311 (573)
T ss_dssp CCCCBHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred cCCCcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence 99999999996543 3589999999999999999999999 99999999999999854 899999999999986554
Q ss_pred ceeeeeecccC
Q 017558 358 THVSTRVMGTF 368 (369)
Q Consensus 358 ~~~~~~~~gt~ 368 (369)
. ....+||+
T Consensus 312 ~--~~~~~GT~ 320 (573)
T 3uto_A 312 S--VKVTTGTA 320 (573)
T ss_dssp E--EEEECSSG
T ss_pred c--eeeeEECc
Confidence 3 23457875
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-32 Score=265.27 Aligned_cols=173 Identities=22% Similarity=0.267 Sum_probs=149.4
Q ss_pred CHHHHHHhhcCCcccceecccCceEEEEEEEcC-CeEEEEEeeccCCc---ccHHHHHHHHHHHHhcCCCccccEeeEEE
Q 017558 193 TYEELKIATDNFSEANLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGSG---QGEREFQAEIEIISQVHHRHLVSLVGYCT 268 (369)
Q Consensus 193 ~~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~ 268 (369)
.+.++....++|++.++||+|+||+||+|+... ++.||||+++.... .....+.+|+.++.+++|+||++++++|.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 345566778899999999999999999999764 78999999965321 12234889999999999999999999999
Q ss_pred eCCeeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeec
Q 017558 269 FGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFG 348 (369)
Q Consensus 269 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFG 348 (369)
+.+..|||||||++|+|.++|.... ..+++..+..++.||+.||.|||++ +|+||||||+||||+.++.+||+|||
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~~-~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFG 220 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKFE-DRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFG 220 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred eCCEEEEEEecCCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchh
Confidence 9999999999999999999997643 3589999999999999999999998 99999999999999999999999999
Q ss_pred cceeeCCCCceeeeeecccCC
Q 017558 349 LAKHSLDTDTHVSTRVMGTFG 369 (369)
Q Consensus 349 la~~~~~~~~~~~~~~~gt~g 369 (369)
+|+.............+||++
T Consensus 221 la~~~~~~~~~~~~~~~GT~~ 241 (437)
T 4aw2_A 221 SCLKLMEDGTVQSSVAVGTPD 241 (437)
T ss_dssp TCEECCTTSCEECCSCCSCGG
T ss_pred hhhhcccCCCcccccccCCcC
Confidence 999887666555555677763
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.6e-32 Score=252.54 Aligned_cols=179 Identities=54% Similarity=0.918 Sum_probs=155.6
Q ss_pred CccCHHHHHHhhcCCcccceecccCceEEEEEEEcCCeEEEEEeeccCCcc-cHHHHHHHHHHHHhcCCCccccEeeEEE
Q 017558 190 STFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVSLVGYCT 268 (369)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~ 268 (369)
..+.+.++....++|+..+.||+|+||.||+|...+++.||||+++..... ....+.+|++++.+++|+||++++++|.
T Consensus 18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 97 (326)
T 3uim_A 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 97 (326)
T ss_dssp EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEEC
T ss_pred ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEe
Confidence 367789999999999999999999999999999888999999999765422 2347899999999999999999999999
Q ss_pred eCCeeEEEEEecCCCcHhhhhcCCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEee
Q 017558 269 FGSQRLLVYEFVPNKTLEFHLHGKD--RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVAD 346 (369)
Q Consensus 269 ~~~~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~D 346 (369)
.....++||||+++|+|.+++.... ...+++..+..|+.|++.||.|||+++..+|+||||||+|||++.++.+||+|
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~D 177 (326)
T 3uim_A 98 TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 177 (326)
T ss_dssp CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECC
T ss_pred cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEecc
Confidence 9999999999999999999998653 23489999999999999999999998666899999999999999999999999
Q ss_pred eccceeeCCCCceeeeeecccC
Q 017558 347 FGLAKHSLDTDTHVSTRVMGTF 368 (369)
Q Consensus 347 FGla~~~~~~~~~~~~~~~gt~ 368 (369)
||+++..............||+
T Consensus 178 fg~~~~~~~~~~~~~~~~~gt~ 199 (326)
T 3uim_A 178 FGLAKLMDYKDTHVTTAVRGTI 199 (326)
T ss_dssp CSSCEECCSSSSCEECCCCSCG
T ss_pred CccccccCcccccccccccCCc
Confidence 9999987665555455555664
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.7e-32 Score=259.49 Aligned_cols=169 Identities=23% Similarity=0.259 Sum_probs=146.4
Q ss_pred HHHHHHhhcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC---cccHHHHHHHHHHHHhcCCCccccEeeEEEe
Q 017558 194 YEELKIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTF 269 (369)
Q Consensus 194 ~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~ 269 (369)
+.++....++|++.+.||+|+||.||+|+.. +++.||+|+++... ....+.+.+|++++..++||||++++++|.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 4455667789999999999999999999975 47899999986521 1223468899999999999999999999999
Q ss_pred CCeeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeecc
Q 017558 270 GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGL 349 (369)
Q Consensus 270 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGl 349 (369)
....||||||+++|+|.+++... .+++..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~ 214 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGT 214 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CCEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccce
Confidence 99999999999999999999753 488999999999999999999998 999999999999999999999999999
Q ss_pred ceeeCCCCceeeeeecccC
Q 017558 350 AKHSLDTDTHVSTRVMGTF 368 (369)
Q Consensus 350 a~~~~~~~~~~~~~~~gt~ 368 (369)
|+.............+||+
T Consensus 215 a~~~~~~~~~~~~~~~gt~ 233 (410)
T 3v8s_A 215 CMKMNKEGMVRCDTAVGTP 233 (410)
T ss_dssp CEECCTTSEEECCSCCSCG
T ss_pred eEeeccCCcccccCCcCCc
Confidence 9987765544444567775
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.4e-32 Score=259.85 Aligned_cols=172 Identities=23% Similarity=0.228 Sum_probs=148.0
Q ss_pred CHHHHHHhhcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCc---ccHHHHHHHHHHHHhcCCCccccEeeEEE
Q 017558 193 TYEELKIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG---QGEREFQAEIEIISQVHHRHLVSLVGYCT 268 (369)
Q Consensus 193 ~~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~ 268 (369)
.+++.....++|++.++||+|+||.||+++.. +++.||||++++... ...+.+.+|.+++.+++|+||++++++|.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 34556667789999999999999999999974 689999999965321 22345889999999999999999999999
Q ss_pred eCCeeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeec
Q 017558 269 FGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFG 348 (369)
Q Consensus 269 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFG 348 (369)
+.+..||||||+++|+|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+||||+.++++||+|||
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFG 207 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFG 207 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeech
Confidence 9999999999999999999997543 3589999999999999999999998 99999999999999999999999999
Q ss_pred cceeeCCCCceeeeeecccC
Q 017558 349 LAKHSLDTDTHVSTRVMGTF 368 (369)
Q Consensus 349 la~~~~~~~~~~~~~~~gt~ 368 (369)
+++.............+||+
T Consensus 208 la~~~~~~~~~~~~~~~Gt~ 227 (412)
T 2vd5_A 208 SCLKLRADGTVRSLVAVGTP 227 (412)
T ss_dssp TCEECCTTSCEECSSCCSCG
T ss_pred hheeccCCCccccceecccc
Confidence 99987665544444457775
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-31 Score=245.64 Aligned_cols=153 Identities=29% Similarity=0.490 Sum_probs=138.0
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEe
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 279 (369)
.++|...+.||+|+||.||+|... +++.||+|++........+.+.+|++++.+++||||++++++|.+++..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 467889999999999999999974 5889999998766666667899999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCCC
Q 017558 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (369)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~~ 357 (369)
+++|+|.+++.... ..+++.+++.|+.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 89 ~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 89 IKGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp CTTCBHHHHHHHCC-TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred cCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 99999999997643 3589999999999999999999999 99999999999999999999999999999865543
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.5e-32 Score=249.68 Aligned_cols=156 Identities=47% Similarity=0.815 Sum_probs=142.2
Q ss_pred HHHhhcCCcccceecccCceEEEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEE
Q 017558 197 LKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (369)
Q Consensus 197 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 276 (369)
+....++|+..+.||+|+||.||+|+..+++.||||++........+.+.+|++++.+++||||++++++|...+..++|
T Consensus 34 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 113 (321)
T 2qkw_B 34 LEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILI 113 (321)
T ss_dssp CCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEE
T ss_pred HHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 44467899999999999999999999888999999998876666667899999999999999999999999999999999
Q ss_pred EEecCCCcHhhhhcCCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 277 YEFVPNKTLEFHLHGKDR--PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 277 ~e~~~~g~L~~~l~~~~~--~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
|||+++|+|.+++..... ..+++..++.++.||+.||.|||++ +++||||||+|||++.++.+||+|||+++...
T Consensus 114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 190 (321)
T 2qkw_B 114 YKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGT 190 (321)
T ss_dssp EECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCEECS
T ss_pred EEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 999999999999976432 3589999999999999999999998 99999999999999999999999999998765
Q ss_pred C
Q 017558 355 D 355 (369)
Q Consensus 355 ~ 355 (369)
.
T Consensus 191 ~ 191 (321)
T 2qkw_B 191 E 191 (321)
T ss_dssp S
T ss_pred c
Confidence 4
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.2e-31 Score=241.42 Aligned_cols=161 Identities=24% Similarity=0.375 Sum_probs=141.9
Q ss_pred hcCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEe
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 279 (369)
.++|+..+.||+|+||.||+|.. .+++.||||++........+.+.+|+.++++++||||++++++|...+..|+||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 46799999999999999999985 56889999999766555667899999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCCCce
Q 017558 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 359 (369)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~~~~ 359 (369)
+++|+|.+++... .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 99 ~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 172 (297)
T 3fxz_A 99 LAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (297)
T ss_dssp CTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred CCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccc
Confidence 9999999999754 488999999999999999999999 9999999999999999999999999999887654432
Q ss_pred eeeeecccC
Q 017558 360 VSTRVMGTF 368 (369)
Q Consensus 360 ~~~~~~gt~ 368 (369)
.....||+
T Consensus 173 -~~~~~gt~ 180 (297)
T 3fxz_A 173 -RSTMVGTP 180 (297)
T ss_dssp -BCCCCSCG
T ss_pred -cCCccCCc
Confidence 22345553
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=3.9e-31 Score=247.07 Aligned_cols=162 Identities=26% Similarity=0.353 Sum_probs=139.8
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccC---CcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEE
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG---SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 276 (369)
.++|++.+.||+|+||.||+|+.. +++.||+|+++.. .....+.+.+|+++|.+++||||+++++++...+..|+|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 468999999999999999999975 5889999999753 223456788999999999999999999999999999999
Q ss_pred EEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCC
Q 017558 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 277 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~ 356 (369)
|||+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 84 MEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred EeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 9999999999999754 3589999999999999999999998 9999999999999999999999999999875433
Q ss_pred CceeeeeecccC
Q 017558 357 DTHVSTRVMGTF 368 (369)
Q Consensus 357 ~~~~~~~~~gt~ 368 (369)
.. .....+||+
T Consensus 159 ~~-~~~~~~gt~ 169 (337)
T 1o6l_A 159 GA-TMKTFCGTP 169 (337)
T ss_dssp TC-CBCCCEECG
T ss_pred CC-cccccccCh
Confidence 32 223345654
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.7e-31 Score=246.35 Aligned_cols=152 Identities=23% Similarity=0.340 Sum_probs=136.5
Q ss_pred hhcCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCC--cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEE
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 276 (369)
..++|++.+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+++|++++||||+++++++...+..|+|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 356899999999999999999996 578999999996542 23445788999999999999999999999999999999
Q ss_pred EEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCC
Q 017558 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 277 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~ 356 (369)
|||+++|+|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 93 ~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAHG--RMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp ECCCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred EECCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 99999999999997543 489999999999999999999998 9999999999999999999999999999876543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-30 Score=240.79 Aligned_cols=171 Identities=25% Similarity=0.320 Sum_probs=146.9
Q ss_pred ccCHHHHHHhhcC----------CcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCc
Q 017558 191 TFTYEELKIATDN----------FSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRH 259 (369)
Q Consensus 191 ~~~~~~~~~~~~~----------~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n 259 (369)
.+.++++..+.+. |...+.||+|+||.||+|+.. +|+.||||+++.......+.+.+|+.++.+++|+|
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n 103 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence 4566777666543 677789999999999999976 68999999998766666778999999999999999
Q ss_pred cccEeeEEEeCCeeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCC
Q 017558 260 LVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS 339 (369)
Q Consensus 260 iv~l~g~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~ 339 (369)
|++++++|...+..|+||||+++++|.+++.. ..+++..+..++.||+.||.|||++ +|+||||||+|||++.+
T Consensus 104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~ 177 (321)
T 2c30_A 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLD 177 (321)
T ss_dssp BCCEEEEEEETTEEEEEECCCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTT
T ss_pred cceEEEEEEECCEEEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCC
Confidence 99999999999999999999999999999864 3489999999999999999999998 99999999999999999
Q ss_pred CcEEEeeeccceeeCCCCceeeeeecccC
Q 017558 340 FEAKVADFGLAKHSLDTDTHVSTRVMGTF 368 (369)
Q Consensus 340 ~~~ki~DFGla~~~~~~~~~~~~~~~gt~ 368 (369)
+.+||+|||+++....... ......||+
T Consensus 178 ~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~ 205 (321)
T 2c30_A 178 GRVKLSDFGFCAQISKDVP-KRKSLVGTP 205 (321)
T ss_dssp CCEEECCCTTCEECCSSSC-CBCCCCSCG
T ss_pred CcEEEeeeeeeeecccCcc-ccccccCCc
Confidence 9999999999988654332 122345553
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.7e-31 Score=248.76 Aligned_cols=164 Identities=29% Similarity=0.407 Sum_probs=135.8
Q ss_pred HhhcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC---cccHHHHHHHHHHHHhc-CCCccccEeeEEEeCCee
Q 017558 199 IATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQR 273 (369)
Q Consensus 199 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 273 (369)
...++|++.++||+|+||.||+|+.. +++.||||+++... ....+.+.+|++++..+ +||||+++++++...+..
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 45578999999999999999999965 57899999997532 22345688999999988 699999999999999999
Q ss_pred EEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceee
Q 017558 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (369)
Q Consensus 274 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~ 353 (369)
||||||+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+|+..
T Consensus 100 ~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeec
Confidence 9999999999999999764 3489999999999999999999999 9999999999999999999999999999875
Q ss_pred CCCCceeeeeecccC
Q 017558 354 LDTDTHVSTRVMGTF 368 (369)
Q Consensus 354 ~~~~~~~~~~~~gt~ 368 (369)
..... .....+||+
T Consensus 175 ~~~~~-~~~~~~gt~ 188 (353)
T 3txo_A 175 ICNGV-TTATFCGTP 188 (353)
T ss_dssp CC----------CCG
T ss_pred ccCCc-cccccCCCc
Confidence 43332 233456664
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.8e-31 Score=250.70 Aligned_cols=163 Identities=26% Similarity=0.363 Sum_probs=139.3
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCc---ccHHHHHHHHHHHHhc-CCCccccEeeEEEeCCeeE
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG---QGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRL 274 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~ 274 (369)
..++|++.++||+|+||.||+|+.. +++.||||+++.... ...+.+.+|..+|.++ +||||+++++++...+..|
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 4578999999999999999999975 478999999976422 2234688999999887 8999999999999999999
Q ss_pred EEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 275 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 275 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
|||||+++|+|..++... ..+++..+..++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+|+...
T Consensus 130 lV~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEEcCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 999999999999999764 3489999999999999999999999 99999999999999999999999999999754
Q ss_pred CCCceeeeeecccC
Q 017558 355 DTDTHVSTRVMGTF 368 (369)
Q Consensus 355 ~~~~~~~~~~~gt~ 368 (369)
.... .....+||+
T Consensus 205 ~~~~-~~~~~~gt~ 217 (396)
T 4dc2_A 205 RPGD-TTSTFCGTP 217 (396)
T ss_dssp CTTC-CBCCCCBCG
T ss_pred cCCC-ccccccCCc
Confidence 4332 233456765
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.2e-31 Score=240.61 Aligned_cols=164 Identities=27% Similarity=0.376 Sum_probs=135.5
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCc---ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEE
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG---QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 275 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 275 (369)
..++|++.+.||+|+||.||+|+.. +++.||+|.+..... ...+.+.+|+.++.+++||||+++++++...+..|+
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 88 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL 88 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence 3578999999999999999999964 578999999865432 233578999999999999999999999999999999
Q ss_pred EEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 276 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 276 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
||||+++++|.+++.... .+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 89 v~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 999999999999997543 589999999999999999999998 999999999999999999999999999987655
Q ss_pred CCceeeeeecccC
Q 017558 356 TDTHVSTRVMGTF 368 (369)
Q Consensus 356 ~~~~~~~~~~gt~ 368 (369)
..........||+
T Consensus 164 ~~~~~~~~~~gt~ 176 (294)
T 4eqm_A 164 TSLTQTNHVLGTV 176 (294)
T ss_dssp -----------CC
T ss_pred ccccccCccccCc
Confidence 4433333445654
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-30 Score=241.63 Aligned_cols=153 Identities=31% Similarity=0.490 Sum_probs=135.7
Q ss_pred hhcCCcccceecccCceEEEEEEEc----CCeEEEEEeeccCCc-ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeE
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVLT----NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRL 274 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 274 (369)
..++|++.+.||+|+||.||+|... .+..||||+++.... ...+.+.+|+++|.+++||||++++++|...+..|
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 126 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM 126 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence 3567899999999999999999974 355799999976533 34467999999999999999999999999999999
Q ss_pred EEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 275 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 275 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
+||||+++|+|.+++.... ..+++..++.|+.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++...
T Consensus 127 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 127 IVTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EEeeCCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 9999999999999997543 3589999999999999999999998 99999999999999999999999999999875
Q ss_pred CC
Q 017558 355 DT 356 (369)
Q Consensus 355 ~~ 356 (369)
..
T Consensus 203 ~~ 204 (325)
T 3kul_A 203 DD 204 (325)
T ss_dssp --
T ss_pred cC
Confidence 54
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-30 Score=245.82 Aligned_cols=155 Identities=28% Similarity=0.493 Sum_probs=136.3
Q ss_pred hhcCCcccceecccCceEEEEEEEc--------CCeEEEEEeeccCCcc-cHHHHHHHHHHHHhc-CCCccccEeeEEEe
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVLT--------NGKVVAIKQLKAGSGQ-GEREFQAEIEIISQV-HHRHLVSLVGYCTF 269 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~l~g~~~~ 269 (369)
..++|++.+.||+|+||.||+|+.. ++..||||+++..... ..+++.+|+++|.++ +||||++++++|..
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 3578999999999999999999863 3467999999765432 346799999999999 89999999999999
Q ss_pred CCeeEEEEEecCCCcHhhhhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEE
Q 017558 270 GSQRLLVYEFVPNKTLEFHLHGKD--------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANIL 335 (369)
Q Consensus 270 ~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nil 335 (369)
.+..|+||||+++|+|.+++.... ...+++..++.++.||+.||+|||++ +|+||||||+|||
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIl 235 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVL 235 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEE
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEE
Confidence 999999999999999999997543 13488999999999999999999998 9999999999999
Q ss_pred ECCCCcEEEeeeccceeeCCCC
Q 017558 336 LDDSFEAKVADFGLAKHSLDTD 357 (369)
Q Consensus 336 l~~~~~~ki~DFGla~~~~~~~ 357 (369)
|+.++.+||+|||+++...+.+
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~ 257 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNID 257 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCC
T ss_pred ECCCCCEEEccccCCcccCccc
Confidence 9999999999999999765543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-30 Score=241.34 Aligned_cols=149 Identities=28% Similarity=0.381 Sum_probs=132.5
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcc-cHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEE
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 278 (369)
.++|++.+.||+|+||.||+|+.. +++.||||++...... ..+.+.+|+.++.+++|+||+++++++.+.+..|+|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999975 6889999998654332 23568899999999999999999999999999999999
Q ss_pred ecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
|+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.+.
T Consensus 86 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 156 (323)
T 3tki_A 86 YCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFR 156 (323)
T ss_dssp CCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred cCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceec
Confidence 99999999999754 3489999999999999999999998 99999999999999999999999999998754
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-30 Score=244.88 Aligned_cols=165 Identities=27% Similarity=0.396 Sum_probs=139.7
Q ss_pred HHhhcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC---cccHHHHHHHHHHHHhc-CCCccccEeeEEEeCCe
Q 017558 198 KIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQ 272 (369)
Q Consensus 198 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~ 272 (369)
....++|.+.+.||+|+||.||+|+.. +++.||||+++... ....+.+..|.+++.++ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 456689999999999999999999975 58899999997542 23345678899999887 89999999999999999
Q ss_pred eEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeecccee
Q 017558 273 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (369)
Q Consensus 273 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~ 352 (369)
.|+||||+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++.
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 99999999999999999754 3489999999999999999999999 999999999999999999999999999987
Q ss_pred eCCCCceeeeeecccC
Q 017558 353 SLDTDTHVSTRVMGTF 368 (369)
Q Consensus 353 ~~~~~~~~~~~~~gt~ 368 (369)
....+.. ....+||+
T Consensus 168 ~~~~~~~-~~~~~gt~ 182 (345)
T 1xjd_A 168 NMLGDAK-TNTFCGTP 182 (345)
T ss_dssp CCCTTCC-BCCCCSCG
T ss_pred cccCCCc-ccCCCCCc
Confidence 5433322 23456664
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.97 E-value=8e-31 Score=257.38 Aligned_cols=156 Identities=27% Similarity=0.433 Sum_probs=140.9
Q ss_pred HHHhhcCCcccceecccCceEEEEEEEcC-CeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEE
Q 017558 197 LKIATDNFSEANLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 275 (369)
Q Consensus 197 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 275 (369)
+++..++|.+.+.||+|+||.||+|.+.. +..||||.++... ...++|.+|+++|.+++||||++++++|......||
T Consensus 215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 293 (495)
T 1opk_A 215 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 293 (495)
T ss_dssp CBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred cccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEE
Confidence 34456788999999999999999999865 7899999997654 346789999999999999999999999999999999
Q ss_pred EEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 276 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 276 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
|||||++|+|.++|.......+++..++.|+.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++....
T Consensus 294 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 370 (495)
T 1opk_A 294 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTG 370 (495)
T ss_dssp EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred EEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccC
Confidence 99999999999999875556689999999999999999999998 999999999999999999999999999998754
Q ss_pred C
Q 017558 356 T 356 (369)
Q Consensus 356 ~ 356 (369)
.
T Consensus 371 ~ 371 (495)
T 1opk_A 371 D 371 (495)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-30 Score=240.75 Aligned_cols=150 Identities=30% Similarity=0.380 Sum_probs=135.2
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC---cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEE
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 276 (369)
.++|++.+.||+|+||.||+++.. +++.||+|+++... ....+.+.+|+.++..++||||+++++++.+....|+|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 467999999999999999999975 58899999997532 23346788999999999999999999999999999999
Q ss_pred EEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 277 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
|||+++|+|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++...+
T Consensus 85 ~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp ECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 99999999999997643 489999999999999999999998 999999999999999999999999999998654
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-30 Score=240.32 Aligned_cols=153 Identities=20% Similarity=0.316 Sum_probs=132.7
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCc-ccHHHHHHHHHHHHhcCCCccccEeeEEEeCC-------
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGS------- 271 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------- 271 (369)
.++|++.+.||+|+||.||+|+.. +++.||||+++.... ...+.+.+|+++|++++||||++++++|.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 467899999999999999999975 688999999975433 34568999999999999999999999986543
Q ss_pred --------------------------------------------------eeEEEEEecCCCcHhhhhcCCCC-CCCCHH
Q 017558 272 --------------------------------------------------QRLLVYEFVPNKTLEFHLHGKDR-PVMNWP 300 (369)
Q Consensus 272 --------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~~-~~l~~~ 300 (369)
..++||||+++++|.+++..... ....+.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 37999999999999999986532 235667
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCC
Q 017558 301 TRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 301 ~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~ 356 (369)
.++.++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++.....
T Consensus 165 ~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 217 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 217 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC
T ss_pred HHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccc
Confidence 7899999999999999998 9999999999999999999999999999987654
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-30 Score=243.63 Aligned_cols=162 Identities=27% Similarity=0.365 Sum_probs=138.8
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCc---ccHHHHHHHHHHHHhc-CCCccccEeeEEEeCCeeEE
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG---QGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLL 275 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~l 275 (369)
.++|++.+.||+|+||.||+|+.. +++.||+|+++.... ...+.+.+|+.++.++ +||||+++++++...+..|+
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 467899999999999999999975 578999999976432 2335688999999988 89999999999999999999
Q ss_pred EEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 276 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 276 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
||||+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++....
T Consensus 88 v~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp EECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 99999999999999754 3489999999999999999999998 999999999999999999999999999987543
Q ss_pred CCceeeeeecccC
Q 017558 356 TDTHVSTRVMGTF 368 (369)
Q Consensus 356 ~~~~~~~~~~gt~ 368 (369)
... .....+||+
T Consensus 163 ~~~-~~~~~~gt~ 174 (345)
T 3a8x_A 163 PGD-TTSTFCGTP 174 (345)
T ss_dssp TTC-CBCCCCSCG
T ss_pred CCC-cccccCCCc
Confidence 332 223345664
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-30 Score=241.96 Aligned_cols=151 Identities=29% Similarity=0.434 Sum_probs=126.7
Q ss_pred hhcCCcccceecccCceEEEEEEE----cCCeEEEEEeeccCC----cccHHHHHHHHHHHHhcCCCccccEeeEEEeCC
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVL----TNGKVVAIKQLKAGS----GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGS 271 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~ 271 (369)
..++|++.+.||+|+||.||+++. .+++.||+|+++... ......+.+|+++|.+++||||+++++++...+
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 94 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGG 94 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCC
Confidence 457899999999999999999997 468899999997642 223356789999999999999999999999999
Q ss_pred eeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccce
Q 017558 272 QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351 (369)
Q Consensus 272 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~ 351 (369)
..|+||||+++++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 95 KLYLILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp CEEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEEeCCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 999999999999999999754 3488999999999999999999999 99999999999999999999999999998
Q ss_pred eeCC
Q 017558 352 HSLD 355 (369)
Q Consensus 352 ~~~~ 355 (369)
....
T Consensus 170 ~~~~ 173 (327)
T 3a62_A 170 ESIH 173 (327)
T ss_dssp ----
T ss_pred cccc
Confidence 7543
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-31 Score=258.97 Aligned_cols=154 Identities=30% Similarity=0.478 Sum_probs=138.7
Q ss_pred HHHhhcCCcccceecccCceEEEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEE
Q 017558 197 LKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (369)
Q Consensus 197 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 276 (369)
+.+..++|.+.+.||+|+||.||+|.+.++..||||+++... ...++|.+|+++|.+++||||+++++++. .+..|+|
T Consensus 183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv 260 (454)
T 1qcf_A 183 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYII 260 (454)
T ss_dssp SBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred eeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEE
Confidence 455678899999999999999999999888999999998654 34678999999999999999999999986 6678999
Q ss_pred EEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 277 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
||||++|+|.++|+......+++..++.++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++...+
T Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 336 (454)
T 1qcf_A 261 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIED 336 (454)
T ss_dssp ECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred EeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence 9999999999999764433588999999999999999999999 999999999999999999999999999987654
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.6e-30 Score=241.96 Aligned_cols=162 Identities=28% Similarity=0.353 Sum_probs=140.0
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcc------cHHHHHHHHHHHHhcCCCccccEeeEEEeCCe
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ------GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQ 272 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 272 (369)
..++|++.+.||+|+||.||+|+.. +|+.||||.++..... ..+.+.+|+.+|.+++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 3567999999999999999999975 5889999999764321 34689999999999999999999999999999
Q ss_pred eEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCC----cEEEeeec
Q 017558 273 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF----EAKVADFG 348 (369)
Q Consensus 273 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~----~~ki~DFG 348 (369)
.|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||+++++ .+||+|||
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTC--SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred EEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 99999999999999999654 3589999999999999999999998 999999999999998876 79999999
Q ss_pred cceeeCCCCceeeeeecccC
Q 017558 349 LAKHSLDTDTHVSTRVMGTF 368 (369)
Q Consensus 349 la~~~~~~~~~~~~~~~gt~ 368 (369)
+++...+... .....||+
T Consensus 165 ~a~~~~~~~~--~~~~~gt~ 182 (361)
T 2yab_A 165 LAHEIEDGVE--FKNIFGTP 182 (361)
T ss_dssp SCEECCTTCC--CCCCCSCG
T ss_pred CceEcCCCCc--cccCCCCc
Confidence 9998765332 22345654
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=247.40 Aligned_cols=153 Identities=32% Similarity=0.505 Sum_probs=129.3
Q ss_pred hhcCCcccceecccCceEEEEEEEc----CCeEEEEEeeccCCc-ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeE
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVLT----NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRL 274 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 274 (369)
..++|++.+.||+|+||.||+|+.. ++..||||+++.... ...++|.+|+++|.+++||||++++++|...+..|
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 122 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence 3467999999999999999999865 467899999976532 34467999999999999999999999999999999
Q ss_pred EEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 275 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 275 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
+||||+++|+|.++++... ..+++..++.|+.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 123 lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 123 IVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 9999999999999997643 3589999999999999999999998 99999999999999999999999999999865
Q ss_pred CC
Q 017558 355 DT 356 (369)
Q Consensus 355 ~~ 356 (369)
..
T Consensus 199 ~~ 200 (373)
T 2qol_A 199 DD 200 (373)
T ss_dssp --
T ss_pred cC
Confidence 43
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-30 Score=246.55 Aligned_cols=161 Identities=26% Similarity=0.346 Sum_probs=139.9
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC---cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEE
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 276 (369)
.++|++.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|+++|.+++||||++++++|.+.+..|+|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 467999999999999999999965 47899999986432 23446788999999999999999999999999999999
Q ss_pred EEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCC
Q 017558 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 277 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~ 356 (369)
|||+.+|+|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++.....
T Consensus 94 ~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp ECCCTTEEHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 9999999999999764 3589999999999999999999999 9999999999999999999999999999986543
Q ss_pred CceeeeeecccC
Q 017558 357 DTHVSTRVMGTF 368 (369)
Q Consensus 357 ~~~~~~~~~gt~ 368 (369)
.. ....+||+
T Consensus 169 ~~--~~~~~gt~ 178 (384)
T 4fr4_A 169 TQ--ITTMAGTK 178 (384)
T ss_dssp CC--BCCCCSCG
T ss_pred Cc--eeccCCCc
Confidence 32 23345654
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-30 Score=235.02 Aligned_cols=151 Identities=32% Similarity=0.539 Sum_probs=137.4
Q ss_pred hhcCCcccceecccCceEEEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEe
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 279 (369)
..++|+..+.||+|+||.||+|...+++.||+|+++... ...+++.+|++++.+++||||+++++++.+....++||||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (269)
T 4hcu_A 8 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 86 (269)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred ChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence 457899999999999999999999888999999997654 3356899999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
+++++|.+++.... ..+++..++.++.|++.||.|||++ +++||||||+|||++.++.+||+|||+++....
T Consensus 87 ~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 158 (269)
T 4hcu_A 87 MEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 158 (269)
T ss_dssp CTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred CCCCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccc
Confidence 99999999997643 3589999999999999999999998 999999999999999999999999999986644
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.7e-30 Score=232.23 Aligned_cols=153 Identities=29% Similarity=0.465 Sum_probs=138.7
Q ss_pred hhcCCcccceecccCceEEEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEe
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 279 (369)
..++|++.+.||+|+||.||+|...++..||||+++.... ..+++.+|++++.+++||||++++++|......++||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 4578999999999999999999998888999999976543 346799999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCCC
Q 017558 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (369)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~~ 357 (369)
+++++|.+++.... ..+++..++.++.|++.||.|||++ +++||||||+|||++.++.+||+|||+++......
T Consensus 85 ~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 85 ISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp CTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred cCCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 99999999997543 3489999999999999999999998 99999999999999999999999999999876544
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-30 Score=241.32 Aligned_cols=156 Identities=29% Similarity=0.509 Sum_probs=132.5
Q ss_pred HHHHhhcCCcccceecccCceEEEEEEEcCCeEEEEEeeccCCc--ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCee
Q 017558 196 ELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQR 273 (369)
Q Consensus 196 ~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 273 (369)
++.+..++|++.+.||+|+||.||+|+. ++..||||++..... ...+++.+|+++|.+++||||+++++++......
T Consensus 31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 3p86_A 31 DMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL 109 (309)
T ss_dssp -CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCC
T ss_pred cccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCce
Confidence 3445667899999999999999999987 688999999876542 2345789999999999999999999999999999
Q ss_pred EEEEEecCCCcHhhhhcCCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eeecCCCCCcEEECCCCcEEEeeeccc
Q 017558 274 LLVYEFVPNKTLEFHLHGKDR-PVMNWPTRMKIALGSARGLAYLHEDCQPK--IIHRDIKSANILLDDSFEAKVADFGLA 350 (369)
Q Consensus 274 ~lv~e~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~~l~yLH~~~~~~--ivHrdlk~~Nill~~~~~~ki~DFGla 350 (369)
++||||+++|+|.+++..... ..+++..++.++.||+.||.|||++ + |+||||||+|||++.++.+||+|||++
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a 186 (309)
T 3p86_A 110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLS 186 (309)
T ss_dssp EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC--
T ss_pred EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCC
Confidence 999999999999999976431 2388999999999999999999998 7 999999999999999999999999999
Q ss_pred eeeCC
Q 017558 351 KHSLD 355 (369)
Q Consensus 351 ~~~~~ 355 (369)
+....
T Consensus 187 ~~~~~ 191 (309)
T 3p86_A 187 RLKAS 191 (309)
T ss_dssp -----
T ss_pred ccccc
Confidence 86543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-30 Score=254.97 Aligned_cols=165 Identities=30% Similarity=0.426 Sum_probs=143.5
Q ss_pred HhhcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC---cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeE
Q 017558 199 IATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRL 274 (369)
Q Consensus 199 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 274 (369)
+..++|+..++||+|+||.||+|+.. +++.||||++.... ......+.+|+++|.+++||||+++++++.+.+..|
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 34567999999999999999999975 68999999996532 233457889999999999999999999999999999
Q ss_pred EEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 275 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 275 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
|||||+++|+|.+++.......+++..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++...
T Consensus 261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecc
Confidence 999999999999999876555699999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCceeeeeecccC
Q 017558 355 DTDTHVSTRVMGTF 368 (369)
Q Consensus 355 ~~~~~~~~~~~gt~ 368 (369)
..... ...+||+
T Consensus 338 ~~~~~--~~~~GT~ 349 (576)
T 2acx_A 338 EGQTI--KGRVGTV 349 (576)
T ss_dssp TTCCE--ECCCSCG
T ss_pred cCccc--cccCCCc
Confidence 54322 2346665
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=8.7e-30 Score=236.39 Aligned_cols=152 Identities=24% Similarity=0.345 Sum_probs=136.2
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEe
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 279 (369)
.++|++.+.||+|+||.||+|... +++.||+|.++... .....+.+|+++|.+++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 468999999999999999999965 57899999987543 3445789999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECC--CCcEEEeeeccceeeCCCC
Q 017558 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD--SFEAKVADFGLAKHSLDTD 357 (369)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~--~~~~ki~DFGla~~~~~~~ 357 (369)
+++|+|.+++.... ..+++..+..++.||+.||.|||++ +|+||||||+|||++. ++.+||+|||+++.....+
T Consensus 83 ~~g~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~ 158 (321)
T 1tki_A 83 ISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred CCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC
Confidence 99999999997543 3589999999999999999999999 9999999999999987 7899999999999876544
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-30 Score=243.89 Aligned_cols=165 Identities=21% Similarity=0.244 Sum_probs=138.8
Q ss_pred HhhcCCcccceecccCceEEEEEE------EcCCeEEEEEeeccCCcccHHHHHHHHHHHHhcC---CCccccEeeEEEe
Q 017558 199 IATDNFSEANLLGQGGFGYVHKGV------LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVH---HRHLVSLVGYCTF 269 (369)
Q Consensus 199 ~~~~~~~~~~~lg~G~fg~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~ 269 (369)
...++|.+.+.||+|+||.||+|. ..+++.||||+++.. ...++..|++++.+++ |+||+.+++++..
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 456789999999999999999994 456789999999754 3457888888888887 9999999999999
Q ss_pred CCeeEEEEEecCCCcHhhhhcCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECC--------
Q 017558 270 GSQRLLVYEFVPNKTLEFHLHGK---DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD-------- 338 (369)
Q Consensus 270 ~~~~~lv~e~~~~g~L~~~l~~~---~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~-------- 338 (369)
.+..||||||+++|+|.+++... ....+++..++.|+.||+.||+|||++ +|+||||||+||||+.
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC---
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCcccc
Confidence 99999999999999999999742 234599999999999999999999998 9999999999999998
Q ss_pred ---CCcEEEeeeccceeeCC-CCceeeeeecccCC
Q 017558 339 ---SFEAKVADFGLAKHSLD-TDTHVSTRVMGTFG 369 (369)
Q Consensus 339 ---~~~~ki~DFGla~~~~~-~~~~~~~~~~gt~g 369 (369)
++.+||+|||+|+.+.. .........+||++
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~ 250 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSG 250 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTS
T ss_pred ccccCCEEEeeCchhhhhhccCCCceeeeecCCCC
Confidence 89999999999987542 22233444667754
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.3e-30 Score=236.25 Aligned_cols=151 Identities=27% Similarity=0.414 Sum_probs=132.7
Q ss_pred hhcCCcccceecccCceEEEEEEEcCCeEEEEEeeccCCcc--cHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEE
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQ--GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 277 (369)
..++|++.+.||+|+||.||+|+..+++.||||+++..... ..+.+.+|++++.+++||||+++++++......++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 35789999999999999999999988999999999754322 2357889999999999999999999999999999999
Q ss_pred EecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 278 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
||++ ++|.+++.... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 99 e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 171 (311)
T 3niz_A 99 EFME-KDLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGI 171 (311)
T ss_dssp ECCS-EEHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred cCCC-CCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence 9997 57888776543 3589999999999999999999998 999999999999999999999999999987653
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-30 Score=242.74 Aligned_cols=164 Identities=25% Similarity=0.332 Sum_probs=139.4
Q ss_pred HhhcCCcccceecccCceEEEEEEEcC-CeEEEEEeeccCC---cccHHHHHHHHHHHHhc-CCCccccEeeEEEeCCee
Q 017558 199 IATDNFSEANLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGS---GQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQR 273 (369)
Q Consensus 199 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 273 (369)
...++|++.+.||+|+||.||+|+... ++.||||+++... ....+.+..|.++|..+ +||||+++++++...+..
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 456789999999999999999999754 7889999997542 23446788999999988 799999999999999999
Q ss_pred EEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceee
Q 017558 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (369)
Q Consensus 274 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~ 353 (369)
||||||+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++..
T Consensus 97 ~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 99999999999999997543 489999999999999999999998 9999999999999999999999999999875
Q ss_pred CCCCceeeeeecccC
Q 017558 354 LDTDTHVSTRVMGTF 368 (369)
Q Consensus 354 ~~~~~~~~~~~~gt~ 368 (369)
..... .....+||+
T Consensus 172 ~~~~~-~~~~~~gt~ 185 (353)
T 2i0e_A 172 IWDGV-TTKTFCGTP 185 (353)
T ss_dssp CCTTC-CBCCCCSCG
T ss_pred ccCCc-ccccccCCc
Confidence 43322 223356664
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-30 Score=241.85 Aligned_cols=151 Identities=28% Similarity=0.307 Sum_probs=135.7
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC---cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEE
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 276 (369)
.++|+..+.||+|+||.||+++.. +++.||||+++... ....+.+.+|+++|.+++||||+++++++.+....|+|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 367899999999999999999975 58899999986532 23346788999999999999999999999999999999
Q ss_pred EEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCC
Q 017558 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 277 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~ 356 (369)
|||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 120 ~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp EECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred EcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCC
Confidence 99999999999997543 489999999999999999999998 9999999999999999999999999999987543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-30 Score=244.12 Aligned_cols=163 Identities=28% Similarity=0.485 Sum_probs=141.2
Q ss_pred ccCHHHHHHhhcCCcccceecccCceEEEEEEEc------CCeEEEEEeeccCCcc-cHHHHHHHHHHHHhc-CCCcccc
Q 017558 191 TFTYEELKIATDNFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLKAGSGQ-GEREFQAEIEIISQV-HHRHLVS 262 (369)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~ 262 (369)
.+...++.+..++|++.+.||+|+||.||+|++. +++.||||+++..... ..+.+.+|++++.++ +||||++
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 4566778888999999999999999999999842 3578999999765433 345799999999999 7999999
Q ss_pred EeeEEEeCC-eeEEEEEecCCCcHhhhhcCCCC-----------------------------------------------
Q 017558 263 LVGYCTFGS-QRLLVYEFVPNKTLEFHLHGKDR----------------------------------------------- 294 (369)
Q Consensus 263 l~g~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~----------------------------------------------- 294 (369)
++++|...+ ..++||||+++|+|.++++....
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 999998755 48999999999999999976432
Q ss_pred -----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCC
Q 017558 295 -----------------PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 295 -----------------~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~ 356 (369)
..+++..++.|+.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++.....
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 246 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 246 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSC
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeeccc
Confidence 1288999999999999999999999 9999999999999999999999999999876543
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-30 Score=246.23 Aligned_cols=153 Identities=26% Similarity=0.453 Sum_probs=136.6
Q ss_pred HhhcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcc-cHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEE
Q 017558 199 IATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (369)
Q Consensus 199 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 276 (369)
+..++|.+.+.||+|+||.||+|++. +++.||||.++..... ..++|.+|+++|.+++||||++++++|...+..|+|
T Consensus 111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 190 (377)
T 3cbl_A 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 190 (377)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence 45578899999999999999999986 6889999998765322 334788999999999999999999999999999999
Q ss_pred EEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 277 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
|||+++|+|.++++... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++...+
T Consensus 191 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 191 MELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265 (377)
T ss_dssp EECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred EEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence 99999999999997543 3488999999999999999999999 999999999999999999999999999997554
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-29 Score=241.61 Aligned_cols=153 Identities=28% Similarity=0.410 Sum_probs=137.1
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEe
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 279 (369)
.++|++.+.||+|+||.||+|... +++.||+|.+......+...+.+|+++|.+++|+||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 467999999999999999999975 5789999999766555556899999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECC--CCcEEEeeeccceeeCCCC
Q 017558 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD--SFEAKVADFGLAKHSLDTD 357 (369)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~--~~~~ki~DFGla~~~~~~~ 357 (369)
+++|+|.+++.... ..+++..++.++.||+.||.|||++ +|+||||||+|||++. ++.+||+|||+++......
T Consensus 130 ~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 205 (387)
T 1kob_A 130 LSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 205 (387)
T ss_dssp CCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence 99999999997543 3589999999999999999999998 9999999999999974 5789999999999876544
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.9e-30 Score=234.23 Aligned_cols=152 Identities=24% Similarity=0.338 Sum_probs=130.1
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcc--------------------------cHHHHHHHHHHH
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ--------------------------GEREFQAEIEII 252 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l 252 (369)
..++|++.+.||+|+||.||+|+.. +++.||||++...... ..+.+.+|+++|
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 3478999999999999999999964 5789999998654311 124688999999
Q ss_pred HhcCCCccccEeeEEEe--CCeeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCC
Q 017558 253 SQVHHRHLVSLVGYCTF--GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIK 330 (369)
Q Consensus 253 ~~l~h~niv~l~g~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk 330 (369)
.+++||||+++++++.+ ....|+||||+++++|.+++.. ..+++..+..++.||+.||.|||++ +|+|||||
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlk 164 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIK 164 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCC
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCC
Confidence 99999999999999987 5688999999999999887643 3589999999999999999999999 99999999
Q ss_pred CCcEEECCCCcEEEeeeccceeeCCCC
Q 017558 331 SANILLDDSFEAKVADFGLAKHSLDTD 357 (369)
Q Consensus 331 ~~Nill~~~~~~ki~DFGla~~~~~~~ 357 (369)
|+|||++.++.+||+|||+++.....+
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 191 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSD 191 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSS
T ss_pred HHHEEECCCCCEEEecCCCcccccccc
Confidence 999999999999999999999876544
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-30 Score=252.91 Aligned_cols=154 Identities=32% Similarity=0.503 Sum_probs=134.8
Q ss_pred HHhhcCCcccceecccCceEEEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEE
Q 017558 198 KIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (369)
Q Consensus 198 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 277 (369)
.+..++|++.+.||+|+||.||+|.+.++..||||+++... ...++|.+|+++|.+++||||+++++++.. +..|+||
T Consensus 180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~ 257 (452)
T 1fmk_A 180 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 257 (452)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred ccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEe
Confidence 44567899999999999999999999888889999997654 335689999999999999999999999875 6789999
Q ss_pred EecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCC
Q 017558 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 278 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~ 356 (369)
||+++|+|.++|.......+++..++.++.||+.||.|||++ +|+||||||+|||+++++.+||+|||+++...+.
T Consensus 258 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 333 (452)
T 1fmk_A 258 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN 333 (452)
T ss_dssp CCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred hhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence 999999999999754334589999999999999999999998 9999999999999999999999999999976543
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-30 Score=234.31 Aligned_cols=156 Identities=31% Similarity=0.501 Sum_probs=138.1
Q ss_pred HHHhhcCCcccceecccCceEEEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEE
Q 017558 197 LKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (369)
Q Consensus 197 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 276 (369)
+.+..++|++.+.||+|+||.||+|...++..||||.++... ...+.+.+|++++.+++|+||+++++++. .+..++|
T Consensus 8 ~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v 85 (279)
T 1qpc_A 8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYII 85 (279)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEE
T ss_pred cccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEE
Confidence 445567899999999999999999999888899999997643 34578999999999999999999999986 4568999
Q ss_pred EEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCC
Q 017558 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 277 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~ 356 (369)
|||+++++|.+++.......+++..++.++.|++.||.|||++ +++||||||+|||+++++.+||+|||+++...+.
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T 1qpc_A 86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (279)
T ss_dssp EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred EecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence 9999999999999754333589999999999999999999998 9999999999999999999999999999987654
Q ss_pred C
Q 017558 357 D 357 (369)
Q Consensus 357 ~ 357 (369)
.
T Consensus 163 ~ 163 (279)
T 1qpc_A 163 E 163 (279)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.97 E-value=6.9e-30 Score=247.89 Aligned_cols=150 Identities=29% Similarity=0.484 Sum_probs=135.5
Q ss_pred HhhcCCcccceecccCceEEEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCC-eeEEEE
Q 017558 199 IATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGS-QRLLVY 277 (369)
Q Consensus 199 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-~~~lv~ 277 (369)
+..++|++.+.||+|+||.||+|.+. ++.||||+++... ..+.|.+|+++|.+++||||++++++|.... ..|+||
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~ 266 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 266 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred cChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence 44577889999999999999999984 7899999997654 4468999999999999999999999987765 789999
Q ss_pred EecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 278 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
|||++|+|.+++.......+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 267 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 267 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 340 (450)
T ss_dssp ECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence 999999999999876555579999999999999999999999 99999999999999999999999999998654
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-30 Score=234.69 Aligned_cols=152 Identities=30% Similarity=0.463 Sum_probs=135.1
Q ss_pred HhhcCCcccceecccCceEEEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEE
Q 017558 199 IATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (369)
Q Consensus 199 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 278 (369)
+..++|++.+.||+|+||.||++.+.++..||||+++.... ..+++.+|++++.+++|+||++++++|......++|||
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 99 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 99 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence 45678999999999999999999998888999999976543 35689999999999999999999999999999999999
Q ss_pred ecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
|+++++|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++...+
T Consensus 100 ~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 172 (283)
T 3gen_A 100 YMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172 (283)
T ss_dssp CCTTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred ccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccccc
Confidence 999999999997633 3489999999999999999999998 999999999999999999999999999987644
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-30 Score=241.87 Aligned_cols=158 Identities=28% Similarity=0.513 Sum_probs=139.3
Q ss_pred HHHHHhhcCCcccceecccCceEEEEEEEcC------CeEEEEEeeccCCcc-cHHHHHHHHHHHHhcCCCccccEeeEE
Q 017558 195 EELKIATDNFSEANLLGQGGFGYVHKGVLTN------GKVVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVSLVGYC 267 (369)
Q Consensus 195 ~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~ 267 (369)
..+....++|++.+.||+|+||.||+|+..+ ++.||||.++..... ..+.+.+|++++.+++||||++++++|
T Consensus 40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 3445667899999999999999999999753 478999999765433 345799999999999999999999999
Q ss_pred EeCCeeEEEEEecCCCcHhhhhcCCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCee
Q 017558 268 TFGSQRLLVYEFVPNKTLEFHLHGKD----------------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKII 325 (369)
Q Consensus 268 ~~~~~~~lv~e~~~~g~L~~~l~~~~----------------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iv 325 (369)
...+..|+||||+++|+|.+++.... ...+++..++.|+.||+.||.|||++ +|+
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~iv 196 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFV 196 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence 99999999999999999999997532 14689999999999999999999999 999
Q ss_pred ecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 326 HRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 326 Hrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
||||||+|||++.++.+||+|||+++....
T Consensus 197 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 226 (343)
T 1luf_A 197 HRDLATRNCLVGENMVVKIADFGLSRNIYS 226 (343)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTG
T ss_pred cCCCCcceEEECCCCeEEEeecCCCccccc
Confidence 999999999999999999999999987643
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-29 Score=234.99 Aligned_cols=151 Identities=26% Similarity=0.337 Sum_probs=135.2
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCc------ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCee
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG------QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQR 273 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 273 (369)
.++|.+.+.||+|+||.||+|... +++.||||.++.... ...+.+.+|+++|.+++||||+++++++......
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 456899999999999999999975 588999999875432 2356899999999999999999999999999999
Q ss_pred EEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCC----cEEEeeecc
Q 017558 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF----EAKVADFGL 349 (369)
Q Consensus 274 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~----~~ki~DFGl 349 (369)
++||||+++++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++ .+||+|||+
T Consensus 90 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 164 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164 (326)
T ss_dssp EEEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence 9999999999999999654 4589999999999999999999998 999999999999999887 899999999
Q ss_pred ceeeCCC
Q 017558 350 AKHSLDT 356 (369)
Q Consensus 350 a~~~~~~ 356 (369)
++.....
T Consensus 165 a~~~~~~ 171 (326)
T 2y0a_A 165 AHKIDFG 171 (326)
T ss_dssp CEECCTT
T ss_pred CeECCCC
Confidence 9987543
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.1e-29 Score=230.68 Aligned_cols=163 Identities=45% Similarity=0.761 Sum_probs=144.6
Q ss_pred CccCHHHHHHhhcCCccc------ceecccCceEEEEEEEcCCeEEEEEeeccCC----cccHHHHHHHHHHHHhcCCCc
Q 017558 190 STFTYEELKIATDNFSEA------NLLGQGGFGYVHKGVLTNGKVVAIKQLKAGS----GQGEREFQAEIEIISQVHHRH 259 (369)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~------~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~n 259 (369)
..|.+.++...+++|... +.||+|+||.||+|.. +++.||||++.... ....+.+.+|++++.+++|||
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 467889999999988876 8999999999999997 67899999986532 223467899999999999999
Q ss_pred cccEeeEEEeCCeeEEEEEecCCCcHhhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECC
Q 017558 260 LVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKD-RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD 338 (369)
Q Consensus 260 iv~l~g~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~ 338 (369)
|+++++++...+..++||||+++++|.+++.... ...+++..++.++.||+.||.|||++ +++||||||+|||++.
T Consensus 92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~ 168 (307)
T 2nru_A 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDE 168 (307)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECT
T ss_pred eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEcC
Confidence 9999999999999999999999999999987432 34589999999999999999999998 9999999999999999
Q ss_pred CCcEEEeeeccceeeCCC
Q 017558 339 SFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 339 ~~~~ki~DFGla~~~~~~ 356 (369)
++.+||+|||+++.....
T Consensus 169 ~~~~kl~Dfg~~~~~~~~ 186 (307)
T 2nru_A 169 AFTAKISDFGLARASEKF 186 (307)
T ss_dssp TCCEEECCCTTCEECCSC
T ss_pred CCcEEEeecccccccccc
Confidence 999999999999876543
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-30 Score=236.27 Aligned_cols=157 Identities=27% Similarity=0.436 Sum_probs=141.3
Q ss_pred HHHhhcCCcccceecccCceEEEEEEEcC-CeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEE
Q 017558 197 LKIATDNFSEANLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 275 (369)
Q Consensus 197 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 275 (369)
+.+..++|++.+.||+|+||.||+|.... +..||+|.+.... ...+.+.+|++++.+++|+||+++++++......++
T Consensus 8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 86 (288)
T 3kfa_A 8 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 86 (288)
T ss_dssp TBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred ccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEE
Confidence 34567889999999999999999999764 7889999997543 345689999999999999999999999999999999
Q ss_pred EEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 276 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 276 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
||||+++++|.+++.......+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 87 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 163 (288)
T 3kfa_A 87 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 163 (288)
T ss_dssp EEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred EEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence 99999999999999876666799999999999999999999999 999999999999999999999999999987665
Q ss_pred CC
Q 017558 356 TD 357 (369)
Q Consensus 356 ~~ 357 (369)
..
T Consensus 164 ~~ 165 (288)
T 3kfa_A 164 DT 165 (288)
T ss_dssp SS
T ss_pred Cc
Confidence 44
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=2.8e-30 Score=236.42 Aligned_cols=153 Identities=28% Similarity=0.495 Sum_probs=133.4
Q ss_pred hhcCCcccceecccCceEEEEEEE-----cCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeC--Ce
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVL-----TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFG--SQ 272 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~ 272 (369)
..++|++.+.||+|+||.||+|++ .+++.||||++........+.+.+|++++.+++||||++++++|... ..
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 87 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence 457899999999999999999985 35789999999876656667899999999999999999999999653 56
Q ss_pred eEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeecccee
Q 017558 273 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (369)
Q Consensus 273 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~ 352 (369)
.++||||+++|+|.+++.... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 88 LKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp CEEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred eEEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 899999999999999997653 3489999999999999999999998 999999999999999999999999999987
Q ss_pred eCCC
Q 017558 353 SLDT 356 (369)
Q Consensus 353 ~~~~ 356 (369)
....
T Consensus 164 ~~~~ 167 (295)
T 3ugc_A 164 LPQD 167 (295)
T ss_dssp ----
T ss_pred ccCC
Confidence 6543
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-29 Score=231.34 Aligned_cols=149 Identities=23% Similarity=0.385 Sum_probs=130.4
Q ss_pred cCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcc--cHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEE
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ--GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 278 (369)
++|++.+.||+|+||.||+|+.. +++.||||+++..... ..+.+.+|++++.+++|+||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57899999999999999999975 5789999999754332 23678899999999999999999999999999999999
Q ss_pred ecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
|+++ +|.+++.... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~~-~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 153 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp CCSE-EHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCS
T ss_pred cCCC-CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCC
Confidence 9976 5555554322 3589999999999999999999999 999999999999999999999999999987653
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-29 Score=250.06 Aligned_cols=165 Identities=31% Similarity=0.453 Sum_probs=142.4
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC---cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEE
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 276 (369)
.++|...++||+|+||.||+|+.. +++.||||++.... ....+.+.+|+++|.+++||||+++++++......|+|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 467899999999999999999975 58999999996532 22346788999999999999999999999999999999
Q ss_pred EEecCCCcHhhhhcCCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 277 YEFVPNKTLEFHLHGKD--RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 277 ~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
|||+++|+|.+++.... ...+++..+..++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++...
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 99999999999997643 34689999999999999999999998 99999999999999999999999999999876
Q ss_pred CCCceeeeeecccCC
Q 017558 355 DTDTHVSTRVMGTFG 369 (369)
Q Consensus 355 ~~~~~~~~~~~gt~g 369 (369)
..... ....+||++
T Consensus 341 ~~~~~-~~~~~GT~~ 354 (543)
T 3c4z_A 341 AGQTK-TKGYAGTPG 354 (543)
T ss_dssp TTCCC-BCCCCSCTT
T ss_pred CCCcc-cccccCCcc
Confidence 54322 233567753
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-30 Score=258.75 Aligned_cols=154 Identities=32% Similarity=0.500 Sum_probs=137.6
Q ss_pred HHHhhcCCcccceecccCceEEEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEE
Q 017558 197 LKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (369)
Q Consensus 197 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 276 (369)
+++..++|++.+.||+|+||.||+|.+.++..||||+++... ...++|.+|+++|.+++|+||++++++|.. +..|||
T Consensus 262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv 339 (535)
T 2h8h_A 262 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 339 (535)
T ss_dssp SBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred eecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEe
Confidence 345667889999999999999999999888889999998654 335689999999999999999999999875 678999
Q ss_pred EEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 277 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
||||++|+|.++|.......+++..++.|+.||+.||.|||++ +|+|||||++||||++++.+||+|||+++...+
T Consensus 340 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 415 (535)
T 2h8h_A 340 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIED 415 (535)
T ss_dssp ECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred eehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence 9999999999999754334589999999999999999999998 999999999999999999999999999987653
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-30 Score=243.56 Aligned_cols=163 Identities=26% Similarity=0.341 Sum_probs=140.0
Q ss_pred hcCCcccceecccCceEEEEEEE----cCCeEEEEEeeccCC----cccHHHHHHHHHHHHhc-CCCccccEeeEEEeCC
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVL----TNGKVVAIKQLKAGS----GQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGS 271 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~ 271 (369)
.++|++.+.||+|+||.||+++. .+++.||||+++... ....+.+.+|+++|.++ +|+||+++++++....
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 46899999999999999999997 368899999987532 12345678899999999 6999999999999999
Q ss_pred eeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccce
Q 017558 272 QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351 (369)
Q Consensus 272 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~ 351 (369)
..+|||||+++|+|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eEEEEeecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 9999999999999999997543 489999999999999999999998 99999999999999999999999999999
Q ss_pred eeCCCCceeeeeecccC
Q 017558 352 HSLDTDTHVSTRVMGTF 368 (369)
Q Consensus 352 ~~~~~~~~~~~~~~gt~ 368 (369)
..............||+
T Consensus 208 ~~~~~~~~~~~~~~gt~ 224 (355)
T 1vzo_A 208 EFVADETERAYDFCGTI 224 (355)
T ss_dssp ECCGGGGGGGCGGGSCC
T ss_pred ecccCCCCcccCcccCc
Confidence 87544433333445664
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.96 E-value=7.7e-30 Score=239.66 Aligned_cols=164 Identities=24% Similarity=0.389 Sum_probs=137.9
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccC-----CcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeE
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG-----SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRL 274 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 274 (369)
.++|++.+.||+|+||.||+|... +++.||||+++.. .....+.+.+|++++.+++||||+++++++..++..|
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 467999999999999999999964 5889999998542 1224578999999999999999999999999999999
Q ss_pred EEEEecCCCcHhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCc---EEEeeecc
Q 017558 275 LVYEFVPNKTLEFHLHGK--DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFE---AKVADFGL 349 (369)
Q Consensus 275 lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~---~ki~DFGl 349 (369)
+||||+++++|.+++... ....+++..+..++.||+.||.|||++ +|+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 999999999998887643 223489999999999999999999999 9999999999999986554 99999999
Q ss_pred ceeeCCCCceeeeeecccC
Q 017558 350 AKHSLDTDTHVSTRVMGTF 368 (369)
Q Consensus 350 a~~~~~~~~~~~~~~~gt~ 368 (369)
++...+... ......||+
T Consensus 180 a~~~~~~~~-~~~~~~gt~ 197 (351)
T 3c0i_A 180 AIQLGESGL-VAGGRVGTP 197 (351)
T ss_dssp CEECCTTSC-BCCCCCSCG
T ss_pred eeEecCCCe-eecCCcCCc
Confidence 998765432 222345554
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-29 Score=234.33 Aligned_cols=154 Identities=25% Similarity=0.358 Sum_probs=135.1
Q ss_pred hcCCcccceecccCceEEEEEEEcC-CeEEEEEeeccCC-cccHHHHHHHHHHHHhcCCCccccEeeEEEeCC--eeEEE
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGS--QRLLV 276 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~--~~~lv 276 (369)
.++|.+.+.||+|+||.||+|+... ++.||||+++... ....+.+.+|+++|.+++||||+++++++.... ..|+|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 4678999999999999999999754 8899999997543 234567889999999999999999999998765 77999
Q ss_pred EEecCCCcHhhhhcCCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEE----CCCCcEEEeeeccce
Q 017558 277 YEFVPNKTLEFHLHGKDR-PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILL----DDSFEAKVADFGLAK 351 (369)
Q Consensus 277 ~e~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill----~~~~~~ki~DFGla~ 351 (369)
|||+++++|.+++..... ..+++..++.++.||+.||.|||++ +|+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999976432 2389999999999999999999999 99999999999999 888889999999999
Q ss_pred eeCCCC
Q 017558 352 HSLDTD 357 (369)
Q Consensus 352 ~~~~~~ 357 (369)
......
T Consensus 165 ~~~~~~ 170 (319)
T 4euu_A 165 ELEDDE 170 (319)
T ss_dssp ECCTTC
T ss_pred ecCCCC
Confidence 876543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-29 Score=238.86 Aligned_cols=162 Identities=25% Similarity=0.350 Sum_probs=138.9
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCc--ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEE
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 276 (369)
..++|++.+.||+|+||.||+|... +++.||||++..... ...+.+.+|++++.+++||||+++++++.+.+..|+|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4567999999999999999999964 578999999976432 2345788999999999999999999999999999999
Q ss_pred EEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCC---CcEEEeeeccceee
Q 017558 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS---FEAKVADFGLAKHS 353 (369)
Q Consensus 277 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~---~~~ki~DFGla~~~ 353 (369)
|||+++|+|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||+++..
T Consensus 107 ~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~ 181 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181 (362)
T ss_dssp ECCCCSCBHHHHHTTC--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred EecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence 9999999999999754 3589999999999999999999999 99999999999999864 45999999999887
Q ss_pred CCCCceeeeeecccC
Q 017558 354 LDTDTHVSTRVMGTF 368 (369)
Q Consensus 354 ~~~~~~~~~~~~gt~ 368 (369)
.+... .....||+
T Consensus 182 ~~~~~--~~~~~gt~ 194 (362)
T 2bdw_A 182 NDSEA--WHGFAGTP 194 (362)
T ss_dssp TTCCS--CCCSCSCT
T ss_pred cCCcc--cccCCCCc
Confidence 64432 22345654
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.96 E-value=7.9e-31 Score=244.75 Aligned_cols=150 Identities=21% Similarity=0.272 Sum_probs=127.0
Q ss_pred HhhcCCcccceecccCceEEEEEEEcCCeEEEEEeeccCC--------cccHHHHHHHHHHHHhcC---------CCccc
Q 017558 199 IATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGS--------GQGEREFQAEIEIISQVH---------HRHLV 261 (369)
Q Consensus 199 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------h~niv 261 (369)
+..++|++.+.||+|+||.||+|+. +++.||||+++... ....+.+.+|+++|++++ |+||+
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred cccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 3456788899999999999999998 68999999997643 223367899999998886 77777
Q ss_pred cEeeEEE------------------------------eCCeeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHH
Q 017558 262 SLVGYCT------------------------------FGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSAR 311 (369)
Q Consensus 262 ~l~g~~~------------------------------~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~ 311 (369)
++.+++. ..+..||||||+++|++.+.+.. ..+++..+..|+.||+.
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTA 172 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHH
Confidence 7777643 26789999999999977776643 35899999999999999
Q ss_pred HHHHHH-hCCCCCeeecCCCCCcEEECCCC--------------------cEEEeeeccceeeCC
Q 017558 312 GLAYLH-EDCQPKIIHRDIKSANILLDDSF--------------------EAKVADFGLAKHSLD 355 (369)
Q Consensus 312 ~l~yLH-~~~~~~ivHrdlk~~Nill~~~~--------------------~~ki~DFGla~~~~~ 355 (369)
||.||| ++ +|+||||||+||||+.++ .+||+|||+|+...+
T Consensus 173 aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~ 234 (336)
T 2vuw_A 173 SLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD 234 (336)
T ss_dssp HHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET
T ss_pred HHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC
Confidence 999999 88 999999999999999887 999999999998754
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3e-30 Score=244.27 Aligned_cols=162 Identities=27% Similarity=0.394 Sum_probs=130.3
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCc---ccHHHHHHHHHH-HHhcCCCccccEeeEEEeCCeeEE
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG---QGEREFQAEIEI-ISQVHHRHLVSLVGYCTFGSQRLL 275 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~-l~~l~h~niv~l~g~~~~~~~~~l 275 (369)
.++|++.+.||+|+||.||+|+.. +++.||||+++.... ...+.+.+|..+ ++.++||||+++++++...+..|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 467999999999999999999975 478899999976432 223456677776 567899999999999999999999
Q ss_pred EEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 276 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 276 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
||||+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++....
T Consensus 117 v~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIE 191 (373)
T ss_dssp EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred EEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence 99999999999999754 3488999999999999999999998 999999999999999999999999999987543
Q ss_pred CCceeeeeecccC
Q 017558 356 TDTHVSTRVMGTF 368 (369)
Q Consensus 356 ~~~~~~~~~~gt~ 368 (369)
... .....+||+
T Consensus 192 ~~~-~~~~~~gt~ 203 (373)
T 2r5t_A 192 HNS-TTSTFCGTP 203 (373)
T ss_dssp CCC-CCCSBSCCC
T ss_pred CCC-ccccccCCc
Confidence 332 223456665
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-29 Score=240.43 Aligned_cols=153 Identities=15% Similarity=0.207 Sum_probs=137.4
Q ss_pred hhcCCcccceeccc--CceEEEEEEEc-CCeEEEEEeeccCC--cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeE
Q 017558 200 ATDNFSEANLLGQG--GFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRL 274 (369)
Q Consensus 200 ~~~~~~~~~~lg~G--~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 274 (369)
..++|++.+.||+| +||.||+|+.. +++.||||+++... ....+.+.+|++++++++||||++++++|...+..|
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 34679999999999 99999999975 58899999997543 223457889999999999999999999999999999
Q ss_pred EEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 275 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 275 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
+|||||++|+|.+++.......+++..+..|+.||+.||.|||++ +|+||||||+||||+.++.+||+|||++....
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 999999999999999876555699999999999999999999999 99999999999999999999999999987654
Q ss_pred C
Q 017558 355 D 355 (369)
Q Consensus 355 ~ 355 (369)
.
T Consensus 180 ~ 180 (389)
T 3gni_B 180 S 180 (389)
T ss_dssp E
T ss_pred c
Confidence 3
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-29 Score=231.62 Aligned_cols=149 Identities=26% Similarity=0.405 Sum_probs=133.4
Q ss_pred cCCcccceecccCceEEEEEEEcCCeEEEEEeeccCCcc--cHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEe
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQ--GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 279 (369)
++|++.+.||+|+||.||+|+..+++.||||+++..... ..+.+.+|++++.+++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 578999999999999999999977999999999654322 236788999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
+++ +|.+++.... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 152 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGI 152 (288)
T ss_dssp CSE-EHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC
T ss_pred cCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCc
Confidence 975 8988887543 3589999999999999999999998 999999999999999999999999999987643
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-29 Score=241.09 Aligned_cols=155 Identities=27% Similarity=0.465 Sum_probs=136.7
Q ss_pred HhhcCCcccceecccCceEEEEEEEc--------CCeEEEEEeeccCCc-ccHHHHHHHHHHHHhc-CCCccccEeeEEE
Q 017558 199 IATDNFSEANLLGQGGFGYVHKGVLT--------NGKVVAIKQLKAGSG-QGEREFQAEIEIISQV-HHRHLVSLVGYCT 268 (369)
Q Consensus 199 ~~~~~~~~~~~lg~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~g~~~ 268 (369)
+..++|.+.+.||+|+||.||+|+.. .+..||||+++.... ...+.+.+|++++.++ +||||++++++|.
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 45678999999999999999999853 235799999976543 3346789999999999 8999999999999
Q ss_pred eCCeeEEEEEecCCCcHhhhhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcE
Q 017558 269 FGSQRLLVYEFVPNKTLEFHLHGKD--------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANI 334 (369)
Q Consensus 269 ~~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Ni 334 (369)
..+..++||||+++|+|.+++.... ...+++..++.|+.||+.||.|||++ +|+||||||+||
T Consensus 146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NI 222 (382)
T 3tt0_A 146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV 222 (382)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGE
T ss_pred cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceE
Confidence 9999999999999999999997643 23589999999999999999999998 999999999999
Q ss_pred EECCCCcEEEeeeccceeeCCC
Q 017558 335 LLDDSFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 335 ll~~~~~~ki~DFGla~~~~~~ 356 (369)
||+.++.+||+|||+++.....
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~ 244 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHI 244 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCC
T ss_pred EEcCCCcEEEcccCcccccccc
Confidence 9999999999999999876543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-30 Score=251.37 Aligned_cols=163 Identities=26% Similarity=0.346 Sum_probs=129.7
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccC---CcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEE
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG---SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 275 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 275 (369)
..++|++.+.||+|+||.||+|... +++.||||+++.. .......+.+|+++|.+++||||++++++|...+..||
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 4567999999999999999999964 5889999999753 22334567889999999999999999999999999999
Q ss_pred EEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 276 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHE-DCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 276 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
||||+++|+|.+++... ..+++..+..++.||+.||+|||+ + +|+||||||+||||+.++.+||+|||+|+...
T Consensus 226 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 226 VMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp EECCCSSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EEeeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 99999999999999754 358999999999999999999998 7 89999999999999999999999999998754
Q ss_pred CCCceeeeeecccC
Q 017558 355 DTDTHVSTRVMGTF 368 (369)
Q Consensus 355 ~~~~~~~~~~~gt~ 368 (369)
..... ....+||+
T Consensus 301 ~~~~~-~~~~~gt~ 313 (446)
T 4ejn_A 301 KDGAT-MKTFCGTP 313 (446)
T ss_dssp C------CCSSSCG
T ss_pred CCCcc-cccccCCc
Confidence 43322 23356664
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.7e-30 Score=236.93 Aligned_cols=152 Identities=27% Similarity=0.423 Sum_probs=129.9
Q ss_pred hhcCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCCccc---HHHHHHHHHHHHhcCCCccccEeeEEEeCCe---
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQG---EREFQAEIEIISQVHHRHLVSLVGYCTFGSQ--- 272 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~--- 272 (369)
..++|++.+.||+|+||.||+|+. .+++.||||+++...... .+.+.+|++++.+++||||+++++++.....
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 357899999999999999999996 568899999997653322 3478899999999999999999999876543
Q ss_pred -eEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccce
Q 017558 273 -RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351 (369)
Q Consensus 273 -~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~ 351 (369)
.|+||||+++++|.++++... .+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred ccEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 399999999999999997543 489999999999999999999998 99999999999999999999999999998
Q ss_pred eeCCC
Q 017558 352 HSLDT 356 (369)
Q Consensus 352 ~~~~~ 356 (369)
.....
T Consensus 165 ~~~~~ 169 (311)
T 3ork_A 165 AIADS 169 (311)
T ss_dssp -----
T ss_pred ccccc
Confidence 76543
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-29 Score=244.83 Aligned_cols=163 Identities=20% Similarity=0.275 Sum_probs=138.3
Q ss_pred hhcCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCCc--ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEE
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 276 (369)
..++|++.+.||+|+||.||+|.. .+++.+|+|++..... ...+.+.+|+++|++++||||+++++++.+.+..|+|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 457799999999999999999985 4688999999976542 2345789999999999999999999999999999999
Q ss_pred EEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEC---CCCcEEEeeeccceee
Q 017558 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLD---DSFEAKVADFGLAKHS 353 (369)
Q Consensus 277 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~---~~~~~ki~DFGla~~~ 353 (369)
|||+++|+|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++ +++.+||+|||+++..
T Consensus 89 ~E~~~gg~L~~~i~~~~--~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~ 163 (444)
T 3soa_A 89 FDLVTGGELFEDIVARE--YYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163 (444)
T ss_dssp ECCCBCCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred EEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence 99999999999997653 489999999999999999999999 999999999999998 5688999999999887
Q ss_pred CCCCceeeeeecccC
Q 017558 354 LDTDTHVSTRVMGTF 368 (369)
Q Consensus 354 ~~~~~~~~~~~~gt~ 368 (369)
...... .....||+
T Consensus 164 ~~~~~~-~~~~~gt~ 177 (444)
T 3soa_A 164 EGEQQA-WFGFAGTP 177 (444)
T ss_dssp CTTCCB-CCCSCSCG
T ss_pred cCCCce-eecccCCc
Confidence 654322 22345654
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-29 Score=245.88 Aligned_cols=161 Identities=26% Similarity=0.375 Sum_probs=140.0
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC---cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEE
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 276 (369)
.++|.+.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+++|+.++||||+++++++...+..|+|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 467999999999999999999975 68999999996532 12345789999999999999999999999999999999
Q ss_pred EEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCC
Q 017558 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 277 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~ 356 (369)
|||+++|+|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++...+.
T Consensus 95 ~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 95 MEYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp EECCSSEEHHHHTTSS--SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred EeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 9999999999999754 3589999999999999999999998 9999999999999999999999999999987654
Q ss_pred CceeeeeecccC
Q 017558 357 DTHVSTRVMGTF 368 (369)
Q Consensus 357 ~~~~~~~~~gt~ 368 (369)
.. ....+||+
T Consensus 170 ~~--~~~~~gt~ 179 (476)
T 2y94_A 170 EF--LRTSCGSP 179 (476)
T ss_dssp CC--BCCCCSCS
T ss_pred cc--ccccCCCc
Confidence 32 22345554
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-29 Score=240.56 Aligned_cols=149 Identities=28% Similarity=0.392 Sum_probs=127.8
Q ss_pred cccceecccCceEEEEEEEc-CCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEecCCC
Q 017558 205 SEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNK 283 (369)
Q Consensus 205 ~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 283 (369)
...+.||+|+||.||+|+.. +++.||+|+++.......+.+.+|+++|.+++||||++++++|...+..+|||||++++
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 33678999999999999964 58899999998766556678999999999999999999999999999999999999999
Q ss_pred cHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEE--CCCCcEEEeeeccceeeCCCC
Q 017558 284 TLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILL--DDSFEAKVADFGLAKHSLDTD 357 (369)
Q Consensus 284 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill--~~~~~~ki~DFGla~~~~~~~ 357 (369)
+|.+++.... ..+++..++.++.||+.||.|||++ +|+||||||+|||+ +.++.+||+|||+++......
T Consensus 172 ~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~ 243 (373)
T 2x4f_A 172 ELFDRIIDES-YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE 243 (373)
T ss_dssp EEHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC
T ss_pred cHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc
Confidence 9999886543 3489999999999999999999998 99999999999999 677899999999999875543
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.8e-29 Score=229.23 Aligned_cols=149 Identities=26% Similarity=0.404 Sum_probs=129.6
Q ss_pred hhcCCcccceecccCceEEEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHh--cCCCccccEeeEEEeC----Cee
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQ--VHHRHLVSLVGYCTFG----SQR 273 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~g~~~~~----~~~ 273 (369)
..++|++.+.||+|+||.||+|+. +++.||||++... ..+.+.+|.+++.. ++||||+++++++... ...
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 457899999999999999999998 6899999998643 34566777777776 7899999999997653 457
Q ss_pred EEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeeecCCCCCcEEECCCCcEEEe
Q 017558 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLH--------EDCQPKIIHRDIKSANILLDDSFEAKVA 345 (369)
Q Consensus 274 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH--------~~~~~~ivHrdlk~~Nill~~~~~~ki~ 345 (369)
|+||||+++|+|.++++. ..+++..++.++.||+.||.||| ++ +|+||||||+|||++.++.+||+
T Consensus 82 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EEEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEEC
T ss_pred EEehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEe
Confidence 999999999999999954 35899999999999999999999 76 99999999999999999999999
Q ss_pred eeccceeeCCCCc
Q 017558 346 DFGLAKHSLDTDT 358 (369)
Q Consensus 346 DFGla~~~~~~~~ 358 (369)
|||+++.......
T Consensus 156 Dfg~a~~~~~~~~ 168 (301)
T 3q4u_A 156 DLGLAVMHSQSTN 168 (301)
T ss_dssp CCTTCEEEETTTT
T ss_pred eCCCeeecccccc
Confidence 9999988765543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.9e-30 Score=248.01 Aligned_cols=149 Identities=25% Similarity=0.376 Sum_probs=122.4
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC--cccHHHHHHHHHHHHhcCCCccccEeeEEEeC-----Ce
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFG-----SQ 272 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~ 272 (369)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+++|.+++|+||++++++|... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 468999999999999999999864 67899999996542 23346789999999999999999999999543 56
Q ss_pred eEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeecccee
Q 017558 273 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (369)
Q Consensus 273 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~ 352 (369)
.|+||||+ +++|.+++... ..+++..+..|+.||+.||+|||++ +|+||||||+||||+.++.+||+|||+|+.
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLART 205 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEecc-ccchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchh
Confidence 89999998 57999998754 3589999999999999999999999 999999999999999999999999999997
Q ss_pred eCC
Q 017558 353 SLD 355 (369)
Q Consensus 353 ~~~ 355 (369)
...
T Consensus 206 ~~~ 208 (458)
T 3rp9_A 206 VDY 208 (458)
T ss_dssp TTS
T ss_pred ccC
Confidence 653
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-29 Score=237.95 Aligned_cols=148 Identities=24% Similarity=0.324 Sum_probs=130.7
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEe
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 279 (369)
.++|++.+.||+|+||.||+++.. +++.||||++...... .+.+.+|+.++++++||||+++++++......|+||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI-DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS-CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc-cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 467999999999999999999975 6889999999765433 35788999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCc--EEEeeeccceeeC
Q 017558 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFE--AKVADFGLAKHSL 354 (369)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~--~ki~DFGla~~~~ 354 (369)
+++|+|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+||||+.++. +||+|||+++...
T Consensus 98 ~~~~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~ 169 (361)
T 3uc3_A 98 ASGGELYERICNAG--RFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 169 (361)
T ss_dssp CCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred CCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence 99999999996543 489999999999999999999998 9999999999999987765 9999999998543
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-29 Score=237.30 Aligned_cols=150 Identities=27% Similarity=0.384 Sum_probs=133.2
Q ss_pred hcCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCC---cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEE
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 276 (369)
.++|.+.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+++|+.++||||+++++++...+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 46799999999999999999996 568899999986431 12235789999999999999999999999999999999
Q ss_pred EEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCC
Q 017558 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 277 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~ 356 (369)
|||+ +|+|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||+++++.+||+|||+++...+.
T Consensus 88 ~E~~-~g~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEKK--RMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG 161 (336)
T ss_dssp ECCC-CEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred EECC-CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence 9999 789999886543 489999999999999999999999 9999999999999999999999999999876543
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=8.5e-30 Score=236.47 Aligned_cols=154 Identities=32% Similarity=0.474 Sum_probs=132.9
Q ss_pred HhhcCCcccceecccCceEEEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCC----eeE
Q 017558 199 IATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGS----QRL 274 (369)
Q Consensus 199 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----~~~ 274 (369)
+..++|++.+.||+|+||.||+|+.. ++.||||++.... .....+.+|+.+|.+++||||+++++++.... ..|
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 98 (322)
T 3soc_A 21 FQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLW 98 (322)
T ss_dssp ETTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cchhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEE
Confidence 35678999999999999999999985 7999999996543 22345667999999999999999999998754 469
Q ss_pred EEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-------CCCCeeecCCCCCcEEECCCCcEEEeee
Q 017558 275 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHED-------CQPKIIHRDIKSANILLDDSFEAKVADF 347 (369)
Q Consensus 275 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-------~~~~ivHrdlk~~Nill~~~~~~ki~DF 347 (369)
+||||+++|+|.+++... .+++..++.++.||+.||.|||++ +..+|+||||||+|||++.++.+||+||
T Consensus 99 lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DF 175 (322)
T 3soc_A 99 LITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF 175 (322)
T ss_dssp EEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCC
T ss_pred EEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccC
Confidence 999999999999999753 389999999999999999999975 1237999999999999999999999999
Q ss_pred ccceeeCCCC
Q 017558 348 GLAKHSLDTD 357 (369)
Q Consensus 348 Gla~~~~~~~ 357 (369)
|+++......
T Consensus 176 g~a~~~~~~~ 185 (322)
T 3soc_A 176 GLALKFEAGK 185 (322)
T ss_dssp TTCEEECTTS
T ss_pred Cccccccccc
Confidence 9998876543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-29 Score=234.11 Aligned_cols=151 Identities=25% Similarity=0.344 Sum_probs=134.0
Q ss_pred hhcCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCCcccHHHHHHHHHHHHhc-CCCccccEeeEEEeCCeeEEEE
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLVY 277 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~ 277 (369)
..++|++.+.||+|+||.||+|+. .+++.||||.+..... .+.+.+|++++.++ +|+||+++++++......++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~ 84 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL 84 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence 347899999999999999999995 5689999999875432 24688999999999 8999999999999999999999
Q ss_pred EecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCc-----EEEeeecccee
Q 017558 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFE-----AKVADFGLAKH 352 (369)
Q Consensus 278 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~-----~ki~DFGla~~ 352 (369)
||+ +++|.+++.... ..+++..++.|+.||+.||+|||++ +|+||||||+|||++.++. +||+|||+++.
T Consensus 85 e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 85 ELL-GPSLEDLFDLCD-RTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp ECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred EeC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 999 999999997642 4599999999999999999999998 9999999999999998887 99999999998
Q ss_pred eCCCC
Q 017558 353 SLDTD 357 (369)
Q Consensus 353 ~~~~~ 357 (369)
..+..
T Consensus 160 ~~~~~ 164 (330)
T 2izr_A 160 YIDPE 164 (330)
T ss_dssp SBCTT
T ss_pred eecCC
Confidence 76543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.7e-29 Score=226.78 Aligned_cols=153 Identities=24% Similarity=0.311 Sum_probs=137.6
Q ss_pred hhcCCcccceecccCceEEEEEEEcC-CeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEE
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 278 (369)
..++|++.+.||+|+||.||+|.... +..+|+|++........+.+.+|++++.+++||||++++++|......++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 34678999999999999999999754 67899999977655667789999999999999999999999999999999999
Q ss_pred ecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEE---CCCCcEEEeeeccceeeCC
Q 017558 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILL---DDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill---~~~~~~ki~DFGla~~~~~ 355 (369)
|+++++|.+++... ..+++..+..++.|++.||.|||++ +++||||||+|||+ +.++.+||+|||+++....
T Consensus 87 ~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 87 LCTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161 (277)
T ss_dssp CCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred ccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence 99999999998754 3489999999999999999999999 99999999999999 7889999999999988654
Q ss_pred CC
Q 017558 356 TD 357 (369)
Q Consensus 356 ~~ 357 (369)
..
T Consensus 162 ~~ 163 (277)
T 3f3z_A 162 GK 163 (277)
T ss_dssp TS
T ss_pred cc
Confidence 43
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.8e-29 Score=231.89 Aligned_cols=151 Identities=25% Similarity=0.271 Sum_probs=129.0
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcc--cHHHHHHHHHHHHhc-CCCccccEeeEEEeCCeeEEE
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ--GEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLV 276 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv 276 (369)
.++|+..+.||+|+||.||+|+.. +++.||||++...... ....+..|+..+.++ +|+||++++++|.+.+..|+|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 367999999999999999999976 6899999998654322 233455666666555 899999999999999999999
Q ss_pred EEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCC
Q 017558 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 277 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~ 356 (369)
|||+ +++|.+++.... ..++|..++.|+.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++.....
T Consensus 136 ~e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~ 210 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA 210 (311)
T ss_dssp EECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred Eecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence 9999 778888887543 3599999999999999999999998 9999999999999999999999999999887543
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.8e-29 Score=242.34 Aligned_cols=150 Identities=27% Similarity=0.371 Sum_probs=131.4
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC--cccHHHHHHHHHHHHhcCCCccccEeeEEEeC-----Ce
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFG-----SQ 272 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~ 272 (369)
.++|++.+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|+++|.+++|+||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 578999999999999999999964 57899999997542 23346789999999999999999999999766 57
Q ss_pred eEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeecccee
Q 017558 273 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (369)
Q Consensus 273 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~ 352 (369)
.|+||||++ ++|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+|+.
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLART 178 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEecCC-cCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence 899999996 6999999754 3589999999999999999999999 999999999999999999999999999998
Q ss_pred eCCC
Q 017558 353 SLDT 356 (369)
Q Consensus 353 ~~~~ 356 (369)
....
T Consensus 179 ~~~~ 182 (432)
T 3n9x_A 179 INSE 182 (432)
T ss_dssp C---
T ss_pred cccc
Confidence 7543
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-29 Score=229.16 Aligned_cols=154 Identities=27% Similarity=0.437 Sum_probs=125.9
Q ss_pred HhhcCCcccceecccCceEEEEEEEcC----CeEEEEEeeccCCc-ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCee
Q 017558 199 IATDNFSEANLLGQGGFGYVHKGVLTN----GKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQR 273 (369)
Q Consensus 199 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 273 (369)
+..++|++.+.||+|+||.||+|.... +..||+|.++.... ...+.+.+|+.++.+++||||+++++++. ++..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~ 90 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 90 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCcc
Confidence 355789999999999999999998643 45799999876433 33457899999999999999999999984 5678
Q ss_pred EEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceee
Q 017558 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (369)
Q Consensus 274 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~ 353 (369)
|+||||+++++|.+++.... ..+++..++.++.|++.||.|||++ +++||||||+|||++.++.+||+|||+++..
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 91 WIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp EEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECcccccccc
Confidence 99999999999999997543 3589999999999999999999998 9999999999999999999999999999887
Q ss_pred CCCC
Q 017558 354 LDTD 357 (369)
Q Consensus 354 ~~~~ 357 (369)
.+..
T Consensus 167 ~~~~ 170 (281)
T 1mp8_A 167 EDST 170 (281)
T ss_dssp ----
T ss_pred Cccc
Confidence 5543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.7e-29 Score=232.53 Aligned_cols=151 Identities=28% Similarity=0.427 Sum_probs=119.7
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCc-ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEE
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 278 (369)
.++|+..+.||+|+||.||+|... +++.||||+++.... ...+.+.+|++++++++||||+++++++..++..|+|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 357888999999999999999864 588999999975432 234678899999999999999999999999999999999
Q ss_pred ecCCCcHhhhhcCCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 279 FVPNKTLEFHLHGKD----RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 279 ~~~~g~L~~~l~~~~----~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
|++ |+|.+++.... ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 68988886421 23588999999999999999999998 99999999999999999999999999998765
Q ss_pred C
Q 017558 355 D 355 (369)
Q Consensus 355 ~ 355 (369)
.
T Consensus 160 ~ 160 (317)
T 2pmi_A 160 I 160 (317)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.9e-29 Score=235.56 Aligned_cols=149 Identities=27% Similarity=0.336 Sum_probs=122.7
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEE
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 278 (369)
..++|++.+.||+|+||.||+|+.. +++.||||+++... ..+.+.+|+++|.+++|+||++++++|...+..++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 4578999999999999999999976 47889999997543 34578899999999999999999999999999999999
Q ss_pred ecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECC---CCcEEEeeeccceeeCC
Q 017558 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD---SFEAKVADFGLAKHSLD 355 (369)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~---~~~~ki~DFGla~~~~~ 355 (369)
|+++|+|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++. ++.+||+|||+++....
T Consensus 129 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 129 LVTGGELFDRIVEK--GYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203 (349)
T ss_dssp CCCSCBHHHHHTTC--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred eCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence 99999999999754 3489999999999999999999998 9999999999999975 88999999999987654
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.9e-29 Score=231.41 Aligned_cols=157 Identities=29% Similarity=0.503 Sum_probs=137.8
Q ss_pred HHhhcCCcccceecccCceEEEEEEEc------CCeEEEEEeeccCCc-ccHHHHHHHHHHHHhcCCCccccEeeEEEeC
Q 017558 198 KIATDNFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFG 270 (369)
Q Consensus 198 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~ 270 (369)
....++|.+.+.||+|+||.||+|... ++..||||+++.... ...+.+.+|++++.+++||||+++++++...
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 98 (314)
T 2ivs_A 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD 98 (314)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC
Confidence 345678999999999999999999852 347899999976543 3446789999999999999999999999999
Q ss_pred CeeEEEEEecCCCcHhhhhcCCCC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecC
Q 017558 271 SQRLLVYEFVPNKTLEFHLHGKDR----------------------PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRD 328 (369)
Q Consensus 271 ~~~~lv~e~~~~g~L~~~l~~~~~----------------------~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrd 328 (369)
+..++||||+++++|.+++..... ..+++..++.++.||+.||.|||++ +|+|||
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~d 175 (314)
T 2ivs_A 99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRD 175 (314)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCC
T ss_pred CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccc
Confidence 999999999999999999975432 2378999999999999999999998 999999
Q ss_pred CCCCcEEECCCCcEEEeeeccceeeCCCC
Q 017558 329 IKSANILLDDSFEAKVADFGLAKHSLDTD 357 (369)
Q Consensus 329 lk~~Nill~~~~~~ki~DFGla~~~~~~~ 357 (369)
|||+|||++.++.+||+|||+++.....+
T Consensus 176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~ 204 (314)
T 2ivs_A 176 LAARNILVAEGRKMKISDFGLSRDVYEED 204 (314)
T ss_dssp CSGGGEEEETTTEEEECCCTTCEECTTTS
T ss_pred cchheEEEcCCCCEEEccccccccccccc
Confidence 99999999999999999999999876544
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-29 Score=235.77 Aligned_cols=157 Identities=26% Similarity=0.479 Sum_probs=135.1
Q ss_pred HHHhhcCCcccceecccCceEEEEEEEc------CCeEEEEEeeccCC-cccHHHHHHHHHHHHhc-CCCccccEeeEEE
Q 017558 197 LKIATDNFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLKAGS-GQGEREFQAEIEIISQV-HHRHLVSLVGYCT 268 (369)
Q Consensus 197 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~ 268 (369)
+.+..++|.+.+.||+|+||.||+|+.. ++..||||+++... ....+.+.+|++++.++ +||||+++++++.
T Consensus 40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 119 (344)
T 1rjb_A 40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 119 (344)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 3446688999999999999999999962 35689999997543 23346799999999999 8999999999999
Q ss_pred eCCeeEEEEEecCCCcHhhhhcCCCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeec
Q 017558 269 FGSQRLLVYEFVPNKTLEFHLHGKDR---------------------PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHR 327 (369)
Q Consensus 269 ~~~~~~lv~e~~~~g~L~~~l~~~~~---------------------~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHr 327 (369)
..+..++||||+++|+|.+++..... ..+++..++.++.||+.||.|||++ +|+||
T Consensus 120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~ 196 (344)
T 1rjb_A 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHR 196 (344)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEET
T ss_pred eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccC
Confidence 99999999999999999999976432 2378999999999999999999998 99999
Q ss_pred CCCCCcEEECCCCcEEEeeeccceeeCCC
Q 017558 328 DIKSANILLDDSFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 328 dlk~~Nill~~~~~~ki~DFGla~~~~~~ 356 (369)
||||+||||+.++.+||+|||+++.....
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~ 225 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSD 225 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGC
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccC
Confidence 99999999999999999999999876544
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.6e-29 Score=228.49 Aligned_cols=150 Identities=24% Similarity=0.366 Sum_probs=133.6
Q ss_pred cCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcc--cHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEE
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ--GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 278 (369)
++|++.+.||+|+||.||+|+.. +++.||||++...... ..+.+.+|++++.+++|+||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 67999999999999999999975 4889999998654332 24568899999999999999999999999999999999
Q ss_pred ecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCC
Q 017558 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~ 356 (369)
|+++++|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~~~~l~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 83 YCDHTVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp CCSEEHHHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred eCCCchHHHHHhhh--cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 99999999988654 3489999999999999999999999 9999999999999999999999999999886543
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-29 Score=227.71 Aligned_cols=151 Identities=32% Similarity=0.518 Sum_probs=137.2
Q ss_pred hhcCCcccceecccCceEEEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEe
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 279 (369)
..++|++.+.||+|+||.||++...+++.||+|+++.... ..+++.+|++++.+++||||+++++++...+..++||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (267)
T 3t9t_A 6 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF 84 (267)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred chhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence 3467899999999999999999998889999999976543 346899999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
+++++|.+++.... ..+++..++.++.|++.||.|||++ +++||||||+|||++.++.+||+|||+++...+
T Consensus 85 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 156 (267)
T 3t9t_A 85 MEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 156 (267)
T ss_dssp CTTCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred CCCCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccc
Confidence 99999999997643 3589999999999999999999999 999999999999999999999999999987643
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.5e-29 Score=228.95 Aligned_cols=153 Identities=30% Similarity=0.506 Sum_probs=132.5
Q ss_pred hcCCcccceecccCceEEEEEEE-----cCCeEEEEEeeccCC-cccHHHHHHHHHHHHhcCCCccccEeeEEEeC--Ce
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVL-----TNGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFG--SQ 272 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~ 272 (369)
.+.|+..+.||+|+||.||+|++ .+++.||||+++... ....+.+.+|++++.+++|+||+++++++... ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 35688899999999999999984 357899999997543 33456899999999999999999999999876 66
Q ss_pred eEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeecccee
Q 017558 273 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (369)
Q Consensus 273 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~ 352 (369)
.++||||+++|+|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECccccccc
Confidence 899999999999999996543 3489999999999999999999998 999999999999999999999999999998
Q ss_pred eCCCC
Q 017558 353 SLDTD 357 (369)
Q Consensus 353 ~~~~~ 357 (369)
.....
T Consensus 176 ~~~~~ 180 (302)
T 4e5w_A 176 IETDK 180 (302)
T ss_dssp CCTTC
T ss_pred ccCCC
Confidence 76544
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-29 Score=229.94 Aligned_cols=151 Identities=28% Similarity=0.439 Sum_probs=134.9
Q ss_pred hhcCCcccceecccCceEEEEEEEcC-C-------eEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCC
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVLTN-G-------KVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGS 271 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~ 271 (369)
..++|.+.+.||+|+||.||+|+... + ..||+|.+........+.+.+|++++.+++||||++++++|...+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD 85 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence 35688999999999999999998543 2 479999997766566678999999999999999999999999999
Q ss_pred eeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCc--------EE
Q 017558 272 QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFE--------AK 343 (369)
Q Consensus 272 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~--------~k 343 (369)
..++||||+++|+|.+++.... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++. +|
T Consensus 86 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 86 ENILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CCEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CCEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceee
Confidence 9999999999999999997643 3489999999999999999999999 9999999999999998887 99
Q ss_pred EeeeccceeeC
Q 017558 344 VADFGLAKHSL 354 (369)
Q Consensus 344 i~DFGla~~~~ 354 (369)
|+|||+++...
T Consensus 162 l~Dfg~~~~~~ 172 (289)
T 4fvq_A 162 LSDPGISITVL 172 (289)
T ss_dssp ECCCCSCTTTS
T ss_pred eccCccccccc
Confidence 99999997654
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.96 E-value=4.6e-29 Score=238.45 Aligned_cols=147 Identities=24% Similarity=0.319 Sum_probs=125.7
Q ss_pred cCCccc-ceecccCceEEEEEEEc-CCeEEEEEeeccCCcccHHHHHHHHHHHHh-cCCCccccEeeEEEe----CCeeE
Q 017558 202 DNFSEA-NLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQ-VHHRHLVSLVGYCTF----GSQRL 274 (369)
Q Consensus 202 ~~~~~~-~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~g~~~~----~~~~~ 274 (369)
++|... ++||+|+||.||+|... +++.||||+++. ...+.+|++++.+ .+|+||++++++|.. ....|
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 556665 78999999999999965 578999999863 2467889988755 589999999999876 56789
Q ss_pred EEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECC---CCcEEEeeeccce
Q 017558 275 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD---SFEAKVADFGLAK 351 (369)
Q Consensus 275 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~---~~~~ki~DFGla~ 351 (369)
||||||++|+|.+++.......+++..+..|+.||+.||.|||++ +|+||||||+||||+. ++.+||+|||+++
T Consensus 136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~ 212 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212 (400)
T ss_dssp EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEeccccc
Confidence 999999999999999876555699999999999999999999998 9999999999999997 7899999999999
Q ss_pred eeCCC
Q 017558 352 HSLDT 356 (369)
Q Consensus 352 ~~~~~ 356 (369)
.....
T Consensus 213 ~~~~~ 217 (400)
T 1nxk_A 213 ETTSH 217 (400)
T ss_dssp ECC--
T ss_pred ccCCC
Confidence 76543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-29 Score=239.06 Aligned_cols=152 Identities=30% Similarity=0.429 Sum_probs=132.6
Q ss_pred hhcCCcccceecccCceEEEEEEEc------CCeEEEEEeeccCC-cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCe
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQ 272 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 272 (369)
..++|++.+.||+|+||.||+|++. +++.||||+++... .....++.+|+.++.+++||||+++++++.....
T Consensus 69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 148 (367)
T 3l9p_A 69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 148 (367)
T ss_dssp CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 3567899999999999999999953 35689999997543 3344578999999999999999999999999999
Q ss_pred eEEEEEecCCCcHhhhhcCCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCC---cEEE
Q 017558 273 RLLVYEFVPNKTLEFHLHGKD-----RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF---EAKV 344 (369)
Q Consensus 273 ~~lv~e~~~~g~L~~~l~~~~-----~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~---~~ki 344 (369)
.|+||||+++|+|.+++.... ...+++.+++.++.||+.||.|||++ +|+||||||+||||+.++ .+||
T Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEE
Confidence 999999999999999997532 23589999999999999999999999 999999999999999554 5999
Q ss_pred eeeccceeeC
Q 017558 345 ADFGLAKHSL 354 (369)
Q Consensus 345 ~DFGla~~~~ 354 (369)
+|||+++...
T Consensus 226 ~DFG~a~~~~ 235 (367)
T 3l9p_A 226 GDFGMARDIY 235 (367)
T ss_dssp CCCHHHHHHH
T ss_pred CCCccccccc
Confidence 9999998653
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.9e-29 Score=229.94 Aligned_cols=152 Identities=22% Similarity=0.310 Sum_probs=130.8
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcc---cHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEE
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ---GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 276 (369)
.++|++.+.||+|+||.||+|+.. +++.||||++...... ..+.+.+|++++.+++||||+++++++..++..|+|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 478999999999999999999965 6889999999764332 235788999999999999999999999999999999
Q ss_pred EEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCC
Q 017558 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 277 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~ 356 (369)
|||+++++|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 113 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred EEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 9999999999999754 3489999999999999999999998 9999999999999999999999999999876554
Q ss_pred C
Q 017558 357 D 357 (369)
Q Consensus 357 ~ 357 (369)
.
T Consensus 188 ~ 188 (309)
T 2h34_A 188 K 188 (309)
T ss_dssp -
T ss_pred c
Confidence 3
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=9.2e-30 Score=236.01 Aligned_cols=158 Identities=28% Similarity=0.462 Sum_probs=123.3
Q ss_pred HHHhhcCCcccceecccCceEEEEEEEcCC----eEEEEEeeccC--CcccHHHHHHHHHHHHhcCCCccccEeeEEEeC
Q 017558 197 LKIATDNFSEANLLGQGGFGYVHKGVLTNG----KVVAIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFG 270 (369)
Q Consensus 197 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~----~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~ 270 (369)
+.+..++|++.+.||+|+||.||+|+.... ..||||+++.. .....+.+.+|++++.+++||||+++++++...
T Consensus 18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 97 (323)
T 3qup_A 18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRS 97 (323)
T ss_dssp TBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred cccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence 445667899999999999999999996443 27999999765 233456899999999999999999999999877
Q ss_pred Cee------EEEEEecCCCcHhhhhcCCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCC
Q 017558 271 SQR------LLVYEFVPNKTLEFHLHGKD----RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF 340 (369)
Q Consensus 271 ~~~------~lv~e~~~~g~L~~~l~~~~----~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~ 340 (369)
... ++||||+++|+|.+++.... ...+++..++.|+.||+.||.|||++ +|+||||||+|||+++++
T Consensus 98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~ 174 (323)
T 3qup_A 98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDM 174 (323)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTS
T ss_pred ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCC
Confidence 655 99999999999999986422 22589999999999999999999999 999999999999999999
Q ss_pred cEEEeeeccceeeCCCC
Q 017558 341 EAKVADFGLAKHSLDTD 357 (369)
Q Consensus 341 ~~ki~DFGla~~~~~~~ 357 (369)
.+||+|||+++.....+
T Consensus 175 ~~kl~Dfg~a~~~~~~~ 191 (323)
T 3qup_A 175 TVCVADFGLSRKIYSGD 191 (323)
T ss_dssp CEEECCCCC--------
T ss_pred CEEEeeccccccccccc
Confidence 99999999998765443
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=5e-29 Score=237.90 Aligned_cols=153 Identities=25% Similarity=0.355 Sum_probs=134.2
Q ss_pred hcCCcccceecccCceEEEEEEEcC-CeEEEEEeeccCC-cccHHHHHHHHHHHHhcCCCccccEeeEEEeCC--eeEEE
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGS--QRLLV 276 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~--~~~lv 276 (369)
.++|.+.+.||+|+||.||+|+... ++.||||+++... ....+.+.+|+++|.+++||||+++++++.... ..|+|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 4678999999999999999999754 8899999997543 234567889999999999999999999998755 67999
Q ss_pred EEecCCCcHhhhhcCCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEE----CCCCcEEEeeeccce
Q 017558 277 YEFVPNKTLEFHLHGKDR-PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILL----DDSFEAKVADFGLAK 351 (369)
Q Consensus 277 ~e~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill----~~~~~~ki~DFGla~ 351 (369)
|||+++|+|.+++..... ..+++..++.++.||+.||.|||++ +|+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999976432 2389999999999999999999999 99999999999999 788889999999999
Q ss_pred eeCCC
Q 017558 352 HSLDT 356 (369)
Q Consensus 352 ~~~~~ 356 (369)
.....
T Consensus 165 ~~~~~ 169 (396)
T 4eut_A 165 ELEDD 169 (396)
T ss_dssp ECCCG
T ss_pred EccCC
Confidence 87554
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.96 E-value=9.1e-29 Score=230.59 Aligned_cols=156 Identities=28% Similarity=0.494 Sum_probs=136.4
Q ss_pred HhhcCCcccceecccCceEEEEEEEc--------CCeEEEEEeeccCCc-ccHHHHHHHHHHHHhc-CCCccccEeeEEE
Q 017558 199 IATDNFSEANLLGQGGFGYVHKGVLT--------NGKVVAIKQLKAGSG-QGEREFQAEIEIISQV-HHRHLVSLVGYCT 268 (369)
Q Consensus 199 ~~~~~~~~~~~lg~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~g~~~ 268 (369)
+..++|.+.+.||+|+||.||+|+.. ++..||||+++.... ...+.+.+|++++.++ +||||++++++|.
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 111 (334)
T 2pvf_A 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 111 (334)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence 34678999999999999999999863 457899999976543 3346789999999999 8999999999999
Q ss_pred eCCeeEEEEEecCCCcHhhhhcCCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcE
Q 017558 269 FGSQRLLVYEFVPNKTLEFHLHGKDR--------------PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANI 334 (369)
Q Consensus 269 ~~~~~~lv~e~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Ni 334 (369)
..+..|+||||+++|+|.+++..... ..+++..++.++.||+.||.|||++ +|+||||||+||
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NI 188 (334)
T 2pvf_A 112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNV 188 (334)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceE
Confidence 99999999999999999999976432 2488999999999999999999998 999999999999
Q ss_pred EECCCCcEEEeeeccceeeCCCC
Q 017558 335 LLDDSFEAKVADFGLAKHSLDTD 357 (369)
Q Consensus 335 ll~~~~~~ki~DFGla~~~~~~~ 357 (369)
|++.++.+||+|||+++......
T Consensus 189 ll~~~~~~kL~Dfg~~~~~~~~~ 211 (334)
T 2pvf_A 189 LVTENNVMKIADFGLARDINNID 211 (334)
T ss_dssp EECTTCCEEECCCTTCEECTTTS
T ss_pred EEcCCCCEEEccccccccccccc
Confidence 99999999999999999876544
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.96 E-value=3.1e-29 Score=254.36 Aligned_cols=165 Identities=25% Similarity=0.330 Sum_probs=140.5
Q ss_pred HhhcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC---cccHHHHHHHHHHHHhc-CCCccccEeeEEEeCCee
Q 017558 199 IATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQR 273 (369)
Q Consensus 199 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 273 (369)
...++|++.++||+|+||.||+|+.. +++.||||+++... ....+.+..|.++|..+ +|+||+.+++++.+.+..
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 44578999999999999999999965 47889999997531 23345788899999988 699999999999999999
Q ss_pred EEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceee
Q 017558 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (369)
Q Consensus 274 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~ 353 (369)
||||||+++|+|.++|+... .+++..+..|+.||+.||+|||++ +|+||||||+||||+.++.+||+|||+|+..
T Consensus 418 ~lV~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEEeCcCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 99999999999999997643 489999999999999999999999 9999999999999999999999999999975
Q ss_pred CCCCceeeeeecccCC
Q 017558 354 LDTDTHVSTRVMGTFG 369 (369)
Q Consensus 354 ~~~~~~~~~~~~gt~g 369 (369)
..... .....+||++
T Consensus 493 ~~~~~-~~~~~~GT~~ 507 (674)
T 3pfq_A 493 IWDGV-TTKTFCGTPD 507 (674)
T ss_dssp CCTTC-CBCCCCSCSS
T ss_pred ccCCc-ccccccCCCc
Confidence 54332 2344677753
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.9e-29 Score=231.28 Aligned_cols=157 Identities=28% Similarity=0.481 Sum_probs=138.4
Q ss_pred HHhhcCCcccceecccCceEEEEEEE------cCCeEEEEEeeccCCc-ccHHHHHHHHHHHHhc-CCCccccEeeEEEe
Q 017558 198 KIATDNFSEANLLGQGGFGYVHKGVL------TNGKVVAIKQLKAGSG-QGEREFQAEIEIISQV-HHRHLVSLVGYCTF 269 (369)
Q Consensus 198 ~~~~~~~~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~ 269 (369)
.+..++|++.+.||+|+||.||+|+. .+++.||||+++.... ...+.+.+|++++.++ +||||++++++|..
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 98 (313)
T 1t46_A 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (313)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence 44567899999999999999999985 2467899999976543 3346789999999999 89999999999999
Q ss_pred CCeeEEEEEecCCCcHhhhhcCCCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCc
Q 017558 270 GSQRLLVYEFVPNKTLEFHLHGKDR----------------PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSAN 333 (369)
Q Consensus 270 ~~~~~lv~e~~~~g~L~~~l~~~~~----------------~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~N 333 (369)
.+..++||||+++|+|.+++..... ..+++..++.++.||+.||.|||++ +++||||||+|
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~N 175 (313)
T 1t46_A 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARN 175 (313)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccce
Confidence 9999999999999999999976432 2489999999999999999999998 99999999999
Q ss_pred EEECCCCcEEEeeeccceeeCCCC
Q 017558 334 ILLDDSFEAKVADFGLAKHSLDTD 357 (369)
Q Consensus 334 ill~~~~~~ki~DFGla~~~~~~~ 357 (369)
||++.++.+||+|||+++......
T Consensus 176 il~~~~~~~kl~Dfg~~~~~~~~~ 199 (313)
T 1t46_A 176 ILLTHGRITKICDFGLARDIKNDS 199 (313)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCT
T ss_pred EEEcCCCCEEEccccccccccccc
Confidence 999999999999999998766543
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.7e-29 Score=234.46 Aligned_cols=153 Identities=27% Similarity=0.343 Sum_probs=135.5
Q ss_pred hhcCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCCcc--------cHHHHHHHHHHHHhcCCCccccEeeEEEeC
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQ--------GEREFQAEIEIISQVHHRHLVSLVGYCTFG 270 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~ 270 (369)
..++|++.+.||+|+||.||+|+. .+++.||||+++..... ..+.+.+|+++|.+++|+||++++++|...
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 356899999999999999999985 46889999999765321 234678899999999999999999999999
Q ss_pred CeeEEEEEecCCC-cHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeecc
Q 017558 271 SQRLLVYEFVPNK-TLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGL 349 (369)
Q Consensus 271 ~~~~lv~e~~~~g-~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGl 349 (369)
+..++||||+.+| +|.+++.... .+++..+..|+.||+.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 176 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHP--RLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGS 176 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeeccc
Confidence 9999999999777 9999997643 489999999999999999999999 999999999999999999999999999
Q ss_pred ceeeCCCC
Q 017558 350 AKHSLDTD 357 (369)
Q Consensus 350 a~~~~~~~ 357 (369)
++......
T Consensus 177 a~~~~~~~ 184 (335)
T 3dls_A 177 AAYLERGK 184 (335)
T ss_dssp CEECCTTC
T ss_pred ceECCCCC
Confidence 99876544
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.6e-29 Score=231.31 Aligned_cols=150 Identities=25% Similarity=0.391 Sum_probs=134.4
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC---cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEE
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 276 (369)
.++|.+.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.++.+++|+||+++++++.+.+..|+|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 467889999999999999999975 46789999986542 23345788999999999999999999999999999999
Q ss_pred EEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 277 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
|||+++++|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 120 ~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 120 LELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp ECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 9999999999998654 3589999999999999999999998 999999999999999999999999999988653
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-28 Score=223.72 Aligned_cols=151 Identities=28% Similarity=0.407 Sum_probs=134.8
Q ss_pred hcCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCC---cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEE
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 276 (369)
.++|++.+.||+|+||.||+|+. .+++.||||.+.... ....+.+.+|++++.+++||||+++++++...+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 46799999999999999999996 468899999986432 12246789999999999999999999999999999999
Q ss_pred EEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 277 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
|||+++++|.+++.... ..+++..++.++.|++.||.|||++ +++||||||+|||++.++.+||+|||+++....
T Consensus 90 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EECCTTEEHHHHHHTCS-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EecCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 99999999999997643 3589999999999999999999998 999999999999999999999999999987653
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.9e-29 Score=230.66 Aligned_cols=153 Identities=29% Similarity=0.447 Sum_probs=136.3
Q ss_pred hcCCcccceecccCceEEEEEEE-----cCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEE--eCCee
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVL-----TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCT--FGSQR 273 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~~ 273 (369)
.++|++.+.||+|+||.||+|++ .+++.||||++........+.+.+|++++.+++|+||+++++++. .....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 46889999999999999999984 357899999998766566678999999999999999999999987 45678
Q ss_pred EEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceee
Q 017558 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (369)
Q Consensus 274 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~ 353 (369)
++||||+++++|.+++.... ..+++..++.|+.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred EEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceec
Confidence 99999999999999997532 2489999999999999999999998 9999999999999999999999999999987
Q ss_pred CCCC
Q 017558 354 LDTD 357 (369)
Q Consensus 354 ~~~~ 357 (369)
....
T Consensus 178 ~~~~ 181 (327)
T 3lxl_A 178 PLDK 181 (327)
T ss_dssp CTTC
T ss_pred ccCC
Confidence 5443
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.1e-29 Score=234.03 Aligned_cols=159 Identities=24% Similarity=0.341 Sum_probs=138.9
Q ss_pred cCHHHHHHhhcCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCCcccHHHHHHHHHHHHhcC-----CCccccEee
Q 017558 192 FTYEELKIATDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVH-----HRHLVSLVG 265 (369)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~g 265 (369)
+.+++.....++|++.+.||+|+||.||+|+. .+++.||||+++.. ....+.+..|++++.++. |+||+++++
T Consensus 25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~ 103 (360)
T 3llt_A 25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHG 103 (360)
T ss_dssp CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence 33444556678999999999999999999997 46789999998743 233456788999999986 999999999
Q ss_pred EEEeCCeeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECC-------
Q 017558 266 YCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD------- 338 (369)
Q Consensus 266 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~------- 338 (369)
++...+..|+||||+ +++|.+++.......+++..+..++.||+.||.|||++ +|+||||||+||||+.
T Consensus 104 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~ 179 (360)
T 3llt_A 104 KFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSL 179 (360)
T ss_dssp EEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEE
T ss_pred eeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccccc
Confidence 999999999999999 99999999876655699999999999999999999998 9999999999999975
Q ss_pred ------------------CCcEEEeeeccceeeCC
Q 017558 339 ------------------SFEAKVADFGLAKHSLD 355 (369)
Q Consensus 339 ------------------~~~~ki~DFGla~~~~~ 355 (369)
++.+||+|||+++....
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~ 214 (360)
T 3llt_A 180 ITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD 214 (360)
T ss_dssp EEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS
T ss_pred cchhcccccccccccccCCCCEEEEeccCceecCC
Confidence 78999999999987544
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.7e-29 Score=234.94 Aligned_cols=156 Identities=25% Similarity=0.313 Sum_probs=132.7
Q ss_pred HHHhhcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccC-----CcccHHHHHHHHHHHHhcCCCccccEeeEEEeC
Q 017558 197 LKIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG-----SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFG 270 (369)
Q Consensus 197 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~ 270 (369)
+....++|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|++++.+++||||++++++|.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 4456678999999999999999999964 5788999998643 233456899999999999999999999999999
Q ss_pred CeeEEEEEecCCCcHhhhhcCCC--------------------------------------CCCCCHHHHHHHHHHHHHH
Q 017558 271 SQRLLVYEFVPNKTLEFHLHGKD--------------------------------------RPVMNWPTRMKIALGSARG 312 (369)
Q Consensus 271 ~~~~lv~e~~~~g~L~~~l~~~~--------------------------------------~~~l~~~~~~~i~~~i~~~ 312 (369)
+..++||||+++|+|.+++.... ...+++..+..|+.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 99999999999999999985210 1123567788899999999
Q ss_pred HHHHHhCCCCCeeecCCCCCcEEECCCC--cEEEeeeccceeeCC
Q 017558 313 LAYLHEDCQPKIIHRDIKSANILLDDSF--EAKVADFGLAKHSLD 355 (369)
Q Consensus 313 l~yLH~~~~~~ivHrdlk~~Nill~~~~--~~ki~DFGla~~~~~ 355 (369)
|.|||++ +|+||||||+|||++.++ .+||+|||+++....
T Consensus 181 l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~ 222 (345)
T 3hko_A 181 LHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYK 222 (345)
T ss_dssp HHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGG
T ss_pred HHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccc
Confidence 9999999 999999999999998766 899999999997644
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-28 Score=228.14 Aligned_cols=151 Identities=29% Similarity=0.374 Sum_probs=135.5
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcc------cHHHHHHHHHHHHhcCCCccccEeeEEEeCCee
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ------GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQR 273 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 273 (369)
.++|++.+.||+|+||.||+|+.. +++.||||.++..... ..+++.+|++++.+++||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 467899999999999999999975 5889999998754321 356899999999999999999999999999999
Q ss_pred EEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCC----cEEEeeecc
Q 017558 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF----EAKVADFGL 349 (369)
Q Consensus 274 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~----~~ki~DFGl 349 (369)
++||||+++++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++ .+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~ 165 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (321)
T ss_dssp EEEECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred EEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence 9999999999999999754 3589999999999999999999998 999999999999999887 799999999
Q ss_pred ceeeCCC
Q 017558 350 AKHSLDT 356 (369)
Q Consensus 350 a~~~~~~ 356 (369)
++...+.
T Consensus 166 ~~~~~~~ 172 (321)
T 2a2a_A 166 AHEIEDG 172 (321)
T ss_dssp CEECCTT
T ss_pred ceecCcc
Confidence 9987653
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.1e-28 Score=225.49 Aligned_cols=148 Identities=34% Similarity=0.541 Sum_probs=132.0
Q ss_pred CcccceecccCceEEEEEEEc-----CCeEEEEEeeccCCc-ccHHHHHHHHHHHHhcCCCccccEeeEEEeC--CeeEE
Q 017558 204 FSEANLLGQGGFGYVHKGVLT-----NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFG--SQRLL 275 (369)
Q Consensus 204 ~~~~~~lg~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~l 275 (369)
|++.+.||+|+||.||++.+. +++.||||+++.... ...+.+.+|+++|.+++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 488999999999999998753 578999999976543 3346789999999999999999999999884 67899
Q ss_pred EEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 276 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 276 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
||||+++|+|.+++... .+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 113 v~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 186 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186 (318)
T ss_dssp EECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred EEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccccc
Confidence 99999999999999754 389999999999999999999999 999999999999999999999999999998765
Q ss_pred CC
Q 017558 356 TD 357 (369)
Q Consensus 356 ~~ 357 (369)
..
T Consensus 187 ~~ 188 (318)
T 3lxp_A 187 GH 188 (318)
T ss_dssp TC
T ss_pred cc
Confidence 43
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.6e-29 Score=233.02 Aligned_cols=152 Identities=22% Similarity=0.352 Sum_probs=136.2
Q ss_pred hhcCCcccceecccCceEEEEEEEcCCeEEEEEeeccCCcc---c--------------HHHHHHHHHHHHhcCCCcccc
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQ---G--------------EREFQAEIEIISQVHHRHLVS 262 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~--------------~~~~~~E~~~l~~l~h~niv~ 262 (369)
..++|.+.+.||+|+||.||+|.. +++.||||++...... . .+.+.+|++++.+++||||++
T Consensus 29 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 29 YINDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp EETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred ccCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 357899999999999999999999 8999999998643211 1 178999999999999999999
Q ss_pred EeeEEEeCCeeEEEEEecCCCcHhhh------hcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCcEE
Q 017558 263 LVGYCTFGSQRLLVYEFVPNKTLEFH------LHGKDRPVMNWPTRMKIALGSARGLAYLHE-DCQPKIIHRDIKSANIL 335 (369)
Q Consensus 263 l~g~~~~~~~~~lv~e~~~~g~L~~~------l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivHrdlk~~Nil 335 (369)
+++++.+.+..++||||+++++|.++ +.......+++..+..++.||+.||.|||+ + +++||||||+|||
T Consensus 108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil 184 (348)
T 2pml_X 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNIL 184 (348)
T ss_dssp CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEE
T ss_pred EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEE
Confidence 99999999999999999999999999 655435679999999999999999999998 7 9999999999999
Q ss_pred ECCCCcEEEeeeccceeeCC
Q 017558 336 LDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 336 l~~~~~~ki~DFGla~~~~~ 355 (369)
++.++.+||+|||+++....
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~ 204 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVD 204 (348)
T ss_dssp ECTTSCEEECCCTTCEECBT
T ss_pred EcCCCcEEEecccccccccc
Confidence 99999999999999988644
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-28 Score=224.00 Aligned_cols=154 Identities=25% Similarity=0.349 Sum_probs=134.7
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC--cccHHHHHHHHHHHHhc-CCCccccEeeEEEeCCeeEEE
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLV 276 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv 276 (369)
.++|++.+.||+|+||.||+|... +++.||||+++... .....++.+|+.++.++ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 467999999999999999999975 68899999997643 23445788999999999 899999999999999999999
Q ss_pred EEecCCCcHhhhhcCCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECC----------------
Q 017558 277 YEFVPNKTLEFHLHGKD--RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD---------------- 338 (369)
Q Consensus 277 ~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~---------------- 338 (369)
|||+++++|.+++.... ...+++..++.|+.||+.||.|||++ +|+||||||+|||++.
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 99999999999997532 14589999999999999999999999 9999999999999984
Q ss_pred ---CCcEEEeeeccceeeCCCC
Q 017558 339 ---SFEAKVADFGLAKHSLDTD 357 (369)
Q Consensus 339 ---~~~~ki~DFGla~~~~~~~ 357 (369)
...+||+|||+++......
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~ 188 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ 188 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC
T ss_pred cCCceEEEEcccccccccCCcc
Confidence 4489999999999876543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-28 Score=227.11 Aligned_cols=149 Identities=24% Similarity=0.386 Sum_probs=131.1
Q ss_pred hcCCccc-ceecccCceEEEEEEE-cCCeEEEEEeeccCCcccHHHHHHHHHHHHhc-CCCccccEeeEEEeCCeeEEEE
Q 017558 201 TDNFSEA-NLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLVY 277 (369)
Q Consensus 201 ~~~~~~~-~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~ 277 (369)
.+.|++. +.||+|+||.||+|.. .+++.||||+++.......+.+.+|++++.++ +||||+++++++.+.+..|+||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 3567764 7899999999999995 46889999999876655667899999999985 7999999999999999999999
Q ss_pred EecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCc---EEEeeeccceeeC
Q 017558 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFE---AKVADFGLAKHSL 354 (369)
Q Consensus 278 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~---~ki~DFGla~~~~ 354 (369)
||+++|+|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++. +||+|||+++...
T Consensus 91 e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 91 EKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp ECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred EcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 999999999999764 3489999999999999999999999 9999999999999998766 9999999998754
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.4e-29 Score=249.66 Aligned_cols=152 Identities=33% Similarity=0.489 Sum_probs=130.6
Q ss_pred hcCCcccc-eecccCceEEEEEEEc---CCeEEEEEeeccCCc-ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEE
Q 017558 201 TDNFSEAN-LLGQGGFGYVHKGVLT---NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 275 (369)
Q Consensus 201 ~~~~~~~~-~lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 275 (369)
.+++.+.+ .||+|+||.||+|.+. ++..||||+++.... ...++|.+|+++|.+++||||++++++|.. +..||
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~l 412 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 412 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEE
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEE
Confidence 34444444 7999999999999874 456799999976533 356789999999999999999999999976 56899
Q ss_pred EEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 276 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 276 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
|||||++|+|.++|.... ..+++..++.|+.||+.||.|||++ +|+||||||+||||++++.+||+|||+++....
T Consensus 413 v~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~ 488 (613)
T 2ozo_A 413 VMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488 (613)
T ss_dssp EEECCTTCBHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred EEEeCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence 999999999999997543 4589999999999999999999999 999999999999999999999999999987654
Q ss_pred CC
Q 017558 356 TD 357 (369)
Q Consensus 356 ~~ 357 (369)
.+
T Consensus 489 ~~ 490 (613)
T 2ozo_A 489 DD 490 (613)
T ss_dssp --
T ss_pred CC
Confidence 43
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-28 Score=222.32 Aligned_cols=149 Identities=28% Similarity=0.378 Sum_probs=134.5
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC-cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEE
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 278 (369)
.++|++.+.||+|+||.||+|... +++.||||+++... ....+.+.+|+.++.+++|+||+++++++...+..|+|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 467899999999999999999975 58899999986543 2334678999999999999999999999999999999999
Q ss_pred ecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
|+++++|.+++... ..+++..+..++.||+.||.|||++ +++||||||+|||++.++.+||+|||+++...
T Consensus 86 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 156 (276)
T 2yex_A 86 YCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFR 156 (276)
T ss_dssp CCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred ecCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccC
Confidence 99999999999654 3589999999999999999999998 99999999999999999999999999998754
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=8.4e-29 Score=231.77 Aligned_cols=162 Identities=23% Similarity=0.291 Sum_probs=133.7
Q ss_pred hhcCCcccceecccCceEEEEEEEcCCeEEEEEeeccCCc--ccHHHHHHHHHHHHhcCC--CccccEeeEEEeCCeeEE
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHH--RHLVSLVGYCTFGSQRLL 275 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h--~niv~l~g~~~~~~~~~l 275 (369)
..++|++.+.||+|+||.||++...+++.||||++..... ...+.+.+|+++|.+++| +||+++++++......||
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 4567999999999999999999988899999999875432 234678999999999986 999999999999999999
Q ss_pred EEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 276 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 276 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
||| +.+++|.+++... ..+++..+..|+.||+.||.|||++ +|+||||||+||||+ ++.+||+|||+++....
T Consensus 87 v~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 87 VME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EEC-CCSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred EEe-CCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 999 5688999999764 3589999999999999999999998 999999999999997 56899999999988654
Q ss_pred CCce-eeeeecccC
Q 017558 356 TDTH-VSTRVMGTF 368 (369)
Q Consensus 356 ~~~~-~~~~~~gt~ 368 (369)
.... ......||+
T Consensus 160 ~~~~~~~~~~~gt~ 173 (343)
T 3dbq_A 160 DTTSVVKDSQVGTV 173 (343)
T ss_dssp ----------CCCC
T ss_pred ccccccCCCCcCCc
Confidence 4322 223345664
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-28 Score=224.78 Aligned_cols=150 Identities=25% Similarity=0.391 Sum_probs=134.1
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC---cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEE
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 276 (369)
.++|...+.||+|+||.||++... +++.||+|.+.... ....+.+.+|+.++++++|+||+++++++...+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 467889999999999999999975 47889999986542 22345788999999999999999999999999999999
Q ss_pred EEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 277 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
|||+++++|.+++... ..+++..++.++.|++.||.|||++ +++||||||+|||++.++.+||+|||+++....
T Consensus 94 ~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 94 LELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp EECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 9999999999988654 3589999999999999999999998 999999999999999999999999999987653
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=5.9e-29 Score=231.30 Aligned_cols=152 Identities=27% Similarity=0.493 Sum_probs=128.3
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCe----EEEEEeeccCC-cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeE
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGK----VVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRL 274 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 274 (369)
.++|+..+.||+|+||.||+|++. +++ .||+|.++... ....+++.+|+.++.+++||||++++++|... ..+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeE
Confidence 467899999999999999999964 333 46888886543 34456899999999999999999999999865 478
Q ss_pred EEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 275 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 275 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
+|+||+.+|+|.+++.... ..+++..++.|+.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 93 ~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred EEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 9999999999999997644 3589999999999999999999998 99999999999999999999999999998765
Q ss_pred CCC
Q 017558 355 DTD 357 (369)
Q Consensus 355 ~~~ 357 (369)
...
T Consensus 169 ~~~ 171 (327)
T 3poz_A 169 AEE 171 (327)
T ss_dssp TTC
T ss_pred CCc
Confidence 443
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.96 E-value=9.2e-29 Score=235.40 Aligned_cols=150 Identities=25% Similarity=0.471 Sum_probs=123.5
Q ss_pred HhhcCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCC--cccHHHHHHHHHHHHhcC-CCccccEeeEEEeCC--e
Q 017558 199 IATDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGS--GQGEREFQAEIEIISQVH-HRHLVSLVGYCTFGS--Q 272 (369)
Q Consensus 199 ~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~--~ 272 (369)
...++|++.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.+|.++. |+||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 3467899999999999999999986 458899999986532 234457889999999997 999999999997644 6
Q ss_pred eEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeecccee
Q 017558 273 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (369)
Q Consensus 273 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~ 352 (369)
.|+|||||+ ++|..++... .+++..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+|+.
T Consensus 86 ~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRS 158 (388)
T ss_dssp EEEEEECCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEecccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence 899999997 6899988753 588999999999999999999999 999999999999999999999999999997
Q ss_pred eCC
Q 017558 353 SLD 355 (369)
Q Consensus 353 ~~~ 355 (369)
...
T Consensus 159 ~~~ 161 (388)
T 3oz6_A 159 FVN 161 (388)
T ss_dssp SSS
T ss_pred ccc
Confidence 643
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-28 Score=226.04 Aligned_cols=153 Identities=29% Similarity=0.443 Sum_probs=129.1
Q ss_pred HhhcCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCCc-----ccHHHHHHHHHHHHhcC---CCccccEeeEEEe
Q 017558 199 IATDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSG-----QGEREFQAEIEIISQVH---HRHLVSLVGYCTF 269 (369)
Q Consensus 199 ~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~ 269 (369)
...++|++.+.||+|+||.||+|+. .+++.||||+++.... .....+.+|++++.+++ ||||++++++|..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 3467899999999999999999995 4688999999864321 12346778888777664 9999999999987
Q ss_pred CC-----eeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEE
Q 017558 270 GS-----QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKV 344 (369)
Q Consensus 270 ~~-----~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki 344 (369)
.. ..++||||+. ++|.+++.......+++..+..|+.||+.||.|||++ +|+||||||+|||++.++.+||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEE
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEE
Confidence 55 5799999996 6999999876666699999999999999999999999 9999999999999999999999
Q ss_pred eeeccceeeCC
Q 017558 345 ADFGLAKHSLD 355 (369)
Q Consensus 345 ~DFGla~~~~~ 355 (369)
+|||+++....
T Consensus 162 ~Dfg~a~~~~~ 172 (308)
T 3g33_A 162 ADFGLARIYSY 172 (308)
T ss_dssp CSCSCTTTSTT
T ss_pred eeCccccccCC
Confidence 99999987643
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.96 E-value=8.1e-29 Score=238.17 Aligned_cols=162 Identities=25% Similarity=0.360 Sum_probs=129.2
Q ss_pred HhhcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC--------cccHHHHHHHHHHHHhcCCCccccEeeEEEe
Q 017558 199 IATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--------GQGEREFQAEIEIISQVHHRHLVSLVGYCTF 269 (369)
Q Consensus 199 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~ 269 (369)
...++|.+.+.||+|+||.||+|... +++.||||++.... ......+.+|+++|.+++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 45688999999999999999999964 57899999986532 111235889999999999999999999985
Q ss_pred CCeeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCC---CcEEEee
Q 017558 270 GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS---FEAKVAD 346 (369)
Q Consensus 270 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~---~~~ki~D 346 (369)
.+..|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~D 285 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD 285 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred cCceEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEee
Confidence 55689999999999999998754 3589999999999999999999998 99999999999999754 4599999
Q ss_pred eccceeeCCCCceeeeeecccC
Q 017558 347 FGLAKHSLDTDTHVSTRVMGTF 368 (369)
Q Consensus 347 FGla~~~~~~~~~~~~~~~gt~ 368 (369)
||+++...+.. ......||+
T Consensus 286 FG~a~~~~~~~--~~~~~~gt~ 305 (419)
T 3i6u_A 286 FGHSKILGETS--LMRTLCGTP 305 (419)
T ss_dssp SSTTTSCC-------------C
T ss_pred cccceecCCCc--cccccCCCC
Confidence 99998765432 223345554
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=6.7e-29 Score=229.19 Aligned_cols=163 Identities=28% Similarity=0.490 Sum_probs=140.4
Q ss_pred ccCHHHHHHhhcCCcccceecccCceEEEEEEE------cCCeEEEEEeeccCCcc-cHHHHHHHHHHHHhc-CCCcccc
Q 017558 191 TFTYEELKIATDNFSEANLLGQGGFGYVHKGVL------TNGKVVAIKQLKAGSGQ-GEREFQAEIEIISQV-HHRHLVS 262 (369)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~ 262 (369)
.+...++....++|++.+.||+|+||.||+|+. .+++.||||+++..... ..+.+.+|++++.++ +||||++
T Consensus 16 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~ 95 (316)
T 2xir_A 16 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 95 (316)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeee
Confidence 345566777889999999999999999999984 24578999999765433 345789999999999 6999999
Q ss_pred EeeEEEeCC-eeEEEEEecCCCcHhhhhcCCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeec
Q 017558 263 LVGYCTFGS-QRLLVYEFVPNKTLEFHLHGKDR--------------PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHR 327 (369)
Q Consensus 263 l~g~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHr 327 (369)
++++|...+ ..++||||+++|+|.+++..... ..+++..++.++.||+.||.|||++ +|+||
T Consensus 96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~ 172 (316)
T 2xir_A 96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHR 172 (316)
T ss_dssp EEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred EEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Ccccc
Confidence 999998754 58999999999999999976532 1278999999999999999999998 99999
Q ss_pred CCCCCcEEECCCCcEEEeeeccceeeCCC
Q 017558 328 DIKSANILLDDSFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 328 dlk~~Nill~~~~~~ki~DFGla~~~~~~ 356 (369)
||||+|||++.++.+||+|||+++.....
T Consensus 173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 201 (316)
T 2xir_A 173 DLAARNILLSEKNVVKICDFGLARDIYKD 201 (316)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCTTTC
T ss_pred cCccceEEECCCCCEEECCCccccccccC
Confidence 99999999999999999999999876543
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-28 Score=231.71 Aligned_cols=157 Identities=25% Similarity=0.393 Sum_probs=138.3
Q ss_pred HHHHHhhcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcc--------cHHHHHHHHHHHHhc-CCCccccEe
Q 017558 195 EELKIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ--------GEREFQAEIEIISQV-HHRHLVSLV 264 (369)
Q Consensus 195 ~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l-~h~niv~l~ 264 (369)
.......++|++.+.||+|+||.||+|+.. +|+.||||+++..... ..+.+.+|++++.++ +||||++++
T Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 444555678999999999999999999975 6899999998754321 134678999999999 799999999
Q ss_pred eEEEeCCeeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEE
Q 017558 265 GYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKV 344 (369)
Q Consensus 265 g~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki 344 (369)
+++......|+||||+++++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||
T Consensus 167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl 241 (365)
T 2y7j_A 167 DSYESSSFMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRL 241 (365)
T ss_dssp EEEEBSSEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEE
T ss_pred EEEeeCCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEE
Confidence 9999999999999999999999999753 3589999999999999999999998 9999999999999999999999
Q ss_pred eeeccceeeCCC
Q 017558 345 ADFGLAKHSLDT 356 (369)
Q Consensus 345 ~DFGla~~~~~~ 356 (369)
+|||+++.....
T Consensus 242 ~DfG~~~~~~~~ 253 (365)
T 2y7j_A 242 SDFGFSCHLEPG 253 (365)
T ss_dssp CCCTTCEECCTT
T ss_pred EecCcccccCCC
Confidence 999999987654
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.96 E-value=9e-29 Score=229.93 Aligned_cols=142 Identities=25% Similarity=0.328 Sum_probs=125.8
Q ss_pred cceecccCceEEEEEEEc-CCeEEEEEeeccCCcccHHHHHHHHHHHHhcC-CCccccEeeEEEeCCeeEEEEEecCCCc
Q 017558 207 ANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVH-HRHLVSLVGYCTFGSQRLLVYEFVPNKT 284 (369)
Q Consensus 207 ~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~~~~g~ 284 (369)
.+.||+|+||.||+|... +++.||||++... ....+.+|+.++.++. ||||+++++++.+....|+||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 478999999999999975 5789999999643 3467889999999997 9999999999999999999999999999
Q ss_pred HhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCC---cEEEeeeccceeeCCC
Q 017558 285 LEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF---EAKVADFGLAKHSLDT 356 (369)
Q Consensus 285 L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~---~~ki~DFGla~~~~~~ 356 (369)
|.+++... ..+++..+..|+.||+.||.|||++ +|+||||||+|||++.++ .+||+|||+++.....
T Consensus 93 L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 162 (325)
T 3kn6_A 93 LFERIKKK--KHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD 162 (325)
T ss_dssp HHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred HHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence 99999765 3589999999999999999999998 999999999999997655 8999999999876543
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.5e-29 Score=225.23 Aligned_cols=150 Identities=27% Similarity=0.462 Sum_probs=133.4
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEe---------
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTF--------- 269 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--------- 269 (369)
..++|+..+.||+|+||.||+|... +++.||+|+++... +.+.+|++++.+++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 4567999999999999999999975 68899999997543 457789999999999999999999864
Q ss_pred -------CCeeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcE
Q 017558 270 -------GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEA 342 (369)
Q Consensus 270 -------~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ 342 (369)
....++||||+++++|.+++.......+++..++.++.||+.||.|||++ +|+||||||+|||+++++.+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCCE
Confidence 34579999999999999999765445689999999999999999999998 99999999999999999999
Q ss_pred EEeeeccceeeCCC
Q 017558 343 KVADFGLAKHSLDT 356 (369)
Q Consensus 343 ki~DFGla~~~~~~ 356 (369)
||+|||+++.....
T Consensus 162 kl~Dfg~~~~~~~~ 175 (284)
T 2a19_B 162 KIGDFGLVTSLKND 175 (284)
T ss_dssp EECCCTTCEESSCC
T ss_pred EECcchhheecccc
Confidence 99999999887654
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.96 E-value=9.4e-29 Score=231.40 Aligned_cols=159 Identities=21% Similarity=0.305 Sum_probs=133.8
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcccHHHHHHHHHHHHhc-CCCccccEeeEEEeCCeeEEEE
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLVY 277 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~ 277 (369)
..++|++.+.||+|+||.||+|... +++.||||+++.... .+.+|+++|.++ +||||+++++++.+....|+||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 3567999999999999999999975 588999999976532 345688888888 7999999999999999999999
Q ss_pred EecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCC----CcEEEeeeccceee
Q 017558 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS----FEAKVADFGLAKHS 353 (369)
Q Consensus 278 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~----~~~ki~DFGla~~~ 353 (369)
||+++|+|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||+.++ +.+||+|||+++..
T Consensus 96 E~~~gg~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 96 ELMKGGELLDKILRQ--KFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp CCCCSCBHHHHHHTC--TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred eCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 999999999999764 3589999999999999999999999 99999999999998543 35999999999987
Q ss_pred CCCCceeeeeecccC
Q 017558 354 LDTDTHVSTRVMGTF 368 (369)
Q Consensus 354 ~~~~~~~~~~~~gt~ 368 (369)
...... ....+||+
T Consensus 171 ~~~~~~-~~~~~gt~ 184 (342)
T 2qr7_A 171 RAENGL-LMTPCYTA 184 (342)
T ss_dssp BCTTCC-BCCSSCCS
T ss_pred cCCCCc-eeccCCCc
Confidence 654322 22345554
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=4.9e-29 Score=236.07 Aligned_cols=150 Identities=29% Similarity=0.482 Sum_probs=123.2
Q ss_pred CCcccceecccCceEEEEEEEcC--C--eEEEEEeeccCCc-ccHHHHHHHHHHHHhcCCCccccEeeEEEe-CCeeEEE
Q 017558 203 NFSEANLLGQGGFGYVHKGVLTN--G--KVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTF-GSQRLLV 276 (369)
Q Consensus 203 ~~~~~~~lg~G~fg~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lv 276 (369)
.|.+.+.||+|+||.||+|.+.+ + ..||||.++.... ...++|.+|+.++.+++||||++++++|.. ++..|+|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 46678899999999999998642 2 4689999875433 345689999999999999999999999864 5678999
Q ss_pred EEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCC
Q 017558 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 277 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~ 356 (369)
|||+++|+|.+++.... ..+++..++.++.||+.||.|||++ +|+||||||+||||++++.+||+|||+++...+.
T Consensus 170 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp EECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EECCCCCCHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccccc
Confidence 99999999999997643 3588999999999999999999999 9999999999999999999999999999876543
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-28 Score=221.67 Aligned_cols=152 Identities=30% Similarity=0.471 Sum_probs=124.3
Q ss_pred hhcCCcccceecccCceEEEEEEEcCCeEEEEEeeccCCc----ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEE
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSG----QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 275 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 275 (369)
..++|+..+.||+|+||.||+|... ++.||||+++.... ...+.+.+|++++.+++||||++++++|...+..++
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (271)
T 3dtc_A 5 DFAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL 83 (271)
T ss_dssp CTTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred chhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence 3468899999999999999999984 88999999875432 234678999999999999999999999999999999
Q ss_pred EEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECC--------CCcEEEeee
Q 017558 276 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD--------SFEAKVADF 347 (369)
Q Consensus 276 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~--------~~~~ki~DF 347 (369)
||||+++++|.+++.. ..+++..++.++.|++.||.|||++...+++||||||+|||++. ++.+||+||
T Consensus 84 v~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 84 VMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EEECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 9999999999999864 35899999999999999999999982222999999999999986 778999999
Q ss_pred ccceeeCC
Q 017558 348 GLAKHSLD 355 (369)
Q Consensus 348 Gla~~~~~ 355 (369)
|+++....
T Consensus 161 g~~~~~~~ 168 (271)
T 3dtc_A 161 GLAREWHR 168 (271)
T ss_dssp CC------
T ss_pred Cccccccc
Confidence 99987654
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-29 Score=233.49 Aligned_cols=158 Identities=28% Similarity=0.500 Sum_probs=137.9
Q ss_pred HHHHhhcCCcccceecccCceEEEEEEEc------CCeEEEEEeeccCCc-ccHHHHHHHHHHHHhcCCCccccEeeEEE
Q 017558 196 ELKIATDNFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCT 268 (369)
Q Consensus 196 ~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~ 268 (369)
++.+..++|.+.+.||+|+||.||+|... .++.||||.+..... .....+.+|++++.+++|+||+++++++.
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 98 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 98 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence 44566788999999999999999999864 367899999976543 23457899999999999999999999999
Q ss_pred eCCeeEEEEEecCCCcHhhhhcCCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCC
Q 017558 269 FGSQRLLVYEFVPNKTLEFHLHGKD--------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF 340 (369)
Q Consensus 269 ~~~~~~lv~e~~~~g~L~~~l~~~~--------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~ 340 (369)
..+..++||||+++|+|.+++.... ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++
T Consensus 99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDF 175 (322)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTC
T ss_pred cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCC
Confidence 9999999999999999999986421 23478999999999999999999999 999999999999999999
Q ss_pred cEEEeeeccceeeCCC
Q 017558 341 EAKVADFGLAKHSLDT 356 (369)
Q Consensus 341 ~~ki~DFGla~~~~~~ 356 (369)
.+||+|||+++.....
T Consensus 176 ~~kl~Dfg~~~~~~~~ 191 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYET 191 (322)
T ss_dssp CEEECCTTCCCGGGGG
T ss_pred eEEECcCccccccccc
Confidence 9999999999876543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-28 Score=225.39 Aligned_cols=151 Identities=28% Similarity=0.459 Sum_probs=130.7
Q ss_pred cCCcccceecccCceEEEEEEEcC----CeEEEEEeeccCCc-ccHHHHHHHHHHHHhcCCCccccEeeEEEe-CCeeEE
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLTN----GKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTF-GSQRLL 275 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~~l 275 (369)
.+|++.+.||+|+||.||+|+..+ ...+|+|.++.... ...+.+.+|+.++++++||||++++++|.. ++..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 457888999999999999998643 23689999876443 334678999999999999999999999754 567899
Q ss_pred EEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 276 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 276 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
||||+++|+|.+++.... ..+++..++.++.|++.||.|||++ +++||||||+|||+++++.+||+|||+++...+
T Consensus 105 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp EEECCTTCBHHHHHHCTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred EEeCCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccccc
Confidence 999999999999997643 4588999999999999999999998 999999999999999999999999999987654
Q ss_pred C
Q 017558 356 T 356 (369)
Q Consensus 356 ~ 356 (369)
.
T Consensus 181 ~ 181 (298)
T 3f66_A 181 K 181 (298)
T ss_dssp G
T ss_pred c
Confidence 3
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.9e-29 Score=225.88 Aligned_cols=153 Identities=24% Similarity=0.314 Sum_probs=132.5
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC-cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEE
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 278 (369)
.++|.+.+.||+|+||.||++... ++..+|+|++.... ....+.+.+|+++|.+++||||+++++++......++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 467889999999999999999964 57899999987643 3345789999999999999999999999999999999999
Q ss_pred ecCCCcHhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEE---CCCCcEEEeeeccceee
Q 017558 279 FVPNKTLEFHLHGK--DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILL---DDSFEAKVADFGLAKHS 353 (369)
Q Consensus 279 ~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill---~~~~~~ki~DFGla~~~ 353 (369)
|+++|+|.+++... ....+++..+..|+.||+.||.|||++ +|+||||||+|||+ +.++.+||+|||+++..
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99999999988542 124589999999999999999999998 99999999999999 45688999999999876
Q ss_pred CCC
Q 017558 354 LDT 356 (369)
Q Consensus 354 ~~~ 356 (369)
...
T Consensus 178 ~~~ 180 (285)
T 3is5_A 178 KSD 180 (285)
T ss_dssp ---
T ss_pred CCc
Confidence 543
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5e-29 Score=231.51 Aligned_cols=152 Identities=31% Similarity=0.518 Sum_probs=130.5
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCe----EEEEEeeccCC-cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeE
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGK----VVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRL 274 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 274 (369)
.++|++.+.||+|+||.||+|+.. +++ .||+|.+.... ....+.+.+|+.++.+++|+||++++++|. +...+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 467889999999999999999964 343 37888875443 233456789999999999999999999986 56689
Q ss_pred EEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 275 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 275 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
+||||+++|+|.+++.... ..+++..++.|+.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 91 ~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp EEEECCTTCBSHHHHHSSG-GGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred EEEEeCCCCCHHHHHHHcc-ccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccC
Confidence 9999999999999997643 3588899999999999999999999 99999999999999999999999999999875
Q ss_pred CCC
Q 017558 355 DTD 357 (369)
Q Consensus 355 ~~~ 357 (369)
...
T Consensus 167 ~~~ 169 (325)
T 3kex_A 167 PDD 169 (325)
T ss_dssp CCT
T ss_pred ccc
Confidence 543
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-28 Score=231.45 Aligned_cols=158 Identities=25% Similarity=0.373 Sum_probs=133.4
Q ss_pred CHHHHHHhhcCCcccceecccCceEEEEEEEcCCeEEEEEeeccCCcc-----------cHHHHHHHHHHHHhcCCCccc
Q 017558 193 TYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQ-----------GEREFQAEIEIISQVHHRHLV 261 (369)
Q Consensus 193 ~~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv 261 (369)
...++....++|.+.+.||+|+||.||+|...++..||||++...... ..+.+.+|++++.+++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 356778889999999999999999999999888999999998653221 126789999999999999999
Q ss_pred cEeeEEEeC-----CeeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEE
Q 017558 262 SLVGYCTFG-----SQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILL 336 (369)
Q Consensus 262 ~l~g~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill 336 (369)
++++++... ...|+||||++ |+|.+++.... ..+++..+..++.||+.||.|||++ +|+||||||+|||+
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~ 167 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR-IVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILL 167 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEE
Confidence 999999542 36799999997 68888887543 3589999999999999999999999 99999999999999
Q ss_pred CCCCcEEEeeeccceeeCC
Q 017558 337 DDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 337 ~~~~~~ki~DFGla~~~~~ 355 (369)
+.++.+||+|||+++....
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~ 186 (362)
T 3pg1_A 168 ADNNDITICDFNLAREDTA 186 (362)
T ss_dssp CTTCCEEECCTTC------
T ss_pred cCCCCEEEEecCccccccc
Confidence 9999999999999986543
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-28 Score=228.28 Aligned_cols=150 Identities=29% Similarity=0.488 Sum_probs=130.8
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcc--cHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEE
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ--GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 277 (369)
.++|++.+.||+|+||.||+|+.. +++.||||++...... ..+.+.+|++++.+++|+||++++++|...+..|+||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 467999999999999999999975 4889999998654332 2356889999999999999999999999999999999
Q ss_pred EecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 278 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
||+++++|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 104 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 104 EFVDHTILDDLELFPN--GLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp ECCSEEHHHHHHHSTT--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecCCcchHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 9999999998876543 489999999999999999999999 999999999999999999999999999987654
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-28 Score=231.65 Aligned_cols=149 Identities=28% Similarity=0.389 Sum_probs=131.3
Q ss_pred cCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCCcc---cHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEE
Q 017558 202 DNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQ---GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 277 (369)
+.|+..+.||+|+||.||+|+. .+++.||||++...... ..+++.+|+++|.+++||||++++++|...+..|+||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4588899999999999999996 56899999999754322 2357889999999999999999999999999999999
Q ss_pred EecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 278 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
||+. |+|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 134 e~~~-g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp ECCS-EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred ecCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 9997 67877775432 3589999999999999999999999 999999999999999999999999999987653
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-28 Score=227.71 Aligned_cols=153 Identities=27% Similarity=0.402 Sum_probs=133.6
Q ss_pred HhhcCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEe----CCee
Q 017558 199 IATDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTF----GSQR 273 (369)
Q Consensus 199 ~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~ 273 (369)
+..++|++.+.||+|+||.||+++. .+++.||||++........+.+.+|++++.+++||||+++++++.. ....
T Consensus 26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 3457899999999999999999996 5688999999977655566789999999999999999999999973 3478
Q ss_pred EEEEEecCCCcHhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccce
Q 017558 274 LLVYEFVPNKTLEFHLHGK--DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351 (369)
Q Consensus 274 ~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~ 351 (369)
|+||||+++|+|.+++... ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~ 182 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMN 182 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcch
Confidence 9999999999999998752 234589999999999999999999999 99999999999999999999999999987
Q ss_pred eeC
Q 017558 352 HSL 354 (369)
Q Consensus 352 ~~~ 354 (369)
...
T Consensus 183 ~~~ 185 (317)
T 2buj_A 183 QAC 185 (317)
T ss_dssp ESC
T ss_pred hcc
Confidence 643
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9.7e-29 Score=240.52 Aligned_cols=159 Identities=24% Similarity=0.311 Sum_probs=127.5
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccC--CcccHHHHHHHHHHHHhcCCCccccEeeEEEeC------
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFG------ 270 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------ 270 (369)
..++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.+|++++||||+++++++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 3578999999999999999999854 5889999999754 223346788999999999999999999999654
Q ss_pred CeeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccc
Q 017558 271 SQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLA 350 (369)
Q Consensus 271 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla 350 (369)
...|||||||+++ |.+++.. .+++..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+|
T Consensus 140 ~~~~lv~E~~~~~-l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 140 QDVYLVMELMDAN-LCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp CEEEEEEECCSEE-HHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred CeEEEEEeCCCCC-HHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEee
Confidence 3579999999765 6666643 388999999999999999999999 9999999999999999999999999999
Q ss_pred eeeCCCCceeeeeecccC
Q 017558 351 KHSLDTDTHVSTRVMGTF 368 (369)
Q Consensus 351 ~~~~~~~~~~~~~~~gt~ 368 (369)
+...... ..+..+||+
T Consensus 212 ~~~~~~~--~~~~~~gt~ 227 (464)
T 3ttj_A 212 RTAGTSF--MMTPYVVTR 227 (464)
T ss_dssp -----CC--CC----CCC
T ss_pred eecCCCc--ccCCCcccc
Confidence 9765432 223345664
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.96 E-value=7.9e-29 Score=233.84 Aligned_cols=152 Identities=20% Similarity=0.273 Sum_probs=127.0
Q ss_pred hhcCCcccceecccCceEEEEEEEcC------CeEEEEEeeccCCcccH-----------HHHHHHHHHHHhcCCCcccc
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVLTN------GKVVAIKQLKAGSGQGE-----------REFQAEIEIISQVHHRHLVS 262 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~ 262 (369)
..++|++.+.||+|+||.||+|.+.. ++.||||++........ ..+..|+..+..++|+||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 45689999999999999999998754 47899999876542111 12345666777888999999
Q ss_pred EeeEEEeC----CeeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEC-
Q 017558 263 LVGYCTFG----SQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLD- 337 (369)
Q Consensus 263 l~g~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~- 337 (369)
+++++... ...||||||+ +++|.+++.... ..+++..++.|+.||+.||.|||++ +|+||||||+||||+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA-KRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNY 187 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEES
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEec
Confidence 99999764 4579999999 999999997643 4599999999999999999999999 999999999999999
Q ss_pred -CCCcEEEeeeccceeeCCC
Q 017558 338 -DSFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 338 -~~~~~ki~DFGla~~~~~~ 356 (369)
.++.+||+|||+++.+...
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~ 207 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPE 207 (364)
T ss_dssp SCTTCEEECCCTTCEESSGG
T ss_pred CCCCeEEEEECCcceecccC
Confidence 8899999999999886543
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.6e-28 Score=222.05 Aligned_cols=151 Identities=28% Similarity=0.390 Sum_probs=132.1
Q ss_pred cCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEec
Q 017558 202 DNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 280 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 280 (369)
++|....+||+|+||.||+|.. .+++.||||.+........+.+.+|+.++.+++|+||+++++++...+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 4455567999999999999996 457899999998766555678999999999999999999999999999999999999
Q ss_pred CCCcHhhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECC-CCcEEEeeeccceeeCC
Q 017558 281 PNKTLEFHLHGKD-RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD-SFEAKVADFGLAKHSLD 355 (369)
Q Consensus 281 ~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~-~~~~ki~DFGla~~~~~ 355 (369)
++++|.+++.... ...+++..+..++.||+.||.|||++ +++||||||+|||++. ++.+||+|||+++....
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~ 175 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence 9999999997643 23467888999999999999999998 9999999999999987 89999999999987654
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-28 Score=228.54 Aligned_cols=153 Identities=31% Similarity=0.481 Sum_probs=130.1
Q ss_pred hhcCCcccceecccCceEEEEEEEcC-----CeEEEEEeeccCCc-ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCee
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVLTN-----GKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQR 273 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 273 (369)
..++|...+.||+|+||.||+|.... +..||||.++.... .....+.+|++++.+++|+||+++++++...+..
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 121 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 121 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCc
Confidence 34678888999999999999998643 24699999976543 2345789999999999999999999999999999
Q ss_pred EEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceee
Q 017558 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (369)
Q Consensus 274 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~ 353 (369)
++||||+++|+|.+++.... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 122 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 122 MIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp EEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 99999999999999997543 3589999999999999999999999 9999999999999999999999999999876
Q ss_pred CCC
Q 017558 354 LDT 356 (369)
Q Consensus 354 ~~~ 356 (369)
...
T Consensus 198 ~~~ 200 (333)
T 1mqb_A 198 EDD 200 (333)
T ss_dssp ---
T ss_pred ccc
Confidence 543
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-28 Score=227.18 Aligned_cols=154 Identities=28% Similarity=0.495 Sum_probs=136.0
Q ss_pred hhcCCcccceecccCceEEEEEEE-----cCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCC--e
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVL-----TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGS--Q 272 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~--~ 272 (369)
..++|++.+.||+|+||.||+|++ .+++.||||++........+.+.+|++++.+++|+||+++++++...+ .
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 118 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 118 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence 346788999999999999999984 357899999998766666678999999999999999999999987644 6
Q ss_pred eEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeecccee
Q 017558 273 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (369)
Q Consensus 273 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~ 352 (369)
.++||||+++++|.+++.... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 119 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 119 LKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp CEEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eEEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 899999999999999997653 3589999999999999999999998 999999999999999999999999999998
Q ss_pred eCCCC
Q 017558 353 SLDTD 357 (369)
Q Consensus 353 ~~~~~ 357 (369)
.....
T Consensus 195 ~~~~~ 199 (326)
T 2w1i_A 195 LPQDK 199 (326)
T ss_dssp CCSSC
T ss_pred ccccc
Confidence 75543
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-28 Score=230.95 Aligned_cols=153 Identities=31% Similarity=0.472 Sum_probs=127.1
Q ss_pred HhhcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcc-----cHHHHHHHHHHHHhcCCCccccEeeEEEeCCe
Q 017558 199 IATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ-----GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQ 272 (369)
Q Consensus 199 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 272 (369)
...++|++.+.||+|+||.||+|+.. +++.||||+++..... ..+.+.+|++++.+++|+||+++++++...+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34578999999999999999999964 5889999998753221 12468899999999999999999999999999
Q ss_pred eEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeecccee
Q 017558 273 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (369)
Q Consensus 273 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~ 352 (369)
.++||||+++ +|.+++.... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKS 161 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred eEEEEEcCCC-CHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEeccccee
Confidence 9999999975 8888886543 3588889999999999999999999 999999999999999999999999999987
Q ss_pred eCCC
Q 017558 353 SLDT 356 (369)
Q Consensus 353 ~~~~ 356 (369)
....
T Consensus 162 ~~~~ 165 (346)
T 1ua2_A 162 FGSP 165 (346)
T ss_dssp TTSC
T ss_pred ccCC
Confidence 6543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.4e-28 Score=221.58 Aligned_cols=151 Identities=32% Similarity=0.445 Sum_probs=136.1
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC-cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEE
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 278 (369)
.+.|+..+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++.+++|+||+++++++......|+|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 467889999999999999999864 57899999997553 3345789999999999999999999999999999999999
Q ss_pred ecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCCC
Q 017558 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (369)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~~ 357 (369)
|+++++|.+++.. ..+++..+..++.||+.||.|||++ +++||||||+|||++.++.+||+|||+++......
T Consensus 101 ~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 101 YLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred eCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 9999999999964 3589999999999999999999998 99999999999999999999999999998876543
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.3e-28 Score=239.99 Aligned_cols=161 Identities=23% Similarity=0.324 Sum_probs=133.8
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC--cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEE
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 277 (369)
.++|++.+.||+|+||.||+|+.. ++..||||+++... ......+.+|+.+|++++||||++++++|......|+||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 457899999999999999999975 57899999997643 233467899999999999999999999999999999999
Q ss_pred EecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECC---CCcEEEeeeccceeeC
Q 017558 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD---SFEAKVADFGLAKHSL 354 (369)
Q Consensus 278 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~---~~~~ki~DFGla~~~~ 354 (369)
||+++|+|.+++... ..+++..+..|+.||+.||.|||++ +|+||||||+|||++. ++.+||+|||+++...
T Consensus 116 e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~ 190 (494)
T 3lij_A 116 ECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190 (494)
T ss_dssp ECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred ecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence 999999999988654 3489999999999999999999998 9999999999999976 4559999999999876
Q ss_pred CCCceeeeeecccC
Q 017558 355 DTDTHVSTRVMGTF 368 (369)
Q Consensus 355 ~~~~~~~~~~~gt~ 368 (369)
.... .....||+
T Consensus 191 ~~~~--~~~~~gt~ 202 (494)
T 3lij_A 191 NQKK--MKERLGTA 202 (494)
T ss_dssp TTBC--BCCCCSCT
T ss_pred CCcc--ccccCCCc
Confidence 5432 22345654
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.6e-28 Score=221.43 Aligned_cols=150 Identities=40% Similarity=0.676 Sum_probs=129.7
Q ss_pred hhcCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCCccc-------HHHHHHHHHHHHhcCCCccccEeeEEEeCC
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQG-------EREFQAEIEIISQVHHRHLVSLVGYCTFGS 271 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~h~niv~l~g~~~~~~ 271 (369)
..++|++.+.||+|+||.||+|+. .+++.||||++....... .+.+.+|++++.+++|+||+++++++.+..
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP 96 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence 347899999999999999999997 468899999986543221 157899999999999999999999986544
Q ss_pred eeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eeecCCCCCcEEECCCCc-----EEE
Q 017558 272 QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPK--IIHRDIKSANILLDDSFE-----AKV 344 (369)
Q Consensus 272 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~--ivHrdlk~~Nill~~~~~-----~ki 344 (369)
++||||+++|+|.+++.... ..+++..++.++.|++.||.|||++ + |+||||||+|||++.++. +||
T Consensus 97 --~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl 170 (287)
T 4f0f_A 97 --RMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKV 170 (287)
T ss_dssp --EEEEECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred --eEEEEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEe
Confidence 79999999999999887644 3589999999999999999999998 7 999999999999988776 999
Q ss_pred eeeccceeeCC
Q 017558 345 ADFGLAKHSLD 355 (369)
Q Consensus 345 ~DFGla~~~~~ 355 (369)
+|||+++....
T Consensus 171 ~Dfg~~~~~~~ 181 (287)
T 4f0f_A 171 ADFGLSQQSVH 181 (287)
T ss_dssp CCCTTCBCCSS
T ss_pred CCCCccccccc
Confidence 99999986543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.1e-29 Score=230.45 Aligned_cols=149 Identities=28% Similarity=0.474 Sum_probs=128.5
Q ss_pred cCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCccc-HHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEe
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQG-EREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 279 (369)
++|.+.+.||+|+||.||+|+.. +++.||||+++...... ...+.+|+++|.+++|+||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57899999999999999999975 67899999997543221 12456899999999999999999999999999999999
Q ss_pred cCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
++ |+|.+++.... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 152 (324)
T 3mtl_A 82 LD-KDLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSI 152 (324)
T ss_dssp CS-EEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC--
T ss_pred cc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccC
Confidence 97 68888887643 3589999999999999999999998 999999999999999999999999999986543
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=6.1e-28 Score=220.06 Aligned_cols=152 Identities=34% Similarity=0.495 Sum_probs=132.8
Q ss_pred hcCCcccc-eecccCceEEEEEEEc---CCeEEEEEeeccCCc-ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEE
Q 017558 201 TDNFSEAN-LLGQGGFGYVHKGVLT---NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 275 (369)
Q Consensus 201 ~~~~~~~~-~lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 275 (369)
.++|.+.+ .||+|+||.||+|... ++..||||+++.... ...+.+.+|++++.+++||||+++++++ ..+..++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 45666666 8999999999999853 577899999976533 3456799999999999999999999999 4567899
Q ss_pred EEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 276 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 276 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
||||+++++|.+++.... ..+++..++.++.||+.||.|||++ +++||||||+|||++.++.+||+|||+++....
T Consensus 87 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp EEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEEeCCCCCHHHHHHhCC-ccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 999999999999997543 4589999999999999999999998 999999999999999999999999999998765
Q ss_pred CC
Q 017558 356 TD 357 (369)
Q Consensus 356 ~~ 357 (369)
..
T Consensus 163 ~~ 164 (287)
T 1u59_A 163 DD 164 (287)
T ss_dssp CS
T ss_pred Cc
Confidence 43
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-28 Score=233.06 Aligned_cols=161 Identities=22% Similarity=0.289 Sum_probs=133.6
Q ss_pred hcCCcccceecccCceEEEEEEEcCCeEEEEEeeccCC--cccHHHHHHHHHHHHhcC--CCccccEeeEEEeCCeeEEE
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGS--GQGEREFQAEIEIISQVH--HRHLVSLVGYCTFGSQRLLV 276 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~~~~~lv 276 (369)
.++|++.+.||+|+||.||++...+++.||||++.... ....+.+.+|+++|.+++ |+||+++++++...+..|||
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 45699999999999999999998889999999986543 233467899999999996 59999999999999999999
Q ss_pred EEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCC
Q 017558 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 277 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~ 356 (369)
|| +.+++|.+++.... .+++..+..|+.||+.||.|||++ +|+||||||+||||+ ++.+||+|||+++.....
T Consensus 135 ~E-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp EE-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred Ee-cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 99 56899999997653 588999999999999999999998 999999999999996 578999999999986543
Q ss_pred Cce-eeeeecccC
Q 017558 357 DTH-VSTRVMGTF 368 (369)
Q Consensus 357 ~~~-~~~~~~gt~ 368 (369)
... .....+||+
T Consensus 208 ~~~~~~~~~~gt~ 220 (390)
T 2zmd_A 208 TTSVVKDSQVGAV 220 (390)
T ss_dssp ------CCSCCCG
T ss_pred CccccCCCCCcCC
Confidence 321 223345654
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.96 E-value=4.5e-28 Score=220.20 Aligned_cols=150 Identities=27% Similarity=0.375 Sum_probs=134.0
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCc------ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCee
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG------QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQR 273 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 273 (369)
.++|++.+.||+|+||.||+++.. +++.||+|.++.... ...+.+.+|++++.+++||||+++++++......
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 457899999999999999999975 588999999865422 2356899999999999999999999999999999
Q ss_pred EEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCC----cEEEeeecc
Q 017558 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF----EAKVADFGL 349 (369)
Q Consensus 274 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~----~~ki~DFGl 349 (369)
++||||+++++|.+++... ..+++..+..++.||+.||.|||++ +++||||||+|||++.++ .+||+|||+
T Consensus 84 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 9999999999999999653 3589999999999999999999998 999999999999998877 899999999
Q ss_pred ceeeCC
Q 017558 350 AKHSLD 355 (369)
Q Consensus 350 a~~~~~ 355 (369)
++....
T Consensus 159 ~~~~~~ 164 (283)
T 3bhy_A 159 AHKIEA 164 (283)
T ss_dssp CEECC-
T ss_pred ceeccC
Confidence 987654
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-28 Score=223.53 Aligned_cols=151 Identities=30% Similarity=0.443 Sum_probs=132.7
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC---cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEE
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 275 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 275 (369)
..++|++.+.||+|+||.||+|... ++..||||++.... ....+.+.+|+.++.+++||||++++++|.+.+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 4578999999999999999999865 46789999986432 1234578999999999999999999999999999999
Q ss_pred EEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 276 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 276 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
||||+++++|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 87 v~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp EECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred EEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 99999999999999754 3489999999999999999999998 999999999999999999999999999866543
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.4e-28 Score=220.72 Aligned_cols=151 Identities=23% Similarity=0.273 Sum_probs=133.9
Q ss_pred hhcCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCCcccHHHHHHHHHHHHhc-CCCccccEeeEEEeCCeeEEEE
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLVY 277 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~ 277 (369)
..++|++.+.||+|+||.||+|.. .+++.||||++.... ..+.+.+|++++.++ +|+||+++++++......++||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 85 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 85 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence 457899999999999999999995 568999999986543 234688999999999 7999999999999999999999
Q ss_pred EecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCc-----EEEeeecccee
Q 017558 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFE-----AKVADFGLAKH 352 (369)
Q Consensus 278 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~-----~ki~DFGla~~ 352 (369)
||+ +++|.+++.... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++. +||+|||+++.
T Consensus 86 e~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 86 DLL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp ECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred Eec-CCCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 999 999999997643 3489999999999999999999998 9999999999999987776 99999999998
Q ss_pred eCCCC
Q 017558 353 SLDTD 357 (369)
Q Consensus 353 ~~~~~ 357 (369)
.....
T Consensus 161 ~~~~~ 165 (298)
T 1csn_A 161 YRDPV 165 (298)
T ss_dssp SBCTT
T ss_pred ccccc
Confidence 76543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=5.1e-28 Score=225.25 Aligned_cols=155 Identities=28% Similarity=0.420 Sum_probs=130.3
Q ss_pred HHHHhhcCCcccceecccCceEEEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHhc--CCCccccEeeEEEeC---
Q 017558 196 ELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQV--HHRHLVSLVGYCTFG--- 270 (369)
Q Consensus 196 ~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~g~~~~~--- 270 (369)
......++|++.+.||+|+||.||+|+.. ++.||||++... ....+.+|.+++..+ +|+||+++++++...
T Consensus 31 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 106 (337)
T 3mdy_A 31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGS 106 (337)
T ss_dssp HHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred cccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence 34455678999999999999999999985 899999998643 234555666666554 899999999999887
Q ss_pred -CeeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeeecCCCCCcEEECCCCcEEE
Q 017558 271 -SQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDC-----QPKIIHRDIKSANILLDDSFEAKV 344 (369)
Q Consensus 271 -~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~-----~~~ivHrdlk~~Nill~~~~~~ki 344 (369)
...|+||||+++|+|.+++... .+++..++.++.|++.||.|||+++ ..+|+||||||+|||++.++.+||
T Consensus 107 ~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl 183 (337)
T 3mdy_A 107 WTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI 183 (337)
T ss_dssp GCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred CCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence 7889999999999999999653 4899999999999999999999751 337999999999999999999999
Q ss_pred eeeccceeeCCCC
Q 017558 345 ADFGLAKHSLDTD 357 (369)
Q Consensus 345 ~DFGla~~~~~~~ 357 (369)
+|||+++......
T Consensus 184 ~Dfg~a~~~~~~~ 196 (337)
T 3mdy_A 184 ADLGLAVKFISDT 196 (337)
T ss_dssp CCCTTCEECC---
T ss_pred EeCCCceeecccc
Confidence 9999998765543
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-28 Score=223.52 Aligned_cols=153 Identities=30% Similarity=0.431 Sum_probs=131.0
Q ss_pred hhcCCcccceecccCceEEEEEEEcC----CeEEEEEeeccCC-cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeE
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVLTN----GKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRL 274 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 274 (369)
..++|.+.+.||+|+||.||+|++.+ +..||+|.++... ....+.+.+|++++.+++||||+++++++.. +..|
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 45789999999999999999998643 2469999987653 2345679999999999999999999999864 5679
Q ss_pred EEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 275 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 275 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
+||||+++++|.+++.... ..+++..++.++.|++.||.|||++ +++||||||+|||++.++.+||+|||+++...
T Consensus 89 ~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp EEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred EEEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 9999999999999997543 3489999999999999999999998 99999999999999999999999999998765
Q ss_pred CCC
Q 017558 355 DTD 357 (369)
Q Consensus 355 ~~~ 357 (369)
...
T Consensus 165 ~~~ 167 (281)
T 3cc6_A 165 DED 167 (281)
T ss_dssp ---
T ss_pred ccc
Confidence 543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.6e-28 Score=220.98 Aligned_cols=151 Identities=26% Similarity=0.386 Sum_probs=133.7
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC--cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEE
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 277 (369)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++.+++|+||+++++++......++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 578999999999999999999964 47899999986543 233457889999999999999999999999999999999
Q ss_pred EecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCc---EEEeeeccceeeC
Q 017558 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFE---AKVADFGLAKHSL 354 (369)
Q Consensus 278 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~---~ki~DFGla~~~~ 354 (369)
||+++++|.+++... ..+++..+..++.|++.||.|||++ +++||||||+|||++.++. +||+|||+++...
T Consensus 85 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp CCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 999999999888754 3489999999999999999999998 9999999999999986655 9999999998765
Q ss_pred CC
Q 017558 355 DT 356 (369)
Q Consensus 355 ~~ 356 (369)
..
T Consensus 160 ~~ 161 (284)
T 3kk8_A 160 DS 161 (284)
T ss_dssp SS
T ss_pred cC
Confidence 44
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.1e-28 Score=224.48 Aligned_cols=149 Identities=26% Similarity=0.439 Sum_probs=132.1
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEE
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 278 (369)
..++|++.+.||+|+||.||+|... +++.||+|.+........+.+.+|++++.+++||||+++++++...+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 4578999999999999999999975 478999999977666667789999999999999999999999999999999999
Q ss_pred ecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeecccee
Q 017558 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (369)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~ 352 (369)
|+++++|.+++.... ..+++..+..++.||+.||.|||++ +++||||||+|||++.++.+||+|||+++.
T Consensus 97 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 166 (302)
T 2j7t_A 97 FCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAK 166 (302)
T ss_dssp CCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHH
T ss_pred eCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcc
Confidence 999999999886533 3489999999999999999999998 999999999999999999999999999764
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.2e-28 Score=226.31 Aligned_cols=158 Identities=21% Similarity=0.305 Sum_probs=136.4
Q ss_pred HHHHhhcCCccc-ceecccCceEEEEEEEc-CCeEEEEEeeccCC--cccHHHHHHHHHHHHhcC-CCccccEeeEEEeC
Q 017558 196 ELKIATDNFSEA-NLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVH-HRHLVSLVGYCTFG 270 (369)
Q Consensus 196 ~~~~~~~~~~~~-~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~ 270 (369)
......++|.+. +.||+|+||.||+|... +++.||||+++... ......+.+|+.++.++. |+||+++++++...
T Consensus 22 ~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~ 101 (327)
T 3lm5_A 22 SMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENT 101 (327)
T ss_dssp CHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred HHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC
Confidence 345556677776 89999999999999965 58899999987542 234568999999999995 69999999999999
Q ss_pred CeeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECC---CCcEEEeee
Q 017558 271 SQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD---SFEAKVADF 347 (369)
Q Consensus 271 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~---~~~~ki~DF 347 (369)
...|+||||+++|+|.+++.......+++..++.++.||+.||+|||++ +|+||||||+|||++. ++.+||+||
T Consensus 102 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~Df 178 (327)
T 3lm5_A 102 SEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDF 178 (327)
T ss_dssp SEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEECCG
T ss_pred CeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEeeC
Confidence 9999999999999999999766556799999999999999999999998 9999999999999998 789999999
Q ss_pred ccceeeCCC
Q 017558 348 GLAKHSLDT 356 (369)
Q Consensus 348 Gla~~~~~~ 356 (369)
|+++.....
T Consensus 179 g~a~~~~~~ 187 (327)
T 3lm5_A 179 GMSRKIGHA 187 (327)
T ss_dssp GGCEEC---
T ss_pred ccccccCCc
Confidence 999986543
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=9.3e-28 Score=224.08 Aligned_cols=154 Identities=29% Similarity=0.386 Sum_probs=135.9
Q ss_pred HHHHHHhhcCCcccceecccCceEEEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHh--cCCCccccEeeEEEeCC
Q 017558 194 YEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQ--VHHRHLVSLVGYCTFGS 271 (369)
Q Consensus 194 ~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~g~~~~~~ 271 (369)
+.......++|.+.+.||+|+||.||+|+. +++.||||++... ..+.+.+|++++.. ++||||+++++++....
T Consensus 34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~ 109 (342)
T 1b6c_B 34 LLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDN 109 (342)
T ss_dssp HHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC
T ss_pred eeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC
Confidence 344455678899999999999999999998 5899999998643 34578889999887 78999999999998776
Q ss_pred ----eeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeeecCCCCCcEEECCC
Q 017558 272 ----QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLH--------EDCQPKIIHRDIKSANILLDDS 339 (369)
Q Consensus 272 ----~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH--------~~~~~~ivHrdlk~~Nill~~~ 339 (369)
..++||||+++|+|.+++... .+++..++.++.||+.||.||| ++ +|+||||||+||||+.+
T Consensus 110 ~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~ 183 (342)
T 1b6c_B 110 GTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKN 183 (342)
T ss_dssp SSCCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTT
T ss_pred CccceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCC
Confidence 789999999999999999753 4899999999999999999999 66 99999999999999999
Q ss_pred CcEEEeeeccceeeCCCC
Q 017558 340 FEAKVADFGLAKHSLDTD 357 (369)
Q Consensus 340 ~~~ki~DFGla~~~~~~~ 357 (369)
+.+||+|||+++......
T Consensus 184 ~~~kL~Dfg~~~~~~~~~ 201 (342)
T 1b6c_B 184 GTCCIADLGLAVRHDSAT 201 (342)
T ss_dssp SCEEECCCTTCEEEETTT
T ss_pred CCEEEEECCCceeccccc
Confidence 999999999998876554
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-28 Score=221.06 Aligned_cols=150 Identities=22% Similarity=0.353 Sum_probs=134.1
Q ss_pred hhcCCcccceecccCceEEEEEEEcCCeEEEEEeeccCC--cccHHHHHHHHHHHHhcCCCccccEeeEEEeC--CeeEE
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFG--SQRLL 275 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~l 275 (369)
..++|++.+.||+|+||.||+|+.. +..||||+++... ....+.+.+|++++.+++||||++++++|... ...++
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (271)
T 3kmu_A 8 DFKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL 86 (271)
T ss_dssp CGGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred CHHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence 3467899999999999999999984 8899999997653 23345799999999999999999999999876 77899
Q ss_pred EEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eeecCCCCCcEEECCCCcEEEeeeccceee
Q 017558 276 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPK--IIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (369)
Q Consensus 276 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~--ivHrdlk~~Nill~~~~~~ki~DFGla~~~ 353 (369)
||||+++|+|.+++.......+++..++.++.||+.||.|||++ + ++||||||+|||++.++.+||+|||++...
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 87 ITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp EEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred eecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeee
Confidence 99999999999999876655689999999999999999999998 7 999999999999999999999999987653
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.7e-28 Score=238.32 Aligned_cols=152 Identities=26% Similarity=0.343 Sum_probs=132.0
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCc-------------ccHHHHHHHHHHHHhcCCCccccEee
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG-------------QGEREFQAEIEIISQVHHRHLVSLVG 265 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~l~g 265 (369)
..++|.+.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+++|.+++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4578999999999999999999975 478999999865421 23467899999999999999999999
Q ss_pred EEEeCCeeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCC---cE
Q 017558 266 YCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF---EA 342 (369)
Q Consensus 266 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~---~~ 342 (369)
+|.+....|+||||+++|+|.+++... ..+++..+..|+.||+.||.|||++ +|+||||||+|||++.++ .+
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~ 188 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNI 188 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSE
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccE
Confidence 999999999999999999999998654 3489999999999999999999998 999999999999998765 69
Q ss_pred EEeeeccceeeCCC
Q 017558 343 KVADFGLAKHSLDT 356 (369)
Q Consensus 343 ki~DFGla~~~~~~ 356 (369)
||+|||+++.....
T Consensus 189 kl~Dfg~a~~~~~~ 202 (504)
T 3q5i_A 189 KIVDFGLSSFFSKD 202 (504)
T ss_dssp EECCCTTCEECCTT
T ss_pred EEEECCCCEEcCCC
Confidence 99999999987544
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-28 Score=229.52 Aligned_cols=150 Identities=23% Similarity=0.396 Sum_probs=127.8
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcc--cHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEE
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ--GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 276 (369)
..++|++.+.||+|+||.||+|+.. +++.||||+++..... ..+.+.+|++++.+++|+||+++++++......++|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 4578999999999999999999854 6889999999754332 234678999999999999999999999999999999
Q ss_pred EEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEE-----CCCCcEEEeeeccce
Q 017558 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILL-----DDSFEAKVADFGLAK 351 (369)
Q Consensus 277 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill-----~~~~~~ki~DFGla~ 351 (369)
|||++ |+|.+++.... .+++..+..|+.||+.||.|||++ +|+||||||+|||| +.++.+||+|||+++
T Consensus 112 ~e~~~-~~L~~~~~~~~--~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~ 185 (329)
T 3gbz_A 112 FEYAE-NDLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185 (329)
T ss_dssp EECCS-EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred EecCC-CCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence 99997 59999997653 489999999999999999999998 99999999999999 455669999999998
Q ss_pred eeCC
Q 017558 352 HSLD 355 (369)
Q Consensus 352 ~~~~ 355 (369)
....
T Consensus 186 ~~~~ 189 (329)
T 3gbz_A 186 AFGI 189 (329)
T ss_dssp HHC-
T ss_pred ccCC
Confidence 7643
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-28 Score=223.62 Aligned_cols=150 Identities=32% Similarity=0.543 Sum_probs=124.8
Q ss_pred HhhcCCcccceecccCceEEEEEEEcCCeEEEEEeeccCCc--ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEE
Q 017558 199 IATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (369)
Q Consensus 199 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 276 (369)
+..++|++.+.||+|+||.||+|+.. ..+|||+++.... ...+.+.+|++++.+++|+||+++++++ .....++|
T Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv 97 (289)
T 3og7_A 21 IPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIV 97 (289)
T ss_dssp CCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred cCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEE
Confidence 45678999999999999999999864 3599999875532 3346789999999999999999999966 45678999
Q ss_pred EEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 277 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
|||+++++|.+++.... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 98 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 98 TQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp EECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred EEecCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceecccccc
Confidence 99999999999997543 4589999999999999999999998 999999999999999999999999999986543
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.9e-28 Score=222.66 Aligned_cols=154 Identities=28% Similarity=0.428 Sum_probs=132.0
Q ss_pred HHhhcCCcccc-eecccCceEEEEEEEc---CCeEEEEEeeccCCcc--cHHHHHHHHHHHHhcCCCccccEeeEEEeCC
Q 017558 198 KIATDNFSEAN-LLGQGGFGYVHKGVLT---NGKVVAIKQLKAGSGQ--GEREFQAEIEIISQVHHRHLVSLVGYCTFGS 271 (369)
Q Consensus 198 ~~~~~~~~~~~-~lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~ 271 (369)
.+..++|.+.+ .||+|+||.||+|.+. .++.||||+++..... ..+++.+|++++.+++||||+++++++ ..+
T Consensus 12 ~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~ 90 (291)
T 1xbb_A 12 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAE 90 (291)
T ss_dssp BCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESS
T ss_pred eecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCC
Confidence 34456788877 9999999999999653 3678999999765322 246799999999999999999999999 567
Q ss_pred eeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccce
Q 017558 272 QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351 (369)
Q Consensus 272 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~ 351 (369)
..++||||+++++|.+++... ..+++..++.++.||+.||.|||++ +++||||||+|||++.++.+||+|||+++
T Consensus 91 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 165 (291)
T 1xbb_A 91 SWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSK 165 (291)
T ss_dssp SEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred CcEEEEEeCCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcce
Confidence 789999999999999999764 3489999999999999999999999 99999999999999999999999999999
Q ss_pred eeCCCC
Q 017558 352 HSLDTD 357 (369)
Q Consensus 352 ~~~~~~ 357 (369)
......
T Consensus 166 ~~~~~~ 171 (291)
T 1xbb_A 166 ALRADE 171 (291)
T ss_dssp ECCTTC
T ss_pred eeccCC
Confidence 876544
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=3.6e-28 Score=222.61 Aligned_cols=150 Identities=27% Similarity=0.458 Sum_probs=132.0
Q ss_pred cCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCc--ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEE
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 278 (369)
++|+..+.||+|+||.||+|+.. +++.||||+++.... ...+.+.+|++++.+++|+||+++++++...+..|+|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (299)
T 2r3i_A 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 82 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccchhhHHHHHHHHHHHHHcCCCCeeeEEEEEecCCceEEEEE
Confidence 67899999999999999999975 688999999865432 223678899999999999999999999999999999999
Q ss_pred ecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
|+. ++|.+++.......+++..+..++.||+.||.|||++ +++||||||+|||++.++.+||+|||+++....
T Consensus 83 ~~~-~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 155 (299)
T 2r3i_A 83 FLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV 155 (299)
T ss_dssp CCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECSTTHHHHHCC
T ss_pred ccc-CCHHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHeEEcCCCCEEECcchhhhhccC
Confidence 997 6999999876555689999999999999999999999 999999999999999999999999999987643
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7e-28 Score=220.58 Aligned_cols=152 Identities=25% Similarity=0.352 Sum_probs=135.1
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCc---------ccHHHHHHHHHHHHhcC-CCccccEeeEEE
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG---------QGEREFQAEIEIISQVH-HRHLVSLVGYCT 268 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~niv~l~g~~~ 268 (369)
..++|++.+.||+|+||.||+|... +++.||||+++.... ...+.+.+|++++.++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 4578999999999999999999975 578999999975431 12346789999999995 999999999999
Q ss_pred eCCeeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeec
Q 017558 269 FGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFG 348 (369)
Q Consensus 269 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFG 348 (369)
.....++||||+++++|.+++... ..+++..+..++.||+.||.|||++ +++||||||+|||++.++.+||+|||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg 169 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG 169 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred cCCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEeccc
Confidence 999999999999999999999754 3589999999999999999999998 99999999999999999999999999
Q ss_pred cceeeCCC
Q 017558 349 LAKHSLDT 356 (369)
Q Consensus 349 la~~~~~~ 356 (369)
+++.....
T Consensus 170 ~~~~~~~~ 177 (298)
T 1phk_A 170 FSCQLDPG 177 (298)
T ss_dssp TCEECCTT
T ss_pred chhhcCCC
Confidence 99886543
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.6e-29 Score=231.71 Aligned_cols=156 Identities=29% Similarity=0.489 Sum_probs=136.0
Q ss_pred HHhhcCCcccceecccCceEEEEEEEcC------CeEEEEEeeccCCc-ccHHHHHHHHHHHHhc-CCCccccEeeEEEe
Q 017558 198 KIATDNFSEANLLGQGGFGYVHKGVLTN------GKVVAIKQLKAGSG-QGEREFQAEIEIISQV-HHRHLVSLVGYCTF 269 (369)
Q Consensus 198 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~ 269 (369)
.+..++|.+.+.||+|+||.||+|.... ...||+|.++.... ...+.+.+|++++.++ +||||++++++|..
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 121 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH 121 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence 4456889999999999999999999643 24799999976543 3346789999999999 89999999999999
Q ss_pred CCeeEEEEEecCCCcHhhhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEC
Q 017558 270 GSQRLLVYEFVPNKTLEFHLHGKD------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLD 337 (369)
Q Consensus 270 ~~~~~lv~e~~~~g~L~~~l~~~~------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~ 337 (369)
.+..|+||||+++|+|.+++.... ...+++..++.++.||+.||.|||++ +|+||||||+|||++
T Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLT 198 (333)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEE
T ss_pred CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEEC
Confidence 999999999999999999986431 23578999999999999999999998 999999999999999
Q ss_pred CCCcEEEeeeccceeeCCC
Q 017558 338 DSFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 338 ~~~~~ki~DFGla~~~~~~ 356 (369)
.++.+||+|||+++.....
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~ 217 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMND 217 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGC
T ss_pred CCCeEEECccccccccccc
Confidence 9999999999999876543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-28 Score=228.20 Aligned_cols=154 Identities=30% Similarity=0.451 Sum_probs=134.2
Q ss_pred HHhhcCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCCcccHHHHHHHHHHHHhc-CCCccccEeeEEEe------
Q 017558 198 KIATDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHRHLVSLVGYCTF------ 269 (369)
Q Consensus 198 ~~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~------ 269 (369)
....++|++.+.||+|+||.||+|+. .+++.||||++.... ...+.+.+|++++.++ +|+||+++++++..
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 98 (326)
T 2x7f_A 20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 98 (326)
T ss_dssp CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CC
T ss_pred cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccc
Confidence 34567899999999999999999997 468899999987543 3346889999999999 79999999999987
Q ss_pred CCeeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeecc
Q 017558 270 GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGL 349 (369)
Q Consensus 270 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGl 349 (369)
.+..|+||||+++|+|.+++.......+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~ 175 (326)
T 2x7f_A 99 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGV 175 (326)
T ss_dssp CCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCTT
T ss_pred cceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeCcC
Confidence 46789999999999999999865445689999999999999999999998 999999999999999999999999999
Q ss_pred ceeeCC
Q 017558 350 AKHSLD 355 (369)
Q Consensus 350 a~~~~~ 355 (369)
++....
T Consensus 176 ~~~~~~ 181 (326)
T 2x7f_A 176 SAQLDR 181 (326)
T ss_dssp TC----
T ss_pred ceecCc
Confidence 987653
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.2e-28 Score=239.45 Aligned_cols=152 Identities=24% Similarity=0.394 Sum_probs=136.0
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC---cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEE
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 275 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 275 (369)
..++|+..+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+++|.+++||||++++++|...+..|+
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3467999999999999999999975 68899999986542 2345689999999999999999999999999999999
Q ss_pred EEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEE---CCCCcEEEeeecccee
Q 017558 276 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILL---DDSFEAKVADFGLAKH 352 (369)
Q Consensus 276 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill---~~~~~~ki~DFGla~~ 352 (369)
||||+.+|+|.+++.... .+++..+..|+.||+.||.|||++ +|+||||||+|||+ +.++.+||+|||+++.
T Consensus 104 v~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp EECCCCSCBHHHHHHTCS--CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 999999999999997643 489999999999999999999999 99999999999999 5678999999999987
Q ss_pred eCCC
Q 017558 353 SLDT 356 (369)
Q Consensus 353 ~~~~ 356 (369)
....
T Consensus 179 ~~~~ 182 (484)
T 3nyv_A 179 FEAS 182 (484)
T ss_dssp BCCC
T ss_pred cccc
Confidence 6544
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.6e-28 Score=226.68 Aligned_cols=159 Identities=28% Similarity=0.448 Sum_probs=127.9
Q ss_pred HHHHHhhcCCcccceecccCceEEEEEEEcC----CeEEEEEeeccCCc--ccHHHHHHHHHHHHhcCCCccccEeeEEE
Q 017558 195 EELKIATDNFSEANLLGQGGFGYVHKGVLTN----GKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCT 268 (369)
Q Consensus 195 ~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~----~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~ 268 (369)
+++.+..++|.+.+.||+|+||.||+|.... +..||||+++.... ...+.+.+|++++.+++||||+++++++.
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 106 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence 3445567789999999999999999998643 45899999875432 23457899999999999999999999998
Q ss_pred eCC-----eeEEEEEecCCCcHhhhhcCC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCC
Q 017558 269 FGS-----QRLLVYEFVPNKTLEFHLHGK----DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS 339 (369)
Q Consensus 269 ~~~-----~~~lv~e~~~~g~L~~~l~~~----~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~ 339 (369)
... ..++||||+++|+|.+++... ....+++..++.++.||+.||.|||++ +|+||||||+|||++.+
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~ 183 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDD 183 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTT
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCC
Confidence 755 349999999999999998432 234589999999999999999999998 99999999999999999
Q ss_pred CcEEEeeeccceeeCCC
Q 017558 340 FEAKVADFGLAKHSLDT 356 (369)
Q Consensus 340 ~~~ki~DFGla~~~~~~ 356 (369)
+.+||+|||+++.....
T Consensus 184 ~~~kl~Dfg~~~~~~~~ 200 (313)
T 3brb_A 184 MTVCVADFGLSKKIYSG 200 (313)
T ss_dssp SCEEECSCSCC------
T ss_pred CcEEEeecCcceecccc
Confidence 99999999999876544
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.95 E-value=7e-28 Score=219.93 Aligned_cols=144 Identities=10% Similarity=-0.016 Sum_probs=127.8
Q ss_pred hhcCCcccceecccCceEEEEEEEcC-CeEEEEEeeccCCcc---cHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEE
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGSGQ---GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 275 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 275 (369)
..++|++.+.||+|+||.||+|+... ++.||||+++..... ..+.+.+|++++.+++|+||+++++++..++..|+
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 108 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV 108 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence 34679999999999999999999754 899999999765433 23678999999999999999999999999999999
Q ss_pred EEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccc
Q 017558 276 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLA 350 (369)
Q Consensus 276 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla 350 (369)
||||+++++|.+++... ....+..+|+.||+.||+|||++ +|+||||||+||||++++.+||+++|..
T Consensus 109 v~e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~~~ 176 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPATM 176 (286)
T ss_dssp EEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCCCC
T ss_pred EEEecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecccc
Confidence 99999999999999542 35567889999999999999999 9999999999999999999999987754
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.5e-28 Score=222.71 Aligned_cols=152 Identities=21% Similarity=0.328 Sum_probs=126.8
Q ss_pred hcCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCC---cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEE
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 276 (369)
.++|++.+.||+|+||.||+|.. .+++.||||+++... ....+.+.+|++++.+++|+||+++++++...+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 35799999999999999999996 468899999997532 22345788999999999999999999999999999999
Q ss_pred EEecCCCcHhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 277 YEFVPNKTLEFHLHGK--DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 277 ~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
|||+++++|.+++... ....+++..++.++.||+.||.|||++ +++||||||+|||++.++.+||+|||+++...
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 9999999999998641 234589999999999999999999998 99999999999999999999999999998765
Q ss_pred C
Q 017558 355 D 355 (369)
Q Consensus 355 ~ 355 (369)
.
T Consensus 188 ~ 188 (310)
T 2wqm_A 188 S 188 (310)
T ss_dssp -
T ss_pred C
Confidence 4
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7.3e-28 Score=225.92 Aligned_cols=149 Identities=29% Similarity=0.425 Sum_probs=129.2
Q ss_pred hcCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCCc--ccHHHHHHHHHHHHhcCCCccccEeeEEEe--------
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTF-------- 269 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-------- 269 (369)
.++|++.+.||+|+||.||+|+. .+++.||||++..... .....+.+|++++.+++|+||++++++|..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 36799999999999999999997 4688999999865432 224578899999999999999999999987
Q ss_pred CCeeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeecc
Q 017558 270 GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGL 349 (369)
Q Consensus 270 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGl 349 (369)
.+..|+||||+++ +|.+++.... ..+++..+..|+.||+.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CceEEEEEeccCC-CHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchh
Confidence 3468999999975 7777776543 3589999999999999999999999 999999999999999999999999999
Q ss_pred ceeeC
Q 017558 350 AKHSL 354 (369)
Q Consensus 350 a~~~~ 354 (369)
++...
T Consensus 171 a~~~~ 175 (351)
T 3mi9_A 171 ARAFS 175 (351)
T ss_dssp CEECC
T ss_pred ccccc
Confidence 98765
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=8.9e-28 Score=221.65 Aligned_cols=152 Identities=32% Similarity=0.451 Sum_probs=130.2
Q ss_pred HhhcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEE
Q 017558 199 IATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (369)
Q Consensus 199 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 277 (369)
...++|++.+.||+|+||.||+|... +++.||||.+.... ..+.+.+|++++.+++|+||+++++++...+..|+||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 35678999999999999999999975 48899999997543 3467899999999999999999999999999999999
Q ss_pred EecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCC
Q 017558 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 278 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~ 356 (369)
||+++++|.+++.... ..+++..+..++.||+.||.|||++ +++|+||||+|||++.++.+||+|||+++...+.
T Consensus 104 e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 104 EYCGAGSVSDIIRLRN-KTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp ECCTTEEHHHHHHHHT-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred ecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 9999999999986332 3589999999999999999999998 9999999999999999999999999999876543
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=3.8e-28 Score=222.22 Aligned_cols=149 Identities=29% Similarity=0.429 Sum_probs=129.2
Q ss_pred CCcccceecccCceEEEEEEEcC----CeEEEEEeeccCCc-ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCee-EEE
Q 017558 203 NFSEANLLGQGGFGYVHKGVLTN----GKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQR-LLV 276 (369)
Q Consensus 203 ~~~~~~~lg~G~fg~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~-~lv 276 (369)
.|...+.||+|+||.||+|.+.+ +..||+|.+..... ...+.+.+|++++++++||||+++++++...+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 35566899999999999998543 23799999876443 3446789999999999999999999999876655 999
Q ss_pred EEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 277 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
|||+.+|+|.+++.... ..+++..++.++.|++.||.|||++ +++||||||+|||+++++.+||+|||+++...+
T Consensus 102 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQ-RNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp ECCCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred EecccCCCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 99999999999997643 4589999999999999999999999 999999999999999999999999999986544
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.5e-28 Score=219.37 Aligned_cols=152 Identities=26% Similarity=0.373 Sum_probs=135.6
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC---cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEE
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 275 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 275 (369)
..++|.+.+.||+|+||.||+|+.. +++.||||.+.... ....+.+.+|++++.+++|+||+++++++...+..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence 4578999999999999999999975 68899999986532 2234578999999999999999999999999999999
Q ss_pred EEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 276 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 276 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
||||+++++|.+++.... .+++..+..++.||+.||.|||++ +++||||||+|||++.++.+||+|||+++....
T Consensus 89 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 89 VMEYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred EEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 999999999999997543 488999999999999999999998 999999999999999999999999999987654
Q ss_pred C
Q 017558 356 T 356 (369)
Q Consensus 356 ~ 356 (369)
.
T Consensus 164 ~ 164 (276)
T 2h6d_A 164 G 164 (276)
T ss_dssp -
T ss_pred C
Confidence 3
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.95 E-value=3.2e-28 Score=222.85 Aligned_cols=149 Identities=28% Similarity=0.433 Sum_probs=131.4
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEe----------
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTF---------- 269 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~---------- 269 (369)
.++|++.+.||+|+||.||+|+.. +++.||||+++.. ....+.+.+|++++.+++||||++++++|.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 467899999999999999999964 6889999999643 2334678999999999999999999999865
Q ss_pred ---CCeeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEee
Q 017558 270 ---GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVAD 346 (369)
Q Consensus 270 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~D 346 (369)
....|+||||+++|+|.+++.... ..+++..++.++.||+.||.|||++ +++||||||+|||++.++.+||+|
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECC
T ss_pred cccCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEee
Confidence 356799999999999999997543 3478889999999999999999999 999999999999999999999999
Q ss_pred eccceeeC
Q 017558 347 FGLAKHSL 354 (369)
Q Consensus 347 FGla~~~~ 354 (369)
||+++...
T Consensus 160 fg~~~~~~ 167 (303)
T 1zy4_A 160 FGLAKNVH 167 (303)
T ss_dssp CCCCSCTT
T ss_pred Ccchhhcc
Confidence 99998754
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.7e-28 Score=239.00 Aligned_cols=152 Identities=24% Similarity=0.375 Sum_probs=134.2
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC--cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEE
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 276 (369)
..++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+++|.+++||||+++++++......|+|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 3467999999999999999999975 68899999986432 23456899999999999999999999999999999999
Q ss_pred EEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEC---CCCcEEEeeeccceee
Q 017558 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLD---DSFEAKVADFGLAKHS 353 (369)
Q Consensus 277 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~---~~~~~ki~DFGla~~~ 353 (369)
|||+.+|+|.+++... ..+++..+..|+.||+.||.|||++ +|+||||||+|||++ .++.+||+|||+++..
T Consensus 100 ~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 100 GELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp ECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred EEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 9999999999988654 3489999999999999999999999 999999999999995 5668999999999876
Q ss_pred CCC
Q 017558 354 LDT 356 (369)
Q Consensus 354 ~~~ 356 (369)
...
T Consensus 175 ~~~ 177 (486)
T 3mwu_A 175 QQN 177 (486)
T ss_dssp CCC
T ss_pred CCC
Confidence 543
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.95 E-value=3.6e-28 Score=223.42 Aligned_cols=150 Identities=25% Similarity=0.395 Sum_probs=132.0
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEE
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 278 (369)
..++|.+.+.||+|+||.||+++.. +++.||+|+++.......+.+.+|++++.+++||||+++++++...+..|+|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 3467899999999999999999975 688999999986654455678999999999999999999999999999999999
Q ss_pred ecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEE---CCCCcEEEeeeccceeeC
Q 017558 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILL---DDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill---~~~~~~ki~DFGla~~~~ 354 (369)
|+++++|.+++... ..+++..+..++.|++.||.|||++ +++||||||+|||+ ++++.+||+|||+++...
T Consensus 87 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 87 LVSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp CCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred cCCCccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 99999999998654 3489999999999999999999998 99999999999999 788999999999998654
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=5.5e-28 Score=219.93 Aligned_cols=150 Identities=31% Similarity=0.430 Sum_probs=134.1
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC---cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEE
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 276 (369)
.++|++.+.||+|+||.||+|+.. ++..||||++.... ....+.+.+|++++.+++|+||+++++++...+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 467999999999999999999975 57889999986432 22346789999999999999999999999999999999
Q ss_pred EEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 277 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
|||+++++|.+++.... .+++..+..++.||+.||.|||++ +++||||||+|||++.++.+||+|||++.....
T Consensus 93 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 93 LEFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp ECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 99999999999997543 489999999999999999999998 999999999999999999999999999987654
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.3e-28 Score=246.43 Aligned_cols=144 Identities=30% Similarity=0.464 Sum_probs=126.2
Q ss_pred ceecccCceEEEEEEEc---CCeEEEEEeeccCCc--ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEecCC
Q 017558 208 NLLGQGGFGYVHKGVLT---NGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPN 282 (369)
Q Consensus 208 ~~lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 282 (369)
+.||+|+||.||+|.+. .++.||||+++.... ...+++.+|+++|.+++|+|||+++++|. .+..+||||||++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 47999999999999753 457899999976432 33568999999999999999999999996 4568999999999
Q ss_pred CcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCCC
Q 017558 283 KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (369)
Q Consensus 283 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~~ 357 (369)
|+|.++|... ..+++..++.|+.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++.+...+
T Consensus 454 g~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 523 (635)
T 4fl3_A 454 GPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 523 (635)
T ss_dssp EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--
T ss_pred CCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCc
Confidence 9999999754 3589999999999999999999998 99999999999999999999999999998765443
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=2.8e-28 Score=230.44 Aligned_cols=148 Identities=25% Similarity=0.392 Sum_probs=124.6
Q ss_pred hcCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCCc--ccHHHHHHHHHHHHhcCCCccccEeeEEEeCC------
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFGS------ 271 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------ 271 (369)
.++|+..+.||+|+||.||+|.. .+|+.||||++..... ...+.+.+|+++|.+++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 46799999999999999999996 4688999999865432 23457889999999999999999999997653
Q ss_pred eeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccce
Q 017558 272 QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351 (369)
Q Consensus 272 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~ 351 (369)
..|+||||+ +++|.+++.. ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 176 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR 176 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence 459999999 8999999875 3488999999999999999999999 99999999999999999999999999999
Q ss_pred eeCC
Q 017558 352 HSLD 355 (369)
Q Consensus 352 ~~~~ 355 (369)
....
T Consensus 177 ~~~~ 180 (367)
T 1cm8_A 177 QADS 180 (367)
T ss_dssp ECCS
T ss_pred cccc
Confidence 8654
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.6e-28 Score=221.97 Aligned_cols=151 Identities=24% Similarity=0.346 Sum_probs=129.6
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC----cccHHHHHHHHHHHHhcCCCccccEeeEEE--eCCee
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS----GQGEREFQAEIEIISQVHHRHLVSLVGYCT--FGSQR 273 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~~ 273 (369)
.++|++.+.||+|+||.||++... +++.||+|+++... ....+.+.+|++++.+++|+||+++++++. .....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 478999999999999999999964 57899999986532 233467999999999999999999999984 45578
Q ss_pred EEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceee
Q 017558 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (369)
Q Consensus 274 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~ 353 (369)
|+||||++++ |.+++.......+++..+..++.||+.||.|||++ +++||||||+|||++.++.+||+|||+++..
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccccc
Confidence 9999999877 66777655555699999999999999999999999 9999999999999999999999999999876
Q ss_pred CC
Q 017558 354 LD 355 (369)
Q Consensus 354 ~~ 355 (369)
..
T Consensus 160 ~~ 161 (305)
T 2wtk_C 160 HP 161 (305)
T ss_dssp CT
T ss_pred Cc
Confidence 53
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7e-28 Score=223.86 Aligned_cols=150 Identities=30% Similarity=0.582 Sum_probs=130.5
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCeE--EEEEeeccCC-cccHHHHHHHHHHHHhc-CCCccccEeeEEEeCCeeEE
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKV--VAIKQLKAGS-GQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLL 275 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~--vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~l 275 (369)
.++|++.+.||+|+||.||+|+.. ++.. +|+|.++... ....+.+.+|++++.++ +||||+++++++...+..|+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 367899999999999999999964 4554 4999887543 23445799999999999 89999999999999999999
Q ss_pred EEEecCCCcHhhhhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCc
Q 017558 276 VYEFVPNKTLEFHLHGKD--------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFE 341 (369)
Q Consensus 276 v~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~ 341 (369)
||||+++|+|.+++.... ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCe
Confidence 999999999999997643 23589999999999999999999998 9999999999999999999
Q ss_pred EEEeeeccceee
Q 017558 342 AKVADFGLAKHS 353 (369)
Q Consensus 342 ~ki~DFGla~~~ 353 (369)
+||+|||+++..
T Consensus 181 ~kL~Dfg~~~~~ 192 (327)
T 1fvr_A 181 AKIADFGLSRGQ 192 (327)
T ss_dssp EEECCTTCEESS
T ss_pred EEEcccCcCccc
Confidence 999999999843
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=3.2e-28 Score=229.15 Aligned_cols=150 Identities=25% Similarity=0.377 Sum_probs=134.0
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCc-ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEE
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 278 (369)
.++|++.+.||+|+||.||++... +++.||+|+++.... ...+.+.+|++++.+++|+||+++++++..++..|+|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 467999999999999999999975 578999999976533 334678999999999999999999999999999999999
Q ss_pred ecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
|+++++|.+++.... .+++..+..++.|++.||.|||++. +|+||||||+|||++.++.+||+|||+++...
T Consensus 112 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 183 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 183 (360)
T ss_dssp CCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred CCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence 999999999997643 4889999999999999999999832 79999999999999999999999999997653
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.95 E-value=7e-29 Score=235.34 Aligned_cols=150 Identities=13% Similarity=0.169 Sum_probs=124.2
Q ss_pred hcCCcccceecccCceEEEEEEE-cCCeEEEEEeeccC---CcccHHHHHHHH---HHHHhcCCCccccEe-------eE
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAG---SGQGEREFQAEI---EIISQVHHRHLVSLV-------GY 266 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~h~niv~l~-------g~ 266 (369)
.++|++.+.||+|+||.||+|+. .+++.||||++... .....+.+.+|+ ++|++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46788899999999999999995 56899999999743 233456789999 455566899999998 66
Q ss_pred EEeCC-----------------eeEEEEEecCCCcHhhhhcCCCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 017558 267 CTFGS-----------------QRLLVYEFVPNKTLEFHLHGKDR-----PVMNWPTRMKIALGSARGLAYLHEDCQPKI 324 (369)
Q Consensus 267 ~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~~-----~~l~~~~~~~i~~~i~~~l~yLH~~~~~~i 324 (369)
+...+ ..||||||+ +|+|.+++..... ..+++..++.|+.||+.||.|||++ +|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 66543 278999999 6899999975321 1233578889999999999999999 99
Q ss_pred eecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 325 IHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 325 vHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
+||||||+||||+.++.+||+|||+++...
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~ 257 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETT
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecC
Confidence 999999999999999999999999999743
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.95 E-value=6.4e-28 Score=229.20 Aligned_cols=152 Identities=26% Similarity=0.397 Sum_probs=125.7
Q ss_pred HHhhcCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeC------
Q 017558 198 KIATDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFG------ 270 (369)
Q Consensus 198 ~~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------ 270 (369)
....++|++.+.||+|+||.||+|+. .+++.||||++..... ...+|+++|+.++|+||++++++|...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 44567899999999999999999986 5689999999875432 234799999999999999999998543
Q ss_pred --------------------------------CeeEEEEEecCCCcHhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHH
Q 017558 271 --------------------------------SQRLLVYEFVPNKTLEFHLHG--KDRPVMNWPTRMKIALGSARGLAYL 316 (369)
Q Consensus 271 --------------------------------~~~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~yL 316 (369)
...++||||++ |+|.+.+.. .....+++..+..++.||+.||.||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 34789999998 577776653 2234589999999999999999999
Q ss_pred HhCCCCCeeecCCCCCcEEEC-CCCcEEEeeeccceeeCCCC
Q 017558 317 HEDCQPKIIHRDIKSANILLD-DSFEAKVADFGLAKHSLDTD 357 (369)
Q Consensus 317 H~~~~~~ivHrdlk~~Nill~-~~~~~ki~DFGla~~~~~~~ 357 (369)
|++ +|+||||||+|||++ .++.+||+|||+|+......
T Consensus 158 H~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~ 196 (383)
T 3eb0_A 158 HSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE 196 (383)
T ss_dssp HTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS
T ss_pred HHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC
Confidence 998 999999999999997 68899999999999865443
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-27 Score=219.42 Aligned_cols=148 Identities=24% Similarity=0.317 Sum_probs=130.1
Q ss_pred hcCCccc-ceecccCceEEEEEEE-cCCeEEEEEeeccCCcccHHHHHHHHHHH-HhcCCCccccEeeEEEe----CCee
Q 017558 201 TDNFSEA-NLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQAEIEII-SQVHHRHLVSLVGYCTF----GSQR 273 (369)
Q Consensus 201 ~~~~~~~-~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~g~~~~----~~~~ 273 (369)
.++|.+. +.||+|+||.||++.. .+++.||||+++. ...+.+|++++ ..++|+||+++++++.. ....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 3567666 7899999999999996 4678999999864 25678899988 55689999999999987 6778
Q ss_pred EEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECC---CCcEEEeeeccc
Q 017558 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD---SFEAKVADFGLA 350 (369)
Q Consensus 274 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~---~~~~ki~DFGla 350 (369)
++||||+++|+|.+++.......+++..++.++.||+.||.|||++ +|+||||||+|||++. ++.+||+|||++
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 9999999999999999876555699999999999999999999998 9999999999999998 789999999999
Q ss_pred eeeCCC
Q 017558 351 KHSLDT 356 (369)
Q Consensus 351 ~~~~~~ 356 (369)
+.....
T Consensus 168 ~~~~~~ 173 (299)
T 3m2w_A 168 KETTGE 173 (299)
T ss_dssp EECTTC
T ss_pred cccccc
Confidence 887654
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.4e-28 Score=223.39 Aligned_cols=150 Identities=33% Similarity=0.500 Sum_probs=125.2
Q ss_pred hcCCcccceecccCceEEEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEec
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 280 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 280 (369)
.++|++.+.||+|+||.||++++. ++.||||++... ...+.|.+|++++.+++||||+++++++. +..++||||+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~ 81 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYA 81 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECC
T ss_pred HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcC
Confidence 367888999999999999999984 788999998643 33468999999999999999999999886 4589999999
Q ss_pred CCCcHhhhhcCCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCc-EEEeeeccceeeCC
Q 017558 281 PNKTLEFHLHGKDR-PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFE-AKVADFGLAKHSLD 355 (369)
Q Consensus 281 ~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~-~ki~DFGla~~~~~ 355 (369)
++|+|.+++..... ..+++..++.++.||+.||.|||+....+|+||||||+|||++.++. +||+|||+++....
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~ 158 (307)
T 2eva_A 82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT 158 (307)
T ss_dssp TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence 99999999986542 24788999999999999999999932228999999999999988876 79999999986543
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=8.1e-28 Score=222.97 Aligned_cols=151 Identities=27% Similarity=0.360 Sum_probs=128.4
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCc--------ccHHHHHHHHHHHHhcCCCccccEeeEEEeC
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG--------QGEREFQAEIEIISQVHHRHLVSLVGYCTFG 270 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~ 270 (369)
..++|.+.+.||+|+||.||+|... +++.||||.+..... .....+.+|+++|.+++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 3467999999999999999999964 578999999865321 1223588999999999999999999998765
Q ss_pred CeeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCc---EEEeee
Q 017558 271 SQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFE---AKVADF 347 (369)
Q Consensus 271 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~---~ki~DF 347 (369)
. .|+||||+++++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++. +||+||
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Df 161 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDF 161 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred c-eEEEEecCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEccC
Confidence 4 89999999999999998654 3589999999999999999999998 9999999999999987654 999999
Q ss_pred ccceeeCCC
Q 017558 348 GLAKHSLDT 356 (369)
Q Consensus 348 Gla~~~~~~ 356 (369)
|+++.....
T Consensus 162 g~~~~~~~~ 170 (322)
T 2ycf_A 162 GHSKILGET 170 (322)
T ss_dssp TTCEECCCC
T ss_pred ccceecccc
Confidence 999886543
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.6e-28 Score=228.65 Aligned_cols=149 Identities=21% Similarity=0.281 Sum_probs=124.2
Q ss_pred hcCCcccceecccCceEEEEEEEc----CCeEEEEEeeccCCcc-----------cHHHHHHHHHHHHhcCCCccccEee
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT----NGKVVAIKQLKAGSGQ-----------GEREFQAEIEIISQVHHRHLVSLVG 265 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~g 265 (369)
.++|.+.+.||+|+||.||+|... .+..+|||++...... ..+.+.+|+.++..++|+||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 467999999999999999999975 4678999998765322 1134668889999999999999999
Q ss_pred EEEe----CCeeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCC-
Q 017558 266 YCTF----GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF- 340 (369)
Q Consensus 266 ~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~- 340 (369)
++.. ....|+||||+ +++|.+++.... .+++..++.|+.||+.||.|||++ +|+||||||+||||+.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~ 189 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNP 189 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSST
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCCC
Confidence 9988 67889999999 999999997654 589999999999999999999998 999999999999998877
Q ss_pred -cEEEeeeccceeeCC
Q 017558 341 -EAKVADFGLAKHSLD 355 (369)
Q Consensus 341 -~~ki~DFGla~~~~~ 355 (369)
.+||+|||+++.+..
T Consensus 190 ~~~kL~Dfg~a~~~~~ 205 (345)
T 2v62_A 190 DQVYLADYGLSYRYCP 205 (345)
T ss_dssp TSEEECCCTTCEESSG
T ss_pred CcEEEEeCCCceeccc
Confidence 999999999987653
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-28 Score=231.14 Aligned_cols=146 Identities=16% Similarity=0.262 Sum_probs=129.0
Q ss_pred hcCCcccceecccCceEEEEEEEcC---------CeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCcccc---------
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLTN---------GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVS--------- 262 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--------- 262 (369)
.++|.+.+.||+|+||.||+|+... ++.||||.+... +.+.+|++++.+++|+||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 4689999999999999999999753 789999998753 46889999999999999988
Q ss_pred ------EeeEEEe-CCeeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEE
Q 017558 263 ------LVGYCTF-GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANIL 335 (369)
Q Consensus 263 ------l~g~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nil 335 (369)
+++++.. ....|+||||+ +++|.+++.......+++..++.|+.||+.||.|||++ +|+||||||+|||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl 191 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIF 191 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEE
Confidence 6778876 77889999999 99999999865345699999999999999999999999 9999999999999
Q ss_pred ECCCC--cEEEeeeccceeeCC
Q 017558 336 LDDSF--EAKVADFGLAKHSLD 355 (369)
Q Consensus 336 l~~~~--~~ki~DFGla~~~~~ 355 (369)
++.++ .+||+|||+++....
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~ 213 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCP 213 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSG
T ss_pred EcCCCCceEEEecCcceeeccC
Confidence 99998 999999999987654
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-28 Score=245.16 Aligned_cols=150 Identities=19% Similarity=0.192 Sum_probs=114.7
Q ss_pred ecccCceEEEEEE-EcCCeEEEEEeeccCC----------cccHHHHHHHHHHHHhc-CCCccccEeeEEEeCCeeEEEE
Q 017558 210 LGQGGFGYVHKGV-LTNGKVVAIKQLKAGS----------GQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLVY 277 (369)
Q Consensus 210 lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~ 277 (369)
.+.|.+|.+..++ .-.|+.++||.+.... ....++|.+|+++|+++ .|+||++|++++++++..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 4556666555543 2347889999986542 12235799999999999 6999999999999999999999
Q ss_pred EecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCCC
Q 017558 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (369)
Q Consensus 278 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~~ 357 (369)
||++|++|.++|.... .++.. +|+.||+.||+|||++ |||||||||+||||++++.+||+|||+|+......
T Consensus 322 Eyv~G~~L~d~i~~~~--~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~ 393 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGE--EIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC 393 (569)
T ss_dssp ECCCSEEHHHHHHTTC--CCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred ecCCCCcHHHHHHhCC--CCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCCCC
Confidence 9999999999997653 35543 5889999999999999 99999999999999999999999999999876543
Q ss_pred ceeeeeecccC
Q 017558 358 THVSTRVMGTF 368 (369)
Q Consensus 358 ~~~~~~~~gt~ 368 (369)
. ..+..+||+
T Consensus 394 ~-~~~t~vGTp 403 (569)
T 4azs_A 394 S-WPTNLVQSF 403 (569)
T ss_dssp C-CSHHHHHHH
T ss_pred c-cccCceech
Confidence 2 233456765
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-28 Score=224.91 Aligned_cols=156 Identities=26% Similarity=0.387 Sum_probs=120.8
Q ss_pred HHHhhcCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCC-cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeE
Q 017558 197 LKIATDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRL 274 (369)
Q Consensus 197 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 274 (369)
+.+..++|++.+.||+|+||.||+|.. .+++.||||++.... ....+++.+|++++.+++||||+++++++...+..+
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 89 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW 89 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEE
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcE
Confidence 345678899999999999999999985 367899999986543 233467889999999999999999999999999999
Q ss_pred EEEEecCCCcHhhhhcC------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeec
Q 017558 275 LVYEFVPNKTLEFHLHG------KDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFG 348 (369)
Q Consensus 275 lv~e~~~~g~L~~~l~~------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFG 348 (369)
+||||+++++|.+++.. .....+++..++.++.||+.||.|||++ +++||||||+|||++.++.+||+|||
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg 166 (303)
T 2vwi_A 90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFG 166 (303)
T ss_dssp EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCH
T ss_pred EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEecc
Confidence 99999999999999863 1234589999999999999999999998 99999999999999999999999999
Q ss_pred cceeeCC
Q 017558 349 LAKHSLD 355 (369)
Q Consensus 349 la~~~~~ 355 (369)
+++....
T Consensus 167 ~~~~~~~ 173 (303)
T 2vwi_A 167 VSAFLAT 173 (303)
T ss_dssp HHHHCC-
T ss_pred chheecc
Confidence 9986543
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-28 Score=222.38 Aligned_cols=150 Identities=29% Similarity=0.480 Sum_probs=127.5
Q ss_pred hhcCCcccceecccCceEEEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeC-CeeEEEEE
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFG-SQRLLVYE 278 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~~lv~e 278 (369)
..++|++.+.||+|+||.||++.. .++.||||.++... ..+.+.+|++++.+++|+||+++++++... +..++|||
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 95 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 95 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred ChhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence 457899999999999999999998 48899999987543 446899999999999999999999997654 47899999
Q ss_pred ecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
|+++++|.+++.......+++..++.++.|++.||.|||++ +++||||||+|||++.++.+||+|||+++....
T Consensus 96 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 96 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred cCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 99999999999754333478899999999999999999998 999999999999999999999999999987543
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.95 E-value=6.2e-28 Score=245.73 Aligned_cols=149 Identities=20% Similarity=0.359 Sum_probs=128.9
Q ss_pred hhcCCcccceecccCceEEEEEEEc--CCeEEEEEeeccCCc-ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCe----
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVLT--NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQ---- 272 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~---- 272 (369)
..++|++.+.||+|+||.||+|... +++.||||++..... ...+.+.+|+++|.+++||||++++++|...+.
T Consensus 78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 3478999999999999999999975 589999999865433 334578899999999999999999999987665
Q ss_pred -eEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccce
Q 017558 273 -RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351 (369)
Q Consensus 273 -~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~ 351 (369)
.||||||+++++|.+++.. .+++.+++.|+.||+.||.|||++ +|+||||||+||||+.+ .+||+|||+++
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred eeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccch
Confidence 6999999999999988754 589999999999999999999998 99999999999999986 89999999999
Q ss_pred eeCCC
Q 017558 352 HSLDT 356 (369)
Q Consensus 352 ~~~~~ 356 (369)
.....
T Consensus 230 ~~~~~ 234 (681)
T 2pzi_A 230 RINSF 234 (681)
T ss_dssp ETTCC
T ss_pred hcccC
Confidence 87543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-27 Score=218.74 Aligned_cols=150 Identities=27% Similarity=0.338 Sum_probs=129.6
Q ss_pred cCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC--cccHHHHHHHHHHHHhcCCCccccEeeEEEe----CCeeE
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTF----GSQRL 274 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~~ 274 (369)
..|.+.+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|++++.+++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 44777889999999999999964 56789999986543 2344678999999999999999999999875 35689
Q ss_pred EEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eeecCCCCCcEEEC-CCCcEEEeeeccce
Q 017558 275 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPK--IIHRDIKSANILLD-DSFEAKVADFGLAK 351 (369)
Q Consensus 275 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~--ivHrdlk~~Nill~-~~~~~ki~DFGla~ 351 (369)
+||||+++++|.+++... ..+++..++.++.||+.||.|||++ + ++||||||+|||++ .++.+||+|||+++
T Consensus 106 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 999999999999999754 3488999999999999999999998 7 99999999999998 78999999999997
Q ss_pred eeCCC
Q 017558 352 HSLDT 356 (369)
Q Consensus 352 ~~~~~ 356 (369)
.....
T Consensus 181 ~~~~~ 185 (290)
T 1t4h_A 181 LKRAS 185 (290)
T ss_dssp GCCTT
T ss_pred ccccc
Confidence 65443
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-27 Score=226.06 Aligned_cols=148 Identities=24% Similarity=0.380 Sum_probs=130.6
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcc-cHHHHHHHHHHHHhcCCCccccEeeEEEeC-----Cee
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVSLVGYCTFG-----SQR 273 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~ 273 (369)
.++|++.+.||+|+||.||+|... +++.||||++...... ..+.+.+|+++|.+++|+||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 468999999999999999999964 6789999999754333 336789999999999999999999999754 368
Q ss_pred EEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceee
Q 017558 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (369)
Q Consensus 274 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~ 353 (369)
|+||||+. |+|.+++... .+++..+..|+.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++..
T Consensus 106 ~iv~e~~~-~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 178 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVA 178 (364)
T ss_dssp EEEEECCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEcccC-cCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEec
Confidence 99999997 6999988653 489999999999999999999999 9999999999999999999999999999876
Q ss_pred CC
Q 017558 354 LD 355 (369)
Q Consensus 354 ~~ 355 (369)
..
T Consensus 179 ~~ 180 (364)
T 3qyz_A 179 DP 180 (364)
T ss_dssp CG
T ss_pred CC
Confidence 54
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.6e-28 Score=224.75 Aligned_cols=155 Identities=25% Similarity=0.399 Sum_probs=133.5
Q ss_pred HHhhcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcccHHHHHHHHHHHHhcC-CCccccEeeEEEe------
Q 017558 198 KIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVH-HRHLVSLVGYCTF------ 269 (369)
Q Consensus 198 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~------ 269 (369)
.+...+|++.++||+|+||.||+|+.. +++.||||++........+.+.+|+.++.++. |+||+++++++..
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 103 (337)
T 3ll6_A 24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD 103 (337)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred eccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence 344568999999999999999999964 67899999997766556678999999999996 9999999999943
Q ss_pred --CCeeEEEEEecCCCcHhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eeecCCCCCcEEECCCCcEEE
Q 017558 270 --GSQRLLVYEFVPNKTLEFHLHG-KDRPVMNWPTRMKIALGSARGLAYLHEDCQPK--IIHRDIKSANILLDDSFEAKV 344 (369)
Q Consensus 270 --~~~~~lv~e~~~~g~L~~~l~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~--ivHrdlk~~Nill~~~~~~ki 344 (369)
....++||||+. |+|.+++.. .....+++..++.|+.||+.||.|||++ + |+||||||+||||+.++.+||
T Consensus 104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl 179 (337)
T 3ll6_A 104 TGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKL 179 (337)
T ss_dssp TSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEB
T ss_pred cCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEE
Confidence 345789999995 789888864 1234589999999999999999999998 7 999999999999999999999
Q ss_pred eeeccceeeCCC
Q 017558 345 ADFGLAKHSLDT 356 (369)
Q Consensus 345 ~DFGla~~~~~~ 356 (369)
+|||+++.....
T Consensus 180 ~Dfg~~~~~~~~ 191 (337)
T 3ll6_A 180 CDFGSATTISHY 191 (337)
T ss_dssp CCCTTCBCCSSC
T ss_pred ecCccceecccc
Confidence 999999876543
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.9e-28 Score=224.90 Aligned_cols=153 Identities=30% Similarity=0.427 Sum_probs=130.6
Q ss_pred hhcCCcccceecccCceEEEEEEE------cCCeEEEEEeeccCC-cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCe
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVL------TNGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQ 272 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 272 (369)
..++|++.+.||+|+||.||+|++ .++..||||++.... .....++.+|+.++.+++||||+++++++.....
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 457899999999999999999984 246789999997543 3344578999999999999999999999999999
Q ss_pred eEEEEEecCCCcHhhhhcCCCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECC---CCcEEE
Q 017558 273 RLLVYEFVPNKTLEFHLHGKDR-----PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD---SFEAKV 344 (369)
Q Consensus 273 ~~lv~e~~~~g~L~~~l~~~~~-----~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~---~~~~ki 344 (369)
.|+||||+++++|.+++..... ..+++..++.++.||+.||.|||++ +|+||||||+|||++. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEE
Confidence 9999999999999999976432 3488999999999999999999998 9999999999999984 456999
Q ss_pred eeeccceeeCC
Q 017558 345 ADFGLAKHSLD 355 (369)
Q Consensus 345 ~DFGla~~~~~ 355 (369)
+|||+++....
T Consensus 185 ~Dfg~~~~~~~ 195 (327)
T 2yfx_A 185 GDFGMARDIYR 195 (327)
T ss_dssp CCCHHHHHHHC
T ss_pred Ccccccccccc
Confidence 99999986543
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-27 Score=221.16 Aligned_cols=145 Identities=23% Similarity=0.380 Sum_probs=129.7
Q ss_pred hcCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCCcccHHHHHHHHHHHHhcC-CCccccEeeEEEe--CCeeEEE
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVH-HRHLVSLVGYCTF--GSQRLLV 276 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~--~~~~~lv 276 (369)
.++|++.+.||+|+||.||+|+. .+++.||||+++.. ..+.+.+|++++.+++ |+||+++++++.. ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 46799999999999999999985 56889999998743 3467999999999997 9999999999987 6678999
Q ss_pred EEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCC-cEEEeeeccceeeCC
Q 017558 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF-EAKVADFGLAKHSLD 355 (369)
Q Consensus 277 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~-~~ki~DFGla~~~~~ 355 (369)
|||+++++|.+++.. +++..+..++.||+.||.|||++ +|+||||||+|||++.++ .+||+|||+++....
T Consensus 112 ~e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp EECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred EeccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 999999999999853 78999999999999999999998 999999999999999766 899999999987654
Q ss_pred C
Q 017558 356 T 356 (369)
Q Consensus 356 ~ 356 (369)
.
T Consensus 184 ~ 184 (330)
T 3nsz_A 184 G 184 (330)
T ss_dssp T
T ss_pred C
Confidence 3
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=8.1e-28 Score=223.65 Aligned_cols=151 Identities=27% Similarity=0.494 Sum_probs=126.7
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCe----EEEEEeeccCC-cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeE
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGK----VVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRL 274 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 274 (369)
.++|++.+.||+|+||.||+|+.. +++ .||+|.++... ....+.+.+|+.++.+++||||++++++|.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 467999999999999999999964 343 36788776543 345678999999999999999999999998654 78
Q ss_pred EEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 275 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 275 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
+|+||+.+|+|.+++.... ..+++..++.|+.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 93 ~v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred EEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 9999999999999997643 3589999999999999999999999 99999999999999999999999999998765
Q ss_pred CC
Q 017558 355 DT 356 (369)
Q Consensus 355 ~~ 356 (369)
..
T Consensus 169 ~~ 170 (327)
T 3lzb_A 169 AE 170 (327)
T ss_dssp --
T ss_pred Cc
Confidence 43
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=4.8e-28 Score=228.80 Aligned_cols=148 Identities=25% Similarity=0.420 Sum_probs=115.7
Q ss_pred hcCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCC--cccHHHHHHHHHHHHhcCCCccccEeeEEEeC------C
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFG------S 271 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~ 271 (369)
.++|+..+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+++|++++|+||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 47899999999999999999985 468899999996542 22345788999999999999999999999654 5
Q ss_pred eeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccce
Q 017558 272 QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351 (369)
Q Consensus 272 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~ 351 (369)
..|+||||+ +++|.+++.. ..+++..+..++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~ 180 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 180 (367)
T ss_dssp CCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC-----
T ss_pred eEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccccc
Confidence 679999999 7899998864 3589999999999999999999998 99999999999999999999999999998
Q ss_pred eeCC
Q 017558 352 HSLD 355 (369)
Q Consensus 352 ~~~~ 355 (369)
...+
T Consensus 181 ~~~~ 184 (367)
T 2fst_X 181 HTAD 184 (367)
T ss_dssp ----
T ss_pred cccc
Confidence 7653
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=1.6e-27 Score=225.56 Aligned_cols=147 Identities=23% Similarity=0.329 Sum_probs=124.9
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCc--ccHHHHHHHHHHHHhcCCCccccEeeEEEeCC------
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFGS------ 271 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------ 271 (369)
.++|++.+.||+|+||.||+|... +++.||||++..... ...+.+.+|+.++++++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 468999999999999999999864 588999999975432 23457889999999999999999999997654
Q ss_pred eeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccce
Q 017558 272 QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351 (369)
Q Consensus 272 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~ 351 (369)
..|+||||++ ++|.+++.. .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 175 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 175 (371)
T ss_dssp EEEEEEECCS-EEHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred ceEEEEEcCC-CCHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeeccc
Confidence 7899999997 578888853 388999999999999999999999 99999999999999999999999999998
Q ss_pred eeCC
Q 017558 352 HSLD 355 (369)
Q Consensus 352 ~~~~ 355 (369)
....
T Consensus 176 ~~~~ 179 (371)
T 2xrw_A 176 TAGT 179 (371)
T ss_dssp ----
T ss_pred cccc
Confidence 7654
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-27 Score=220.30 Aligned_cols=148 Identities=27% Similarity=0.391 Sum_probs=125.1
Q ss_pred hcCCcccceecccCceEEEEEEEcC-CeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEE-----------
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCT----------- 268 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~----------- 268 (369)
.++|+..+.||+|+||.||+|.... ++.||||++........+.+.+|++++.+++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 4689999999999999999999764 8999999998665555678999999999999999999999873
Q ss_pred ---eCCeeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEC-CCCcEEE
Q 017558 269 ---FGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLD-DSFEAKV 344 (369)
Q Consensus 269 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~-~~~~~ki 344 (369)
.....|+||||++ |+|.+++.. ..+++..+..++.||+.||.|||++ +|+||||||+|||++ +++.+||
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEE
Confidence 3467899999997 699999864 3488999999999999999999998 999999999999997 5779999
Q ss_pred eeeccceeeCC
Q 017558 345 ADFGLAKHSLD 355 (369)
Q Consensus 345 ~DFGla~~~~~ 355 (369)
+|||+++....
T Consensus 163 ~Dfg~~~~~~~ 173 (320)
T 2i6l_A 163 GDFGLARIMDP 173 (320)
T ss_dssp CCCTTCBCC--
T ss_pred ccCccccccCC
Confidence 99999987643
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=8.4e-28 Score=217.97 Aligned_cols=152 Identities=22% Similarity=0.384 Sum_probs=131.4
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC--cccHHHHHHHHHHHHhcCCCccccEeeEEEe--CCeeEE
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTF--GSQRLL 275 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~l 275 (369)
.++|++.+.||+|+||.||++... +++.||+|++.... ....+.+.+|++++.+++||||+++++++.. ....|+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 467899999999999999999975 58899999997543 2334578999999999999999999998854 568899
Q ss_pred EEEecCCCcHhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-----eeecCCCCCcEEECCCCcEEEeeec
Q 017558 276 VYEFVPNKTLEFHLHGK--DRPVMNWPTRMKIALGSARGLAYLHEDCQPK-----IIHRDIKSANILLDDSFEAKVADFG 348 (369)
Q Consensus 276 v~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~-----ivHrdlk~~Nill~~~~~~ki~DFG 348 (369)
||||+++++|.+++... ....+++..++.++.|++.||.|||++ + ++||||||+|||++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 99999999999999753 233489999999999999999999998 7 9999999999999999999999999
Q ss_pred cceeeCC
Q 017558 349 LAKHSLD 355 (369)
Q Consensus 349 la~~~~~ 355 (369)
+++....
T Consensus 162 ~~~~~~~ 168 (279)
T 2w5a_A 162 LARILNH 168 (279)
T ss_dssp HHHHC--
T ss_pred hheeecc
Confidence 9987654
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-27 Score=242.55 Aligned_cols=155 Identities=27% Similarity=0.438 Sum_probs=134.1
Q ss_pred HHhhcCCcccceecccCceEEEEEEEcC----CeEEEEEeeccCCcc-cHHHHHHHHHHHHhcCCCccccEeeEEEeCCe
Q 017558 198 KIATDNFSEANLLGQGGFGYVHKGVLTN----GKVVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQ 272 (369)
Q Consensus 198 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 272 (369)
.+..++|++.+.||+|+||.||+|.+.. +..||||+++..... ..+.+.+|+.+|.+++||||+++++++. ++.
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~ 464 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 464 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCc
Confidence 3456789999999999999999999743 467999998764333 3467999999999999999999999985 567
Q ss_pred eEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeecccee
Q 017558 273 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (369)
Q Consensus 273 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~ 352 (369)
.|+||||+++|+|.+++.... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 465 ~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 465 VWIIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY 540 (656)
T ss_dssp CEEEEECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred eEEEEEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCee
Confidence 899999999999999997543 3589999999999999999999998 999999999999999999999999999998
Q ss_pred eCCCC
Q 017558 353 SLDTD 357 (369)
Q Consensus 353 ~~~~~ 357 (369)
..+..
T Consensus 541 ~~~~~ 545 (656)
T 2j0j_A 541 MEDST 545 (656)
T ss_dssp CCC--
T ss_pred cCCCc
Confidence 75543
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.2e-27 Score=220.02 Aligned_cols=149 Identities=31% Similarity=0.516 Sum_probs=124.3
Q ss_pred hhcCCcccceecccCceEEEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHH--HHhcCCCccccEeeEEEe-----CCe
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEI--ISQVHHRHLVSLVGYCTF-----GSQ 272 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~g~~~~-----~~~ 272 (369)
..++|++.+.||+|+||.||+|+. +++.||||++.... ...+..|.++ +..++|+||+++++++.. ...
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred ChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 457899999999999999999987 68999999986432 3345555555 445899999999987643 235
Q ss_pred eEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------CCCeeecCCCCCcEEECCCCcEEEee
Q 017558 273 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDC------QPKIIHRDIKSANILLDDSFEAKVAD 346 (369)
Q Consensus 273 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~------~~~ivHrdlk~~Nill~~~~~~ki~D 346 (369)
.++||||+++|+|.+++... .+++..+..|+.||+.||.|||++. ..+|+||||||+||||+.++.+||+|
T Consensus 87 ~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D 163 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD 163 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred EEEEEecCCCCcHHHHHhhc---ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEee
Confidence 68999999999999999754 3588999999999999999999762 23799999999999999999999999
Q ss_pred eccceeeCC
Q 017558 347 FGLAKHSLD 355 (369)
Q Consensus 347 FGla~~~~~ 355 (369)
||+++....
T Consensus 164 FG~a~~~~~ 172 (336)
T 3g2f_A 164 FGLSMRLTG 172 (336)
T ss_dssp CTTCEECSS
T ss_pred ccceeeccc
Confidence 999998754
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.7e-27 Score=228.17 Aligned_cols=151 Identities=25% Similarity=0.349 Sum_probs=131.9
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcccHHHHHHHHHHHHhc------CCCccccEeeEEEeCCe
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQV------HHRHLVSLVGYCTFGSQ 272 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~g~~~~~~~ 272 (369)
...+|++.+.||+|+||.||+|... +++.||||+++... ...+.+.+|++++..+ +|+||+++++++.....
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 3467999999999999999999864 47899999997532 2345778888888877 57799999999999999
Q ss_pred eEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCc--EEEeeeccc
Q 017558 273 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFE--AKVADFGLA 350 (369)
Q Consensus 273 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~--~ki~DFGla 350 (369)
.++||||+. ++|.+++.......+++..+..|+.||+.||.|||++ +|+||||||+||||+.++. +||+|||++
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccc
Confidence 999999996 6899998876656699999999999999999999999 9999999999999999887 999999999
Q ss_pred eeeCC
Q 017558 351 KHSLD 355 (369)
Q Consensus 351 ~~~~~ 355 (369)
+....
T Consensus 250 ~~~~~ 254 (429)
T 3kvw_A 250 CYEHQ 254 (429)
T ss_dssp EETTC
T ss_pred eecCC
Confidence 87543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-27 Score=221.43 Aligned_cols=151 Identities=30% Similarity=0.482 Sum_probs=130.1
Q ss_pred hhcCCcccceecccCceEEEEEEE--cCCeEEEEEeeccCCc--ccHHHHHHHHHHHHhc---CCCccccEeeEEE----
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVL--TNGKVVAIKQLKAGSG--QGEREFQAEIEIISQV---HHRHLVSLVGYCT---- 268 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~g~~~---- 268 (369)
..++|++.+.||+|+||.||+|+. .+++.||||+++.... .....+.+|+.++..+ +||||++++++|.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999997 4678999999865322 1223567788777766 8999999999997
Q ss_pred -eCCeeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeee
Q 017558 269 -FGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADF 347 (369)
Q Consensus 269 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DF 347 (369)
.....++||||++ |+|.+++.......+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+||
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~Df 164 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF 164 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEecC
Confidence 4567899999997 6999999876555689999999999999999999998 9999999999999999999999999
Q ss_pred ccceeeC
Q 017558 348 GLAKHSL 354 (369)
Q Consensus 348 Gla~~~~ 354 (369)
|+++...
T Consensus 165 g~~~~~~ 171 (326)
T 1blx_A 165 GLARIYS 171 (326)
T ss_dssp CSCCCCC
T ss_pred ccccccc
Confidence 9998754
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=1.6e-27 Score=229.25 Aligned_cols=147 Identities=29% Similarity=0.419 Sum_probs=121.8
Q ss_pred cCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeC------CeeE
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFG------SQRL 274 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~~ 274 (369)
.+|+..+.||+|+||.||+|+.. +++.||||++.... +.+.+|+++|++++|+||++++++|... ...+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 46888999999999999999975 58899999986543 2345799999999999999999998542 2367
Q ss_pred EEEEecCCCcHhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCC-CcEEEeeeccce
Q 017558 275 LVYEFVPNKTLEFHLHG--KDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS-FEAKVADFGLAK 351 (369)
Q Consensus 275 lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~-~~~ki~DFGla~ 351 (369)
+||||+++ +|.+++.. .....+++..+..++.||++||.|||++ +|+||||||+||||+.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 89999975 55555432 1234589999999999999999999998 99999999999999954 678999999999
Q ss_pred eeCCC
Q 017558 352 HSLDT 356 (369)
Q Consensus 352 ~~~~~ 356 (369)
.....
T Consensus 206 ~~~~~ 210 (420)
T 1j1b_A 206 QLVRG 210 (420)
T ss_dssp ECCTT
T ss_pred hcccC
Confidence 86544
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-27 Score=227.79 Aligned_cols=148 Identities=24% Similarity=0.338 Sum_probs=116.5
Q ss_pred cCCcc-cceecccCceEEEEEEEc---CCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEe--CCeeEE
Q 017558 202 DNFSE-ANLLGQGGFGYVHKGVLT---NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTF--GSQRLL 275 (369)
Q Consensus 202 ~~~~~-~~~lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~l 275 (369)
+.|++ +++||+|+||.||+|+.. +++.||||++..... ...+.+|+++|.+++||||++++++|.. ....||
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 34555 568999999999999975 478899999975432 3578899999999999999999999965 678899
Q ss_pred EEEecCCCcHhhhhcCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEE----CCCCcEEE
Q 017558 276 VYEFVPNKTLEFHLHGK-------DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILL----DDSFEAKV 344 (369)
Q Consensus 276 v~e~~~~g~L~~~l~~~-------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill----~~~~~~ki 344 (369)
||||+. ++|.+++... ....+++..+..|+.||+.||.|||++ +|+||||||+|||| +.++.+||
T Consensus 98 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEE
Confidence 999996 5777777521 122489999999999999999999999 99999999999999 77899999
Q ss_pred eeeccceeeCC
Q 017558 345 ADFGLAKHSLD 355 (369)
Q Consensus 345 ~DFGla~~~~~ 355 (369)
+|||+|+....
T Consensus 174 ~Dfg~a~~~~~ 184 (405)
T 3rgf_A 174 ADMGFARLFNS 184 (405)
T ss_dssp CCTTCCC----
T ss_pred EECCCceecCC
Confidence 99999987654
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-27 Score=227.02 Aligned_cols=149 Identities=31% Similarity=0.396 Sum_probs=124.3
Q ss_pred hcCCcccceecccCceEEEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCe------eE
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQ------RL 274 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~------~~ 274 (369)
..+|...+.||+|+||.||+|+...+..+|+|++..... ...+|+++|+.++|+||++++++|...+. .+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 457899999999999999999987777799998865432 23479999999999999999999965443 78
Q ss_pred EEEEecCCCcHhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEC-CCCcEEEeeecccee
Q 017558 275 LVYEFVPNKTLEFHLHG-KDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLD-DSFEAKVADFGLAKH 352 (369)
Q Consensus 275 lv~e~~~~g~L~~~l~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~-~~~~~ki~DFGla~~ 352 (369)
+||||++++.+....+. .....+++..+..++.||+.||.|||++ +|+||||||+||||+ .++.+||+|||+|+.
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 99999987655443321 1234589999999999999999999998 999999999999999 799999999999998
Q ss_pred eCCC
Q 017558 353 SLDT 356 (369)
Q Consensus 353 ~~~~ 356 (369)
....
T Consensus 192 ~~~~ 195 (394)
T 4e7w_A 192 LIAG 195 (394)
T ss_dssp CCTT
T ss_pred ccCC
Confidence 6544
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.95 E-value=2.3e-27 Score=216.20 Aligned_cols=154 Identities=23% Similarity=0.339 Sum_probs=121.1
Q ss_pred hhcCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCCcc-cH-HHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEE
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQ-GE-REFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~-~~-~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 276 (369)
..++|++.+.||+|+||.||+|.. .+++.||||+++..... .. +.+.++...++.++||||+++++++...+..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 457899999999999999999996 46899999999765322 22 2344555568888999999999999999999999
Q ss_pred EEecCCCcHhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 277 YEFVPNKTLEFHLHG--KDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 277 ~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
|||++ |+|.+++.. .....+++..+..|+.||+.||.|||++. +++||||||+|||++.++.+||+|||+++...
T Consensus 85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 99997 588777653 12345899999999999999999999852 79999999999999999999999999998765
Q ss_pred CC
Q 017558 355 DT 356 (369)
Q Consensus 355 ~~ 356 (369)
..
T Consensus 162 ~~ 163 (290)
T 3fme_A 162 DD 163 (290)
T ss_dssp --
T ss_pred cc
Confidence 43
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=7.4e-28 Score=222.07 Aligned_cols=155 Identities=26% Similarity=0.302 Sum_probs=125.7
Q ss_pred HHHhhcCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCCcc------cHHHHHHHHHHHHhc----CCCccccEee
Q 017558 197 LKIATDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQ------GEREFQAEIEIISQV----HHRHLVSLVG 265 (369)
Q Consensus 197 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~h~niv~l~g 265 (369)
.....++|++.+.||+|+||.||+|+. .+++.||||++...... ....+.+|++++.++ +|+||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 344567899999999999999999985 46789999999654322 223466799999998 8999999999
Q ss_pred EEEeCCeeEEEEEe-cCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEC-CCCcEE
Q 017558 266 YCTFGSQRLLVYEF-VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLD-DSFEAK 343 (369)
Q Consensus 266 ~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~-~~~~~k 343 (369)
++...+..++|||| +.+++|.+++.... .+++..++.++.||+.||.|||++ +|+||||||+|||++ +++.+|
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~k 180 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAK 180 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEE
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEE
Confidence 99999999999999 78999999997643 489999999999999999999999 999999999999999 889999
Q ss_pred EeeeccceeeCCC
Q 017558 344 VADFGLAKHSLDT 356 (369)
Q Consensus 344 i~DFGla~~~~~~ 356 (369)
|+|||+++.....
T Consensus 181 l~dfg~~~~~~~~ 193 (312)
T 2iwi_A 181 LIDFGSGALLHDE 193 (312)
T ss_dssp ECCCSSCEECCSS
T ss_pred EEEcchhhhcccC
Confidence 9999999987543
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.8e-27 Score=228.61 Aligned_cols=150 Identities=23% Similarity=0.331 Sum_probs=129.8
Q ss_pred hcCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCC-CccccEeeEEEeCCeeEEEEE
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHH-RHLVSLVGYCTFGSQRLLVYE 278 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lv~e 278 (369)
.++|++.++||+|+||.||+|+. .+++.||||++...... .++.+|++++..++| ++|..+..++...+..+||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 47899999999999999999996 46889999987654332 468899999999986 556666666777889999999
Q ss_pred ecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEE---CCCCcEEEeeeccceeeCC
Q 017558 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILL---DDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill---~~~~~~ki~DFGla~~~~~ 355 (369)
|+ +++|.+++.... ..+++..++.|+.||+.||+|||++ +|+||||||+|||| +.++.+||+|||+++.+..
T Consensus 84 ~~-g~sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp CC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred CC-CCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 99 999999997533 3599999999999999999999999 99999999999999 6889999999999998766
Q ss_pred CC
Q 017558 356 TD 357 (369)
Q Consensus 356 ~~ 357 (369)
..
T Consensus 159 ~~ 160 (483)
T 3sv0_A 159 TS 160 (483)
T ss_dssp TT
T ss_pred Cc
Confidence 54
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.95 E-value=5.2e-27 Score=214.33 Aligned_cols=151 Identities=24% Similarity=0.361 Sum_probs=126.7
Q ss_pred hhcCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEE-EeCCeeEEEE
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYC-TFGSQRLLVY 277 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~-~~~~~~~lv~ 277 (369)
..++|++.+.||+|+||.||+|+. .+++.||||++...... +.+.+|++++.+++|+|++..+++| ......++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 457899999999999999999996 56889999987654322 3688999999999988877777766 5677889999
Q ss_pred EecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEE---CCCCcEEEeeeccceeeC
Q 017558 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILL---DDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 278 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill---~~~~~~ki~DFGla~~~~ 354 (369)
||+ +++|.+++.... ..+++..++.++.||+.||.|||++ +|+||||||+|||+ ++++.+||+|||+++...
T Consensus 85 e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp ECC-CCBHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred Ecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 999 999999997433 3589999999999999999999999 99999999999999 788999999999999876
Q ss_pred CCC
Q 017558 355 DTD 357 (369)
Q Consensus 355 ~~~ 357 (369)
...
T Consensus 160 ~~~ 162 (296)
T 4hgt_A 160 DAR 162 (296)
T ss_dssp CTT
T ss_pred Ccc
Confidence 543
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.1e-27 Score=220.13 Aligned_cols=148 Identities=24% Similarity=0.416 Sum_probs=130.5
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCc-ccHHHHHHHHHHHHhcCCCccccEeeEEEeC-----Cee
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFG-----SQR 273 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~ 273 (369)
.++|++.+.||+|+||.||+|... +++.||||+++.... .....+.+|++++.+++|+||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 478999999999999999999975 588999999975433 2345788999999999999999999998754 678
Q ss_pred EEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceee
Q 017558 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (369)
Q Consensus 274 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~ 353 (369)
|+||||+. ++|.+++... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 90 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp EEEECCCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeccC-ccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 99999997 6899988753 489999999999999999999998 9999999999999999999999999999986
Q ss_pred CC
Q 017558 354 LD 355 (369)
Q Consensus 354 ~~ 355 (369)
..
T Consensus 163 ~~ 164 (353)
T 2b9h_A 163 DE 164 (353)
T ss_dssp C-
T ss_pred cc
Confidence 54
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.2e-27 Score=218.26 Aligned_cols=151 Identities=22% Similarity=0.356 Sum_probs=132.4
Q ss_pred hhcCCcccceecccCceEEEEEEE--cCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCC------ccccEeeEEEeCC
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVL--TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHR------HLVSLVGYCTFGS 271 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~------niv~l~g~~~~~~ 271 (369)
..++|++.+.||+|+||.||+|.. .+++.||||+++... ...+.+.+|++++..++|+ +|+++++++...+
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~ 90 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG 90 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence 457899999999999999999986 367899999987532 3346788999999988765 4999999999999
Q ss_pred eeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECC-------------
Q 017558 272 QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD------------- 338 (369)
Q Consensus 272 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~------------- 338 (369)
..++||||+ +++|.+++.......+++..+..++.||+.||.|||++ +|+||||||+|||++.
T Consensus 91 ~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 91 HICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred cEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCcccc
Confidence 999999999 89999999876655689999999999999999999998 9999999999999987
Q ss_pred ------CCcEEEeeeccceeeCC
Q 017558 339 ------SFEAKVADFGLAKHSLD 355 (369)
Q Consensus 339 ------~~~~ki~DFGla~~~~~ 355 (369)
++.+||+|||+++....
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~ 189 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDE 189 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTS
T ss_pred ccccccCCCceEeeCcccccCcc
Confidence 67899999999987544
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-27 Score=217.02 Aligned_cols=153 Identities=29% Similarity=0.438 Sum_probs=125.1
Q ss_pred hhcCCcccceecccCceEEEEEEEcC--C--eEEEEEeeccCC---cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCe
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVLTN--G--KVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQ 272 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~~~--~--~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 272 (369)
..++|++.+.||+|+||.||+|++.. + ..||||+++... ....+.+.+|++++.+++|+||+++++++....
T Consensus 16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 94 (291)
T 1u46_A 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP- 94 (291)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-
Confidence 34679999999999999999998632 2 368999987542 233467899999999999999999999998654
Q ss_pred eEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeecccee
Q 017558 273 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (369)
Q Consensus 273 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~ 352 (369)
.++||||+++++|.+++.... ..+++..+..++.||+.||.|||++ +++||||||+|||++.++.+||+|||+++.
T Consensus 95 ~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 95 MKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp CEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred ceeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcccccccc
Confidence 899999999999999997542 3488999999999999999999998 999999999999999999999999999998
Q ss_pred eCCCC
Q 017558 353 SLDTD 357 (369)
Q Consensus 353 ~~~~~ 357 (369)
.....
T Consensus 171 ~~~~~ 175 (291)
T 1u46_A 171 LPQND 175 (291)
T ss_dssp CCC-C
T ss_pred ccccc
Confidence 76543
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-26 Score=212.49 Aligned_cols=151 Identities=24% Similarity=0.360 Sum_probs=130.5
Q ss_pred hhcCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEE-EeCCeeEEEE
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYC-TFGSQRLLVY 277 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~-~~~~~~~lv~ 277 (369)
..++|++.+.||+|+||.||+|+. .+++.||||++..... .+++.+|++++.+++|+|++..++++ ......++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 357899999999999999999996 5789999999875433 24689999999999988877766666 5577889999
Q ss_pred EecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEE---CCCCcEEEeeeccceeeC
Q 017558 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILL---DDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 278 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill---~~~~~~ki~DFGla~~~~ 354 (369)
||+ +++|.+++.... ..+++..++.++.||+.||.|||++ +|+||||||+|||+ ++++.+||+|||+++...
T Consensus 85 e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp ECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred Eec-CCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 999 999999997433 3589999999999999999999999 99999999999999 488899999999999876
Q ss_pred CCC
Q 017558 355 DTD 357 (369)
Q Consensus 355 ~~~ 357 (369)
...
T Consensus 160 ~~~ 162 (296)
T 3uzp_A 160 DAR 162 (296)
T ss_dssp CTT
T ss_pred ccc
Confidence 543
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6.5e-27 Score=213.23 Aligned_cols=154 Identities=23% Similarity=0.369 Sum_probs=135.2
Q ss_pred HHhhcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC--cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeE
Q 017558 198 KIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRL 274 (369)
Q Consensus 198 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 274 (369)
....++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++.+++||||+++++++......+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 344578999999999999999999975 68899999986542 234568999999999999999999999999999999
Q ss_pred EEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECC---CCcEEEeeeccce
Q 017558 275 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD---SFEAKVADFGLAK 351 (369)
Q Consensus 275 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~---~~~~ki~DFGla~ 351 (369)
+||||+++++|.+++.... .+++..++.++.||+.||.|||++ +++||||||+|||++. ++.+||+|||+++
T Consensus 98 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp EEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 9999999999999886543 489999999999999999999998 9999999999999975 4479999999998
Q ss_pred eeCCC
Q 017558 352 HSLDT 356 (369)
Q Consensus 352 ~~~~~ 356 (369)
.....
T Consensus 173 ~~~~~ 177 (287)
T 2wei_A 173 CFQQN 177 (287)
T ss_dssp TBCCC
T ss_pred eecCC
Confidence 76543
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.94 E-value=4.4e-27 Score=222.50 Aligned_cols=147 Identities=24% Similarity=0.418 Sum_probs=126.5
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcc--cHHHHHHHHHHHHhcCCCccccEeeEEEeCCee----
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ--GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQR---- 273 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~---- 273 (369)
.++|...+.||+|+||.||+|... +++.||||++...... ..+.+.+|+.++.+++||||++++++|...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 468999999999999999999964 5889999999764322 245788999999999999999999999876654
Q ss_pred --EEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccce
Q 017558 274 --LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351 (369)
Q Consensus 274 --~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~ 351 (369)
|+||||+. ++|.+++.. .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 192 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM----EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLAR 192 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred eEEEEEcccc-ccHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCccc
Confidence 99999997 788888743 389999999999999999999999 99999999999999999999999999998
Q ss_pred eeCC
Q 017558 352 HSLD 355 (369)
Q Consensus 352 ~~~~ 355 (369)
....
T Consensus 193 ~~~~ 196 (371)
T 4exu_A 193 HADA 196 (371)
T ss_dssp ----
T ss_pred cccc
Confidence 7643
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.3e-27 Score=224.43 Aligned_cols=149 Identities=12% Similarity=0.041 Sum_probs=113.0
Q ss_pred cCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCc---ccHHHHHHHHHHHHhc--CCCccccEe-------eEEE
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG---QGEREFQAEIEIISQV--HHRHLVSLV-------GYCT 268 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l--~h~niv~l~-------g~~~ 268 (369)
.+|...+.||+|+||.||+|+.. +++.||||+++.... ...+.+.+|++++..+ +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 45888999999999999999964 689999999987543 2334677885554444 699977754 4554
Q ss_pred eC-----------------CeeEEEEEecCCCcHhhhhcCCCCCCCCHHHH------HHHHHHHHHHHHHHHhCCCCCee
Q 017558 269 FG-----------------SQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTR------MKIALGSARGLAYLHEDCQPKII 325 (369)
Q Consensus 269 ~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~------~~i~~~i~~~l~yLH~~~~~~iv 325 (369)
.. ...||||||++ |+|.+++..... .+.+..+ +.++.||+.||.|||++ +|+
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~iv 216 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-VYVFRGDEGILALHILTAQLIRLAANLQSK---GLV 216 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-ccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCc
Confidence 33 33799999998 999999975422 2455556 78889999999999999 999
Q ss_pred ecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 326 HRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 326 Hrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
||||||+||||+.++.+||+|||+|+....
T Consensus 217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~ 246 (371)
T 3q60_A 217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGT 246 (371)
T ss_dssp ETTCSGGGEEECTTSCEEECCGGGEEETTC
T ss_pred cCcCCHHHEEECCCCCEEEEecceeeecCC
Confidence 999999999999999999999999997643
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.7e-26 Score=215.47 Aligned_cols=149 Identities=22% Similarity=0.302 Sum_probs=123.2
Q ss_pred hhcCCccc-ceecccCceEEEEEEEc-CCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEe----CCee
Q 017558 200 ATDNFSEA-NLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTF----GSQR 273 (369)
Q Consensus 200 ~~~~~~~~-~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~ 273 (369)
..++|.+. ++||+|+||.||+|... +++.||||++... .+...+....+..++|+||+++++++.. ....
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 45678885 46999999999999975 5889999998653 1222233334667799999999999976 4458
Q ss_pred EEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECC---CCcEEEeeeccc
Q 017558 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD---SFEAKVADFGLA 350 (369)
Q Consensus 274 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~---~~~~ki~DFGla 350 (369)
++||||+++|+|.+++.......+++..++.++.||+.||.|||++ +|+||||||+|||++. ++.+||+|||++
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 9999999999999999876656799999999999999999999999 9999999999999976 455999999999
Q ss_pred eeeCC
Q 017558 351 KHSLD 355 (369)
Q Consensus 351 ~~~~~ 355 (369)
+....
T Consensus 179 ~~~~~ 183 (336)
T 3fhr_A 179 KETTQ 183 (336)
T ss_dssp EEC--
T ss_pred eeccc
Confidence 87654
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.94 E-value=8.5e-27 Score=219.19 Aligned_cols=158 Identities=25% Similarity=0.324 Sum_probs=120.2
Q ss_pred HHHHHhhcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCe-
Q 017558 195 EELKIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQ- 272 (369)
Q Consensus 195 ~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~- 272 (369)
.+.....++|++.+.||+|+||.||+|+.. +++.||||++..... ....+.+|++.+..++||||++++++|...+.
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 456677789999999999999999999974 588999999865432 23466788888999999999999999976443
Q ss_pred ------eEEEEEecCCCcHhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCeeecCCCCCcEEECC-CCc
Q 017558 273 ------RLLVYEFVPNKTLEFHLHG--KDRPVMNWPTRMKIALGSARGLAYLH--EDCQPKIIHRDIKSANILLDD-SFE 341 (369)
Q Consensus 273 ------~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~yLH--~~~~~~ivHrdlk~~Nill~~-~~~ 341 (369)
.++||||++++.+ ..+.. .....+++..+..++.|++.||.||| ++ +|+||||||+||||+. ++.
T Consensus 95 ~~~~~~~~lv~e~~~~~l~-~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPDTLH-RCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp CTTCEEEEEEEECCSCBHH-HHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTE
T ss_pred cccceeEEEEeecccccHH-HHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCc
Confidence 7899999987533 33321 22345889999999999999999999 77 9999999999999996 899
Q ss_pred EEEeeeccceeeCCCC
Q 017558 342 AKVADFGLAKHSLDTD 357 (369)
Q Consensus 342 ~ki~DFGla~~~~~~~ 357 (369)
+||+|||+++......
T Consensus 171 ~kl~Dfg~a~~~~~~~ 186 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPSE 186 (360)
T ss_dssp EEECCCTTCBCCCTTS
T ss_pred EEEeeCCCceecCCCC
Confidence 9999999999876543
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.5e-27 Score=223.67 Aligned_cols=136 Identities=28% Similarity=0.373 Sum_probs=114.6
Q ss_pred hcCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCCcccHHHHHHHHHHHHhcC--------CCccccEeeEEE---
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVH--------HRHLVSLVGYCT--- 268 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~g~~~--- 268 (369)
.++|++.+.||+|+||.||+|+. .+++.||||+++.. ....+.+.+|+++|.+++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 47899999999999999999985 45789999999743 233467889999999985 788999999987
Q ss_pred -eCCeeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCC
Q 017558 269 -FGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF 340 (369)
Q Consensus 269 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~ 340 (369)
.....||||||+ +++|.+++.......+++..++.|+.||+.||.|||+++ +|+||||||+||||+.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~ 184 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNE 184 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCH
T ss_pred CCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccc
Confidence 455789999999 566666665544456999999999999999999999863 799999999999999775
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=7.3e-27 Score=219.37 Aligned_cols=147 Identities=24% Similarity=0.414 Sum_probs=127.2
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcc--cHHHHHHHHHHHHhcCCCccccEeeEEEeCCe-----
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ--GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQ----- 272 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~----- 272 (369)
.++|...+.||+|+||.||+|... +|+.||||++...... ..+.+.+|+.++.+++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 467999999999999999999964 5899999999754322 24578899999999999999999999987654
Q ss_pred -eEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccce
Q 017558 273 -RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351 (369)
Q Consensus 273 -~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~ 351 (369)
.|+||||+. ++|.+++.. .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 174 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLAR 174 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred eEEEEecccc-CCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeeccccc
Confidence 499999997 688887743 389999999999999999999998 99999999999999999999999999998
Q ss_pred eeCC
Q 017558 352 HSLD 355 (369)
Q Consensus 352 ~~~~ 355 (369)
....
T Consensus 175 ~~~~ 178 (353)
T 3coi_A 175 HADA 178 (353)
T ss_dssp C---
T ss_pred CCCC
Confidence 7543
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=3.4e-27 Score=218.73 Aligned_cols=156 Identities=24% Similarity=0.320 Sum_probs=133.9
Q ss_pred HHHHhhcCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCCcc------cHHHHHHHHHHHHhcC--CCccccEeeE
Q 017558 196 ELKIATDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQ------GEREFQAEIEIISQVH--HRHLVSLVGY 266 (369)
Q Consensus 196 ~~~~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~niv~l~g~ 266 (369)
+.....++|++.+.||+|+||.||+|+. .+++.||||+++..... ..+.+.+|+.++.+++ |+||++++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 3445678899999999999999999985 46889999999754321 1245778999999996 5999999999
Q ss_pred EEeCCeeEEEEEecCC-CcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEC-CCCcEEE
Q 017558 267 CTFGSQRLLVYEFVPN-KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLD-DSFEAKV 344 (369)
Q Consensus 267 ~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~-~~~~~ki 344 (369)
+...+..++||||+.+ ++|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+|||++ +++.+||
T Consensus 117 ~~~~~~~~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL 191 (320)
T 3a99_A 117 FERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKL 191 (320)
T ss_dssp EECSSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEE
T ss_pred EecCCcEEEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEE
Confidence 9999999999999986 8999999754 3589999999999999999999998 999999999999999 7899999
Q ss_pred eeeccceeeCCC
Q 017558 345 ADFGLAKHSLDT 356 (369)
Q Consensus 345 ~DFGla~~~~~~ 356 (369)
+|||+++...+.
T Consensus 192 ~Dfg~~~~~~~~ 203 (320)
T 3a99_A 192 IDFGSGALLKDT 203 (320)
T ss_dssp CCCTTCEECCSS
T ss_pred eeCccccccccc
Confidence 999999987543
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=9.5e-27 Score=214.80 Aligned_cols=153 Identities=22% Similarity=0.297 Sum_probs=132.5
Q ss_pred HHHhhcCCcccceecccCceEEEEEEEcCCeEEEEEeeccCC--cccHHHHHHHHHHHHhcC--CCccccEeeEEEeCCe
Q 017558 197 LKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGS--GQGEREFQAEIEIISQVH--HRHLVSLVGYCTFGSQ 272 (369)
Q Consensus 197 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~~~ 272 (369)
+.+..++|++.+.||+|+||.||++...+++.||||++.... ....+.+.+|++++.+++ |+||+++++++.....
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 102 (313)
T 3cek_A 23 MSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 102 (313)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSE
T ss_pred eeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCE
Confidence 445667899999999999999999998889999999996543 234467899999999997 5999999999999999
Q ss_pred eEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeecccee
Q 017558 273 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (369)
Q Consensus 273 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~ 352 (369)
.|+||| +.+++|.+++.... .+++..++.++.||+.||.|||++ +|+||||||+|||+++ +.+||+|||+++.
T Consensus 103 ~~lv~e-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~ 175 (313)
T 3cek_A 103 IYMVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQ 175 (313)
T ss_dssp EEEEEC-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC
T ss_pred EEEEEe-cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeecccccc
Confidence 999999 56899999997643 588999999999999999999999 9999999999999965 7999999999987
Q ss_pred eCCC
Q 017558 353 SLDT 356 (369)
Q Consensus 353 ~~~~ 356 (369)
....
T Consensus 176 ~~~~ 179 (313)
T 3cek_A 176 MQPD 179 (313)
T ss_dssp ----
T ss_pred ccCc
Confidence 6543
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-26 Score=223.55 Aligned_cols=149 Identities=24% Similarity=0.270 Sum_probs=121.2
Q ss_pred cCCcccceecccCceEEEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHhc-CCCccccEeeEEEeCCeeEEEEEec
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLVYEFV 280 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~ 280 (369)
+.|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|+++|.++ +||||+++++++......||||||+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 345567889999999998776668999999998653 235678999999886 8999999999999999999999999
Q ss_pred CCCcHhhhhcCCCCCC-----CCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECC-------------CCcE
Q 017558 281 PNKTLEFHLHGKDRPV-----MNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD-------------SFEA 342 (369)
Q Consensus 281 ~~g~L~~~l~~~~~~~-----l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~-------------~~~~ 342 (369)
. |+|.+++....... ..+..++.|+.||+.||.|||++ +|+||||||+||||+. ++.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEE
Confidence 5 79999997653211 12334578999999999999998 9999999999999965 4589
Q ss_pred EEeeeccceeeCCCC
Q 017558 343 KVADFGLAKHSLDTD 357 (369)
Q Consensus 343 ki~DFGla~~~~~~~ 357 (369)
||+|||+++......
T Consensus 168 kL~DFG~a~~~~~~~ 182 (434)
T 2rio_A 168 LISDFGLCKKLDSGQ 182 (434)
T ss_dssp EECCCTTCEECCC--
T ss_pred EEcccccceecCCCC
Confidence 999999999876543
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.2e-26 Score=214.37 Aligned_cols=151 Identities=23% Similarity=0.374 Sum_probs=129.2
Q ss_pred hhcCCcccceecccCceEEEEEEEc-C-CeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCc------cccEeeEEEeCC
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVLT-N-GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRH------LVSLVGYCTFGS 271 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~g~~~~~~ 271 (369)
..++|++.+.||+|+||.||+|... + +..||||+++... ...+.+.+|++++.+++|+| ++.+++++...+
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 95 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG 95 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence 3578999999999999999999964 3 3789999997532 33457889999999987665 999999999999
Q ss_pred eeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEE---------------
Q 017558 272 QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILL--------------- 336 (369)
Q Consensus 272 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill--------------- 336 (369)
..++||||+ +++|.+++.......+++..++.|+.||+.||.|||++ +|+||||||+||||
T Consensus 96 ~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 96 HMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred eEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccccccc
Confidence 999999999 66676777655545699999999999999999999998 99999999999999
Q ss_pred ----CCCCcEEEeeeccceeeCC
Q 017558 337 ----DDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 337 ----~~~~~~ki~DFGla~~~~~ 355 (369)
+.++.+||+|||+++....
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~ 194 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHE 194 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTS
T ss_pred cccccCCCcEEEeecCccccccc
Confidence 5678999999999987543
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.5e-26 Score=223.15 Aligned_cols=150 Identities=23% Similarity=0.311 Sum_probs=123.6
Q ss_pred HhhcCCcccceecccCceEEEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHhc-CCCccccEeeEEEeCCeeEEEE
Q 017558 199 IATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLVY 277 (369)
Q Consensus 199 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~ 277 (369)
+...+|...++||+|+||.||.....+++.||||++..... ..+.+|+++|.++ +||||+++++++.+....||||
T Consensus 21 i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 97 (432)
T 3p23_A 21 VGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI 97 (432)
T ss_dssp ETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred EccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence 34556888999999999996655556789999999965432 2466899999999 7999999999999999999999
Q ss_pred EecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEC-----CCCcEEEeeecccee
Q 017558 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLD-----DSFEAKVADFGLAKH 352 (369)
Q Consensus 278 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~-----~~~~~ki~DFGla~~ 352 (369)
||+. |+|.+++..... .+.+...+.++.||+.||.|||++ +|+||||||+||||+ ....+||+|||+|+.
T Consensus 98 E~~~-g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 98 ELCA-ATLQEYVEQKDF-AHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp ECCS-EEHHHHHHSSSC-CCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred ECCC-CCHHHHHHhcCC-CccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 9996 699999976543 344556678999999999999998 999999999999994 334688999999998
Q ss_pred eCCC
Q 017558 353 SLDT 356 (369)
Q Consensus 353 ~~~~ 356 (369)
....
T Consensus 173 ~~~~ 176 (432)
T 3p23_A 173 LAVG 176 (432)
T ss_dssp C---
T ss_pred ccCC
Confidence 6543
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.8e-26 Score=212.92 Aligned_cols=153 Identities=25% Similarity=0.430 Sum_probs=126.7
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcc-cHHHHHHHHH-HHHhcCCCccccEeeEEEeCCeeEEE
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ-GEREFQAEIE-IISQVHHRHLVSLVGYCTFGSQRLLV 276 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lv 276 (369)
..++|+..+.||+|+||.||+|... +++.||||+++..... ...++..|+. +++.++||||+++++++...+..++|
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv 99 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC 99 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence 4578899999999999999999974 6899999999765432 3345666666 67778999999999999999999999
Q ss_pred EEecCCCcHhhhhcC---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceee
Q 017558 277 YEFVPNKTLEFHLHG---KDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (369)
Q Consensus 277 ~e~~~~g~L~~~l~~---~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~ 353 (369)
|||+++ +|.+++.. .....+++..+..++.|++.||.|||++. +++||||||+|||++.++.+||+|||+++..
T Consensus 100 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 100 MELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp ECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred EeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 999975 77777652 22346899999999999999999999852 7999999999999999999999999999876
Q ss_pred CC
Q 017558 354 LD 355 (369)
Q Consensus 354 ~~ 355 (369)
.+
T Consensus 177 ~~ 178 (327)
T 3aln_A 177 VD 178 (327)
T ss_dssp --
T ss_pred cc
Confidence 54
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.1e-26 Score=215.97 Aligned_cols=153 Identities=27% Similarity=0.315 Sum_probs=130.4
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcccHHHHHHHHHHHHhcC-CC-----ccccEeeEEEeCCe
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVH-HR-----HLVSLVGYCTFGSQ 272 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~g~~~~~~~ 272 (369)
..++|++.+.||+|+||.||+|... +++.||||+++... ...+++..|++++..++ |+ +|+++++++...+.
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 4578999999999999999999965 57899999997432 23457788999988885 55 49999999999999
Q ss_pred eEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEC--CCCcEEEeeeccc
Q 017558 273 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLD--DSFEAKVADFGLA 350 (369)
Q Consensus 273 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~--~~~~~ki~DFGla 350 (369)
.|+||||++ ++|.+++.......+++..+..++.||+.||.|||++ ..+|+||||||+||||+ .++.+||+|||++
T Consensus 131 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a 208 (382)
T 2vx3_A 131 LCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208 (382)
T ss_dssp EEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred eEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence 999999996 5999999876555699999999999999999999952 23899999999999994 5788999999999
Q ss_pred eeeCC
Q 017558 351 KHSLD 355 (369)
Q Consensus 351 ~~~~~ 355 (369)
+....
T Consensus 209 ~~~~~ 213 (382)
T 2vx3_A 209 CQLGQ 213 (382)
T ss_dssp EETTC
T ss_pred eeccc
Confidence 88754
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.7e-27 Score=218.84 Aligned_cols=154 Identities=26% Similarity=0.429 Sum_probs=131.1
Q ss_pred HHHHHHhhcCCcccceecccCceEEEEEEEcCCeEEEEEeeccCC--cccHHHHHHHHHHHHhcCCCccccEeeEEEeCC
Q 017558 194 YEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGS 271 (369)
Q Consensus 194 ~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~ 271 (369)
++++.+..++|++.+.||+|+||.||+|...+ .+|+|.++... ....+.+.+|++++.+++|+||+++++++....
T Consensus 25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102 (319)
T ss_dssp GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred cccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 34455667889999999999999999999854 48999886542 223356889999999999999999999999999
Q ss_pred eeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccce
Q 017558 272 QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351 (369)
Q Consensus 272 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~ 351 (369)
..++||||+++++|.+++.... ..+++..++.++.||+.||.|||++ +++||||||+|||++ ++.+||+|||+++
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~ 177 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFS 177 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC
T ss_pred ceEEEeecccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCcc
Confidence 9999999999999999997643 3589999999999999999999998 999999999999998 6799999999987
Q ss_pred eeC
Q 017558 352 HSL 354 (369)
Q Consensus 352 ~~~ 354 (369)
...
T Consensus 178 ~~~ 180 (319)
T 2y4i_B 178 ISG 180 (319)
T ss_dssp ---
T ss_pred ccc
Confidence 653
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.3e-26 Score=211.30 Aligned_cols=152 Identities=23% Similarity=0.353 Sum_probs=117.1
Q ss_pred hhcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcc-cH-HHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEE
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ-GE-REFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~-~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 276 (369)
..++|+..+.||+|+||.||+|+.. +++.||||++...... .. +.+.++..++..++|+||+++++++...+..++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA 102 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence 4578899999999999999999975 6889999999765432 22 2344555678888999999999999999999999
Q ss_pred EEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHE-DCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 277 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
|||+ ++.+..++... ...+++..+..++.||+.||.|||+ + +++||||||+|||++.++.+||+|||+++....
T Consensus 103 ~e~~-~~~~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 103 MELM-GTCAEKLKKRM-QGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp ECCC-SEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred Eecc-CCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 9999 55555554332 3458999999999999999999998 4 799999999999999999999999999987654
Q ss_pred C
Q 017558 356 T 356 (369)
Q Consensus 356 ~ 356 (369)
.
T Consensus 178 ~ 178 (318)
T 2dyl_A 178 D 178 (318)
T ss_dssp -
T ss_pred C
Confidence 3
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.93 E-value=4.2e-26 Score=215.39 Aligned_cols=151 Identities=24% Similarity=0.357 Sum_probs=129.8
Q ss_pred hcCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCCcccHHHHHHHHHHHHhcC-----------CCccccEeeEEE
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVH-----------HRHLVSLVGYCT 268 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~g~~~ 268 (369)
.++|.+.+.||+|+||.||+|+. .+++.||||++.... ...+.+.+|++++.+++ |+||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 46899999999999999999996 468899999997432 23457889999999886 899999999998
Q ss_pred eCC----eeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEC------C
Q 017558 269 FGS----QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLD------D 338 (369)
Q Consensus 269 ~~~----~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~------~ 338 (369)
..+ ..++||||+ +++|.+++.......+++..+..++.||+.||.|||+++ +|+||||||+||||+ .
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~~ 173 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPEN 173 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCcC
Confidence 654 789999999 999999998755556999999999999999999999853 799999999999994 4
Q ss_pred CCcEEEeeeccceeeCC
Q 017558 339 SFEAKVADFGLAKHSLD 355 (369)
Q Consensus 339 ~~~~ki~DFGla~~~~~ 355 (369)
.+.+||+|||+++....
T Consensus 174 ~~~~kl~Dfg~a~~~~~ 190 (373)
T 1q8y_A 174 LIQIKIADLGNACWYDE 190 (373)
T ss_dssp EEEEEECCCTTCEETTB
T ss_pred cceEEEcccccccccCC
Confidence 55899999999987654
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=8.1e-26 Score=205.68 Aligned_cols=144 Identities=15% Similarity=0.127 Sum_probs=117.5
Q ss_pred HHHHhhcCCcccceecccCceEEEEEEEcCCeEEEEEeeccCCc------------------ccHHHHHHHHHHHHhcCC
Q 017558 196 ELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSG------------------QGEREFQAEIEIISQVHH 257 (369)
Q Consensus 196 ~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h 257 (369)
.+......|.+.+.||+|+||.||+|...+|+.||||.++.... .....+.+|+++|.+++
T Consensus 84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~- 162 (282)
T 1zar_A 84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ- 162 (282)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-
Confidence 33444566778899999999999999997799999999964321 12346889999999999
Q ss_pred CccccEeeEEEeCCeeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEC
Q 017558 258 RHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLD 337 (369)
Q Consensus 258 ~niv~l~g~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~ 337 (369)
| +++.+++.. +..|+||||+++++|.+ +.. .....++.||+.||.|||++ +|+||||||+|||++
T Consensus 163 -~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~ 227 (282)
T 1zar_A 163 -G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS 227 (282)
T ss_dssp -T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE
T ss_pred -C-CCcCeEEec-cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE
Confidence 5 677775543 56699999999999988 421 12447999999999999998 999999999999999
Q ss_pred CCCcEEEeeeccceeeCCC
Q 017558 338 DSFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 338 ~~~~~ki~DFGla~~~~~~ 356 (369)
++.+||+|||+|+...+.
T Consensus 228 -~~~vkl~DFG~a~~~~~~ 245 (282)
T 1zar_A 228 -EEGIWIIDFPQSVEVGEE 245 (282)
T ss_dssp -TTEEEECCCTTCEETTST
T ss_pred -CCcEEEEECCCCeECCCC
Confidence 999999999999987654
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.7e-26 Score=231.03 Aligned_cols=152 Identities=29% Similarity=0.393 Sum_probs=130.1
Q ss_pred cCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCC-cccHHHHHHHHHHHHhcCCCccccEeeEEEe------CCee
Q 017558 202 DNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTF------GSQR 273 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~------~~~~ 273 (369)
++|++.+.||+|+||.||+|.. .+++.||||+++... ....+.+.+|++++.+++||||+++++++.. .+..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 6799999999999999999996 458899999987643 3344678999999999999999999998765 6678
Q ss_pred EEEEEecCCCcHhhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCc---EEEeeecc
Q 017558 274 LLVYEFVPNKTLEFHLHGKD-RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFE---AKVADFGL 349 (369)
Q Consensus 274 ~lv~e~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~---~ki~DFGl 349 (369)
|+||||+++|+|.+++.... ...+++..++.|+.||+.||.|||++ +|+||||||+|||++.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 99999999999999998643 23588899999999999999999998 9999999999999997664 99999999
Q ss_pred ceeeCCC
Q 017558 350 AKHSLDT 356 (369)
Q Consensus 350 a~~~~~~ 356 (369)
++.....
T Consensus 171 a~~~~~~ 177 (676)
T 3qa8_A 171 AKELDQG 177 (676)
T ss_dssp CCBTTSC
T ss_pred ccccccc
Confidence 9886544
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.7e-25 Score=219.78 Aligned_cols=135 Identities=18% Similarity=0.237 Sum_probs=109.3
Q ss_pred ccceecccCceEEEEEEEcCCeEEEEEeeccCCcc--------cHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEE
Q 017558 206 EANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQ--------GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (369)
Q Consensus 206 ~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 277 (369)
..+.||+|+||.||+|.. .+..+++|+....... ..+.+.+|+++|.+++|+||+++..++...+..||||
T Consensus 340 ~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp --------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 357899999999999965 5677888876443211 1235899999999999999997777777888889999
Q ss_pred EecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCC
Q 017558 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 278 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~ 356 (369)
||+++++|.+++.. ++.|+.||+.||+|||++ +|+||||||+|||+++ .+||+|||+|+...+.
T Consensus 419 E~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 419 SYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp ECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred ECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence 99999999999864 458999999999999998 9999999999999999 9999999999987654
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.3e-24 Score=208.48 Aligned_cols=150 Identities=13% Similarity=0.153 Sum_probs=114.2
Q ss_pred hcCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCCc---ccHHHHHHHHHHHHhcCC-Ccccc-------------
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSG---QGEREFQAEIEIISQVHH-RHLVS------------- 262 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h-~niv~------------- 262 (369)
..+|...+.||+|+||.||+|+. .+++.||||+++.... ...+.|.+|+.++..++| .|+..
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 34577789999999999999995 4688999999874432 235689999999999987 32211
Q ss_pred --------EeeEEEe-----CCeeEEEEEecCCCcHhhhhc-----CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 017558 263 --------LVGYCTF-----GSQRLLVYEFVPNKTLEFHLH-----GKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKI 324 (369)
Q Consensus 263 --------l~g~~~~-----~~~~~lv~e~~~~g~L~~~l~-----~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~i 324 (369)
++.++.. ....+++|+++ +++|.+++. ......+++..++.|+.||+.||+|||++ +|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Cc
Confidence 1111111 12345666655 789999884 22234578889999999999999999998 99
Q ss_pred eecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 325 IHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 325 vHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
+||||||+||||+.++.+||+|||+++...
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~ 262 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETT
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecC
Confidence 999999999999999999999999998754
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=4.9e-23 Score=184.96 Aligned_cols=140 Identities=17% Similarity=0.140 Sum_probs=109.4
Q ss_pred CcccceecccCceEEEEEEE-cCCeE--EEEEeeccCCcc------------------------cHHHHHHHHHHHHhcC
Q 017558 204 FSEANLLGQGGFGYVHKGVL-TNGKV--VAIKQLKAGSGQ------------------------GEREFQAEIEIISQVH 256 (369)
Q Consensus 204 ~~~~~~lg~G~fg~Vy~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 256 (369)
|++.+.||+|+||.||+|.. .+|+. ||||+++..... ....+.+|+++|.++.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56789999999999999997 67888 999987543211 0125789999999998
Q ss_pred CCcc--ccEeeEEEeCCeeEEEEEecCC-C----cHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeeecC
Q 017558 257 HRHL--VSLVGYCTFGSQRLLVYEFVPN-K----TLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLH-EDCQPKIIHRD 328 (369)
Q Consensus 257 h~ni--v~l~g~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH-~~~~~~ivHrd 328 (369)
|+|| ..++++ ...+|||||+.+ | .|.+++.. ..+.....++.|++.+|.||| +. +|+|||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~---givHrD 196 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEA---ELVHAD 196 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTS---CEECSS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHC---CEEeCC
Confidence 8754 444432 356899999942 4 66665432 224456789999999999999 87 999999
Q ss_pred CCCCcEEECCCCcEEEeeeccceeeCCCC
Q 017558 329 IKSANILLDDSFEAKVADFGLAKHSLDTD 357 (369)
Q Consensus 329 lk~~Nill~~~~~~ki~DFGla~~~~~~~ 357 (369)
|||+|||++. .++|+|||+|....+..
T Consensus 197 lkp~NILl~~--~~~liDFG~a~~~~~~~ 223 (258)
T 1zth_A 197 LSEYNIMYID--KVYFIDMGQAVTLRHPM 223 (258)
T ss_dssp CSTTSEEESS--SEEECCCTTCEETTSTT
T ss_pred CCHHHEEEcC--cEEEEECcccccCCCcc
Confidence 9999999998 99999999999875543
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.78 E-value=1.7e-19 Score=168.98 Aligned_cols=142 Identities=15% Similarity=0.118 Sum_probs=102.4
Q ss_pred cCCcccceecccCceEEEEEEEcCCeEEEEEeeccCCc--------------ccHHH--------HHHHHHHHHhcCCCc
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSG--------------QGERE--------FQAEIEIISQVHHRH 259 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~--------------~~~~~--------~~~E~~~l~~l~h~n 259 (369)
.-|++.+.||+|+||.||+|...+|+.||||+++.... ..... ..+|...|.++.+.+
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 34899999999999999999988899999998764210 00111 134566666664443
Q ss_pred cccEeeEEEeCCeeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCC
Q 017558 260 LVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS 339 (369)
Q Consensus 260 iv~l~g~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~ 339 (369)
+....-+.. ...+|||||++++.|..++.. .....++.||+.+|.|||.+ +||||||||.||||+++
T Consensus 175 v~vp~p~~~--~~~~LVME~i~G~~L~~l~~~--------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~d 241 (397)
T 4gyi_A 175 FPVPEPIAQ--SRHTIVMSLVDALPMRQVSSV--------PDPASLYADLIALILRLAKH---GLIHGDFNEFNILIREE 241 (397)
T ss_dssp CSCCCEEEE--ETTEEEEECCSCEEGGGCCCC--------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEE
T ss_pred CCCCeeeec--cCceEEEEecCCccHhhhccc--------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCC
Confidence 321111111 234799999999998765421 12346789999999999998 99999999999999877
Q ss_pred C----------cEEEeeeccceeeCCC
Q 017558 340 F----------EAKVADFGLAKHSLDT 356 (369)
Q Consensus 340 ~----------~~ki~DFGla~~~~~~ 356 (369)
+ .+.|+||+=+....+.
T Consensus 242 gd~~d~~~~~~~~~iID~~Q~V~~~hp 268 (397)
T 4gyi_A 242 KDAEDPSSITLTPIIIXFPQMVSMDHP 268 (397)
T ss_dssp ECSSCTTSEEEEEEECCCTTCEETTST
T ss_pred CCcccccccccceEEEEeCCcccCCCC
Confidence 6 3899999987765544
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.59 E-value=1.1e-14 Score=130.46 Aligned_cols=149 Identities=13% Similarity=0.047 Sum_probs=116.9
Q ss_pred HHHhhcCCcccceecccCceEEEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHhcC-CCccccEeeEEEeCCeeEE
Q 017558 197 LKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVH-HRHLVSLVGYCTFGSQRLL 275 (369)
Q Consensus 197 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~l 275 (369)
+....+.|.....++.|+++.||++... +..+++|............+.+|+++|..+. +.++.++++++...+..|+
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence 3444567888888999999999999864 6789999986532222346889999999884 7788999999999899999
Q ss_pred EEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhC------------------------------------
Q 017558 276 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHED------------------------------------ 319 (369)
Q Consensus 276 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~------------------------------------ 319 (369)
||||++|.+|.+.+.. ......++.+++.+|..||+.
T Consensus 88 v~e~i~G~~l~~~~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 88 LMSEADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEECCSSEEHHHHCCT-------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred EEEecCCeehhhccCC-------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 9999999999876421 122347888999999999981
Q ss_pred --------------------CCCCeeecCCCCCcEEECCCCcEEEeeeccceee
Q 017558 320 --------------------CQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (369)
Q Consensus 320 --------------------~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~ 353 (369)
....++|+|+++.|||++++..+.|+||+.+...
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~g 214 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA 214 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcccC
Confidence 0135999999999999987666679999988653
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.46 E-value=1.6e-13 Score=122.27 Aligned_cols=138 Identities=17% Similarity=0.088 Sum_probs=102.6
Q ss_pred CCcccceecccCceEEEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCc--cccEeeEEEeCCeeEEEEEec
Q 017558 203 NFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRH--LVSLVGYCTFGSQRLLVYEFV 280 (369)
Q Consensus 203 ~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~g~~~~~~~~~lv~e~~ 280 (369)
.+....+.+.|..+.||++...+|..+++|..... ....+.+|++++..+.+.+ +.++++++...+..++||||+
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i 97 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV 97 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence 44443333466679999998777788999987653 2246788999999885434 567888888878889999999
Q ss_pred CCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 017558 281 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDC---------------------------------------- 320 (369)
Q Consensus 281 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~---------------------------------------- 320 (369)
+|.+|. ... .. ...++.+++..|..||...
T Consensus 98 ~G~~l~--~~~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
T 1nd4_A 98 PGQDLL--SSH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAP 167 (264)
T ss_dssp SSEETT--TSC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCH
T ss_pred CCcccC--cCc-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccH
Confidence 999884 211 12 2356778888888888641
Q ss_pred ---------------CCCeeecCCCCCcEEECCCCcEEEeeeccceee
Q 017558 321 ---------------QPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (369)
Q Consensus 321 ---------------~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~ 353 (369)
...++|+|+++.|||++++..++|+|||.+...
T Consensus 168 ~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g 215 (264)
T 1nd4_A 168 AELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA 215 (264)
T ss_dssp HHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred HHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence 113999999999999988766779999998764
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.38 E-value=2.1e-12 Score=120.94 Aligned_cols=143 Identities=16% Similarity=0.192 Sum_probs=108.3
Q ss_pred ccceecccCceEEEEEEEcCCeEEEEEeec--cCCc-ccHHHHHHHHHHHHhcC--CCccccEeeEEEeC---CeeEEEE
Q 017558 206 EANLLGQGGFGYVHKGVLTNGKVVAIKQLK--AGSG-QGEREFQAEIEIISQVH--HRHLVSLVGYCTFG---SQRLLVY 277 (369)
Q Consensus 206 ~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~--~~~~-~~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~---~~~~lv~ 277 (369)
..+.|+.|.+..||+....+ ..+++|+.. .... .....+.+|.+++..+. +.++.++++++.+. +..|+||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 46789999999999998754 567888776 3321 22347889999999987 46689999998776 4589999
Q ss_pred EecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 017558 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDC------------------------------------- 320 (369)
Q Consensus 278 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~------------------------------------- 320 (369)
||++|..+.+.. ...++..++..++.++++.|..||...
T Consensus 121 e~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 121 EFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp ECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred EecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 999998875422 123678888899999999999999730
Q ss_pred ------------------CCCeeecCCCCCcEEECCCCc--EEEeeeccceee
Q 017558 321 ------------------QPKIIHRDIKSANILLDDSFE--AKVADFGLAKHS 353 (369)
Q Consensus 321 ------------------~~~ivHrdlk~~Nill~~~~~--~ki~DFGla~~~ 353 (369)
...++|+|+++.|||++.++. +.|+||+++...
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 247999999999999997653 689999998753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.98 E-value=1.5e-09 Score=99.16 Aligned_cols=137 Identities=22% Similarity=0.209 Sum_probs=99.9
Q ss_pred cceecccCceEEEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHhcC-CCc--cccEeeEEEeCC---eeEEEEEec
Q 017558 207 ANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVH-HRH--LVSLVGYCTFGS---QRLLVYEFV 280 (369)
Q Consensus 207 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~g~~~~~~---~~~lv~e~~ 280 (369)
.+.++.|.+..||+.. ..+++|+.... .....+.+|.++|..+. +.. +.+++.++...+ ..|+||||+
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4668999999999853 45788876432 23457889999998883 333 445555543332 348999999
Q ss_pred CCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------------
Q 017558 281 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHED----------------------------------------- 319 (369)
Q Consensus 281 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~----------------------------------------- 319 (369)
+|..|..... ..++.+++..++.+++..|..||..
T Consensus 99 ~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 99 KGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred CCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 9998875432 1366777778888888888888861
Q ss_pred --------------CCCCeeecCCCCCcEEECC--CCcEEEeeeccceee
Q 017558 320 --------------CQPKIIHRDIKSANILLDD--SFEAKVADFGLAKHS 353 (369)
Q Consensus 320 --------------~~~~ivHrdlk~~Nill~~--~~~~ki~DFGla~~~ 353 (369)
....++|+|+++.||++++ +..+.|+||+.+...
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~ 224 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS 224 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence 1245899999999999998 556789999998764
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.85 E-value=3.9e-08 Score=89.85 Aligned_cols=137 Identities=21% Similarity=0.209 Sum_probs=94.8
Q ss_pred cceecccCceEEEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCC---ccccEeeEEE-eCCeeEEEEEecCC
Q 017558 207 ANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHR---HLVSLVGYCT-FGSQRLLVYEFVPN 282 (369)
Q Consensus 207 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~g~~~-~~~~~~lv~e~~~~ 282 (369)
.+.++.|....||+. +..+++|+-.. ......+.+|.++|..+.+. .|.+.+.++. ..+..|+||||++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 567888988899987 46678887532 22345788999999999642 3667777774 34567899999999
Q ss_pred CcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-------------------------------------------
Q 017558 283 KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHED------------------------------------------- 319 (369)
Q Consensus 283 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~------------------------------------------- 319 (369)
..|...... .++......++.+++..|..||..
T Consensus 98 ~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 98 QILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp EECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred eECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 888763211 133444444555555555555432
Q ss_pred --------------CCCCeeecCCCCCcEEECC---CCc-EEEeeeccceee
Q 017558 320 --------------CQPKIIHRDIKSANILLDD---SFE-AKVADFGLAKHS 353 (369)
Q Consensus 320 --------------~~~~ivHrdlk~~Nill~~---~~~-~ki~DFGla~~~ 353 (369)
....++|+|+++.|||++. ++. +.|+||+.+...
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 2335799999999999987 455 489999988764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.82 E-value=4.3e-08 Score=87.56 Aligned_cols=137 Identities=17% Similarity=0.091 Sum_probs=97.7
Q ss_pred ceecccCce-EEEEEEEc-CCeEEEEEeeccCCcccHHHHHHHHHHHHhcC-CCccccEeeEEEeCCeeEEEEEecCCCc
Q 017558 208 NLLGQGGFG-YVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVH-HRHLVSLVGYCTFGSQRLLVYEFVPNKT 284 (369)
Q Consensus 208 ~~lg~G~fg-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~~~~g~ 284 (369)
+.+..|..+ .||+.... ++..+++|+-... ...++.+|.++|+.+. +--|.++++++.+.+..|+|||++++.+
T Consensus 30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EEEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred EEccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 345556555 68987754 4567888876532 2457889999998884 4457889999999999999999999988
Q ss_pred HhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---------------------------------------------
Q 017558 285 LEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHED--------------------------------------------- 319 (369)
Q Consensus 285 L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~--------------------------------------------- 319 (369)
+.+..... ......++.+++..|.-||..
T Consensus 107 ~~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 107 AFQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred ccccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 87654321 112334555566666666641
Q ss_pred ----------CCCCeeecCCCCCcEEECCCCcEEEeeeccceee
Q 017558 320 ----------CQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (369)
Q Consensus 320 ----------~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~ 353 (369)
..+.++|+|+.+.|||+++++.+-|+||+.+...
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~g 224 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIA 224 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccC
Confidence 1223799999999999998776779999998754
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.78 E-value=2.2e-08 Score=93.36 Aligned_cols=80 Identities=10% Similarity=-0.004 Sum_probs=56.9
Q ss_pred ccee-cccCceEEEEEEEc-------CCeEEEEEeeccCC---cccHHHHHHHHHHHHhcC-C--CccccEeeEEEeC--
Q 017558 207 ANLL-GQGGFGYVHKGVLT-------NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVH-H--RHLVSLVGYCTFG-- 270 (369)
Q Consensus 207 ~~~l-g~G~fg~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~niv~l~g~~~~~-- 270 (369)
.+.| +.|....+|+.... ++..+++|...... ......+.+|..+|..+. + -.+.++++++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4667 88989999998764 25678888765432 111246788888888874 3 4578888887655
Q ss_pred -CeeEEEEEecCCCcHh
Q 017558 271 -SQRLLVYEFVPNKTLE 286 (369)
Q Consensus 271 -~~~~lv~e~~~~g~L~ 286 (369)
+..|+||||++|..+.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 3568999999987664
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.61 E-value=2.5e-07 Score=85.32 Aligned_cols=141 Identities=18% Similarity=0.298 Sum_probs=82.3
Q ss_pred cceecccCceEEEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHhcC--CCccccEee------EEEeCCeeEEEEE
Q 017558 207 ANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVH--HRHLVSLVG------YCTFGSQRLLVYE 278 (369)
Q Consensus 207 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~g------~~~~~~~~~lv~e 278 (369)
.+.|+.|....||+....++ .+++|+.... ..++..|.+++..+. .-.|.+++. +....+..+++||
T Consensus 37 ~~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EEECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 34566677889999987554 4889988652 234445555555442 113344443 2234677899999
Q ss_pred ecCCCcHh--------------hhhcC--CC---C-------CCCCHHHHH-----------------------------
Q 017558 279 FVPNKTLE--------------FHLHG--KD---R-------PVMNWPTRM----------------------------- 303 (369)
Q Consensus 279 ~~~~g~L~--------------~~l~~--~~---~-------~~l~~~~~~----------------------------- 303 (369)
|++|..+. ..||. .. . ....|....
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 99986542 11221 00 0 012332210
Q ss_pred --HHHHHHHHHHHHHHh----------CCCCCeeecCCCCCcEEECCCCcEEEeeecccee
Q 017558 304 --KIALGSARGLAYLHE----------DCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (369)
Q Consensus 304 --~i~~~i~~~l~yLH~----------~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~ 352 (369)
.+...+..++.+|+. .....++|+|+++.|||++.++.+.|+||+.+..
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 111223446667763 0234899999999999998888999999998864
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.53 E-value=5.5e-07 Score=85.13 Aligned_cols=75 Identities=13% Similarity=0.060 Sum_probs=50.2
Q ss_pred cceecccCceEEEEEEEc-CCeEEEEEeeccCCc-------ccHHHHHHHHHHHHhcCC--C-ccccEeeEEEeCCeeEE
Q 017558 207 ANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG-------QGEREFQAEIEIISQVHH--R-HLVSLVGYCTFGSQRLL 275 (369)
Q Consensus 207 ~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~-niv~l~g~~~~~~~~~l 275 (369)
.+.||.|.++.||++... +++.++||....... ...+.+..|.++|..+.. + .+.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 567999999999999753 467899997643211 123456789999887742 3 34455543 3456789
Q ss_pred EEEecCCC
Q 017558 276 VYEFVPNK 283 (369)
Q Consensus 276 v~e~~~~g 283 (369)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999864
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.40 E-value=1.5e-06 Score=78.32 Aligned_cols=81 Identities=16% Similarity=0.167 Sum_probs=60.6
Q ss_pred hcCCcccceecccCceEEEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCC---CccccEeeEEEeCCeeEEEE
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHH---RHLVSLVGYCTFGSQRLLVY 277 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~g~~~~~~~~~lv~ 277 (369)
...+...+.+|.|..+.||+.++.+|+.|++|+...........|..|.+.|+.+.. -.+.+.+++. ..++||
T Consensus 14 G~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~ 89 (288)
T 3f7w_A 14 GREVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAM 89 (288)
T ss_dssp CCCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEE
T ss_pred CCCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEE
Confidence 445666788999999999999999999999998765544444578899999988842 2355555542 347899
Q ss_pred EecCCCcH
Q 017558 278 EFVPNKTL 285 (369)
Q Consensus 278 e~~~~g~L 285 (369)
||++++..
T Consensus 90 e~l~~~~~ 97 (288)
T 3f7w_A 90 EWVDERPP 97 (288)
T ss_dssp ECCCCCCC
T ss_pred EeecccCC
Confidence 99987643
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.31 E-value=7e-06 Score=74.87 Aligned_cols=139 Identities=15% Similarity=0.131 Sum_probs=93.9
Q ss_pred cccceecccCceEEEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHhcC---CCccccEeeEEEeCCeeEEEEEecC
Q 017558 205 SEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVH---HRHLVSLVGYCTFGSQRLLVYEFVP 281 (369)
Q Consensus 205 ~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~lv~e~~~ 281 (369)
...+.|+.|.+..+|+... ++..+++|..... ....+..|.+.|+.+. ...|.+.++++...+..|+||||++
T Consensus 39 ~~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp CEEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred eeeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 3457799999999999886 4667888876542 2457889999888874 3678899999988889999999999
Q ss_pred CCcHhh-----------hhcCCCC-C-------------------CCCHHHHH---HHHH----------------HHHH
Q 017558 282 NKTLEF-----------HLHGKDR-P-------------------VMNWPTRM---KIAL----------------GSAR 311 (369)
Q Consensus 282 ~g~L~~-----------~l~~~~~-~-------------------~l~~~~~~---~i~~----------------~i~~ 311 (369)
+..+.. .||.... . .-+|.... ++.. .+..
T Consensus 115 G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~ 194 (312)
T 3jr1_A 115 KSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQ 194 (312)
T ss_dssp CCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHH
T ss_pred CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHH
Confidence 876521 2232211 0 12454321 1111 1111
Q ss_pred H-HHHHHh-CCCCCeeecCCCCCcEEECCCCcEEEeeec
Q 017558 312 G-LAYLHE-DCQPKIIHRDIKSANILLDDSFEAKVADFG 348 (369)
Q Consensus 312 ~-l~yLH~-~~~~~ivHrdlk~~Nill~~~~~~ki~DFG 348 (369)
. ...|.. ...+.+||+|+.+.|++++.++ +.|.||.
T Consensus 195 ~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 195 IVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 1 123421 2356899999999999999887 8999984
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.26 E-value=6.9e-06 Score=78.22 Aligned_cols=74 Identities=16% Similarity=0.201 Sum_probs=46.6
Q ss_pred ccceecccCceEEEEEEEcCCeEEEEEeeccC-----C----cccHHHHHHHHHHHH-hcCCCccccEeeEEEeCCeeEE
Q 017558 206 EANLLGQGGFGYVHKGVLTNGKVVAIKQLKAG-----S----GQGEREFQAEIEIIS-QVHHRHLVSLVGYCTFGSQRLL 275 (369)
Q Consensus 206 ~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~-----~----~~~~~~~~~E~~~l~-~l~h~niv~l~g~~~~~~~~~l 275 (369)
..+.||.|....||++.. ++..++||..... . ......+..|+..+. ......+.+++.+. .+..++
T Consensus 38 ~i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~l 114 (420)
T 2pyw_A 38 VIKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALI 114 (420)
T ss_dssp EEEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEE
T ss_pred EEEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEE
Confidence 357799999999999975 4677899943211 1 012233444444332 22335667777665 567799
Q ss_pred EEEec-CC
Q 017558 276 VYEFV-PN 282 (369)
Q Consensus 276 v~e~~-~~ 282 (369)
||||+ ++
T Consensus 115 v~e~l~~g 122 (420)
T 2pyw_A 115 GMRYLEPP 122 (420)
T ss_dssp EECCCCTT
T ss_pred EEeecCCc
Confidence 99999 76
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.11 E-value=2.5e-05 Score=71.28 Aligned_cols=157 Identities=11% Similarity=0.100 Sum_probs=88.8
Q ss_pred CHHHHHHhhcCCcc-----cceecccCceEEEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCC--CccccEee
Q 017558 193 TYEELKIATDNFSE-----ANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHH--RHLVSLVG 265 (369)
Q Consensus 193 ~~~~~~~~~~~~~~-----~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~g 265 (369)
+.+++....+.|.. .+.|+.|....+|+....++ .+++|...... ..+++..|+.++..+.. -.+.+++.
T Consensus 8 ~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~ 84 (322)
T 2ppq_A 8 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLP 84 (322)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccC
Confidence 34555555555654 34566788889999987655 57889876521 22356677777776632 12333332
Q ss_pred E------EEeCCeeEEEEEecCCCcHhh--------------hhcCC----CCC---C---CCHHHHHH-----------
Q 017558 266 Y------CTFGSQRLLVYEFVPNKTLEF--------------HLHGK----DRP---V---MNWPTRMK----------- 304 (369)
Q Consensus 266 ~------~~~~~~~~lv~e~~~~g~L~~--------------~l~~~----~~~---~---l~~~~~~~----------- 304 (369)
. ....+..+++|+|++|..+.. .+|.. ... . ..|.....
T Consensus 85 ~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~ 164 (322)
T 2ppq_A 85 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 164 (322)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred CCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhh
Confidence 1 223466789999999865321 12211 100 0 11322110
Q ss_pred -HHHHHHHHHHHHHhC----CCCCeeecCCCCCcEEECCCCcEEEeeecccee
Q 017558 305 -IALGSARGLAYLHED----CQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (369)
Q Consensus 305 -i~~~i~~~l~yLH~~----~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~ 352 (369)
+...+...+++|+.. ....++|+|+.+.|||++++..+.|+||+.+..
T Consensus 165 ~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 165 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 011244455666532 234799999999999998876568999998764
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.97 E-value=0.00013 Score=66.55 Aligned_cols=142 Identities=15% Similarity=0.131 Sum_probs=84.2
Q ss_pred ceecccCceEEEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCC--CccccEeeE-----EEeCCeeEEEEEec
Q 017558 208 NLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHH--RHLVSLVGY-----CTFGSQRLLVYEFV 280 (369)
Q Consensus 208 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~g~-----~~~~~~~~lv~e~~ 280 (369)
+.|+ |....||+....+|+.+++|...... .....+..|..++..+.. -.+.+++.. ....+..+++|||+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 4566 77789999887677779999886432 234567778888877742 224444442 22355678899999
Q ss_pred CCCcHhh-----h---------hcC----CC---CCCCCHHHH----HHH---------------HHHHHHHHHHHHhC-
Q 017558 281 PNKTLEF-----H---------LHG----KD---RPVMNWPTR----MKI---------------ALGSARGLAYLHED- 319 (369)
Q Consensus 281 ~~g~L~~-----~---------l~~----~~---~~~l~~~~~----~~i---------------~~~i~~~l~yLH~~- 319 (369)
+|..+.. + +|. .. ...+++... ..+ ...+...++.+...
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 8865421 0 111 00 111222211 001 11111223333221
Q ss_pred ---CCCCeeecCCCCCcEEECCCCcEEEeeeccceee
Q 017558 320 ---CQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (369)
Q Consensus 320 ---~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~ 353 (369)
....++|+|+++.|||++ + .+.|+||+.+...
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g 224 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG 224 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence 234689999999999999 4 8999999888754
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.90 E-value=8.2e-05 Score=68.25 Aligned_cols=142 Identities=13% Similarity=0.088 Sum_probs=74.5
Q ss_pred cceecccCceE-EEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHhcC--CCccccEeeEEEeCCeeEEEEEecCCC
Q 017558 207 ANLLGQGGFGY-VHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVH--HRHLVSLVGYCTFGSQRLLVYEFVPNK 283 (369)
Q Consensus 207 ~~~lg~G~fg~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~~~~~lv~e~~~~g 283 (369)
.+.|+.|.... +|+....++..+++|....... .++..|+.++..+. .-.+.+++.+....+ +++||++.+.
T Consensus 23 ~~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~ 97 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDA 97 (333)
T ss_dssp ECC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSC
T ss_pred eeECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCc
Confidence 34565554444 6676653366677775543221 23455667666663 234667776644333 7899999776
Q ss_pred cHhhhhcC---------------------CC---CCCCCHHHHH-------H-H------------HHHHHHHHHHHHh-
Q 017558 284 TLEFHLHG---------------------KD---RPVMNWPTRM-------K-I------------ALGSARGLAYLHE- 318 (369)
Q Consensus 284 ~L~~~l~~---------------------~~---~~~l~~~~~~-------~-i------------~~~i~~~l~yLH~- 318 (369)
.+.+++.. .. ...+...... . + ...+...+..|..
T Consensus 98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~ 177 (333)
T 3csv_A 98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA 177 (333)
T ss_dssp BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence 66543321 11 0112211100 0 0 0011122233311
Q ss_pred --CCCCCeeecCCCCCcEEECCC----CcEEEeeeccceee
Q 017558 319 --DCQPKIIHRDIKSANILLDDS----FEAKVADFGLAKHS 353 (369)
Q Consensus 319 --~~~~~ivHrdlk~~Nill~~~----~~~ki~DFGla~~~ 353 (369)
.....++|+|+.+.|||++.+ ..+.|+||+.+...
T Consensus 178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 123479999999999999874 68999999998764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.89 E-value=5.9e-05 Score=68.26 Aligned_cols=138 Identities=12% Similarity=0.067 Sum_probs=76.4
Q ss_pred cceecccCceEEEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCcc-ccEeeEEEeCCeeEEEEEec-CCCc
Q 017558 207 ANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHL-VSLVGYCTFGSQRLLVYEFV-PNKT 284 (369)
Q Consensus 207 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lv~e~~-~~g~ 284 (369)
.+.|+.|....+|+. ..+++|+....... ..+..+|..++..+...++ .++++++ .+.-++++||+ ++..
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCcc
Confidence 678999999999998 45778877643211 1123567777776642222 4555443 44457999999 6655
Q ss_pred Hhh------------------hhcCCCCC---CCCH-HHHHHHHH--------------HHHHHHH----HHHh-CCCCC
Q 017558 285 LEF------------------HLHGKDRP---VMNW-PTRMKIAL--------------GSARGLA----YLHE-DCQPK 323 (369)
Q Consensus 285 L~~------------------~l~~~~~~---~l~~-~~~~~i~~--------------~i~~~l~----yLH~-~~~~~ 323 (369)
|.. .||..... .+.. .....+.. .+...+. .|.. .....
T Consensus 95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~ 174 (301)
T 3dxq_A 95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA 174 (301)
T ss_dssp CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence 431 11221110 0111 11111110 0111111 1211 12346
Q ss_pred eeecCCCCCcEEECCCCcEEEeeeccceee
Q 017558 324 IIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (369)
Q Consensus 324 ivHrdlk~~Nill~~~~~~ki~DFGla~~~ 353 (369)
++|+|+.+.||+ ..++.+.|+||..+...
T Consensus 175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 175 ACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp EECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred eeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 899999999999 55667899999988754
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.87 E-value=3.3e-05 Score=73.69 Aligned_cols=73 Identities=16% Similarity=0.166 Sum_probs=50.0
Q ss_pred cceecccCceEEEEEEEcC--------CeEEEEEeeccCCcccHHHHHHHHHHHHhcC-CCccccEeeEEEeCCeeEEEE
Q 017558 207 ANLLGQGGFGYVHKGVLTN--------GKVVAIKQLKAGSGQGEREFQAEIEIISQVH-HRHLVSLVGYCTFGSQRLLVY 277 (369)
Q Consensus 207 ~~~lg~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~ 277 (369)
.+.|+.|....+|++...+ +..+++|+.... .....+.+|..++..+. +.-..++++.+. + .+||
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEE
Confidence 4568888889999998753 467888887432 11245668999888875 333467776653 2 3899
Q ss_pred EecCCCcH
Q 017558 278 EFVPNKTL 285 (369)
Q Consensus 278 e~~~~g~L 285 (369)
||++|..|
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99986444
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=97.86 E-value=3.2e-06 Score=50.48 Aligned_cols=20 Identities=25% Similarity=0.581 Sum_probs=15.3
Q ss_pred CCCCCCceeeeehHHHHHHH
Q 017558 66 GYLPPGALAGMVVGVVIGAG 85 (369)
Q Consensus 66 ~~~~~~~~~~ivvg~~~~~~ 85 (369)
++++.++++|||||++++++
T Consensus 6 ~~ls~GaIAGiVvG~v~gv~ 25 (38)
T 2k1k_A 6 RGLTGGEIVAVIFGLLLGAA 25 (38)
T ss_dssp TTCCHHHHHHHHHHHHHHHH
T ss_pred CCCCCCceeeeehHHHHHHH
Confidence 45778889999998886543
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.78 E-value=0.00036 Score=66.98 Aligned_cols=74 Identities=12% Similarity=0.071 Sum_probs=48.4
Q ss_pred cceecccCceEEEEEEEcC-CeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCcc-ccEeeEEEeCCeeEEEEEecCCCc
Q 017558 207 ANLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHL-VSLVGYCTFGSQRLLVYEFVPNKT 284 (369)
Q Consensus 207 ~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lv~e~~~~g~ 284 (369)
.+.|+.|-...+|++...+ +..+++|+....... .-+..+|..++..+...++ .++++++. + .+||||++|..
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 4568888889999998754 477888877543211 1123578888888864444 57777663 2 35999998755
Q ss_pred H
Q 017558 285 L 285 (369)
Q Consensus 285 L 285 (369)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.76 E-value=1.9e-05 Score=48.57 Aligned_cols=30 Identities=20% Similarity=0.222 Sum_probs=16.2
Q ss_pred eeehHHHHHHHHHHHHHHHHHHHHhhhhhh
Q 017558 75 GMVVGVVIGAGIVLAAVGIFLIFYKRRKRK 104 (369)
Q Consensus 75 ~ivvg~~~~~~~~l~~~~~~~~~~rrr~~~ 104 (369)
+|++|++.|+++++++++++++++|||+++
T Consensus 12 ~IA~gVVgGv~~~~ii~~~~~~~~RRr~~~ 41 (44)
T 2ks1_B 12 SIATGMVGALLLLLVVALGIGLFMRRRHIV 41 (44)
T ss_dssp SSTHHHHHHHHHHHHHHHHHHHHHHTTTCC
T ss_pred eEEeehhHHHHHHHHHHHHHHHHhhhhHhh
Confidence 366666665555555555555555554443
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.72 E-value=0.00011 Score=68.64 Aligned_cols=141 Identities=17% Similarity=0.175 Sum_probs=83.9
Q ss_pred cceecccCceEEEEEEEcC--------CeEEEEEeeccCCcccHHHHHHHHHHHHhcC-CCccccEeeEEEeCCeeEEEE
Q 017558 207 ANLLGQGGFGYVHKGVLTN--------GKVVAIKQLKAGSGQGEREFQAEIEIISQVH-HRHLVSLVGYCTFGSQRLLVY 277 (369)
Q Consensus 207 ~~~lg~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~ 277 (369)
.+.|..|-...+|++...+ ++.+++|+.... ......+.+|.++++.+. +.-..++++++.+ .+||
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~ 129 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE 129 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence 3567778788899988642 467888886432 223456778999988874 3334667766643 2999
Q ss_pred EecCCCcHhhh-----------------hcCCC---CCCCC--HHHHHHHHHHHH-------------------HHHHHH
Q 017558 278 EFVPNKTLEFH-----------------LHGKD---RPVMN--WPTRMKIALGSA-------------------RGLAYL 316 (369)
Q Consensus 278 e~~~~g~L~~~-----------------l~~~~---~~~l~--~~~~~~i~~~i~-------------------~~l~yL 316 (369)
||++|..|... ||... ..... |.+..++..++. ..+.+|
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 99998665311 12211 11122 344444443332 123333
Q ss_pred Hh----C-CCCCeeecCCCCCcEEECCC----CcEEEeeecccee
Q 017558 317 HE----D-CQPKIIHRDIKSANILLDDS----FEAKVADFGLAKH 352 (369)
Q Consensus 317 H~----~-~~~~ivHrdlk~~Nill~~~----~~~ki~DFGla~~ 352 (369)
.. . ....++|+|+.+.|||++.+ +.+.|+||..|..
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 22 1 23469999999999999876 7899999998864
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.72 E-value=1.8e-05 Score=48.56 Aligned_cols=30 Identities=23% Similarity=0.330 Sum_probs=16.2
Q ss_pred eeehHHHHHHHHHHHHHHHHHHHHhhhhhh
Q 017558 75 GMVVGVVIGAGIVLAAVGIFLIFYKRRKRK 104 (369)
Q Consensus 75 ~ivvg~~~~~~~~l~~~~~~~~~~rrr~~~ 104 (369)
+|+.|++.|+++++++++++++++|||+++
T Consensus 11 aIA~gVVgGv~~v~ii~~~~~~~~RRRr~~ 40 (44)
T 2l2t_A 11 LIAAGVIGGLFILVIVGLTFAVYVRRKSIK 40 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHTTCSS
T ss_pred eEEEeehHHHHHHHHHHHHHHHHhhhhhhh
Confidence 366666665555555555555555554443
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.60 E-value=0.00016 Score=67.36 Aligned_cols=74 Identities=11% Similarity=0.032 Sum_probs=44.6
Q ss_pred cceecccCceEEEEEEEcC---------CeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCc-cccEeeEEEeCCeeEEE
Q 017558 207 ANLLGQGGFGYVHKGVLTN---------GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRH-LVSLVGYCTFGSQRLLV 276 (369)
Q Consensus 207 ~~~lg~G~fg~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~g~~~~~~~~~lv 276 (369)
.+.|+.|..-.+|+....+ +..+++|+....... ..+...|.+++..+...+ +.++++.. . -++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence 4567788888999998753 257888876543211 113467888887774323 45666544 2 3789
Q ss_pred EEecCCCcH
Q 017558 277 YEFVPNKTL 285 (369)
Q Consensus 277 ~e~~~~g~L 285 (369)
|||++|..+
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999987554
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.46 E-value=0.0017 Score=59.74 Aligned_cols=32 Identities=19% Similarity=0.295 Sum_probs=28.4
Q ss_pred CCeeecCCCCCcEEECCCCcEEEeeeccceee
Q 017558 322 PKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (369)
Q Consensus 322 ~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~ 353 (369)
..++|+|+.+.||+++.++.+.|+||+.+...
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 47999999999999998888999999887653
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=97.03 E-value=0.00047 Score=42.12 Aligned_cols=25 Identities=32% Similarity=0.493 Sum_probs=9.8
Q ss_pred hHHHHHHHHHHHHHHHHHHHHhhhh
Q 017558 78 VGVVIGAGIVLAAVGIFLIFYKRRK 102 (369)
Q Consensus 78 vg~~~~~~~~l~~~~~~~~~~rrr~ 102 (369)
++.++|+++++++++++++|.|||+
T Consensus 15 a~~vVGvll~vi~~l~~~~~~RRR~ 39 (44)
T 2jwa_A 15 ISAVVGILLVVVLGVVFGILIKRRQ 39 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHHHhheehhh
Confidence 3333333333333334344444443
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.92 E-value=0.003 Score=59.82 Aligned_cols=74 Identities=9% Similarity=0.086 Sum_probs=49.0
Q ss_pred cceecccCceEEEEEEEcC--------CeEEEEEeeccCCcccHHHHHHHHHHHHhcC-CCccccEeeEEEeCCeeEEEE
Q 017558 207 ANLLGQGGFGYVHKGVLTN--------GKVVAIKQLKAGSGQGEREFQAEIEIISQVH-HRHLVSLVGYCTFGSQRLLVY 277 (369)
Q Consensus 207 ~~~lg~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~ 277 (369)
.+.|..|-.-.+|+....+ +..+++|+....... .-+..+|.+++..+. +.-..++++.+ . -++||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEE
Confidence 4567778888999998753 567888886543211 123457888887774 33345666543 2 37899
Q ss_pred EecCCCcH
Q 017558 278 EFVPNKTL 285 (369)
Q Consensus 278 e~~~~g~L 285 (369)
||++|..|
T Consensus 150 efI~G~~l 157 (424)
T 3mes_A 150 EFIDGEPL 157 (424)
T ss_dssp ECCCSEEC
T ss_pred EEeCCccC
Confidence 99998764
|
| >2k9y_A Ephrin type-A receptor 2; receptor tyrosine kinase, membrane protein, dimeric transmembrane domain, ephrin receptor, ATP-binding, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.78 E-value=0.00038 Score=42.56 Aligned_cols=27 Identities=22% Similarity=0.477 Sum_probs=13.2
Q ss_pred eeeehHHHHHHHHHHHHHHHHHHHHhh
Q 017558 74 AGMVVGVVIGAGIVLAAVGIFLIFYKR 100 (369)
Q Consensus 74 ~~ivvg~~~~~~~~l~~~~~~~~~~rr 100 (369)
++|++|+++|+++++++++++++++||
T Consensus 13 ~~I~~~vv~Gv~ll~~iv~~~~~~~rR 39 (41)
T 2k9y_A 13 LAVIGGVAVGVVLLLVLAGVGFFIHRR 39 (41)
T ss_dssp THHHHHHHHHHHHHHHHHHHHHSSSSS
T ss_pred EEEEeehhHHHHHHHHHHHHheeEeee
Confidence 456666666555433234444444443
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.92 E-value=0.1 Score=48.81 Aligned_cols=30 Identities=27% Similarity=0.405 Sum_probs=25.5
Q ss_pred CeeecCCCCCcEEE------CCCCcEEEeeecccee
Q 017558 323 KIIHRDIKSANILL------DDSFEAKVADFGLAKH 352 (369)
Q Consensus 323 ~ivHrdlk~~Nill------~~~~~~ki~DFGla~~ 352 (369)
.++|+|+.+.|||+ +++..++++||-+|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36899999999999 4567899999998864
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.62 E-value=0.018 Score=35.28 Aligned_cols=35 Identities=17% Similarity=0.264 Sum_probs=26.1
Q ss_pred CCceeeeehHHHHHHHHHHHHHHHHHHHHhhhhhh
Q 017558 70 PGALAGMVVGVVIGAGIVLAAVGIFLIFYKRRKRK 104 (369)
Q Consensus 70 ~~~~~~ivvg~~~~~~~~l~~~~~~~~~~rrr~~~ 104 (369)
.++|++.|||.+++++++++++.+++-.+++++++
T Consensus 10 ~~~IA~gVVgGv~~~~ii~~~~~~~~RRr~~~~kR 44 (44)
T 2ks1_B 10 IPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKR 44 (44)
T ss_dssp SSSSTHHHHHHHHHHHHHHHHHHHHHHTTTCCSCC
T ss_pred cceEEeehhHHHHHHHHHHHHHHHHhhhhHhhccC
Confidence 45567777776666778888888899888877654
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.31 E-value=0.012 Score=35.98 Aligned_cols=36 Identities=17% Similarity=0.155 Sum_probs=27.1
Q ss_pred CCCceeeeehHHHHHHHHHHHHHHHHHHHHhhhhhh
Q 017558 69 PPGALAGMVVGVVIGAGIVLAAVGIFLIFYKRRKRK 104 (369)
Q Consensus 69 ~~~~~~~ivvg~~~~~~~~l~~~~~~~~~~rrr~~~ 104 (369)
..+++++.|||.+++++++++++.+++-.++++++|
T Consensus 8 ~~~aIA~gVVgGv~~v~ii~~~~~~~~RRRr~~~kr 43 (44)
T 2l2t_A 8 RTPLIAAGVIGGLFILVIVGLTFAVYVRRKSIKKKR 43 (44)
T ss_dssp SSHHHHHHHHHHHHHHHHHHHHHHHHHHTTCSSCCC
T ss_pred CcceEEEeehHHHHHHHHHHHHHHHHhhhhhhhhcc
Confidence 345677777776667778888888888888877765
|
| >1iij_A ERBB-2 receptor protein-tyrosine kinase; alpha-helix-PI-bulge-alpha-helix, signaling protein; NMR {Synthetic} SCOP: j.35.1.1 | Back alignment and structure |
|---|
Probab=93.22 E-value=0.02 Score=33.00 Aligned_cols=10 Identities=40% Similarity=0.448 Sum_probs=4.1
Q ss_pred HHHHHHHhhh
Q 017558 92 GIFLIFYKRR 101 (369)
Q Consensus 92 ~~~~~~~rrr 101 (369)
+.+.+++|||
T Consensus 25 l~~~~~iRRr 34 (35)
T 1iij_A 25 VVVGILIKRR 34 (35)
T ss_dssp TTTTHHHHHC
T ss_pred HHhheEEeec
Confidence 3333444444
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=92.14 E-value=0.057 Score=32.93 Aligned_cols=33 Identities=21% Similarity=0.335 Sum_probs=25.0
Q ss_pred CceeeeehHHHHHHHHHHHHHHHHHHHHhhhhhh
Q 017558 71 GALAGMVVGVVIGAGIVLAAVGIFLIFYKRRKRK 104 (369)
Q Consensus 71 ~~~~~ivvg~~~~~~~~l~~~~~~~~~~rrr~~~ 104 (369)
..+++++||++ .++++.+++++++-.++.+++|
T Consensus 12 ~~Ia~~vVGvl-l~vi~~l~~~~~~RRR~~~~kK 44 (44)
T 2jwa_A 12 TSIISAVVGIL-LVVVLGVVFGILIKRRQQKIRK 44 (44)
T ss_dssp HHHHHHHHHHH-HHHHHHHHHHHHHHHHCSCCCC
T ss_pred cchHHHHHHHH-HHHHHHHHHHhheehhhhhccC
Confidence 34778888844 5778888888889888877654
|
| >2klu_A T-cell surface glycoprotein CD4; cell membrane, disulfide bond, HOST- virus interaction, immune response, immunoglobulin domain, lipoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=91.84 E-value=0.086 Score=34.76 Aligned_cols=7 Identities=43% Similarity=0.648 Sum_probs=3.0
Q ss_pred eehHHHH
Q 017558 76 MVVGVVI 82 (369)
Q Consensus 76 ivvg~~~ 82 (369)
||+|.++
T Consensus 12 ivlGg~~ 18 (70)
T 2klu_A 12 IVLGGVA 18 (70)
T ss_dssp HHHHHHH
T ss_pred HHHhHHH
Confidence 3444443
|
| >2l34_A TYRO protein tyrosine kinase-binding protein; immunoreceptor, transmembrane assembly, DAP12, protein bindi; NMR {Homo sapiens} PDB: 2l35_B | Back alignment and structure |
|---|
Probab=91.63 E-value=0.12 Score=29.47 Aligned_cols=16 Identities=50% Similarity=0.895 Sum_probs=10.5
Q ss_pred CCCCceeeeehHHHHH
Q 017558 68 LPPGALAGMVVGVVIG 83 (369)
Q Consensus 68 ~~~~~~~~ivvg~~~~ 83 (369)
++.++++||++|.+++
T Consensus 4 L~~gaIaGIVvgdi~~ 19 (33)
T 2l34_A 4 VSPGVLAGIVVGDLVL 19 (33)
T ss_dssp CCTHHHHHHHHHHHHH
T ss_pred cCcceEEeEeHHHHHH
Confidence 4566777777777653
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=91.36 E-value=0.44 Score=40.25 Aligned_cols=87 Identities=8% Similarity=0.015 Sum_probs=62.1
Q ss_pred CCCccccEeeEEEeCCeeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEE
Q 017558 256 HHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANIL 335 (369)
Q Consensus 256 ~h~niv~l~g~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nil 335 (369)
.||+.+.. .+-...+...+.|+.-+.+.=+..+. .++...+++++..|+.-..+++. -+|--|.|+|++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik-----~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL~ 111 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK-----SFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDELF 111 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG-----GSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGEE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH-----hcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceEE
Confidence 57888766 35555666555565544332222232 36788999999999988877764 478889999999
Q ss_pred ECCCCcEEEeeeccceee
Q 017558 336 LDDSFEAKVADFGLAKHS 353 (369)
Q Consensus 336 l~~~~~~ki~DFGla~~~ 353 (369)
++.++.++|.-.|+-..+
T Consensus 112 f~~~~~p~i~~RGik~~l 129 (215)
T 4ann_A 112 FTRDGLPIAKTRGLQNVV 129 (215)
T ss_dssp ECTTSCEEESCCEETTTB
T ss_pred EcCCCCEEEEEccCccCC
Confidence 999999999999875443
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=91.23 E-value=0.69 Score=39.19 Aligned_cols=86 Identities=7% Similarity=0.010 Sum_probs=60.9
Q ss_pred CCCccccEeeEEEeCCeeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHH-HHHhCCCCCeeecCCCCCcE
Q 017558 256 HHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLA-YLHEDCQPKIIHRDIKSANI 334 (369)
Q Consensus 256 ~h~niv~l~g~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~-yLH~~~~~~ivHrdlk~~Ni 334 (369)
.||+. -...-..++.+.+.|+.-+++.=+..++ .++...+++++..|+.-.. +++ .-+|--|.|+|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~-----~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~NL 115 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR-----KTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPENL 115 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH-----TSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGGGE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH-----hcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCceE
Confidence 56776 2233355666666666654443333443 3678889999998887777 665 457888999999
Q ss_pred EECCCCcEEEeeeccceee
Q 017558 335 LLDDSFEAKVADFGLAKHS 353 (369)
Q Consensus 335 ll~~~~~~ki~DFGla~~~ 353 (369)
++|.++.++|.-.|+-..+
T Consensus 116 ~f~~~~~p~i~hRGi~~~l 134 (219)
T 4ano_A 116 MFNRALEPFFLHVGVKESL 134 (219)
T ss_dssp EECTTCCEEESCCEETTTB
T ss_pred EEeCCCcEEEEEcCCcccC
Confidence 9999999999999985544
|
| >2l9u_A Receptor tyrosine-protein kinase ERBB-3; transmenbrane dimer, membrane protein, EGFR; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=91.15 E-value=0.2 Score=28.33 Aligned_cols=26 Identities=15% Similarity=0.516 Sum_probs=14.3
Q ss_pred ehHHHHHHHHHHHHHHHHHHHHhhhh
Q 017558 77 VVGVVIGAGIVLAAVGIFLIFYKRRK 102 (369)
Q Consensus 77 vvg~~~~~~~~l~~~~~~~~~~rrr~ 102 (369)
.+-+++|.++++++++..|++||-|+
T Consensus 9 alt~i~gl~vif~~lg~tflywrgrr 34 (40)
T 2l9u_A 9 ALTVIAGLVVIFMMLGGTFLYWRGRR 34 (40)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCceeEEEcccc
Confidence 34455565566666665555555443
|
| >2l34_A TYRO protein tyrosine kinase-binding protein; immunoreceptor, transmembrane assembly, DAP12, protein bindi; NMR {Homo sapiens} PDB: 2l35_B | Back alignment and structure |
|---|
Probab=90.86 E-value=0.094 Score=29.92 Aligned_cols=28 Identities=21% Similarity=0.533 Sum_probs=18.9
Q ss_pred eeeeehHHHHHHHHHHHHHHHHHHHHhh
Q 017558 73 LAGMVVGVVIGAGIVLAAVGIFLIFYKR 100 (369)
Q Consensus 73 ~~~ivvg~~~~~~~~l~~~~~~~~~~rr 100 (369)
..+.++|++++-++..+++++.+|++.|
T Consensus 5 ~~gaIaGIVvgdi~~t~~i~~~vy~~~r 32 (33)
T 2l34_A 5 SPGVLAGIVVGDLVLTVLIALAVYFLGR 32 (33)
T ss_dssp CTHHHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred CcceEEeEeHHHHHHHHHHHHHHhheec
Confidence 3567888998877766666655555544
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=90.75 E-value=0.24 Score=29.22 Aligned_cols=33 Identities=27% Similarity=0.456 Sum_probs=21.5
Q ss_pred CCCCceeeeehHHHHHHHHHHHHH-HHHHHHHhh
Q 017558 68 LPPGALAGMVVGVVIGAGIVLAAV-GIFLIFYKR 100 (369)
Q Consensus 68 ~~~~~~~~ivvg~~~~~~~~l~~~-~~~~~~~rr 100 (369)
.+.+...|.+.|+++|+++.++++ ++.+|++||
T Consensus 4 ~~~~ls~GaIAGiVvG~v~gv~li~~l~~~~~rr 37 (38)
T 2k1k_A 4 VSRGLTGGEIVAVIFGLLLGAALLLGILVFRSRR 37 (38)
T ss_dssp SSTTCCHHHHHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCCCCCceeeeehHHHHHHHHHHHHHHHHeec
Confidence 456677888999999887655544 444444444
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=89.95 E-value=0.039 Score=52.85 Aligned_cols=60 Identities=3% Similarity=-0.034 Sum_probs=17.6
Q ss_pred ccceecccCceEEEEEEEcC-CeEEEE------EeeccCCc--ccHHHHHHHHHHHHhcCCCccccEeeEEE
Q 017558 206 EANLLGQGGFGYVHKGVLTN-GKVVAI------KQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCT 268 (369)
Q Consensus 206 ~~~~lg~G~fg~Vy~~~~~~-~~~vav------K~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~ 268 (369)
..+.|| ||+||+|.+.. ...||| |..+.... .....|.+|..++..++|+|+++.+++..
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 345666 99999999854 357888 76654322 22346888999999999999999988764
|
| >2l8s_A Integrin alpha-1; transmembrane region, detergent micelle, CE adhesion; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=89.52 E-value=0.47 Score=30.19 Aligned_cols=22 Identities=9% Similarity=0.025 Sum_probs=9.7
Q ss_pred eeehHHHHHHHHHHHHHHHHHH
Q 017558 75 GMVVGVVIGAGIVLAAVGIFLI 96 (369)
Q Consensus 75 ~ivvg~~~~~~~~l~~~~~~~~ 96 (369)
.++++.+++.+++++++++.+|
T Consensus 10 WiIi~svl~GLLLL~Lii~~Lw 31 (54)
T 2l8s_A 10 WVILLSAFAGLLLLMLLILALW 31 (54)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHHH
Confidence 3444444444444444443333
|
| >2knc_B Integrin beta-3; transmembrane signaling, protein structure, cell A cleavage on PAIR of basic residues, disease mutation, disul bond, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=87.52 E-value=0.37 Score=33.68 Aligned_cols=10 Identities=10% Similarity=0.072 Sum_probs=5.0
Q ss_pred eeeehHHHHH
Q 017558 74 AGMVVGVVIG 83 (369)
Q Consensus 74 ~~ivvg~~~~ 83 (369)
.+|++|+++|
T Consensus 11 ~~Iv~gvi~g 20 (79)
T 2knc_B 11 LVVLLSVMGA 20 (79)
T ss_dssp HHHHHHHHHH
T ss_pred hhhHHHHHHH
Confidence 3455555543
|
| >2knc_A Integrin alpha-IIB; transmembrane signaling, protein structure, cell A cleavage on PAIR of basic residues, disease mutation, disul bond, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=84.10 E-value=1.6 Score=27.87 Aligned_cols=22 Identities=18% Similarity=0.167 Sum_probs=9.5
Q ss_pred eeehHHHHHHHHHHHHHHHHHH
Q 017558 75 GMVVGVVIGAGIVLAAVGIFLI 96 (369)
Q Consensus 75 ~ivvg~~~~~~~~l~~~~~~~~ 96 (369)
.++++.+++.+++++++++.+|
T Consensus 13 wiIi~svl~GLllL~li~~~Lw 34 (54)
T 2knc_A 13 WWVLVGVLGGLLLLTILVLAMW 34 (54)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHHH
Confidence 3444444444444444433333
|
| >2jp3_A FXYD domain-containing ION transport regulator 4; protein, transcription; NMR {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=83.45 E-value=1.3 Score=29.35 Aligned_cols=18 Identities=17% Similarity=0.488 Sum_probs=8.0
Q ss_pred ehHHHHHHHHHHHHHHHH
Q 017558 77 VVGVVIGAGIVLAAVGIF 94 (369)
Q Consensus 77 vvg~~~~~~~~l~~~~~~ 94 (369)
+.|++++++++++.++++
T Consensus 19 igGLifA~vLfi~GI~ii 36 (67)
T 2jp3_A 19 LGGLIFGGLLCIAGIALA 36 (67)
T ss_dssp HHHHHHHHHHHHHHHHHH
T ss_pred ecchhhHHHHHHHHHHHH
Confidence 345555444444333333
|
| >2llm_A Amyloid beta A4 protein; alzheimer'S disease, protein fibril; NMR {Homo sapiens} PDB: 2loh_A | Back alignment and structure |
|---|
Probab=83.46 E-value=0.24 Score=29.63 Aligned_cols=7 Identities=43% Similarity=1.047 Sum_probs=2.9
Q ss_pred Cceeeee
Q 017558 71 GALAGMV 77 (369)
Q Consensus 71 ~~~~~iv 77 (369)
++.+|+.
T Consensus 17 ga~iGL~ 23 (43)
T 2llm_A 17 GAIIGLM 23 (43)
Confidence 3444443
|
| >1q55_A EP-cadherin, C-cadherin; trans interaction, desmosome, junction, adhesion, structural protein; HET: NAG NDG; 30.00A {Mus musculus} SCOP: i.20.1.1 PDB: 1q5a_A* 1q5b_A* 1q5c_A* | Back alignment and structure |
|---|
Probab=82.68 E-value=0.25 Score=51.20 Aligned_cols=29 Identities=17% Similarity=0.194 Sum_probs=0.0
Q ss_pred ceeeeehHHHHHHHHHHHHHHHHHHHHhh
Q 017558 72 ALAGMVVGVVIGAGIVLAAVGIFLIFYKR 100 (369)
Q Consensus 72 ~~~~ivvg~~~~~~~~l~~~~~~~~~~rr 100 (369)
...+++++++++++++|++++++++++||
T Consensus 702 l~~~aii~il~~~~~ll~~~ll~~~~~~~ 730 (880)
T 1q55_A 702 FDLPIILVILGSVLALLILFLLLLLFLKR 730 (880)
T ss_dssp -----------------------------
T ss_pred ccHHHHHHHHHHHHHHHHHHHHHHhhhhh
Confidence 33444555555444444444444444333
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 369 | ||||
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-51 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-51 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-51 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-49 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-48 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-48 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-47 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-47 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 8e-47 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 6e-46 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 8e-46 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 9e-46 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-45 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-45 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-44 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 8e-44 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-43 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-43 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 6e-43 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 7e-43 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-41 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-40 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-40 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-40 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-40 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-40 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-39 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-39 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-38 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-38 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-38 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-37 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-37 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-36 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-35 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-35 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 8e-35 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-34 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 6e-34 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 6e-34 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 8e-34 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-33 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 9e-33 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-32 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-32 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-32 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 6e-32 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-31 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-30 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 8e-30 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-29 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-29 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-29 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-28 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-28 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-28 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-28 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 8e-28 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-26 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-25 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-24 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-21 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 7e-19 |
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (433), Expect = 1e-51
Identities = 50/175 (28%), Positives = 78/175 (44%), Gaps = 5/175 (2%)
Query: 195 EELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQ 254
+E ++ + LG G FG V G VA+K LK GS F AE ++ Q
Sbjct: 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQ 64
Query: 255 VHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLA 314
+ H+ LV L T ++ E++ N +L L + + +A A G+A
Sbjct: 65 LQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 123
Query: 315 YLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFG 369
++ E IHRD+++ANIL+ D+ K+ADFGLA+ D +
Sbjct: 124 FIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK 175
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (433), Expect = 2e-51
Identities = 49/176 (27%), Positives = 85/176 (48%), Gaps = 6/176 (3%)
Query: 195 EELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQ 254
++ +I + +G G FG V+KG V + + A + Q + F+ E+ ++ +
Sbjct: 1 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRK 60
Query: 255 VHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLA 314
H +++ +GY T Q +V ++ +L HLH + + IA +A+G+
Sbjct: 61 TRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMD 118
Query: 315 YLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH-SLDTDTHVSTRVMGTFG 369
YLH IIHRD+KS NI L + K+ DFGLA S + +H ++ G+
Sbjct: 119 YLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 171
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 6e-51
Identities = 43/175 (24%), Positives = 83/175 (47%), Gaps = 9/175 (5%)
Query: 197 LKIATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGERE-FQAEIEIISQ 254
+++ D+F + + LG G G V K +G V+A K + R E++++ +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 255 VHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLA 314
+ ++V G + + E + +L+ L R + K+++ +GL
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLT 118
Query: 315 YLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFG 369
YL E KI+HRD+K +NIL++ E K+ DFG++ +D+ ++ +GT
Sbjct: 119 YLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRS 168
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 166 bits (422), Expect = 1e-49
Identities = 56/197 (28%), Positives = 91/197 (46%), Gaps = 19/197 (9%)
Query: 188 FKSTFTYEELKIATDNFSEA---------NLLGQGGFGYVHKGVLT----NGKVVAIKQL 234
F FT+E+ A F++ ++G G FG V G L VAIK L
Sbjct: 3 FIDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTL 62
Query: 235 KAG-SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKD 293
K+G + + R+F +E I+ Q H +++ L G T + +++ EF+ N +L+ L D
Sbjct: 63 KSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQND 122
Query: 294 RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH- 352
+ + G A G+ YL +HRD+ + NIL++ + KV+DFGL++
Sbjct: 123 GQ-FTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 178
Query: 353 SLDTDTHVSTRVMGTFG 369
DT T +G
Sbjct: 179 EDDTSDPTYTSALGGKI 195
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (412), Expect = 1e-48
Identities = 46/168 (27%), Positives = 73/168 (43%), Gaps = 5/168 (2%)
Query: 202 DNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLV 261
+ + LG G FG V G VAIK +K GS E EF E +++ + H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62
Query: 262 SLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQ 321
L G CT ++ E++ N L +L +++ + YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLE---S 118
Query: 322 PKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFG 369
+ +HRD+ + N L++D KV+DFGL+++ LD + S
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR 166
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 3e-48
Identities = 49/180 (27%), Positives = 80/180 (44%), Gaps = 5/180 (2%)
Query: 190 STFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEI 249
+ +I ++ LGQG FG V G VAIK LK G+ F E
Sbjct: 5 QGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEA 63
Query: 250 EIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGS 309
+++ ++ H LV L + +V E++ +L L G+ + P + +A
Sbjct: 64 QVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQI 122
Query: 310 ARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFG 369
A G+AY+ + +HRD+++ANIL+ ++ KVADFGLA+ D +
Sbjct: 123 ASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK 179
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 1e-47
Identities = 51/168 (30%), Positives = 78/168 (46%), Gaps = 5/168 (2%)
Query: 202 DNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLV 261
+ +G G FG VH G N VAIK ++ G+ E +F E E++ ++ H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLV 63
Query: 262 SLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQ 321
L G C + LV+EF+ + L R + T + + L G+AYL E
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCL-SDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE--- 119
Query: 322 PKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFG 369
+IHRD+ + N L+ ++ KV+DFG+ + LD ST
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK 167
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 159 bits (403), Expect = 5e-47
Identities = 46/181 (25%), Positives = 85/181 (46%), Gaps = 5/181 (2%)
Query: 190 STFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGSGQGEREFQAE 248
S+ Y++ ++ + + + LG G +G V++GV VA+K LK + + E EF E
Sbjct: 5 SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKE 63
Query: 249 IEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALG 308
++ ++ H +LV L+G CT ++ EF+ L +L +R ++ + +A
Sbjct: 64 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 123
Query: 309 SARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF 368
+ + YL + IHRD+ + N L+ ++ KVADFGL++
Sbjct: 124 ISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 180
Query: 369 G 369
Sbjct: 181 K 181
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (402), Expect = 8e-47
Identities = 43/175 (24%), Positives = 78/175 (44%), Gaps = 8/175 (4%)
Query: 194 YEELKI---ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEI 249
YE + D + LG G FG V+K + A K + S + ++ EI
Sbjct: 1 YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 60
Query: 250 EIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGS 309
+I++ H ++V L+ + + ++ EF ++ + +RP + + +
Sbjct: 61 DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP-LTESQIQVVCKQT 119
Query: 310 ARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRV 364
L YLH+ KIIHRD+K+ NIL + K+ADFG++ + T + +
Sbjct: 120 LDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI 171
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 157 bits (398), Expect = 6e-46
Identities = 44/167 (26%), Positives = 72/167 (43%), Gaps = 9/167 (5%)
Query: 201 TDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGE---REFQAEIEIISQVH 256
FS+ +G G FG V+ + N +VVAIK++ Q ++ E+ + ++
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 257 HRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYL 316
H + + G LV E+ + K + + G+ +GLAYL
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP--LQEVEIAAVTHGALQGLAYL 131
Query: 317 HEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTR 363
H +IHRD+K+ NILL + K+ DFG A ++ V T
Sbjct: 132 HS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTP 175
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 8e-46
Identities = 51/182 (28%), Positives = 85/182 (46%), Gaps = 12/182 (6%)
Query: 195 EELKIATDNFSEANL-LGQGGFGYVHKGVL---TNGKVVAIKQLKAGSGQGERE-FQAEI 249
++L + DN A++ LG G FG V +GV VAIK LK G+ + + E E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 250 EIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGS 309
+I+ Q+ + ++V L+G C +LV E L L GK + ++
Sbjct: 61 QIMHQLDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQV 118
Query: 310 ARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK--HSLDTDTHVSTRVMGT 367
+ G+ YL + +HRD+ + N+LL + AK++DFGL+K + D+ +
Sbjct: 119 SMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 175
Query: 368 FG 369
Sbjct: 176 LK 177
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 9e-46
Identities = 47/167 (28%), Positives = 77/167 (46%), Gaps = 7/167 (4%)
Query: 202 DNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLV 261
+G+G FG V G G VA+K +K + + F AE +++Q+ H +LV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLV 63
Query: 262 SLVGYCTFGSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDC 320
L+G L +V E++ +L +L + R V+ +K +L + YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--- 120
Query: 321 QPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGT 367
+HRD+ + N+L+ + AKV+DFGL K + T V T
Sbjct: 121 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT 167
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 2e-45
Identities = 48/172 (27%), Positives = 81/172 (47%), Gaps = 17/172 (9%)
Query: 210 LGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTF 269
+G+G FG V +G G+ VA+K + + +AEI + H +++ +
Sbjct: 11 IGKGRFGEVWRGKWR-GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNK 68
Query: 270 G----SQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDC----- 320
+Q LV ++ + +L +L+ R + +K+AL +A GLA+LH +
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASGLAHLHMEIVGTQG 125
Query: 321 QPKIIHRDIKSANILLDDSFEAKVADFGLAK---HSLDTDTHVSTRVMGTFG 369
+P I HRD+KS NIL+ + +AD GLA + DT +GT
Sbjct: 126 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 177
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 155 bits (392), Expect = 3e-45
Identities = 47/206 (22%), Positives = 83/206 (40%), Gaps = 33/206 (16%)
Query: 194 YEELKIATDNFSEANLLGQGGFGYVHKGVLTN------GKVVAIKQLK-AGSGQGEREFQ 246
L+ +N +G+G FG V + +VA+K LK S + +FQ
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64
Query: 247 AEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDR------------ 294
E ++++ + ++V L+G C G L++E++ L L
Sbjct: 65 REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124
Query: 295 ----------PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKV 344
P ++ ++ IA A G+AYL E K +HRD+ + N L+ ++ K+
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKI 181
Query: 345 ADFGLAKHSLDTD-THVSTRVMGTFG 369
ADFGL+++ D
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIR 207
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 1e-44
Identities = 41/177 (23%), Positives = 79/177 (44%), Gaps = 10/177 (5%)
Query: 202 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHR 258
+++ +G G +G K ++GK++ K+L GS ++ +E+ ++ ++ H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 259 HLVSLVGYCTFGSQRLL--VYEFVPNKTLEFHLH--GKDRPVMNWPTRMKIALGSARGLA 314
++V + L V E+ L + K+R ++ +++ L
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 315 YLHE--DCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFG 369
H D ++HRD+K AN+ LD K+ DFGLA+ L+ DT + +GT
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI-LNHDTSFAKAFVGTPY 179
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 8e-44
Identities = 49/200 (24%), Positives = 82/200 (41%), Gaps = 28/200 (14%)
Query: 195 EELKIATDNFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLKAGSGQGERE-FQA 247
+ + + S LG G FG V + VA+K LK + ERE +
Sbjct: 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS 75
Query: 248 EIEIISQV-HHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGK-------------- 292
E++++S + +H ++V+L+G CT G L++ E+ L L K
Sbjct: 76 ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 135
Query: 293 --DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLA 350
D ++ + + A+G+A+L IHRD+ + NILL K+ DFGLA
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLA 192
Query: 351 KHSLDTDTH-VSTRVMGTFG 369
+ + + V
Sbjct: 193 RDIKNDSNYVVKGNARLPVK 212
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (376), Expect = 2e-43
Identities = 46/172 (26%), Positives = 78/172 (45%), Gaps = 12/172 (6%)
Query: 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLK---AGSGQGEREFQAEIEIISQVHH 257
++F LG+G FG V+ + ++A+K L E + + E+EI S + H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 258 RHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLH 317
+++ L GY ++ L+ E+ P T+ L + + A L+Y H
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCH 123
Query: 318 EDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFG 369
++IHRDIK N+LL + E K+ADFG + H+ + + GT
Sbjct: 124 S---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLCGTLD 169
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 4e-43
Identities = 47/211 (22%), Positives = 84/211 (39%), Gaps = 34/211 (16%)
Query: 190 STFTYEEL-KIATDNFSEANLLGQGGFGYVHKGVLTN------GKVVAIKQLKAGSGQGE 242
+ Y+ + +N +LG G FG V VA+K LK + E
Sbjct: 24 REYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSE 83
Query: 243 RE-FQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGK-------- 292
RE +E+++++Q+ H ++V+L+G CT L++E+ L +L K
Sbjct: 84 REALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDE 143
Query: 293 -------------DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS 339
D V+ + + A A+G+ +L +HRD+ + N+L+
Sbjct: 144 IEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHG 200
Query: 340 FEAKVADFGLAKHSLDTDTHVS-TRVMGTFG 369
K+ DFGLA+ + +V
Sbjct: 201 KVVKICDFGLARDIMSDSNYVVRGNARLPVK 231
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 6e-43
Identities = 44/171 (25%), Positives = 72/171 (42%), Gaps = 8/171 (4%)
Query: 202 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGERE-FQAEIEIISQVHHRH 259
+++ LG+G +G V V + VA+K + E + EI I ++H +
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 260 LVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHED 319
+V G+ G+ + L E+ L + M P + G+ YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHG- 121
Query: 320 CQPKIIHRDIKSANILLDDSFEAKVADFGLAK-HSLDTDTHVSTRVMGTFG 369
I HRDIK N+LLD+ K++DFGLA + + ++ GT
Sbjct: 122 --IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 170
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 7e-43
Identities = 44/176 (25%), Positives = 77/176 (43%), Gaps = 10/176 (5%)
Query: 199 IATDNFSEANLLGQGGFGYVHKGVLTN----GKVVAIKQLKAGSGQGERE-FQAEIEIIS 253
I + +G+G FG VH+G+ + VAIK K + RE F E +
Sbjct: 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMR 63
Query: 254 QVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGL 313
Q H H+V L+G T ++ E L L + ++ + + A + L
Sbjct: 64 QFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTAL 121
Query: 314 AYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFG 369
AYL + +HRDI + N+L+ + K+ DFGL+++ D+ + +++
Sbjct: 122 AYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 174
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 6e-41
Identities = 44/171 (25%), Positives = 73/171 (42%), Gaps = 13/171 (7%)
Query: 206 EANLLGQGGFGYVHKGVLTN---GKVVAIKQLKAGSGQGE--REFQAEIEIISQVHHRHL 260
E LG G FG V KG K VA+K LK + E AE ++ Q+ + ++
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 261 VSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDC 320
V ++G C S +LV E L +L + +++ + G+ YL
Sbjct: 71 VRMIGICEAES-WMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLE--- 124
Query: 321 QPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTR--VMGTFG 369
+ +HRD+ + N+LL AK++DFGL+K + + +
Sbjct: 125 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 175
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 1e-40
Identities = 48/188 (25%), Positives = 80/188 (42%), Gaps = 18/188 (9%)
Query: 191 TFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGK----VVAIKQLKAGSGQGE-REF 245
L + +F+E ++G+G FG V+ G L + A+K L + GE +F
Sbjct: 21 VIGPSSLIV---HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF 75
Query: 246 QAEIEIISQVHHRHLVSLVGYCTFG-SQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMK 304
E I+ H +++SL+G C L+V ++ + L + + +
Sbjct: 76 LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL-RNFIRNETHNPTVKDLIG 134
Query: 305 IALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD---THVS 361
L A+G+ K +HRD+ + N +LD+ F KVADFGLA+ D + H
Sbjct: 135 FGLQVAKGM---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 191
Query: 362 TRVMGTFG 369
T
Sbjct: 192 TGAKLPVK 199
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 2e-40
Identities = 47/187 (25%), Positives = 83/187 (44%), Gaps = 24/187 (12%)
Query: 202 DNFSEANLLGQGGFGYVHKGVLTNG---KVVAIKQLK-AGSGQGEREFQAEIEIISQV-H 256
++ +++G+G FG V K + AIK++K S R+F E+E++ ++ H
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 257 HRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKD--------------RPVMNWPTR 302
H ++++L+G C L E+ P+ L L ++
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 303 MKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 362
+ A ARG+ YL Q + IHRD+ + NIL+ +++ AK+ADFGL++ T
Sbjct: 130 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--T 184
Query: 363 RVMGTFG 369
Sbjct: 185 MGRLPVR 191
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 2e-40
Identities = 46/180 (25%), Positives = 82/180 (45%), Gaps = 12/180 (6%)
Query: 198 KIATDNFSEANLLGQGGFGYVHKGVLTNG-----KVVAIKQLKAGSGQGER-EFQAEIEI 251
+I + ++G G FG V+KG+L VAIK LKAG + +R +F E I
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 62
Query: 252 ISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSAR 311
+ Q H +++ L G + +++ E++ N + + + + G A
Sbjct: 63 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGA-LDKFLREKDGEFSVLQLVGMLRGIAA 121
Query: 312 GLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD--THVSTRVMGTFG 369
G+ YL +HRD+ + NIL++ + KV+DFGL++ D T+ ++
Sbjct: 122 GMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 2e-40
Identities = 46/180 (25%), Positives = 70/180 (38%), Gaps = 14/180 (7%)
Query: 199 IATDNFSEANLLGQGGFGYVHKGVLT----NGKVVAIKQLK---AGSGQGEREFQAEIEI 251
I + LG G FG V +G VA+K LK + +F E+
Sbjct: 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 252 ISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSAR 311
+ + HR+L+ L G + +V E P +L K + T + A+ A
Sbjct: 65 MHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSL-LDRLRKHQGHFLLGTLSRYAVQVAE 122
Query: 312 GLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH--VSTRVMGTFG 369
G+ YL + IHRD+ + N+LL K+ DFGL + D H + F
Sbjct: 123 GMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 179
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 3e-40
Identities = 44/168 (26%), Positives = 72/168 (42%), Gaps = 14/168 (8%)
Query: 210 LGQGGFGYVHKGVLT-NGKVVAIKQLK--AGSGQGEREFQAEIEIISQVHHRHLVSLVGY 266
+G+G F V+KG+ T VA +L+ + + F+ E E++ + H ++V
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 267 CTFGSQR----LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQP 322
+ +LV E + + TL+ +L VM +GL +LH P
Sbjct: 77 WESTVKGKKCIVLVTELMTSGTLKTYLK--RFKVMKIKVLRSWCRQILKGLQFLHTRT-P 133
Query: 323 KIIHRDIKSANILLDD-SFEAKVADFGLAKHSLDTDTHVSTRVMGTFG 369
IIHRD+K NI + + K+ D GLA + V+GT
Sbjct: 134 PIIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAVIGTPE 178
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 141 bits (356), Expect = 2e-39
Identities = 43/167 (25%), Positives = 71/167 (42%), Gaps = 12/167 (7%)
Query: 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLK---AGSGQGEREFQAEIEIISQVH- 256
++FS ++G+GGFG V+ GK+ A+K L QGE E ++S V
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 257 --HRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLA 314
+V + + + + + L +HL V + A GL
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS--QHGVFSEADMRFYAAEIILGLE 121
Query: 315 YLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVS 361
++H +++RD+K ANILLD+ +++D GLA H S
Sbjct: 122 HMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS 165
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 4e-39
Identities = 45/181 (24%), Positives = 85/181 (46%), Gaps = 13/181 (7%)
Query: 197 LKIAT-DNFSEANLLGQGGFGYVHKGV-LTNGKV----VAIKQLK-AGSGQGEREFQAEI 249
L+I F + +LG G FG V+KG+ + G+ VAIK+L+ A S + +E E
Sbjct: 3 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 62
Query: 250 EIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGS 309
+++ V + H+ L+G C + +L + + +P L + + + + +
Sbjct: 63 YVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCL-LDYVREHKDNIGSQYLLNWCVQI 120
Query: 310 ARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT-HVSTRVMGTF 368
A+G+ YL +++HRD+ + N+L+ K+ DFGLAK + + +
Sbjct: 121 AKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177
Query: 369 G 369
Sbjct: 178 K 178
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (347), Expect = 1e-38
Identities = 39/165 (23%), Positives = 71/165 (43%), Gaps = 7/165 (4%)
Query: 201 TDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRH 259
++ +GQG G V+ + + G+ VAI+Q+ + EI ++ + + +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 260 LVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHED 319
+V+ + G + +V E++ +L + M+ + + L +LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVT---ETCMDEGQIAAVCRECLQALEFLH-- 133
Query: 320 CQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRV 364
++IHRDIKS NILL K+ DFG + ST V
Sbjct: 134 -SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV 177
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 3e-38
Identities = 49/195 (25%), Positives = 79/195 (40%), Gaps = 27/195 (13%)
Query: 199 IATDNFSEANLLGQGGFGYVHKGV------LTNGKVVAIKQLKAGSGQGE-REFQAEIEI 251
D LG+G FG V + + VA+K LK G+ E R +E++I
Sbjct: 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKI 69
Query: 252 ISQ-VHHRHLVSLVGYCTF-GSQRLLVYEFVPNKTLEFHLHGKD--------------RP 295
+ HH ++V+L+G CT G +++ EF L +L K +
Sbjct: 70 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 129
Query: 296 VMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355
+ + + A+G+ +L K IHRD+ + NILL + K+ DFGLA+
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 186
Query: 356 TDTHV-STRVMGTFG 369
+V
Sbjct: 187 DPDYVRKGDARLPLK 201
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 137 bits (346), Expect = 5e-38
Identities = 41/167 (24%), Positives = 71/167 (42%), Gaps = 7/167 (4%)
Query: 202 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHL 260
D++ LG G FG VH+ G A K + + + EI+ +S + H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 261 VSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDC 320
V+L ++ +++YEF+ L + + M+ ++ +GL ++HE+
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKGLCHMHENN 144
Query: 321 QPKIIHRDIKSANILL--DDSFEAKVADFGLAKHSLDTDTHVSTRVM 365
+H D+K NI+ S E K+ DFGL H + T
Sbjct: 145 ---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGT 188
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 2e-37
Identities = 47/191 (24%), Positives = 86/191 (45%), Gaps = 19/191 (9%)
Query: 195 EELKIATDNFSEANLLGQGGFGYVHKGVLTN------GKVVAIKQLKAGSGQGER-EFQA 247
+E ++A + + + LGQG FG V++GV VAIK + + ER EF
Sbjct: 13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 72
Query: 248 EIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDR--------PVMNW 299
E ++ + + H+V L+G + G L++ E + L+ +L +
Sbjct: 73 EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 132
Query: 300 PTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD-T 358
+++A A G+AYL K +HRD+ + N ++ + F K+ DFG+ + +TD
Sbjct: 133 SKMIQMAGEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 189
Query: 359 HVSTRVMGTFG 369
+ +
Sbjct: 190 RKGGKGLLPVR 200
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 135 bits (341), Expect = 3e-37
Identities = 45/170 (26%), Positives = 73/170 (42%), Gaps = 7/170 (4%)
Query: 202 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHL 260
D + LG G FG VH+ V G+V K + + + EI I++Q+HH L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 261 VSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDC 320
++L + +L+ EF+ L + +D M+ + + GL ++HE
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQACEGLKHMHE-- 145
Query: 321 QPKIIHRDIKSANILLD--DSFEAKVADFGLAKHSLDTDTHVSTRVMGTF 368
I+H DIK NI+ + + K+ DFGLA + T F
Sbjct: 146 -HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEF 194
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 2e-36
Identities = 41/177 (23%), Positives = 66/177 (37%), Gaps = 10/177 (5%)
Query: 198 KIATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLK---AGSGQGEREFQAEIEIIS 253
K ++F +LG+G F V L + AIK L+ E +++S
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 254 QVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGL 313
++ H V L + + N L ++ + L
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSAL 121
Query: 314 AYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK-HSLDTDTHVSTRVMGTFG 369
YLH IIHRD+K NILL++ ++ DFG AK S ++ + +GT
Sbjct: 122 EYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 175
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 129 bits (324), Expect = 1e-35
Identities = 37/169 (21%), Positives = 75/169 (44%), Gaps = 7/169 (4%)
Query: 202 DNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLK--AGSGQGEREFQAEIEIISQVHHRH 259
+ + +G+G +G V+K G+ A+K+++ EI I+ ++ H +
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 260 LVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHED 319
+V L + +LV+E + + + + T L G+AY H+
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG--LESVTAKSFLLQLLNGIAYCHD- 118
Query: 320 CQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF 368
+++HRD+K N+L++ E K+ADFGLA+ + ++ +
Sbjct: 119 --RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLW 165
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 129 bits (324), Expect = 2e-35
Identities = 41/179 (22%), Positives = 70/179 (39%), Gaps = 18/179 (10%)
Query: 202 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSG---------QGEREFQAEIEI 251
+N+ +LG+G V + + K A+K + G + E++I
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 252 ISQVH-HRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSA 310
+ +V H +++ L + LV++ + L +L K ++ KI
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRALL 120
Query: 311 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFG 369
+ LH+ I+HRD+K NILLDD K+ DFG + V GT
Sbjct: 121 EVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEKLREVCGTPS 174
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 8e-35
Identities = 41/170 (24%), Positives = 83/170 (48%), Gaps = 7/170 (4%)
Query: 202 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAG--SGQGEREFQAEIEIISQVHHR 258
+NF + +G+G +G V+K G+VVA+K+++ + EI ++ +++H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 259 HLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHE 318
++V L+ ++ LV+EF+ ++ L+ + + P +GLA+ H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 319 DCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF 368
++HRD+K N+L++ K+ADFGLA+ + V+ +
Sbjct: 121 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW 167
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 2e-34
Identities = 45/191 (23%), Positives = 81/191 (42%), Gaps = 27/191 (14%)
Query: 199 IATDNFSEANLLGQGGFGYVHKGVLT--------NGKVVAIKQLKAGSGQGE-REFQAEI 249
+ D LG+G FG V VA+K LK+ + + + + +E+
Sbjct: 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEM 69
Query: 250 EIISQV-HHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRP------------- 295
E++ + H+++++L+G CT ++ E+ L +L + P
Sbjct: 70 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 129
Query: 296 -VMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354
++ + A ARG+ YL K IHRD+ + N+L+ + K+ADFGLA+
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 186
Query: 355 DTDTHVSTRVM 365
D + T
Sbjct: 187 HIDYYKKTTNG 197
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 6e-34
Identities = 47/173 (27%), Positives = 83/173 (47%), Gaps = 16/173 (9%)
Query: 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHL 260
++++ ++G G FG V++ L +G++VAIK++ Q +R E++I+ ++ H ++
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNI 75
Query: 261 VSLVGYCTFGSQR------LLVYEFVPNKTLEFHLH-GKDRPVMNWPTRMKIALGSARGL 313
V L + ++ LV ++VP H + + + R L
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 314 AYLHEDCQPKIIHRDIKSANILLD-DSFEAKVADFGLAKHSLDTDTHVSTRVM 365
AY+H I HRDIK N+LLD D+ K+ DFG AK + + +VS
Sbjct: 136 AYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS 185
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (316), Expect = 6e-34
Identities = 37/166 (22%), Positives = 68/166 (40%), Gaps = 8/166 (4%)
Query: 202 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHL 260
+ + A LG+G FG VH+ V ++ K K +K G + + EI I++ HR++
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRNI 63
Query: 261 VSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDC 320
+ L + ++++EF+ + ++ +N + L +LH
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERINTSAFE-LNEREIVSYVHQVCEALQFLHS-- 120
Query: 321 QPKIIHRDIKSANILLD--DSFEAKVADFGLAKHSLDTDTHVSTRV 364
I H DI+ NI+ S K+ +FG A+ D
Sbjct: 121 -HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFT 165
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 125 bits (315), Expect = 8e-34
Identities = 41/163 (25%), Positives = 62/163 (38%), Gaps = 9/163 (5%)
Query: 202 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLK---AGSGQGEREFQAEIEIISQVHH 257
+F LG G FG VH NG+ A+K LK + E ++S V H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 258 RHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLH 317
++ + G Q ++ +++ L L R + L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV-----CLALE 118
Query: 318 EDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 360
II+RD+K NILLD + K+ DFG AK+ D +
Sbjct: 119 YLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTL 161
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 124 bits (312), Expect = 2e-33
Identities = 42/181 (23%), Positives = 80/181 (44%), Gaps = 12/181 (6%)
Query: 194 YEELKIATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGERE-FQAEIEI 251
+++ + D + ++LG G F V K+VAIK + + +G+ + EI +
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 252 ISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSAR 311
+ ++ H ++V+L G L+ + V L + K ++
Sbjct: 61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF--YTERDASRLIFQVLD 118
Query: 312 GLAYLHEDCQPKIIHRDIKSANILL---DDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF 368
+ YLH+ I+HRD+K N+L D+ + ++DFGL+K ++ V + GT
Sbjct: 119 AVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSK--MEDPGSVLSTACGTP 173
Query: 369 G 369
G
Sbjct: 174 G 174
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 9e-33
Identities = 46/182 (25%), Positives = 78/182 (42%), Gaps = 18/182 (9%)
Query: 200 ATDNFSEANLLGQGGFGYVHKG--VLTNGKVVAIKQLKAGSGQGEREFQAEIEI-----I 252
A + +G+G +G V K + G+ VA+K+++ +G+ E+ +
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 253 SQVHHRHLVSLVGYCTFGSQR-----LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIAL 307
H ++V L CT LV+E V + P + T +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMF 123
Query: 308 GSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGT 367
RGL +LH +++HRD+K NIL+ S + K+ADFGLA+ + + T V+ T
Sbjct: 124 QLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR--IYSFQMALTSVVVT 178
Query: 368 FG 369
Sbjct: 179 LW 180
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (308), Expect = 1e-32
Identities = 35/166 (21%), Positives = 72/166 (43%), Gaps = 8/166 (4%)
Query: 201 TDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGERE-FQAEIEIISQVHHR 258
++ + +G+G +G V N VAIK++ Q + EI+I+ + H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 259 HLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHG--KDRPVMNWPTRMKIALGSARGLAYL 316
+++ + + + ++ + L+ K + ++ RGL Y+
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-LSNDHICYFLYQILRGLKYI 125
Query: 317 HEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 362
H ++HRD+K +N+LL+ + + K+ DFGLA+ + H
Sbjct: 126 HS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 168
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (303), Expect = 2e-32
Identities = 48/168 (28%), Positives = 79/168 (47%), Gaps = 12/168 (7%)
Query: 208 NLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGSGQG-----EREFQAEIEIISQVHHRHLV 261
+ LG+G F V+K N ++VAIK++K G R EI+++ ++ H +++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 262 SLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQ 321
L+ S LV++F+ + L + +GL YLH+
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLV--LTPSHIKAYMLMTLQGLEYLHQHW- 120
Query: 322 PKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFG 369
I+HRD+K N+LLD++ K+ADFGLAK S + T + T
Sbjct: 121 --ILHRDLKPNNLLLDENGVLKLADFGLAK-SFGSPNRAYTHQVVTRW 165
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 3e-32
Identities = 44/173 (25%), Positives = 69/173 (39%), Gaps = 11/173 (6%)
Query: 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGERE---FQAEIEIIS-QVH 256
++F +LG+G FG V + AIK LK + + E ++S
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 257 HRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYL 316
H L + V E++ L +H+ + + A GL +L
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFL 119
Query: 317 HEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFG 369
H I++RD+K NILLD K+ADFG+ K ++ D +T GT
Sbjct: 120 HS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPD 168
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 119 bits (299), Expect = 6e-32
Identities = 47/179 (26%), Positives = 82/179 (45%), Gaps = 15/179 (8%)
Query: 201 TDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGE---REFQAEIEIISQVH 256
+D + +LG GG VH L + VA+K L+A + F+ E + + ++
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 257 HRHLVSLVGYC----TFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARG 312
H +V++ G +V E+V TL +H + M +++ + +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQA 123
Query: 313 LAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV--STRVMGTFG 369
L + H+ IIHRD+K ANI++ + KV DFG+A+ D+ V + V+GT
Sbjct: 124 LNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 4e-31
Identities = 40/174 (22%), Positives = 63/174 (36%), Gaps = 10/174 (5%)
Query: 198 KIATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLK---AGSGQGEREFQAEIEIIS 253
K+ ++F LLG+G FG V G+ A+K L+ + E ++
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 254 QVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGL 313
H L +L + V E+ L FHL + A +
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV--FTEERARFYG---AEIV 115
Query: 314 AYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGT 367
+ L +++RDIK N++LD K+ DFGL K + GT
Sbjct: 116 SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGT 168
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 115 bits (288), Expect = 3e-30
Identities = 38/177 (21%), Positives = 66/177 (37%), Gaps = 13/177 (7%)
Query: 196 ELKIATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQ 254
EL++ + + +G G FG ++ G + G+ VAIK + + E +I
Sbjct: 2 ELRVG-NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKM 58
Query: 255 VHHRHLVSLVGYC-TFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGL 313
+ + + +C G ++V E + + + + T + +A +
Sbjct: 59 MQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRI 116
Query: 314 AYLHEDCQPKIIHRDIKSANIL---LDDSFEAKVADFGLAKHSLDTDTHVSTRVMGT 367
Y+H IHRD+K N L + DFGLAK D TH
Sbjct: 117 EYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYREN 170
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 8e-30
Identities = 34/171 (19%), Positives = 71/171 (41%), Gaps = 8/171 (4%)
Query: 202 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAG--SGQGEREFQAEIEIISQVHHR 258
+ + +G+G +G V K ++VA+K+++ EI ++ ++ H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 259 HLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHE 318
++V L + LV+EF ++ ++ + L L
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS--CNGDLDPEIVKSFL---FQLLKGLGF 116
Query: 319 DCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFG 369
++HRD+K N+L++ + E K+A+FGLA+ S V+ +
Sbjct: 117 CHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWY 167
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 113 bits (284), Expect = 1e-29
Identities = 32/166 (19%), Positives = 56/166 (33%), Gaps = 14/166 (8%)
Query: 209 LLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHRHLVSLVGY 266
+G+G FG + +G L N + VAIK + + E + + ++ +
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEP--RRSDAPQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 267 CTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIH 326
G +LV + + L + T A + +H + +++
Sbjct: 70 GQEGLHNVLVIDLLGP--SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVY 124
Query: 327 RDIKSANILLDDSF-----EAKVADFGLAKHSLDTDTHVSTRVMGT 367
RDIK N L+ V DFG+ K D T
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREK 170
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 2e-29
Identities = 34/163 (20%), Positives = 59/163 (36%), Gaps = 17/163 (10%)
Query: 209 LLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHRHLVSLVGY 266
+LG G G V + + A+K L+ + + E+E+ + H+V +V
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRIVDV 73
Query: 267 C----TFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQP 322
L+V E + L + + +I + YLH
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---I 130
Query: 323 KIIHRDIKSANILLDDSFE---AKVADFGLAKHSLDTDTHVST 362
I HRD+K N+L K+ DFG AK + ++ +
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP 173
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (283), Expect = 2e-29
Identities = 43/182 (23%), Positives = 82/182 (45%), Gaps = 19/182 (10%)
Query: 202 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQG--EREFQAEIEIISQVHHR 258
+ + +GQG FG V K G+ VA+K++ + + EI+I+ + H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 259 HLVSLVGYCTFGSQR--------LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSA 310
++V+L+ C + LV++F + + + ++ R+ L
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML--- 126
Query: 311 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH---SLDTDTHVSTRVMGT 367
L L+ + KI+HRD+K+AN+L+ K+ADFGLA+ + ++ + T + T
Sbjct: 127 --LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT 184
Query: 368 FG 369
Sbjct: 185 LW 186
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 1e-28
Identities = 41/171 (23%), Positives = 67/171 (39%), Gaps = 17/171 (9%)
Query: 209 LLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGERE------FQAEIEIISQVHHRH-- 259
LLG GGFG V+ G+ +++ VAIK ++ E E+ ++ +V
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 260 LVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHED 319
++ L+ + +L+ E F +R + + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHCHN- 128
Query: 320 CQPKIIHRDIKSANILLD-DSFEAKVADFGLAKHSLDTDTHVSTRVMGTFG 369
++HRDIK NIL+D + E K+ DFG DT T GT
Sbjct: 129 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY---TDFDGTRV 174
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 2e-28
Identities = 44/191 (23%), Positives = 72/191 (37%), Gaps = 21/191 (10%)
Query: 190 STFTYEELKIATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLK------AGSGQGE 242
+ F E + D + LG G F V K + G A K +K + G
Sbjct: 1 TVFRQENVD---DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSR 57
Query: 243 REFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTR 302
+ + E+ I+ ++ H ++++L + +L+ E V L L K+ +
Sbjct: 58 EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEA 115
Query: 303 MKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD----SFEAKVADFGLAKHSLDTDT 358
+ G+ YLH I H D+K NI+L D K+ DFGLA +
Sbjct: 116 TEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 172
Query: 359 HVSTRVMGTFG 369
+ GT
Sbjct: 173 F--KNIFGTPE 181
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 3e-28
Identities = 44/193 (22%), Positives = 79/193 (40%), Gaps = 23/193 (11%)
Query: 189 KSTFTYEELKIAT----DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAG--SGQG 241
+S F +E+ + + +G G +G V V G VAIK+L S
Sbjct: 1 RSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELF 60
Query: 242 EREFQAEIEIISQVHHRHLVSLVGYCTFGSQR------LLVYEFVPNKTLEFHLHGKDRP 295
+ E+ ++ + H +++ L+ T LV F+ + H K
Sbjct: 61 AKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK--- 117
Query: 296 VMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355
+ + +GL Y+H IIHRD+K N+ +++ E K+ DFGLA+
Sbjct: 118 -LGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQ--- 170
Query: 356 TDTHVSTRVMGTF 368
D+ ++ V+ +
Sbjct: 171 ADSEMTGYVVTRW 183
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 4e-28
Identities = 42/178 (23%), Positives = 73/178 (41%), Gaps = 14/178 (7%)
Query: 198 KIATDNFSEANLLGQGGFGYVHKGVLT----NGKVVAIKQLK----AGSGQGEREFQAEI 249
K+ +NF +LG G +G V GK+ A+K LK + + E
Sbjct: 20 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTER 79
Query: 250 EIISQV-HHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALG 308
+++ + LV+L ++ L+ +++ L HL ++R +
Sbjct: 80 QVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY----- 134
Query: 309 SARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMG 366
+ L + II+RDIK NILLD + + DFGL+K + +T + G
Sbjct: 135 VGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCG 192
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 109 bits (274), Expect = 8e-28
Identities = 43/163 (26%), Positives = 60/163 (36%), Gaps = 9/163 (5%)
Query: 202 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGERE---FQAEIEIISQVHH 257
D F LG G FG V +G A+K L ++ E I+ V+
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 258 RHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLH 317
LV L S +V E+V + HL R + P A YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLH 158
Query: 318 EDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 360
+I+RD+K N+L+D +V DFG AK +
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTL 198
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 104 bits (261), Expect = 3e-26
Identities = 37/187 (19%), Positives = 78/187 (41%), Gaps = 21/187 (11%)
Query: 189 KSTFTYEELKIAT---DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGERE 244
+ + YE + D++ LG+G + V + + +TN + V +K LK +++
Sbjct: 19 REYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKK 75
Query: 245 FQAEIEIISQV-HHRHLVSLVGYCTFGSQRL--LVYEFVPNKTLEFHLHGKDRPVMNWPT 301
+ EI+I+ + ++++L R LV+E V N + +
Sbjct: 76 IKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-----LTDYD 130
Query: 302 RMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLD-DSFEAKVADFGLAKHSLDTDTHV 360
+ L Y H I+HRD+K N+++D + + ++ D+GLA+ +
Sbjct: 131 IRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY- 186
Query: 361 STRVMGT 367
+ +
Sbjct: 187 -NVRVAS 192
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 99.5 bits (247), Expect = 2e-25
Identities = 26/154 (16%), Positives = 47/154 (30%), Gaps = 19/154 (12%)
Query: 208 NLLGQGGFGYVHKGVLTNGKVVAIKQLKAGS----------GQGEREFQAEIEIISQVHH 257
L+G+G V +K K G G+ F ++
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 258 RHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLH 317
R L L G VY + N L + K+ + ++ +A +
Sbjct: 66 RALQKLQGLAVPK-----VYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120
Query: 318 EDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351
I+H D+ N+L+ + + DF +
Sbjct: 121 HRG---IVHGDLSQYNVLVSE-EGIWIIDFPQSV 150
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (248), Expect = 2e-24
Identities = 37/189 (19%), Positives = 72/189 (38%), Gaps = 25/189 (13%)
Query: 194 YEELKIATDNFSEAN------LLGQGGFGYVHKGV-LTNGKVVAIKQLKAG--SGQGERE 244
+ +++ F+ +G G G V + VAIK+L + +
Sbjct: 3 FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKR 62
Query: 245 FQAEIEIISQVHHRHLVSLVGYCT------FGSQRLLVYEFVPNKTLEFHLHGKDRPVMN 298
E+ ++ V+H++++SL+ T LV E + + ++
Sbjct: 63 AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME-----LD 117
Query: 299 WPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 358
+ G+ +LH IHRD+K +NI++ K+ DFGLA+ +
Sbjct: 118 HERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLART--AGTS 172
Query: 359 HVSTRVMGT 367
+ T + T
Sbjct: 173 FMMTPYVVT 181
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.3 bits (228), Expect = 1e-21
Identities = 41/177 (23%), Positives = 71/177 (40%), Gaps = 20/177 (11%)
Query: 189 KSTFTYEELKIA----TDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAG--SGQG 241
+ TF +EL + + + +G G +G V G VA+K+L S
Sbjct: 1 RPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH 60
Query: 242 EREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKD------RP 295
+ E+ ++ + H +++ L+ T + L HL G D
Sbjct: 61 AKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY----LVTHLMGADLNNIVKCQ 116
Query: 296 VMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352
+ + RGL Y+H HRD+K +N+ +++ E K+ DFGLA+H
Sbjct: 117 KLTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARH 170
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 84.7 bits (208), Expect = 7e-19
Identities = 37/175 (21%), Positives = 66/175 (37%), Gaps = 24/175 (13%)
Query: 209 LLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHH---------- 257
LG G F V + N VA+K ++ E + EI+++ +V+
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEA-AEDEIKLLQRVNDADNTKEDSMG 78
Query: 258 -RHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLH---GKDRPVMNWPTRMKIALGSARGL 313
H++ L+ + + V E L + + +I+ GL
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 314 AYLHEDCQPKIIHRDIKSANILLD------DSFEAKVADFGLAKHSLDTDTHVST 362
Y+H + IIH DIK N+L++ + + K+AD G A + T+
Sbjct: 139 DYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 369 | |||
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 99.98 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 99.98 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 99.97 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 99.97 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 99.97 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 99.97 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 99.97 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 99.97 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 99.97 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 99.97 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.97 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.96 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.96 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.96 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.9 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 99.02 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.47 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.15 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.82 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.42 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.21 |
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.9e-39 Score=292.21 Aligned_cols=167 Identities=26% Similarity=0.387 Sum_probs=146.9
Q ss_pred HHHhhcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEE
Q 017558 197 LKIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 275 (369)
Q Consensus 197 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 275 (369)
+++..++|++.+.||+|+||.||+|++. +++.||||+++... ...++|.+|+++|++++|||||+++|+|.+.+..||
T Consensus 12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 90 (287)
T d1opja_ 12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 90 (287)
T ss_dssp TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEE
Confidence 3456678999999999999999999975 48899999997654 345789999999999999999999999999999999
Q ss_pred EEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 276 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 276 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
||||+++|+|.++|.......+++..+++|+.||+.||+|||++ +|+||||||+||||++++.+||+|||+|+....
T Consensus 91 v~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (287)
T d1opja_ 91 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 167 (287)
T ss_dssp EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred EeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCC
Confidence 99999999999999876666799999999999999999999998 999999999999999999999999999998766
Q ss_pred CCceeeeeeccc
Q 017558 356 TDTHVSTRVMGT 367 (369)
Q Consensus 356 ~~~~~~~~~~gt 367 (369)
..........||
T Consensus 168 ~~~~~~~~~~g~ 179 (287)
T d1opja_ 168 DTYTAHAGAKFP 179 (287)
T ss_dssp SSSEEETTEEEC
T ss_pred CCceeecccccc
Confidence 554444334444
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-39 Score=288.55 Aligned_cols=167 Identities=29% Similarity=0.450 Sum_probs=145.5
Q ss_pred HHHhhcCCcccceecccCceEEEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEE
Q 017558 197 LKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (369)
Q Consensus 197 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 276 (369)
+++..++|++.+.||+|+||.||+|+++++..||||+++... ...++|.+|+++|++++|||||+++|+|. ++..|||
T Consensus 8 wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv 85 (272)
T d1qpca_ 8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYII 85 (272)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEE
T ss_pred eecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeEEE
Confidence 344567899999999999999999999888999999997643 34568999999999999999999999885 4567999
Q ss_pred EEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCC
Q 017558 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 277 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~ 356 (369)
|||+++|+|.+++.......++|..+++|+.||+.||.|||++ +|+||||||+||||++++.+||+|||+|+...+.
T Consensus 86 ~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~ 162 (272)
T d1qpca_ 86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (272)
T ss_dssp EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred EEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCC
Confidence 9999999999988765544689999999999999999999998 9999999999999999999999999999988765
Q ss_pred CceeeeeecccC
Q 017558 357 DTHVSTRVMGTF 368 (369)
Q Consensus 357 ~~~~~~~~~gt~ 368 (369)
.........||+
T Consensus 163 ~~~~~~~~~gt~ 174 (272)
T d1qpca_ 163 EYTAREGAKFPI 174 (272)
T ss_dssp CEECCTTCCCCT
T ss_pred ccccccccCCcc
Confidence 544444456664
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-38 Score=281.56 Aligned_cols=162 Identities=31% Similarity=0.493 Sum_probs=132.9
Q ss_pred cCCcccceecccCceEEEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEecC
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVP 281 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 281 (369)
++|++.+.||+|+||.||+|++.+++.||||+++... ...++|.+|++++++++|||||+++|+|..++..|+||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 5788899999999999999999888999999997644 345789999999999999999999999999999999999999
Q ss_pred CCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCCCceee
Q 017558 282 NKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVS 361 (369)
Q Consensus 282 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~~~~~~ 361 (369)
+|+|.+++.... ..++|..++.|+.||+.||.|||++ +|+||||||+||||++++.+||+|||+++...+......
T Consensus 84 ~g~L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~ 159 (263)
T d1sm2a_ 84 HGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 159 (263)
T ss_dssp TCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred CCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCceee
Confidence 999999987653 4589999999999999999999998 999999999999999999999999999998766554444
Q ss_pred eeecccC
Q 017558 362 TRVMGTF 368 (369)
Q Consensus 362 ~~~~gt~ 368 (369)
....||+
T Consensus 160 ~~~~gt~ 166 (263)
T d1sm2a_ 160 TGTKFPV 166 (263)
T ss_dssp -----CT
T ss_pred cceecCc
Confidence 4455654
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-38 Score=281.32 Aligned_cols=163 Identities=26% Similarity=0.384 Sum_probs=140.4
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCc-ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEE
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 278 (369)
.++|++.+.||+|+||+||+|+.. +++.||||+++.... ...+.+.+|+++|++++|||||++++++.+++..|||||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 367999999999999999999974 588999999975432 234578999999999999999999999999999999999
Q ss_pred ecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCCCc
Q 017558 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 358 (369)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~~~ 358 (369)
|+++|+|.++|... ..+++.++..|+.||+.||+|||++ +|+||||||+||||++++.+||+|||+|+.....+.
T Consensus 84 y~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 84 YCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp CCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred ccCCCcHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence 99999999999754 3599999999999999999999998 999999999999999999999999999998654432
Q ss_pred -eeeeeecccC
Q 017558 359 -HVSTRVMGTF 368 (369)
Q Consensus 359 -~~~~~~~gt~ 368 (369)
...+..+||+
T Consensus 159 ~~~~~~~~GT~ 169 (271)
T d1nvra_ 159 ERLLNKMCGTL 169 (271)
T ss_dssp ECCBCCCCSCG
T ss_pred cccccceeeCc
Confidence 2334567876
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-37 Score=280.89 Aligned_cols=160 Identities=24% Similarity=0.372 Sum_probs=142.7
Q ss_pred cCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEec
Q 017558 202 DNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 280 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 280 (369)
++|++.+.||+|+||+||+|+. .+|+.||||+++.......+.+.+|+++|++++|||||++++++.+++..||||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 4799999999999999999995 468999999997665556678999999999999999999999999999999999999
Q ss_pred CCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCCCcee
Q 017558 281 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 360 (369)
Q Consensus 281 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~~~~~ 360 (369)
++|+|.+++... .+++.++..|+.||+.||+|||++ +|+||||||+||||+.++.+||+|||+|+.+..... .
T Consensus 100 ~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-~ 172 (293)
T d1yhwa1 100 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 172 (293)
T ss_dssp TTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-C
T ss_pred CCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccccc-c
Confidence 999999988653 489999999999999999999999 999999999999999999999999999998765443 2
Q ss_pred eeeecccC
Q 017558 361 STRVMGTF 368 (369)
Q Consensus 361 ~~~~~gt~ 368 (369)
....+||+
T Consensus 173 ~~~~~gt~ 180 (293)
T d1yhwa1 173 RSTMVGTP 180 (293)
T ss_dssp BCCCCSCG
T ss_pred ccccccCC
Confidence 34456775
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-37 Score=281.30 Aligned_cols=162 Identities=25% Similarity=0.387 Sum_probs=141.9
Q ss_pred cCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEec
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 280 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 280 (369)
+.|++.+.||+|+||.||+|+.. +++.||||+++.......+.+.+|+++|++++|||||++++++.+++..|||||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 56899999999999999999964 58899999998766666778999999999999999999999999999999999999
Q ss_pred CCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCCCcee
Q 017558 281 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 360 (369)
Q Consensus 281 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~~~~~ 360 (369)
++|+|.+++.... ..+++.++..|+.||+.||.|||++ +|+||||||+||||+.++.+||+|||+|+....... .
T Consensus 92 ~~g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~-~ 166 (288)
T d2jfla1 92 AGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-R 166 (288)
T ss_dssp TTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH-H
T ss_pred CCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCcc-c
Confidence 9999999976533 3589999999999999999999999 999999999999999999999999999987643321 1
Q ss_pred eeeecccC
Q 017558 361 STRVMGTF 368 (369)
Q Consensus 361 ~~~~~gt~ 368 (369)
.....||+
T Consensus 167 ~~~~~Gt~ 174 (288)
T d2jfla1 167 RDSFIGTP 174 (288)
T ss_dssp HTCCCSCC
T ss_pred cccccccc
Confidence 22345664
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-37 Score=280.67 Aligned_cols=163 Identities=31% Similarity=0.507 Sum_probs=134.3
Q ss_pred HhhcCCcccceecccCceEEEEEEEcCCeEEEEEeeccCC--cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEE
Q 017558 199 IATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (369)
Q Consensus 199 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 276 (369)
+..++|++.+.||+|+||.||+|++. ..||||+++... ....+.|.+|+++|.+++|||||+++|++. ++..+||
T Consensus 5 i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv 81 (276)
T d1uwha_ 5 IPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIV 81 (276)
T ss_dssp CCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred cccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEE
Confidence 45678999999999999999999864 359999987543 334568999999999999999999999985 4568999
Q ss_pred EEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCC
Q 017558 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 277 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~ 356 (369)
||||++|+|.++|+... ..+++..++.|+.||+.||+|||++ +||||||||+||||++++.+||+|||+|+.....
T Consensus 82 ~Ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 82 TQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp EECCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred EecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 99999999999997644 3599999999999999999999998 9999999999999999999999999999887653
Q ss_pred Cc-eeeeeecccC
Q 017558 357 DT-HVSTRVMGTF 368 (369)
Q Consensus 357 ~~-~~~~~~~gt~ 368 (369)
.. .......||+
T Consensus 158 ~~~~~~~~~~gt~ 170 (276)
T d1uwha_ 158 SGSHQFEQLSGSI 170 (276)
T ss_dssp --------CCCCG
T ss_pred CCcccccccccCc
Confidence 32 2334456765
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-36 Score=271.46 Aligned_cols=163 Identities=28% Similarity=0.411 Sum_probs=143.9
Q ss_pred hcCCcccceecccCceEEEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEec
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 280 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 280 (369)
.++|++.++||+|+||+||+|++++++.||||+++.... ..++|.+|++++++++||||++++|+|.+++..++||||+
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 368899999999999999999998888999999986543 4578999999999999999999999999999999999999
Q ss_pred CCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCCCcee
Q 017558 281 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 360 (369)
Q Consensus 281 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~~~~~ 360 (369)
++|+|..++.... ..+.+..+++|+.||++||+|||++ +|+||||||+|||+++++.+||+|||+++...+.+...
T Consensus 82 ~~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 157 (258)
T d1k2pa_ 82 ANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 157 (258)
T ss_dssp TTEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred CCCcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence 9999999976544 3588999999999999999999998 99999999999999999999999999999876655444
Q ss_pred eeeecccC
Q 017558 361 STRVMGTF 368 (369)
Q Consensus 361 ~~~~~gt~ 368 (369)
.....||+
T Consensus 158 ~~~~~~t~ 165 (258)
T d1k2pa_ 158 SVGSKFPV 165 (258)
T ss_dssp CCCSCCCG
T ss_pred ecccCCCC
Confidence 43445553
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-37 Score=280.95 Aligned_cols=164 Identities=29% Similarity=0.456 Sum_probs=135.9
Q ss_pred hhcCCcccceecccCceEEEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEe
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 279 (369)
..++|++.+.||+|+||+||+|+++++..||||+++... ...+.|.+|+.+|++++|+|||+++|+|. ++..|+||||
T Consensus 15 ~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey 92 (285)
T d1fmka3 15 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY 92 (285)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred CHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEe
Confidence 457899999999999999999999888899999997543 34578999999999999999999999985 5668999999
Q ss_pred cCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCCCce
Q 017558 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 359 (369)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~~~~ 359 (369)
+++|+|..++.......++|.+++.|+.||+.||.|||++ +|+||||||+|||||+++.+||+|||+|+...+....
T Consensus 93 ~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~ 169 (285)
T d1fmka3 93 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 169 (285)
T ss_dssp CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred cCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCce
Confidence 9999999998765545699999999999999999999998 9999999999999999999999999999987654433
Q ss_pred eeeeecccC
Q 017558 360 VSTRVMGTF 368 (369)
Q Consensus 360 ~~~~~~gt~ 368 (369)
......||+
T Consensus 170 ~~~~~~gt~ 178 (285)
T d1fmka3 170 ARQGAKFPI 178 (285)
T ss_dssp ------CCG
T ss_pred eeccccccc
Confidence 333345554
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-36 Score=271.54 Aligned_cols=159 Identities=30% Similarity=0.451 Sum_probs=139.7
Q ss_pred cCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC---cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEE
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 277 (369)
++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+++|++++|||||++++++.+++..||||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 67999999999999999999975 57899999986432 233567899999999999999999999999999999999
Q ss_pred EecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCCC
Q 017558 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (369)
Q Consensus 278 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~~ 357 (369)
||+++|+|.+++.... .+++..+..|+.||+.||+|||++ +|+||||||+||||++++.+||+|||+|+...+..
T Consensus 86 Ey~~~g~L~~~l~~~~--~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~ 160 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 160 (263)
T ss_dssp ECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC
T ss_pred eecCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCCc
Confidence 9999999999997543 489999999999999999999998 99999999999999999999999999998765443
Q ss_pred ceeeeeecccC
Q 017558 358 THVSTRVMGTF 368 (369)
Q Consensus 358 ~~~~~~~~gt~ 368 (369)
. ....||+
T Consensus 161 ~---~~~~Gt~ 168 (263)
T d2j4za1 161 R---TTLCGTL 168 (263)
T ss_dssp C---EETTEEG
T ss_pred c---cccCCCC
Confidence 2 3356765
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-37 Score=286.11 Aligned_cols=164 Identities=25% Similarity=0.375 Sum_probs=140.8
Q ss_pred HhhcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCc-ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEE
Q 017558 199 IATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (369)
Q Consensus 199 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 276 (369)
+..++|++.+.||+|+||.||+|+.. +|+.||+|+++.... ...+.+.+|+++|++++|||||+++++|.+++..|||
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV 82 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 82 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 34678999999999999999999964 689999999976533 3346789999999999999999999999999999999
Q ss_pred EEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCC
Q 017558 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 277 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~ 356 (369)
||||++|+|.+++.... .+++..+..++.||+.||.|||++. +|+||||||+||||++++.+||+|||+|+...+.
T Consensus 83 mEy~~gg~L~~~l~~~~--~l~~~~~~~~~~qil~aL~yLH~~~--~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 158 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158 (322)
T ss_dssp EECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred EEcCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHhC--CEEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence 99999999999997543 4899999999999999999999731 7999999999999999999999999999976532
Q ss_pred CceeeeeecccCC
Q 017558 357 DTHVSTRVMGTFG 369 (369)
Q Consensus 357 ~~~~~~~~~gt~g 369 (369)
. ....+||++
T Consensus 159 ~---~~~~~GT~~ 168 (322)
T d1s9ja_ 159 M---ANSFVGTRS 168 (322)
T ss_dssp T---C---CCSSC
T ss_pred c---cccccCCcc
Confidence 2 234577763
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-36 Score=274.65 Aligned_cols=162 Identities=23% Similarity=0.298 Sum_probs=138.4
Q ss_pred cCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC---cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEE
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 277 (369)
++|++.+.||+|+||+||+|+.. +++.||||+++... ....+.+.+|+++|++++||||+++++++.+++..||||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 67999999999999999999974 68899999986432 233467899999999999999999999999999999999
Q ss_pred EecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCCC
Q 017558 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (369)
Q Consensus 278 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~~ 357 (369)
||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||||++++.+||+|||+|+.+....
T Consensus 88 Ey~~gg~L~~~~~~~~--~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp CCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EccCCCCHHHhhhccC--CCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccCC
Confidence 9999999999987543 589999999999999999999999 99999999999999999999999999999875433
Q ss_pred -ceeeeeecccC
Q 017558 358 -THVSTRVMGTF 368 (369)
Q Consensus 358 -~~~~~~~~gt~ 368 (369)
.......+||+
T Consensus 163 ~~~~~~~~~GT~ 174 (288)
T d1uu3a_ 163 KQARANSFVGTA 174 (288)
T ss_dssp -------CCCCG
T ss_pred cccccccccCCc
Confidence 22334467775
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=9.1e-36 Score=276.95 Aligned_cols=162 Identities=26% Similarity=0.382 Sum_probs=142.9
Q ss_pred hcCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEe
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 279 (369)
.++|++.+.||+|+||.||+|+. .+|+.||||++......+.+.+.+|+++|++++|||||++++++.+++..||||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 46899999999999999999996 46899999999876656667899999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEC--CCCcEEEeeeccceeeCCCC
Q 017558 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLD--DSFEAKVADFGLAKHSLDTD 357 (369)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~--~~~~~ki~DFGla~~~~~~~ 357 (369)
|++|+|.+++.... ..+++..+..|+.||+.||+|||++ +||||||||+||||+ .++.+||+|||+|+......
T Consensus 105 ~~gg~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 105 MSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp CCSCBHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred CCCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 99999999996543 3599999999999999999999999 999999999999996 46789999999999876554
Q ss_pred ceeeeeecccC
Q 017558 358 THVSTRVMGTF 368 (369)
Q Consensus 358 ~~~~~~~~gt~ 368 (369)
. .....||+
T Consensus 181 ~--~~~~~gT~ 189 (350)
T d1koaa2 181 S--VKVTTGTA 189 (350)
T ss_dssp C--EEEECSCT
T ss_pred c--cceecCcc
Confidence 3 23456765
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.9e-36 Score=273.93 Aligned_cols=152 Identities=32% Similarity=0.511 Sum_probs=127.1
Q ss_pred hcCCcccceecccCceEEEEEEEcC-C---eEEEEEeeccCCc-ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEE
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLTN-G---KVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 275 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~~-~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 275 (369)
.++|++.++||+|+||+||+|++.. + ..||||++..... ...++|.+|+++|++++|||||+++|+|...+..||
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 3567778999999999999999742 2 3689998876543 345689999999999999999999999999999999
Q ss_pred EEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 276 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 276 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
|||||++|+|.+++.... ..++|.+++.|+.||+.||.|||++ +|+||||||+||||+.++.+||+|||+|+...+
T Consensus 105 v~Ey~~~g~L~~~~~~~~-~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp EEECCTTEEHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEEecCCCcceeeecccc-CCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEccC
Confidence 999999999999887643 3589999999999999999999998 999999999999999999999999999998765
Q ss_pred C
Q 017558 356 T 356 (369)
Q Consensus 356 ~ 356 (369)
.
T Consensus 181 ~ 181 (299)
T d1jpaa_ 181 D 181 (299)
T ss_dssp -
T ss_pred C
Confidence 4
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.4e-35 Score=275.86 Aligned_cols=162 Identities=27% Similarity=0.382 Sum_probs=142.0
Q ss_pred hcCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEe
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 279 (369)
.++|++.+.||+|+||.||+|+. .+|+.||||+++.....+.+.+.+|+++|++++|||||++++++.+++..||||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 36799999999999999999996 46899999999876655566889999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEC--CCCcEEEeeeccceeeCCCC
Q 017558 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLD--DSFEAKVADFGLAKHSLDTD 357 (369)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~--~~~~~ki~DFGla~~~~~~~ 357 (369)
|++|+|.+++.... ..+++.++..|+.||+.||+|||++ +|+||||||+||||+ .++.+||+|||+|+......
T Consensus 108 ~~gg~L~~~~~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 108 LSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183 (352)
T ss_dssp CCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCCChHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCCC
Confidence 99999998876543 3589999999999999999999998 999999999999998 67899999999999876544
Q ss_pred ceeeeeecccC
Q 017558 358 THVSTRVMGTF 368 (369)
Q Consensus 358 ~~~~~~~~gt~ 368 (369)
. .....||+
T Consensus 184 ~--~~~~~gt~ 192 (352)
T d1koba_ 184 I--VKVTTATA 192 (352)
T ss_dssp C--EEEECSSG
T ss_pred c--eeeccCcc
Confidence 3 23345554
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-36 Score=272.52 Aligned_cols=168 Identities=21% Similarity=0.348 Sum_probs=128.6
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCc--ccHHHHHHHHHHHHhcCCCccccEeeEEEe--CCeeEE
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTF--GSQRLL 275 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~l 275 (369)
.++|++.+.||+|+||.||+|+.. +|+.||||+++.... ...+.+.+|+++|++++|||||++++++.+ .+..||
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 368999999999999999999964 588999999976532 234578999999999999999999999965 456899
Q ss_pred EEEecCCCcHhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeeecCCCCCcEEECCCCcEEEeeeccce
Q 017558 276 VYEFVPNKTLEFHLHGK--DRPVMNWPTRMKIALGSARGLAYLHEDC--QPKIIHRDIKSANILLDDSFEAKVADFGLAK 351 (369)
Q Consensus 276 v~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~yLH~~~--~~~ivHrdlk~~Nill~~~~~~ki~DFGla~ 351 (369)
||||+++|+|.+++... ....+++..++.++.||+.||+|||++. ..+|+||||||+||||+.++.+||+|||+|+
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 99999999999998642 2346999999999999999999999862 1249999999999999999999999999999
Q ss_pred eeCCCCceeeeeecccCC
Q 017558 352 HSLDTDTHVSTRVMGTFG 369 (369)
Q Consensus 352 ~~~~~~~~~~~~~~gt~g 369 (369)
...+... ......||++
T Consensus 163 ~~~~~~~-~~~~~~gt~~ 179 (269)
T d2java1 163 ILNHDTS-FAKAFVGTPY 179 (269)
T ss_dssp HC------------CCCS
T ss_pred ecccCCC-ccccCCCCcc
Confidence 8765432 3344677763
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-35 Score=267.93 Aligned_cols=154 Identities=33% Similarity=0.506 Sum_probs=133.6
Q ss_pred hhcCCcccce-ecccCceEEEEEEEc---CCeEEEEEeeccCCcc-cHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeE
Q 017558 200 ATDNFSEANL-LGQGGFGYVHKGVLT---NGKVVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRL 274 (369)
Q Consensus 200 ~~~~~~~~~~-lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 274 (369)
..++|.+.+. ||+|+||.||+|.++ ++..||||+++..... ..++|.+|+++|++++|||||+++|+|.. +..|
T Consensus 6 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~ 84 (285)
T d1u59a_ 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM 84 (285)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEE
T ss_pred cccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEE
Confidence 3466777775 999999999999864 3557999999765433 45689999999999999999999999964 5689
Q ss_pred EEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 275 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 275 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
||||||++|+|.+++.... ..+++..+++|+.||+.||+|||++ +|+||||||+||||+.++.+||+|||+|+...
T Consensus 85 lvmE~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 85 LVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EEEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEEeCCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhccc
Confidence 9999999999999986543 3589999999999999999999998 99999999999999999999999999999887
Q ss_pred CCCc
Q 017558 355 DTDT 358 (369)
Q Consensus 355 ~~~~ 358 (369)
..+.
T Consensus 161 ~~~~ 164 (285)
T d1u59a_ 161 ADDS 164 (285)
T ss_dssp TCSC
T ss_pred cccc
Confidence 6543
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-36 Score=275.88 Aligned_cols=162 Identities=26% Similarity=0.351 Sum_probs=142.5
Q ss_pred hcCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCC---cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEE
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 276 (369)
.++|++.+.||+|+||.||+|+. .+++.||||++++.. ....+.+.+|+.+|++++||||+++++++.+++..|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 46899999999999999999996 468999999997532 23456788999999999999999999999999999999
Q ss_pred EEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCC
Q 017558 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 277 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~ 356 (369)
||||++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+|+.....
T Consensus 84 ~ey~~gg~L~~~~~~~~--~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 84 MEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eeccCCCchhhhhhccc--CCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 99999999999997643 488999999999999999999999 9999999999999999999999999999987654
Q ss_pred CceeeeeecccC
Q 017558 357 DTHVSTRVMGTF 368 (369)
Q Consensus 357 ~~~~~~~~~gt~ 368 (369)
.. .....+||+
T Consensus 159 ~~-~~~~~~GT~ 169 (337)
T d1o6la_ 159 GA-TMKTFCGTP 169 (337)
T ss_dssp TC-CBCCCEECG
T ss_pred Cc-ccccceeCH
Confidence 43 234467776
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-35 Score=272.00 Aligned_cols=148 Identities=28% Similarity=0.398 Sum_probs=132.7
Q ss_pred CCcccceecccCceEEEEEEE-cCCeEEEEEeeccCCcc---cHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEE
Q 017558 203 NFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQ---GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (369)
Q Consensus 203 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 278 (369)
.|+..+.||+|+||.||+|+. .+++.||||+++..... ..+.+.+|+++|++++|||||+++++|.+++..|||||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 488899999999999999996 46889999999765432 23568899999999999999999999999999999999
Q ss_pred ecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
||++|+|..++... ..+++.++..|+.||+.||.|||++ +|+||||||+||||++++.+||+|||+|+....
T Consensus 96 ~~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 96 YCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp CCSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred ecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 99999998776543 3589999999999999999999999 999999999999999999999999999987654
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-36 Score=269.48 Aligned_cols=152 Identities=31% Similarity=0.489 Sum_probs=129.6
Q ss_pred hcCCcccceecccCceEEEEEEEcCC-----eEEEEEeeccCCcc-cHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeE
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLTNG-----KVVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRL 274 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~~~-----~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 274 (369)
.+.|+..++||+|+||.||+|.++.. ..||||+++..... ...+|.+|+++|.+++|||||+++|+|...+..+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 35688899999999999999997542 47999999765433 3457999999999999999999999999999999
Q ss_pred EEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 275 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 275 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
+||||+.+++|.+++.... ..++|.++++|+.||+.||+|||++ +|+||||||+||||+.++.+||+|||+|+...
T Consensus 86 ~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 86 IITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEEecccCcchhhhhccc-ccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhccc
Confidence 9999999999999886543 4599999999999999999999998 99999999999999999999999999999875
Q ss_pred CC
Q 017558 355 DT 356 (369)
Q Consensus 355 ~~ 356 (369)
+.
T Consensus 162 ~~ 163 (283)
T d1mqba_ 162 DD 163 (283)
T ss_dssp --
T ss_pred CC
Confidence 54
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-35 Score=274.42 Aligned_cols=167 Identities=25% Similarity=0.436 Sum_probs=138.9
Q ss_pred HhhcCCcccceecccCceEEEEEEEcCC------eEEEEEeeccCC-cccHHHHHHHHHHHHhc-CCCccccEeeEEEeC
Q 017558 199 IATDNFSEANLLGQGGFGYVHKGVLTNG------KVVAIKQLKAGS-GQGEREFQAEIEIISQV-HHRHLVSLVGYCTFG 270 (369)
Q Consensus 199 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~~------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~ 270 (369)
+..++|++.++||+|+||+||+|++... ..||||.+.... ......+.+|+.+|.++ +|||||+++++|.+.
T Consensus 34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 113 (325)
T d1rjba_ 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 113 (325)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence 4567899999999999999999996432 368999986543 33446799999999998 899999999999999
Q ss_pred CeeEEEEEecCCCcHhhhhcCCCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCC
Q 017558 271 SQRLLVYEFVPNKTLEFHLHGKDR---------------------PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDI 329 (369)
Q Consensus 271 ~~~~lv~e~~~~g~L~~~l~~~~~---------------------~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdl 329 (369)
+..|||||||++|+|.++|+.... ..+++..++.|+.||+.||+|||++ +||||||
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDl 190 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDL 190 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTC
T ss_pred CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccC
Confidence 999999999999999999976431 3489999999999999999999998 9999999
Q ss_pred CCCcEEECCCCcEEEeeeccceeeCCCCce-eeeeecccC
Q 017558 330 KSANILLDDSFEAKVADFGLAKHSLDTDTH-VSTRVMGTF 368 (369)
Q Consensus 330 k~~Nill~~~~~~ki~DFGla~~~~~~~~~-~~~~~~gt~ 368 (369)
||+|||++.++.+||+|||+|+........ ......||+
T Consensus 191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~ 230 (325)
T d1rjba_ 191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPV 230 (325)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECG
T ss_pred chhccccccCCeEEEeeccccccccCCCceeeeccccCCC
Confidence 999999999999999999999986654432 333455664
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-35 Score=264.70 Aligned_cols=155 Identities=28% Similarity=0.408 Sum_probs=128.9
Q ss_pred ceecccCceEEEEEEEcC---CeEEEEEeeccCCc--ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEecCC
Q 017558 208 NLLGQGGFGYVHKGVLTN---GKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPN 282 (369)
Q Consensus 208 ~~lg~G~fg~Vy~~~~~~---~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 282 (369)
++||+|+||.||+|.+++ ++.||||+++.... ...++|.+|+++|++++|||||+++|+|.. +..||||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 579999999999998653 46899999975432 234579999999999999999999999964 567899999999
Q ss_pred CcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCCCceee-
Q 017558 283 KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVS- 361 (369)
Q Consensus 283 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~~~~~~- 361 (369)
|+|.++++.. ..+++..++.|+.||+.||+|||++ +|+||||||+||||+.++.+||+|||+|+..........
T Consensus 92 g~L~~~l~~~--~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 166 (277)
T d1xbba_ 92 GPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 166 (277)
T ss_dssp EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred CcHHHHHhhc--cCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence 9999999764 3489999999999999999999998 999999999999999999999999999998765543322
Q ss_pred -eeecccC
Q 017558 362 -TRVMGTF 368 (369)
Q Consensus 362 -~~~~gt~ 368 (369)
....||+
T Consensus 167 ~~~~~gt~ 174 (277)
T d1xbba_ 167 QTHGKWPV 174 (277)
T ss_dssp ----CCCG
T ss_pred ccccCCCc
Confidence 2245554
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-35 Score=264.42 Aligned_cols=159 Identities=28% Similarity=0.350 Sum_probs=132.6
Q ss_pred cccceecccCceEEEEEEEc-CCeEEEEEeeccCC--cccHHHHHHHHHHHHhcCCCccccEeeEEEe----CCeeEEEE
Q 017558 205 SEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTF----GSQRLLVY 277 (369)
Q Consensus 205 ~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~~lv~ 277 (369)
++.+.||+|+||+||+|+.. +++.||+|++.... ....+.|.+|+++|++++|||||+++++|.. ....||||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 56678999999999999975 57899999986543 2344578999999999999999999999875 34679999
Q ss_pred EecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEC-CCCcEEEeeeccceeeCCC
Q 017558 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLD-DSFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 278 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~-~~~~~ki~DFGla~~~~~~ 356 (369)
||+++|+|.+++... ..+++..+..|+.||+.||+|||++ ..+|+||||||+||||+ +++.+||+|||+|+.....
T Consensus 92 E~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~ 168 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 168 (270)
T ss_dssp ECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred eCCCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC
Confidence 999999999999754 3589999999999999999999998 11399999999999996 5789999999999865433
Q ss_pred CceeeeeecccCC
Q 017558 357 DTHVSTRVMGTFG 369 (369)
Q Consensus 357 ~~~~~~~~~gt~g 369 (369)
. ....+||+.
T Consensus 169 ~---~~~~~GT~~ 178 (270)
T d1t4ha_ 169 F---AKAVIGTPE 178 (270)
T ss_dssp S---BEESCSSCC
T ss_pred c---cCCcccCcc
Confidence 2 234678763
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4.9e-35 Score=263.56 Aligned_cols=160 Identities=26% Similarity=0.349 Sum_probs=139.2
Q ss_pred cCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCCcc---------cHHHHHHHHHHHHhcC-CCccccEeeEEEeC
Q 017558 202 DNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQ---------GEREFQAEIEIISQVH-HRHLVSLVGYCTFG 270 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~ 270 (369)
++|++.+.||+|+||+||+|+. .+++.||||+++..... ..+.+.+|+.+|++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 6899999999999999999996 46899999998654321 1235789999999997 99999999999999
Q ss_pred CeeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccc
Q 017558 271 SQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLA 350 (369)
Q Consensus 271 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla 350 (369)
+..|||||||++|+|.++|..+. .+++.++..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||++
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a 157 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFS 157 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred cceEEEEEcCCCchHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchhe
Confidence 99999999999999999997543 589999999999999999999998 9999999999999999999999999999
Q ss_pred eeeCCCCceeeeeecccC
Q 017558 351 KHSLDTDTHVSTRVMGTF 368 (369)
Q Consensus 351 ~~~~~~~~~~~~~~~gt~ 368 (369)
+...... ..+...||+
T Consensus 158 ~~~~~~~--~~~~~~gt~ 173 (277)
T d1phka_ 158 CQLDPGE--KLREVCGTP 173 (277)
T ss_dssp EECCTTC--CBCCCCSCG
T ss_pred eEccCCC--ceeeeeccC
Confidence 9875432 223355664
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.1e-35 Score=269.78 Aligned_cols=159 Identities=30% Similarity=0.373 Sum_probs=140.3
Q ss_pred cCCcccceecccCceEEEEEEE-cCCeEEEEEeeccC---CcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEE
Q 017558 202 DNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAG---SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 277 (369)
++|++.+.||+|+||+||+|+. .+|+.||||+++.. .....+.+.+|+.+|++++|||||++++++.+.+..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 5799999999999999999996 45899999999643 2234567899999999999999999999999999999999
Q ss_pred EecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCCC
Q 017558 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (369)
Q Consensus 278 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~~ 357 (369)
|||++|+|..++.... .+.+..+..++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+|+...+..
T Consensus 84 E~~~gg~l~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~ 158 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT 158 (316)
T ss_dssp CCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB
T ss_pred eecCCccccccccccc--cccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecccc
Confidence 9999999999987653 478889999999999999999998 99999999999999999999999999999876543
Q ss_pred ceeeeeecccCC
Q 017558 358 THVSTRVMGTFG 369 (369)
Q Consensus 358 ~~~~~~~~gt~g 369 (369)
...+||++
T Consensus 159 ----~~~~Gt~~ 166 (316)
T d1fota_ 159 ----YTLCGTPD 166 (316)
T ss_dssp ----CCCCSCTT
T ss_pred ----ccccCccc
Confidence 34677763
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.2e-35 Score=269.67 Aligned_cols=162 Identities=25% Similarity=0.352 Sum_probs=124.9
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCc-ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEE
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 278 (369)
.+.|++.+.||+|+||+||+|+.. +++.||||++..... ...+.+.+|+++|++++|||||++++++.+++..|||||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 467999999999999999999975 588999999975432 233568899999999999999999999999999999999
Q ss_pred ecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEC---CCCcEEEeeeccceeeCC
Q 017558 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLD---DSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~---~~~~~ki~DFGla~~~~~ 355 (369)
||++|+|.++|... ..+++..+..|+.||+.||+|||++ +|+||||||+|||+. +++.+||+|||+|+....
T Consensus 88 ~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~ 162 (307)
T d1a06a_ 88 LVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 162 (307)
T ss_dssp CCCSCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred ccCCCcHHHhhhcc--cCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence 99999999999764 3599999999999999999999999 999999999999994 578999999999987654
Q ss_pred CCceeeeeecccCC
Q 017558 356 TDTHVSTRVMGTFG 369 (369)
Q Consensus 356 ~~~~~~~~~~gt~g 369 (369)
... ....+||++
T Consensus 163 ~~~--~~~~~GT~~ 174 (307)
T d1a06a_ 163 GSV--LSTACGTPG 174 (307)
T ss_dssp ------------CT
T ss_pred CCe--eeeeeeCcc
Confidence 432 234567763
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-34 Score=263.35 Aligned_cols=151 Identities=26% Similarity=0.347 Sum_probs=135.2
Q ss_pred hcCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCCc------ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCee
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSG------QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQR 273 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 273 (369)
.++|++.+.||+|+||.||+|+. .+|+.||||+++.... ...+.+.+|+++|++++|||||+++++|.+++..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 46799999999999999999997 4688999999865321 2356899999999999999999999999999999
Q ss_pred EEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCC----cEEEeeecc
Q 017558 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF----EAKVADFGL 349 (369)
Q Consensus 274 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~----~~ki~DFGl 349 (369)
|||||||++|+|.++|.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEEcCCCccccchhcccc--ccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchhh
Confidence 99999999999999997543 599999999999999999999999 999999999999998776 599999999
Q ss_pred ceeeCCC
Q 017558 350 AKHSLDT 356 (369)
Q Consensus 350 a~~~~~~ 356 (369)
|+.....
T Consensus 164 a~~~~~~ 170 (293)
T d1jksa_ 164 AHKIDFG 170 (293)
T ss_dssp CEECTTS
T ss_pred hhhcCCC
Confidence 9987544
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-35 Score=266.19 Aligned_cols=165 Identities=25% Similarity=0.392 Sum_probs=127.8
Q ss_pred HhhcCCcccceecccCceEEEEEEEcC----CeEEEEEeeccCCcc-cHHHHHHHHHHHHhcCCCccccEeeEEEeCCee
Q 017558 199 IATDNFSEANLLGQGGFGYVHKGVLTN----GKVVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQR 273 (369)
Q Consensus 199 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 273 (369)
+..++|++.+.||+|+||.||+|++.. +..||||.++..... ..+.|.+|+++|++++|||||+++|+|. ++..
T Consensus 4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 82 (273)
T d1mp8a_ 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 82 (273)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeE
Confidence 446789999999999999999998643 356899998765433 3457999999999999999999999996 5678
Q ss_pred EEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceee
Q 017558 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (369)
Q Consensus 274 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~ 353 (369)
|+||||+++|+|.+++.... ..+++..++.++.||+.||.|||++ +|+||||||+|||+++++.+||+|||+|+..
T Consensus 83 ~iv~E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp EEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEEEeccCCcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheec
Confidence 99999999999999876543 4589999999999999999999999 9999999999999999999999999999987
Q ss_pred CCCCceeeeeecccC
Q 017558 354 LDTDTHVSTRVMGTF 368 (369)
Q Consensus 354 ~~~~~~~~~~~~gt~ 368 (369)
........+...||+
T Consensus 159 ~~~~~~~~~~~~gt~ 173 (273)
T d1mp8a_ 159 EDSTYYKASKGKLPI 173 (273)
T ss_dssp ------------CCG
T ss_pred cCCcceeccceecCc
Confidence 665544445556664
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-34 Score=264.23 Aligned_cols=152 Identities=24% Similarity=0.345 Sum_probs=135.7
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEe
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 279 (369)
.++|++.+.||+|+||.||+|... +++.||||.++... .+...+.+|+++|++++|||||++++++.+++..||||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 478999999999999999999975 68899999997653 3345688999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECC--CCcEEEeeeccceeeCCCC
Q 017558 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD--SFEAKVADFGLAKHSLDTD 357 (369)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~--~~~~ki~DFGla~~~~~~~ 357 (369)
|++|+|.++|.... ..+++.++..|+.||+.||+|||++ +|+||||||+|||++. ...+||+|||+++.....+
T Consensus 83 ~~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~ 158 (321)
T d1tkia_ 83 ISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred CCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccCC
Confidence 99999999997543 3589999999999999999999998 9999999999999984 4589999999999876544
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3e-35 Score=268.48 Aligned_cols=160 Identities=28% Similarity=0.505 Sum_probs=140.7
Q ss_pred HHHHHHhhcCCcccceecccCceEEEEEEEc------CCeEEEEEeeccCCcc-cHHHHHHHHHHHHhcCCCccccEeeE
Q 017558 194 YEELKIATDNFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVSLVGY 266 (369)
Q Consensus 194 ~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~ 266 (369)
+.++++..++|++.+.||+|+||.||+|++. +++.||||+++..... ..++|.+|+++|++++||||++++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 4456677889999999999999999999974 3478999999765433 34579999999999999999999999
Q ss_pred EEeCCeeEEEEEecCCCcHhhhhcCCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 017558 267 CTFGSQRLLVYEFVPNKTLEFHLHGKD----------------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKI 324 (369)
Q Consensus 267 ~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~i 324 (369)
|...+..+++|||+++|+|.++|+... ...+++..++.|+.||+.||+|||++ ++
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~i 161 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KF 161 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---Ce
Confidence 999999999999999999999996421 23488999999999999999999998 99
Q ss_pred eecCCCCCcEEECCCCcEEEeeeccceeeCCC
Q 017558 325 IHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 325 vHrdlk~~Nill~~~~~~ki~DFGla~~~~~~ 356 (369)
|||||||+|||||.++.+||+|||+|+...+.
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~ 193 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSA 193 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGG
T ss_pred EeeEEcccceEECCCCcEEEccchhheeccCC
Confidence 99999999999999999999999999876543
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.3e-34 Score=267.60 Aligned_cols=158 Identities=28% Similarity=0.302 Sum_probs=139.4
Q ss_pred cCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC---cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEE
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 277 (369)
++|++.+.||+|+||.||+|+.+ +|+.||||++.... ....+.+.+|+++|++++|||||++++++......++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 67999999999999999999974 68999999986432 233467899999999999999999999999999999999
Q ss_pred EecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCCC
Q 017558 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (369)
Q Consensus 278 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~~ 357 (369)
||+.+|+|..++.... .+++..+..|+.||+.||.|||++ +||||||||+||||+.++.+||+|||+|+......
T Consensus 121 e~~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~ 195 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195 (350)
T ss_dssp ECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB
T ss_pred ccccccchhhhHhhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccccc
Confidence 9999999999997643 489999999999999999999999 99999999999999999999999999999876433
Q ss_pred ceeeeeecccC
Q 017558 358 THVSTRVMGTF 368 (369)
Q Consensus 358 ~~~~~~~~gt~ 368 (369)
....||+
T Consensus 196 ----~~~~Gt~ 202 (350)
T d1rdqe_ 196 ----WTLCGTP 202 (350)
T ss_dssp ----CCCEECG
T ss_pred ----ccccCcc
Confidence 2345664
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-34 Score=260.88 Aligned_cols=162 Identities=25% Similarity=0.401 Sum_probs=134.9
Q ss_pred cCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCCc--ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEE
Q 017558 202 DNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 278 (369)
++|++.+.||+|+||.||+|+. .+++.||||+++.... ...+.+.+|+++|++++|||||++++++.+.+..|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 6899999999999999999996 4689999999965432 234678999999999999999999999999999999999
Q ss_pred ecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCCCc
Q 017558 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 358 (369)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~~~ 358 (369)
|+.++.+ +++.......+++..+..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+.......
T Consensus 82 ~~~~~~~-~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~ 157 (298)
T d1gz8a_ 82 FLHQDLK-KFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 157 (298)
T ss_dssp CCSEEHH-HHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB
T ss_pred ecCCchh-hhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCcc
Confidence 9975544 444444445699999999999999999999999 999999999999999999999999999988765432
Q ss_pred eeeeeecccC
Q 017558 359 HVSTRVMGTF 368 (369)
Q Consensus 359 ~~~~~~~gt~ 368 (369)
. .....||+
T Consensus 158 ~-~~~~~gt~ 166 (298)
T d1gz8a_ 158 T-YTHEVVTL 166 (298)
T ss_dssp C-TTCCBCCC
T ss_pred c-ceeecccc
Confidence 2 22345554
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3e-34 Score=268.15 Aligned_cols=160 Identities=26% Similarity=0.349 Sum_probs=135.3
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC---cccHHHHHH---HHHHHHhcCCCccccEeeEEEeCCee
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQA---EIEIISQVHHRHLVSLVGYCTFGSQR 273 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~---E~~~l~~l~h~niv~l~g~~~~~~~~ 273 (369)
.++|++.++||+|+||.||+|+.. +|+.||||++.... ......+.+ |+++++.++|||||++++++.+.+..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 368999999999999999999965 58999999986432 112233444 46677778899999999999999999
Q ss_pred EEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceee
Q 017558 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (369)
Q Consensus 274 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~ 353 (369)
|||||||++|+|.++|... ..+++..+..|+.||+.||.|||++ +|+||||||+||||+.++.+||+|||+|+.+
T Consensus 83 ~ivmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEEECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEEecCCCcHHHHHHhc--ccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 9999999999999999764 3488999999999999999999999 9999999999999999999999999999987
Q ss_pred CCCCceeeeeecccC
Q 017558 354 LDTDTHVSTRVMGTF 368 (369)
Q Consensus 354 ~~~~~~~~~~~~gt~ 368 (369)
..... ...+||+
T Consensus 158 ~~~~~---~~~~GT~ 169 (364)
T d1omwa3 158 SKKKP---HASVGTH 169 (364)
T ss_dssp SSSCC---CSCCSCG
T ss_pred CCCcc---ccccccc
Confidence 65432 3346765
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-35 Score=260.83 Aligned_cols=151 Identities=29% Similarity=0.482 Sum_probs=128.0
Q ss_pred hhcCCcccceecccCceEEEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEe-CCeeEEEEE
Q 017558 200 ATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTF-GSQRLLVYE 278 (369)
Q Consensus 200 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lv~e 278 (369)
..++|++.+.||+|+||.||+|++ .|..||||+++... ..++|.+|+++|++++||||++++|+|.+ ++..|||||
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e 81 (262)
T d1byga_ 5 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 81 (262)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred CHHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEe
Confidence 456788899999999999999998 47889999997543 34689999999999999999999999965 456899999
Q ss_pred ecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCC
Q 017558 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~ 356 (369)
|+++|+|.++|+......++|..+++|+.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 y~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~ 156 (262)
T d1byga_ 82 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 156 (262)
T ss_dssp CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCC
Confidence 99999999999765444589999999999999999999998 9999999999999999999999999999976543
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-34 Score=262.03 Aligned_cols=161 Identities=27% Similarity=0.391 Sum_probs=137.7
Q ss_pred cCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCC---cccHHHHHHHHHHHH-hcCCCccccEeeEEEeCCeeEEE
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIIS-QVHHRHLVSLVGYCTFGSQRLLV 276 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~h~niv~l~g~~~~~~~~~lv 276 (369)
++|++.+.||+|+||+||+|+.. +++.||||+++... ....+.+..|+.++. .++|||||++++++.+++..|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 68999999999999999999974 58999999996532 233456677777765 68999999999999999999999
Q ss_pred EEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCC
Q 017558 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (369)
Q Consensus 277 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~ 356 (369)
||||++|+|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+.....
T Consensus 82 mEy~~~g~L~~~i~~~~--~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EeecCCCcHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcccc
Confidence 99999999999997543 488999999999999999999999 9999999999999999999999999999976544
Q ss_pred CceeeeeecccC
Q 017558 357 DTHVSTRVMGTF 368 (369)
Q Consensus 357 ~~~~~~~~~gt~ 368 (369)
.. ..+...||+
T Consensus 157 ~~-~~~~~~gt~ 167 (320)
T d1xjda_ 157 DA-KTNTFCGTP 167 (320)
T ss_dssp TC-CBCCCCSCG
T ss_pred cc-cccccCCCC
Confidence 33 233456765
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-34 Score=262.00 Aligned_cols=173 Identities=27% Similarity=0.430 Sum_probs=133.7
Q ss_pred CHHHHHHhhcCCcccceecccCceEEEEEEEc------CCeEEEEEeeccCCc-ccHHHHHHHHHHHHhc-CCCccccEe
Q 017558 193 TYEELKIATDNFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLKAGSG-QGEREFQAEIEIISQV-HHRHLVSLV 264 (369)
Q Consensus 193 ~~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~ 264 (369)
+..++++..++|++.+.||+|+||.||+|++. +++.||||+++.... ...+.+.+|+.++.++ +|+||+.++
T Consensus 4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~ 83 (299)
T d1ywna1 4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 83 (299)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence 34556677789999999999999999999864 246899999976543 3445788888888877 689999999
Q ss_pred eEEEeC-CeeEEEEEecCCCcHhhhhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCC
Q 017558 265 GYCTFG-SQRLLVYEFVPNKTLEFHLHGKD--------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDI 329 (369)
Q Consensus 265 g~~~~~-~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdl 329 (369)
+++... ...++|||||++|+|.++|+... ...+++.+++.|+.||+.||.|||++ +|+||||
T Consensus 84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDl 160 (299)
T d1ywna1 84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDL 160 (299)
T ss_dssp EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcC
Confidence 998764 46899999999999999997532 23488999999999999999999998 9999999
Q ss_pred CCCcEEECCCCcEEEeeeccceeeCCCCce-eeeeecccC
Q 017558 330 KSANILLDDSFEAKVADFGLAKHSLDTDTH-VSTRVMGTF 368 (369)
Q Consensus 330 k~~Nill~~~~~~ki~DFGla~~~~~~~~~-~~~~~~gt~ 368 (369)
||+||||++++.+||+|||+|+........ ..+...||+
T Consensus 161 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~ 200 (299)
T d1ywna1 161 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 200 (299)
T ss_dssp CGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGG
T ss_pred CccceeECCCCcEEEccCcchhhccccccccccCceeeCc
Confidence 999999999999999999999986554332 333456765
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-34 Score=261.22 Aligned_cols=162 Identities=26% Similarity=0.451 Sum_probs=132.3
Q ss_pred cCCcccceecccCceEEEEEEEc-CCe----EEEEEeeccCC-cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEE
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLT-NGK----VVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 275 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 275 (369)
++|++.++||+|+||+||+|++. +|+ .||+|+++... ....++|.+|+++|++++|||||+++|+|.+ +..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-~~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCeeE
Confidence 56999999999999999999864 333 68999887543 3456789999999999999999999999986 45688
Q ss_pred EEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCC
Q 017558 276 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 276 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~ 355 (369)
+|||+.+|+|.+++.... ..+++..+++|+.||+.||.|||++ +|+||||||+||||+.++.+||+|||+|+....
T Consensus 88 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EEECCTTCBHHHHHHHTS-SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred EEEeccCCcccccccccc-cCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 899999999999887653 4589999999999999999999998 999999999999999999999999999998765
Q ss_pred CCcee-eeeecccC
Q 017558 356 TDTHV-STRVMGTF 368 (369)
Q Consensus 356 ~~~~~-~~~~~gt~ 368 (369)
.+... .....||+
T Consensus 164 ~~~~~~~~~~~gt~ 177 (317)
T d1xkka_ 164 EEKEYHAEGGKVPI 177 (317)
T ss_dssp TCC--------CCT
T ss_pred ccccccccccccCc
Confidence 54332 22345554
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-34 Score=263.28 Aligned_cols=159 Identities=28% Similarity=0.490 Sum_probs=138.6
Q ss_pred HHHhhcCCcccceecccCceEEEEEEEc------CCeEEEEEeeccCCc-ccHHHHHHHHHHHHhcCCCccccEeeEEEe
Q 017558 197 LKIATDNFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTF 269 (369)
Q Consensus 197 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~ 269 (369)
+++..++|.+.+.||+|+||.||+|.+. ++..||||+++.... .....|.+|++++++++|||||+++|+|..
T Consensus 15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~ 94 (308)
T d1p4oa_ 15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 94 (308)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence 4556688999999999999999999863 256899999976433 333578999999999999999999999999
Q ss_pred CCeeEEEEEecCCCcHhhhhcCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCc
Q 017558 270 GSQRLLVYEFVPNKTLEFHLHGK--------DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFE 341 (369)
Q Consensus 270 ~~~~~lv~e~~~~g~L~~~l~~~--------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~ 341 (369)
++..++||||+++|+|.++++.. ....+++..+.+|+.|++.||.|||++ +|+||||||+||||++++.
T Consensus 95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~ 171 (308)
T d1p4oa_ 95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFT 171 (308)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCC
T ss_pred CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCce
Confidence 99999999999999999998642 223478999999999999999999998 9999999999999999999
Q ss_pred EEEeeeccceeeCCCCc
Q 017558 342 AKVADFGLAKHSLDTDT 358 (369)
Q Consensus 342 ~ki~DFGla~~~~~~~~ 358 (369)
+||+|||+|+...+...
T Consensus 172 ~Kl~DFGla~~~~~~~~ 188 (308)
T d1p4oa_ 172 VKIGDFGMTRDIYETDY 188 (308)
T ss_dssp EEECCTTCCCGGGGGGC
T ss_pred EEEeecccceeccCCcc
Confidence 99999999998765543
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-34 Score=259.44 Aligned_cols=157 Identities=30% Similarity=0.410 Sum_probs=130.1
Q ss_pred ccceecccCceEEEEEEE-cCCeEEEEEeeccCCcc-----cHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEe
Q 017558 206 EANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQ-----GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (369)
Q Consensus 206 ~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 279 (369)
.+++||+|+||+||+|+. .+|+.||||+++..... ..+.+.+|+++|++++|||||++++++..++..||||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 467899999999999996 45889999998654322 124688999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCCCce
Q 017558 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 359 (369)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~~~~ 359 (369)
+.++++..++... ..+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+...+....
T Consensus 82 ~~~~~~~~~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~ 156 (299)
T d1ua2a_ 82 METDLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA 156 (299)
T ss_dssp CSEEHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred hcchHHhhhhhcc--cCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCccc
Confidence 9998887766433 4588889999999999999999999 9999999999999999999999999999887654322
Q ss_pred eeeeecccC
Q 017558 360 VSTRVMGTF 368 (369)
Q Consensus 360 ~~~~~~gt~ 368 (369)
....+||+
T Consensus 157 -~~~~~gt~ 164 (299)
T d1ua2a_ 157 -YTHQVVTR 164 (299)
T ss_dssp -CCCSCCCC
T ss_pred -ccceecCh
Confidence 22345654
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-34 Score=259.42 Aligned_cols=150 Identities=30% Similarity=0.579 Sum_probs=131.1
Q ss_pred cCCcccceecccCceEEEEEEEcC-Ce--EEEEEeeccCC-cccHHHHHHHHHHHHhc-CCCccccEeeEEEeCCeeEEE
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLTN-GK--VVAIKQLKAGS-GQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLV 276 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv 276 (369)
++|++.++||+|+||.||+|++.+ +. .||||+++... ....++|.+|+++|.++ +|||||+++|+|.+++..|+|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 688889999999999999999754 43 57888886543 33456899999999999 799999999999999999999
Q ss_pred EEecCCCcHhhhhcCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcE
Q 017558 277 YEFVPNKTLEFHLHGK--------------DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEA 342 (369)
Q Consensus 277 ~e~~~~g~L~~~l~~~--------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ 342 (369)
|||+++|+|.++|+.. ....+++..+++++.||+.||.|||++ +|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence 9999999999999754 234689999999999999999999998 99999999999999999999
Q ss_pred EEeeeccceeeC
Q 017558 343 KVADFGLAKHSL 354 (369)
Q Consensus 343 ki~DFGla~~~~ 354 (369)
||+|||+|+...
T Consensus 167 kl~DfG~a~~~~ 178 (309)
T d1fvra_ 167 KIADFGLSRGQE 178 (309)
T ss_dssp EECCTTCEESSC
T ss_pred EEcccccccccc
Confidence 999999998654
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-33 Score=256.56 Aligned_cols=147 Identities=29% Similarity=0.489 Sum_probs=128.5
Q ss_pred cceecccCceEEEEEEEcCC----eEEEEEeeccCC-cccHHHHHHHHHHHHhcCCCccccEeeEEEe-CCeeEEEEEec
Q 017558 207 ANLLGQGGFGYVHKGVLTNG----KVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTF-GSQRLLVYEFV 280 (369)
Q Consensus 207 ~~~lg~G~fg~Vy~~~~~~~----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lv~e~~ 280 (369)
.++||+|+||+||+|++.++ ..||||+++... ....++|.+|+++|++++||||++++|+|.. +...++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 57899999999999997442 368999997543 3345689999999999999999999999876 56889999999
Q ss_pred CCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCCC
Q 017558 281 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (369)
Q Consensus 281 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~~ 357 (369)
++|+|.++++... ..+.+..+++++.|++.||.|||+. +|+||||||+||||++++.+||+|||+++......
T Consensus 112 ~~g~l~~~~~~~~-~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 112 KHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp TTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred ecCchhhhhcccc-ccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 9999999988654 3578889999999999999999998 99999999999999999999999999999876544
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-33 Score=257.39 Aligned_cols=160 Identities=29% Similarity=0.404 Sum_probs=130.6
Q ss_pred cCCcccceecccCceEEEEEEEcCCeEEEEEeeccCCcccHHHHH--HHHHHHHhcCCCccccEeeEEEeCC----eeEE
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQ--AEIEIISQVHHRHLVSLVGYCTFGS----QRLL 275 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~--~E~~~l~~l~h~niv~l~g~~~~~~----~~~l 275 (369)
++|.+.+.||+|+||.||+|++ +|+.||||+++... .+++. .|+..+.+++|||||+++|+|..++ ..||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 4677789999999999999997 68899999986432 23443 4555556789999999999998654 6799
Q ss_pred EEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCeeecCCCCCcEEECCCCcEEEeeeccc
Q 017558 276 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHED-----CQPKIIHRDIKSANILLDDSFEAKVADFGLA 350 (369)
Q Consensus 276 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-----~~~~ivHrdlk~~Nill~~~~~~ki~DFGla 350 (369)
|||||++|+|.++|+.. .++|..+++++.|++.||.|||+. ...+|+||||||+||||++++.+||+|||++
T Consensus 79 v~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 99999999999999764 489999999999999999999963 1248999999999999999999999999999
Q ss_pred eeeCCCCcee---eeeecccC
Q 017558 351 KHSLDTDTHV---STRVMGTF 368 (369)
Q Consensus 351 ~~~~~~~~~~---~~~~~gt~ 368 (369)
+......... .....||+
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~ 176 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTK 176 (303)
T ss_dssp EEEETTTTEECC----CCSCG
T ss_pred ccccCCCcceeccccceeccc
Confidence 9876654322 23356765
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-33 Score=259.27 Aligned_cols=158 Identities=23% Similarity=0.289 Sum_probs=134.2
Q ss_pred hcCCccc-ceecccCceEEEEEEE-cCCeEEEEEeeccCCcccHHHHHHHHHHHHhc-CCCccccEeeEEEe----CCee
Q 017558 201 TDNFSEA-NLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHRHLVSLVGYCTF----GSQR 273 (369)
Q Consensus 201 ~~~~~~~-~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~----~~~~ 273 (369)
.++|++. ++||+|+||.||+|+. .+++.||||+++. .+.+.+|++++.++ +|||||+++++|.+ +...
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 4678876 4699999999999996 4688999999864 35678899987665 89999999999875 4568
Q ss_pred EEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECC---CCcEEEeeeccc
Q 017558 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD---SFEAKVADFGLA 350 (369)
Q Consensus 274 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~---~~~~ki~DFGla 350 (369)
|||||||++|+|.++|.......+++.++..|+.||+.||+|||++ +|+||||||+|||+++ ++.+||+|||+|
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccccccccccee
Confidence 9999999999999999876555799999999999999999999999 9999999999999985 567999999999
Q ss_pred eeeCCCCceeeeeecccC
Q 017558 351 KHSLDTDTHVSTRVMGTF 368 (369)
Q Consensus 351 ~~~~~~~~~~~~~~~gt~ 368 (369)
+....... .....||+
T Consensus 162 ~~~~~~~~--~~~~~gt~ 177 (335)
T d2ozaa1 162 KETTSHNS--LTTPCYTP 177 (335)
T ss_dssp EECCCCCC--CCCCSCCC
T ss_pred eeccCCCc--cccccCCc
Confidence 98765443 23356765
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-34 Score=259.56 Aligned_cols=168 Identities=27% Similarity=0.435 Sum_probs=143.0
Q ss_pred HHhhcCCcccceecccCceEEEEEEEc------CCeEEEEEeeccCCcc-cHHHHHHHHHHHHhc-CCCccccEeeEEEe
Q 017558 198 KIATDNFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLKAGSGQ-GEREFQAEIEIISQV-HHRHLVSLVGYCTF 269 (369)
Q Consensus 198 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~l~g~~~~ 269 (369)
++..++|++.++||+|+||.||+|++. +++.||||+++..... ...+|.+|+.++.++ +|||||+++|+|.+
T Consensus 19 ~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~ 98 (311)
T d1t46a_ 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (311)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee
Confidence 345688999999999999999999863 3568999999765433 445789999999999 69999999999999
Q ss_pred CCeeEEEEEecCCCcHhhhhcCCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCc
Q 017558 270 GSQRLLVYEFVPNKTLEFHLHGKD----------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSAN 333 (369)
Q Consensus 270 ~~~~~lv~e~~~~g~L~~~l~~~~----------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~N 333 (369)
....|||||||++|+|.++|+... ...+++..+++|+.||+.||+|||++ +++||||||+|
T Consensus 99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~N 175 (311)
T d1t46a_ 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARN 175 (311)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccc
Confidence 999999999999999999997532 23588999999999999999999999 99999999999
Q ss_pred EEECCCCcEEEeeeccceeeCCCCc-eeeeeecccC
Q 017558 334 ILLDDSFEAKVADFGLAKHSLDTDT-HVSTRVMGTF 368 (369)
Q Consensus 334 ill~~~~~~ki~DFGla~~~~~~~~-~~~~~~~gt~ 368 (369)
||++.++.+||+|||+++...+... ...+...||+
T Consensus 176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~ 211 (311)
T d1t46a_ 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPV 211 (311)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECG
T ss_pred ccccccCcccccccchheeccCCCcceEeeecccCh
Confidence 9999999999999999998765443 3334456654
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.6e-33 Score=255.23 Aligned_cols=151 Identities=25% Similarity=0.369 Sum_probs=135.1
Q ss_pred cCCcccceecccCceEEEEEEEcCCeEEEEEeeccCCc--ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEEe
Q 017558 202 DNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 279 (369)
++|++.+.||+|+||.||+|+..+++.||||+++.... ...+.+.+|+.+|++++||||+++++++..++..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 68999999999999999999998899999999966532 2246899999999999999999999999999999999999
Q ss_pred cCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCCC
Q 017558 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (369)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~~ 357 (369)
+.++.+..+.... ..+++..+..|+.||+.||+|||++ +|+||||||+||||+.++.+||+|||+|.......
T Consensus 82 ~~~~~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 82 LDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp CSEEHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred ehhhhHHHHHhhc--CCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence 9888887776543 4599999999999999999999998 99999999999999999999999999998865543
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-34 Score=254.79 Aligned_cols=152 Identities=29% Similarity=0.443 Sum_probs=125.1
Q ss_pred hcCCcccceecccCceEEEEEEEcC--C--eEEEEEeeccCC---cccHHHHHHHHHHHHhcCCCccccEeeEEEeCCee
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLTN--G--KVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQR 273 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~~--~--~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 273 (369)
.++|++.+.||+|+||.||+|++.. + ..||||+++... ....++|.+|+++|++++||||++++|+|.+ ...
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 4679999999999999999998642 2 378999987542 2334689999999999999999999999965 567
Q ss_pred EEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceee
Q 017558 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (369)
Q Consensus 274 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~ 353 (369)
++||||+++|+|.+++.... ..+++..+++++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++..
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred heeeeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhc
Confidence 89999999999998887543 3489999999999999999999998 9999999999999999999999999999987
Q ss_pred CCCC
Q 017558 354 LDTD 357 (369)
Q Consensus 354 ~~~~ 357 (369)
....
T Consensus 162 ~~~~ 165 (273)
T d1u46a_ 162 PQND 165 (273)
T ss_dssp CC-C
T ss_pred ccCC
Confidence 6654
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.2e-33 Score=252.01 Aligned_cols=164 Identities=27% Similarity=0.395 Sum_probs=133.2
Q ss_pred hcCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCCcc---cHHHHHHHHHHHHhcCCCccccEeeEEEeCC----e
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQ---GEREFQAEIEIISQVHHRHLVSLVGYCTFGS----Q 272 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----~ 272 (369)
.++|++.+.||+|+||.||+|+. .+++.||||+++..... ..+.|.+|+++|++++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 47899999999999999999996 46899999999765432 2346899999999999999999999997654 3
Q ss_pred eEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeecccee
Q 017558 273 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (369)
Q Consensus 273 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~ 352 (369)
.||||||+++++|.+++.... .+++.+++.|+.||+.||+|||++ +|+||||||+||||+.++..+|+|||+++.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~--~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARA 160 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred EEEEEECCCCCEehhhhcccC--CCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhhh
Confidence 789999999999999886543 589999999999999999999998 999999999999999999999999999987
Q ss_pred eCCCCc--eeeeeecccCC
Q 017558 353 SLDTDT--HVSTRVMGTFG 369 (369)
Q Consensus 353 ~~~~~~--~~~~~~~gt~g 369 (369)
...... ......+||++
T Consensus 161 ~~~~~~~~~~~~~~~Gt~~ 179 (277)
T d1o6ya_ 161 IADSGNSVTQTAAVIGTAQ 179 (277)
T ss_dssp CC----------------T
T ss_pred hccccccccccccccCccc
Confidence 654332 23334567753
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=6e-33 Score=252.85 Aligned_cols=156 Identities=28% Similarity=0.473 Sum_probs=132.0
Q ss_pred HhhcCCcccceecccCceEEEEEEEcC--------CeEEEEEeeccCCcc-cHHHHHHHHHHHHhc-CCCccccEeeEEE
Q 017558 199 IATDNFSEANLLGQGGFGYVHKGVLTN--------GKVVAIKQLKAGSGQ-GEREFQAEIEIISQV-HHRHLVSLVGYCT 268 (369)
Q Consensus 199 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~l~g~~~ 268 (369)
+..++|++++.||+|+||.||+|+... +..||||+++.+... ...++.+|...+.++ +|||||+++++|.
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 456789999999999999999998532 247999999766543 346788999999888 7999999999999
Q ss_pred eCCeeEEEEEecCCCcHhhhhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcE
Q 017558 269 FGSQRLLVYEFVPNKTLEFHLHGKD--------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANI 334 (369)
Q Consensus 269 ~~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Ni 334 (369)
+++..++||||+++|+|.++|.... ...+++..+++++.||+.||+|||++ +||||||||+||
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~Ni 166 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV 166 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccce
Confidence 9999999999999999999997543 23589999999999999999999999 999999999999
Q ss_pred EECCCCcEEEeeeccceeeCCCC
Q 017558 335 LLDDSFEAKVADFGLAKHSLDTD 357 (369)
Q Consensus 335 ll~~~~~~ki~DFGla~~~~~~~ 357 (369)
|++.++.+||+|||+++...+..
T Consensus 167 Ll~~~~~~kl~dfg~~~~~~~~~ 189 (299)
T d1fgka_ 167 LVTEDNVMKIADFGLARDIHHID 189 (299)
T ss_dssp EECTTCCEEECSTTCCCCGGGCC
T ss_pred eecCCCCeEeccchhhccccccc
Confidence 99999999999999999876543
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=6.5e-33 Score=249.39 Aligned_cols=160 Identities=24% Similarity=0.299 Sum_probs=134.3
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcc------cHHHHHHHHHHHHhcC--CCccccEeeEEEeCC
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ------GEREFQAEIEIISQVH--HRHLVSLVGYCTFGS 271 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~~ 271 (369)
.++|++.+.||+|+||.||+|+.. +++.||||+++..... ....+.+|+.+|++++ |||||++++++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 357999999999999999999964 6899999998653211 1234678999999996 899999999999999
Q ss_pred eeEEEEEecCC-CcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECC-CCcEEEeeecc
Q 017558 272 QRLLVYEFVPN-KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD-SFEAKVADFGL 349 (369)
Q Consensus 272 ~~~lv~e~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~-~~~~ki~DFGl 349 (369)
..|+||||+.+ +++.+++... ..+++.++..++.||+.||+|||++ +|+||||||+|||++. ++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred eEEEEEEeccCcchHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECcccc
Confidence 99999999976 6788887654 3589999999999999999999999 9999999999999985 57999999999
Q ss_pred ceeeCCCCceeeeeecccC
Q 017558 350 AKHSLDTDTHVSTRVMGTF 368 (369)
Q Consensus 350 a~~~~~~~~~~~~~~~gt~ 368 (369)
|+...... .+...||+
T Consensus 158 a~~~~~~~---~~~~~GT~ 173 (273)
T d1xwsa_ 158 GALLKDTV---YTDFDGTR 173 (273)
T ss_dssp CEECCSSC---BCCCCSCG
T ss_pred ceeccccc---ccccccCC
Confidence 98765432 23456775
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.3e-31 Score=243.14 Aligned_cols=151 Identities=22% Similarity=0.361 Sum_probs=135.8
Q ss_pred cCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCCc--ccHHHHHHHHHHHHhcCCCccccEeeEEEeCCeeEEEEE
Q 017558 202 DNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 278 (369)
++|++.+.||+|+||+||+|+. .+++.||||+++.... ...+.+.+|+.+|++++|+||++++++|......++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 6899999999999999999996 4678999999975433 234688999999999999999999999999999999999
Q ss_pred ecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeCCCC
Q 017558 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (369)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~~~~ 357 (369)
|+.+++|..++... ..+.+..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+......
T Consensus 82 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred eccccccccccccc--cccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 99999998888654 3588999999999999999999998 99999999999999999999999999999876544
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=99.97 E-value=2e-31 Score=246.03 Aligned_cols=144 Identities=24% Similarity=0.380 Sum_probs=127.2
Q ss_pred cCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCCcccHHHHHHHHHHHHhcC-CCccccEeeEEEeC--CeeEEEE
Q 017558 202 DNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVH-HRHLVSLVGYCTFG--SQRLLVY 277 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~--~~~~lv~ 277 (369)
++|++.+.||+|+||+||+|+. .+++.||||+++.. ..+++.+|+++|.+++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 6799999999999999999996 46899999999753 3467899999999995 99999999999753 5689999
Q ss_pred EecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCC-cEEEeeeccceeeCCC
Q 017558 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF-EAKVADFGLAKHSLDT 356 (369)
Q Consensus 278 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~-~~ki~DFGla~~~~~~ 356 (369)
||+.+++|..+.+ .+++..+..++.||+.||+|||++ +|+||||||+||||+.++ .+||+|||+|+.....
T Consensus 112 e~~~~~~L~~~~~-----~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 112 EHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp ECCCSCBGGGTTT-----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred eecCCCcHHHHhc-----CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccCC
Confidence 9999999987642 489999999999999999999999 999999999999998654 6999999999987654
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.2e-31 Score=249.64 Aligned_cols=148 Identities=28% Similarity=0.428 Sum_probs=123.8
Q ss_pred CCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccEeeEEEeC------CeeEE
Q 017558 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFG------SQRLL 275 (369)
Q Consensus 203 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~~l 275 (369)
+|...++||+|+||+||+|+.. +++.||||+++.... .+.+|+++|++++|+||++++++|... ...||
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5788899999999999999974 589999999976432 334799999999999999999998643 34789
Q ss_pred EEEecCCCcHhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCC-cEEEeeeccceee
Q 017558 276 VYEFVPNKTLEFHLHG-KDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF-EAKVADFGLAKHS 353 (369)
Q Consensus 276 v~e~~~~g~L~~~l~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~-~~ki~DFGla~~~ 353 (369)
|||||+++.+..+.+. .....+++.++..|+.||+.||+|||++ +|+||||||+||||+.++ .+||+|||+++..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999987755444321 2234699999999999999999999998 999999999999999764 8999999999987
Q ss_pred CCCC
Q 017558 354 LDTD 357 (369)
Q Consensus 354 ~~~~ 357 (369)
...+
T Consensus 174 ~~~~ 177 (350)
T d1q5ka_ 174 VRGE 177 (350)
T ss_dssp CTTS
T ss_pred cCCc
Confidence 6544
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.1e-32 Score=250.45 Aligned_cols=163 Identities=26% Similarity=0.341 Sum_probs=138.2
Q ss_pred hcCCcccceecccCceEEEEEEEc----CCeEEEEEeeccCC----cccHHHHHHHHHHHHhcCC-CccccEeeEEEeCC
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT----NGKVVAIKQLKAGS----GQGEREFQAEIEIISQVHH-RHLVSLVGYCTFGS 271 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h-~niv~l~g~~~~~~ 271 (369)
.++|++.+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+++|.+++| |||+++++++.+..
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 377999999999999999999852 47899999986532 2234578899999999976 89999999999999
Q ss_pred eeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccce
Q 017558 272 QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351 (369)
Q Consensus 272 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~ 351 (369)
..+++|||+.+|+|.+++.... .+.+.....++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+|+
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred ceeeeeecccccHHHHHHHhcc--cccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchh
Confidence 9999999999999999997654 467888899999999999999998 99999999999999999999999999999
Q ss_pred eeCCCCceeeeeecccC
Q 017558 352 HSLDTDTHVSTRVMGTF 368 (369)
Q Consensus 352 ~~~~~~~~~~~~~~gt~ 368 (369)
.+............||+
T Consensus 178 ~~~~~~~~~~~~~~g~~ 194 (322)
T d1vzoa_ 178 EFVADETERAYDFCGTI 194 (322)
T ss_dssp ECCGGGGGGGCGGGSCC
T ss_pred hhccccccccccccccc
Confidence 87554433333344443
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.5e-31 Score=248.45 Aligned_cols=150 Identities=22% Similarity=0.356 Sum_probs=127.1
Q ss_pred hcCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCCc-ccHHHHHHHHHHHHhcCCCccccEeeEEEeCC----eeE
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGS----QRL 274 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----~~~ 274 (369)
.++|++.+.||+|+||+||+|+. .+++.||||+++.... ...+.+.+|+++|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 45799999999999999999985 5789999999975443 33457899999999999999999999997543 335
Q ss_pred EEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccceeeC
Q 017558 275 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (369)
Q Consensus 275 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~~ 354 (369)
++++|+.+|+|.+++... .+++..+..++.||+.||+|||++ +||||||||+||||++++.+||+|||+|+...
T Consensus 87 ~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp EEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence 566777899999999653 489999999999999999999999 99999999999999999999999999998765
Q ss_pred CC
Q 017558 355 DT 356 (369)
Q Consensus 355 ~~ 356 (369)
..
T Consensus 161 ~~ 162 (345)
T d1pmea_ 161 PD 162 (345)
T ss_dssp GG
T ss_pred CC
Confidence 43
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=7.5e-31 Score=241.03 Aligned_cols=151 Identities=27% Similarity=0.402 Sum_probs=127.4
Q ss_pred hcCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCC--cccHHHHHHHHHHHHhcCCCccccEeeEEEe--------
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTF-------- 269 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-------- 269 (369)
.++|++.+.||+|+||+||+|+. .+|+.||||++.... ....+++.+|+++|++++|+||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 37899999999999999999996 468999999986542 2334678999999999999999999999855
Q ss_pred CCeeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeecc
Q 017558 270 GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGL 349 (369)
Q Consensus 270 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGl 349 (369)
.+..|+||||+.++.+..+... ...+.+.....|+.||+.||.|||++ +|+||||||+||||+.++.+||+|||+
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~--~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred CceEEEEEeccCCCccchhhhc--ccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecce
Confidence 3467999999988887766543 34588899999999999999999998 999999999999999999999999999
Q ss_pred ceeeCCC
Q 017558 350 AKHSLDT 356 (369)
Q Consensus 350 a~~~~~~ 356 (369)
++.....
T Consensus 164 ~~~~~~~ 170 (318)
T d3blha1 164 ARAFSLA 170 (318)
T ss_dssp CEECCC-
T ss_pred eeecccc
Confidence 9876543
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=6.8e-31 Score=244.18 Aligned_cols=149 Identities=25% Similarity=0.388 Sum_probs=124.5
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCc--ccHHHHHHHHHHHHhcCCCccccEeeEEEeCC------
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFGS------ 271 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------ 271 (369)
.++|++.+.||+|+||.||+|... +|+.||||+++.... ...+.+.+|+++|++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 578999999999999999999964 589999999975432 23457889999999999999999999997654
Q ss_pred eeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccce
Q 017558 272 QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351 (369)
Q Consensus 272 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~ 351 (369)
..||||||+ +.+|..+++. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~ 169 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR 169 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhccccccccccccccee
Confidence 569999999 6778777654 3489999999999999999999999 99999999999999999999999999999
Q ss_pred eeCCC
Q 017558 352 HSLDT 356 (369)
Q Consensus 352 ~~~~~ 356 (369)
.....
T Consensus 170 ~~~~~ 174 (346)
T d1cm8a_ 170 QADSE 174 (346)
T ss_dssp ECCSS
T ss_pred ccCCc
Confidence 87543
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=9.3e-31 Score=238.99 Aligned_cols=162 Identities=28% Similarity=0.430 Sum_probs=130.4
Q ss_pred hcCCcccceecccCceEEEEEEEc--CCeEEEEEeeccCCc--ccHHHHHHHHHHHHhc---CCCccccEeeEEEe----
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT--NGKVVAIKQLKAGSG--QGEREFQAEIEIISQV---HHRHLVSLVGYCTF---- 269 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~--~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~g~~~~---- 269 (369)
.++|++.+.||+|+||.||+|+.. +++.||||+++.... .....+.+|+++|+.+ +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 478999999999999999999963 367899999865322 2233566788777665 79999999999853
Q ss_pred -CCeeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeec
Q 017558 270 -GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFG 348 (369)
Q Consensus 270 -~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFG 348 (369)
....+++|||++++.+....... ...+++.....++.||+.||+|||++ +|+||||||+|||+++++.+||+|||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred cCceEEEEEEeccCCchhhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecchh
Confidence 34679999999988876555433 34689999999999999999999999 99999999999999999999999999
Q ss_pred cceeeCCCCceeeeeecccC
Q 017558 349 LAKHSLDTDTHVSTRVMGTF 368 (369)
Q Consensus 349 la~~~~~~~~~~~~~~~gt~ 368 (369)
+++...... ......||+
T Consensus 162 ~~~~~~~~~--~~~~~~gT~ 179 (305)
T d1blxa_ 162 LARIYSFQM--ALTSVVVTL 179 (305)
T ss_dssp SCCCCCGGG--GGCCCCCCC
T ss_pred hhhhhcccc--cCCCcccCh
Confidence 998754332 223456665
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.97 E-value=4.7e-30 Score=232.88 Aligned_cols=161 Identities=23% Similarity=0.272 Sum_probs=135.9
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCcccHHHHHHHHHHHHhcCC-CccccEeeEEEeCCeeEEEEE
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHH-RHLVSLVGYCTFGSQRLLVYE 278 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lv~e 278 (369)
.++|++.+.||+|+||.||+|+.. +|+.||||++..... ...+.+|++++..++| +||+.+++++......++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 468999999999999999999964 689999998865432 2467889999999975 899999999999999999999
Q ss_pred ecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECC-----CCcEEEeeeccceee
Q 017558 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD-----SFEAKVADFGLAKHS 353 (369)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~-----~~~~ki~DFGla~~~ 353 (369)
|+ +++|.++++... ..+++.++..++.|++.||+|||++ +|+||||||+||||+. ++.+||+|||+|+.+
T Consensus 82 ~~-~~~l~~~~~~~~-~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 82 LL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp CC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred ec-CCCHHHHHHhhc-cchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 99 789998887544 3589999999999999999999998 9999999999999974 578999999999987
Q ss_pred CCCCce------eeeeecccC
Q 017558 354 LDTDTH------VSTRVMGTF 368 (369)
Q Consensus 354 ~~~~~~------~~~~~~gt~ 368 (369)
.+.... ....++||+
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~ 177 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTA 177 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCT
T ss_pred ccCccccceeecccCceEEch
Confidence 654321 223457776
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=3.2e-30 Score=239.71 Aligned_cols=149 Identities=23% Similarity=0.400 Sum_probs=126.7
Q ss_pred hcCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCCc--ccHHHHHHHHHHHHhcCCCccccEeeEEEeC-----Ce
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFG-----SQ 272 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~ 272 (369)
.++|++.+.||+|+||+||+|+. .+|+.||||+++.... ...+.+.+|+++|++++|+|||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 57899999999999999999995 4689999999975432 2335788999999999999999999998643 34
Q ss_pred eEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeecccee
Q 017558 273 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (369)
Q Consensus 273 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~ 352 (369)
.+++|+|+.+|+|.+++..+ .+++..+..|+.||+.||+|||++ +|+||||||+|||++.++.+|++|||++..
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~ 170 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARH 170 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred eEEEEEeecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhcc
Confidence 57778888999999999643 489999999999999999999999 999999999999999999999999999987
Q ss_pred eCC
Q 017558 353 SLD 355 (369)
Q Consensus 353 ~~~ 355 (369)
...
T Consensus 171 ~~~ 173 (348)
T d2gfsa1 171 TDD 173 (348)
T ss_dssp CTG
T ss_pred cCc
Confidence 543
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.96 E-value=2.4e-29 Score=228.94 Aligned_cols=161 Identities=24% Similarity=0.311 Sum_probs=128.1
Q ss_pred hcCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCccccE-eeEEEeCCeeEEEEE
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSL-VGYCTFGSQRLLVYE 278 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l-~g~~~~~~~~~lv~e 278 (369)
.++|++.+.||+|+||.||+|+. .+++.||||.+..... .+++..|++++++++|+|++.+ .+++.+.+..++|||
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 35799999999999999999996 4589999998875432 2468899999999987765555 455567788899999
Q ss_pred ecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEC---CCCcEEEeeeccceeeCC
Q 017558 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLD---DSFEAKVADFGLAKHSLD 355 (369)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~---~~~~~ki~DFGla~~~~~ 355 (369)
|+. ++|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||++ .+..+||+|||+|+.+.+
T Consensus 84 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 84 LLG-PSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp CCC-CBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred EcC-Cchhhhhhhcc-CCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 994 55555554333 3589999999999999999999999 999999999999986 456799999999998766
Q ss_pred CCce------eeeeecccC
Q 017558 356 TDTH------VSTRVMGTF 368 (369)
Q Consensus 356 ~~~~------~~~~~~gt~ 368 (369)
.... ......||+
T Consensus 159 ~~~~~~~~~~~~~~~~gt~ 177 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTA 177 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCS
T ss_pred cccccceeccccCCcCCCc
Confidence 4432 223456765
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.9e-29 Score=235.11 Aligned_cols=148 Identities=24% Similarity=0.331 Sum_probs=121.0
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCeEEEEEeeccCCc--ccHHHHHHHHHHHHhcCCCccccEeeEEEe------CC
Q 017558 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTF------GS 271 (369)
Q Consensus 201 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~------~~ 271 (369)
.++|++.++||+|+||+||+|+.. +|+.||||+++.... ...+.+.+|+.+|++++||||++++++|.. ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 367999999999999999999965 589999999975432 233568899999999999999999999964 36
Q ss_pred eeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEeeeccce
Q 017558 272 QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351 (369)
Q Consensus 272 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~ 351 (369)
..|+||||+.++.+. .++. .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+|++|||+++
T Consensus 96 ~~~iv~Ey~~~~l~~-~~~~----~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 96 DVYLVMELMDANLCQ-VIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEEECCSEEHHH-HHTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eeEEEEeccchHHHH-hhhc----CCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhh
Confidence 789999999766554 4432 488999999999999999999999 99999999999999999999999999998
Q ss_pred eeCCC
Q 017558 352 HSLDT 356 (369)
Q Consensus 352 ~~~~~ 356 (369)
.....
T Consensus 168 ~~~~~ 172 (355)
T d2b1pa1 168 TAGTS 172 (355)
T ss_dssp -----
T ss_pred ccccc
Confidence 76543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=1.9e-25 Score=189.48 Aligned_cols=136 Identities=15% Similarity=0.158 Sum_probs=108.3
Q ss_pred cccceecccCceEEEEEEEcCCeEEEEEeeccCCcc------------------cHHHHHHHHHHHHhcCCCccccEeeE
Q 017558 205 SEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQ------------------GEREFQAEIEIISQVHHRHLVSLVGY 266 (369)
Q Consensus 205 ~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~------------------~~~~~~~E~~~l~~l~h~niv~l~g~ 266 (369)
.+.+.||+|+||.||+|+..+|+.||||+++..... ....+.+|...+.++.|.|++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 457899999999999999888999999987632110 01234568889999999999988765
Q ss_pred EEeCCeeEEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCCcEEEee
Q 017558 267 CTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVAD 346 (369)
Q Consensus 267 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~~~ki~D 346 (369)
. ..+++|||+++..+.. +.+.....++.|++.+|.|||++ +|+||||||+|||++++ .++|+|
T Consensus 83 ~----~~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~liD 145 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWIID 145 (191)
T ss_dssp E----TTEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEECC
T ss_pred c----CCEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEEE
Confidence 3 2379999998877643 22334567899999999999998 99999999999999976 589999
Q ss_pred eccceeeCCCC
Q 017558 347 FGLAKHSLDTD 357 (369)
Q Consensus 347 FGla~~~~~~~ 357 (369)
||+|+...++.
T Consensus 146 FG~a~~~~~~~ 156 (191)
T d1zara2 146 FPQSVEVGEEG 156 (191)
T ss_dssp CTTCEETTSTT
T ss_pred CCCcccCCCCC
Confidence 99998876544
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.90 E-value=3.7e-24 Score=199.38 Aligned_cols=152 Identities=23% Similarity=0.262 Sum_probs=119.8
Q ss_pred cCCcccceecccCceEEEEEEE-cCCeEEEEEeeccCCcccHHHHHHHHHHHHhcC-----------CCccccEeeEEEe
Q 017558 202 DNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVH-----------HRHLVSLVGYCTF 269 (369)
Q Consensus 202 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~g~~~~ 269 (369)
.+|+++++||+|+||+||+|+. .+|+.||||+++.... ..+.+.+|++++++++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 3599999999999999999996 4689999999975432 2356788999888775 5789999998865
Q ss_pred --CCeeEEEEEecCCCcH-hhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEECCCC------
Q 017558 270 --GSQRLLVYEFVPNKTL-EFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF------ 340 (369)
Q Consensus 270 --~~~~~lv~e~~~~g~L-~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrdlk~~Nill~~~~------ 340 (369)
....+++|+++..+.. ..+........+.+..+..++.||+.||.|||+.. +|+||||||+||||+.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~--~IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTEE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc--CcccccCChhHeeeeccCcccccc
Confidence 3566677777655543 33333344456889999999999999999999832 899999999999998654
Q ss_pred cEEEeeeccceeeCCC
Q 017558 341 EAKVADFGLAKHSLDT 356 (369)
Q Consensus 341 ~~ki~DFGla~~~~~~ 356 (369)
.+||+|||.++.....
T Consensus 170 ~~kl~dfg~s~~~~~~ 185 (362)
T d1q8ya_ 170 QIKIADLGNACWYDEH 185 (362)
T ss_dssp EEEECCCTTCEETTBC
T ss_pred eeeEeecccccccccc
Confidence 4999999999876543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=99.02 E-value=1.4e-09 Score=94.65 Aligned_cols=151 Identities=13% Similarity=0.066 Sum_probs=106.1
Q ss_pred HHHHHhhcCCcccceecccCceEEEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHhcC-CCccccEeeEEEeCCee
Q 017558 195 EELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVH-HRHLVSLVGYCTFGSQR 273 (369)
Q Consensus 195 ~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~ 273 (369)
.++....+.|+..+..+.++...||+... ++..+++|+...........+.+|..++..+. +--+.+++.++..++..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 45666667887766655555678999875 45567788776544333446788988888774 54578888888888999
Q ss_pred EEEEEecCCCcHhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhC----------------------------------
Q 017558 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHED---------------------------------- 319 (369)
Q Consensus 274 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~---------------------------------- 319 (369)
++||+++++..+....... . ....++.++++.|..||+.
T Consensus 86 ~lv~~~l~G~~~~~~~~~~----~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDE----Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEEECCSSEEHHHHTTTC----S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred EEEEEeccccccccccccc----c---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence 9999999998886654221 1 1223455555666666641
Q ss_pred ----------------------CCCCeeecCCCCCcEEECCCCcEEEeeeccceee
Q 017558 320 ----------------------CQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (369)
Q Consensus 320 ----------------------~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~ 353 (369)
....++|+|+.+.|||+++++.+-|+||+.+...
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~g 214 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA 214 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcccC
Confidence 0223799999999999998766679999988754
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.47 E-value=5.6e-07 Score=77.30 Aligned_cols=132 Identities=17% Similarity=0.100 Sum_probs=87.6
Q ss_pred eecccCc-eEEEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHhcC--CCccccEeeEEEeCCeeEEEEEecCCCcH
Q 017558 209 LLGQGGF-GYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVH--HRHLVSLVGYCTFGSQRLLVYEFVPNKTL 285 (369)
Q Consensus 209 ~lg~G~f-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~~~~~lv~e~~~~g~L 285 (369)
.+..|.. ..||+....++..+++|...... ..++..|...|+.+. .-.+.++++++.+++..++||||++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 3445543 67999998778788889765443 235677888777663 34477888888888889999999998776
Q ss_pred hhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHH------------------------------------------------
Q 017558 286 EFHLHGKDRPVMNWPTRMKIALGSARGLAYLH------------------------------------------------ 317 (369)
Q Consensus 286 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH------------------------------------------------ 317 (369)
.... +... .++.+++..|.-||
T Consensus 94 ~~~~-------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (255)
T d1nd4a_ 94 LSSH-------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 163 (255)
T ss_dssp TTSC-------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred cccc-------ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHH
Confidence 4311 1100 11122222222322
Q ss_pred ---hC----CCCCeeecCCCCCcEEECCCCcEEEeeeccceee
Q 017558 318 ---ED----CQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (369)
Q Consensus 318 ---~~----~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~~ 353 (369)
.. ....++|+|+.+.|||++++..+-|+||+.+...
T Consensus 164 ~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~g 206 (255)
T d1nd4a_ 164 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA 206 (255)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred HHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcccC
Confidence 21 1234899999999999998766789999988753
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.15 E-value=8.1e-06 Score=74.77 Aligned_cols=76 Identities=16% Similarity=0.092 Sum_probs=49.1
Q ss_pred cceecccCceEEEEEEEcC-CeEEEEEeeccC------C-cccHHHHHHHHHHHHhcC-C--CccccEeeEEEeCCeeEE
Q 017558 207 ANLLGQGGFGYVHKGVLTN-GKVVAIKQLKAG------S-GQGEREFQAEIEIISQVH-H--RHLVSLVGYCTFGSQRLL 275 (369)
Q Consensus 207 ~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~------~-~~~~~~~~~E~~~l~~l~-h--~niv~l~g~~~~~~~~~l 275 (369)
.+.||.|..-.||+....+ ++.++||.-... . .........|.+.|..+. + ..+.+++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 4579999999999998644 567888864321 1 112334567888887663 3 345666544 4556789
Q ss_pred EEEecCCCc
Q 017558 276 VYEFVPNKT 284 (369)
Q Consensus 276 v~e~~~~g~ 284 (369)
||||+++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.82 E-value=5.8e-05 Score=66.98 Aligned_cols=135 Identities=16% Similarity=0.180 Sum_probs=80.5
Q ss_pred eEEEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCcc--ccEee-----EEEeCCeeEEEEEecCCCcHhh-
Q 017558 216 GYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHL--VSLVG-----YCTFGSQRLLVYEFVPNKTLEF- 287 (369)
Q Consensus 216 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~g-----~~~~~~~~~lv~e~~~~g~L~~- 287 (369)
=.||++..++|..+++|..+.... ..+++..|.+.|..|...+| +..+. .+...+..+.+++|++|..+..
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~-s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCC-CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 379999998999999999876533 35678889988887742222 11111 2345677889999998754321
Q ss_pred ---h----------hcC----C---CCCCCCHH-------------------HHHHHHHHHHHHHHHHHh----CCCCCe
Q 017558 288 ---H----------LHG----K---DRPVMNWP-------------------TRMKIALGSARGLAYLHE----DCQPKI 324 (369)
Q Consensus 288 ---~----------l~~----~---~~~~l~~~-------------------~~~~i~~~i~~~l~yLH~----~~~~~i 324 (369)
. +|. . .+..+++. ....+...+...++.+.. ....++
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 0 010 0 01111111 111122222333333322 234578
Q ss_pred eecCCCCCcEEECCCCcEEEeeeccceee
Q 017558 325 IHRDIKSANILLDDSFEAKVADFGLAKHS 353 (369)
Q Consensus 325 vHrdlk~~Nill~~~~~~ki~DFGla~~~ 353 (369)
||+|+.+.|||++++ ..++||+-|...
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~g 221 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARNG 221 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCEE
T ss_pred ecCCCCcccEEEeCC--ceEEechhcccC
Confidence 999999999999754 468999988764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.42 E-value=0.00025 Score=64.53 Aligned_cols=73 Identities=16% Similarity=0.145 Sum_probs=49.3
Q ss_pred cceecccCceEEEEEEEcCC--------eEEEEEeeccCCcccHHHHHHHHHHHHhcC-CCccccEeeEEEeCCeeEEEE
Q 017558 207 ANLLGQGGFGYVHKGVLTNG--------KVVAIKQLKAGSGQGEREFQAEIEIISQVH-HRHLVSLVGYCTFGSQRLLVY 277 (369)
Q Consensus 207 ~~~lg~G~fg~Vy~~~~~~~--------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~ 277 (369)
.+.|+.|-.=.+|++...++ +.|.+++.. .. ....+..+|..+++.+. +.-..+++++|.+ .+||
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Cc-chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 45688888888999986543 456666554 22 22345678888888875 4445677777742 6899
Q ss_pred EecCCCcH
Q 017558 278 EFVPNKTL 285 (369)
Q Consensus 278 e~~~~g~L 285 (369)
||+++..|
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEeccccC
Confidence 99987554
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.21 E-value=0.0014 Score=57.18 Aligned_cols=158 Identities=12% Similarity=0.080 Sum_probs=83.3
Q ss_pred cCHHHHHHhhcCCcccce-----ecccCceEEEEEEEcCCeEEEEEeeccCCcccHHHHHHHHHHHHhcCCCc--cccEe
Q 017558 192 FTYEELKIATDNFSEANL-----LGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRH--LVSLV 264 (369)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~-----lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~ 264 (369)
.+.+++.....+|.+++. |..|--=..|+.+..+|+ +++|++.... ..+++..|+++|..+...+ +...+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccc
Confidence 345677777778876544 335555678998876654 8889886532 2245556676666653211 11111
Q ss_pred e------EEEeCCeeEEEEEecCCCcHhhh--------------hcC--C--C----CCCCCH-----------------
Q 017558 265 G------YCTFGSQRLLVYEFVPNKTLEFH--------------LHG--K--D----RPVMNW----------------- 299 (369)
Q Consensus 265 g------~~~~~~~~~lv~e~~~~g~L~~~--------------l~~--~--~----~~~l~~----------------- 299 (369)
- +.........++.++.+...... ++. . . .....+
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 1 12234566777777766443210 000 0 0 000000
Q ss_pred HHHHHHHHHHHHHHHHHH-hCCCCCeeecCCCCCcEEECCCCcEEEeeecccee
Q 017558 300 PTRMKIALGSARGLAYLH-EDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (369)
Q Consensus 300 ~~~~~i~~~i~~~l~yLH-~~~~~~ivHrdlk~~Nill~~~~~~ki~DFGla~~ 352 (369)
......+..+...+.-.+ .....++||+|+.+.||+++.+...-|+||+.|..
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 001111112222222222 12345799999999999999887778999998864
|